*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 53 SER^? 12.21 OXT ACT A1182 A 524 ASP A 55 ASP.? 17.41 O ACT A1181 A 556 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 A 445 SER B 53 SER^? 12.05 O ACT C1183 A 524 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 556 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 A 445 SER C 53 SER^? 12.05 OXT ACT C1183 A 524 ASP C 55 ASP.? 19.45 CA CA C1184 A 556 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 4 3 # 4 A 445 SER D 53 SER^? 12.18 O ACT A1182 A 524 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 556 HIS D 114 HIS^? 15.97 O ACT A1182 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -34.02 -15.52 17.15 -35.80 -16.25 16.32 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 4 hits 3o4g_o00 naa= 3 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 1 3 # 1 A 29 ASP A 144 ASP.? 22.46 O ACT A1181 A 117 LYS A 35 LYS~? 23.91 O ACT A1181 A 150 CYH A 145 CYH.? 18.06 O ACT A1181 coo 37.97 47.82 5.46 38.65 48.02 7.40 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 41.02 51.33 13.36 40.18 47.06 9.99 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo 39.17 42.30 8.54 40.94 44.26 7.78 -28.16 21.72 2.56 -30.09 23.43 3.54 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 2 3 # 2 A 29 ASP B 144 ASP.? 6.66 CA CA B1183 A 117 LYS B 35 LYS~? 11.04 CA CA B1183 A 150 CYH B 145 CYH.? 5.45 CA CA B1183 coo 37.97 47.82 5.46 38.65 48.02 7.40 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 41.02 51.33 13.36 40.18 47.06 9.99 -68.46 9.78 -10.58 -72.55 6.75 -11.95 coo 39.17 42.30 8.54 40.94 44.26 7.78 -62.49 1.50 -10.58 -60.97 -0.38 -12.04 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 3 3 # 3 A 29 ASP C 144 ASP.? 6.69 CA CA C1184 A 117 LYS C 35 LYS~? 10.20 CA CA C1184 A 150 CYH C 145 CYH.? 5.42 CA CA C1184 coo 37.97 47.82 5.46 38.65 48.02 7.40 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 41.02 51.33 13.36 40.18 47.06 9.99 -68.45 -9.84 37.00 -72.38 -5.53 38.73 coo 39.17 42.30 8.54 40.94 44.26 7.78 -62.51 -1.53 37.02 -61.06 0.37 38.52 ULMN 3 3uao_o00 PUTATIVE ISOCHORISMATASE user 4 3 # 4 A 29 ASP D 144 ASP.? 22.37 O2 GOL D1181 A 117 LYS D 35 LYS~? 23.81 O2 GOL D1181 A 150 CYH D 145 CYH.? 17.92 O2 GOL D1181 coo 37.97 47.82 5.46 38.65 48.02 7.40 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 41.02 51.33 13.36 40.18 47.06 9.99 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo 39.17 42.30 8.54 40.94 44.26 7.78 -28.17 -21.73 23.90 -30.12 -23.42 22.95 3uao_o00 source 3UAO PUTATIVE ISOCHORISMATASE : 4 hits 3uao_o00 naa= 3 ULMN 5 1gdh_c00 D-GLYCERATE DEHYDROGENASE (APO FORM)user 1 5 # 1 A 240 ARG A 58 ARG~? 14.46 O ACT A1181 A 242 ASP A 55 ASP.? 17.41 O ACT A1181 A 264 ASP A 152 ASP.? 5.90 O ACT A1181 A 269 GLU A 150 GLU.? 17.29 O ACT A1181 A 287 HIS A 151 HIS.? 15.84 O ACT A1181 coo 17.36 8.35 16.57 16.96 6.04 18.54 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 21.36 6.05 14.95 19.24 5.81 14.80 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 21.49 19.11 18.39 20.81 19.66 20.29 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 23.48 10.69 22.39 22.24 12.31 21.83 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 20.16 15.49 22.94 18.67 14.36 21.99 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 5 1gdh_c00 D-GLYCERATE DEHYDROGENASE (APO FORM)user 2 5 # 2 A 240 ARG B 58 ARG~? 12.97 O3 GOL B1182 A 242 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 264 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 269 GLU B 150 GLU.? 13.13 O3 GOL B1182 A 287 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 17.36 8.35 16.57 16.96 6.04 18.54 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 21.36 6.05 14.95 19.24 5.81 14.80 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 21.49 19.11 18.39 20.81 19.66 20.29 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 23.48 10.69 22.39 22.24 12.31 21.83 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 20.16 15.49 22.94 18.67 14.36 21.99 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 5 1gdh_c00 D-GLYCERATE DEHYDROGENASE (APO FORM)user 3 5 # 3 A 240 ARG C 58 ARG~? 18.42 O3 GOL D1181 A 242 ASP C 55 ASP.? 19.45 CA CA C1184 A 264 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 269 GLU C 150 GLU.? 16.95 CA CA C1184 A 287 HIS C 151 HIS.? 19.99 CA CA C1184 coo 17.36 8.35 16.57 16.96 6.04 18.54 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 21.36 6.05 14.95 19.24 5.81 14.80 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 21.49 19.11 18.39 20.81 19.66 20.29 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 23.48 10.69 22.39 22.24 12.31 21.83 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 20.16 15.49 22.94 18.67 14.36 21.99 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 5 1gdh_c00 D-GLYCERATE DEHYDROGENASE (APO FORM)user 4 5 # 4 A 240 ARG D 58 ARG~? 14.52 O2 GOL D1181 A 242 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 264 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 269 GLU D 150 GLU.? 17.20 O2 GOL D1181 A 287 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 17.36 8.35 16.57 16.96 6.04 18.54 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 21.36 6.05 14.95 19.24 5.81 14.80 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 21.49 19.11 18.39 20.81 19.66 20.29 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 23.48 10.69 22.39 22.24 12.31 21.83 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 20.16 15.49 22.94 18.67 14.36 21.99 -45.79 -27.28 22.21 -45.52 -27.23 20.13 1gdh_c00 source 1gdh D-GLYCERATE DEHYDROGENASE (APO FORM) (E.C.1.1.: 4 hits 1gdh_c00 naa= 5 ULMN 5 1gdh_c01 D-GLYCERATE DEHYDROGENASE (APO FORM)user 1 5 # 1 B 240 ARG A 58 ARG~? 14.46 O ACT A1181 B 242 ASP A 55 ASP.? 17.41 O ACT A1181 B 264 ASP A 152 ASP.? 5.90 O ACT A1181 B 269 GLU A 150 GLU.? 17.29 O ACT A1181 B 287 HIS A 151 HIS.? 15.84 O ACT A1181 coo 32.06 52.83 17.17 34.90 53.72 17.93 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 33.52 53.25 23.28 32.78 54.06 21.46 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 29.98 41.40 17.79 31.11 40.78 16.13 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 37.72 45.90 19.85 36.33 45.31 18.40 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 34.65 43.41 15.42 33.80 45.28 15.03 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 5 1gdh_c01 D-GLYCERATE DEHYDROGENASE (APO FORM)user 2 5 # 2 B 240 ARG B 58 ARG~? 12.97 O3 GOL B1182 B 242 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 264 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 269 GLU B 150 GLU.? 13.13 O3 GOL B1182 B 287 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 32.06 52.83 17.17 34.90 53.72 17.93 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 33.52 53.25 23.28 32.78 54.06 21.46 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 29.98 41.40 17.79 31.11 40.78 16.13 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 37.72 45.90 19.85 36.33 45.31 18.40 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 34.65 43.41 15.42 33.80 45.28 15.03 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 5 1gdh_c01 D-GLYCERATE DEHYDROGENASE (APO FORM)user 3 5 # 3 B 240 ARG C 58 ARG~? 18.42 O3 GOL D1181 B 242 ASP C 55 ASP.? 19.45 CA CA C1184 B 264 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 269 GLU C 150 GLU.? 16.95 CA CA C1184 B 287 HIS C 151 HIS.? 19.99 CA CA C1184 coo 32.06 52.83 17.17 34.90 53.72 17.93 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 33.52 53.25 23.28 32.78 54.06 21.46 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 29.98 41.40 17.79 31.11 40.78 16.13 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 37.72 45.90 19.85 36.33 45.31 18.40 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 34.65 43.41 15.42 33.80 45.28 15.03 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 5 1gdh_c01 D-GLYCERATE DEHYDROGENASE (APO FORM)user 4 5 # 4 B 240 ARG D 58 ARG~? 14.52 O2 GOL D1181 B 242 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 264 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 269 GLU D 150 GLU.? 17.20 O2 GOL D1181 B 287 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 32.06 52.83 17.17 34.90 53.72 17.93 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 33.52 53.25 23.28 32.78 54.06 21.46 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 29.98 41.40 17.79 31.11 40.78 16.13 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 37.72 45.90 19.85 36.33 45.31 18.40 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 34.65 43.41 15.42 33.80 45.28 15.03 -45.79 -27.28 22.21 -45.52 -27.23 20.13 1gdh_c01 source 1gdh D-GLYCERATE DEHYDROGENASE (APO FORM) (E.C.1.1.: 4 hits 1gdh_c01 naa= 5 ULMN 4 1am5_c05 PEPSIN user 1 4 # 1 32 ASP A 84 ASP^? 7.98 OXT ACT A1182 35 SER A 88 SER.? 4.86 OXT ACT A1182 75 TYR A 91 TYR.? 11.44 OXT ACT A1182 215 ASP D 84 ASP^? 8.02 O ACT A1182 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -36.44 3.40 10.01 -38.05 4.61 10.68 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -34.67 3.69 16.47 -32.74 5.08 16.23 coo -13.30 2.78 144.49 -12.77 1.96 147.02 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 4 1am5_c05 PEPSIN user 2 4 # 2 32 ASP B 84 ASP^? 7.80 O ACT C1183 35 SER B 88 SER.? 4.64 O ACT C1183 75 TYR B 91 TYR.? 11.41 O ACT C1183 215 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -54.22 1.68 8.96 -52.58 0.65 8.12 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo -13.30 2.78 144.49 -12.77 1.96 147.02 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 4 1am5_c05 PEPSIN user 3 4 # 3 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 35 SER C 88 SER.? 4.69 OXT ACT C1183 75 TYR C 91 TYR.? 11.38 OXT ACT C1183 215 ASP B 84 ASP^? 7.80 O ACT C1183 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -56.10 4.45 15.54 -58.39 5.12 16.05 coo -13.30 2.78 144.49 -12.77 1.96 147.02 -54.93 7.42 20.88 -53.88 7.33 23.48 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 4 1am5_c05 PEPSIN user 4 4 # 4 32 ASP D 84 ASP^? 8.02 O ACT A1182 35 SER D 88 SER.? 4.67 O ACT A1182 75 TYR D 91 TYR.? 11.52 O ACT A1182 215 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo -13.30 2.78 144.49 -12.77 1.96 147.02 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -36.44 3.40 10.01 -38.05 4.61 10.68 1am5_c05 source 1am5 PEPSIN : 4 hits 1am5_c05 naa= 4 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 A 232 GLU A 121 GLU~? 23.87 OXT ACT A1182 A 280 GLU A 139 GLU.? 21.64 O ACT A1181 A 283 LYS A 117 LYS.? 20.14 O ACT A1181 A 288 GLU A 119 GLU.? 19.75 OXT ACT A1182 coo 5.76 85.47 37.35 6.76 85.56 39.24 -33.98 22.68 21.15 -32.78 23.95 19.94 coo 4.25 95.66 42.75 4.18 93.57 42.69 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 9.66 95.18 46.95 8.19 90.97 44.00 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 13.49 92.75 43.16 12.39 91.15 42.33 -40.83 18.78 13.92 -42.39 17.53 13.21 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 2 4 # 2 A 232 GLU B 121 GLU~? 20.57 CA CA B1183 A 280 GLU B 139 GLU.? 13.29 O3 GOL B1182 A 283 LYS B 117 LYS.? 17.47 O3 GOL B1182 A 288 GLU B 119 GLU.? 18.74 O3 GOL B1182 coo 5.76 85.47 37.35 6.76 85.56 39.24 -56.51 -16.27 -4.35 -57.29 -15.23 -6.03 coo 4.25 95.66 42.75 4.18 93.57 42.69 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 9.66 95.18 46.95 8.19 90.97 44.00 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 13.49 92.75 43.16 12.39 91.15 42.33 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 3 4 # 3 A 232 GLU D 121 GLU~? 23.78 O ACT A1182 A 280 GLU D 139 GLU.? 21.84 O2 GOL D1181 A 283 LYS D 117 LYS.? 19.88 O2 GOL D1181 A 288 GLU D 119 GLU.? 19.65 O ACT A1182 coo 5.76 85.47 37.35 6.76 85.56 39.24 -33.90 -22.59 5.14 -32.85 -23.80 6.52 coo 4.25 95.66 42.75 4.18 93.57 42.69 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 9.66 95.18 46.95 8.19 90.97 44.00 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 13.49 92.75 43.16 12.39 91.15 42.33 -40.78 -18.80 12.54 -42.26 -17.44 13.18 1aq0_c00 source 1aq0 1,3-1,4-BETA-GLUCANASE : 3 hits 1aq0_c00 naa= 4 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 B 232 GLU A 121 GLU~? 23.87 OXT ACT A1182 B 280 GLU A 139 GLU.? 21.64 O ACT A1181 B 283 LYS A 117 LYS.? 20.14 O ACT A1181 B 288 GLU A 119 GLU.? 19.75 OXT ACT A1182 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -33.98 22.68 21.15 -32.78 23.95 19.94 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -34.64 27.04 8.52 -35.38 28.56 9.82 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 -38.62 20.41 10.01 -44.40 21.40 11.23 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -40.83 18.78 13.92 -42.39 17.53 13.21 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 2 4 # 2 B 232 GLU B 121 GLU~? 20.57 CA CA B1183 B 280 GLU B 139 GLU.? 13.29 O3 GOL B1182 B 283 LYS B 117 LYS.? 17.47 O3 GOL B1182 B 288 GLU B 119 GLU.? 18.74 O3 GOL B1182 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -56.51 -16.27 -4.35 -57.29 -15.23 -6.03 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 3 4 # 3 B 232 GLU D 121 GLU~? 23.78 O ACT A1182 B 280 GLU D 139 GLU.? 21.84 O2 GOL D1181 B 283 LYS D 117 LYS.? 19.88 O2 GOL D1181 B 288 GLU D 119 GLU.? 19.65 O ACT A1182 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -33.90 -22.59 5.14 -32.85 -23.80 6.52 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -40.78 -18.80 12.54 -42.26 -17.44 13.18 1aq0_c01 source 1aq0 1,3-1,4-BETA-GLUCANASE : 3 hits 1aq0_c01 naa= 4 ULMN 4 1bbs_c02 RENIN user 1 4 # 1 32 ASP A 84 ASP^? 7.98 OXT ACT A1182 35 SER A 88 SER.? 4.86 OXT ACT A1182 215 ASP D 84 ASP^? 8.02 O ACT A1182 218 ALA D 87 ALA.? 6.96 O ACT A1182 coo 61.19 45.85 78.73 62.86 45.48 77.48 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 66.00 46.17 80.29 64.31 47.92 79.91 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 63.61 40.10 74.06 64.05 42.07 74.70 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 61.04 42.48 71.22 62.11 41.40 71.19 -37.91 -4.38 11.75 -38.33 -3.29 12.71 ULMN 4 1bbs_c02 RENIN user 2 4 # 2 32 ASP B 84 ASP^? 7.80 O ACT C1183 35 SER B 88 SER.? 4.64 O ACT C1183 215 ASP C 84 ASP^? 7.78 OXT ACT C1183 218 ALA C 87 ALA.? 6.87 OXT ACT C1183 coo 61.19 45.85 78.73 62.86 45.48 77.48 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 66.00 46.17 80.29 64.31 47.92 79.91 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 63.61 40.10 74.06 64.05 42.07 74.70 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 61.04 42.48 71.22 62.11 41.40 71.19 -52.69 3.10 16.59 -52.21 1.83 15.91 ULMN 4 1bbs_c02 RENIN user 3 4 # 3 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 35 SER C 88 SER.? 4.69 OXT ACT C1183 215 ASP B 84 ASP^? 7.80 O ACT C1183 218 ALA B 87 ALA.? 6.83 O ACT C1183 coo 61.19 45.85 78.73 62.86 45.48 77.48 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 66.00 46.17 80.29 64.31 47.92 79.91 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 63.61 40.10 74.06 64.05 42.07 74.70 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 61.04 42.48 71.22 62.11 41.40 71.19 -52.69 -3.08 9.85 -52.24 -1.81 10.51 ULMN 4 1bbs_c02 RENIN user 4 4 # 4 32 ASP D 84 ASP^? 8.02 O ACT A1182 35 SER D 88 SER.? 4.67 O ACT A1182 215 ASP A 84 ASP^? 7.98 OXT ACT A1182 218 ALA A 87 ALA.? 6.96 OXT ACT A1182 coo 61.19 45.85 78.73 62.86 45.48 77.48 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 66.00 46.17 80.29 64.31 47.92 79.91 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 63.61 40.10 74.06 64.05 42.07 74.70 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 61.04 42.48 71.22 62.11 41.40 71.19 -37.93 4.41 14.70 -38.35 3.33 13.74 1bbs_c02 source 1bbs RENIN : 4 hits 1bbs_c02 naa= 4 ULMN 4 1bbs_c03 RENIN user 1 4 # 1 32 ASP A 84 ASP^? 7.98 OXT ACT A1182 35 SER A 88 SER.? 4.86 OXT ACT A1182 215 ASP D 84 ASP^? 8.02 O ACT A1182 218 ALA D 87 ALA.? 6.96 O ACT A1182 coo 61.19 45.85 78.73 62.86 45.48 77.48 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 66.00 46.17 80.29 64.31 47.92 79.91 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 63.61 40.10 74.06 64.05 42.07 74.70 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 61.04 42.48 71.22 62.11 41.40 71.19 -37.91 -4.38 11.75 -38.33 -3.29 12.71 ULMN 4 1bbs_c03 RENIN user 2 4 # 2 32 ASP B 84 ASP^? 7.80 O ACT C1183 35 SER B 88 SER.? 4.64 O ACT C1183 215 ASP C 84 ASP^? 7.78 OXT ACT C1183 218 ALA C 87 ALA.? 6.87 OXT ACT C1183 coo 61.19 45.85 78.73 62.86 45.48 77.48 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 66.00 46.17 80.29 64.31 47.92 79.91 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 63.61 40.10 74.06 64.05 42.07 74.70 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 61.04 42.48 71.22 62.11 41.40 71.19 -52.69 3.10 16.59 -52.21 1.83 15.91 ULMN 4 1bbs_c03 RENIN user 3 4 # 3 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 35 SER C 88 SER.? 4.69 OXT ACT C1183 215 ASP B 84 ASP^? 7.80 O ACT C1183 218 ALA B 87 ALA.? 6.83 O ACT C1183 coo 61.19 45.85 78.73 62.86 45.48 77.48 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 66.00 46.17 80.29 64.31 47.92 79.91 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 63.61 40.10 74.06 64.05 42.07 74.70 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 61.04 42.48 71.22 62.11 41.40 71.19 -52.69 -3.08 9.85 -52.24 -1.81 10.51 ULMN 4 1bbs_c03 RENIN user 4 4 # 4 32 ASP D 84 ASP^? 8.02 O ACT A1182 35 SER D 88 SER.? 4.67 O ACT A1182 215 ASP A 84 ASP^? 7.98 OXT ACT A1182 218 ALA A 87 ALA.? 6.96 OXT ACT A1182 coo 61.19 45.85 78.73 62.86 45.48 77.48 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 66.00 46.17 80.29 64.31 47.92 79.91 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 63.61 40.10 74.06 64.05 42.07 74.70 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 61.04 42.48 71.22 62.11 41.40 71.19 -37.93 4.41 14.70 -38.35 3.33 13.74 1bbs_c03 source 1bbs RENIN : 4 hits 1bbs_c03 naa= 4 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 1 4 # 1 A 325 ASP D 14 ASP~? 14.81 O1 GOL D1181 A 354 GLU D 10 GLU~? 18.53 CA CA C1181 A 356 TRP D 7 TRP~? 13.25 CA CA C1181 A 421 ASP D 6 ASP~? 16.12 CA CA C1181 coo 31.05 49.37 64.51 31.97 51.11 63.85 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 29.07 50.42 58.36 29.02 52.18 59.49 -62.08 -25.49 39.96 -63.41 -27.01 39.21 coo 32.40 51.51 54.93 28.61 52.36 55.13 -64.48 -23.47 34.59 -63.03 -20.04 33.30 coo 30.82 59.76 58.47 31.12 59.02 60.40 -69.27 -22.53 40.17 -70.96 -22.24 41.39 1bvz_c02 source 1bvz ALPHA-AMYLASE II : 1 hits 1bvz_c02 naa= 4 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 1 4 # 1 A 149 PHE A 90 PHE.? 6.14 OXT ACT A1182 A 215 SER A 99 SER~? 12.20 OXT ACT A1182 A 218 THR A 102 THR~? 11.01 OXT ACT A1182 A 255 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 44.60 28.41 9.39 42.46 29.45 10.83 -29.59 4.57 18.91 -28.81 1.88 19.12 coo 38.32 30.82 8.35 40.14 29.77 7.21 -27.81 9.50 21.53 -30.13 10.20 21.65 coo 39.65 24.77 7.41 41.19 24.89 8.93 -24.41 5.58 21.31 -25.97 4.66 22.51 coo 36.63 36.86 14.86 40.52 38.40 10.14 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 2 4 # 2 A 149 PHE A 134 PHE^? 18.18 O ACT A1181 A 215 SER A 133 SER^? 18.22 CH3 ACT A1182 A 218 THR A 40 THR~? 17.59 CH3 ACT A1182 A 255 LYS A 142 LYS.? 21.46 CH3 ACT A1182 coo 44.60 28.41 9.39 42.46 29.45 10.83 -28.37 13.63 1.61 -29.29 13.61 -1.07 coo 38.32 30.82 8.35 40.14 29.77 7.21 -25.30 14.53 6.77 -25.42 16.79 7.63 coo 39.65 24.77 7.41 41.19 24.89 8.93 -23.93 10.90 -0.33 -25.94 11.33 0.34 coo 36.63 36.86 14.86 40.52 38.40 10.14 -25.15 24.34 9.11 -21.81 19.66 9.96 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 3 4 # 3 A 149 PHE B 90 PHE.? 6.30 O ACT C1183 A 215 SER B 99 SER~? 12.12 O ACT C1183 A 218 THR B 102 THR~? 11.18 CH3 ACT C1183 A 255 LYS B 93 LYS.? 14.57 O ACT C1183 coo 44.60 28.41 9.39 42.46 29.45 10.83 -61.00 -7.10 11.28 -61.80 -6.20 13.81 coo 38.32 30.82 8.35 40.14 29.77 7.21 -62.79 -11.40 7.59 -60.42 -11.55 7.06 coo 39.65 24.77 7.41 41.19 24.89 8.93 -66.17 -9.62 11.24 -64.70 -10.41 12.61 coo 36.63 36.86 14.86 40.52 38.40 10.14 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 4 4 # 4 A 149 PHE B 134 PHE^? 10.29 O2 GOL B1182 A 215 SER B 133 SER^? 12.08 CA CA B1183 A 218 THR B 40 THR~? 13.23 O2 GOL B1182 A 255 LYS B 130 LYS.? 19.82 CH3 ACT C1183 coo 44.60 28.41 9.39 42.46 29.45 10.83 -62.26 5.34 -3.80 -61.37 7.78 -4.90 coo 38.32 30.82 8.35 40.14 29.77 7.21 -65.35 0.26 -2.64 -65.36 -1.24 -4.55 coo 39.65 24.77 7.41 41.19 24.89 8.93 -66.85 8.08 -2.24 -64.82 7.37 -2.52 coo 36.63 36.86 14.86 40.52 38.40 10.14 -71.06 -6.27 -2.00 -70.24 -10.95 -0.22 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 5 4 # 5 A 149 PHE B 134 PHE^? 10.29 O2 GOL B1182 A 215 SER B 133 SER^? 12.08 CA CA B1183 A 218 THR B 40 THR~? 13.23 O2 GOL B1182 A 255 LYS B 142 LYS.? 10.67 CA CA B1183 coo 44.60 28.41 9.39 42.46 29.45 10.83 -62.26 5.34 -3.80 -61.37 7.78 -4.90 coo 38.32 30.82 8.35 40.14 29.77 7.21 -65.35 0.26 -2.64 -65.36 -1.24 -4.55 coo 39.65 24.77 7.41 41.19 24.89 8.93 -66.85 8.08 -2.24 -64.82 7.37 -2.52 coo 36.63 36.86 14.86 40.52 38.40 10.14 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 6 4 # 6 A 149 PHE C 90 PHE.? 6.24 OXT ACT C1183 A 215 SER C 99 SER~? 11.91 OXT ACT C1183 A 218 THR C 102 THR~? 11.11 OXT ACT C1183 A 255 LYS C 93 LYS.? 19.61 OXT ACT C1183 coo 44.60 28.41 9.39 42.46 29.45 10.83 -61.01 7.09 15.23 -61.82 6.22 12.71 coo 38.32 30.82 8.35 40.14 29.77 7.21 -62.74 11.40 18.89 -60.36 11.40 19.38 coo 39.65 24.77 7.41 41.19 24.89 8.93 -66.13 9.63 15.26 -64.66 10.40 13.87 coo 36.63 36.86 14.86 40.52 38.40 10.14 -54.93 14.23 21.55 -53.38 19.08 19.32 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 7 4 # 7 A 149 PHE C 134 PHE^? 13.25 CA CA C1184 A 215 SER C 133 SER^? 12.04 CA CA C1184 A 218 THR C 40 THR~? 15.04 CA CA C1184 A 255 LYS C 130 LYS.? 19.26 CH3 ACT C1183 coo 44.60 28.41 9.39 42.46 29.45 10.83 -62.23 -5.37 30.24 -61.37 -7.83 31.34 coo 38.32 30.82 8.35 40.14 29.77 7.21 -65.34 -0.23 29.09 -65.38 1.19 31.06 coo 39.65 24.77 7.41 41.19 24.89 8.93 -66.85 -8.05 28.72 -64.85 -7.34 28.99 coo 36.63 36.86 14.86 40.52 38.40 10.14 -71.03 6.26 28.36 -70.68 9.47 26.70 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 8 4 # 8 A 149 PHE C 134 PHE^? 13.25 CA CA C1184 A 215 SER C 133 SER^? 12.04 CA CA C1184 A 218 THR C 40 THR~? 15.04 CA CA C1184 A 255 LYS C 142 LYS.? 12.38 CA CA C1184 coo 44.60 28.41 9.39 42.46 29.45 10.83 -62.23 -5.37 30.24 -61.37 -7.83 31.34 coo 38.32 30.82 8.35 40.14 29.77 7.21 -65.34 -0.23 29.09 -65.38 1.19 31.06 coo 39.65 24.77 7.41 41.19 24.89 8.93 -66.85 -8.05 28.72 -64.85 -7.34 28.99 coo 36.63 36.86 14.86 40.52 38.40 10.14 -64.58 4.07 38.03 -66.58 4.11 31.93 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 9 4 # 9 A 149 PHE D 90 PHE.? 6.22 O ACT A1182 A 215 SER D 99 SER~? 12.19 O ACT A1182 A 218 THR D 102 THR~? 11.03 O ACT A1182 A 255 LYS D 93 LYS.? 12.21 O ACT A1182 coo 44.60 28.41 9.39 42.46 29.45 10.83 -29.59 -4.57 7.52 -28.77 -1.89 7.30 coo 38.32 30.82 8.35 40.14 29.77 7.21 -27.80 -9.54 4.93 -30.15 -10.16 4.86 coo 39.65 24.77 7.41 41.19 24.89 8.93 -24.39 -5.56 5.17 -25.97 -4.66 3.97 coo 36.63 36.86 14.86 40.52 38.40 10.14 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 4 1d3g_c01 DIHYDROOROTATE DEHYDROGENASE user 10 4 # 10 A 149 PHE D 134 PHE^? 17.04 O3 GOL D1181 A 215 SER D 133 SER^? 18.24 CH3 ACT A1182 A 218 THR D 40 THR~? 17.62 CH3 ACT A1182 A 255 LYS D 130 LYS.? 19.81 CH3 ACT A1182 coo 44.60 28.41 9.39 42.46 29.45 10.83 -28.39 -13.60 24.85 -29.22 -13.68 27.54 coo 38.32 30.82 8.35 40.14 29.77 7.21 -25.30 -14.52 19.70 -25.48 -16.79 18.86 coo 39.65 24.77 7.41 41.19 24.89 8.93 -23.95 -10.93 26.82 -25.97 -11.31 26.17 coo 36.63 36.86 14.86 40.52 38.40 10.14 -19.48 -16.44 13.55 -20.26 -16.74 8.72 1d3g_c01 source 1d3g DIHYDROOROTATE DEHYDROGENASE : 10 hits 1d3g_c01 naa= 4 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 1 4 # 1 A 132 GLU A 29 GLU~? 11.10 O ACT A1181 A 136 ARG A 30 ARG.? 15.23 O ACT A1181 A 275 ASP A 144 ASP.? 22.46 O ACT A1181 A 435 GLU A 140 GLU.? 22.35 O ACT A1181 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo -4.99 57.22 1.82 -7.93 56.43 2.21 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 -24.09 23.13 1.13 -22.88 24.73 0.42 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 -27.69 26.26 5.34 -26.17 27.35 4.33 1dl2_c00 source 1dl2 CLASS I ALPHA-1,2-MANNOSIDASE : 1 hits 1dl2_c00 naa= 4 ULMN 4 1exp_c00 BETA-1,4-D-GLYCANASE CEX-CD user 1 4 # 1 127 GLU C 139 GLU.? 13.61 CA CA C1184 205 HIS C 151 HIS.? 19.99 CA CA C1184 233 GLU C 150 GLU.? 16.95 CA CA C1184 235 ASP C 152 ASP.? 13.45 O3 GOL D1181 coo 21.30 74.05 33.80 19.79 72.64 33.96 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 23.08 64.94 33.21 22.54 65.31 35.19 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 25.12 67.63 37.99 23.29 68.70 37.64 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 24.30 59.55 35.21 23.07 61.13 34.61 -47.03 -4.77 41.79 -47.13 -6.84 42.24 1exp_c00 source 1exp BETA-1,4-D-GLYCANASE CEX-CD : 1 hits 1exp_c00 naa= 4 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 A 231 GLU B 121 GLU~? 20.57 CA CA B1183 A 279 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 282 LYS B 117 LYS.? 17.47 O3 GOL B1182 A 288 GLU B 139 GLU.? 13.29 O3 GOL B1182 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -56.51 -16.27 -4.35 -57.29 -15.23 -6.03 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 4 # 2 A 231 GLU B 121 GLU~? 20.57 CA CA B1183 A 279 GLU B 139 GLU.? 13.29 O3 GOL B1182 A 282 LYS B 117 LYS.? 17.47 O3 GOL B1182 A 288 GLU B 119 GLU.? 18.74 O3 GOL B1182 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -56.51 -16.27 -4.35 -57.29 -15.23 -6.03 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 1ghs_c00 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 2 hits 1ghs_c00 naa= 4 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 B 231 GLU B 121 GLU~? 20.57 CA CA B1183 B 279 GLU B 139 GLU.? 13.29 O3 GOL B1182 B 282 LYS B 117 LYS.? 17.47 O3 GOL B1182 B 288 GLU B 119 GLU.? 18.74 O3 GOL B1182 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -56.51 -16.27 -4.35 -57.29 -15.23 -6.03 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 4 # 2 B 231 GLU D 121 GLU~? 23.78 O ACT A1182 B 279 GLU D 139 GLU.? 21.84 O2 GOL D1181 B 282 LYS D 117 LYS.? 19.88 O2 GOL D1181 B 288 GLU D 119 GLU.? 19.65 O ACT A1182 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -33.90 -22.59 5.14 -32.85 -23.80 6.52 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -40.78 -18.80 12.54 -42.26 -17.44 13.18 1ghs_c01 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 2 hits 1ghs_c01 naa= 4 ULMN 4 1grc_c01 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 4 # 1 B 106 ASN C 63 ASN~? 14.81 O ACT C1183 B 108 HIS D 59 HIS~? 14.28 O ACT A1182 B 135 SER D 56 SER.? 20.40 O ACT A1182 B 144 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 36.64 101.02 13.15 38.55 101.84 12.78 -47.81 -6.22 21.11 -47.01 -7.28 19.44 coo 41.00 107.18 12.86 42.70 107.82 11.96 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 36.51 108.90 17.50 37.10 110.80 16.19 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 31.60 110.69 6.14 29.69 109.74 5.94 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1grc_c01 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 1 hits 1grc_c01 naa= 4 ULMN 4 1i9a_c00 ISOPENTENYL-DIPHOSPHATE DELTA-ISOMERuser 1 4 # 1 A 67 CYH A 145 CYH.? 18.06 O ACT A1181 A 87 GLU A 143 GLU.? 25.89 CH3 ACT A1182 A 116 GLU A 29 GLU~? 11.10 O ACT A1181 A 161 TRP A 136 TRP^? 14.38 O ACT A1181 coo 17.72 23.22 51.52 17.51 22.56 48.78 -28.16 21.72 2.56 -30.09 23.43 3.54 coo 25.03 20.81 51.72 23.17 21.37 50.84 -21.50 21.88 6.93 -19.95 23.25 7.45 coo 10.22 17.99 48.79 12.11 18.91 49.06 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 14.24 25.86 46.74 15.48 22.98 44.36 -31.97 16.13 1.41 -34.31 14.15 -1.08 1i9a_c00 source 1i9a ISOPENTENYL-DIPHOSPHATE DELTA-ISOMERASE : 1 hits 1i9a_c00 naa= 4 ULMN 4 1i9a_c01 ISOPENTENYL-DIPHOSPHATE DELTA-ISOMERuser 1 4 # 1 B1067 CYH A 145 CYH.? 18.06 O ACT A1181 B1087 GLU A 143 GLU.? 25.89 CH3 ACT A1182 B1116 GLU A 29 GLU~? 11.10 O ACT A1181 B1161 TRP A 136 TRP^? 14.38 O ACT A1181 coo 28.43 31.11 20.66 29.36 30.51 23.27 -28.16 21.72 2.56 -30.09 23.43 3.54 coo 25.64 23.94 19.66 26.51 25.64 20.59 -21.50 21.88 6.93 -19.95 23.25 7.45 coo 37.17 33.56 22.85 35.23 32.67 22.82 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 28.72 34.96 26.05 30.26 31.74 27.72 -31.97 16.13 1.41 -34.31 14.15 -1.08 1i9a_c01 source 1i9a ISOPENTENYL-DIPHOSPHATE DELTA-ISOMERASE : 1 hits 1i9a_c01 naa= 4 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 A 481 GLU A 150 GLU.? 17.29 O ACT A1181 A 485 LYS A 117 LYS.? 20.14 O ACT A1181 A 488 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 603 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -43.03 24.31 5.88 -42.80 24.92 7.90 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -38.62 20.41 10.01 -44.40 21.40 11.23 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -40.83 18.78 13.92 -42.39 17.53 13.21 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 4 # 2 A 481 GLU B 150 GLU.? 13.13 O3 GOL B1182 A 485 LYS B 117 LYS.? 17.47 O3 GOL B1182 A 488 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 603 LYS A 72 LYS.? 19.74 O ACT A1182 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 4 # 3 A 481 GLU C 150 GLU.? 16.95 CA CA C1184 A 485 LYS C 117 LYS.? 21.58 CA CA C1184 A 488 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 603 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -48.03 2.43 38.96 -48.57 4.48 38.82 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -51.85 4.98 33.11 -46.06 6.47 33.64 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -49.67 7.91 30.13 -48.14 6.69 29.28 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 4 # 4 A 481 GLU D 150 GLU.? 17.20 O2 GOL D1181 A 485 LYS D 117 LYS.? 19.88 O2 GOL D1181 A 488 GLU D 119 GLU.? 19.65 O ACT A1182 A 603 LYS C 72 LYS.? 18.71 O ACT C1183 coo -7.79 3.39 10.29 -9.01 4.74 9.32 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -51.58 -16.11 13.18 -47.22 -15.59 10.10 1jxa_c01 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 4 hits 1jxa_c01 naa= 4 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 481 GLU A 150 GLU.? 17.29 O ACT A1181 485 LYS A 117 LYS.? 20.14 O ACT A1181 488 GLU A 119 GLU.? 19.75 OXT ACT A1182 603 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 24.49 18.95 6.71 25.16 18.17 4.85 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 21.77 13.74 4.55 26.03 15.07 4.05 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 22.93 13.34 0.22 24.67 14.21 1.12 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 31.74 12.46 -4.74 33.15 13.34 0.17 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 4 # 2 481 GLU B 150 GLU.? 13.13 O3 GOL B1182 485 LYS B 117 LYS.? 17.47 O3 GOL B1182 488 GLU B 119 GLU.? 18.74 O3 GOL B1182 603 LYS A 72 LYS.? 19.74 O ACT A1182 coo 24.49 18.95 6.71 25.16 18.17 4.85 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 21.77 13.74 4.55 26.03 15.07 4.05 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 22.93 13.34 0.22 24.67 14.21 1.12 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 31.74 12.46 -4.74 33.15 13.34 0.17 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 4 # 3 481 GLU C 150 GLU.? 16.95 CA CA C1184 485 LYS C 117 LYS.? 21.58 CA CA C1184 488 GLU C 119 GLU.? 19.60 OXT ACT C1183 603 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 24.49 18.95 6.71 25.16 18.17 4.85 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 21.77 13.74 4.55 26.03 15.07 4.05 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 22.93 13.34 0.22 24.67 14.21 1.12 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 31.74 12.46 -4.74 33.15 13.34 0.17 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 4 # 4 481 GLU D 150 GLU.? 17.20 O2 GOL D1181 485 LYS D 117 LYS.? 19.88 O2 GOL D1181 488 GLU D 119 GLU.? 19.65 O ACT A1182 603 LYS C 72 LYS.? 18.71 O ACT C1183 coo 24.49 18.95 6.71 25.16 18.17 4.85 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 21.77 13.74 4.55 26.03 15.07 4.05 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 22.93 13.34 0.22 24.67 14.21 1.12 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 31.74 12.46 -4.74 33.15 13.34 0.17 -51.58 -16.11 13.18 -47.22 -15.59 10.10 1moq_c00 source 1moq GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 4 hits 1moq_c00 naa= 4 ULMN 4 1mpp_c05 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 4 # 1 32 ASP B 84 ASP^? 7.80 O ACT C1183 35 SER B 88 SER.? 4.64 O ACT C1183 75 TYR B 91 TYR.? 11.41 O ACT C1183 215 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 20.97 14.47 32.28 19.66 15.96 31.62 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 16.04 14.72 33.82 17.27 13.71 31.95 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 15.29 15.16 26.38 15.79 12.61 27.66 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 20.65 22.00 33.80 20.06 20.56 32.39 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 4 1mpp_c05 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 4 # 2 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 35 SER C 88 SER.? 4.69 OXT ACT C1183 75 TYR C 91 TYR.? 11.38 OXT ACT C1183 215 ASP B 84 ASP^? 7.80 O ACT C1183 coo 20.97 14.47 32.28 19.66 15.96 31.62 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 16.04 14.72 33.82 17.27 13.71 31.95 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 15.29 15.16 26.38 15.79 12.61 27.66 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 20.65 22.00 33.80 20.06 20.56 32.39 -54.22 1.68 8.96 -52.58 0.65 8.12 1mpp_c05 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 2 hits 1mpp_c05 naa= 4 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 A 192 LYS D 124 LYS~? 24.78 O ACT A1182 A 268 GLU D 140 GLU.? 20.95 O2 GOL D1181 A 302 SER D 31 SER.? 13.74 O2 GOL D1181 A 399 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 85.01 60.31 56.44 83.15 64.89 56.44 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 71.86 54.60 60.61 70.38 53.71 61.84 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 68.68 62.06 66.08 69.52 59.75 65.97 -28.89 -24.92 29.95 -30.70 -23.38 29.44 coo 66.34 67.16 63.84 67.47 65.57 63.06 -32.61 -23.54 32.68 -33.42 -24.92 31.28 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 A 192 LYS D 124 LYS~? 24.78 O ACT A1182 A 268 GLU D 140 GLU.? 20.95 O2 GOL D1181 A 302 SER D 32 SER~? 19.72 O2 GOL D1181 A 399 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 85.01 60.31 56.44 83.15 64.89 56.44 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 71.86 54.60 60.61 70.38 53.71 61.84 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 68.68 62.06 66.08 69.52 59.75 65.97 -26.01 -22.49 30.36 -24.18 -23.98 29.86 coo 66.34 67.16 63.84 67.47 65.57 63.06 -32.61 -23.54 32.68 -33.42 -24.92 31.28 1o04_c00 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c00 naa= 4 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 C 192 LYS D 124 LYS~? 24.78 O ACT A1182 C 268 GLU D 140 GLU.? 20.95 O2 GOL D1181 C 302 SER D 31 SER.? 13.74 O2 GOL D1181 C 399 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 83.30 16.28 88.61 85.25 11.75 88.79 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 79.88 15.02 74.11 80.06 15.36 72.02 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 87.46 9.36 71.39 86.33 11.53 71.37 -28.89 -24.92 29.95 -30.70 -23.38 29.44 coo 87.65 3.44 72.32 86.49 4.99 73.13 -32.61 -23.54 32.68 -33.42 -24.92 31.28 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 C 192 LYS D 124 LYS~? 24.78 O ACT A1182 C 268 GLU D 140 GLU.? 20.95 O2 GOL D1181 C 302 SER D 32 SER~? 19.72 O2 GOL D1181 C 399 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 83.30 16.28 88.61 85.25 11.75 88.79 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 79.88 15.02 74.11 80.06 15.36 72.02 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 87.46 9.36 71.39 86.33 11.53 71.37 -26.01 -22.49 30.36 -24.18 -23.98 29.86 coo 87.65 3.44 72.32 86.49 4.99 73.13 -32.61 -23.54 32.68 -33.42 -24.92 31.28 1o04_c02 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c02 naa= 4 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 D 192 LYS D 124 LYS~? 24.78 O ACT A1182 D 268 GLU D 140 GLU.? 20.95 O2 GOL D1181 D 302 SER D 31 SER.? 13.74 O2 GOL D1181 D 399 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 51.91 3.68 69.52 49.61 2.30 73.71 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 55.94 16.93 75.09 55.86 19.04 75.37 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 48.09 18.43 80.84 49.40 18.94 78.77 -28.89 -24.92 29.95 -30.70 -23.38 29.44 coo 47.32 15.81 86.19 48.62 15.41 84.58 -32.61 -23.54 32.68 -33.42 -24.92 31.28 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 D 192 LYS D 124 LYS~? 24.78 O ACT A1182 D 268 GLU D 140 GLU.? 20.95 O2 GOL D1181 D 302 SER D 32 SER~? 19.72 O2 GOL D1181 D 399 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 51.91 3.68 69.52 49.61 2.30 73.71 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 55.94 16.93 75.09 55.86 19.04 75.37 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 48.09 18.43 80.84 49.40 18.94 78.77 -26.01 -22.49 30.36 -24.18 -23.98 29.86 coo 47.32 15.81 86.19 48.62 15.41 84.58 -32.61 -23.54 32.68 -33.42 -24.92 31.28 1o04_c03 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c03 naa= 4 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 E 192 LYS D 124 LYS~? 24.78 O ACT A1182 E 268 GLU D 140 GLU.? 20.95 O2 GOL D1181 E 302 SER D 31 SER.? 13.74 O2 GOL D1181 E 399 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 52.46 147.49 107.94 50.14 148.75 103.77 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 57.01 134.41 102.36 57.01 132.29 102.10 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 49.26 132.62 96.59 50.54 132.08 98.67 -28.89 -24.92 29.95 -30.70 -23.38 29.44 coo 48.52 135.25 91.24 49.73 135.67 92.87 -32.61 -23.54 32.68 -33.42 -24.92 31.28 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 E 192 LYS D 124 LYS~? 24.78 O ACT A1182 E 268 GLU D 140 GLU.? 20.95 O2 GOL D1181 E 302 SER D 32 SER~? 19.72 O2 GOL D1181 E 399 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 52.46 147.49 107.94 50.14 148.75 103.77 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 57.01 134.41 102.36 57.01 132.29 102.10 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 49.26 132.62 96.59 50.54 132.08 98.67 -26.01 -22.49 30.36 -24.18 -23.98 29.86 coo 48.52 135.25 91.24 49.73 135.67 92.87 -32.61 -23.54 32.68 -33.42 -24.92 31.28 1o04_c04 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c04 naa= 4 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 F 192 LYS D 124 LYS~? 24.78 O ACT A1182 F 268 GLU D 140 GLU.? 20.95 O2 GOL D1181 F 302 SER D 31 SER.? 13.74 O2 GOL D1181 F 399 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 84.18 136.24 88.80 85.96 140.90 88.66 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 80.72 137.29 103.27 80.90 136.95 105.39 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 87.99 143.28 106.06 86.95 141.03 106.01 -28.89 -24.92 29.95 -30.70 -23.38 29.44 coo 87.94 149.19 105.12 86.87 147.57 104.33 -32.61 -23.54 32.68 -33.42 -24.92 31.28 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 F 192 LYS D 124 LYS~? 24.78 O ACT A1182 F 268 GLU D 140 GLU.? 20.95 O2 GOL D1181 F 302 SER D 32 SER~? 19.72 O2 GOL D1181 F 399 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 84.18 136.24 88.80 85.96 140.90 88.66 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 80.72 137.29 103.27 80.90 136.95 105.39 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 87.99 143.28 106.06 86.95 141.03 106.01 -26.01 -22.49 30.36 -24.18 -23.98 29.86 coo 87.94 149.19 105.12 86.87 147.57 104.33 -32.61 -23.54 32.68 -33.42 -24.92 31.28 1o04_c05 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c05 naa= 4 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 G 192 LYS D 124 LYS~? 24.78 O ACT A1182 G 268 GLU D 140 GLU.? 20.95 O2 GOL D1181 G 302 SER D 31 SER.? 13.74 O2 GOL D1181 G 399 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 56.79 103.91 140.42 58.85 102.76 144.77 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 69.06 110.82 135.59 70.39 112.47 135.16 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 72.18 114.35 144.24 71.25 114.81 141.99 -28.89 -24.92 29.95 -30.70 -23.38 29.44 coo 75.14 110.89 148.28 73.91 110.46 146.63 -32.61 -23.54 32.68 -33.42 -24.92 31.28 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 2 4 # 2 G 192 LYS D 124 LYS~? 24.78 O ACT A1182 G 268 GLU D 140 GLU.? 20.95 O2 GOL D1181 G 302 SER D 32 SER~? 19.72 O2 GOL D1181 G 399 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 56.79 103.91 140.42 58.85 102.76 144.77 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 69.06 110.82 135.59 70.39 112.47 135.16 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 72.18 114.35 144.24 71.25 114.81 141.99 -26.01 -22.49 30.36 -24.18 -23.98 29.86 coo 75.14 110.89 148.28 73.91 110.46 146.63 -32.61 -23.54 32.68 -33.42 -24.92 31.28 1o04_c06 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 2 hits 1o04_c06 naa= 4 ULMN 4 1pya_c00 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 1 4 # 1 A 62 TYR C 175 TYR~? 10.79 CA CA C1181 E 81 SER C 172 SER~? 11.19 CA CA C1181 F 195 PHE C 166 PHE~? 15.64 CA CA C1181 F 197 GLU C 167 GLU~? 15.18 C1 GOL D1181 coo 21.01 117.52 52.05 23.52 118.14 53.02 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 26.04 111.43 51.39 26.10 113.09 53.23 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 24.21 105.21 44.37 26.00 103.45 43.24 -60.33 -11.66 28.96 -62.13 -10.76 26.98 coo 21.61 104.53 49.23 23.55 104.37 50.08 -56.84 -16.73 27.22 -55.09 -16.98 26.08 ULMN 4 1pya_c00 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 2 4 # 2 A 62 TYR D 175 TYR.? 24.43 OXT ACT A1182 E 81 SER D 172 SER~? 19.02 O3 GOL D1181 F 195 PHE D 166 PHE~? 16.66 O3 GOL D1181 F 197 GLU D 167 GLU~? 14.12 O3 GOL D1181 coo 21.01 117.52 52.05 23.52 118.14 53.02 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 26.04 111.43 51.39 26.10 113.09 53.23 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 24.21 105.21 44.37 26.00 103.45 43.24 -30.33 -9.93 30.20 -28.59 -8.35 28.64 coo 21.61 104.53 49.23 23.55 104.37 50.08 -33.98 -6.43 34.19 -35.73 -5.26 33.93 1pya_c00 source 1pya PYRUVOYL-DEPENDENT HISTIDINE DECARBOXYLASE : 2 hits 1pya_c00 naa= 4 ULMN 4 1pya_c01 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 1 4 # 1 A 81 SER B 172 SER~? 11.09 CA CA B1181 B 195 PHE B 166 PHE~? 13.46 C3 GOL B1182 B 197 GLU B 167 GLU~? 15.72 O ACT A1181 C 62 TYR B 175 TYR~? 10.51 CA CA B1181 coo 33.85 117.83 62.00 33.48 115.65 62.93 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 34.74 126.89 58.64 35.76 127.46 56.11 -60.35 11.65 -2.48 -62.14 10.72 -0.50 coo 29.77 125.13 60.32 30.09 123.64 58.88 -56.85 16.74 -0.78 -55.11 17.01 0.42 coo 34.01 116.98 69.72 34.94 114.70 68.46 -65.36 23.11 4.03 -63.61 22.29 6.06 ULMN 4 1pya_c01 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 2 4 # 2 A 81 SER C 172 SER~? 11.19 CA CA C1181 B 195 PHE C 166 PHE~? 15.64 CA CA C1181 B 197 GLU C 167 GLU~? 15.18 C1 GOL D1181 C 62 TYR C 175 TYR~? 10.79 CA CA C1181 coo 33.85 117.83 62.00 33.48 115.65 62.93 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 34.74 126.89 58.64 35.76 127.46 56.11 -60.33 -11.66 28.96 -62.13 -10.76 26.98 coo 29.77 125.13 60.32 30.09 123.64 58.88 -56.84 -16.73 27.22 -55.09 -16.98 26.08 coo 34.01 116.98 69.72 34.94 114.70 68.46 -65.38 -23.09 22.41 -63.58 -22.29 20.40 ULMN 4 1pya_c01 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 3 4 # 3 A 81 SER D 172 SER~? 19.02 O3 GOL D1181 B 195 PHE D 166 PHE~? 16.66 O3 GOL D1181 B 197 GLU D 167 GLU~? 14.12 O3 GOL D1181 C 62 TYR D 175 TYR.? 24.43 OXT ACT A1182 coo 33.85 117.83 62.00 33.48 115.65 62.93 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 34.74 126.89 58.64 35.76 127.46 56.11 -30.33 -9.93 30.20 -28.59 -8.35 28.64 coo 29.77 125.13 60.32 30.09 123.64 58.88 -33.98 -6.43 34.19 -35.73 -5.26 33.93 coo 34.01 116.98 69.72 34.94 114.70 68.46 -25.75 0.70 38.70 -27.49 2.18 37.04 1pya_c01 source 1pya PYRUVOYL-DEPENDENT HISTIDINE DECARBOXYLASE : 3 hits 1pya_c01 naa= 4 ULMN 4 1pya_c02 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 1 4 # 1 C 81 SER C 172 SER~? 11.19 CA CA C1181 D 195 PHE C 166 PHE~? 15.64 CA CA C1181 D 197 GLU C 167 GLU~? 15.18 C1 GOL D1181 E 62 TYR C 175 TYR~? 10.79 CA CA C1181 coo 33.24 103.14 61.07 31.36 104.32 60.00 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 40.56 100.60 66.46 43.12 101.64 66.41 -60.33 -11.66 28.96 -62.13 -10.76 26.98 coo 36.24 102.96 69.12 36.80 104.56 67.83 -56.84 -16.73 27.22 -55.09 -16.98 26.08 coo 27.20 98.12 60.65 27.40 99.75 58.44 -65.38 -23.09 22.41 -63.58 -22.29 20.40 ULMN 4 1pya_c02 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 2 4 # 2 C 81 SER D 172 SER~? 19.02 O3 GOL D1181 D 195 PHE D 166 PHE~? 16.66 O3 GOL D1181 D 197 GLU D 167 GLU~? 14.12 O3 GOL D1181 E 62 TYR D 175 TYR.? 24.43 OXT ACT A1182 coo 33.24 103.14 61.07 31.36 104.32 60.00 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 40.56 100.60 66.46 43.12 101.64 66.41 -30.33 -9.93 30.20 -28.59 -8.35 28.64 coo 36.24 102.96 69.12 36.80 104.56 67.83 -33.98 -6.43 34.19 -35.73 -5.26 33.93 coo 27.20 98.12 60.65 27.40 99.75 58.44 -25.75 0.70 38.70 -27.49 2.18 37.04 1pya_c02 source 1pya PYRUVOYL-DEPENDENT HISTIDINE DECARBOXYLASE : 2 hits 1pya_c02 naa= 4 ULMN 4 1xyz_c01 1,4-BETA-D-XYLAN-XYLANOHYDROLASE user 1 4 # 1 B 645 GLU C 139 GLU.? 13.61 CA CA C1184 B 723 HIS C 151 HIS.? 19.99 CA CA C1184 B 754 GLU C 150 GLU.? 16.95 CA CA C1184 B 756 ASP C 152 ASP.? 13.45 O3 GOL D1181 coo 15.60 30.64 69.31 14.72 29.15 68.11 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 9.08 25.15 72.84 8.18 26.43 71.44 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 7.29 30.67 71.38 8.86 30.34 70.00 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 3.67 23.22 73.36 5.48 23.51 72.37 -47.03 -4.77 41.79 -47.13 -6.84 42.24 1xyz_c01 source 1xyz 1,4-BETA-D-XYLAN-XYLANOHYDROLASE : 1 hits 1xyz_c01 naa= 4 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 64 TYR~? 13.66 OXT ACT A1181 B 190 LYS A 158 LYS~? -4.64 O ACT A1181s B 222 ASP A 156 ASP~? 10.59 O ACT A1181 coo 7.17 16.59 41.26 8.01 19.20 40.73 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 13.38 20.00 35.06 11.43 22.49 39.53 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 9.76 26.58 38.10 11.63 25.78 38.76 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR A 157 TYR~? 5.66 OXT ACT A1181 B 190 LYS B 158 LYS~? 6.73 O3 GOL B1182 B 222 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 7.17 16.59 41.26 8.01 19.20 40.73 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 13.38 20.00 35.06 11.43 22.49 39.53 -50.07 10.43 -10.30 -49.56 8.69 -16.32 coo 9.76 26.58 38.10 11.63 25.78 38.76 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR B 64 TYR~? 13.94 OXT ACT A1181 B 190 LYS B 158 LYS~? 6.73 O3 GOL B1182 B 222 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 7.17 16.59 41.26 8.01 19.20 40.73 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 13.38 20.00 35.06 11.43 22.49 39.53 -50.07 10.43 -10.30 -49.56 8.69 -16.32 coo 9.76 26.58 38.10 11.63 25.78 38.76 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR B 157 TYR~? 6.24 OXT ACT A1181 B 190 LYS A 158 LYS~? -4.64 O ACT A1181s B 222 ASP A 156 ASP~? 10.59 O ACT A1181 coo 7.17 16.59 41.26 8.01 19.20 40.73 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo 13.38 20.00 35.06 11.43 22.49 39.53 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 9.76 26.58 38.10 11.63 25.78 38.76 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 140 TYR C 64 TYR~? 13.24 O3 GOL D1181 B 190 LYS C 158 LYS~? 13.55 O3 GOL D1181 B 222 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 7.17 16.59 41.26 8.01 19.20 40.73 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 13.38 20.00 35.06 11.43 22.49 39.53 -50.05 -10.42 36.79 -49.63 -8.70 42.89 coo 9.76 26.58 38.10 11.63 25.78 38.76 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 140 TYR C 157 TYR~? 5.26 O3 GOL D1181 B 190 LYS D 158 LYS~? -4.46 O2 GOL D1181s B 222 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 7.17 16.59 41.26 8.01 19.20 40.73 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo 13.38 20.00 35.06 11.43 22.49 39.53 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo 9.76 26.58 38.10 11.63 25.78 38.76 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 7 3 # 7 A 140 TYR D 64 TYR~? 12.19 O3 GOL D1181 B 190 LYS D 158 LYS~? -4.46 O2 GOL D1181s B 222 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 7.17 16.59 41.26 8.01 19.20 40.73 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 13.38 20.00 35.06 11.43 22.49 39.53 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo 9.76 26.58 38.10 11.63 25.78 38.76 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 8 3 # 8 A 140 TYR D 157 TYR~? -5.31 C1 GOL D1181s B 190 LYS C 158 LYS~? 13.55 O3 GOL D1181 B 222 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 7.17 16.59 41.26 8.01 19.20 40.73 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 13.38 20.00 35.06 11.43 22.49 39.53 -50.05 -10.42 36.79 -49.63 -8.70 42.89 coo 9.76 26.58 38.10 11.63 25.78 38.76 -44.46 -7.83 33.81 -43.76 -5.84 33.54 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 8 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 158 LYS~? -4.64 O ACT A1181s A 222 ASP A 156 ASP~? 10.59 O ACT A1181 B 140 TYR A 64 TYR~? 13.66 OXT ACT A1181 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 1.51 16.60 24.17 0.82 19.23 24.79 -41.23 7.24 -1.52 -40.97 7.41 -4.31 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS A 158 LYS~? -4.64 O ACT A1181s A 222 ASP A 156 ASP~? 10.59 O ACT A1181 B 140 TYR B 157 TYR~? 6.24 OXT ACT A1181 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 1.51 16.60 24.17 0.82 19.23 24.79 -44.58 12.35 -10.09 -41.80 12.65 -10.19 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS B 158 LYS~? 6.73 O3 GOL B1182 A 222 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 140 TYR A 157 TYR~? 5.66 OXT ACT A1181 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -50.07 10.43 -10.30 -49.56 8.69 -16.32 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 1.51 16.60 24.17 0.82 19.23 24.79 -46.22 16.76 -7.11 -49.01 16.68 -7.45 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS B 158 LYS~? 6.73 O3 GOL B1182 A 222 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 140 TYR B 64 TYR~? 13.94 OXT ACT A1181 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -50.07 10.43 -10.30 -49.56 8.69 -16.32 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 1.51 16.60 24.17 0.82 19.23 24.79 -49.49 10.87 0.95 -49.71 13.38 -0.30 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 190 LYS C 158 LYS~? 13.55 O3 GOL D1181 A 222 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 140 TYR C 64 TYR~? 13.24 O3 GOL D1181 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -50.05 -10.42 36.79 -49.63 -8.70 42.89 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 1.51 16.60 24.17 0.82 19.23 24.79 -49.46 -10.91 25.49 -49.72 -13.40 26.79 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 190 LYS C 158 LYS~? 13.55 O3 GOL D1181 A 222 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 140 TYR D 157 TYR~? -5.31 C1 GOL D1181s coo -4.61 20.12 30.34 -2.74 22.65 25.95 -50.05 -10.42 36.79 -49.63 -8.70 42.89 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 1.51 16.60 24.17 0.82 19.23 24.79 -46.23 -16.78 33.55 -49.03 -16.71 33.91 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 7 3 # 7 A 190 LYS D 158 LYS~? -4.46 O2 GOL D1181s A 222 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 140 TYR C 157 TYR~? 5.26 O3 GOL D1181 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 1.51 16.60 24.17 0.82 19.23 24.79 -44.58 -12.33 36.53 -41.80 -12.65 36.66 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 8 3 # 8 A 190 LYS D 158 LYS~? -4.46 O2 GOL D1181s A 222 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 140 TYR D 64 TYR~? 12.19 O3 GOL D1181 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 1.51 16.60 24.17 0.82 19.23 24.79 -41.23 -7.21 27.99 -40.99 -7.39 30.78 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 8 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c00 TRYPSIN user 1 3 # 1 A 57 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 102 ASP A 55 ASP.? 17.41 O ACT A1181 A 195 SER A 53 SER^? 12.21 OXT ACT A1182 coo 25.57 41.22 61.68 24.18 39.98 62.50 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 22.33 45.48 59.73 23.35 43.67 60.06 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 20.90 36.72 61.65 22.18 37.53 63.52 -35.29 10.69 9.61 -33.77 12.39 10.51 ULMN 3 1a0j_c00 TRYPSIN user 2 3 # 2 A 57 HIS B 59 HIS~? 15.18 O ACT C1183 A 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 195 SER B 53 SER^? 12.05 O ACT C1183 coo 25.57 41.22 61.68 24.18 39.98 62.50 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 22.33 45.48 59.73 23.35 43.67 60.06 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 20.90 36.72 61.65 22.18 37.53 63.52 -55.28 -0.85 2.05 -56.85 -2.35 0.91 ULMN 3 1a0j_c00 TRYPSIN user 3 3 # 3 A 57 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 195 SER B 53 SER^? 12.05 O ACT C1183 coo 25.57 41.22 61.68 24.18 39.98 62.50 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 22.33 45.48 59.73 23.35 43.67 60.06 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 20.90 36.72 61.65 22.18 37.53 63.52 -55.28 -0.85 2.05 -56.85 -2.35 0.91 ULMN 3 1a0j_c00 TRYPSIN user 4 3 # 4 A 57 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 102 ASP C 55 ASP.? 19.45 CA CA C1184 A 195 SER C 53 SER^? 12.05 OXT ACT C1183 coo 25.57 41.22 61.68 24.18 39.98 62.50 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 22.33 45.48 59.73 23.35 43.67 60.06 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 20.90 36.72 61.65 22.18 37.53 63.52 -55.28 0.90 24.40 -56.83 2.38 25.58 ULMN 3 1a0j_c00 TRYPSIN user 5 3 # 5 A 57 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 102 ASP C 55 ASP.? 19.45 CA CA C1184 A 195 SER C 53 SER^? 12.05 OXT ACT C1183 coo 25.57 41.22 61.68 24.18 39.98 62.50 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 22.33 45.48 59.73 23.35 43.67 60.06 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 20.90 36.72 61.65 22.18 37.53 63.52 -55.28 0.90 24.40 -56.83 2.38 25.58 ULMN 3 1a0j_c00 TRYPSIN user 6 3 # 6 A 57 HIS D 114 HIS^? 15.97 O ACT A1182 A 102 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 195 SER D 53 SER^? 12.18 O ACT A1182 coo 25.57 41.22 61.68 24.18 39.98 62.50 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 22.33 45.48 59.73 23.35 43.67 60.06 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 20.90 36.72 61.65 22.18 37.53 63.52 -35.31 -10.69 16.86 -33.78 -12.33 15.90 1a0j_c00 source 1a0j TRYPSIN : 6 hits 1a0j_c00 naa= 3 ULMN 3 1a0j_c01 TRYPSIN user 1 3 # 1 B 57 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 102 ASP A 55 ASP.? 17.41 O ACT A1181 B 195 SER A 53 SER^? 12.21 OXT ACT A1182 coo 44.08 45.58 52.81 45.86 46.55 52.85 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 43.04 44.75 47.18 43.31 45.51 49.13 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 48.11 50.52 52.24 48.62 48.46 53.13 -35.29 10.69 9.61 -33.77 12.39 10.51 ULMN 3 1a0j_c01 TRYPSIN user 2 3 # 2 B 57 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 195 SER B 53 SER^? 12.05 O ACT C1183 coo 44.08 45.58 52.81 45.86 46.55 52.85 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 43.04 44.75 47.18 43.31 45.51 49.13 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 48.11 50.52 52.24 48.62 48.46 53.13 -55.28 -0.85 2.05 -56.85 -2.35 0.91 ULMN 3 1a0j_c01 TRYPSIN user 3 3 # 3 B 57 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 102 ASP C 55 ASP.? 19.45 CA CA C1184 B 195 SER C 53 SER^? 12.05 OXT ACT C1183 coo 44.08 45.58 52.81 45.86 46.55 52.85 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 43.04 44.75 47.18 43.31 45.51 49.13 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 48.11 50.52 52.24 48.62 48.46 53.13 -55.28 0.90 24.40 -56.83 2.38 25.58 ULMN 3 1a0j_c01 TRYPSIN user 4 3 # 4 B 57 HIS D 114 HIS^? 15.97 O ACT A1182 B 102 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 195 SER D 53 SER^? 12.18 O ACT A1182 coo 44.08 45.58 52.81 45.86 46.55 52.85 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 43.04 44.75 47.18 43.31 45.51 49.13 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 48.11 50.52 52.24 48.62 48.46 53.13 -35.31 -10.69 16.86 -33.78 -12.33 15.90 1a0j_c01 source 1a0j TRYPSIN : 4 hits 1a0j_c01 naa= 3 ULMN 3 1a0j_c02 TRYPSIN user 1 3 # 1 C 57 HIS A 114 HIS^? 15.94 OXT ACT A1182 C 102 ASP A 55 ASP.? 17.41 O ACT A1181 C 195 SER A 53 SER^? 12.21 OXT ACT A1182 coo 34.37 41.18 73.21 34.04 43.09 73.87 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 34.89 38.34 78.12 35.11 39.59 76.42 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 36.16 46.87 75.66 34.01 46.43 74.59 -35.29 10.69 9.61 -33.77 12.39 10.51 ULMN 3 1a0j_c02 TRYPSIN user 2 3 # 2 C 57 HIS B 59 HIS~? 15.18 O ACT C1183 C 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 195 SER B 53 SER^? 12.05 O ACT C1183 coo 34.37 41.18 73.21 34.04 43.09 73.87 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 34.89 38.34 78.12 35.11 39.59 76.42 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 36.16 46.87 75.66 34.01 46.43 74.59 -55.28 -0.85 2.05 -56.85 -2.35 0.91 ULMN 3 1a0j_c02 TRYPSIN user 3 3 # 3 C 57 HIS B 114 HIS^? 14.73 O2 GOL B1182 C 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 195 SER B 53 SER^? 12.05 O ACT C1183 coo 34.37 41.18 73.21 34.04 43.09 73.87 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 34.89 38.34 78.12 35.11 39.59 76.42 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 36.16 46.87 75.66 34.01 46.43 74.59 -55.28 -0.85 2.05 -56.85 -2.35 0.91 ULMN 3 1a0j_c02 TRYPSIN user 4 3 # 4 C 57 HIS C 59 HIS~? 15.17 OXT ACT C1183 C 102 ASP C 55 ASP.? 19.45 CA CA C1184 C 195 SER C 53 SER^? 12.05 OXT ACT C1183 coo 34.37 41.18 73.21 34.04 43.09 73.87 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 34.89 38.34 78.12 35.11 39.59 76.42 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 36.16 46.87 75.66 34.01 46.43 74.59 -55.28 0.90 24.40 -56.83 2.38 25.58 ULMN 3 1a0j_c02 TRYPSIN user 5 3 # 5 C 57 HIS C 114 HIS^? 15.77 OXT ACT C1183 C 102 ASP C 55 ASP.? 19.45 CA CA C1184 C 195 SER C 53 SER^? 12.05 OXT ACT C1183 coo 34.37 41.18 73.21 34.04 43.09 73.87 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 34.89 38.34 78.12 35.11 39.59 76.42 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 36.16 46.87 75.66 34.01 46.43 74.59 -55.28 0.90 24.40 -56.83 2.38 25.58 ULMN 3 1a0j_c02 TRYPSIN user 6 3 # 6 C 57 HIS D 114 HIS^? 15.97 O ACT A1182 C 102 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 195 SER D 53 SER^? 12.18 O ACT A1182 coo 34.37 41.18 73.21 34.04 43.09 73.87 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 34.89 38.34 78.12 35.11 39.59 76.42 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 36.16 46.87 75.66 34.01 46.43 74.59 -35.31 -10.69 16.86 -33.78 -12.33 15.90 1a0j_c02 source 1a0j TRYPSIN : 6 hits 1a0j_c02 naa= 3 ULMN 3 1a0j_c03 TRYPSIN user 1 3 # 1 D 57 HIS A 114 HIS^? 15.94 OXT ACT A1182 D 102 ASP A 55 ASP.? 17.41 O ACT A1181 D 195 SER A 53 SER^? 12.21 OXT ACT A1182 coo 8.19 15.01 95.72 7.78 16.53 97.01 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 13.53 16.28 93.98 11.45 16.21 94.40 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 6.63 21.03 97.42 6.71 19.20 98.95 -35.29 10.69 9.61 -33.77 12.39 10.51 ULMN 3 1a0j_c03 TRYPSIN user 2 3 # 2 D 57 HIS B 114 HIS^? 14.73 O2 GOL B1182 D 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 D 195 SER B 53 SER^? 12.05 O ACT C1183 coo 8.19 15.01 95.72 7.78 16.53 97.01 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 13.53 16.28 93.98 11.45 16.21 94.40 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 6.63 21.03 97.42 6.71 19.20 98.95 -55.28 -0.85 2.05 -56.85 -2.35 0.91 ULMN 3 1a0j_c03 TRYPSIN user 3 3 # 3 D 57 HIS C 114 HIS^? 15.77 OXT ACT C1183 D 102 ASP C 55 ASP.? 19.45 CA CA C1184 D 195 SER C 53 SER^? 12.05 OXT ACT C1183 coo 8.19 15.01 95.72 7.78 16.53 97.01 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 13.53 16.28 93.98 11.45 16.21 94.40 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 6.63 21.03 97.42 6.71 19.20 98.95 -55.28 0.90 24.40 -56.83 2.38 25.58 ULMN 3 1a0j_c03 TRYPSIN user 4 3 # 4 D 57 HIS D 114 HIS^? 15.97 O ACT A1182 D 102 ASP D 55 ASP.? 17.43 O2 GOL D1181 D 195 SER D 53 SER^? 12.18 O ACT A1182 coo 8.19 15.01 95.72 7.78 16.53 97.01 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 13.53 16.28 93.98 11.45 16.21 94.40 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 6.63 21.03 97.42 6.71 19.20 98.95 -35.31 -10.69 16.86 -33.78 -12.33 15.90 1a0j_c03 source 1a0j TRYPSIN : 4 hits 1a0j_c03 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 102 ASP A 55 ASP.? 17.41 O ACT A1181 A 193 GLY A 122 GLY~? 17.38 OXT ACT A1182 coo 25.57 41.22 61.68 24.18 39.98 62.50 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 22.33 45.48 59.73 23.35 43.67 60.06 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 22.57 32.23 64.13 21.98 32.82 64.22 -31.93 16.98 20.49 -32.19 17.34 19.79 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 193 GLY B 122 GLY~? 17.40 O ACT C1183 coo 25.57 41.22 61.68 24.18 39.98 62.50 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 22.33 45.48 59.73 23.35 43.67 60.06 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 22.57 32.23 64.13 21.98 32.82 64.22 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 ULMN 3 1a0j_c12 TRYPSIN user 3 3 # 3 A 57 HIS B 151 HIS.? 14.53 O3 GOL B1182 A 102 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 193 GLY B 116 GLY.? 11.34 O3 GOL B1182 coo 25.57 41.22 61.68 24.18 39.98 62.50 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 22.33 45.48 59.73 23.35 43.67 60.06 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 22.57 32.23 64.13 21.98 32.82 64.22 -52.33 -1.19 -6.26 -53.05 -1.53 -6.05 ULMN 3 1a0j_c12 TRYPSIN user 4 3 # 4 A 57 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 102 ASP C 55 ASP.? 19.45 CA CA C1184 A 193 GLY C 122 GLY~? 17.34 OXT ACT C1183 coo 25.57 41.22 61.68 24.18 39.98 62.50 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 22.33 45.48 59.73 23.35 43.67 60.06 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 22.57 32.23 64.13 21.98 32.82 64.22 -58.64 13.32 25.99 -58.38 12.82 26.62 ULMN 3 1a0j_c12 TRYPSIN user 5 3 # 5 A 57 HIS D 114 HIS^? 15.97 O ACT A1182 A 102 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 193 GLY D 122 GLY~? 17.40 O ACT A1182 coo 25.57 41.22 61.68 24.18 39.98 62.50 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 22.33 45.48 59.73 23.35 43.67 60.06 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 22.57 32.23 64.13 21.98 32.82 64.22 -32.03 -16.93 5.96 -32.26 -17.35 6.67 1a0j_c12 source 1a0j TRYPSIN : 5 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 102 ASP A 55 ASP.? 17.41 O ACT A1181 B 193 GLY A 122 GLY~? 17.38 OXT ACT A1182 coo 44.08 45.58 52.81 45.86 46.55 52.85 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 43.04 44.75 47.18 43.31 45.51 49.13 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 50.46 51.91 56.90 50.65 51.62 56.14 -31.93 16.98 20.49 -32.19 17.34 19.79 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 193 GLY B 122 GLY~? 17.40 O ACT C1183 coo 44.08 45.58 52.81 45.86 46.55 52.85 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 43.04 44.75 47.18 43.31 45.51 49.13 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 50.46 51.91 56.90 50.65 51.62 56.14 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 102 ASP C 55 ASP.? 19.45 CA CA C1184 B 193 GLY C 122 GLY~? 17.34 OXT ACT C1183 coo 44.08 45.58 52.81 45.86 46.55 52.85 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 43.04 44.75 47.18 43.31 45.51 49.13 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 50.46 51.91 56.90 50.65 51.62 56.14 -58.64 13.32 25.99 -58.38 12.82 26.62 ULMN 3 1a0j_c13 TRYPSIN user 4 3 # 4 B 57 HIS D 114 HIS^? 15.97 O ACT A1182 B 102 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 193 GLY D 122 GLY~? 17.40 O ACT A1182 coo 44.08 45.58 52.81 45.86 46.55 52.85 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 43.04 44.75 47.18 43.31 45.51 49.13 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 50.46 51.91 56.90 50.65 51.62 56.14 -32.03 -16.93 5.96 -32.26 -17.35 6.67 1a0j_c13 source 1a0j TRYPSIN : 4 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 114 HIS^? 15.94 OXT ACT A1182 C 102 ASP A 55 ASP.? 17.41 O ACT A1181 C 193 GLY A 122 GLY~? 17.38 OXT ACT A1182 coo 34.37 41.18 73.21 34.04 43.09 73.87 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 34.89 38.34 78.12 35.11 39.59 76.42 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 35.43 51.03 72.12 35.20 50.72 72.87 -31.93 16.98 20.49 -32.19 17.34 19.79 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS B 114 HIS^? 14.73 O2 GOL B1182 C 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 193 GLY B 122 GLY~? 17.40 O ACT C1183 coo 34.37 41.18 73.21 34.04 43.09 73.87 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 34.89 38.34 78.12 35.11 39.59 76.42 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 35.43 51.03 72.12 35.20 50.72 72.87 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 ULMN 3 1a0j_c14 TRYPSIN user 3 3 # 3 C 57 HIS B 151 HIS.? 14.53 O3 GOL B1182 C 102 ASP B 152 ASP.? 8.52 O3 GOL B1182 C 193 GLY B 116 GLY.? 11.34 O3 GOL B1182 coo 34.37 41.18 73.21 34.04 43.09 73.87 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 34.89 38.34 78.12 35.11 39.59 76.42 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 35.43 51.03 72.12 35.20 50.72 72.87 -52.33 -1.19 -6.26 -53.05 -1.53 -6.05 ULMN 3 1a0j_c14 TRYPSIN user 4 3 # 4 C 57 HIS C 114 HIS^? 15.77 OXT ACT C1183 C 102 ASP C 55 ASP.? 19.45 CA CA C1184 C 193 GLY C 122 GLY~? 17.34 OXT ACT C1183 coo 34.37 41.18 73.21 34.04 43.09 73.87 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 34.89 38.34 78.12 35.11 39.59 76.42 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 35.43 51.03 72.12 35.20 50.72 72.87 -58.64 13.32 25.99 -58.38 12.82 26.62 ULMN 3 1a0j_c14 TRYPSIN user 5 3 # 5 C 57 HIS C 151 HIS.? 19.99 CA CA C1184 C 102 ASP C 152 ASP.? 13.45 O3 GOL D1181 C 193 GLY C 116 GLY.? 15.57 CA CA C1184 coo 34.37 41.18 73.21 34.04 43.09 73.87 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 34.89 38.34 78.12 35.11 39.59 76.42 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 35.43 51.03 72.12 35.20 50.72 72.87 -52.37 1.22 32.72 -53.07 1.55 32.51 ULMN 3 1a0j_c14 TRYPSIN user 6 3 # 6 C 57 HIS D 114 HIS^? 15.97 O ACT A1182 C 102 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 193 GLY D 122 GLY~? 17.40 O ACT A1182 coo 34.37 41.18 73.21 34.04 43.09 73.87 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 34.89 38.34 78.12 35.11 39.59 76.42 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 35.43 51.03 72.12 35.20 50.72 72.87 -32.03 -16.93 5.96 -32.26 -17.35 6.67 1a0j_c14 source 1a0j TRYPSIN : 6 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 114 HIS^? 15.94 OXT ACT A1182 D 102 ASP A 55 ASP.? 17.41 O ACT A1181 D 193 GLY A 122 GLY~? 17.38 OXT ACT A1182 coo 8.19 15.01 95.72 7.78 16.53 97.01 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 13.53 16.28 93.98 11.45 16.21 94.40 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 1.80 21.25 100.04 2.61 21.42 100.18 -31.93 16.98 20.49 -32.19 17.34 19.79 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS B 114 HIS^? 14.73 O2 GOL B1182 D 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 D 193 GLY B 122 GLY~? 17.40 O ACT C1183 coo 8.19 15.01 95.72 7.78 16.53 97.01 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 13.53 16.28 93.98 11.45 16.21 94.40 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 1.80 21.25 100.04 2.61 21.42 100.18 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS C 114 HIS^? 15.77 OXT ACT C1183 D 102 ASP C 55 ASP.? 19.45 CA CA C1184 D 193 GLY C 122 GLY~? 17.34 OXT ACT C1183 coo 8.19 15.01 95.72 7.78 16.53 97.01 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 13.53 16.28 93.98 11.45 16.21 94.40 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 1.80 21.25 100.04 2.61 21.42 100.18 -58.64 13.32 25.99 -58.38 12.82 26.62 ULMN 3 1a0j_c15 TRYPSIN user 4 3 # 4 D 57 HIS C 151 HIS.? 19.99 CA CA C1184 D 102 ASP C 152 ASP.? 13.45 O3 GOL D1181 D 193 GLY C 116 GLY.? 15.57 CA CA C1184 coo 8.19 15.01 95.72 7.78 16.53 97.01 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 13.53 16.28 93.98 11.45 16.21 94.40 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 1.80 21.25 100.04 2.61 21.42 100.18 -52.37 1.22 32.72 -53.07 1.55 32.51 ULMN 3 1a0j_c15 TRYPSIN user 5 3 # 5 D 57 HIS D 114 HIS^? 15.97 O ACT A1182 D 102 ASP D 55 ASP.? 17.43 O2 GOL D1181 D 193 GLY D 122 GLY~? 17.40 O ACT A1182 coo 8.19 15.01 95.72 7.78 16.53 97.01 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 13.53 16.28 93.98 11.45 16.21 94.40 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 1.80 21.25 100.04 2.61 21.42 100.18 -32.03 -16.93 5.96 -32.26 -17.35 6.67 1a0j_c15 source 1a0j TRYPSIN : 5 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 58 ARG~? 14.46 O ACT A1181 265 HIS A 114 HIS^? 15.94 OXT ACT A1182 274 TYR A 33 TYR~? 13.22 O ACT A1181 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -43.27 15.99 4.53 -43.95 18.83 5.47 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 0.94 52.26 9.16 1.95 54.78 9.91 -29.65 19.68 -6.55 -29.87 20.32 -9.24 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG D 58 ARG~? 14.52 O2 GOL D1181 265 HIS D 114 HIS^? 15.97 O ACT A1182 274 TYR D 33 TYR~? 12.91 O3 GOL D1181 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 0.94 52.26 9.16 1.95 54.78 9.91 -29.64 -19.70 33.03 -29.80 -20.31 35.72 1a41_c01 source 1a41 TOPOISOMERASE I : 2 hits 1a41_c01 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 91 TYR.? 11.44 OXT ACT A1182 A 125 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 156 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -35.52 10.03 17.00 -36.51 12.40 15.90 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR B 91 TYR.? 11.41 O ACT C1183 A 125 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 156 LYS B 124 LYS~? 15.51 CA CA B1183 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 3 3 # 3 A 115 TYR C 91 TYR.? 11.38 OXT ACT C1183 A 125 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 156 LYS C 124 LYS~? 15.99 CA CA C1184 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 4 3 # 4 A 115 TYR D 91 TYR.? 11.52 O ACT A1182 A 125 HIS D 114 HIS^? 15.97 O ACT A1182 A 156 LYS D 124 LYS~? 24.78 O ACT A1182 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 91 TYR.? 11.44 OXT ACT A1182 B 125 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 156 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -35.52 10.03 17.00 -36.51 12.40 15.90 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR B 91 TYR.? 11.41 O ACT C1183 B 125 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 156 LYS B 124 LYS~? 15.51 CA CA B1183 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 3 3 # 3 B 115 TYR C 91 TYR.? 11.38 OXT ACT C1183 B 125 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 156 LYS C 124 LYS~? 15.99 CA CA C1184 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 4 3 # 4 B 115 TYR D 91 TYR.? 11.52 O ACT A1182 B 125 HIS D 114 HIS^? 15.97 O ACT A1182 B 156 LYS D 124 LYS~? 24.78 O ACT A1182 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 91 TYR.? 11.44 OXT ACT A1182 C 125 HIS A 114 HIS^? 15.94 OXT ACT A1182 C 156 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -35.52 10.03 17.00 -36.51 12.40 15.90 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR B 91 TYR.? 11.41 O ACT C1183 C 125 HIS B 114 HIS^? 14.73 O2 GOL B1182 C 156 LYS B 124 LYS~? 15.51 CA CA B1183 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 3 3 # 3 C 115 TYR C 91 TYR.? 11.38 OXT ACT C1183 C 125 HIS C 114 HIS^? 15.77 OXT ACT C1183 C 156 LYS C 124 LYS~? 15.99 CA CA C1184 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 4 3 # 4 C 115 TYR D 91 TYR.? 11.52 O ACT A1182 C 125 HIS D 114 HIS^? 15.97 O ACT A1182 C 156 LYS D 124 LYS~? 24.78 O ACT A1182 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 91 TYR.? 11.44 OXT ACT A1182 D 125 HIS A 114 HIS^? 15.94 OXT ACT A1182 D 156 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 54.10 1.42 85.16 54.14 4.17 85.62 -35.52 10.03 17.00 -36.51 12.40 15.90 coo 61.27 5.43 85.32 62.73 6.38 86.49 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 60.28 4.62 76.00 58.35 6.41 80.65 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR B 91 TYR.? 11.41 O ACT C1183 D 125 HIS B 114 HIS^? 14.73 O2 GOL B1182 D 156 LYS B 124 LYS~? 15.51 CA CA B1183 coo 54.10 1.42 85.16 54.14 4.17 85.62 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 61.27 5.43 85.32 62.73 6.38 86.49 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 60.28 4.62 76.00 58.35 6.41 80.65 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 3 3 # 3 D 115 TYR C 91 TYR.? 11.38 OXT ACT C1183 D 125 HIS C 114 HIS^? 15.77 OXT ACT C1183 D 156 LYS C 124 LYS~? 15.99 CA CA C1184 coo 54.10 1.42 85.16 54.14 4.17 85.62 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 61.27 5.43 85.32 62.73 6.38 86.49 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 60.28 4.62 76.00 58.35 6.41 80.65 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 4 3 # 4 D 115 TYR D 91 TYR.? 11.52 O ACT A1182 D 125 HIS D 114 HIS^? 15.97 O ACT A1182 D 156 LYS D 124 LYS~? 24.78 O ACT A1182 coo 54.10 1.42 85.16 54.14 4.17 85.62 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo 61.27 5.43 85.32 62.73 6.38 86.49 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 60.28 4.62 76.00 58.35 6.41 80.65 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c03 naa= 3 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 1 3 # 1 A 98 SER A 53 SER^? 12.21 OXT ACT A1182 A 228 ASP A 55 ASP.? 17.41 O ACT A1181 A 257 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 9.47 41.64 34.15 9.10 39.28 33.93 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 2.03 38.95 28.44 3.60 38.60 29.83 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 6.85 37.62 29.99 7.50 38.47 31.78 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 2 3 # 2 A 98 SER B 53 SER^? 12.05 O ACT C1183 A 228 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 257 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 9.47 41.64 34.15 9.10 39.28 33.93 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 2.03 38.95 28.44 3.60 38.60 29.83 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 6.85 37.62 29.99 7.50 38.47 31.78 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 3 3 # 3 A 98 SER C 53 SER^? 12.05 OXT ACT C1183 A 228 ASP C 55 ASP.? 19.45 CA CA C1184 A 257 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 9.47 41.64 34.15 9.10 39.28 33.93 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 2.03 38.95 28.44 3.60 38.60 29.83 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 6.85 37.62 29.99 7.50 38.47 31.78 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 4 3 # 4 A 98 SER D 53 SER^? 12.18 O ACT A1182 A 228 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 257 HIS D 114 HIS^? 15.97 O ACT A1182 coo 9.47 41.64 34.15 9.10 39.28 33.93 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 2.03 38.95 28.44 3.60 38.60 29.83 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 6.85 37.62 29.99 7.50 38.47 31.78 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1a7u_c02 source 1a7u CHLOROPEROXIDASE T : 4 hits 1a7u_c02 naa= 3 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 1 3 # 1 B 98 SER A 53 SER^? 12.21 OXT ACT A1182 B 228 ASP A 55 ASP.? 17.41 O ACT A1181 B 257 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 28.35 71.07 3.94 30.08 69.46 4.49 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 32.76 68.02 0.70 31.21 68.44 2.05 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 2 3 # 2 B 98 SER B 53 SER^? 12.05 O ACT C1183 B 228 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 257 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 28.35 71.07 3.94 30.08 69.46 4.49 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 32.76 68.02 0.70 31.21 68.44 2.05 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 3 3 # 3 B 98 SER C 53 SER^? 12.05 OXT ACT C1183 B 228 ASP C 55 ASP.? 19.45 CA CA C1184 B 257 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 28.35 71.07 3.94 30.08 69.46 4.49 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 32.76 68.02 0.70 31.21 68.44 2.05 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 4 3 # 4 B 98 SER D 53 SER^? 12.18 O ACT A1182 B 228 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 257 HIS D 114 HIS^? 15.97 O ACT A1182 coo 28.35 71.07 3.94 30.08 69.46 4.49 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 32.76 68.02 0.70 31.21 68.44 2.05 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1a7u_c03 source 1a7u CHLOROPEROXIDASE T : 4 hits 1a7u_c03 naa= 3 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 1 3 # 1 94 SER A 53 SER^? 12.21 OXT ACT A1182 223 ASP A 55 ASP.? 17.41 O ACT A1181 252 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 40.95 0.07 3.20 39.54 1.39 4.66 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 41.54 1.64 9.09 40.82 1.05 7.19 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 2 3 # 2 94 SER B 53 SER^? 12.05 O ACT C1183 223 ASP B 55 ASP.? 14.29 O3 GOL B1182 252 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 40.95 0.07 3.20 39.54 1.39 4.66 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 41.54 1.64 9.09 40.82 1.05 7.19 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 3 3 # 3 94 SER C 53 SER^? 12.05 OXT ACT C1183 223 ASP C 55 ASP.? 19.45 CA CA C1184 252 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 40.95 0.07 3.20 39.54 1.39 4.66 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 41.54 1.64 9.09 40.82 1.05 7.19 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 4 3 # 4 94 SER D 53 SER^? 12.18 O ACT A1182 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 252 HIS D 114 HIS^? 15.97 O ACT A1182 coo 40.95 0.07 3.20 39.54 1.39 4.66 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 41.54 1.64 9.09 40.82 1.05 7.19 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1a8q_c00 source 1a8q BROMOPEROXIDASE A1 : 4 hits 1a8q_c00 naa= 3 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 1 3 # 1 94 SER A 53 SER^? 12.21 OXT ACT A1182 224 ASP A 55 ASP.? 17.41 O ACT A1181 253 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 16.00 80.13 58.60 16.16 82.12 59.96 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 8.47 84.84 62.27 10.52 84.40 62.08 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 13.14 83.03 63.68 14.37 82.62 62.02 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 2 3 # 2 94 SER B 53 SER^? 12.05 O ACT C1183 224 ASP B 55 ASP.? 14.29 O3 GOL B1182 253 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 16.00 80.13 58.60 16.16 82.12 59.96 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 8.47 84.84 62.27 10.52 84.40 62.08 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 13.14 83.03 63.68 14.37 82.62 62.02 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 3 3 # 3 94 SER C 53 SER^? 12.05 OXT ACT C1183 224 ASP C 55 ASP.? 19.45 CA CA C1184 253 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 16.00 80.13 58.60 16.16 82.12 59.96 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 8.47 84.84 62.27 10.52 84.40 62.08 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 13.14 83.03 63.68 14.37 82.62 62.02 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 4 3 # 4 94 SER D 53 SER^? 12.18 O ACT A1182 224 ASP D 55 ASP.? 17.43 O2 GOL D1181 253 HIS D 114 HIS^? 15.97 O ACT A1182 coo 16.00 80.13 58.60 16.16 82.12 59.96 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 8.47 84.84 62.27 10.52 84.40 62.08 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 13.14 83.03 63.68 14.37 82.62 62.02 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1a8s_c00 source 1a8s CHLOROPEROXIDASE F : 4 hits 1a8s_c00 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 7 TRP~? 13.17 CA CA B1181 223 ASP A 6 ASP~? 16.17 CA CA B1181 258 LYS B 35 LYS~? 11.04 CA CA B1183 coo 127.19 33.46 26.14 126.78 36.79 28.15 -64.51 23.48 -8.12 -63.01 20.07 -6.83 coo 126.95 41.66 23.38 128.48 40.72 24.51 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 138.83 37.95 25.17 133.50 36.37 26.52 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP A 7 TRP~? 13.17 CA CA B1181 223 ASP A 14 ASP~? 14.99 CH3 ACT A1181 258 LYS B 164 LYS~? 10.34 O ACT A1181 coo 127.19 33.46 26.14 126.78 36.79 28.15 -64.51 23.48 -8.12 -63.01 20.07 -6.83 coo 126.95 41.66 23.38 128.48 40.72 24.51 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 138.83 37.95 25.17 133.50 36.37 26.52 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 3 3 # 3 142 TRP A 60 TRP~? 14.03 O ACT A1181 223 ASP A 55 ASP.? 17.41 O ACT A1181 258 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 127.19 33.46 26.14 126.78 36.79 28.15 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 126.95 41.66 23.38 128.48 40.72 24.51 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 138.83 37.95 25.17 133.50 36.37 26.52 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 4 3 # 4 142 TRP B 7 TRP~? 18.47 OXT ACT A1181 223 ASP B 6 ASP~? 24.59 OXT ACT A1181 258 LYS A 35 LYS~? 23.91 O ACT A1181 coo 127.19 33.46 26.14 126.78 36.79 28.15 -26.39 11.02 -16.75 -27.73 11.07 -13.04 coo 126.95 41.66 23.38 128.48 40.72 24.51 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 138.83 37.95 25.17 133.50 36.37 26.52 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 5 3 # 5 142 TRP B 7 TRP~? 18.47 OXT ACT A1181 223 ASP B 14 ASP~? 13.85 OXT ACT A1181 258 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 127.19 33.46 26.14 126.78 36.79 28.15 -26.39 11.02 -16.75 -27.73 11.07 -13.04 coo 126.95 41.66 23.38 128.48 40.72 24.51 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo 138.83 37.95 25.17 133.50 36.37 26.52 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 6 3 # 6 142 TRP B 60 TRP~? 15.39 OXT ACT A1181 223 ASP B 55 ASP.? 14.29 O3 GOL B1182 258 LYS A 72 LYS.? 19.74 O ACT A1182 coo 127.19 33.46 26.14 126.78 36.79 28.15 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 126.95 41.66 23.38 128.48 40.72 24.51 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 138.83 37.95 25.17 133.50 36.37 26.52 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 7 3 # 7 142 TRP C 7 TRP~? 16.43 CA CA C1182 223 ASP C 6 ASP~? 17.85 CA CA C1182 258 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 127.19 33.46 26.14 126.78 36.79 28.15 -26.42 -11.04 43.18 -27.72 -11.10 39.46 coo 126.95 41.66 23.38 128.48 40.72 24.51 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 138.83 37.95 25.17 133.50 36.37 26.52 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 8 3 # 8 142 TRP C 7 TRP~? 16.43 CA CA C1182 223 ASP C 14 ASP~? 9.29 CA CA C1182 258 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 127.19 33.46 26.14 126.78 36.79 28.15 -26.42 -11.04 43.18 -27.72 -11.10 39.46 coo 126.95 41.66 23.38 128.48 40.72 24.51 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 138.83 37.95 25.17 133.50 36.37 26.52 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 9 3 # 9 142 TRP C 60 TRP~? 14.18 O3 GOL D1181 223 ASP C 55 ASP.? 19.45 CA CA C1184 258 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 127.19 33.46 26.14 126.78 36.79 28.15 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 126.95 41.66 23.38 128.48 40.72 24.51 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 138.83 37.95 25.17 133.50 36.37 26.52 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 10 3 # 10 142 TRP D 7 TRP~? 13.25 CA CA C1181 223 ASP D 6 ASP~? 16.12 CA CA C1181 258 LYS C 35 LYS~? 10.20 CA CA C1184 coo 127.19 33.46 26.14 126.78 36.79 28.15 -64.48 -23.47 34.59 -63.03 -20.04 33.30 coo 126.95 41.66 23.38 128.48 40.72 24.51 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 138.83 37.95 25.17 133.50 36.37 26.52 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 11 3 # 11 142 TRP D 7 TRP~? 13.25 CA CA C1181 223 ASP D 14 ASP~? 14.81 O1 GOL D1181 258 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 127.19 33.46 26.14 126.78 36.79 28.15 -64.48 -23.47 34.59 -63.03 -20.04 33.30 coo 126.95 41.66 23.38 128.48 40.72 24.51 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 138.83 37.95 25.17 133.50 36.37 26.52 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 12 3 # 12 142 TRP D 60 TRP~? 12.96 O3 GOL D1181 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 258 LYS C 72 LYS.? 18.71 O ACT C1183 coo 127.19 33.46 26.14 126.78 36.79 28.15 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 126.95 41.66 23.38 128.48 40.72 24.51 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 138.83 37.95 25.17 133.50 36.37 26.52 -51.58 -16.11 13.18 -47.22 -15.59 10.10 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 12 hits 1aam_c01 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 58 ARG~? 14.46 O ACT A1181 78 HIS A 59 HIS~? 15.34 OXT ACT A1182 122 TYR C 107 TYR~? -4.63 CH3 ACT C1183s coo 48.32 72.26 30.89 48.69 69.28 31.53 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 53.63 68.24 34.99 53.08 69.10 33.16 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 75.01 61.87 32.93 75.34 59.26 31.96 -65.75 1.19 15.99 -63.10 1.53 15.19 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG A 58 ARG~? 14.46 O ACT A1181 78 HIS A 59 HIS~? 15.34 OXT ACT A1182 122 TYR D 91 TYR.? 11.52 O ACT A1182 coo 48.32 72.26 30.89 48.69 69.28 31.53 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 53.63 68.24 34.99 53.08 69.10 33.16 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 75.01 61.87 32.93 75.34 59.26 31.96 -35.52 -10.04 9.46 -36.46 -12.45 10.54 ULMN 3 1ab4_c00 GYRASE A user 3 3 # 3 32 ARG A 58 ARG~? 14.46 O ACT A1181 78 HIS A 59 HIS~? 15.34 OXT ACT A1182 122 TYR D 107 TYR~? -4.59 CH3 ACT A1182s coo 48.32 72.26 30.89 48.69 69.28 31.53 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 53.63 68.24 34.99 53.08 69.10 33.16 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 75.01 61.87 32.93 75.34 59.26 31.96 -24.79 -2.98 13.13 -27.46 -2.42 12.49 ULMN 3 1ab4_c00 GYRASE A user 4 3 # 4 32 ARG B 58 ARG~? 12.97 O3 GOL B1182 78 HIS B 59 HIS~? 15.18 O ACT C1183 122 TYR C 91 TYR.? 11.38 OXT ACT C1183 coo 48.32 72.26 30.89 48.69 69.28 31.53 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 53.63 68.24 34.99 53.08 69.10 33.16 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 75.01 61.87 32.93 75.34 59.26 31.96 -54.93 7.42 20.88 -53.88 7.33 23.48 ULMN 3 1ab4_c00 GYRASE A user 5 3 # 5 32 ARG B 58 ARG~? 12.97 O3 GOL B1182 78 HIS B 59 HIS~? 15.18 O ACT C1183 122 TYR C 107 TYR~? -4.63 CH3 ACT C1183s coo 48.32 72.26 30.89 48.69 69.28 31.53 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 53.63 68.24 34.99 53.08 69.10 33.16 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 75.01 61.87 32.93 75.34 59.26 31.96 -65.75 1.19 15.99 -63.10 1.53 15.19 ULMN 3 1ab4_c00 GYRASE A user 6 3 # 6 32 ARG B 58 ARG~? 12.97 O3 GOL B1182 78 HIS B 59 HIS~? 15.18 O ACT C1183 122 TYR D 107 TYR~? -4.59 CH3 ACT A1182s coo 48.32 72.26 30.89 48.69 69.28 31.53 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 53.63 68.24 34.99 53.08 69.10 33.16 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 75.01 61.87 32.93 75.34 59.26 31.96 -24.79 -2.98 13.13 -27.46 -2.42 12.49 ULMN 3 1ab4_c00 GYRASE A user 7 3 # 7 32 ARG C 58 ARG~? 18.42 O3 GOL D1181 78 HIS C 59 HIS~? 15.17 OXT ACT C1183 122 TYR B 91 TYR.? 11.41 O ACT C1183 coo 48.32 72.26 30.89 48.69 69.28 31.53 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 53.63 68.24 34.99 53.08 69.10 33.16 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 75.01 61.87 32.93 75.34 59.26 31.96 -54.93 -7.42 5.60 -53.90 -7.36 2.99 ULMN 3 1ab4_c00 GYRASE A user 8 3 # 8 32 ARG C 58 ARG~? 18.42 O3 GOL D1181 78 HIS C 59 HIS~? 15.17 OXT ACT C1183 122 TYR B 107 TYR~? -4.64 CH3 ACT C1183s coo 48.32 72.26 30.89 48.69 69.28 31.53 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 53.63 68.24 34.99 53.08 69.10 33.16 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 75.01 61.87 32.93 75.34 59.26 31.96 -65.76 -1.20 10.47 -63.11 -1.54 11.28 ULMN 3 1ab4_c00 GYRASE A user 9 3 # 9 32 ARG C 58 ARG~? 18.42 O3 GOL D1181 78 HIS C 59 HIS~? 15.17 OXT ACT C1183 122 TYR D 91 TYR.? 11.52 O ACT A1182 coo 48.32 72.26 30.89 48.69 69.28 31.53 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 53.63 68.24 34.99 53.08 69.10 33.16 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 75.01 61.87 32.93 75.34 59.26 31.96 -35.52 -10.04 9.46 -36.46 -12.45 10.54 ULMN 3 1ab4_c00 GYRASE A user 10 3 # 10 32 ARG C 58 ARG~? 18.42 O3 GOL D1181 78 HIS C 114 HIS^? 15.77 OXT ACT C1183 122 TYR B 107 TYR~? -4.64 CH3 ACT C1183s coo 48.32 72.26 30.89 48.69 69.28 31.53 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 53.63 68.24 34.99 53.08 69.10 33.16 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 75.01 61.87 32.93 75.34 59.26 31.96 -65.76 -1.20 10.47 -63.11 -1.54 11.28 ULMN 3 1ab4_c00 GYRASE A user 11 3 # 11 32 ARG D 58 ARG~? 14.52 O2 GOL D1181 78 HIS D 59 HIS~? 14.28 O ACT A1182 122 TYR A 107 TYR~? -4.55 CH3 ACT A1182s coo 48.32 72.26 30.89 48.69 69.28 31.53 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 53.63 68.24 34.99 53.08 69.10 33.16 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 75.01 61.87 32.93 75.34 59.26 31.96 -24.81 2.99 13.30 -27.48 2.42 13.94 ULMN 3 1ab4_c00 GYRASE A user 12 3 # 12 32 ARG D 58 ARG~? 14.52 O2 GOL D1181 78 HIS D 59 HIS~? 14.28 O ACT A1182 122 TYR B 107 TYR~? -4.64 CH3 ACT C1183s coo 48.32 72.26 30.89 48.69 69.28 31.53 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 53.63 68.24 34.99 53.08 69.10 33.16 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 75.01 61.87 32.93 75.34 59.26 31.96 -65.76 -1.20 10.47 -63.11 -1.54 11.28 ULMN 3 1ab4_c00 GYRASE A user 13 3 # 13 32 ARG D 58 ARG~? 14.52 O2 GOL D1181 78 HIS D 59 HIS~? 14.28 O ACT A1182 122 TYR C 107 TYR~? -4.63 CH3 ACT C1183s coo 48.32 72.26 30.89 48.69 69.28 31.53 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 53.63 68.24 34.99 53.08 69.10 33.16 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 75.01 61.87 32.93 75.34 59.26 31.96 -65.75 1.19 15.99 -63.10 1.53 15.19 1ab4_c00 source 1ab4 GYRASE A : 13 hits 1ab4_c00 naa= 3 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 1 3 # 1 B 223 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 262 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 312 ASP A 55 ASP.? 17.41 O ACT A1181 coo 23.86 29.50 91.20 24.12 31.58 91.00 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 29.35 31.42 99.15 28.72 33.09 98.04 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 20.42 28.25 99.26 20.25 29.62 97.63 -40.70 16.96 10.07 -41.68 17.42 8.23 1aj8_c01 source 1aj8 CITRATE SYNTHASE : 1 hits 1aj8_c01 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 73 ASP.? 22.06 O ACT A1182 187 GLU B 119 GLU.? 18.74 O3 GOL B1182 229 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 95 ASP~? 18.75 OXT ACT A1182 187 GLU A 121 GLU~? 23.87 OXT ACT A1182 229 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -30.02 14.86 26.58 -28.64 13.51 27.46 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -33.98 22.68 21.15 -32.78 23.95 19.94 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP A 156 ASP~? 10.59 O ACT A1181 187 GLU A 150 GLU.? 17.29 O ACT A1181 229 LYS A 149 LYS.? 8.87 O ACT A1181 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -43.03 24.31 5.88 -42.80 24.92 7.90 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP B 55 ASP.? 14.29 O3 GOL B1182 187 GLU B 150 GLU.? 13.13 O3 GOL B1182 229 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP B 73 ASP.? 22.00 OXT ACT C1183 187 GLU A 119 GLU.? 19.75 OXT ACT A1182 229 LYS A 117 LYS.? 20.14 O ACT A1181 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -52.42 20.74 13.73 -53.54 22.42 14.42 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -40.83 18.78 13.92 -42.39 17.53 13.21 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 6 3 # 6 33 ASP B 95 ASP.? 16.79 O ACT C1183 187 GLU B 121 GLU~? 20.57 CA CA B1183 229 LYS B 124 LYS~? 15.51 CA CA B1183 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -56.51 -16.27 -4.35 -57.29 -15.23 -6.03 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 7 3 # 7 33 ASP B 156 ASP~? 13.25 OXT ACT A1181 187 GLU B 150 GLU.? 13.13 O3 GOL B1182 229 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 8 3 # 8 33 ASP C 55 ASP.? 19.45 CA CA C1184 187 GLU C 150 GLU.? 16.95 CA CA C1184 229 LYS C 149 LYS.? 9.01 CA CA C1184 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -48.03 2.43 38.96 -48.57 4.48 38.82 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 9 3 # 9 33 ASP C 73 ASP.? 22.09 O ACT C1183 187 GLU D 119 GLU.? 19.65 O ACT A1182 229 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 10 3 # 10 33 ASP C 95 ASP~? 18.98 OXT ACT C1183 187 GLU C 121 GLU~? 20.76 CA CA C1184 229 LYS C 124 LYS~? 15.99 CA CA C1184 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -60.88 17.87 20.49 -62.76 18.57 19.77 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -56.38 16.29 30.73 -57.04 15.33 32.51 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 11 3 # 11 33 ASP C 156 ASP~? 12.06 O3 GOL D1181 187 GLU C 150 GLU.? 16.95 CA CA C1184 229 LYS C 149 LYS.? 9.01 CA CA C1184 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -48.03 2.43 38.96 -48.57 4.48 38.82 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 12 3 # 12 33 ASP D 73 ASP.? 21.98 OXT ACT A1182 187 GLU C 119 GLU.? 19.60 OXT ACT C1183 229 LYS C 117 LYS.? 21.58 CA CA C1184 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -38.49 8.41 31.97 -37.49 9.71 33.33 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -49.67 7.91 30.13 -48.14 6.69 29.28 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 13 3 # 13 33 ASP D 156 ASP~? 10.44 C2 GOL D1181 187 GLU D 150 GLU.? 17.20 O2 GOL D1181 229 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -40.00 -25.59 26.00 -40.81 -29.12 24.35 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 13 hits 1ald_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 84 ASP^? 7.98 OXT ACT A1182 35 SER A 88 SER.? 4.86 OXT ACT A1182 215 ASP D 84 ASP^? 8.02 O ACT A1182 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -36.44 3.40 10.01 -38.05 4.61 10.68 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -34.67 3.69 16.47 -32.74 5.08 16.23 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP A 152 ASP.? 5.90 O ACT A1181 35 SER A 153 SER.? 8.36 O ACT A1181 215 ASP A 156 ASP~? 10.59 O ACT A1181 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1am5_c04 PEPSIN user 3 3 # 3 32 ASP B 84 ASP^? 7.80 O ACT C1183 35 SER B 88 SER.? 4.64 O ACT C1183 215 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -54.22 1.68 8.96 -52.58 0.65 8.12 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1am5_c04 PEPSIN user 4 3 # 4 32 ASP B 152 ASP.? 8.52 O3 GOL B1182 35 SER B 153 SER.? 13.04 OXT ACT A1181 215 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1am5_c04 PEPSIN user 5 3 # 5 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 35 SER C 88 SER.? 4.69 OXT ACT C1183 215 ASP B 84 ASP^? 7.80 O ACT C1183 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -56.10 4.45 15.54 -58.39 5.12 16.05 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1am5_c04 PEPSIN user 6 3 # 6 32 ASP C 152 ASP.? 13.45 O3 GOL D1181 35 SER C 153 SER.? 12.45 O3 GOL D1181 215 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1am5_c04 PEPSIN user 7 3 # 7 32 ASP D 84 ASP^? 8.02 O ACT A1182 35 SER A 88 SER.? 4.86 OXT ACT A1182 215 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -34.67 3.69 16.47 -32.74 5.08 16.23 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1am5_c04 PEPSIN user 8 3 # 8 32 ASP D 84 ASP^? 8.02 O ACT A1182 35 SER D 88 SER.? 4.67 O ACT A1182 215 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1am5_c04 PEPSIN user 9 3 # 9 32 ASP D 152 ASP.? 5.75 O2 GOL D1181 35 SER D 153 SER.? 8.24 O2 GOL D1181 215 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1am5_c04 source 1am5 PEPSIN : 9 hits 1am5_c04 naa= 3 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 1 3 # 1 A 457 SER B 32 SER~? 5.72 CA CA B1183 A 630 CYH B 145 CYH.? 5.45 CA CA B1183 A 675 ASP B 144 ASP.? 6.66 CA CA B1183 coo 2.70 -0.05 22.31 2.42 1.39 24.24 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 0.87 7.55 27.28 1.82 5.91 25.24 -62.49 1.50 -10.58 -60.97 -0.38 -12.04 coo 0.10 3.62 28.03 1.23 2.44 26.67 -67.28 1.35 -10.84 -69.02 1.72 -11.95 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 2 3 # 2 A 457 SER B 133 SER^? 12.08 CA CA B1183 A 630 CYH B 145 CYH.? 5.45 CA CA B1183 A 675 ASP B 144 ASP.? 6.66 CA CA B1183 coo 2.70 -0.05 22.31 2.42 1.39 24.24 -65.35 0.26 -2.64 -65.36 -1.24 -4.55 coo 0.87 7.55 27.28 1.82 5.91 25.24 -62.49 1.50 -10.58 -60.97 -0.38 -12.04 coo 0.10 3.62 28.03 1.23 2.44 26.67 -67.28 1.35 -10.84 -69.02 1.72 -11.95 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 3 3 # 3 A 457 SER C 32 SER~? 5.57 CA CA C1184 A 630 CYH C 145 CYH.? 5.42 CA CA C1184 A 675 ASP C 144 ASP.? 6.69 CA CA C1184 coo 2.70 -0.05 22.31 2.42 1.39 24.24 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 0.87 7.55 27.28 1.82 5.91 25.24 -62.51 -1.53 37.02 -61.06 0.37 38.52 coo 0.10 3.62 28.03 1.23 2.44 26.67 -67.28 -1.35 37.26 -69.02 -1.78 38.35 ULMN 3 1amo_c00 NADPH-CYTOCHROME P450 REDUCTASE user 4 3 # 4 A 457 SER C 133 SER^? 12.04 CA CA C1184 A 630 CYH C 145 CYH.? 5.42 CA CA C1184 A 675 ASP C 144 ASP.? 6.69 CA CA C1184 coo 2.70 -0.05 22.31 2.42 1.39 24.24 -65.34 -0.23 29.09 -65.38 1.19 31.06 coo 0.87 7.55 27.28 1.82 5.91 25.24 -62.51 -1.53 37.02 -61.06 0.37 38.52 coo 0.10 3.62 28.03 1.23 2.44 26.67 -67.28 -1.35 37.26 -69.02 -1.78 38.35 1amo_c00 source 1amo NADPH-CYTOCHROME P450 REDUCTASE : 4 hits 1amo_c00 naa= 3 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 1 3 # 1 B 457 SER B 32 SER~? 5.72 CA CA B1183 B 630 CYH B 145 CYH.? 5.45 CA CA B1183 B 675 ASP B 144 ASP.? 6.66 CA CA B1183 coo 48.68 26.05 22.04 49.09 24.42 23.79 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 50.83 17.98 26.05 49.75 19.82 24.27 -62.49 1.50 -10.58 -60.97 -0.38 -12.04 coo 51.67 21.81 27.15 50.44 23.13 26.00 -67.28 1.35 -10.84 -69.02 1.72 -11.95 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 2 3 # 2 B 457 SER B 133 SER^? 12.08 CA CA B1183 B 630 CYH B 145 CYH.? 5.45 CA CA B1183 B 675 ASP B 144 ASP.? 6.66 CA CA B1183 coo 48.68 26.05 22.04 49.09 24.42 23.79 -65.35 0.26 -2.64 -65.36 -1.24 -4.55 coo 50.83 17.98 26.05 49.75 19.82 24.27 -62.49 1.50 -10.58 -60.97 -0.38 -12.04 coo 51.67 21.81 27.15 50.44 23.13 26.00 -67.28 1.35 -10.84 -69.02 1.72 -11.95 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 3 3 # 3 B 457 SER C 32 SER~? 5.57 CA CA C1184 B 630 CYH C 145 CYH.? 5.42 CA CA C1184 B 675 ASP C 144 ASP.? 6.69 CA CA C1184 coo 48.68 26.05 22.04 49.09 24.42 23.79 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 50.83 17.98 26.05 49.75 19.82 24.27 -62.51 -1.53 37.02 -61.06 0.37 38.52 coo 51.67 21.81 27.15 50.44 23.13 26.00 -67.28 -1.35 37.26 -69.02 -1.78 38.35 ULMN 3 1amo_c01 NADPH-CYTOCHROME P450 REDUCTASE user 4 3 # 4 B 457 SER C 133 SER^? 12.04 CA CA C1184 B 630 CYH C 145 CYH.? 5.42 CA CA C1184 B 675 ASP C 144 ASP.? 6.69 CA CA C1184 coo 48.68 26.05 22.04 49.09 24.42 23.79 -65.34 -0.23 29.09 -65.38 1.19 31.06 coo 50.83 17.98 26.05 49.75 19.82 24.27 -62.51 -1.53 37.02 -61.06 0.37 38.52 coo 51.67 21.81 27.15 50.44 23.13 26.00 -67.28 -1.35 37.26 -69.02 -1.78 38.35 1amo_c01 source 1amo NADPH-CYTOCHROME P450 REDUCTASE : 4 hits 1amo_c01 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 84 ASP^? 7.98 OXT ACT A1182 214 ASP D 144 ASP.? 22.37 O2 GOL D1181 289 ASP D 84 ASP^? 8.02 O ACT A1182 coo -0.62 65.95 29.97 0.31 67.47 31.05 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 84 ASP^? 7.98 OXT ACT A1182 214 ASP D 152 ASP.? 5.75 O2 GOL D1181 289 ASP D 84 ASP^? 8.02 O ACT A1182 coo -0.62 65.95 29.97 0.31 67.47 31.05 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 26.86 59.76 46.36 25.42 58.23 45.92 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 9.42 68.07 30.27 7.35 68.27 30.10 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 95 ASP~? 18.75 OXT ACT A1182 214 ASP C 84 ASP^? 7.78 OXT ACT C1183 289 ASP D 73 ASP.? 21.98 OXT ACT A1182 coo -0.62 65.95 29.97 0.31 67.47 31.05 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 26.86 59.76 46.36 25.42 58.23 45.92 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.49 8.41 31.97 -37.49 9.71 33.33 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 95 ASP~? 18.75 OXT ACT A1182 214 ASP C 95 ASP~? 18.98 OXT ACT C1183 289 ASP D 73 ASP.? 21.98 OXT ACT A1182 coo -0.62 65.95 29.97 0.31 67.47 31.05 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 26.86 59.76 46.36 25.42 58.23 45.92 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 9.42 68.07 30.27 7.35 68.27 30.10 -38.49 8.41 31.97 -37.49 9.71 33.33 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 152 ASP.? 5.90 O ACT A1181 214 ASP A 73 ASP.? 22.06 O ACT A1182 289 ASP A 156 ASP~? 10.59 O ACT A1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 84 ASP^? 7.80 O ACT C1183 214 ASP C 144 ASP.? 6.69 CA CA C1184 289 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo -0.62 65.95 29.97 0.31 67.47 31.05 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 26.86 59.76 46.36 25.42 58.23 45.92 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP B 84 ASP^? 7.80 O ACT C1183 214 ASP C 152 ASP.? 13.45 O3 GOL D1181 289 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo -0.62 65.95 29.97 0.31 67.47 31.05 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 26.86 59.76 46.36 25.42 58.23 45.92 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP B 95 ASP.? 16.79 O ACT C1183 214 ASP C 156 ASP~? 12.06 O3 GOL D1181 289 ASP C 73 ASP.? 22.09 O ACT C1183 coo -0.62 65.95 29.97 0.31 67.47 31.05 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 26.86 59.76 46.36 25.42 58.23 45.92 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -52.43 -20.77 12.85 -53.47 -22.46 12.11 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP B 95 ASP.? 16.79 O ACT C1183 214 ASP D 14 ASP~? 14.81 O1 GOL D1181 289 ASP C 73 ASP.? 22.09 O ACT C1183 coo -0.62 65.95 29.97 0.31 67.47 31.05 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 26.86 59.76 46.36 25.42 58.23 45.92 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 9.42 68.07 30.27 7.35 68.27 30.10 -52.43 -20.77 12.85 -53.47 -22.46 12.11 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP B 152 ASP.? 8.52 O3 GOL B1182 214 ASP A 144 ASP.? 22.46 O ACT A1181 289 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP B 152 ASP.? 8.52 O3 GOL B1182 214 ASP B 73 ASP.? 22.00 OXT ACT C1183 289 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 26.86 59.76 46.36 25.42 58.23 45.92 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP B 156 ASP~? 13.25 OXT ACT A1181 214 ASP C 95 ASP~? 18.98 OXT ACT C1183 289 ASP A 156 ASP~? 10.59 O ACT A1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 26.86 59.76 46.36 25.42 58.23 45.92 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP C 84 ASP^? 7.78 OXT ACT C1183 214 ASP B 144 ASP.? 6.66 CA CA B1183 289 ASP B 84 ASP^? 7.80 O ACT C1183 coo -0.62 65.95 29.97 0.31 67.47 31.05 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 26.86 59.76 46.36 25.42 58.23 45.92 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 9.42 68.07 30.27 7.35 68.27 30.10 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP C 84 ASP^? 7.78 OXT ACT C1183 214 ASP B 152 ASP.? 8.52 O3 GOL B1182 289 ASP B 84 ASP^? 7.80 O ACT C1183 coo -0.62 65.95 29.97 0.31 67.47 31.05 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 26.86 59.76 46.36 25.42 58.23 45.92 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 9.42 68.07 30.27 7.35 68.27 30.10 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP C 95 ASP~? 18.98 OXT ACT C1183 214 ASP A 14 ASP~? 14.99 CH3 ACT A1181 289 ASP B 73 ASP.? 22.00 OXT ACT C1183 coo -0.62 65.95 29.97 0.31 67.47 31.05 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 9.42 68.07 30.27 7.35 68.27 30.10 -52.42 20.74 13.73 -53.54 22.42 14.42 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP C 95 ASP~? 18.98 OXT ACT C1183 214 ASP A 95 ASP~? 18.75 OXT ACT A1182 289 ASP B 73 ASP.? 22.00 OXT ACT C1183 coo -0.62 65.95 29.97 0.31 67.47 31.05 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 9.42 68.07 30.27 7.35 68.27 30.10 -52.42 20.74 13.73 -53.54 22.42 14.42 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP C 95 ASP~? 18.98 OXT ACT C1183 214 ASP B 156 ASP~? 13.25 OXT ACT A1181 289 ASP B 73 ASP.? 22.00 OXT ACT C1183 coo -0.62 65.95 29.97 0.31 67.47 31.05 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 26.86 59.76 46.36 25.42 58.23 45.92 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 -52.42 20.74 13.73 -53.54 22.42 14.42 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP C 152 ASP.? 13.45 O3 GOL D1181 214 ASP C 73 ASP.? 22.09 O ACT C1183 289 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 26.86 59.76 46.36 25.42 58.23 45.92 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP C 152 ASP.? 13.45 O3 GOL D1181 214 ASP D 144 ASP.? 22.37 O2 GOL D1181 289 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP C 156 ASP~? 12.06 O3 GOL D1181 214 ASP B 95 ASP.? 16.79 O ACT C1183 289 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 21 3 # 21 179 ASP D 84 ASP^? 8.02 O ACT A1182 214 ASP A 144 ASP.? 22.46 O ACT A1181 289 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo -0.62 65.95 29.97 0.31 67.47 31.05 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 26.86 59.76 46.36 25.42 58.23 45.92 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 9.42 68.07 30.27 7.35 68.27 30.10 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 22 3 # 22 179 ASP D 84 ASP^? 8.02 O ACT A1182 214 ASP A 152 ASP.? 5.90 O ACT A1181 289 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo -0.62 65.95 29.97 0.31 67.47 31.05 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 26.86 59.76 46.36 25.42 58.23 45.92 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 9.42 68.07 30.27 7.35 68.27 30.10 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 23 3 # 23 179 ASP D 152 ASP.? 5.75 O2 GOL D1181 214 ASP D 73 ASP.? 21.98 OXT ACT A1182 289 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 26.86 59.76 46.36 25.42 58.23 45.92 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 23 hits 1amy_c01 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 152 ASP.? 5.90 O ACT A1181 227 GLU A 119 GLU.? 19.75 OXT ACT A1182 289 ASP A 156 ASP~? 10.59 O ACT A1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 152 ASP.? 5.90 O ACT A1181 227 GLU A 139 GLU.? 21.64 O ACT A1181 289 ASP A 156 ASP~? 10.59 O ACT A1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 156 ASP~? 10.59 O ACT A1181 227 GLU A 119 GLU.? 19.75 OXT ACT A1182 289 ASP A 152 ASP.? 5.90 O ACT A1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.60 24.63 -2.03 -43.51 24.01 -4.05 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 152 ASP.? 8.52 O3 GOL B1182 227 GLU B 119 GLU.? 18.74 O3 GOL B1182 289 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 3.96 55.76 41.24 4.83 57.69 41.17 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 152 ASP.? 8.52 O3 GOL B1182 227 GLU B 139 GLU.? 13.29 O3 GOL B1182 289 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 3.96 55.76 41.24 4.83 57.69 41.17 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 156 ASP~? 13.25 OXT ACT A1181 227 GLU B 119 GLU.? 18.74 O3 GOL B1182 289 ASP B 152 ASP.? 8.52 O3 GOL B1182 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 3.96 55.76 41.24 4.83 57.69 41.17 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 9.42 68.07 30.27 7.35 68.27 30.10 -47.04 4.74 -15.30 -47.17 6.82 -15.76 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 152 ASP.? 13.45 O3 GOL D1181 227 GLU C 119 GLU.? 19.60 OXT ACT C1183 289 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 3.96 55.76 41.24 4.83 57.69 41.17 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP C 156 ASP~? 12.06 O3 GOL D1181 227 GLU C 119 GLU.? 19.60 OXT ACT C1183 289 ASP C 152 ASP.? 13.45 O3 GOL D1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 -47.03 -4.77 41.79 -47.13 -6.84 42.24 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP D 152 ASP.? 5.75 O2 GOL D1181 227 GLU D 119 GLU.? 19.65 O ACT A1182 289 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP D 152 ASP.? 5.75 O2 GOL D1181 227 GLU D 139 GLU.? 21.84 O2 GOL D1181 289 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 3.96 55.76 41.24 4.83 57.69 41.17 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP D 156 ASP~? 10.44 C2 GOL D1181 227 GLU D 119 GLU.? 19.65 O ACT A1182 289 ASP D 152 ASP.? 5.75 O2 GOL D1181 coo -0.62 65.95 29.97 0.31 67.47 31.05 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 9.42 68.07 30.27 7.35 68.27 30.10 -43.59 -24.59 28.46 -43.51 -24.00 30.49 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 11 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 84 ASP^? 7.98 OXT ACT A1182 E 36 SER A 88 SER.? 4.86 OXT ACT A1182 E 213 ASP D 84 ASP^? 8.02 O ACT A1182 coo 26.30 12.96 16.78 25.46 12.99 18.72 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 28.33 15.15 21.27 28.70 13.12 19.97 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 20.15 16.04 19.79 21.65 14.49 19.86 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP A 152 ASP.? 5.90 O ACT A1181 E 36 SER A 153 SER.? 8.36 O ACT A1181 E 213 ASP A 156 ASP~? 10.59 O ACT A1181 coo 26.30 12.96 16.78 25.46 12.99 18.72 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 28.33 15.15 21.27 28.70 13.12 19.97 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 20.15 16.04 19.79 21.65 14.49 19.86 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 3 3 # 3 E 33 ASP B 84 ASP^? 7.80 O ACT C1183 E 36 SER B 88 SER.? 4.64 O ACT C1183 E 213 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 26.30 12.96 16.78 25.46 12.99 18.72 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 28.33 15.15 21.27 28.70 13.12 19.97 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 20.15 16.04 19.79 21.65 14.49 19.86 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 4 3 # 4 E 33 ASP B 84 ASP^? 7.80 O ACT C1183 E 36 SER C 88 SER.? 4.69 OXT ACT C1183 E 213 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 26.30 12.96 16.78 25.46 12.99 18.72 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 28.33 15.15 21.27 28.70 13.12 19.97 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 20.15 16.04 19.79 21.65 14.49 19.86 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 5 3 # 5 E 33 ASP B 152 ASP.? 8.52 O3 GOL B1182 E 36 SER B 153 SER.? 13.04 OXT ACT A1181 E 213 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 26.30 12.96 16.78 25.46 12.99 18.72 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 28.33 15.15 21.27 28.70 13.12 19.97 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo 20.15 16.04 19.79 21.65 14.49 19.86 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 6 3 # 6 E 33 ASP C 84 ASP^? 7.78 OXT ACT C1183 E 36 SER B 88 SER.? 4.64 O ACT C1183 E 213 ASP B 84 ASP^? 7.80 O ACT C1183 coo 26.30 12.96 16.78 25.46 12.99 18.72 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 28.33 15.15 21.27 28.70 13.12 19.97 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 20.15 16.04 19.79 21.65 14.49 19.86 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 7 3 # 7 E 33 ASP C 84 ASP^? 7.78 OXT ACT C1183 E 36 SER C 88 SER.? 4.69 OXT ACT C1183 E 213 ASP B 84 ASP^? 7.80 O ACT C1183 coo 26.30 12.96 16.78 25.46 12.99 18.72 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 28.33 15.15 21.27 28.70 13.12 19.97 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 20.15 16.04 19.79 21.65 14.49 19.86 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 8 3 # 8 E 33 ASP C 152 ASP.? 13.45 O3 GOL D1181 E 36 SER C 153 SER.? 12.45 O3 GOL D1181 E 213 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 26.30 12.96 16.78 25.46 12.99 18.72 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 28.33 15.15 21.27 28.70 13.12 19.97 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo 20.15 16.04 19.79 21.65 14.49 19.86 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 9 3 # 9 E 33 ASP D 84 ASP^? 8.02 O ACT A1182 E 36 SER A 88 SER.? 4.86 OXT ACT A1182 E 213 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 26.30 12.96 16.78 25.46 12.99 18.72 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 28.33 15.15 21.27 28.70 13.12 19.97 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 20.15 16.04 19.79 21.65 14.49 19.86 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 10 3 # 10 E 33 ASP D 84 ASP^? 8.02 O ACT A1182 E 36 SER D 88 SER.? 4.67 O ACT A1182 E 213 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 26.30 12.96 16.78 25.46 12.99 18.72 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 28.33 15.15 21.27 28.70 13.12 19.97 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 20.15 16.04 19.79 21.65 14.49 19.86 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 11 3 # 11 E 33 ASP D 152 ASP.? 5.75 O2 GOL D1181 E 36 SER D 153 SER.? 8.24 O2 GOL D1181 E 213 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 26.30 12.96 16.78 25.46 12.99 18.72 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 28.33 15.15 21.27 28.70 13.12 19.97 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo 20.15 16.04 19.79 21.65 14.49 19.86 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 11 hits 1apt_c04 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS A 151 HIS.? 15.84 O ACT A1181 254 LYS A 149 LYS.? 8.87 O ACT A1181 333 ARG A 58 ARG~? 14.46 O ACT A1181 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -46.06 27.03 4.30 -45.69 27.09 6.36 coo 26.09 4.87 14.60 27.89 3.33 10.26 -40.01 25.58 0.52 -39.09 27.65 -5.03 coo 37.35 7.47 11.84 34.90 6.11 10.60 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS B 151 HIS.? 14.53 O3 GOL B1182 254 LYS B 149 LYS.? 7.98 O3 GOL B1182 333 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 26.09 4.87 14.60 27.89 3.33 10.26 -50.82 2.31 -15.26 -51.03 5.84 -20.47 coo 37.35 7.47 11.84 34.90 6.11 10.60 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 3 3 # 3 232 HIS C 151 HIS.? 19.99 CA CA C1184 254 LYS C 149 LYS.? 9.01 CA CA C1184 333 ARG C 58 ARG~? 18.42 O3 GOL D1181 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 26.09 4.87 14.60 27.89 3.33 10.26 -50.86 -2.28 41.74 -55.49 -4.16 43.55 coo 37.35 7.47 11.84 34.90 6.11 10.60 -48.43 -0.71 31.25 -46.65 0.17 33.60 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 4 3 # 4 232 HIS D 151 HIS.? 15.73 O2 GOL D1181 254 LYS D 149 LYS.? 13.85 O2 GOL D1181 333 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo 26.09 4.87 14.60 27.89 3.33 10.26 -40.00 -25.59 26.00 -40.81 -29.12 24.35 coo 37.35 7.47 11.84 34.90 6.11 10.60 -43.20 -16.00 21.95 -43.92 -18.81 20.94 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 4 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 53 SER^? 12.21 OXT ACT A1182 A 292 ASP B 73 ASP.? 22.00 OXT ACT C1183 A 322 HIS A 43 HIS~? 14.01 CH3 ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 19.73 19.18 41.39 21.50 18.65 40.34 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.65 8.05 3.64 -22.04 7.30 5.57 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 53 SER^? 12.21 OXT ACT A1182 A 292 ASP B 84 ASP^? 7.80 O ACT C1183 A 322 HIS A 43 HIS~? 14.01 CH3 ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 19.73 19.18 41.39 21.50 18.65 40.34 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.65 8.05 3.64 -22.04 7.30 5.57 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 53 SER^? 12.21 OXT ACT A1182 A 292 ASP D 73 ASP.? 21.98 OXT ACT A1182 A 322 HIS A 43 HIS~? 14.01 CH3 ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 19.73 19.18 41.39 21.50 18.65 40.34 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.65 8.05 3.64 -22.04 7.30 5.57 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER A 56 SER.? 20.33 OXT ACT A1182 A 292 ASP C 55 ASP.? 19.45 CA CA C1184 A 322 HIS A 151 HIS.? 15.84 O ACT A1181 coo 36.34 32.23 39.60 36.43 34.62 39.93 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 19.73 19.18 41.39 21.50 18.65 40.34 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 41.69 45.14 46.60 41.78 47.19 46.18 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER A 56 SER.? 20.33 OXT ACT A1182 A 292 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 322 HIS A 151 HIS.? 15.84 O ACT A1181 coo 36.34 32.23 39.60 36.43 34.62 39.93 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 19.73 19.18 41.39 21.50 18.65 40.34 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER A 56 SER.? 20.33 OXT ACT A1182 A 292 ASP D 73 ASP.? 21.98 OXT ACT A1182 A 322 HIS A 151 HIS.? 15.84 O ACT A1181 coo 36.34 32.23 39.60 36.43 34.62 39.93 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 19.73 19.18 41.39 21.50 18.65 40.34 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER A 56 SER.? 20.33 OXT ACT A1182 A 292 ASP D 84 ASP^? 8.02 O ACT A1182 A 322 HIS A 151 HIS.? 15.84 O ACT A1181 coo 36.34 32.23 39.60 36.43 34.62 39.93 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 19.73 19.18 41.39 21.50 18.65 40.34 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 41.69 45.14 46.60 41.78 47.19 46.18 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER A 67 SER~? 15.83 O ACT A1182 A 292 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 322 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -39.02 0.91 0.50 -41.06 2.13 -0.03 coo 19.73 19.18 41.39 21.50 18.65 40.34 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 A 194 SER A 88 SER.? 4.86 OXT ACT A1182 A 292 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 322 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 19.73 19.18 41.39 21.50 18.65 40.34 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 41.69 45.14 46.60 41.78 47.19 46.18 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 A 194 SER A 88 SER.? 4.86 OXT ACT A1182 A 292 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 322 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 A 194 SER A 89 SER.? 7.33 OXT ACT A1182 A 292 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 322 HIS D 43 HIS~? 14.01 CH3 ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 19.73 19.18 41.39 21.50 18.65 40.34 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.76 -7.99 22.88 -22.00 -7.32 20.90 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 A 194 SER A 89 SER.? 7.33 OXT ACT A1182 A 292 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 322 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 19.73 19.18 41.39 21.50 18.65 40.34 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 41.69 45.14 46.60 41.78 47.19 46.18 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 13 3 # 13 A 194 SER A 89 SER.? 7.33 OXT ACT A1182 A 292 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 322 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 14 3 # 14 A 194 SER B 53 SER^? 12.05 O ACT C1183 A 292 ASP A 73 ASP.? 22.06 O ACT A1182 A 322 HIS B 43 HIS~? 14.15 CH3 ACT C1183 coo 36.34 32.23 39.60 36.43 34.62 39.93 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 19.73 19.18 41.39 21.50 18.65 40.34 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 41.69 45.14 46.60 41.78 47.19 46.18 -68.93 5.59 2.00 -68.67 4.03 3.39 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 15 3 # 15 A 194 SER B 53 SER^? 12.05 O ACT C1183 A 292 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 322 HIS B 43 HIS~? 14.15 CH3 ACT C1183 coo 36.34 32.23 39.60 36.43 34.62 39.93 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 19.73 19.18 41.39 21.50 18.65 40.34 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 41.69 45.14 46.60 41.78 47.19 46.18 -68.93 5.59 2.00 -68.67 4.03 3.39 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 16 3 # 16 A 194 SER B 53 SER^? 12.05 O ACT C1183 A 292 ASP C 73 ASP.? 22.09 O ACT C1183 A 322 HIS B 43 HIS~? 14.15 CH3 ACT C1183 coo 36.34 32.23 39.60 36.43 34.62 39.93 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 19.73 19.18 41.39 21.50 18.65 40.34 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 41.69 45.14 46.60 41.78 47.19 46.18 -68.93 5.59 2.00 -68.67 4.03 3.39 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 17 3 # 17 A 194 SER B 56 SER.? 19.73 O3 GOL B1182 A 292 ASP C 73 ASP.? 22.09 O ACT C1183 A 322 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 19.73 19.18 41.39 21.50 18.65 40.34 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 41.69 45.14 46.60 41.78 47.19 46.18 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 18 3 # 18 A 194 SER B 56 SER.? 19.73 O3 GOL B1182 A 292 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 322 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 19.73 19.18 41.39 21.50 18.65 40.34 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 19 3 # 19 A 194 SER B 56 SER.? 19.73 O3 GOL B1182 A 292 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 322 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 20 3 # 20 A 194 SER B 56 SER.? 19.73 O3 GOL B1182 A 292 ASP D 84 ASP^? 8.02 O ACT A1182 A 322 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 19.73 19.18 41.39 21.50 18.65 40.34 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 41.69 45.14 46.60 41.78 47.19 46.18 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 21 3 # 21 A 194 SER B 67 SER~? 15.74 OXT ACT C1183 A 292 ASP D 84 ASP^? 8.02 O ACT A1182 A 322 HIS A 151 HIS.? 15.84 O ACT A1181 coo 36.34 32.23 39.60 36.43 34.62 39.93 -51.74 11.42 7.51 -49.69 11.53 6.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 41.69 45.14 46.60 41.78 47.19 46.18 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 22 3 # 22 A 194 SER B 89 SER.? 7.47 O ACT C1183 A 292 ASP C 55 ASP.? 19.45 CA CA C1184 A 322 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 19.73 19.18 41.39 21.50 18.65 40.34 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 41.69 45.14 46.60 41.78 47.19 46.18 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 23 3 # 23 A 194 SER B 89 SER.? 7.47 O ACT C1183 A 292 ASP D 84 ASP^? 8.02 O ACT A1182 A 322 HIS C 43 HIS~? 14.16 CH3 ACT C1183 coo 36.34 32.23 39.60 36.43 34.62 39.93 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 19.73 19.18 41.39 21.50 18.65 40.34 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 41.69 45.14 46.60 41.78 47.19 46.18 -69.05 -5.52 24.49 -68.63 -4.06 23.04 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 24 3 # 24 A 194 SER B 89 SER.? 7.47 O ACT C1183 A 292 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 322 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 19.73 19.18 41.39 21.50 18.65 40.34 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 41.69 45.14 46.60 41.78 47.19 46.18 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 25 3 # 25 A 194 SER C 53 SER^? 12.05 OXT ACT C1183 A 292 ASP B 73 ASP.? 22.00 OXT ACT C1183 A 322 HIS C 43 HIS~? 14.16 CH3 ACT C1183 coo 36.34 32.23 39.60 36.43 34.62 39.93 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 19.73 19.18 41.39 21.50 18.65 40.34 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 41.69 45.14 46.60 41.78 47.19 46.18 -69.05 -5.52 24.49 -68.63 -4.06 23.04 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 26 3 # 26 A 194 SER C 53 SER^? 12.05 OXT ACT C1183 A 292 ASP D 73 ASP.? 21.98 OXT ACT A1182 A 322 HIS C 43 HIS~? 14.16 CH3 ACT C1183 coo 36.34 32.23 39.60 36.43 34.62 39.93 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 19.73 19.18 41.39 21.50 18.65 40.34 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -69.05 -5.52 24.49 -68.63 -4.06 23.04 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 27 3 # 27 A 194 SER C 53 SER^? 12.05 OXT ACT C1183 A 292 ASP D 84 ASP^? 8.02 O ACT A1182 A 322 HIS C 43 HIS~? 14.16 CH3 ACT C1183 coo 36.34 32.23 39.60 36.43 34.62 39.93 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 19.73 19.18 41.39 21.50 18.65 40.34 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 41.69 45.14 46.60 41.78 47.19 46.18 -69.05 -5.52 24.49 -68.63 -4.06 23.04 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 28 3 # 28 A 194 SER C 56 SER.? 20.22 OXT ACT C1183 A 292 ASP A 55 ASP.? 17.41 O ACT A1181 A 322 HIS C 151 HIS.? 19.99 CA CA C1184 coo 36.34 32.23 39.60 36.43 34.62 39.93 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 29 3 # 29 A 194 SER C 56 SER.? 20.22 OXT ACT C1183 A 292 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 322 HIS C 151 HIS.? 19.99 CA CA C1184 coo 36.34 32.23 39.60 36.43 34.62 39.93 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 19.73 19.18 41.39 21.50 18.65 40.34 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 41.69 45.14 46.60 41.78 47.19 46.18 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 30 3 # 30 A 194 SER C 56 SER.? 20.22 OXT ACT C1183 A 292 ASP B 73 ASP.? 22.00 OXT ACT C1183 A 322 HIS C 151 HIS.? 19.99 CA CA C1184 coo 36.34 32.23 39.60 36.43 34.62 39.93 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 19.73 19.18 41.39 21.50 18.65 40.34 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 41.69 45.14 46.60 41.78 47.19 46.18 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 31 3 # 31 A 194 SER C 56 SER.? 20.22 OXT ACT C1183 A 292 ASP B 84 ASP^? 7.80 O ACT C1183 A 322 HIS C 151 HIS.? 19.99 CA CA C1184 coo 36.34 32.23 39.60 36.43 34.62 39.93 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 19.73 19.18 41.39 21.50 18.65 40.34 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 41.69 45.14 46.60 41.78 47.19 46.18 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 32 3 # 32 A 194 SER C 67 SER~? 15.70 O ACT C1183 A 292 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 322 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 36.34 32.23 39.60 36.43 34.62 39.93 -51.74 -11.42 18.94 -49.72 -11.51 20.26 coo 19.73 19.18 41.39 21.50 18.65 40.34 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 41.69 45.14 46.60 41.78 47.19 46.18 -45.79 -27.28 22.21 -45.52 -27.23 20.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 33 3 # 33 A 194 SER C 88 SER.? 4.69 OXT ACT C1183 A 292 ASP A 156 ASP~? 10.59 O ACT A1181 A 322 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 36.34 32.23 39.60 36.43 34.62 39.93 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 19.73 19.18 41.39 21.50 18.65 40.34 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 41.69 45.14 46.60 41.78 47.19 46.18 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 34 3 # 34 A 194 SER C 88 SER.? 4.69 OXT ACT C1183 A 292 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 322 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 36.34 32.23 39.60 36.43 34.62 39.93 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 19.73 19.18 41.39 21.50 18.65 40.34 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 41.69 45.14 46.60 41.78 47.19 46.18 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 35 3 # 35 A 194 SER C 89 SER.? 7.45 OXT ACT C1183 A 292 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 322 HIS B 43 HIS~? 14.15 CH3 ACT C1183 coo 36.34 32.23 39.60 36.43 34.62 39.93 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 19.73 19.18 41.39 21.50 18.65 40.34 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 41.69 45.14 46.60 41.78 47.19 46.18 -68.93 5.59 2.00 -68.67 4.03 3.39 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 36 3 # 36 A 194 SER C 89 SER.? 7.45 OXT ACT C1183 A 292 ASP A 156 ASP~? 10.59 O ACT A1181 A 322 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 36.34 32.23 39.60 36.43 34.62 39.93 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 19.73 19.18 41.39 21.50 18.65 40.34 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 41.69 45.14 46.60 41.78 47.19 46.18 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 37 3 # 37 A 194 SER C 89 SER.? 7.45 OXT ACT C1183 A 292 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 322 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 36.34 32.23 39.60 36.43 34.62 39.93 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 19.73 19.18 41.39 21.50 18.65 40.34 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 41.69 45.14 46.60 41.78 47.19 46.18 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 38 3 # 38 A 194 SER D 53 SER^? 12.18 O ACT A1182 A 292 ASP A 73 ASP.? 22.06 O ACT A1182 A 322 HIS D 43 HIS~? 14.01 CH3 ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 19.73 19.18 41.39 21.50 18.65 40.34 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.76 -7.99 22.88 -22.00 -7.32 20.90 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 39 3 # 39 A 194 SER D 53 SER^? 12.18 O ACT A1182 A 292 ASP C 73 ASP.? 22.09 O ACT C1183 A 322 HIS D 43 HIS~? 14.01 CH3 ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 19.73 19.18 41.39 21.50 18.65 40.34 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.76 -7.99 22.88 -22.00 -7.32 20.90 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 40 3 # 40 A 194 SER D 53 SER^? 12.18 O ACT A1182 A 292 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 322 HIS D 43 HIS~? 14.01 CH3 ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 19.73 19.18 41.39 21.50 18.65 40.34 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.76 -7.99 22.88 -22.00 -7.32 20.90 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 41 3 # 41 A 194 SER D 56 SER.? 20.40 O ACT A1182 A 292 ASP A 73 ASP.? 22.06 O ACT A1182 A 322 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 36.34 32.23 39.60 36.43 34.62 39.93 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 19.73 19.18 41.39 21.50 18.65 40.34 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 41.69 45.14 46.60 41.78 47.19 46.18 -45.79 -27.28 22.21 -45.52 -27.23 20.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 42 3 # 42 A 194 SER D 56 SER.? 20.40 O ACT A1182 A 292 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 322 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 36.34 32.23 39.60 36.43 34.62 39.93 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 19.73 19.18 41.39 21.50 18.65 40.34 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 41.69 45.14 46.60 41.78 47.19 46.18 -45.79 -27.28 22.21 -45.52 -27.23 20.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 43 3 # 43 A 194 SER D 56 SER.? 20.40 O ACT A1182 A 292 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 322 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 36.34 32.23 39.60 36.43 34.62 39.93 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 19.73 19.18 41.39 21.50 18.65 40.34 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 41.69 45.14 46.60 41.78 47.19 46.18 -45.79 -27.28 22.21 -45.52 -27.23 20.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 44 3 # 44 A 194 SER D 56 SER.? 20.40 O ACT A1182 A 292 ASP B 84 ASP^? 7.80 O ACT C1183 A 322 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 36.34 32.23 39.60 36.43 34.62 39.93 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 19.73 19.18 41.39 21.50 18.65 40.34 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 41.69 45.14 46.60 41.78 47.19 46.18 -45.79 -27.28 22.21 -45.52 -27.23 20.13 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 45 3 # 45 A 194 SER D 67 SER~? 15.83 OXT ACT A1182 A 292 ASP B 84 ASP^? 7.80 O ACT C1183 A 322 HIS C 151 HIS.? 19.99 CA CA C1184 coo 36.34 32.23 39.60 36.43 34.62 39.93 -39.02 -0.93 25.94 -41.07 -2.17 26.53 coo 19.73 19.18 41.39 21.50 18.65 40.34 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 41.69 45.14 46.60 41.78 47.19 46.18 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 46 3 # 46 A 194 SER D 88 SER.? 4.67 O ACT A1182 A 292 ASP A 55 ASP.? 17.41 O ACT A1181 A 322 HIS D 114 HIS^? 15.97 O ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -34.02 -15.52 17.15 -35.80 -16.25 16.32 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 47 3 # 47 A 194 SER D 89 SER.? 7.37 O ACT A1182 A 292 ASP A 55 ASP.? 17.41 O ACT A1181 A 322 HIS D 114 HIS^? 15.97 O ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 19.73 19.18 41.39 21.50 18.65 40.34 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 41.69 45.14 46.60 41.78 47.19 46.18 -34.02 -15.52 17.15 -35.80 -16.25 16.32 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 48 3 # 48 A 194 SER D 89 SER.? 7.37 O ACT A1182 A 292 ASP B 84 ASP^? 7.80 O ACT C1183 A 322 HIS A 43 HIS~? 14.01 CH3 ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 19.73 19.18 41.39 21.50 18.65 40.34 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.65 8.05 3.64 -22.04 7.30 5.57 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 49 3 # 49 A 194 SER D 89 SER.? 7.37 O ACT A1182 A 292 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 322 HIS D 114 HIS^? 15.97 O ACT A1182 coo 36.34 32.23 39.60 36.43 34.62 39.93 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 19.73 19.18 41.39 21.50 18.65 40.34 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 41.69 45.14 46.60 41.78 47.19 46.18 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 49 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 53 SER^? 12.21 OXT ACT A1182 B 292 ASP B 73 ASP.? 22.00 OXT ACT C1183 B 322 HIS A 43 HIS~? 14.01 CH3 ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.65 8.05 3.64 -22.04 7.30 5.57 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 53 SER^? 12.21 OXT ACT A1182 B 292 ASP B 84 ASP^? 7.80 O ACT C1183 B 322 HIS A 43 HIS~? 14.01 CH3 ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.65 8.05 3.64 -22.04 7.30 5.57 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER A 53 SER^? 12.21 OXT ACT A1182 B 292 ASP D 73 ASP.? 21.98 OXT ACT A1182 B 322 HIS A 43 HIS~? 14.01 CH3 ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.65 8.05 3.64 -22.04 7.30 5.57 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER A 56 SER.? 20.33 OXT ACT A1182 B 292 ASP C 55 ASP.? 19.45 CA CA C1184 B 322 HIS A 151 HIS.? 15.84 O ACT A1181 coo 35.42 71.28 22.94 36.24 69.06 22.37 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 24.74 78.07 5.59 24.32 79.03 7.46 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 48.81 64.16 26.34 49.30 62.16 26.73 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER A 56 SER.? 20.33 OXT ACT A1182 B 292 ASP D 73 ASP.? 21.98 OXT ACT A1182 B 322 HIS A 151 HIS.? 15.84 O ACT A1181 coo 35.42 71.28 22.94 36.24 69.06 22.37 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 24.74 78.07 5.59 24.32 79.03 7.46 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER A 56 SER.? 20.33 OXT ACT A1182 B 292 ASP D 84 ASP^? 8.02 O ACT A1182 B 322 HIS A 151 HIS.? 15.84 O ACT A1181 coo 35.42 71.28 22.94 36.24 69.06 22.37 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 24.74 78.07 5.59 24.32 79.03 7.46 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 48.81 64.16 26.34 49.30 62.16 26.73 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER A 67 SER~? 15.83 O ACT A1182 B 292 ASP C 84 ASP^? 7.78 OXT ACT C1183 B 322 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -39.02 0.91 0.50 -41.06 2.13 -0.03 coo 24.74 78.07 5.59 24.32 79.03 7.46 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 B 194 SER A 88 SER.? 4.86 OXT ACT A1182 B 292 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 322 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 24.74 78.07 5.59 24.32 79.03 7.46 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 48.81 64.16 26.34 49.30 62.16 26.73 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 B 194 SER A 88 SER.? 4.86 OXT ACT A1182 B 292 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 322 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 24.74 78.07 5.59 24.32 79.03 7.46 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 B 194 SER A 89 SER.? 7.33 OXT ACT A1182 B 292 ASP B 84 ASP^? 7.80 O ACT C1183 B 322 HIS D 43 HIS~? 14.01 CH3 ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 24.74 78.07 5.59 24.32 79.03 7.46 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.76 -7.99 22.88 -22.00 -7.32 20.90 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 B 194 SER A 89 SER.? 7.33 OXT ACT A1182 B 292 ASP C 84 ASP^? 7.78 OXT ACT C1183 B 322 HIS D 43 HIS~? 14.01 CH3 ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 24.74 78.07 5.59 24.32 79.03 7.46 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.76 -7.99 22.88 -22.00 -7.32 20.90 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 B 194 SER A 89 SER.? 7.33 OXT ACT A1182 B 292 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 322 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 24.74 78.07 5.59 24.32 79.03 7.46 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 48.81 64.16 26.34 49.30 62.16 26.73 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 13 3 # 13 B 194 SER A 89 SER.? 7.33 OXT ACT A1182 B 292 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 322 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 24.74 78.07 5.59 24.32 79.03 7.46 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 14 3 # 14 B 194 SER B 53 SER^? 12.05 O ACT C1183 B 292 ASP A 73 ASP.? 22.06 O ACT A1182 B 322 HIS B 43 HIS~? 14.15 CH3 ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 24.74 78.07 5.59 24.32 79.03 7.46 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 48.81 64.16 26.34 49.30 62.16 26.73 -68.93 5.59 2.00 -68.67 4.03 3.39 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 15 3 # 15 B 194 SER B 53 SER^? 12.05 O ACT C1183 B 292 ASP A 84 ASP^? 7.98 OXT ACT A1182 B 322 HIS B 43 HIS~? 14.15 CH3 ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 24.74 78.07 5.59 24.32 79.03 7.46 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 48.81 64.16 26.34 49.30 62.16 26.73 -68.93 5.59 2.00 -68.67 4.03 3.39 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 16 3 # 16 B 194 SER B 53 SER^? 12.05 O ACT C1183 B 292 ASP C 73 ASP.? 22.09 O ACT C1183 B 322 HIS B 43 HIS~? 14.15 CH3 ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 24.74 78.07 5.59 24.32 79.03 7.46 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 48.81 64.16 26.34 49.30 62.16 26.73 -68.93 5.59 2.00 -68.67 4.03 3.39 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 17 3 # 17 B 194 SER B 56 SER.? 19.73 O3 GOL B1182 B 292 ASP C 73 ASP.? 22.09 O ACT C1183 B 322 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 24.74 78.07 5.59 24.32 79.03 7.46 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 48.81 64.16 26.34 49.30 62.16 26.73 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 18 3 # 18 B 194 SER B 56 SER.? 19.73 O3 GOL B1182 B 292 ASP C 84 ASP^? 7.78 OXT ACT C1183 B 322 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 24.74 78.07 5.59 24.32 79.03 7.46 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 19 3 # 19 B 194 SER B 56 SER.? 19.73 O3 GOL B1182 B 292 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 322 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 24.74 78.07 5.59 24.32 79.03 7.46 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 20 3 # 20 B 194 SER B 67 SER~? 15.74 OXT ACT C1183 B 292 ASP D 84 ASP^? 8.02 O ACT A1182 B 322 HIS A 151 HIS.? 15.84 O ACT A1181 coo 35.42 71.28 22.94 36.24 69.06 22.37 -51.74 11.42 7.51 -49.69 11.53 6.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 48.81 64.16 26.34 49.30 62.16 26.73 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 21 3 # 21 B 194 SER B 88 SER.? 4.64 O ACT C1183 B 292 ASP C 55 ASP.? 19.45 CA CA C1184 B 322 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 24.74 78.07 5.59 24.32 79.03 7.46 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 48.81 64.16 26.34 49.30 62.16 26.73 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 22 3 # 22 B 194 SER B 88 SER.? 4.64 O ACT C1183 B 292 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 322 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 24.74 78.07 5.59 24.32 79.03 7.46 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 48.81 64.16 26.34 49.30 62.16 26.73 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 23 3 # 23 B 194 SER B 89 SER.? 7.47 O ACT C1183 B 292 ASP C 55 ASP.? 19.45 CA CA C1184 B 322 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 24.74 78.07 5.59 24.32 79.03 7.46 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 48.81 64.16 26.34 49.30 62.16 26.73 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 24 3 # 24 B 194 SER B 89 SER.? 7.47 O ACT C1183 B 292 ASP D 84 ASP^? 8.02 O ACT A1182 B 322 HIS C 43 HIS~? 14.16 CH3 ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 24.74 78.07 5.59 24.32 79.03 7.46 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 48.81 64.16 26.34 49.30 62.16 26.73 -69.05 -5.52 24.49 -68.63 -4.06 23.04 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 25 3 # 25 B 194 SER B 89 SER.? 7.47 O ACT C1183 B 292 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 322 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 24.74 78.07 5.59 24.32 79.03 7.46 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 48.81 64.16 26.34 49.30 62.16 26.73 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 26 3 # 26 B 194 SER C 53 SER^? 12.05 OXT ACT C1183 B 292 ASP B 73 ASP.? 22.00 OXT ACT C1183 B 322 HIS C 43 HIS~? 14.16 CH3 ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 24.74 78.07 5.59 24.32 79.03 7.46 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 48.81 64.16 26.34 49.30 62.16 26.73 -69.05 -5.52 24.49 -68.63 -4.06 23.04 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 27 3 # 27 B 194 SER C 53 SER^? 12.05 OXT ACT C1183 B 292 ASP D 73 ASP.? 21.98 OXT ACT A1182 B 322 HIS C 43 HIS~? 14.16 CH3 ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 24.74 78.07 5.59 24.32 79.03 7.46 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -69.05 -5.52 24.49 -68.63 -4.06 23.04 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 28 3 # 28 B 194 SER C 53 SER^? 12.05 OXT ACT C1183 B 292 ASP D 84 ASP^? 8.02 O ACT A1182 B 322 HIS C 43 HIS~? 14.16 CH3 ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 24.74 78.07 5.59 24.32 79.03 7.46 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 48.81 64.16 26.34 49.30 62.16 26.73 -69.05 -5.52 24.49 -68.63 -4.06 23.04 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 29 3 # 29 B 194 SER C 56 SER.? 20.22 OXT ACT C1183 B 292 ASP A 55 ASP.? 17.41 O ACT A1181 B 322 HIS C 151 HIS.? 19.99 CA CA C1184 coo 35.42 71.28 22.94 36.24 69.06 22.37 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 24.74 78.07 5.59 24.32 79.03 7.46 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 30 3 # 30 B 194 SER C 56 SER.? 20.22 OXT ACT C1183 B 292 ASP B 73 ASP.? 22.00 OXT ACT C1183 B 322 HIS C 151 HIS.? 19.99 CA CA C1184 coo 35.42 71.28 22.94 36.24 69.06 22.37 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 24.74 78.07 5.59 24.32 79.03 7.46 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 48.81 64.16 26.34 49.30 62.16 26.73 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 31 3 # 31 B 194 SER C 56 SER.? 20.22 OXT ACT C1183 B 292 ASP B 84 ASP^? 7.80 O ACT C1183 B 322 HIS C 151 HIS.? 19.99 CA CA C1184 coo 35.42 71.28 22.94 36.24 69.06 22.37 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 24.74 78.07 5.59 24.32 79.03 7.46 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 48.81 64.16 26.34 49.30 62.16 26.73 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 32 3 # 32 B 194 SER C 67 SER~? 15.70 O ACT C1183 B 292 ASP A 84 ASP^? 7.98 OXT ACT A1182 B 322 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 35.42 71.28 22.94 36.24 69.06 22.37 -51.74 -11.42 18.94 -49.72 -11.51 20.26 coo 24.74 78.07 5.59 24.32 79.03 7.46 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 48.81 64.16 26.34 49.30 62.16 26.73 -45.79 -27.28 22.21 -45.52 -27.23 20.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 33 3 # 33 B 194 SER C 88 SER.? 4.69 OXT ACT C1183 B 292 ASP A 156 ASP~? 10.59 O ACT A1181 B 322 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 24.74 78.07 5.59 24.32 79.03 7.46 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 48.81 64.16 26.34 49.30 62.16 26.73 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 34 3 # 34 B 194 SER C 88 SER.? 4.69 OXT ACT C1183 B 292 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 322 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 24.74 78.07 5.59 24.32 79.03 7.46 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 48.81 64.16 26.34 49.30 62.16 26.73 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 35 3 # 35 B 194 SER C 89 SER.? 7.45 OXT ACT C1183 B 292 ASP A 84 ASP^? 7.98 OXT ACT A1182 B 322 HIS B 43 HIS~? 14.15 CH3 ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 48.81 64.16 26.34 49.30 62.16 26.73 -68.93 5.59 2.00 -68.67 4.03 3.39 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 36 3 # 36 B 194 SER C 89 SER.? 7.45 OXT ACT C1183 B 292 ASP A 156 ASP~? 10.59 O ACT A1181 B 322 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 48.81 64.16 26.34 49.30 62.16 26.73 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 37 3 # 37 B 194 SER C 89 SER.? 7.45 OXT ACT C1183 B 292 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 322 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 48.81 64.16 26.34 49.30 62.16 26.73 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 38 3 # 38 B 194 SER C 89 SER.? 7.45 OXT ACT C1183 B 292 ASP D 84 ASP^? 8.02 O ACT A1182 B 322 HIS B 43 HIS~? 14.15 CH3 ACT C1183 coo 35.42 71.28 22.94 36.24 69.06 22.37 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 48.81 64.16 26.34 49.30 62.16 26.73 -68.93 5.59 2.00 -68.67 4.03 3.39 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 39 3 # 39 B 194 SER D 53 SER^? 12.18 O ACT A1182 B 292 ASP A 73 ASP.? 22.06 O ACT A1182 B 322 HIS D 43 HIS~? 14.01 CH3 ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 24.74 78.07 5.59 24.32 79.03 7.46 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.76 -7.99 22.88 -22.00 -7.32 20.90 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 40 3 # 40 B 194 SER D 53 SER^? 12.18 O ACT A1182 B 292 ASP C 73 ASP.? 22.09 O ACT C1183 B 322 HIS D 43 HIS~? 14.01 CH3 ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 24.74 78.07 5.59 24.32 79.03 7.46 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.76 -7.99 22.88 -22.00 -7.32 20.90 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 41 3 # 41 B 194 SER D 53 SER^? 12.18 O ACT A1182 B 292 ASP C 84 ASP^? 7.78 OXT ACT C1183 B 322 HIS D 43 HIS~? 14.01 CH3 ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 24.74 78.07 5.59 24.32 79.03 7.46 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.76 -7.99 22.88 -22.00 -7.32 20.90 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 42 3 # 42 B 194 SER D 56 SER.? 20.40 O ACT A1182 B 292 ASP A 73 ASP.? 22.06 O ACT A1182 B 322 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 35.42 71.28 22.94 36.24 69.06 22.37 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 24.74 78.07 5.59 24.32 79.03 7.46 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 48.81 64.16 26.34 49.30 62.16 26.73 -45.79 -27.28 22.21 -45.52 -27.23 20.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 43 3 # 43 B 194 SER D 56 SER.? 20.40 O ACT A1182 B 292 ASP A 84 ASP^? 7.98 OXT ACT A1182 B 322 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 35.42 71.28 22.94 36.24 69.06 22.37 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 24.74 78.07 5.59 24.32 79.03 7.46 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 48.81 64.16 26.34 49.30 62.16 26.73 -45.79 -27.28 22.21 -45.52 -27.23 20.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 44 3 # 44 B 194 SER D 56 SER.? 20.40 O ACT A1182 B 292 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 322 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 35.42 71.28 22.94 36.24 69.06 22.37 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 24.74 78.07 5.59 24.32 79.03 7.46 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 48.81 64.16 26.34 49.30 62.16 26.73 -45.79 -27.28 22.21 -45.52 -27.23 20.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 45 3 # 45 B 194 SER D 56 SER.? 20.40 O ACT A1182 B 292 ASP B 84 ASP^? 7.80 O ACT C1183 B 322 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 35.42 71.28 22.94 36.24 69.06 22.37 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 24.74 78.07 5.59 24.32 79.03 7.46 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 48.81 64.16 26.34 49.30 62.16 26.73 -45.79 -27.28 22.21 -45.52 -27.23 20.13 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 46 3 # 46 B 194 SER D 67 SER~? 15.83 OXT ACT A1182 B 292 ASP B 84 ASP^? 7.80 O ACT C1183 B 322 HIS C 151 HIS.? 19.99 CA CA C1184 coo 35.42 71.28 22.94 36.24 69.06 22.37 -39.02 -0.93 25.94 -41.07 -2.17 26.53 coo 24.74 78.07 5.59 24.32 79.03 7.46 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 48.81 64.16 26.34 49.30 62.16 26.73 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 47 3 # 47 B 194 SER D 88 SER.? 4.67 O ACT A1182 B 292 ASP A 55 ASP.? 17.41 O ACT A1181 B 322 HIS D 114 HIS^? 15.97 O ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 24.74 78.07 5.59 24.32 79.03 7.46 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 -34.02 -15.52 17.15 -35.80 -16.25 16.32 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 48 3 # 48 B 194 SER D 88 SER.? 4.67 O ACT A1182 B 292 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 322 HIS D 114 HIS^? 15.97 O ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 24.74 78.07 5.59 24.32 79.03 7.46 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 48.81 64.16 26.34 49.30 62.16 26.73 -34.02 -15.52 17.15 -35.80 -16.25 16.32 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 49 3 # 49 B 194 SER D 89 SER.? 7.37 O ACT A1182 B 292 ASP A 55 ASP.? 17.41 O ACT A1181 B 322 HIS D 114 HIS^? 15.97 O ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 24.74 78.07 5.59 24.32 79.03 7.46 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 48.81 64.16 26.34 49.30 62.16 26.73 -34.02 -15.52 17.15 -35.80 -16.25 16.32 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 50 3 # 50 B 194 SER D 89 SER.? 7.37 O ACT A1182 B 292 ASP B 84 ASP^? 7.80 O ACT C1183 B 322 HIS A 43 HIS~? 14.01 CH3 ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 24.74 78.07 5.59 24.32 79.03 7.46 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.65 8.05 3.64 -22.04 7.30 5.57 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 51 3 # 51 B 194 SER D 89 SER.? 7.37 O ACT A1182 B 292 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 322 HIS D 114 HIS^? 15.97 O ACT A1182 coo 35.42 71.28 22.94 36.24 69.06 22.37 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 24.74 78.07 5.59 24.32 79.03 7.46 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 48.81 64.16 26.34 49.30 62.16 26.73 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 51 hits 1aql_c03 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 35 SER A 88 SER.? 4.86 OXT ACT A1182 A 217 ASP D 84 ASP^? 8.02 O ACT A1182 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -36.44 3.40 10.01 -38.05 4.61 10.68 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -34.67 3.69 16.47 -32.74 5.08 16.23 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP A 152 ASP.? 5.90 O ACT A1181 A 35 SER A 153 SER.? 8.36 O ACT A1181 A 217 ASP A 156 ASP~? 10.59 O ACT A1181 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1avf_c04 GASTRICSIN user 3 3 # 3 A 32 ASP B 84 ASP^? 7.80 O ACT C1183 A 35 SER B 88 SER.? 4.64 O ACT C1183 A 217 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -54.22 1.68 8.96 -52.58 0.65 8.12 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1avf_c04 GASTRICSIN user 4 3 # 4 A 32 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 35 SER B 153 SER.? 13.04 OXT ACT A1181 A 217 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1avf_c04 GASTRICSIN user 5 3 # 5 A 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 35 SER C 88 SER.? 4.69 OXT ACT C1183 A 217 ASP B 84 ASP^? 7.80 O ACT C1183 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -56.10 4.45 15.54 -58.39 5.12 16.05 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1avf_c04 GASTRICSIN user 6 3 # 6 A 32 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 35 SER C 153 SER.? 12.45 O3 GOL D1181 A 217 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1avf_c04 GASTRICSIN user 7 3 # 7 A 32 ASP D 84 ASP^? 8.02 O ACT A1182 A 35 SER D 88 SER.? 4.67 O ACT A1182 A 217 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1avf_c04 GASTRICSIN user 8 3 # 8 A 32 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 35 SER D 153 SER.? 8.24 O2 GOL D1181 A 217 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1avf_c04 source 1avf GASTRICSIN : 8 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 84 ASP^? 7.98 OXT ACT A1182 J 35 SER A 88 SER.? 4.86 OXT ACT A1182 J 217 ASP D 84 ASP^? 8.02 O ACT A1182 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -36.44 3.40 10.01 -38.05 4.61 10.68 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -34.67 3.69 16.47 -32.74 5.08 16.23 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP A 152 ASP.? 5.90 O ACT A1181 J 35 SER A 153 SER.? 8.36 O ACT A1181 J 217 ASP A 156 ASP~? 10.59 O ACT A1181 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1avf_c05 GASTRICSIN user 3 3 # 3 J 32 ASP B 84 ASP^? 7.80 O ACT C1183 J 35 SER B 88 SER.? 4.64 O ACT C1183 J 217 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -54.22 1.68 8.96 -52.58 0.65 8.12 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1avf_c05 GASTRICSIN user 4 3 # 4 J 32 ASP B 152 ASP.? 8.52 O3 GOL B1182 J 35 SER B 153 SER.? 13.04 OXT ACT A1181 J 217 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1avf_c05 GASTRICSIN user 5 3 # 5 J 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 J 35 SER C 88 SER.? 4.69 OXT ACT C1183 J 217 ASP B 84 ASP^? 7.80 O ACT C1183 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -56.10 4.45 15.54 -58.39 5.12 16.05 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1avf_c05 GASTRICSIN user 6 3 # 6 J 32 ASP C 152 ASP.? 13.45 O3 GOL D1181 J 35 SER C 153 SER.? 12.45 O3 GOL D1181 J 217 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1avf_c05 GASTRICSIN user 7 3 # 7 J 32 ASP D 84 ASP^? 8.02 O ACT A1182 J 35 SER D 88 SER.? 4.67 O ACT A1182 J 217 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1avf_c05 GASTRICSIN user 8 3 # 8 J 32 ASP D 152 ASP.? 5.75 O2 GOL D1181 J 35 SER D 153 SER.? 8.24 O2 GOL D1181 J 217 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1avf_c05 source 1avf GASTRICSIN : 8 hits 1avf_c05 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 223 ASP A 55 ASP.? 17.41 O ACT A1181 A 265 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 39.74 52.86 65.74 41.15 55.14 66.52 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 30.70 47.50 67.53 29.83 49.47 67.39 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 223 ASP A 55 ASP.? 17.41 O ACT A1181 A 265 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 39.74 52.86 65.74 41.15 55.14 66.52 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 30.70 47.50 67.53 29.83 49.47 67.39 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 223 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 265 LYS A 72 LYS.? 19.74 O ACT A1182 coo 39.74 52.86 65.74 41.15 55.14 66.52 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 30.70 47.50 67.53 29.83 49.47 67.39 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 19.99 54.53 64.11 20.55 58.78 68.33 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 265 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 39.74 52.86 65.74 41.15 55.14 66.52 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 265 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 39.74 52.86 65.74 41.15 55.14 66.52 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE A 85 PHE.? 8.27 OXT ACT A1182 A 223 ASP A 55 ASP.? 17.41 O ACT A1181 A 265 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 39.74 52.86 65.74 41.15 55.14 66.52 -32.11 8.47 13.22 -30.83 9.73 15.38 coo 30.70 47.50 67.53 29.83 49.47 67.39 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE A 138 PHE.? 14.29 O ACT A1181 A 223 ASP A 152 ASP.? 5.90 O ACT A1181 A 265 LYS B 164 LYS~? 10.34 O ACT A1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 30.70 47.50 67.53 29.83 49.47 67.39 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 19.99 54.53 64.11 20.55 58.78 68.33 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE A 138 PHE.? 14.29 O ACT A1181 A 223 ASP A 156 ASP~? 10.59 O ACT A1181 A 265 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 A 223 ASP A 156 ASP~? 10.59 O ACT A1181 A 265 LYS A 117 LYS.? 20.14 O ACT A1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ax4_c04 TRYPTOPHANASE user 10 3 # 10 A 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 A 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 265 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 39.74 52.86 65.74 41.15 55.14 66.52 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ax4_c04 TRYPTOPHANASE user 11 3 # 11 A 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 A 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 265 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 39.74 52.86 65.74 41.15 55.14 66.52 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1ax4_c04 TRYPTOPHANASE user 12 3 # 12 A 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 A 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 265 LYS B 164 LYS~? 10.34 O ACT A1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ax4_c04 TRYPTOPHANASE user 13 3 # 13 A 130 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 223 ASP A 156 ASP~? 10.59 O ACT A1181 A 265 LYS A 117 LYS.? 20.14 O ACT A1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ax4_c04 TRYPTOPHANASE user 14 3 # 14 A 130 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 223 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 265 LYS B 124 LYS~? 15.51 CA CA B1183 coo 39.74 52.86 65.74 41.15 55.14 66.52 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 30.70 47.50 67.53 29.83 49.47 67.39 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 19.99 54.53 64.11 20.55 58.78 68.33 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1ax4_c04 TRYPTOPHANASE user 15 3 # 15 A 130 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 223 ASP B 84 ASP^? 7.80 O ACT C1183 A 265 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 39.74 52.86 65.74 41.15 55.14 66.52 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 30.70 47.50 67.53 29.83 49.47 67.39 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 19.99 54.53 64.11 20.55 58.78 68.33 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1ax4_c04 TRYPTOPHANASE user 16 3 # 16 A 130 PHE B 138 PHE.? 9.75 O3 GOL B1182 A 223 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 265 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 30.70 47.50 67.53 29.83 49.47 67.39 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 19.99 54.53 64.11 20.55 58.78 68.33 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ax4_c04 TRYPTOPHANASE user 17 3 # 17 A 130 PHE B 138 PHE.? 9.75 O3 GOL B1182 A 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 265 LYS B 164 LYS~? 10.34 O ACT A1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ax4_c04 TRYPTOPHANASE user 18 3 # 18 A 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 A 223 ASP A 156 ASP~? 10.59 O ACT A1181 A 265 LYS A 117 LYS.? 20.14 O ACT A1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ax4_c04 TRYPTOPHANASE user 19 3 # 19 A 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 A 223 ASP A 156 ASP~? 10.59 O ACT A1181 A 265 LYS A 149 LYS.? 8.87 O ACT A1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1ax4_c04 TRYPTOPHANASE user 20 3 # 20 A 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 A 223 ASP A 156 ASP~? 10.59 O ACT A1181 A 265 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ax4_c04 TRYPTOPHANASE user 21 3 # 21 A 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 A 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 265 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 39.74 52.86 65.74 41.15 55.14 66.52 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 19.99 54.53 64.11 20.55 58.78 68.33 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ax4_c04 TRYPTOPHANASE user 22 3 # 22 A 130 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 223 ASP C 55 ASP.? 19.45 CA CA C1184 A 265 LYS C 124 LYS~? 15.99 CA CA C1184 coo 39.74 52.86 65.74 41.15 55.14 66.52 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 30.70 47.50 67.53 29.83 49.47 67.39 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 19.99 54.53 64.11 20.55 58.78 68.33 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1ax4_c04 TRYPTOPHANASE user 23 3 # 23 A 130 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 223 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 265 LYS C 72 LYS.? 18.71 O ACT C1183 coo 39.74 52.86 65.74 41.15 55.14 66.52 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 30.70 47.50 67.53 29.83 49.47 67.39 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 19.99 54.53 64.11 20.55 58.78 68.33 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1ax4_c04 TRYPTOPHANASE user 24 3 # 24 A 130 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 265 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 19.99 54.53 64.11 20.55 58.78 68.33 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 1ax4_c04 TRYPTOPHANASE user 25 3 # 25 A 130 PHE C 138 PHE.? 14.85 CA CA C1184 A 223 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 265 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 30.70 47.50 67.53 29.83 49.47 67.39 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 19.99 54.53 64.11 20.55 58.78 68.33 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ax4_c04 TRYPTOPHANASE user 26 3 # 26 A 130 PHE C 138 PHE.? 14.85 CA CA C1184 A 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 265 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ax4_c04 TRYPTOPHANASE user 27 3 # 27 A 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 A 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 265 LYS C 117 LYS.? 21.58 CA CA C1184 coo 39.74 52.86 65.74 41.15 55.14 66.52 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ax4_c04 TRYPTOPHANASE user 28 3 # 28 A 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 A 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 265 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 19.99 54.53 64.11 20.55 58.78 68.33 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 1ax4_c04 TRYPTOPHANASE user 29 3 # 29 A 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 A 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 265 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 19.99 54.53 64.11 20.55 58.78 68.33 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1ax4_c04 TRYPTOPHANASE user 30 3 # 30 A 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 A 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 265 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 19.99 54.53 64.11 20.55 58.78 68.33 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ax4_c04 TRYPTOPHANASE user 31 3 # 31 A 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 265 LYS C 117 LYS.? 21.58 CA CA C1184 coo 39.74 52.86 65.74 41.15 55.14 66.52 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ax4_c04 TRYPTOPHANASE user 32 3 # 32 A 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 265 LYS C 149 LYS.? 9.01 CA CA C1184 coo 39.74 52.86 65.74 41.15 55.14 66.52 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1ax4_c04 TRYPTOPHANASE user 33 3 # 33 A 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 265 LYS D 93 LYS.? 12.21 O ACT A1182 coo 39.74 52.86 65.74 41.15 55.14 66.52 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 30.70 47.50 67.53 29.83 49.47 67.39 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ax4_c04 TRYPTOPHANASE user 34 3 # 34 A 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 265 LYS D 124 LYS~? 24.78 O ACT A1182 coo 39.74 52.86 65.74 41.15 55.14 66.52 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 30.70 47.50 67.53 29.83 49.47 67.39 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 -30.92 -19.78 10.48 -31.91 -25.53 10.85 ULMN 3 1ax4_c04 TRYPTOPHANASE user 35 3 # 35 A 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 223 ASP D 84 ASP^? 8.02 O ACT A1182 A 265 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 39.74 52.86 65.74 41.15 55.14 66.52 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 30.70 47.50 67.53 29.83 49.47 67.39 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 19.99 54.53 64.11 20.55 58.78 68.33 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1ax4_c04 TRYPTOPHANASE user 36 3 # 36 A 130 PHE D 85 PHE.? 8.31 O ACT A1182 A 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 265 LYS C 72 LYS.? 18.71 O ACT C1183 coo 39.74 52.86 65.74 41.15 55.14 66.52 -32.09 -8.44 13.22 -30.90 -9.74 11.02 coo 30.70 47.50 67.53 29.83 49.47 67.39 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1ax4_c04 TRYPTOPHANASE user 37 3 # 37 A 130 PHE D 138 PHE.? 14.22 O2 GOL D1181 A 223 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 265 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 30.70 47.50 67.53 29.83 49.47 67.39 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 19.99 54.53 64.11 20.55 58.78 68.33 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ax4_c04 TRYPTOPHANASE user 38 3 # 38 A 130 PHE D 138 PHE.? 14.22 O2 GOL D1181 A 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 265 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 19.99 54.53 64.11 20.55 58.78 68.33 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ax4_c04 TRYPTOPHANASE user 39 3 # 39 A 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 A 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 265 LYS C 117 LYS.? 21.58 CA CA C1184 coo 39.74 52.86 65.74 41.15 55.14 66.52 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ax4_c04 TRYPTOPHANASE user 40 3 # 40 A 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 A 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 265 LYS C 149 LYS.? 9.01 CA CA C1184 coo 39.74 52.86 65.74 41.15 55.14 66.52 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1ax4_c04 TRYPTOPHANASE user 41 3 # 41 A 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 A 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 265 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo 30.70 47.50 67.53 29.83 49.47 67.39 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ax4_c04 TRYPTOPHANASE user 42 3 # 42 A 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 A 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 265 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 39.74 52.86 65.74 41.15 55.14 66.52 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 19.99 54.53 64.11 20.55 58.78 68.33 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1ax4_c04 source 1ax4 TRYPTOPHANASE : 42 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 B 223 ASP A 55 ASP.? 17.41 O ACT A1181 B 265 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 7.48 54.94 99.62 7.67 52.27 100.42 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 10.43 61.66 91.81 9.80 60.04 90.61 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 B 223 ASP A 55 ASP.? 17.41 O ACT A1181 B 265 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 7.48 54.94 99.62 7.67 52.27 100.42 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 10.43 61.66 91.81 9.80 60.04 90.61 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 B 223 ASP A 84 ASP^? 7.98 OXT ACT A1182 B 265 LYS A 72 LYS.? 19.74 O ACT A1182 coo 7.48 54.94 99.62 7.67 52.27 100.42 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 10.43 61.66 91.81 9.80 60.04 90.61 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 5.43 58.06 80.08 8.57 53.00 79.37 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 B 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 265 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 7.48 54.94 99.62 7.67 52.27 100.42 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 B 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 265 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 7.48 54.94 99.62 7.67 52.27 100.42 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE A 85 PHE.? 8.27 OXT ACT A1182 B 223 ASP A 55 ASP.? 17.41 O ACT A1181 B 265 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 7.48 54.94 99.62 7.67 52.27 100.42 -32.11 8.47 13.22 -30.83 9.73 15.38 coo 10.43 61.66 91.81 9.80 60.04 90.61 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE A 138 PHE.? 14.29 O ACT A1181 B 223 ASP A 152 ASP.? 5.90 O ACT A1181 B 265 LYS B 164 LYS~? 10.34 O ACT A1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 10.43 61.66 91.81 9.80 60.04 90.61 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 5.43 58.06 80.08 8.57 53.00 79.37 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE A 138 PHE.? 14.29 O ACT A1181 B 223 ASP A 156 ASP~? 10.59 O ACT A1181 B 265 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 B 223 ASP A 156 ASP~? 10.59 O ACT A1181 B 265 LYS A 117 LYS.? 20.14 O ACT A1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ax4_c05 TRYPTOPHANASE user 10 3 # 10 B 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 B 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 265 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 7.48 54.94 99.62 7.67 52.27 100.42 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ax4_c05 TRYPTOPHANASE user 11 3 # 11 B 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 B 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 265 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 7.48 54.94 99.62 7.67 52.27 100.42 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1ax4_c05 TRYPTOPHANASE user 12 3 # 12 B 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 B 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 265 LYS B 164 LYS~? 10.34 O ACT A1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ax4_c05 TRYPTOPHANASE user 13 3 # 13 B 130 PHE B 61 PHE~? 12.02 O3 GOL B1182 B 223 ASP A 156 ASP~? 10.59 O ACT A1181 B 265 LYS A 117 LYS.? 20.14 O ACT A1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ax4_c05 TRYPTOPHANASE user 14 3 # 14 B 130 PHE B 61 PHE~? 12.02 O3 GOL B1182 B 223 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 265 LYS B 124 LYS~? 15.51 CA CA B1183 coo 7.48 54.94 99.62 7.67 52.27 100.42 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 10.43 61.66 91.81 9.80 60.04 90.61 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 5.43 58.06 80.08 8.57 53.00 79.37 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1ax4_c05 TRYPTOPHANASE user 15 3 # 15 B 130 PHE B 61 PHE~? 12.02 O3 GOL B1182 B 223 ASP B 84 ASP^? 7.80 O ACT C1183 B 265 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 7.48 54.94 99.62 7.67 52.27 100.42 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 10.43 61.66 91.81 9.80 60.04 90.61 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 5.43 58.06 80.08 8.57 53.00 79.37 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1ax4_c05 TRYPTOPHANASE user 16 3 # 16 B 130 PHE B 138 PHE.? 9.75 O3 GOL B1182 B 223 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 265 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 10.43 61.66 91.81 9.80 60.04 90.61 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 5.43 58.06 80.08 8.57 53.00 79.37 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ax4_c05 TRYPTOPHANASE user 17 3 # 17 B 130 PHE B 138 PHE.? 9.75 O3 GOL B1182 B 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 265 LYS B 164 LYS~? 10.34 O ACT A1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ax4_c05 TRYPTOPHANASE user 18 3 # 18 B 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 B 223 ASP A 156 ASP~? 10.59 O ACT A1181 B 265 LYS A 117 LYS.? 20.14 O ACT A1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ax4_c05 TRYPTOPHANASE user 19 3 # 19 B 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 B 223 ASP A 156 ASP~? 10.59 O ACT A1181 B 265 LYS A 149 LYS.? 8.87 O ACT A1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1ax4_c05 TRYPTOPHANASE user 20 3 # 20 B 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 B 223 ASP A 156 ASP~? 10.59 O ACT A1181 B 265 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ax4_c05 TRYPTOPHANASE user 21 3 # 21 B 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 B 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 265 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 7.48 54.94 99.62 7.67 52.27 100.42 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 5.43 58.06 80.08 8.57 53.00 79.37 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ax4_c05 TRYPTOPHANASE user 22 3 # 22 B 130 PHE C 61 PHE~? 15.37 O3 GOL D1181 B 223 ASP C 55 ASP.? 19.45 CA CA C1184 B 265 LYS C 124 LYS~? 15.99 CA CA C1184 coo 7.48 54.94 99.62 7.67 52.27 100.42 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 10.43 61.66 91.81 9.80 60.04 90.61 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 5.43 58.06 80.08 8.57 53.00 79.37 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1ax4_c05 TRYPTOPHANASE user 23 3 # 23 B 130 PHE C 61 PHE~? 15.37 O3 GOL D1181 B 223 ASP C 84 ASP^? 7.78 OXT ACT C1183 B 265 LYS C 72 LYS.? 18.71 O ACT C1183 coo 7.48 54.94 99.62 7.67 52.27 100.42 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 10.43 61.66 91.81 9.80 60.04 90.61 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 5.43 58.06 80.08 8.57 53.00 79.37 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1ax4_c05 TRYPTOPHANASE user 24 3 # 24 B 130 PHE C 61 PHE~? 15.37 O3 GOL D1181 B 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 265 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 5.43 58.06 80.08 8.57 53.00 79.37 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 1ax4_c05 TRYPTOPHANASE user 25 3 # 25 B 130 PHE C 138 PHE.? 14.85 CA CA C1184 B 223 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 265 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 10.43 61.66 91.81 9.80 60.04 90.61 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 5.43 58.06 80.08 8.57 53.00 79.37 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ax4_c05 TRYPTOPHANASE user 26 3 # 26 B 130 PHE C 138 PHE.? 14.85 CA CA C1184 B 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 265 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ax4_c05 TRYPTOPHANASE user 27 3 # 27 B 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 B 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 265 LYS C 117 LYS.? 21.58 CA CA C1184 coo 7.48 54.94 99.62 7.67 52.27 100.42 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ax4_c05 TRYPTOPHANASE user 28 3 # 28 B 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 B 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 265 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 5.43 58.06 80.08 8.57 53.00 79.37 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 1ax4_c05 TRYPTOPHANASE user 29 3 # 29 B 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 B 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 265 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 5.43 58.06 80.08 8.57 53.00 79.37 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1ax4_c05 TRYPTOPHANASE user 30 3 # 30 B 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 B 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 265 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 5.43 58.06 80.08 8.57 53.00 79.37 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ax4_c05 TRYPTOPHANASE user 31 3 # 31 B 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 B 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 265 LYS C 117 LYS.? 21.58 CA CA C1184 coo 7.48 54.94 99.62 7.67 52.27 100.42 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ax4_c05 TRYPTOPHANASE user 32 3 # 32 B 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 B 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 265 LYS C 149 LYS.? 9.01 CA CA C1184 coo 7.48 54.94 99.62 7.67 52.27 100.42 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1ax4_c05 TRYPTOPHANASE user 33 3 # 33 B 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 B 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 265 LYS D 93 LYS.? 12.21 O ACT A1182 coo 7.48 54.94 99.62 7.67 52.27 100.42 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 10.43 61.66 91.81 9.80 60.04 90.61 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ax4_c05 TRYPTOPHANASE user 34 3 # 34 B 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 B 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 265 LYS D 124 LYS~? 24.78 O ACT A1182 coo 7.48 54.94 99.62 7.67 52.27 100.42 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 10.43 61.66 91.81 9.80 60.04 90.61 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 -30.92 -19.78 10.48 -31.91 -25.53 10.85 ULMN 3 1ax4_c05 TRYPTOPHANASE user 35 3 # 35 B 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 B 223 ASP D 84 ASP^? 8.02 O ACT A1182 B 265 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 7.48 54.94 99.62 7.67 52.27 100.42 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 10.43 61.66 91.81 9.80 60.04 90.61 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 5.43 58.06 80.08 8.57 53.00 79.37 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1ax4_c05 TRYPTOPHANASE user 36 3 # 36 B 130 PHE D 85 PHE.? 8.31 O ACT A1182 B 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 265 LYS C 72 LYS.? 18.71 O ACT C1183 coo 7.48 54.94 99.62 7.67 52.27 100.42 -32.09 -8.44 13.22 -30.90 -9.74 11.02 coo 10.43 61.66 91.81 9.80 60.04 90.61 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1ax4_c05 TRYPTOPHANASE user 37 3 # 37 B 130 PHE D 138 PHE.? 14.22 O2 GOL D1181 B 223 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 265 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 10.43 61.66 91.81 9.80 60.04 90.61 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 5.43 58.06 80.08 8.57 53.00 79.37 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ax4_c05 TRYPTOPHANASE user 38 3 # 38 B 130 PHE D 138 PHE.? 14.22 O2 GOL D1181 B 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 265 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 5.43 58.06 80.08 8.57 53.00 79.37 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ax4_c05 TRYPTOPHANASE user 39 3 # 39 B 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 B 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 265 LYS C 117 LYS.? 21.58 CA CA C1184 coo 7.48 54.94 99.62 7.67 52.27 100.42 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ax4_c05 TRYPTOPHANASE user 40 3 # 40 B 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 B 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 265 LYS C 149 LYS.? 9.01 CA CA C1184 coo 7.48 54.94 99.62 7.67 52.27 100.42 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1ax4_c05 TRYPTOPHANASE user 41 3 # 41 B 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 B 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 265 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo 10.43 61.66 91.81 9.80 60.04 90.61 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ax4_c05 TRYPTOPHANASE user 42 3 # 42 B 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 B 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 265 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 7.48 54.94 99.62 7.67 52.27 100.42 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 5.43 58.06 80.08 8.57 53.00 79.37 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1ax4_c05 source 1ax4 TRYPTOPHANASE : 42 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 C 223 ASP A 55 ASP.? 17.41 O ACT A1181 C 265 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 C 223 ASP A 55 ASP.? 17.41 O ACT A1181 C 265 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 C 223 ASP A 84 ASP^? 7.98 OXT ACT A1182 C 265 LYS A 72 LYS.? 19.74 O ACT A1182 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -36.44 3.40 10.01 -38.05 4.61 10.68 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE A 85 PHE.? 8.27 OXT ACT A1182 C 223 ASP A 55 ASP.? 17.41 O ACT A1181 C 265 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -32.11 8.47 13.22 -30.83 9.73 15.38 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE A 138 PHE.? 14.29 O ACT A1181 C 223 ASP A 152 ASP.? 5.90 O ACT A1181 C 265 LYS B 164 LYS~? 10.34 O ACT A1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -38.96 23.20 5.34 -40.61 21.03 4.70 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE A 138 PHE.? 14.29 O ACT A1181 C 223 ASP A 156 ASP~? 10.59 O ACT A1181 C 265 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -38.96 23.20 5.34 -40.61 21.03 4.70 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 C 223 ASP A 156 ASP~? 10.59 O ACT A1181 C 265 LYS A 117 LYS.? 20.14 O ACT A1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 C 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 265 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 C 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 265 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1ax4_c06 TRYPTOPHANASE user 10 3 # 10 C 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 C 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 265 LYS B 164 LYS~? 10.34 O ACT A1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ax4_c06 TRYPTOPHANASE user 11 3 # 11 C 130 PHE B 61 PHE~? 12.02 O3 GOL B1182 C 223 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 265 LYS B 124 LYS~? 15.51 CA CA B1183 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1ax4_c06 TRYPTOPHANASE user 12 3 # 12 C 130 PHE B 85 PHE.? 8.15 O ACT C1183 C 223 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 265 LYS A 72 LYS.? 19.74 O ACT A1182 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -58.48 -3.31 5.56 -59.66 -5.84 5.32 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1ax4_c06 TRYPTOPHANASE user 13 3 # 13 C 130 PHE B 138 PHE.? 9.75 O3 GOL B1182 C 223 ASP B 152 ASP.? 8.52 O3 GOL B1182 C 265 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ax4_c06 TRYPTOPHANASE user 14 3 # 14 C 130 PHE B 138 PHE.? 9.75 O3 GOL B1182 C 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 265 LYS B 164 LYS~? 10.34 O ACT A1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ax4_c06 TRYPTOPHANASE user 15 3 # 15 C 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 C 223 ASP A 156 ASP~? 10.59 O ACT A1181 C 265 LYS A 117 LYS.? 20.14 O ACT A1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ax4_c06 TRYPTOPHANASE user 16 3 # 16 C 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 C 223 ASP A 156 ASP~? 10.59 O ACT A1181 C 265 LYS A 149 LYS.? 8.87 O ACT A1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1ax4_c06 TRYPTOPHANASE user 17 3 # 17 C 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 C 223 ASP A 156 ASP~? 10.59 O ACT A1181 C 265 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ax4_c06 TRYPTOPHANASE user 18 3 # 18 C 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 C 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 265 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ax4_c06 TRYPTOPHANASE user 19 3 # 19 C 130 PHE C 61 PHE~? 15.37 O3 GOL D1181 C 223 ASP C 55 ASP.? 19.45 CA CA C1184 C 265 LYS C 124 LYS~? 15.99 CA CA C1184 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1ax4_c06 TRYPTOPHANASE user 20 3 # 20 C 130 PHE C 138 PHE.? 14.85 CA CA C1184 C 223 ASP C 152 ASP.? 13.45 O3 GOL D1181 C 265 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -51.47 1.75 37.48 -49.88 0.19 35.78 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ax4_c06 TRYPTOPHANASE user 21 3 # 21 C 130 PHE C 138 PHE.? 14.85 CA CA C1184 C 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 265 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -51.47 1.75 37.48 -49.88 0.19 35.78 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ax4_c06 TRYPTOPHANASE user 22 3 # 22 C 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 C 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 265 LYS C 117 LYS.? 21.58 CA CA C1184 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ax4_c06 TRYPTOPHANASE user 23 3 # 23 C 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 C 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 265 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 1ax4_c06 TRYPTOPHANASE user 24 3 # 24 C 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 C 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 265 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1ax4_c06 TRYPTOPHANASE user 25 3 # 25 C 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 C 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 265 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ax4_c06 TRYPTOPHANASE user 26 3 # 26 C 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 C 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 265 LYS D 93 LYS.? 12.21 O ACT A1182 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ax4_c06 TRYPTOPHANASE user 27 3 # 27 C 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 C 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 265 LYS D 124 LYS~? 24.78 O ACT A1182 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -30.92 -19.78 10.48 -31.91 -25.53 10.85 ULMN 3 1ax4_c06 TRYPTOPHANASE user 28 3 # 28 C 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 C 223 ASP D 84 ASP^? 8.02 O ACT A1182 C 265 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1ax4_c06 TRYPTOPHANASE user 29 3 # 29 C 130 PHE D 85 PHE.? 8.31 O ACT A1182 C 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 265 LYS C 72 LYS.? 18.71 O ACT C1183 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -32.09 -8.44 13.22 -30.90 -9.74 11.02 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1ax4_c06 TRYPTOPHANASE user 30 3 # 30 C 130 PHE D 138 PHE.? 14.22 O2 GOL D1181 C 223 ASP D 152 ASP.? 5.75 O2 GOL D1181 C 265 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ax4_c06 TRYPTOPHANASE user 31 3 # 31 C 130 PHE D 138 PHE.? 14.22 O2 GOL D1181 C 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 265 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ax4_c06 TRYPTOPHANASE user 32 3 # 32 C 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 C 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 265 LYS C 117 LYS.? 21.58 CA CA C1184 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ax4_c06 TRYPTOPHANASE user 33 3 # 33 C 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 C 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 265 LYS C 149 LYS.? 9.01 CA CA C1184 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1ax4_c06 TRYPTOPHANASE user 34 3 # 34 C 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 C 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 265 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ax4_c06 TRYPTOPHANASE user 35 3 # 35 C 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 C 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 265 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1ax4_c06 source 1ax4 TRYPTOPHANASE : 35 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 D 223 ASP A 55 ASP.? 17.41 O ACT A1181 D 265 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 D 223 ASP A 55 ASP.? 17.41 O ACT A1181 D 265 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 D 223 ASP A 84 ASP^? 7.98 OXT ACT A1182 D 265 LYS A 72 LYS.? 19.74 O ACT A1182 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -36.44 3.40 10.01 -38.05 4.61 10.68 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 D 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 265 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE A 61 PHE~? 13.18 OXT ACT A1181 D 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 265 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE A 85 PHE.? 8.27 OXT ACT A1182 D 223 ASP A 55 ASP.? 17.41 O ACT A1181 D 265 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -32.11 8.47 13.22 -30.83 9.73 15.38 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE A 138 PHE.? 14.29 O ACT A1181 D 223 ASP A 152 ASP.? 5.90 O ACT A1181 D 265 LYS B 164 LYS~? 10.34 O ACT A1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -38.96 23.20 5.34 -40.61 21.03 4.70 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE A 138 PHE.? 14.29 O ACT A1181 D 223 ASP A 156 ASP~? 10.59 O ACT A1181 D 265 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -38.96 23.20 5.34 -40.61 21.03 4.70 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 D 223 ASP A 156 ASP~? 10.59 O ACT A1181 D 265 LYS A 117 LYS.? 20.14 O ACT A1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ax4_c07 TRYPTOPHANASE user 10 3 # 10 D 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 D 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 265 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ax4_c07 TRYPTOPHANASE user 11 3 # 11 D 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 D 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 265 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1ax4_c07 TRYPTOPHANASE user 12 3 # 12 D 130 PHE A 163 PHE~? 15.05 OXT ACT A1181 D 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 265 LYS B 164 LYS~? 10.34 O ACT A1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ax4_c07 TRYPTOPHANASE user 13 3 # 13 D 130 PHE B 61 PHE~? 12.02 O3 GOL B1182 D 223 ASP A 156 ASP~? 10.59 O ACT A1181 D 265 LYS A 117 LYS.? 20.14 O ACT A1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ax4_c07 TRYPTOPHANASE user 14 3 # 14 D 130 PHE B 61 PHE~? 12.02 O3 GOL B1182 D 223 ASP B 55 ASP.? 14.29 O3 GOL B1182 D 265 LYS B 124 LYS~? 15.51 CA CA B1183 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1ax4_c07 TRYPTOPHANASE user 15 3 # 15 D 130 PHE B 85 PHE.? 8.15 O ACT C1183 D 223 ASP B 55 ASP.? 14.29 O3 GOL B1182 D 265 LYS A 72 LYS.? 19.74 O ACT A1182 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -58.48 -3.31 5.56 -59.66 -5.84 5.32 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1ax4_c07 TRYPTOPHANASE user 16 3 # 16 D 130 PHE B 138 PHE.? 9.75 O3 GOL B1182 D 223 ASP B 152 ASP.? 8.52 O3 GOL B1182 D 265 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ax4_c07 TRYPTOPHANASE user 17 3 # 17 D 130 PHE B 138 PHE.? 9.75 O3 GOL B1182 D 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 265 LYS B 164 LYS~? 10.34 O ACT A1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ax4_c07 TRYPTOPHANASE user 18 3 # 18 D 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 D 223 ASP A 156 ASP~? 10.59 O ACT A1181 D 265 LYS A 117 LYS.? 20.14 O ACT A1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ax4_c07 TRYPTOPHANASE user 19 3 # 19 D 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 D 223 ASP A 156 ASP~? 10.59 O ACT A1181 D 265 LYS A 149 LYS.? 8.87 O ACT A1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1ax4_c07 TRYPTOPHANASE user 20 3 # 20 D 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 D 223 ASP A 156 ASP~? 10.59 O ACT A1181 D 265 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ax4_c07 TRYPTOPHANASE user 21 3 # 21 D 130 PHE B 163 PHE~? 14.45 C3 GOL B1182 D 223 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 265 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ax4_c07 TRYPTOPHANASE user 22 3 # 22 D 130 PHE C 61 PHE~? 15.37 O3 GOL D1181 D 223 ASP C 55 ASP.? 19.45 CA CA C1184 D 265 LYS C 124 LYS~? 15.99 CA CA C1184 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1ax4_c07 TRYPTOPHANASE user 23 3 # 23 D 130 PHE C 61 PHE~? 15.37 O3 GOL D1181 D 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 265 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 1ax4_c07 TRYPTOPHANASE user 24 3 # 24 D 130 PHE C 138 PHE.? 14.85 CA CA C1184 D 223 ASP C 152 ASP.? 13.45 O3 GOL D1181 D 265 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -51.47 1.75 37.48 -49.88 0.19 35.78 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ax4_c07 TRYPTOPHANASE user 25 3 # 25 D 130 PHE C 138 PHE.? 14.85 CA CA C1184 D 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 265 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -51.47 1.75 37.48 -49.88 0.19 35.78 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ax4_c07 TRYPTOPHANASE user 26 3 # 26 D 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 D 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 265 LYS C 117 LYS.? 21.58 CA CA C1184 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ax4_c07 TRYPTOPHANASE user 27 3 # 27 D 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 D 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 265 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 1ax4_c07 TRYPTOPHANASE user 28 3 # 28 D 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 D 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 265 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1ax4_c07 TRYPTOPHANASE user 29 3 # 29 D 130 PHE C 163 PHE~? 16.31 C1 GOL D1181 D 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 265 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ax4_c07 TRYPTOPHANASE user 30 3 # 30 D 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 D 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 265 LYS C 117 LYS.? 21.58 CA CA C1184 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ax4_c07 TRYPTOPHANASE user 31 3 # 31 D 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 D 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 265 LYS C 149 LYS.? 9.01 CA CA C1184 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1ax4_c07 TRYPTOPHANASE user 32 3 # 32 D 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 D 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 D 265 LYS D 93 LYS.? 12.21 O ACT A1182 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ax4_c07 TRYPTOPHANASE user 33 3 # 33 D 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 D 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 D 265 LYS D 124 LYS~? 24.78 O ACT A1182 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -30.92 -19.78 10.48 -31.91 -25.53 10.85 ULMN 3 1ax4_c07 TRYPTOPHANASE user 34 3 # 34 D 130 PHE D 61 PHE~? 11.72 O3 GOL D1181 D 223 ASP D 84 ASP^? 8.02 O ACT A1182 D 265 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1ax4_c07 TRYPTOPHANASE user 35 3 # 35 D 130 PHE D 85 PHE.? 8.31 O ACT A1182 D 223 ASP D 55 ASP.? 17.43 O2 GOL D1181 D 265 LYS C 72 LYS.? 18.71 O ACT C1183 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -32.09 -8.44 13.22 -30.90 -9.74 11.02 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1ax4_c07 TRYPTOPHANASE user 36 3 # 36 D 130 PHE D 138 PHE.? 14.22 O2 GOL D1181 D 223 ASP D 152 ASP.? 5.75 O2 GOL D1181 D 265 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ax4_c07 TRYPTOPHANASE user 37 3 # 37 D 130 PHE D 138 PHE.? 14.22 O2 GOL D1181 D 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 265 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ax4_c07 TRYPTOPHANASE user 38 3 # 38 D 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 D 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 265 LYS C 117 LYS.? 21.58 CA CA C1184 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ax4_c07 TRYPTOPHANASE user 39 3 # 39 D 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 D 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 265 LYS C 149 LYS.? 9.01 CA CA C1184 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1ax4_c07 TRYPTOPHANASE user 40 3 # 40 D 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 D 223 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 265 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ax4_c07 TRYPTOPHANASE user 41 3 # 41 D 130 PHE D 163 PHE~? 13.40 O3 GOL D1181 D 223 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 265 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1ax4_c07 source 1ax4 TRYPTOPHANASE : 41 hits 1ax4_c07 naa= 3 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 A 140 TRP A 7 TRP~? 13.17 CA CA B1181 A 222 ASP A 14 ASP~? 14.99 CH3 ACT A1181 A 258 LYS B 164 LYS~? 10.34 O ACT A1181 coo 89.83 15.40 0.01 90.61 18.86 1.71 -64.51 23.48 -8.12 -63.01 20.07 -6.83 coo 82.92 20.43 2.47 84.82 20.45 1.55 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 A 140 TRP A 60 TRP~? 14.03 O ACT A1181 A 222 ASP A 55 ASP.? 17.41 O ACT A1181 A 258 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 89.83 15.40 0.01 90.61 18.86 1.71 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 82.92 20.43 2.47 84.82 20.45 1.55 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 A 140 TRP A 60 TRP~? 14.03 O ACT A1181 A 222 ASP A 156 ASP~? 10.59 O ACT A1181 A 258 LYS A 117 LYS.? 20.14 O ACT A1181 coo 89.83 15.40 0.01 90.61 18.86 1.71 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 82.92 20.43 2.47 84.82 20.45 1.55 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 A 140 TRP B 7 TRP~? 18.47 OXT ACT A1181 A 222 ASP B 14 ASP~? 13.85 OXT ACT A1181 A 258 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 89.83 15.40 0.01 90.61 18.86 1.71 -26.39 11.02 -16.75 -27.73 11.07 -13.04 coo 82.92 20.43 2.47 84.82 20.45 1.55 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 A 140 TRP B 60 TRP~? 15.39 OXT ACT A1181 A 222 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 258 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 89.83 15.40 0.01 90.61 18.86 1.71 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 82.92 20.43 2.47 84.82 20.45 1.55 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 A 140 TRP C 7 TRP~? 16.43 CA CA C1182 A 222 ASP C 14 ASP~? 9.29 CA CA C1182 A 258 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 89.83 15.40 0.01 90.61 18.86 1.71 -26.42 -11.04 43.18 -27.72 -11.10 39.46 coo 82.92 20.43 2.47 84.82 20.45 1.55 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 A 140 TRP C 60 TRP~? 14.18 O3 GOL D1181 A 222 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 258 LYS C 117 LYS.? 21.58 CA CA C1184 coo 89.83 15.40 0.01 90.61 18.86 1.71 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 82.92 20.43 2.47 84.82 20.45 1.55 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 8 3 # 8 A 140 TRP D 7 TRP~? 13.25 CA CA C1181 A 222 ASP D 14 ASP~? 14.81 O1 GOL D1181 A 258 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 89.83 15.40 0.01 90.61 18.86 1.71 -64.48 -23.47 34.59 -63.03 -20.04 33.30 coo 82.92 20.43 2.47 84.82 20.45 1.55 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 9 3 # 9 A 140 TRP D 60 TRP~? 12.96 O3 GOL D1181 A 222 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 258 LYS C 72 LYS.? 18.71 O ACT C1183 coo 89.83 15.40 0.01 90.61 18.86 1.71 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 82.92 20.43 2.47 84.82 20.45 1.55 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 10 3 # 10 A 140 TRP D 60 TRP~? 12.96 O3 GOL D1181 A 222 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 258 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 89.83 15.40 0.01 90.61 18.86 1.71 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 82.92 20.43 2.47 84.82 20.45 1.55 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1ay4_c02 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 10 hits 1ay4_c02 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 7 TRP~? 13.17 CA CA B1181 B 222 ASP A 14 ASP~? 14.99 CH3 ACT A1181 B 258 LYS B 164 LYS~? 10.34 O ACT A1181 coo 103.45 44.39 16.20 102.66 41.02 14.32 -64.51 23.48 -8.12 -63.01 20.07 -6.83 coo 110.10 38.66 15.58 108.40 39.41 14.53 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 107.51 45.54 4.76 105.41 44.51 10.25 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP A 60 TRP~? 14.03 O ACT A1181 B 222 ASP A 55 ASP.? 17.41 O ACT A1181 B 258 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 103.45 44.39 16.20 102.66 41.02 14.32 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 110.10 38.66 15.58 108.40 39.41 14.53 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 107.51 45.54 4.76 105.41 44.51 10.25 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 B 140 TRP A 60 TRP~? 14.03 O ACT A1181 B 222 ASP A 156 ASP~? 10.59 O ACT A1181 B 258 LYS A 117 LYS.? 20.14 O ACT A1181 coo 103.45 44.39 16.20 102.66 41.02 14.32 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 110.10 38.66 15.58 108.40 39.41 14.53 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 107.51 45.54 4.76 105.41 44.51 10.25 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 B 140 TRP B 7 TRP~? 18.47 OXT ACT A1181 B 222 ASP B 14 ASP~? 13.85 OXT ACT A1181 B 258 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 103.45 44.39 16.20 102.66 41.02 14.32 -26.39 11.02 -16.75 -27.73 11.07 -13.04 coo 110.10 38.66 15.58 108.40 39.41 14.53 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo 107.51 45.54 4.76 105.41 44.51 10.25 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 B 140 TRP B 60 TRP~? 15.39 OXT ACT A1181 B 222 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 258 LYS A 72 LYS.? 19.74 O ACT A1182 coo 103.45 44.39 16.20 102.66 41.02 14.32 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 110.10 38.66 15.58 108.40 39.41 14.53 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 107.51 45.54 4.76 105.41 44.51 10.25 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 B 140 TRP B 60 TRP~? 15.39 OXT ACT A1181 B 222 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 258 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 103.45 44.39 16.20 102.66 41.02 14.32 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 110.10 38.66 15.58 108.40 39.41 14.53 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 107.51 45.54 4.76 105.41 44.51 10.25 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 B 140 TRP C 7 TRP~? 16.43 CA CA C1182 B 222 ASP C 14 ASP~? 9.29 CA CA C1182 B 258 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 103.45 44.39 16.20 102.66 41.02 14.32 -26.42 -11.04 43.18 -27.72 -11.10 39.46 coo 110.10 38.66 15.58 108.40 39.41 14.53 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 107.51 45.54 4.76 105.41 44.51 10.25 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 8 3 # 8 B 140 TRP C 60 TRP~? 14.18 O3 GOL D1181 B 222 ASP C 55 ASP.? 19.45 CA CA C1184 B 258 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 103.45 44.39 16.20 102.66 41.02 14.32 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 110.10 38.66 15.58 108.40 39.41 14.53 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 107.51 45.54 4.76 105.41 44.51 10.25 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 9 3 # 9 B 140 TRP C 60 TRP~? 14.18 O3 GOL D1181 B 222 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 258 LYS C 117 LYS.? 21.58 CA CA C1184 coo 103.45 44.39 16.20 102.66 41.02 14.32 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 110.10 38.66 15.58 108.40 39.41 14.53 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 107.51 45.54 4.76 105.41 44.51 10.25 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 10 3 # 10 B 140 TRP D 7 TRP~? 13.25 CA CA C1181 B 222 ASP D 14 ASP~? 14.81 O1 GOL D1181 B 258 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 103.45 44.39 16.20 102.66 41.02 14.32 -64.48 -23.47 34.59 -63.03 -20.04 33.30 coo 110.10 38.66 15.58 108.40 39.41 14.53 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 107.51 45.54 4.76 105.41 44.51 10.25 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 11 3 # 11 B 140 TRP D 60 TRP~? 12.96 O3 GOL D1181 B 222 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 258 LYS C 72 LYS.? 18.71 O ACT C1183 coo 103.45 44.39 16.20 102.66 41.02 14.32 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 110.10 38.66 15.58 108.40 39.41 14.53 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 107.51 45.54 4.76 105.41 44.51 10.25 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 12 3 # 12 B 140 TRP D 60 TRP~? 12.96 O3 GOL D1181 B 222 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 258 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 103.45 44.39 16.20 102.66 41.02 14.32 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 110.10 38.66 15.58 108.40 39.41 14.53 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 107.51 45.54 4.76 105.41 44.51 10.25 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 12 hits 1ay4_c03 naa= 3 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 110 SER A 53 SER^? 12.21 OXT ACT A1182 A 266 ASP A 55 ASP.? 17.41 O ACT A1181 A 294 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 32.07 25.76 77.83 34.46 26.05 77.46 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 33.07 35.01 79.81 33.39 33.02 79.13 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 35.53 30.26 79.89 34.62 28.71 78.80 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 110 SER B 53 SER^? 12.05 O ACT C1183 A 266 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 294 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 32.07 25.76 77.83 34.46 26.05 77.46 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 33.07 35.01 79.81 33.39 33.02 79.13 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 35.53 30.26 79.89 34.62 28.71 78.80 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 110 SER C 53 SER^? 12.05 OXT ACT C1183 A 266 ASP C 55 ASP.? 19.45 CA CA C1184 A 294 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 32.07 25.76 77.83 34.46 26.05 77.46 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 33.07 35.01 79.81 33.39 33.02 79.13 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 35.53 30.26 79.89 34.62 28.71 78.80 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 110 SER D 53 SER^? 12.18 O ACT A1182 A 266 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 294 HIS D 114 HIS^? 15.97 O ACT A1182 coo 32.07 25.76 77.83 34.46 26.05 77.46 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 33.07 35.01 79.81 33.39 33.02 79.13 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 35.53 30.26 79.89 34.62 28.71 78.80 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1azw_c00 source 1azw PROLINE IMINOPEPTIDASE : 4 hits 1azw_c00 naa= 3 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 1 3 # 1 B 110 SER A 53 SER^? 12.21 OXT ACT A1182 B 266 ASP A 55 ASP.? 17.41 O ACT A1181 B 294 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 51.18 33.22 36.61 49.29 31.79 37.02 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 44.19 39.32 34.54 45.21 37.66 35.38 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 45.79 34.26 34.63 47.54 33.80 35.70 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 2 3 # 2 B 110 SER B 53 SER^? 12.05 O ACT C1183 B 266 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 294 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 51.18 33.22 36.61 49.29 31.79 37.02 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 44.19 39.32 34.54 45.21 37.66 35.38 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 45.79 34.26 34.63 47.54 33.80 35.70 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 3 3 # 3 B 110 SER C 53 SER^? 12.05 OXT ACT C1183 B 266 ASP C 55 ASP.? 19.45 CA CA C1184 B 294 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 51.18 33.22 36.61 49.29 31.79 37.02 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 44.19 39.32 34.54 45.21 37.66 35.38 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 45.79 34.26 34.63 47.54 33.80 35.70 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 4 3 # 4 B 110 SER D 53 SER^? 12.18 O ACT A1182 B 266 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 294 HIS D 114 HIS^? 15.97 O ACT A1182 coo 51.18 33.22 36.61 49.29 31.79 37.02 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 44.19 39.32 34.54 45.21 37.66 35.38 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 45.79 34.26 34.63 47.54 33.80 35.70 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1azw_c01 source 1azw PROLINE IMINOPEPTIDASE : 4 hits 1azw_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 95 ASP~? 18.75 OXT ACT A1182 A 182 GLU A 121 GLU~? 23.87 OXT ACT A1182 A 286 ASN A 97 ASN~? 20.44 OXT ACT A1182 coo 26.03 44.66 108.90 25.67 42.61 108.82 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 18.06 44.02 105.38 18.08 45.37 107.03 -33.98 22.68 21.15 -32.78 23.95 19.94 coo 25.47 38.28 112.06 27.26 39.30 111.54 -24.46 14.50 24.96 -23.77 16.46 24.44 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 1 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 95 ASP~? 18.75 OXT ACT A1182 B 182 GLU A 121 GLU~? 23.87 OXT ACT A1182 B 286 ASN A 97 ASN~? 20.44 OXT ACT A1182 coo 13.82 69.26 132.27 11.87 70.14 132.51 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 8.74 63.05 136.42 9.87 62.19 134.79 -33.98 22.68 21.15 -32.78 23.95 19.94 coo 8.26 72.60 129.22 10.14 73.45 129.80 -24.46 14.50 24.96 -23.77 16.46 24.44 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 1 hits 1b57_c01 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS D 59 HIS~? 14.28 O ACT A1182 A 91 ARG D 58 ARG~? 14.52 O2 GOL D1181 A 129 SER D 56 SER.? 20.40 O ACT A1182 coo 24.39 47.01 49.70 26.42 47.04 49.21 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 25.98 44.20 42.23 28.53 42.98 43.43 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 30.00 49.76 45.68 28.73 48.72 47.47 -44.06 -14.32 15.00 -45.00 -16.31 13.86 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 1 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 91 ARG A 58 ARG~? 14.46 O ACT A1181 B 129 SER A 53 SER^? 12.21 OXT ACT A1182 coo 18.19 17.03 40.71 18.55 17.18 38.64 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 25.60 21.10 38.54 23.57 20.93 36.25 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 21.33 14.29 34.62 19.25 14.88 35.71 -35.29 10.69 9.61 -33.77 12.39 10.51 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 B 18 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 91 ARG A 58 ARG~? 14.46 O ACT A1181 B 129 SER B 67 SER~? 15.74 OXT ACT C1183 coo 18.19 17.03 40.71 18.55 17.18 38.64 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 25.60 21.10 38.54 23.57 20.93 36.25 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 21.33 14.29 34.62 19.25 14.88 35.71 -51.74 11.42 7.51 -49.69 11.53 6.21 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 B 18 HIS B 59 HIS~? 15.18 O ACT C1183 B 91 ARG B 58 ARG~? 12.97 O3 GOL B1182 B 129 SER A 67 SER~? 15.83 O ACT A1182 coo 18.19 17.03 40.71 18.55 17.18 38.64 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 25.60 21.10 38.54 23.57 20.93 36.25 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 21.33 14.29 34.62 19.25 14.88 35.71 -39.02 0.91 0.50 -41.06 2.13 -0.03 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 B 18 HIS B 59 HIS~? 15.18 O ACT C1183 B 91 ARG B 58 ARG~? 12.97 O3 GOL B1182 B 129 SER B 53 SER^? 12.05 O ACT C1183 coo 18.19 17.03 40.71 18.55 17.18 38.64 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 25.60 21.10 38.54 23.57 20.93 36.25 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 21.33 14.29 34.62 19.25 14.88 35.71 -55.28 -0.85 2.05 -56.85 -2.35 0.91 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 5 3 # 5 B 18 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 91 ARG C 58 ARG~? 18.42 O3 GOL D1181 B 129 SER C 53 SER^? 12.05 OXT ACT C1183 coo 18.19 17.03 40.71 18.55 17.18 38.64 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 25.60 21.10 38.54 23.57 20.93 36.25 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 21.33 14.29 34.62 19.25 14.88 35.71 -55.28 0.90 24.40 -56.83 2.38 25.58 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 6 3 # 6 B 18 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 91 ARG C 58 ARG~? 18.42 O3 GOL D1181 B 129 SER D 67 SER~? 15.83 OXT ACT A1182 coo 18.19 17.03 40.71 18.55 17.18 38.64 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 25.60 21.10 38.54 23.57 20.93 36.25 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 21.33 14.29 34.62 19.25 14.88 35.71 -39.02 -0.93 25.94 -41.07 -2.17 26.53 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 7 3 # 7 B 18 HIS D 59 HIS~? 14.28 O ACT A1182 B 91 ARG D 58 ARG~? 14.52 O2 GOL D1181 B 129 SER C 67 SER~? 15.70 O ACT C1183 coo 18.19 17.03 40.71 18.55 17.18 38.64 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 25.60 21.10 38.54 23.57 20.93 36.25 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 21.33 14.29 34.62 19.25 14.88 35.71 -51.74 -11.42 18.94 -49.72 -11.51 20.26 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 8 3 # 8 B 18 HIS D 59 HIS~? 14.28 O ACT A1182 B 91 ARG D 58 ARG~? 14.52 O2 GOL D1181 B 129 SER D 53 SER^? 12.18 O ACT A1182 coo 18.19 17.03 40.71 18.55 17.18 38.64 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 25.60 21.10 38.54 23.57 20.93 36.25 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 21.33 14.29 34.62 19.25 14.88 35.71 -35.31 -10.69 16.86 -33.78 -12.33 15.90 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 9 3 # 9 B 18 HIS D 59 HIS~? 14.28 O ACT A1182 B 91 ARG D 58 ARG~? 14.52 O2 GOL D1181 B 129 SER D 56 SER.? 20.40 O ACT A1182 coo 18.19 17.03 40.71 18.55 17.18 38.64 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 25.60 21.10 38.54 23.57 20.93 36.25 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 21.33 14.29 34.62 19.25 14.88 35.71 -44.06 -14.32 15.00 -45.00 -16.31 13.86 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 9 hits 1b6t_c01 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 230 ASP A 156 ASP~? 10.59 O ACT A1181 A 273 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 9.23 21.44 106.88 10.18 19.34 105.31 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 1.45 22.80 104.16 2.58 21.02 104.01 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 2.97 11.64 107.87 6.59 15.13 107.03 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 230 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 273 LYS A 158 LYS~? -4.64 O ACT A1181s coo 9.23 21.44 106.88 10.18 19.34 105.31 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 1.45 22.80 104.16 2.58 21.02 104.01 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 2.97 11.64 107.87 6.59 15.13 107.03 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 A 145 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 230 ASP A 156 ASP~? 10.59 O ACT A1181 A 273 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 9.23 21.44 106.88 10.18 19.34 105.31 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 1.45 22.80 104.16 2.58 21.02 104.01 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 2.97 11.64 107.87 6.59 15.13 107.03 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 A 145 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 230 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 273 LYS A 158 LYS~? -4.64 O ACT A1181s coo 9.23 21.44 106.88 10.18 19.34 105.31 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 1.45 22.80 104.16 2.58 21.02 104.01 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 2.97 11.64 107.87 6.59 15.13 107.03 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 A 145 TYR B 91 TYR.? 11.41 O ACT C1183 A 230 ASP B 95 ASP.? 16.79 O ACT C1183 A 273 LYS B 124 LYS~? 15.51 CA CA B1183 coo 9.23 21.44 106.88 10.18 19.34 105.31 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 1.45 22.80 104.16 2.58 21.02 104.01 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 2.97 11.64 107.87 6.59 15.13 107.03 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 A 145 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 230 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 273 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 9.23 21.44 106.88 10.18 19.34 105.31 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 1.45 22.80 104.16 2.58 21.02 104.01 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 2.97 11.64 107.87 6.59 15.13 107.03 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 A 145 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 230 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 273 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 9.23 21.44 106.88 10.18 19.34 105.31 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 1.45 22.80 104.16 2.58 21.02 104.01 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 2.97 11.64 107.87 6.59 15.13 107.03 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 A 145 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 230 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 273 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 9.23 21.44 106.88 10.18 19.34 105.31 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 1.45 22.80 104.16 2.58 21.02 104.01 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 2.97 11.64 107.87 6.59 15.13 107.03 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 A 145 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 230 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 273 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 9.23 21.44 106.88 10.18 19.34 105.31 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 1.45 22.80 104.16 2.58 21.02 104.01 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 2.97 11.64 107.87 6.59 15.13 107.03 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 9 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 64 TYR~? 13.66 OXT ACT A1181 B 230 ASP A 156 ASP~? 10.59 O ACT A1181 B 273 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 11.81 13.41 73.03 10.00 13.03 75.12 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 19.17 11.01 76.14 17.26 10.42 76.77 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 11.10 2.31 76.60 10.24 7.24 75.62 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR A 64 TYR~? 13.66 OXT ACT A1181 B 230 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 273 LYS A 158 LYS~? -4.64 O ACT A1181s coo 11.81 13.41 73.03 10.00 13.03 75.12 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 19.17 11.01 76.14 17.26 10.42 76.77 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 11.10 2.31 76.60 10.24 7.24 75.62 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 B 145 TYR B 64 TYR~? 13.94 OXT ACT A1181 B 230 ASP A 156 ASP~? 10.59 O ACT A1181 B 273 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 11.81 13.41 73.03 10.00 13.03 75.12 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 19.17 11.01 76.14 17.26 10.42 76.77 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 11.10 2.31 76.60 10.24 7.24 75.62 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 B 145 TYR B 64 TYR~? 13.94 OXT ACT A1181 B 230 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 273 LYS A 158 LYS~? -4.64 O ACT A1181s coo 11.81 13.41 73.03 10.00 13.03 75.12 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 19.17 11.01 76.14 17.26 10.42 76.77 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 11.10 2.31 76.60 10.24 7.24 75.62 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 B 145 TYR B 91 TYR.? 11.41 O ACT C1183 B 230 ASP B 95 ASP.? 16.79 O ACT C1183 B 273 LYS B 124 LYS~? 15.51 CA CA B1183 coo 11.81 13.41 73.03 10.00 13.03 75.12 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 19.17 11.01 76.14 17.26 10.42 76.77 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 11.10 2.31 76.60 10.24 7.24 75.62 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 B 145 TYR C 64 TYR~? 13.24 O3 GOL D1181 B 230 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 273 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 11.81 13.41 73.03 10.00 13.03 75.12 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 19.17 11.01 76.14 17.26 10.42 76.77 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 11.10 2.31 76.60 10.24 7.24 75.62 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 B 145 TYR C 64 TYR~? 13.24 O3 GOL D1181 B 230 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 273 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 11.81 13.41 73.03 10.00 13.03 75.12 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 19.17 11.01 76.14 17.26 10.42 76.77 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 11.10 2.31 76.60 10.24 7.24 75.62 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 B 145 TYR D 64 TYR~? 12.19 O3 GOL D1181 B 230 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 273 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 11.81 13.41 73.03 10.00 13.03 75.12 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 19.17 11.01 76.14 17.26 10.42 76.77 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 11.10 2.31 76.60 10.24 7.24 75.62 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 B 145 TYR D 64 TYR~? 12.19 O3 GOL D1181 B 230 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 273 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 11.81 13.41 73.03 10.00 13.03 75.12 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 19.17 11.01 76.14 17.26 10.42 76.77 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 11.10 2.31 76.60 10.24 7.24 75.62 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 9 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 4 PHE~? 11.12 CA CA B1181 A 159 ASP A 6 ASP~? 16.17 CA CA B1181 A 188 LYS B 177 LYS.? 12.69 CA CA B1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -68.73 16.96 -7.75 -66.64 15.21 -7.29 coo 20.97 28.40 16.26 20.19 30.15 15.34 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 22.55 41.65 15.60 18.92 37.20 14.63 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 11 PHE~? 14.32 C1 GOL B1182 A 159 ASP A 6 ASP~? 16.17 CA CA B1181 A 188 LYS B 177 LYS.? 12.69 CA CA B1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 20.97 28.40 16.26 20.19 30.15 15.34 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 22.55 41.65 15.60 18.92 37.20 14.63 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 18 PHE~? 7.18 CH3 ACT A1181 A 159 ASP A 152 ASP.? 5.90 O ACT A1181 A 188 LYS B 164 LYS~? 10.34 O ACT A1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -49.53 25.29 -10.30 -47.93 26.67 -8.41 coo 20.97 28.40 16.26 20.19 30.15 15.34 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 22.55 41.65 15.60 18.92 37.20 14.63 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 159 ASP A 156 ASP~? 10.59 O ACT A1181 A 188 LYS A 117 LYS.? 20.14 O ACT A1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 20.97 28.40 16.26 20.19 30.15 15.34 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 22.55 41.65 15.60 18.92 37.20 14.63 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 159 ASP A 156 ASP~? 10.59 O ACT A1181 A 188 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 20.97 28.40 16.26 20.19 30.15 15.34 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 22.55 41.65 15.60 18.92 37.20 14.63 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE B 4 PHE~? 20.64 OXT ACT A1181 A 159 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 188 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -22.20 13.21 -10.55 -24.23 13.70 -8.68 coo 20.97 28.40 16.26 20.19 30.15 15.34 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 22.55 41.65 15.60 18.92 37.20 14.63 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE B 11 PHE~? 13.58 OXT ACT A1181 A 159 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 188 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 20.97 28.40 16.26 20.19 30.15 15.34 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 22.55 41.65 15.60 18.92 37.20 14.63 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE B 18 PHE~? 12.22 OXT ACT A1181 A 159 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 188 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -41.22 12.14 -19.23 -42.79 9.87 -19.80 coo 20.97 28.40 16.26 20.19 30.15 15.34 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 22.55 41.65 15.60 18.92 37.20 14.63 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 9 3 # 9 A 88 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 159 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 188 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 13.91 34.58 14.67 12.95 36.00 12.47 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 22.55 41.65 15.60 18.92 37.20 14.63 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 10 3 # 10 A 88 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 159 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 188 LYS B 164 LYS~? 10.34 O ACT A1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 22.55 41.65 15.60 18.92 37.20 14.63 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 11 3 # 11 A 88 PHE B 90 PHE.? 6.30 O ACT C1183 A 159 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 188 LYS C 72 LYS.? 18.71 O ACT C1183 coo 13.91 34.58 14.67 12.95 36.00 12.47 -61.00 -7.10 11.28 -61.80 -6.20 13.81 coo 20.97 28.40 16.26 20.19 30.15 15.34 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 22.55 41.65 15.60 18.92 37.20 14.63 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 12 3 # 12 A 88 PHE C 4 PHE~? 19.56 CA CA C1182 A 159 ASP C 6 ASP~? 17.85 CA CA C1182 A 188 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -22.18 -13.20 37.01 -24.26 -13.66 35.19 coo 20.97 28.40 16.26 20.19 30.15 15.34 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 22.55 41.65 15.60 18.92 37.20 14.63 -22.65 -4.76 42.92 -27.69 -1.89 42.71 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 13 3 # 13 A 88 PHE C 11 PHE~? 12.63 O3 GOL D1181 A 159 ASP C 6 ASP~? 17.85 CA CA C1182 A 188 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 20.97 28.40 16.26 20.19 30.15 15.34 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 22.55 41.65 15.60 18.92 37.20 14.63 -22.65 -4.76 42.92 -27.69 -1.89 42.71 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 14 3 # 14 A 88 PHE C 18 PHE~? 12.17 O3 GOL D1181 A 159 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 188 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -41.21 -12.14 45.70 -42.78 -9.88 46.28 coo 20.97 28.40 16.26 20.19 30.15 15.34 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 22.55 41.65 15.60 18.92 37.20 14.63 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 15 3 # 15 A 88 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 159 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 188 LYS C 117 LYS.? 21.58 CA CA C1184 coo 13.91 34.58 14.67 12.95 36.00 12.47 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 22.55 41.65 15.60 18.92 37.20 14.63 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 16 3 # 16 A 88 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 159 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 188 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 20.97 28.40 16.26 20.19 30.15 15.34 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 22.55 41.65 15.60 18.92 37.20 14.63 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 17 3 # 17 A 88 PHE C 90 PHE.? 6.24 OXT ACT C1183 A 159 ASP B 84 ASP^? 7.80 O ACT C1183 A 188 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 13.91 34.58 14.67 12.95 36.00 12.47 -61.01 7.09 15.23 -61.82 6.22 12.71 coo 20.97 28.40 16.26 20.19 30.15 15.34 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 22.55 41.65 15.60 18.92 37.20 14.63 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 18 3 # 18 A 88 PHE D 4 PHE~? 11.06 CA CA C1181 A 159 ASP D 6 ASP~? 16.12 CA CA C1181 A 188 LYS C 177 LYS.? 13.52 CA CA C1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -68.78 -16.94 34.22 -66.66 -15.22 33.70 coo 20.97 28.40 16.26 20.19 30.15 15.34 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 22.55 41.65 15.60 18.92 37.20 14.63 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 19 3 # 19 A 88 PHE D 11 PHE~? 14.07 C1 GOL D1181 A 159 ASP D 6 ASP~? 16.12 CA CA C1181 A 188 LYS C 177 LYS.? 13.52 CA CA C1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 20.97 28.40 16.26 20.19 30.15 15.34 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 22.55 41.65 15.60 18.92 37.20 14.63 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 20 3 # 20 A 88 PHE D 18 PHE~? 7.09 O1 GOL D1181 A 159 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 188 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -49.53 -25.28 36.78 -47.96 -26.67 34.88 coo 20.97 28.40 16.26 20.19 30.15 15.34 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 22.55 41.65 15.60 18.92 37.20 14.63 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 21 3 # 21 A 88 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 159 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 188 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 20.97 28.40 16.26 20.19 30.15 15.34 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 22.55 41.65 15.60 18.92 37.20 14.63 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 22 3 # 22 A 88 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 159 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 188 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 13.91 34.58 14.67 12.95 36.00 12.47 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 20.97 28.40 16.26 20.19 30.15 15.34 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 22.55 41.65 15.60 18.92 37.20 14.63 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 23 3 # 23 A 88 PHE D 90 PHE.? 6.22 O ACT A1182 A 159 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 188 LYS A 72 LYS.? 19.74 O ACT A1182 coo 13.91 34.58 14.67 12.95 36.00 12.47 -29.59 -4.57 7.52 -28.77 -1.89 7.30 coo 20.97 28.40 16.26 20.19 30.15 15.34 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 22.55 41.65 15.60 18.92 37.20 14.63 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 23 hits 1b9h_c02 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 84 ASP^? 7.98 OXT ACT A1182 35 SER A 88 SER.? 4.86 OXT ACT A1182 215 ASP D 84 ASP^? 8.02 O ACT A1182 coo 61.19 45.85 78.73 62.86 45.48 77.48 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 66.00 46.17 80.29 64.31 47.92 79.91 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 63.61 40.10 74.06 64.05 42.07 74.70 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP A 152 ASP.? 5.90 O ACT A1181 35 SER A 153 SER.? 8.36 O ACT A1181 215 ASP A 156 ASP~? 10.59 O ACT A1181 coo 61.19 45.85 78.73 62.86 45.48 77.48 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 66.00 46.17 80.29 64.31 47.92 79.91 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 63.61 40.10 74.06 64.05 42.07 74.70 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1bbs_c06 RENIN user 3 3 # 3 32 ASP B 84 ASP^? 7.80 O ACT C1183 35 SER B 88 SER.? 4.64 O ACT C1183 215 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 61.19 45.85 78.73 62.86 45.48 77.48 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 66.00 46.17 80.29 64.31 47.92 79.91 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 63.61 40.10 74.06 64.05 42.07 74.70 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1bbs_c06 RENIN user 4 3 # 4 32 ASP B 152 ASP.? 8.52 O3 GOL B1182 35 SER B 153 SER.? 13.04 OXT ACT A1181 215 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 61.19 45.85 78.73 62.86 45.48 77.48 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 66.00 46.17 80.29 64.31 47.92 79.91 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo 63.61 40.10 74.06 64.05 42.07 74.70 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1bbs_c06 RENIN user 5 3 # 5 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 35 SER C 88 SER.? 4.69 OXT ACT C1183 215 ASP B 84 ASP^? 7.80 O ACT C1183 coo 61.19 45.85 78.73 62.86 45.48 77.48 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 66.00 46.17 80.29 64.31 47.92 79.91 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 63.61 40.10 74.06 64.05 42.07 74.70 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1bbs_c06 RENIN user 6 3 # 6 32 ASP C 152 ASP.? 13.45 O3 GOL D1181 35 SER C 153 SER.? 12.45 O3 GOL D1181 215 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 61.19 45.85 78.73 62.86 45.48 77.48 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 66.00 46.17 80.29 64.31 47.92 79.91 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo 63.61 40.10 74.06 64.05 42.07 74.70 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1bbs_c06 RENIN user 7 3 # 7 32 ASP D 84 ASP^? 8.02 O ACT A1182 35 SER D 88 SER.? 4.67 O ACT A1182 215 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 61.19 45.85 78.73 62.86 45.48 77.48 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 66.00 46.17 80.29 64.31 47.92 79.91 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 63.61 40.10 74.06 64.05 42.07 74.70 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1bbs_c06 RENIN user 8 3 # 8 32 ASP D 152 ASP.? 5.75 O2 GOL D1181 35 SER D 153 SER.? 8.24 O2 GOL D1181 215 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 61.19 45.85 78.73 62.86 45.48 77.48 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 66.00 46.17 80.29 64.31 47.92 79.91 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo 63.61 40.10 74.06 64.05 42.07 74.70 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1bbs_c06 source 1bbs RENIN : 8 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 84 ASP^? 7.98 OXT ACT A1182 35 SER A 88 SER.? 4.86 OXT ACT A1182 215 ASP D 84 ASP^? 8.02 O ACT A1182 coo 61.19 45.85 78.73 62.86 45.48 77.48 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 66.00 46.17 80.29 64.31 47.92 79.91 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 63.61 40.10 74.06 64.05 42.07 74.70 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP A 152 ASP.? 5.90 O ACT A1181 35 SER A 153 SER.? 8.36 O ACT A1181 215 ASP A 156 ASP~? 10.59 O ACT A1181 coo 61.19 45.85 78.73 62.86 45.48 77.48 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 66.00 46.17 80.29 64.31 47.92 79.91 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 63.61 40.10 74.06 64.05 42.07 74.70 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1bbs_c07 RENIN user 3 3 # 3 32 ASP B 84 ASP^? 7.80 O ACT C1183 35 SER B 88 SER.? 4.64 O ACT C1183 215 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 61.19 45.85 78.73 62.86 45.48 77.48 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 66.00 46.17 80.29 64.31 47.92 79.91 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 63.61 40.10 74.06 64.05 42.07 74.70 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1bbs_c07 RENIN user 4 3 # 4 32 ASP B 152 ASP.? 8.52 O3 GOL B1182 35 SER B 153 SER.? 13.04 OXT ACT A1181 215 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 61.19 45.85 78.73 62.86 45.48 77.48 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 66.00 46.17 80.29 64.31 47.92 79.91 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo 63.61 40.10 74.06 64.05 42.07 74.70 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1bbs_c07 RENIN user 5 3 # 5 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 35 SER C 88 SER.? 4.69 OXT ACT C1183 215 ASP B 84 ASP^? 7.80 O ACT C1183 coo 61.19 45.85 78.73 62.86 45.48 77.48 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 66.00 46.17 80.29 64.31 47.92 79.91 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 63.61 40.10 74.06 64.05 42.07 74.70 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1bbs_c07 RENIN user 6 3 # 6 32 ASP C 152 ASP.? 13.45 O3 GOL D1181 35 SER C 153 SER.? 12.45 O3 GOL D1181 215 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 61.19 45.85 78.73 62.86 45.48 77.48 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 66.00 46.17 80.29 64.31 47.92 79.91 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo 63.61 40.10 74.06 64.05 42.07 74.70 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1bbs_c07 RENIN user 7 3 # 7 32 ASP D 84 ASP^? 8.02 O ACT A1182 35 SER D 88 SER.? 4.67 O ACT A1182 215 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 61.19 45.85 78.73 62.86 45.48 77.48 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 66.00 46.17 80.29 64.31 47.92 79.91 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 63.61 40.10 74.06 64.05 42.07 74.70 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1bbs_c07 RENIN user 8 3 # 8 32 ASP D 152 ASP.? 5.75 O2 GOL D1181 35 SER D 153 SER.? 8.24 O2 GOL D1181 215 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 61.19 45.85 78.73 62.86 45.48 77.48 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 66.00 46.17 80.29 64.31 47.92 79.91 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo 63.61 40.10 74.06 64.05 42.07 74.70 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1bbs_c07 source 1bbs RENIN : 8 hits 1bbs_c07 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU A 150 GLU.? 17.29 O ACT A1181 70 HIS A 151 HIS.? 15.84 O ACT A1181 281 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 66.09 46.17 155.81 66.77 48.19 155.70 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 69.05 50.55 157.03 68.00 52.29 156.51 -46.06 27.03 4.30 -45.69 27.09 6.36 coo 100.93 36.73 156.02 100.47 38.42 157.18 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 2 3 # 2 28 GLU B 150 GLU.? 13.13 O3 GOL B1182 70 HIS B 151 HIS.? 14.53 O3 GOL B1182 281 HIS D 114 HIS^? 15.97 O ACT A1182 coo 66.09 46.17 155.81 66.77 48.19 155.70 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 69.05 50.55 157.03 68.00 52.29 156.51 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 100.93 36.73 156.02 100.47 38.42 157.18 -34.02 -15.52 17.15 -35.80 -16.25 16.32 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 3 3 # 3 28 GLU C 150 GLU.? 16.95 CA CA C1184 70 HIS C 151 HIS.? 19.99 CA CA C1184 281 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 66.09 46.17 155.81 66.77 48.19 155.70 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 69.05 50.55 157.03 68.00 52.29 156.51 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 100.93 36.73 156.02 100.47 38.42 157.18 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 4 3 # 4 28 GLU C 150 GLU.? 16.95 CA CA C1184 70 HIS C 151 HIS.? 19.99 CA CA C1184 281 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 66.09 46.17 155.81 66.77 48.19 155.70 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 69.05 50.55 157.03 68.00 52.29 156.51 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 100.93 36.73 156.02 100.47 38.42 157.18 -45.79 -27.28 22.21 -45.52 -27.23 20.13 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 5 3 # 5 28 GLU D 150 GLU.? 17.20 O2 GOL D1181 70 HIS D 151 HIS.? 15.73 O2 GOL D1181 281 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 66.09 46.17 155.81 66.77 48.19 155.70 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 69.05 50.55 157.03 68.00 52.29 156.51 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo 100.93 36.73 156.02 100.47 38.42 157.18 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 5 hits 1bfd_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 27 GLU~? -12.01 CH3 ACT A1181s A 503 TYR A 33 TYR~? 13.22 O ACT A1181 A 537 GLU A 29 GLU~? 11.10 O ACT A1181 coo 24.06 146.21 11.09 22.89 146.18 9.36 -34.14 22.58 -15.68 -34.47 22.99 -17.72 coo 15.91 140.69 8.32 15.71 143.39 9.13 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 16.65 144.44 13.24 18.34 145.22 12.33 -32.63 23.57 -6.21 -33.51 24.93 -4.84 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU B 27 GLU~? 13.41 O1 GOL B1182 A 503 TYR B 33 TYR~? -4.73 C1 GOL B1182s A 537 GLU B 29 GLU~? -3.75 O1 GOL B1182s coo 24.06 146.21 11.09 22.89 146.18 9.36 -57.79 18.33 -19.74 -56.95 20.26 -20.07 coo 15.91 140.69 8.32 15.71 143.39 9.13 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 16.65 144.44 13.24 18.34 145.22 12.33 -57.44 9.91 -17.53 -57.08 7.94 -18.23 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU D 27 GLU~? 2.91 CA CA C1182s A 503 TYR D 33 TYR~? 12.91 O3 GOL D1181 A 537 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 24.06 146.21 11.09 22.89 146.18 9.36 -34.10 -22.57 42.20 -34.50 -23.02 44.23 coo 15.91 140.69 8.32 15.71 143.39 9.13 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 16.65 144.44 13.24 18.34 145.22 12.33 -32.61 -23.54 32.68 -33.42 -24.92 31.28 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 3 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU B 27 GLU~? 13.41 O1 GOL B1182 A 504 TYR B 33 TYR~? -4.73 C1 GOL B1182s A 540 GLU B 29 GLU~? -3.75 O1 GOL B1182s coo 81.34 87.29 87.22 82.36 86.09 88.61 -57.79 18.33 -19.74 -56.95 20.26 -20.07 coo 80.85 81.34 94.77 81.70 80.16 92.41 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 79.94 80.46 88.84 81.11 81.36 87.27 -57.44 9.91 -17.53 -57.08 7.94 -18.23 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c02 naa= 3 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 A 757 ASP A 55 ASP.? 17.41 O ACT A1181 A 759 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 810 SER A 56 SER.? 20.33 OXT ACT A1182 coo 30.11 61.02 29.12 29.36 59.77 27.63 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 30.94 56.62 25.28 29.94 54.94 26.14 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 25.05 62.74 29.97 26.88 61.45 29.19 -44.08 14.33 11.46 -44.92 16.36 12.58 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 A 757 ASP A 152 ASP.? 5.90 O ACT A1181 A 759 HIS A 151 HIS.? 15.84 O ACT A1181 A 810 SER A 153 SER.? 8.36 O ACT A1181 coo 30.11 61.02 29.12 29.36 59.77 27.63 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 30.94 56.62 25.28 29.94 54.94 26.14 -46.06 27.03 4.30 -45.69 27.09 6.36 coo 25.05 62.74 29.97 26.88 61.45 29.19 -48.21 23.38 -2.65 -49.08 24.42 -4.65 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 3 3 # 3 A 757 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 759 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 810 SER B 56 SER.? 19.73 O3 GOL B1182 coo 30.11 61.02 29.12 29.36 59.77 27.63 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 30.94 56.62 25.28 29.94 54.94 26.14 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 25.05 62.74 29.97 26.88 61.45 29.19 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 4 3 # 4 A 757 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 759 HIS B 151 HIS.? 14.53 O3 GOL B1182 A 810 SER B 153 SER.? 13.04 OXT ACT A1181 coo 30.11 61.02 29.12 29.36 59.77 27.63 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 30.94 56.62 25.28 29.94 54.94 26.14 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 25.05 62.74 29.97 26.88 61.45 29.19 -42.50 5.86 -14.56 -41.69 7.35 -16.29 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 5 3 # 5 A 757 ASP C 55 ASP.? 19.45 CA CA C1184 A 759 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 810 SER C 56 SER.? 20.22 OXT ACT C1183 coo 30.11 61.02 29.12 29.36 59.77 27.63 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 30.94 56.62 25.28 29.94 54.94 26.14 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 25.05 62.74 29.97 26.88 61.45 29.19 -46.48 3.79 27.00 -45.42 5.54 28.32 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 6 3 # 6 A 757 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 759 HIS C 151 HIS.? 19.99 CA CA C1184 A 810 SER C 153 SER.? 12.45 O3 GOL D1181 coo 30.11 61.02 29.12 29.36 59.77 27.63 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 30.94 56.62 25.28 29.94 54.94 26.14 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 25.05 62.74 29.97 26.88 61.45 29.19 -42.49 -5.86 41.01 -41.72 -7.33 42.77 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 7 3 # 7 A 757 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 759 HIS D 114 HIS^? 15.97 O ACT A1182 A 810 SER D 56 SER.? 20.40 O ACT A1182 coo 30.11 61.02 29.12 29.36 59.77 27.63 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 30.94 56.62 25.28 29.94 54.94 26.14 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 25.05 62.74 29.97 26.88 61.45 29.19 -44.06 -14.32 15.00 -45.00 -16.31 13.86 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 8 3 # 8 A 757 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 759 HIS D 151 HIS.? 15.73 O2 GOL D1181 A 810 SER D 153 SER.? 8.24 O2 GOL D1181 coo 30.11 61.02 29.12 29.36 59.77 27.63 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 30.94 56.62 25.28 29.94 54.94 26.14 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo 25.05 62.74 29.97 26.88 61.45 29.19 -48.20 -23.41 29.14 -49.00 -24.50 31.12 1bmt_c04 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 8 hits 1bmt_c04 naa= 3 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 B 757 ASP A 55 ASP.? 17.41 O ACT A1181 B 759 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 810 SER A 56 SER.? 20.33 OXT ACT A1182 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 1.96 66.39 3.07 2.10 68.48 3.58 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -44.08 14.33 11.46 -44.92 16.36 12.58 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 B 757 ASP A 152 ASP.? 5.90 O ACT A1181 B 759 HIS A 151 HIS.? 15.84 O ACT A1181 B 810 SER A 153 SER.? 8.36 O ACT A1181 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 1.96 66.39 3.07 2.10 68.48 3.58 -46.06 27.03 4.30 -45.69 27.09 6.36 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -48.21 23.38 -2.65 -49.08 24.42 -4.65 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 3 3 # 3 B 757 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 759 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 810 SER B 56 SER.? 19.73 O3 GOL B1182 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 1.96 66.39 3.07 2.10 68.48 3.58 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 4 3 # 4 B 757 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 759 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 810 SER B 57 SER.? 17.44 O3 GOL B1182 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 1.96 66.39 3.07 2.10 68.48 3.58 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 5 3 # 5 B 757 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 759 HIS B 151 HIS.? 14.53 O3 GOL B1182 B 810 SER B 153 SER.? 13.04 OXT ACT A1181 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 1.96 66.39 3.07 2.10 68.48 3.58 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -42.50 5.86 -14.56 -41.69 7.35 -16.29 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 6 3 # 6 B 757 ASP C 55 ASP.? 19.45 CA CA C1184 B 759 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 810 SER C 56 SER.? 20.22 OXT ACT C1183 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 1.96 66.39 3.07 2.10 68.48 3.58 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -46.48 3.79 27.00 -45.42 5.54 28.32 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 7 3 # 7 B 757 ASP C 55 ASP.? 19.45 CA CA C1184 B 759 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 810 SER C 57 SER.? 20.56 O3 GOL D1181 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 1.96 66.39 3.07 2.10 68.48 3.58 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 8 3 # 8 B 757 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 759 HIS C 151 HIS.? 19.99 CA CA C1184 B 810 SER C 153 SER.? 12.45 O3 GOL D1181 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 1.96 66.39 3.07 2.10 68.48 3.58 -44.62 2.10 41.60 -44.48 3.82 40.41 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -42.49 -5.86 41.01 -41.72 -7.33 42.77 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 9 3 # 9 B 757 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 759 HIS D 114 HIS^? 15.97 O ACT A1182 B 810 SER D 56 SER.? 20.40 O ACT A1182 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 1.96 66.39 3.07 2.10 68.48 3.58 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -44.06 -14.32 15.00 -45.00 -16.31 13.86 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 10 3 # 10 B 757 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 759 HIS D 114 HIS^? 15.97 O ACT A1182 B 810 SER D 57 SER.? 18.28 O2 GOL D1181 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 1.96 66.39 3.07 2.10 68.48 3.58 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -45.75 -15.36 18.26 -46.91 -17.39 17.79 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 11 3 # 11 B 757 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 759 HIS D 151 HIS.? 15.73 O2 GOL D1181 B 810 SER D 153 SER.? 8.24 O2 GOL D1181 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 1.96 66.39 3.07 2.10 68.48 3.58 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -48.20 -23.41 29.14 -49.00 -24.50 31.12 1bmt_c05 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 11 hits 1bmt_c05 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 122 GLY~? 17.38 OXT ACT A1182 48 HIS A 114 HIS^? 15.94 OXT ACT A1182 99 ASP A 55 ASP.? 17.41 O ACT A1181 coo 12.38 5.55 24.25 13.27 5.59 24.39 -31.93 16.98 20.49 -32.19 17.34 19.79 coo 18.80 12.68 24.53 17.69 13.54 26.08 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 17.07 18.51 26.62 16.67 17.07 28.09 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY B 122 GLY~? 17.40 O ACT C1183 48 HIS B 114 HIS^? 14.73 O2 GOL B1182 99 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 12.38 5.55 24.25 13.27 5.59 24.39 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 coo 18.80 12.68 24.53 17.69 13.54 26.08 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 17.07 18.51 26.62 16.67 17.07 28.09 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY C 122 GLY~? 17.34 OXT ACT C1183 48 HIS C 114 HIS^? 15.77 OXT ACT C1183 99 ASP C 55 ASP.? 19.45 CA CA C1184 coo 12.38 5.55 24.25 13.27 5.59 24.39 -58.64 13.32 25.99 -58.38 12.82 26.62 coo 18.80 12.68 24.53 17.69 13.54 26.08 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 17.07 18.51 26.62 16.67 17.07 28.09 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 4 3 # 4 30 GLY D 122 GLY~? 17.40 O ACT A1182 48 HIS D 114 HIS^? 15.97 O ACT A1182 99 ASP D 55 ASP.? 17.43 O2 GOL D1181 coo 12.38 5.55 24.25 13.27 5.59 24.39 -32.03 -16.93 5.96 -32.26 -17.35 6.67 coo 18.80 12.68 24.53 17.69 13.54 26.08 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 17.07 18.51 26.62 16.67 17.07 28.09 -40.72 -16.97 16.40 -41.69 -17.43 18.23 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 4 hits 1bp2_c00 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 4 PHE~? 11.12 CA CA B1181 A 205 ASP A 14 ASP~? 14.99 CH3 ACT A1181 A 236 LYS B 164 LYS~? 10.34 O ACT A1181 coo 4.14 2.10 36.34 6.69 3.08 36.92 -68.73 16.96 -7.75 -66.64 15.21 -7.29 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 11 PHE~? 14.32 C1 GOL B1182 A 205 ASP A 156 ASP~? 10.59 O ACT A1181 A 236 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 4.14 2.10 36.34 6.69 3.08 36.92 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 134 PHE^? 18.18 O ACT A1181 A 205 ASP A 55 ASP.? 17.41 O ACT A1181 A 236 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 4.14 2.10 36.34 6.69 3.08 36.92 -28.37 13.63 1.61 -29.29 13.61 -1.07 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE A 166 PHE~? 18.23 OXT ACT A1181 A 205 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 236 LYS A 158 LYS~? -4.64 O ACT A1181s coo 4.14 2.10 36.34 6.69 3.08 36.92 -30.34 9.87 -3.70 -28.58 8.30 -2.17 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE B 4 PHE~? 20.64 OXT ACT A1181 A 205 ASP B 14 ASP~? 13.85 OXT ACT A1181 A 236 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 4.14 2.10 36.34 6.69 3.08 36.92 -22.20 13.21 -10.55 -24.23 13.70 -8.68 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE B 11 PHE~? 13.58 OXT ACT A1181 A 205 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 236 LYS A 158 LYS~? -4.64 O ACT A1181s coo 4.14 2.10 36.34 6.69 3.08 36.92 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE B 134 PHE^? 10.29 O2 GOL B1182 A 205 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 236 LYS B 124 LYS~? 15.51 CA CA B1183 coo 4.14 2.10 36.34 6.69 3.08 36.92 -62.26 5.34 -3.80 -61.37 7.78 -4.90 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE B 166 PHE~? 13.46 C3 GOL B1182 A 205 ASP A 156 ASP~? 10.59 O ACT A1181 A 236 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 4.14 2.10 36.34 6.69 3.08 36.92 -60.35 11.65 -2.48 -62.14 10.72 -0.50 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 9 3 # 9 A 109 PHE C 4 PHE~? 19.56 CA CA C1182 A 205 ASP C 14 ASP~? 9.29 CA CA C1182 A 236 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 4.14 2.10 36.34 6.69 3.08 36.92 -22.18 -13.20 37.01 -24.26 -13.66 35.19 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 10 3 # 10 A 109 PHE C 11 PHE~? 12.63 O3 GOL D1181 A 205 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 236 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 4.14 2.10 36.34 6.69 3.08 36.92 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 11 3 # 11 A 109 PHE C 134 PHE^? 13.25 CA CA C1184 A 205 ASP C 55 ASP.? 19.45 CA CA C1184 A 236 LYS C 124 LYS~? 15.99 CA CA C1184 coo 4.14 2.10 36.34 6.69 3.08 36.92 -62.23 -5.37 30.24 -61.37 -7.83 31.34 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 12 3 # 12 A 109 PHE C 166 PHE~? 15.64 CA CA C1181 A 205 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 236 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 4.14 2.10 36.34 6.69 3.08 36.92 -60.33 -11.66 28.96 -62.13 -10.76 26.98 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 13 3 # 13 A 109 PHE D 4 PHE~? 11.06 CA CA C1181 A 205 ASP D 14 ASP~? 14.81 O1 GOL D1181 A 236 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 4.14 2.10 36.34 6.69 3.08 36.92 -68.78 -16.94 34.22 -66.66 -15.22 33.70 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 14 3 # 14 A 109 PHE D 11 PHE~? 14.07 C1 GOL D1181 A 205 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 236 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 4.14 2.10 36.34 6.69 3.08 36.92 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 15 3 # 15 A 109 PHE D 134 PHE^? 17.04 O3 GOL D1181 A 205 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 236 LYS D 124 LYS~? 24.78 O ACT A1182 coo 4.14 2.10 36.34 6.69 3.08 36.92 -28.39 -13.60 24.85 -29.22 -13.68 27.54 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -30.92 -19.78 10.48 -31.91 -25.53 10.85 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 16 3 # 16 A 109 PHE D 166 PHE~? 16.66 O3 GOL D1181 A 205 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 236 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 4.14 2.10 36.34 6.69 3.08 36.92 -30.33 -9.93 30.20 -28.59 -8.35 28.64 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -40.69 -17.70 31.92 -41.11 -24.00 32.63 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 16 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 15 GLN~? 11.07 C3 GOL B1182 A 91 LEU B 26 LEU~? 5.85 C1 GOL B1182 A 133 GLU A 17 GLU~? 13.61 CH3 ACT A1181 coo 43.58 43.67 66.73 42.32 42.78 68.15 -53.85 19.12 -9.94 -54.79 17.30 -9.37 coo 38.58 45.09 70.44 38.28 45.21 72.59 -55.85 13.90 -14.75 -57.02 12.86 -13.20 coo 44.05 36.87 70.65 43.15 38.64 69.97 -53.17 23.87 -17.57 -54.60 25.28 -18.31 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 15 GLN~? 8.49 OXT ACT A1181 A 91 LEU A 26 LEU~? 8.46 O ACT A1181 A 133 GLU B 17 GLU~? -13.09 CH3 ACT A1181s coo 43.58 43.67 66.73 42.32 42.78 68.15 -37.01 14.07 -13.41 -36.09 14.23 -11.49 coo 38.58 45.09 70.44 38.28 45.21 72.59 -35.11 20.39 -10.59 -34.03 19.20 -9.13 coo 44.05 36.87 70.65 43.15 38.64 69.97 -38.08 19.88 -20.29 -36.49 20.35 -21.57 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 15 GLN~? 8.49 OXT ACT A1181 A 91 LEU A 165 LEU~? 12.03 OXT ACT A1181 A 133 GLU A 27 GLU~? -12.01 CH3 ACT A1181s coo 43.58 43.67 66.73 42.32 42.78 68.15 -37.01 14.07 -13.41 -36.09 14.23 -11.49 coo 38.58 45.09 70.44 38.28 45.21 72.59 -32.81 13.49 -8.77 -31.34 14.80 -9.66 coo 44.05 36.87 70.65 43.15 38.64 69.97 -34.14 22.58 -15.68 -34.47 22.99 -17.72 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN C 15 GLN~? 7.40 O3 GOL D1181 A 91 LEU D 26 LEU~? 8.11 O3 GOL D1181 A 133 GLU C 17 GLU~? 3.68 CA CA C1182s coo 43.58 43.67 66.73 42.32 42.78 68.15 -36.99 -14.05 39.90 -36.11 -14.23 37.95 coo 38.58 45.09 70.44 38.28 45.21 72.59 -35.09 -20.40 37.03 -33.99 -19.24 35.55 coo 44.05 36.87 70.65 43.15 38.64 69.97 -38.10 -19.90 46.72 -36.47 -20.40 47.99 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN C 15 GLN~? 7.40 O3 GOL D1181 A 91 LEU D 165 LEU~? 10.81 O3 GOL D1181 A 133 GLU D 27 GLU~? 2.91 CA CA C1182s coo 43.58 43.67 66.73 42.32 42.78 68.15 -36.99 -14.05 39.90 -36.11 -14.23 37.95 coo 38.58 45.09 70.44 38.28 45.21 72.59 -32.84 -13.46 35.23 -31.36 -14.76 36.14 coo 44.05 36.87 70.65 43.15 38.64 69.97 -34.10 -22.57 42.20 -34.50 -23.02 44.23 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN D 15 GLN~? 10.48 C1 GOL D1181 A 91 LEU C 26 LEU~? 14.05 C1 GOL D1181 A 133 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 43.58 43.67 66.73 42.32 42.78 68.15 -53.83 -19.14 36.40 -54.76 -17.32 35.80 coo 38.58 45.09 70.44 38.28 45.21 72.59 -55.92 -14.00 41.24 -57.21 -13.07 39.65 coo 44.05 36.87 70.65 43.15 38.64 69.97 -53.10 -23.91 44.12 -54.66 -25.27 44.77 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 6 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 15 GLN~? 11.07 C3 GOL B1182 B 591 LEU B 26 LEU~? 5.85 C1 GOL B1182 B 633 GLU A 17 GLU~? 13.61 CH3 ACT A1181 coo 88.06 44.34 57.19 89.06 45.53 55.74 -53.85 19.12 -9.94 -54.79 17.30 -9.37 coo 86.70 48.66 52.61 87.15 48.69 50.51 -55.85 13.90 -14.75 -57.02 12.86 -13.20 coo 95.42 44.52 54.43 93.46 45.31 54.70 -53.17 23.87 -17.57 -54.60 25.28 -18.31 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN B 15 GLN~? 8.49 OXT ACT A1181 B 591 LEU A 26 LEU~? 8.46 O ACT A1181 B 633 GLU B 17 GLU~? -13.09 CH3 ACT A1181s coo 88.06 44.34 57.19 89.06 45.53 55.74 -37.01 14.07 -13.41 -36.09 14.23 -11.49 coo 86.70 48.66 52.61 87.15 48.69 50.51 -35.11 20.39 -10.59 -34.03 19.20 -9.13 coo 95.42 44.52 54.43 93.46 45.31 54.70 -38.08 19.88 -20.29 -36.49 20.35 -21.57 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN B 15 GLN~? 8.49 OXT ACT A1181 B 591 LEU A 165 LEU~? 12.03 OXT ACT A1181 B 633 GLU A 27 GLU~? -12.01 CH3 ACT A1181s coo 88.06 44.34 57.19 89.06 45.53 55.74 -37.01 14.07 -13.41 -36.09 14.23 -11.49 coo 86.70 48.66 52.61 87.15 48.69 50.51 -32.81 13.49 -8.77 -31.34 14.80 -9.66 coo 95.42 44.52 54.43 93.46 45.31 54.70 -34.14 22.58 -15.68 -34.47 22.99 -17.72 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN C 15 GLN~? 7.40 O3 GOL D1181 B 591 LEU D 26 LEU~? 8.11 O3 GOL D1181 B 633 GLU C 17 GLU~? 3.68 CA CA C1182s coo 88.06 44.34 57.19 89.06 45.53 55.74 -36.99 -14.05 39.90 -36.11 -14.23 37.95 coo 86.70 48.66 52.61 87.15 48.69 50.51 -35.09 -20.40 37.03 -33.99 -19.24 35.55 coo 95.42 44.52 54.43 93.46 45.31 54.70 -38.10 -19.90 46.72 -36.47 -20.40 47.99 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN C 15 GLN~? 7.40 O3 GOL D1181 B 591 LEU D 165 LEU~? 10.81 O3 GOL D1181 B 633 GLU D 27 GLU~? 2.91 CA CA C1182s coo 88.06 44.34 57.19 89.06 45.53 55.74 -36.99 -14.05 39.90 -36.11 -14.23 37.95 coo 86.70 48.66 52.61 87.15 48.69 50.51 -32.84 -13.46 35.23 -31.36 -14.76 36.14 coo 95.42 44.52 54.43 93.46 45.31 54.70 -34.10 -22.57 42.20 -34.50 -23.02 44.23 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 6 3 # 6 B 550 GLN D 15 GLN~? 10.48 C1 GOL D1181 B 591 LEU C 26 LEU~? 14.05 C1 GOL D1181 B 633 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 88.06 44.34 57.19 89.06 45.53 55.74 -53.83 -19.14 36.40 -54.76 -17.32 35.80 coo 86.70 48.66 52.61 87.15 48.69 50.51 -55.92 -14.00 41.24 -57.21 -13.07 39.65 coo 95.42 44.52 54.43 93.46 45.31 54.70 -53.10 -23.91 44.12 -54.66 -25.27 44.77 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 6 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 15 GLN~? 11.07 C3 GOL B1182 C1091 LEU B 26 LEU~? 5.85 C1 GOL B1182 C1133 GLU A 17 GLU~? 13.61 CH3 ACT A1181 coo 68.29 34.44 43.03 66.67 34.74 44.37 -53.85 19.12 -9.94 -54.79 17.30 -9.37 coo 65.83 38.95 47.05 65.46 38.90 49.20 -55.85 13.90 -14.75 -57.02 12.86 -13.20 coo 63.14 29.39 46.25 63.84 31.31 45.74 -53.17 23.87 -17.57 -54.60 25.28 -18.31 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN B 15 GLN~? 8.49 OXT ACT A1181 C1091 LEU A 26 LEU~? 8.46 O ACT A1181 C1133 GLU B 17 GLU~? -13.09 CH3 ACT A1181s coo 68.29 34.44 43.03 66.67 34.74 44.37 -37.01 14.07 -13.41 -36.09 14.23 -11.49 coo 65.83 38.95 47.05 65.46 38.90 49.20 -35.11 20.39 -10.59 -34.03 19.20 -9.13 coo 63.14 29.39 46.25 63.84 31.31 45.74 -38.08 19.88 -20.29 -36.49 20.35 -21.57 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN B 15 GLN~? 8.49 OXT ACT A1181 C1091 LEU A 165 LEU~? 12.03 OXT ACT A1181 C1133 GLU A 27 GLU~? -12.01 CH3 ACT A1181s coo 68.29 34.44 43.03 66.67 34.74 44.37 -37.01 14.07 -13.41 -36.09 14.23 -11.49 coo 65.83 38.95 47.05 65.46 38.90 49.20 -32.81 13.49 -8.77 -31.34 14.80 -9.66 coo 63.14 29.39 46.25 63.84 31.31 45.74 -34.14 22.58 -15.68 -34.47 22.99 -17.72 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN C 15 GLN~? 7.40 O3 GOL D1181 C1091 LEU D 26 LEU~? 8.11 O3 GOL D1181 C1133 GLU C 17 GLU~? 3.68 CA CA C1182s coo 68.29 34.44 43.03 66.67 34.74 44.37 -36.99 -14.05 39.90 -36.11 -14.23 37.95 coo 65.83 38.95 47.05 65.46 38.90 49.20 -35.09 -20.40 37.03 -33.99 -19.24 35.55 coo 63.14 29.39 46.25 63.84 31.31 45.74 -38.10 -19.90 46.72 -36.47 -20.40 47.99 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN C 15 GLN~? 7.40 O3 GOL D1181 C1091 LEU D 165 LEU~? 10.81 O3 GOL D1181 C1133 GLU D 27 GLU~? 2.91 CA CA C1182s coo 68.29 34.44 43.03 66.67 34.74 44.37 -36.99 -14.05 39.90 -36.11 -14.23 37.95 coo 65.83 38.95 47.05 65.46 38.90 49.20 -32.84 -13.46 35.23 -31.36 -14.76 36.14 coo 63.14 29.39 46.25 63.84 31.31 45.74 -34.10 -22.57 42.20 -34.50 -23.02 44.23 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN D 15 GLN~? 10.48 C1 GOL D1181 C1091 LEU C 26 LEU~? 14.05 C1 GOL D1181 C1133 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 68.29 34.44 43.03 66.67 34.74 44.37 -53.83 -19.14 36.40 -54.76 -17.32 35.80 coo 65.83 38.95 47.05 65.46 38.90 49.20 -55.92 -14.00 41.24 -57.21 -13.07 39.65 coo 63.14 29.39 46.25 63.84 31.31 45.74 -53.10 -23.91 44.12 -54.66 -25.27 44.77 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 6 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 15 GLN~? 11.07 C3 GOL B1182 A 91 LEU B 26 LEU~? 5.85 C1 GOL B1182 A 133 GLU A 17 GLU~? 13.61 CH3 ACT A1181 coo 38.23 53.34 67.59 38.84 53.87 69.56 -53.85 19.12 -9.94 -54.79 17.30 -9.37 coo 35.40 53.22 73.30 35.37 54.87 74.74 -55.85 13.90 -14.75 -57.02 12.86 -13.20 coo 45.08 56.04 70.60 43.15 55.19 70.77 -53.17 23.87 -17.57 -54.60 25.28 -18.31 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 15 GLN~? 8.49 OXT ACT A1181 A 91 LEU A 26 LEU~? 8.46 O ACT A1181 A 133 GLU B 17 GLU~? -13.09 CH3 ACT A1181s coo 38.23 53.34 67.59 38.84 53.87 69.56 -37.01 14.07 -13.41 -36.09 14.23 -11.49 coo 35.40 53.22 73.30 35.37 54.87 74.74 -35.11 20.39 -10.59 -34.03 19.20 -9.13 coo 45.08 56.04 70.60 43.15 55.19 70.77 -38.08 19.88 -20.29 -36.49 20.35 -21.57 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 15 GLN~? 8.49 OXT ACT A1181 A 91 LEU A 165 LEU~? 12.03 OXT ACT A1181 A 133 GLU A 27 GLU~? -12.01 CH3 ACT A1181s coo 38.23 53.34 67.59 38.84 53.87 69.56 -37.01 14.07 -13.41 -36.09 14.23 -11.49 coo 35.40 53.22 73.30 35.37 54.87 74.74 -32.81 13.49 -8.77 -31.34 14.80 -9.66 coo 45.08 56.04 70.60 43.15 55.19 70.77 -34.14 22.58 -15.68 -34.47 22.99 -17.72 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN C 15 GLN~? 7.40 O3 GOL D1181 A 91 LEU D 26 LEU~? 8.11 O3 GOL D1181 A 133 GLU C 17 GLU~? 3.68 CA CA C1182s coo 38.23 53.34 67.59 38.84 53.87 69.56 -36.99 -14.05 39.90 -36.11 -14.23 37.95 coo 35.40 53.22 73.30 35.37 54.87 74.74 -35.09 -20.40 37.03 -33.99 -19.24 35.55 coo 45.08 56.04 70.60 43.15 55.19 70.77 -38.10 -19.90 46.72 -36.47 -20.40 47.99 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN C 15 GLN~? 7.40 O3 GOL D1181 A 91 LEU D 165 LEU~? 10.81 O3 GOL D1181 A 133 GLU D 27 GLU~? 2.91 CA CA C1182s coo 38.23 53.34 67.59 38.84 53.87 69.56 -36.99 -14.05 39.90 -36.11 -14.23 37.95 coo 35.40 53.22 73.30 35.37 54.87 74.74 -32.84 -13.46 35.23 -31.36 -14.76 36.14 coo 45.08 56.04 70.60 43.15 55.19 70.77 -34.10 -22.57 42.20 -34.50 -23.02 44.23 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN D 15 GLN~? 10.48 C1 GOL D1181 A 91 LEU C 26 LEU~? 14.05 C1 GOL D1181 A 133 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 38.23 53.34 67.59 38.84 53.87 69.56 -53.83 -19.14 36.40 -54.76 -17.32 35.80 coo 35.40 53.22 73.30 35.37 54.87 74.74 -55.92 -14.00 41.24 -57.21 -13.07 39.65 coo 45.08 56.04 70.60 43.15 55.19 70.77 -53.10 -23.91 44.12 -54.66 -25.27 44.77 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 6 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 6 ASP~? 16.17 CA CA B1181 A 354 GLU A 10 GLU~? 17.55 CA CA B1181 A 421 ASP A 14 ASP~? 14.99 CH3 ACT A1181 coo 31.05 49.37 64.51 31.97 51.11 63.85 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 29.07 50.42 58.36 29.02 52.18 59.49 -63.89 24.62 -14.30 -65.11 25.98 -13.14 coo 30.82 59.76 58.47 31.12 59.02 60.40 -56.57 24.69 -12.57 -57.85 26.13 -13.49 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 354 GLU B 10 GLU~? 20.86 OXT ACT A1181 A 421 ASP B 14 ASP~? 13.85 OXT ACT A1181 coo 31.05 49.37 64.51 31.97 51.11 63.85 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 29.07 50.42 58.36 29.02 52.18 59.49 -27.02 16.65 -20.13 -25.98 15.39 -21.46 coo 30.82 59.76 58.47 31.12 59.02 60.40 -34.30 14.67 -19.52 -35.49 13.01 -20.13 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP D 14 ASP~? 14.81 O1 GOL D1181 A 354 GLU D 10 GLU~? 18.53 CA CA C1181 A 421 ASP D 6 ASP~? 16.12 CA CA C1181 coo 31.05 49.37 64.51 31.97 51.11 63.85 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 29.07 50.42 58.36 29.02 52.18 59.49 -62.08 -25.49 39.96 -63.41 -27.01 39.21 coo 30.82 59.76 58.47 31.12 59.02 60.40 -69.27 -22.53 40.17 -70.96 -22.24 41.39 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 3 hits 1bvz_c08 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN A 68 ASN~? 16.27 OXT ACT A1181 192 ASP B 55 ASP.? 14.29 O3 GOL B1182 195 HIS B 59 HIS~? 15.18 O ACT C1183 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -37.69 3.73 -3.29 -39.63 4.05 -4.09 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN B 68 ASN~? 15.57 O ACT A1181 192 ASP A 55 ASP.? 17.41 O ACT A1181 195 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -53.02 13.76 3.43 -51.10 14.43 2.89 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 3 3 # 3 104 ASN D 68 ASN~? 14.78 O3 GOL D1181 192 ASP C 55 ASP.? 19.45 CA CA C1184 195 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -37.72 -3.74 29.70 -39.65 -4.05 30.55 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -46.89 1.05 23.56 -47.29 3.11 23.40 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 3 hits 1bwp_c01 naa= 3 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 1 3 # 1 A 110 SER A 53 SER^? 12.21 OXT ACT A1182 A 235 ASP A 55 ASP.? 17.41 O ACT A1181 A 263 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 30.32 56.27 16.76 31.62 57.99 17.94 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 31.33 62.80 9.68 31.68 62.04 11.62 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 30.23 62.32 14.77 30.86 60.47 15.53 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 2 3 # 2 A 110 SER B 53 SER^? 12.05 O ACT C1183 A 235 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 263 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 30.32 56.27 16.76 31.62 57.99 17.94 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 31.33 62.80 9.68 31.68 62.04 11.62 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 30.23 62.32 14.77 30.86 60.47 15.53 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 3 3 # 3 A 110 SER C 53 SER^? 12.05 OXT ACT C1183 A 235 ASP C 55 ASP.? 19.45 CA CA C1184 A 263 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 30.32 56.27 16.76 31.62 57.99 17.94 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 31.33 62.80 9.68 31.68 62.04 11.62 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 30.23 62.32 14.77 30.86 60.47 15.53 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 4 3 # 4 A 110 SER D 53 SER^? 12.18 O ACT A1182 A 235 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 263 HIS D 114 HIS^? 15.97 O ACT A1182 coo 30.32 56.27 16.76 31.62 57.99 17.94 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 31.33 62.80 9.68 31.68 62.04 11.62 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 30.23 62.32 14.77 30.86 60.47 15.53 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1c4x_c00 source 1c4x 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDR: 4 hits 1c4x_c00 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 65 ARG A 58 ARG~? 14.46 O ACT A1181 A 85 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -40.83 18.78 13.92 -42.39 17.53 13.21 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -43.27 15.99 4.53 -43.95 18.83 5.47 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 65 ARG A 58 ARG~? 14.46 O ACT A1181 A 85 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -40.83 18.78 13.92 -42.39 17.53 13.21 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -43.27 15.99 4.53 -43.95 18.83 5.47 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1c54_c00 RIBONUCLEASE SA user 3 3 # 3 A 54 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 65 ARG B 58 ARG~? 12.97 O3 GOL B1182 A 85 HIS B 59 HIS~? 15.18 O ACT C1183 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1c54_c00 RIBONUCLEASE SA user 4 3 # 4 A 54 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 65 ARG B 58 ARG~? 12.97 O3 GOL B1182 A 85 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1c54_c00 RIBONUCLEASE SA user 5 3 # 5 A 54 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 65 ARG C 58 ARG~? 18.42 O3 GOL D1181 A 85 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -49.67 7.91 30.13 -48.14 6.69 29.28 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -46.89 1.05 23.56 -47.29 3.11 23.40 ULMN 3 1c54_c00 RIBONUCLEASE SA user 6 3 # 6 A 54 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 65 ARG C 58 ARG~? 18.42 O3 GOL D1181 A 85 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -49.67 7.91 30.13 -48.14 6.69 29.28 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1c54_c00 RIBONUCLEASE SA user 7 3 # 7 A 54 GLU D 119 GLU.? 19.65 O ACT A1182 A 65 ARG D 58 ARG~? 14.52 O2 GOL D1181 A 85 HIS D 59 HIS~? 14.28 O ACT A1182 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -44.08 -8.12 17.12 -43.68 -6.15 16.50 ULMN 3 1c54_c00 RIBONUCLEASE SA user 8 3 # 8 A 54 GLU D 119 GLU.? 19.65 O ACT A1182 A 65 ARG D 58 ARG~? 14.52 O2 GOL D1181 A 85 HIS D 114 HIS^? 15.97 O ACT A1182 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1c54_c00 source 1c54 RIBONUCLEASE SA : 8 hits 1c54_c00 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 73 ASP.? 22.06 O ACT A1182 264 GLU B 121 GLU~? 20.57 CA CA B1183 328 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 45.62 80.42 43.69 45.65 82.01 45.07 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 59.69 92.71 39.85 58.53 92.03 41.47 -56.51 -16.27 -4.35 -57.29 -15.23 -6.03 coo 45.39 90.72 40.63 45.07 89.14 41.90 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 156 ASP~? 10.59 O ACT A1181 264 GLU A 139 GLU.? 21.64 O ACT A1181 328 ASP A 152 ASP.? 5.90 O ACT A1181 coo 45.62 80.42 43.69 45.65 82.01 45.07 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 59.69 92.71 39.85 58.53 92.03 41.47 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 45.39 90.72 40.63 45.07 89.14 41.90 -43.60 24.63 -2.03 -43.51 24.01 -4.05 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP B 55 ASP.? 14.29 O3 GOL B1182 264 GLU A 167 GLU~? 17.93 OXT ACT A1181 328 ASP A 73 ASP.? 22.06 O ACT A1182 coo 45.62 80.42 43.69 45.65 82.01 45.07 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 59.69 92.71 39.85 58.53 92.03 41.47 -32.78 4.71 -6.52 -34.47 3.65 -5.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 95 ASP.? 16.79 O ACT C1183 264 GLU C 167 GLU~? 15.18 C1 GOL D1181 328 ASP C 73 ASP.? 22.09 O ACT C1183 coo 45.62 80.42 43.69 45.65 82.01 45.07 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 59.69 92.71 39.85 58.53 92.03 41.47 -56.84 -16.73 27.22 -55.09 -16.98 26.08 coo 45.39 90.72 40.63 45.07 89.14 41.90 -52.43 -20.77 12.85 -53.47 -22.46 12.11 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 156 ASP~? 13.25 OXT ACT A1181 264 GLU A 29 GLU~? 11.10 O ACT A1181 328 ASP A 156 ASP~? 10.59 O ACT A1181 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 59.69 92.71 39.85 58.53 92.03 41.47 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 45.39 90.72 40.63 45.07 89.14 41.90 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 156 ASP~? 13.25 OXT ACT A1181 264 GLU B 139 GLU.? 13.29 O3 GOL B1182 328 ASP B 152 ASP.? 8.52 O3 GOL B1182 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 59.69 92.71 39.85 58.53 92.03 41.47 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 45.39 90.72 40.63 45.07 89.14 41.90 -47.04 4.74 -15.30 -47.17 6.82 -15.76 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP C 55 ASP.? 19.45 CA CA C1184 264 GLU D 167 GLU~? 14.12 O3 GOL D1181 328 ASP D 73 ASP.? 21.98 OXT ACT A1182 coo 45.62 80.42 43.69 45.65 82.01 45.07 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 59.69 92.71 39.85 58.53 92.03 41.47 -33.98 -6.43 34.19 -35.73 -5.26 33.93 coo 45.39 90.72 40.63 45.07 89.14 41.90 -38.49 8.41 31.97 -37.49 9.71 33.33 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP C 73 ASP.? 22.09 O ACT C1183 264 GLU B 119 GLU.? 18.74 O3 GOL B1182 328 ASP B 95 ASP.? 16.79 O ACT C1183 coo 45.62 80.42 43.69 45.65 82.01 45.07 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 59.69 92.71 39.85 58.53 92.03 41.47 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 45.39 90.72 40.63 45.07 89.14 41.90 -58.00 -16.84 6.87 -57.88 -17.33 8.94 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP C 156 ASP~? 12.06 O3 GOL D1181 264 GLU C 139 GLU.? 13.61 CA CA C1184 328 ASP C 152 ASP.? 13.45 O3 GOL D1181 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 59.69 92.71 39.85 58.53 92.03 41.47 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 45.39 90.72 40.63 45.07 89.14 41.90 -47.03 -4.77 41.79 -47.13 -6.84 42.24 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP C 156 ASP~? 12.06 O3 GOL D1181 264 GLU D 29 GLU~? 11.05 O2 GOL D1181 328 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 45.62 80.42 43.69 45.65 82.01 45.07 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 59.69 92.71 39.85 58.53 92.03 41.47 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo 45.39 90.72 40.63 45.07 89.14 41.90 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 11 3 # 11 229 ASP D 73 ASP.? 21.98 OXT ACT A1182 264 GLU C 121 GLU~? 20.76 CA CA C1184 328 ASP C 55 ASP.? 19.45 CA CA C1184 coo 45.62 80.42 43.69 45.65 82.01 45.07 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 59.69 92.71 39.85 58.53 92.03 41.47 -56.38 16.29 30.73 -57.04 15.33 32.51 coo 45.39 90.72 40.63 45.07 89.14 41.90 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 12 3 # 12 229 ASP D 156 ASP~? 10.44 C2 GOL D1181 264 GLU D 139 GLU.? 21.84 O2 GOL D1181 328 ASP D 152 ASP.? 5.75 O2 GOL D1181 coo 45.62 80.42 43.69 45.65 82.01 45.07 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 59.69 92.71 39.85 58.53 92.03 41.47 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 45.39 90.72 40.63 45.07 89.14 41.90 -43.59 -24.59 28.46 -43.51 -24.00 30.49 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 12 hits 1cdg_c00 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 84 ASP^? 7.98 OXT ACT A1182 37 SER A 88 SER.? 4.86 OXT ACT A1182 216 ASP D 84 ASP^? 8.02 O ACT A1182 coo 16.90 26.20 29.49 16.22 24.50 28.41 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 12.23 24.31 30.40 14.55 23.96 31.03 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 13.93 25.52 22.10 14.75 24.44 23.75 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP A 152 ASP.? 5.90 O ACT A1181 37 SER A 153 SER.? 8.36 O ACT A1181 216 ASP A 156 ASP~? 10.59 O ACT A1181 coo 16.90 26.20 29.49 16.22 24.50 28.41 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 12.23 24.31 30.40 14.55 23.96 31.03 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 13.93 25.52 22.10 14.75 24.44 23.75 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 3 3 # 3 34 ASP B 84 ASP^? 7.80 O ACT C1183 37 SER B 88 SER.? 4.64 O ACT C1183 216 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 16.90 26.20 29.49 16.22 24.50 28.41 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 12.23 24.31 30.40 14.55 23.96 31.03 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 13.93 25.52 22.10 14.75 24.44 23.75 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 4 3 # 4 34 ASP B 152 ASP.? 8.52 O3 GOL B1182 37 SER B 153 SER.? 13.04 OXT ACT A1181 216 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 16.90 26.20 29.49 16.22 24.50 28.41 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 12.23 24.31 30.40 14.55 23.96 31.03 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo 13.93 25.52 22.10 14.75 24.44 23.75 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 5 3 # 5 34 ASP C 84 ASP^? 7.78 OXT ACT C1183 37 SER C 88 SER.? 4.69 OXT ACT C1183 216 ASP B 84 ASP^? 7.80 O ACT C1183 coo 16.90 26.20 29.49 16.22 24.50 28.41 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 12.23 24.31 30.40 14.55 23.96 31.03 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 13.93 25.52 22.10 14.75 24.44 23.75 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 6 3 # 6 34 ASP C 152 ASP.? 13.45 O3 GOL D1181 37 SER C 153 SER.? 12.45 O3 GOL D1181 216 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 16.90 26.20 29.49 16.22 24.50 28.41 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 12.23 24.31 30.40 14.55 23.96 31.03 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo 13.93 25.52 22.10 14.75 24.44 23.75 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 7 3 # 7 34 ASP D 84 ASP^? 8.02 O ACT A1182 37 SER D 88 SER.? 4.67 O ACT A1182 216 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 16.90 26.20 29.49 16.22 24.50 28.41 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 12.23 24.31 30.40 14.55 23.96 31.03 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 13.93 25.52 22.10 14.75 24.44 23.75 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 8 3 # 8 34 ASP D 152 ASP.? 5.75 O2 GOL D1181 37 SER D 153 SER.? 8.24 O2 GOL D1181 216 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 16.90 26.20 29.49 16.22 24.50 28.41 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 12.23 24.31 30.40 14.55 23.96 31.03 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo 13.93 25.52 22.10 14.75 24.44 23.75 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 8 hits 1cms_c04 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 29 GLU~? 11.10 O ACT A1181 A 89 GLU A 27 GLU~? -12.01 CH3 ACT A1181s A 120 SER A 23 SER~? -5.63 CH3 ACT A1181s coo -24.35 9.53 67.64 -25.07 11.29 68.60 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -34.14 22.58 -15.68 -34.47 22.99 -17.72 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -42.07 21.42 -13.85 -42.41 21.34 -16.27 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 150 GLU.? 17.29 O ACT A1181 A 89 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 120 SER A 57 SER.? 18.23 O ACT A1181 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -43.03 24.31 5.88 -42.80 24.92 7.90 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -40.83 18.78 13.92 -42.39 17.53 13.21 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU B 150 GLU.? 13.13 O3 GOL B1182 A 89 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 120 SER B 57 SER.? 17.44 O3 GOL B1182 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU C 150 GLU.? 16.95 CA CA C1184 A 89 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 120 SER C 57 SER.? 20.56 O3 GOL D1181 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -48.03 2.43 38.96 -48.57 4.48 38.82 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -49.67 7.91 30.13 -48.14 6.69 29.28 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU D 29 GLU~? 11.05 O2 GOL D1181 A 89 GLU D 27 GLU~? 2.91 CA CA C1182s A 120 SER D 23 SER~? -5.37 O1 GOL D1181s coo -24.35 9.53 67.64 -25.07 11.29 68.60 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -34.10 -22.57 42.20 -34.50 -23.02 44.23 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -42.08 -21.40 40.30 -42.34 -21.31 42.73 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU D 140 GLU.? 20.95 O2 GOL D1181 A 89 GLU D 29 GLU~? 11.05 O2 GOL D1181 A 120 SER D 32 SER~? 19.72 O2 GOL D1181 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -26.01 -22.49 30.36 -24.18 -23.98 29.86 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU D 150 GLU.? 17.20 O2 GOL D1181 A 89 GLU D 119 GLU.? 19.65 O ACT A1182 A 120 SER D 57 SER.? 18.28 O2 GOL D1181 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1cns_c00 source 1cns CHITINASE : 7 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 140 GLU.? 22.35 O ACT A1181 B 89 GLU A 29 GLU~? 11.10 O ACT A1181 B 120 SER A 32 SER~? 19.83 O ACT A1181 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -27.69 26.26 5.34 -26.17 27.35 4.33 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -26.00 22.49 -3.90 -24.16 23.96 -3.37 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 150 GLU.? 17.29 O ACT A1181 B 89 GLU A 119 GLU.? 19.75 OXT ACT A1182 B 120 SER A 57 SER.? 18.23 O ACT A1181 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 140 GLU.? 3.43 CA CA B1183s B 89 GLU B 29 GLU~? -3.75 O1 GOL B1182s B 120 SER B 32 SER~? 5.72 CA CA B1183 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -61.69 -2.09 -15.49 -62.76 -1.73 -17.26 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -57.44 9.91 -17.53 -57.08 7.94 -18.23 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 150 GLU.? 13.13 O3 GOL B1182 B 89 GLU B 119 GLU.? 18.74 O3 GOL B1182 B 120 SER B 57 SER.? 17.44 O3 GOL B1182 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU C 150 GLU.? 16.95 CA CA C1184 B 89 GLU C 119 GLU.? 19.60 OXT ACT C1183 B 120 SER C 57 SER.? 20.56 O3 GOL D1181 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU D 140 GLU.? 20.95 O2 GOL D1181 B 89 GLU D 29 GLU~? 11.05 O2 GOL D1181 B 120 SER D 32 SER~? 19.72 O2 GOL D1181 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -26.01 -22.49 30.36 -24.18 -23.98 29.86 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU D 150 GLU.? 17.20 O2 GOL D1181 B 89 GLU D 119 GLU.? 19.65 O ACT A1182 B 120 SER D 57 SER.? 18.28 O2 GOL D1181 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1cns_c01 source 1cns CHITINASE : 7 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 173 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 48 ARG A 58 ARG~? 14.46 O ACT A1181 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 24.35 4.55 25.11 25.94 3.23 25.53 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 173 ASP A 156 ASP~? 10.59 O ACT A1181 C 48 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 24.35 4.55 25.11 25.94 3.23 25.53 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 173 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 48 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 24.35 4.55 25.11 25.94 3.23 25.53 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -43.20 -16.00 21.95 -43.92 -18.81 20.94 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 58 ARG~? 14.46 O ACT A1181 C 101 TYR A 64 TYR~? 13.66 OXT ACT A1181 C 173 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 32.27 5.62 48.15 31.93 6.48 51.06 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 29.64 3.64 57.39 31.22 5.14 55.65 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 58 ARG~? 12.97 O3 GOL B1182 C 101 TYR B 64 TYR~? 13.94 OXT ACT A1181 C 173 ASP A 156 ASP~? 10.59 O ACT A1181 coo 32.27 5.62 48.15 31.93 6.48 51.06 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 29.64 3.64 57.39 31.22 5.14 55.65 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG C 58 ARG~? 18.42 O3 GOL D1181 C 101 TYR C 64 TYR~? 13.24 O3 GOL D1181 C 173 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 32.27 5.62 48.15 31.93 6.48 51.06 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 29.64 3.64 57.39 31.22 5.14 55.65 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG D 58 ARG~? 14.52 O2 GOL D1181 C 101 TYR D 64 TYR~? 12.19 O3 GOL D1181 C 173 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 32.27 5.62 48.15 31.93 6.48 51.06 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 29.64 3.64 57.39 31.22 5.14 55.65 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -44.46 -7.83 33.81 -43.76 -5.84 33.54 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 58 ARG~? 14.46 O ACT A1181 D 101 TYR A 64 TYR~? 13.66 OXT ACT A1181 D 173 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 69.08 8.58 32.60 69.70 10.81 30.58 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 71.77 11.86 24.26 70.23 12.22 26.56 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 71.60 6.14 19.25 70.26 6.87 20.69 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 58 ARG~? 12.97 O3 GOL B1182 D 101 TYR B 64 TYR~? 13.94 OXT ACT A1181 D 173 ASP A 156 ASP~? 10.59 O ACT A1181 coo 69.08 8.58 32.60 69.70 10.81 30.58 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 71.77 11.86 24.26 70.23 12.22 26.56 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 71.60 6.14 19.25 70.26 6.87 20.69 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG D 58 ARG~? 14.52 O2 GOL D1181 D 101 TYR D 64 TYR~? 12.19 O3 GOL D1181 D 173 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 69.08 8.58 32.60 69.70 10.81 30.58 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 71.77 11.86 24.26 70.23 12.22 26.56 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 71.60 6.14 19.25 70.26 6.87 20.69 -44.46 -7.83 33.81 -43.76 -5.84 33.54 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 64 TYR~? 13.66 OXT ACT A1181 B 173 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 48 ARG A 58 ARG~? 14.46 O ACT A1181 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 64 TYR~? 13.94 OXT ACT A1181 B 173 ASP A 156 ASP~? 10.59 O ACT A1181 D 48 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR C 64 TYR~? 13.24 O3 GOL D1181 B 173 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 48 ARG C 58 ARG~? 18.42 O3 GOL D1181 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -48.43 -0.71 31.25 -46.65 0.17 33.60 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR D 64 TYR~? 12.19 O3 GOL D1181 B 173 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 48 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -43.20 -16.00 21.95 -43.92 -18.81 20.94 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1cs1_c03 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 55 ASP.? 17.41 O ACT A1181 315 GLU A 119 GLU.? 19.75 OXT ACT A1182 390 TYR A 91 TYR.? 11.44 OXT ACT A1182 coo 32.46 99.13 19.34 30.94 100.38 20.07 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 32.04 94.22 18.23 30.57 94.75 16.88 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 21.10 94.74 18.36 23.09 96.71 18.59 -35.52 10.03 17.00 -36.51 12.40 15.90 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP B 55 ASP.? 14.29 O3 GOL B1182 315 GLU B 119 GLU.? 18.74 O3 GOL B1182 390 TYR B 91 TYR.? 11.41 O ACT C1183 coo 32.46 99.13 19.34 30.94 100.38 20.07 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 32.04 94.22 18.23 30.57 94.75 16.88 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 21.10 94.74 18.36 23.09 96.71 18.59 -54.93 -7.42 5.60 -53.90 -7.36 2.99 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP C 55 ASP.? 19.45 CA CA C1184 315 GLU C 119 GLU.? 19.60 OXT ACT C1183 390 TYR C 91 TYR.? 11.38 OXT ACT C1183 coo 32.46 99.13 19.34 30.94 100.38 20.07 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 32.04 94.22 18.23 30.57 94.75 16.88 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 21.10 94.74 18.36 23.09 96.71 18.59 -54.93 7.42 20.88 -53.88 7.33 23.48 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP D 55 ASP.? 17.43 O2 GOL D1181 315 GLU D 119 GLU.? 19.65 O ACT A1182 390 TYR D 91 TYR.? 11.52 O ACT A1182 coo 32.46 99.13 19.34 30.94 100.38 20.07 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 32.04 94.22 18.23 30.57 94.75 16.88 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 21.10 94.74 18.36 23.09 96.71 18.59 -35.52 -10.04 9.46 -36.46 -12.45 10.54 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 4 hits 1ctn_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 56 ILE A 103 ILE~? 9.23 CH3 ACT A1182 A 82 TYR A 107 TYR~? -4.55 CH3 ACT A1182s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -25.45 7.39 16.89 -26.42 8.06 16.19 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -24.81 2.99 13.30 -27.48 2.42 13.94 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 144 ASP.? 22.46 O ACT A1181 A 56 ILE A 37 ILE~? 17.12 OXT ACT A1181 A 82 TYR A 33 TYR~? 13.22 O ACT A1181 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -26.81 13.98 -5.23 -27.97 13.65 -6.03 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -29.65 19.68 -6.55 -29.87 20.32 -9.24 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP A 152 ASP.? 5.90 O ACT A1181 A 56 ILE A 19 ILE~? -4.78 CH3 ACT A1181s A 82 TYR A 157 TYR~? 5.66 OXT ACT A1181 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -48.23 19.59 -12.57 -48.43 18.31 -12.08 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -46.22 16.76 -7.11 -49.01 16.68 -7.45 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP A 156 ASP~? 10.59 O ACT A1181 A 56 ILE B 19 ILE~? 4.83 OXT ACT A1181 A 82 TYR B 157 TYR~? 6.24 OXT ACT A1181 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -42.78 16.21 -14.87 -42.59 16.17 -13.52 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -44.58 12.35 -10.09 -41.80 12.65 -10.19 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP B 84 ASP^? 7.80 O ACT C1183 A 56 ILE B 103 ILE~? 9.33 CH3 ACT C1183 A 82 TYR B 107 TYR~? -4.64 CH3 ACT C1183s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -65.07 -6.29 7.81 -64.12 -5.91 6.92 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -65.76 -1.20 10.47 -63.11 -1.54 11.28 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP B 144 ASP.? 6.66 CA CA B1183 A 56 ILE B 37 ILE~? 9.52 C1 GOL B1182 A 82 TYR B 33 TYR~? -4.73 C1 GOL B1182s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -64.02 11.40 -6.99 -62.81 12.21 -6.99 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -61.61 10.66 -12.93 -61.26 13.14 -14.14 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 7 3 # 7 A 37 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 56 ILE B 19 ILE~? 4.83 OXT ACT A1181 A 82 TYR B 157 TYR~? 6.24 OXT ACT A1181 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -42.78 16.21 -14.87 -42.59 16.17 -13.52 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -44.58 12.35 -10.09 -41.80 12.65 -10.19 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 8 3 # 8 A 37 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 56 ILE A 19 ILE~? -4.78 CH3 ACT A1181s A 82 TYR A 157 TYR~? 5.66 OXT ACT A1181 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -48.23 19.59 -12.57 -48.43 18.31 -12.08 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -46.22 16.76 -7.11 -49.01 16.68 -7.45 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 9 3 # 9 A 37 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 56 ILE C 103 ILE~? 9.29 CH3 ACT C1183 A 82 TYR C 107 TYR~? -4.63 CH3 ACT C1183s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -65.07 6.27 18.62 -64.13 5.88 19.53 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -65.75 1.19 15.99 -63.10 1.53 15.19 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 10 3 # 10 A 37 ASP C 144 ASP.? 6.69 CA CA C1184 A 56 ILE C 37 ILE~? 14.03 CA CA C1184 A 82 TYR C 33 TYR~? 11.20 CA CA C1184 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -64.07 -11.44 33.47 -62.86 -12.23 33.46 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -61.66 -10.64 39.47 -61.26 -13.15 40.60 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 11 3 # 11 A 37 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 56 ILE C 19 ILE~? 4.87 C3 GOL D1181 A 82 TYR C 157 TYR~? 5.26 O3 GOL D1181 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -42.77 -16.22 41.36 -42.59 -16.18 40.00 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -44.58 -12.33 36.53 -41.80 -12.65 36.66 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 12 3 # 12 A 37 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 56 ILE D 19 ILE~? -4.34 C1 GOL D1181s A 82 TYR D 157 TYR~? -5.31 C1 GOL D1181s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -48.22 -19.61 39.03 -48.43 -18.32 38.57 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -46.23 -16.78 33.55 -49.03 -16.71 33.91 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 13 3 # 13 A 37 ASP D 84 ASP^? 8.02 O ACT A1182 A 56 ILE D 103 ILE~? 9.25 CH3 ACT A1182 A 82 TYR D 107 TYR~? -4.59 CH3 ACT A1182s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -25.43 -7.38 9.60 -26.41 -8.04 10.31 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -24.79 -2.98 13.13 -27.46 -2.42 12.49 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 14 3 # 14 A 37 ASP D 144 ASP.? 22.37 O2 GOL D1181 A 56 ILE D 37 ILE~? 15.84 O3 GOL D1181 A 82 TYR D 33 TYR~? 12.91 O3 GOL D1181 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -26.82 -13.96 31.70 -27.95 -13.68 32.52 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -29.64 -19.70 33.03 -29.80 -20.31 35.72 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 15 3 # 15 A 37 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 56 ILE D 19 ILE~? -4.34 C1 GOL D1181s A 82 TYR D 157 TYR~? -5.31 C1 GOL D1181s coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -48.22 -19.61 39.03 -48.43 -18.32 38.57 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -46.23 -16.78 33.55 -49.03 -16.71 33.91 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 16 3 # 16 A 37 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 56 ILE C 19 ILE~? 4.87 C3 GOL D1181 A 82 TYR C 157 TYR~? 5.26 O3 GOL D1181 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -42.77 -16.22 41.36 -42.59 -16.18 40.00 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -44.58 -12.33 36.53 -41.80 -12.65 36.66 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 16 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 144 ASP.? 22.46 O ACT A1181 B 56 ILE A 37 ILE~? 17.12 OXT ACT A1181 B 82 TYR A 33 TYR~? 13.22 O ACT A1181 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -26.81 13.98 -5.23 -27.97 13.65 -6.03 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -29.65 19.68 -6.55 -29.87 20.32 -9.24 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 152 ASP.? 5.90 O ACT A1181 B 56 ILE A 19 ILE~? -4.78 CH3 ACT A1181s B 82 TYR A 157 TYR~? 5.66 OXT ACT A1181 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -48.23 19.59 -12.57 -48.43 18.31 -12.08 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -46.22 16.76 -7.11 -49.01 16.68 -7.45 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP B 144 ASP.? 6.66 CA CA B1183 B 56 ILE B 37 ILE~? 9.52 C1 GOL B1182 B 82 TYR B 33 TYR~? -4.73 C1 GOL B1182s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -64.02 11.40 -6.99 -62.81 12.21 -6.99 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -61.61 10.66 -12.93 -61.26 13.14 -14.14 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 56 ILE B 19 ILE~? 4.83 OXT ACT A1181 B 82 TYR B 157 TYR~? 6.24 OXT ACT A1181 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -42.78 16.21 -14.87 -42.59 16.17 -13.52 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -44.58 12.35 -10.09 -41.80 12.65 -10.19 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 56 ILE A 19 ILE~? -4.78 CH3 ACT A1181s B 82 TYR A 157 TYR~? 5.66 OXT ACT A1181 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -48.23 19.59 -12.57 -48.43 18.31 -12.08 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -46.22 16.76 -7.11 -49.01 16.68 -7.45 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP C 144 ASP.? 6.69 CA CA C1184 B 56 ILE C 37 ILE~? 14.03 CA CA C1184 B 82 TYR C 33 TYR~? 11.20 CA CA C1184 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -64.07 -11.44 33.47 -62.86 -12.23 33.46 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -61.66 -10.64 39.47 -61.26 -13.15 40.60 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 7 3 # 7 B 37 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 56 ILE C 19 ILE~? 4.87 C3 GOL D1181 B 82 TYR C 157 TYR~? 5.26 O3 GOL D1181 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -42.77 -16.22 41.36 -42.59 -16.18 40.00 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -44.58 -12.33 36.53 -41.80 -12.65 36.66 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 8 3 # 8 B 37 ASP D 144 ASP.? 22.37 O2 GOL D1181 B 56 ILE D 37 ILE~? 15.84 O3 GOL D1181 B 82 TYR D 33 TYR~? 12.91 O3 GOL D1181 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -26.82 -13.96 31.70 -27.95 -13.68 32.52 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -29.64 -19.70 33.03 -29.80 -20.31 35.72 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 9 3 # 9 B 37 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 56 ILE D 19 ILE~? -4.34 C1 GOL D1181s B 82 TYR D 157 TYR~? -5.31 C1 GOL D1181s coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -48.22 -19.61 39.03 -48.43 -18.32 38.57 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -46.23 -16.78 33.55 -49.03 -16.71 33.91 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 9 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 138 TRP A 60 TRP~? 14.03 O ACT A1181 A 243 ASP A 55 ASP.? 17.41 O ACT A1181 A 272 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 18.21 54.75 18.05 19.91 55.17 21.59 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 16.93 55.67 9.65 17.16 54.23 11.19 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 14.13 45.79 13.40 14.25 49.41 18.30 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 138 TRP A 60 TRP~? 14.03 O ACT A1181 A 243 ASP A 156 ASP~? 10.59 O ACT A1181 A 272 LYS B 164 LYS~? 10.34 O ACT A1181 coo 18.21 54.75 18.05 19.91 55.17 21.59 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 16.93 55.67 9.65 17.16 54.23 11.19 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 14.13 45.79 13.40 14.25 49.41 18.30 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 138 TRP B 60 TRP~? 15.39 OXT ACT A1181 A 243 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 272 LYS A 72 LYS.? 19.74 O ACT A1182 coo 18.21 54.75 18.05 19.91 55.17 21.59 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 16.93 55.67 9.65 17.16 54.23 11.19 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 14.13 45.79 13.40 14.25 49.41 18.30 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 138 TRP C 7 TRP~? 16.43 CA CA C1182 A 243 ASP C 14 ASP~? 9.29 CA CA C1182 A 272 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 18.21 54.75 18.05 19.91 55.17 21.59 -26.42 -11.04 43.18 -27.72 -11.10 39.46 coo 16.93 55.67 9.65 17.16 54.23 11.19 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 14.13 45.79 13.40 14.25 49.41 18.30 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 138 TRP C 60 TRP~? 14.18 O3 GOL D1181 A 243 ASP C 55 ASP.? 19.45 CA CA C1184 A 272 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 18.21 54.75 18.05 19.91 55.17 21.59 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 16.93 55.67 9.65 17.16 54.23 11.19 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 14.13 45.79 13.40 14.25 49.41 18.30 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 138 TRP D 60 TRP~? 12.96 O3 GOL D1181 A 243 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 272 LYS C 72 LYS.? 18.71 O ACT C1183 coo 18.21 54.75 18.05 19.91 55.17 21.59 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 16.93 55.67 9.65 17.16 54.23 11.19 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 14.13 45.79 13.40 14.25 49.41 18.30 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 138 TRP D 60 TRP~? 12.96 O3 GOL D1181 A 243 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 272 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 18.21 54.75 18.05 19.91 55.17 21.59 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 16.93 55.67 9.65 17.16 54.23 11.19 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 14.13 45.79 13.40 14.25 49.41 18.30 -54.90 -15.84 30.45 -50.06 -17.66 28.47 1d7r_c01 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 7 hits 1d7r_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 243 ASP B 73 ASP.? 22.00 OXT ACT C1183 A 272 LYS C 93 LYS.? 19.61 OXT ACT C1183 coo 2.03 68.31 21.46 0.66 68.36 23.90 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 16.93 55.67 9.65 17.16 54.23 11.19 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 14.13 45.79 13.40 14.25 49.41 18.30 -54.93 14.23 21.55 -53.38 19.08 19.32 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 157 TYR~? 5.66 OXT ACT A1181 A 243 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 272 LYS A 72 LYS.? 19.74 O ACT A1182 coo 2.03 68.31 21.46 0.66 68.36 23.90 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 16.93 55.67 9.65 17.16 54.23 11.19 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 14.13 45.79 13.40 14.25 49.41 18.30 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 175 TYR~? 24.50 O ACT A1182 A 243 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 272 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 2.03 68.31 21.46 0.66 68.36 23.90 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 14.13 45.79 13.40 14.25 49.41 18.30 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 243 ASP A 73 ASP.? 22.06 O ACT A1182 A 272 LYS D 93 LYS.? 12.21 O ACT A1182 coo 2.03 68.31 21.46 0.66 68.36 23.90 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 16.93 55.67 9.65 17.16 54.23 11.19 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 14.13 45.79 13.40 14.25 49.41 18.30 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 243 ASP B 144 ASP.? 6.66 CA CA B1183 A 272 LYS B 130 LYS.? 19.82 CH3 ACT C1183 coo 2.03 68.31 21.46 0.66 68.36 23.90 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 16.93 55.67 9.65 17.16 54.23 11.19 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 14.13 45.79 13.40 14.25 49.41 18.30 -71.06 -6.27 -2.00 -70.24 -10.95 -0.22 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR B 107 TYR~? -4.64 CH3 ACT C1183s A 243 ASP C 95 ASP~? 18.98 OXT ACT C1183 A 272 LYS B 75 LYS.? 22.83 O ACT A1181 coo 2.03 68.31 21.46 0.66 68.36 23.90 -65.76 -1.20 10.47 -63.11 -1.54 11.28 coo 16.93 55.67 9.65 17.16 54.23 11.19 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 14.13 45.79 13.40 14.25 49.41 18.30 -57.47 22.90 13.02 -52.58 24.12 11.55 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR B 175 TYR~? 10.51 CA CA B1181 A 243 ASP A 156 ASP~? 10.59 O ACT A1181 A 272 LYS A 149 LYS.? 8.87 O ACT A1181 coo 2.03 68.31 21.46 0.66 68.36 23.90 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 16.93 55.67 9.65 17.16 54.23 11.19 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 14.13 45.79 13.40 14.25 49.41 18.30 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 243 ASP C 144 ASP.? 6.69 CA CA C1184 A 272 LYS C 130 LYS.? 19.26 CH3 ACT C1183 coo 2.03 68.31 21.46 0.66 68.36 23.90 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 16.93 55.67 9.65 17.16 54.23 11.19 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 14.13 45.79 13.40 14.25 49.41 18.30 -71.03 6.26 28.36 -70.68 9.47 26.70 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 243 ASP D 73 ASP.? 21.98 OXT ACT A1182 A 272 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 2.03 68.31 21.46 0.66 68.36 23.90 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 16.93 55.67 9.65 17.16 54.23 11.19 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 14.13 45.79 13.40 14.25 49.41 18.30 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR C 107 TYR~? -4.63 CH3 ACT C1183s A 243 ASP B 95 ASP.? 16.79 O ACT C1183 A 272 LYS C 75 LYS.? 21.97 O2 GOL D1181 coo 2.03 68.31 21.46 0.66 68.36 23.90 -65.75 1.19 15.99 -63.10 1.53 15.19 coo 16.93 55.67 9.65 17.16 54.23 11.19 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 14.13 45.79 13.40 14.25 49.41 18.30 -57.40 -22.87 13.44 -53.97 -26.42 17.14 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR C 175 TYR~? 10.79 CA CA C1181 A 243 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 272 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 2.03 68.31 21.46 0.66 68.36 23.90 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 16.93 55.67 9.65 17.16 54.23 11.19 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 14.13 45.79 13.40 14.25 49.41 18.30 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 243 ASP C 73 ASP.? 22.09 O ACT C1183 A 272 LYS B 93 LYS.? 14.57 O ACT C1183 coo 2.03 68.31 21.46 0.66 68.36 23.90 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 16.93 55.67 9.65 17.16 54.23 11.19 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 14.13 45.79 13.40 14.25 49.41 18.30 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 173 TYR D 91 TYR.? 11.52 O ACT A1182 A 243 ASP B 95 ASP.? 16.79 O ACT C1183 A 272 LYS B 124 LYS~? 15.51 CA CA B1183 coo 2.03 68.31 21.46 0.66 68.36 23.90 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo 16.93 55.67 9.65 17.16 54.23 11.19 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 14.13 45.79 13.40 14.25 49.41 18.30 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 14 3 # 14 A 173 TYR D 91 TYR.? 11.52 O ACT A1182 A 243 ASP B 95 ASP.? 16.79 O ACT C1183 A 272 LYS C 75 LYS.? 21.97 O2 GOL D1181 coo 2.03 68.31 21.46 0.66 68.36 23.90 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo 16.93 55.67 9.65 17.16 54.23 11.19 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 14.13 45.79 13.40 14.25 49.41 18.30 -57.40 -22.87 13.44 -53.97 -26.42 17.14 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 15 3 # 15 A 173 TYR D 107 TYR~? -4.59 CH3 ACT A1182s A 243 ASP A 95 ASP~? 18.75 OXT ACT A1182 A 272 LYS D 75 LYS.? 24.88 O3 GOL D1181 coo 2.03 68.31 21.46 0.66 68.36 23.90 -24.79 -2.98 13.13 -27.46 -2.42 12.49 coo 16.93 55.67 9.65 17.16 54.23 11.19 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 14.13 45.79 13.40 14.25 49.41 18.30 -33.47 8.69 34.45 -37.51 6.70 37.91 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 16 3 # 16 A 173 TYR D 175 TYR.? 24.43 OXT ACT A1182 A 243 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 272 LYS C 149 LYS.? 9.01 CA CA C1184 coo 2.03 68.31 21.46 0.66 68.36 23.90 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 16.93 55.67 9.65 17.16 54.23 11.19 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 14.13 45.79 13.40 14.25 49.41 18.30 -50.86 -2.28 41.74 -55.49 -4.16 43.55 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 16 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 93 LYS.? 11.72 OXT ACT A1182 A 177 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 201 LEU A 123 LEU~? 14.88 OXT ACT A1182 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -33.56 16.12 15.97 -33.69 15.04 14.07 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 124 LYS~? 24.92 OXT ACT A1182 A 177 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 201 LEU A 123 LEU~? 14.88 OXT ACT A1182 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -30.92 19.75 15.99 -32.39 25.70 15.74 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -33.56 16.12 15.97 -33.69 15.04 14.07 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS A 124 LYS~? 24.92 OXT ACT A1182 A 177 GLU A 139 GLU.? 21.64 O ACT A1181 A 201 LEU A 141 LEU.? 22.36 OXT ACT A1182 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -30.92 19.75 15.99 -32.39 25.70 15.74 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -29.13 23.30 9.85 -29.08 22.31 11.78 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS A 124 LYS~? 24.92 OXT ACT A1182 A 177 GLU A 140 GLU.? 22.35 O ACT A1181 A 201 LEU A 141 LEU.? 22.36 OXT ACT A1182 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -30.92 19.75 15.99 -32.39 25.70 15.74 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -27.69 26.26 5.34 -26.17 27.35 4.33 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -29.13 23.30 9.85 -29.08 22.31 11.78 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS A 142 LYS.? 21.46 CH3 ACT A1182 A 177 GLU A 139 GLU.? 21.64 O ACT A1181 A 201 LEU A 141 LEU.? 22.36 OXT ACT A1182 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -25.15 24.34 9.11 -21.81 19.66 9.96 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -29.13 23.30 9.85 -29.08 22.31 11.78 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS A 149 LYS.? 8.87 O ACT A1181 A 177 GLU A 29 GLU~? 11.10 O ACT A1181 A 201 LEU A 147 LEU^? 15.19 O ACT A1181 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -40.01 25.58 0.52 -39.09 27.65 -5.03 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -32.90 25.17 0.16 -32.14 26.51 1.66 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS B 93 LYS.? 14.57 O ACT C1183 A 177 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 201 LEU B 123 LEU~? 14.76 O ACT C1183 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -56.96 -8.84 -0.37 -56.82 -6.67 -0.15 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 A 145 LYS B 124 LYS~? 15.51 CA CA B1183 A 177 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 201 LEU B 123 LEU~? 14.76 O ACT C1183 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -56.96 -8.84 -0.37 -56.82 -6.67 -0.15 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 A 145 LYS B 124 LYS~? 15.51 CA CA B1183 A 177 GLU B 139 GLU.? 13.29 O3 GOL B1182 A 201 LEU B 141 LEU.? 11.01 CA CA B1183 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -60.45 -6.61 -10.73 -58.57 -7.78 -11.06 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 A 145 LYS B 142 LYS.? 10.67 CA CA B1183 A 177 GLU B 139 GLU.? 13.29 O3 GOL B1182 A 201 LEU B 137 LEU^? 9.63 O2 GOL B1182 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -57.25 -1.91 -9.74 -58.40 -2.76 -8.13 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 11 3 # 11 A 145 LYS B 142 LYS.? 10.67 CA CA B1183 A 177 GLU B 139 GLU.? 13.29 O3 GOL B1182 A 201 LEU B 141 LEU.? 11.01 CA CA B1183 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -60.45 -6.61 -10.73 -58.57 -7.78 -11.06 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 12 3 # 12 A 145 LYS B 149 LYS.? 7.98 O3 GOL B1182 A 177 GLU B 140 GLU.? 3.43 CA CA B1183s A 201 LEU B 147 LEU^? -4.90 O2 GOL B1182s coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -50.82 2.31 -15.26 -51.03 5.84 -20.47 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -61.69 -2.09 -15.49 -62.76 -1.73 -17.26 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -57.70 1.88 -14.83 -58.68 0.02 -15.15 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 13 3 # 13 A 145 LYS C 93 LYS.? 19.61 OXT ACT C1183 A 177 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 201 LEU C 123 LEU~? 14.68 OXT ACT C1183 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -56.96 8.82 26.82 -56.82 6.64 26.57 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 14 3 # 14 A 145 LYS C 124 LYS~? 15.99 CA CA C1184 A 177 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 201 LEU C 123 LEU~? 14.68 OXT ACT C1183 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -59.48 10.16 30.27 -60.09 12.26 35.28 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -56.96 8.82 26.82 -56.82 6.64 26.57 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 15 3 # 15 A 145 LYS C 124 LYS~? 15.99 CA CA C1184 A 177 GLU C 139 GLU.? 13.61 CA CA C1184 A 201 LEU C 141 LEU.? 10.84 CA CA C1184 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -59.48 10.16 30.27 -60.09 12.26 35.28 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -60.53 6.49 37.07 -58.53 7.36 37.60 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 16 3 # 16 A 145 LYS C 142 LYS.? 12.38 CA CA C1184 A 177 GLU C 139 GLU.? 13.61 CA CA C1184 A 201 LEU C 137 LEU^? 10.28 CA CA C1184 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -64.58 4.07 38.03 -66.58 4.11 31.93 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -57.22 1.94 36.20 -58.39 2.78 34.63 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 17 3 # 17 A 145 LYS C 142 LYS.? 12.38 CA CA C1184 A 177 GLU C 139 GLU.? 13.61 CA CA C1184 A 201 LEU C 141 LEU.? 10.84 CA CA C1184 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -64.58 4.07 38.03 -66.58 4.11 31.93 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -60.53 6.49 37.07 -58.53 7.36 37.60 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 18 3 # 18 A 145 LYS C 149 LYS.? 9.01 CA CA C1184 A 177 GLU C 140 GLU.? 3.48 CA CA C1184s A 201 LEU C 147 LEU^? 5.95 CA CA C1184 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -50.86 -2.28 41.74 -55.49 -4.16 43.55 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -61.62 1.99 42.01 -62.64 1.68 43.84 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -57.68 -1.91 41.33 -58.71 -0.07 41.69 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 19 3 # 19 A 145 LYS D 93 LYS.? 12.21 O ACT A1182 A 177 GLU D 119 GLU.? 19.65 O ACT A1182 A 201 LEU D 123 LEU~? 14.95 O ACT A1182 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -33.63 -16.15 10.50 -33.77 -15.05 12.40 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 20 3 # 20 A 145 LYS D 124 LYS~? 24.78 O ACT A1182 A 177 GLU D 119 GLU.? 19.65 O ACT A1182 A 201 LEU D 123 LEU~? 14.95 O ACT A1182 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -33.63 -16.15 10.50 -33.77 -15.05 12.40 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 21 3 # 21 A 145 LYS D 124 LYS~? 24.78 O ACT A1182 A 177 GLU D 139 GLU.? 21.84 O2 GOL D1181 A 201 LEU D 141 LEU.? 22.36 O ACT A1182 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -29.00 -23.23 16.68 -28.82 -22.22 14.77 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 22 3 # 22 A 145 LYS D 124 LYS~? 24.78 O ACT A1182 A 177 GLU D 140 GLU.? 20.95 O2 GOL D1181 A 201 LEU D 141 LEU.? 22.36 O ACT A1182 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -29.00 -23.23 16.68 -28.82 -22.22 14.77 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 23 3 # 23 A 145 LYS D 142 LYS.? 24.20 CH3 ACT A1182 A 177 GLU D 139 GLU.? 21.84 O2 GOL D1181 A 201 LEU D 141 LEU.? 22.36 O ACT A1182 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -25.06 -24.88 17.65 -21.32 -22.55 15.38 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -29.00 -23.23 16.68 -28.82 -22.22 14.77 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 24 3 # 24 A 145 LYS D 149 LYS.? 13.85 O2 GOL D1181 A 177 GLU D 29 GLU~? 11.05 O2 GOL D1181 A 201 LEU D 147 LEU^? 15.08 O2 GOL D1181 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -40.00 -25.59 26.00 -40.81 -29.12 24.35 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -32.92 -25.16 26.24 -32.16 -26.48 24.73 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 24 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 124 LYS~? 24.92 OXT ACT A1182 B 177 GLU A 139 GLU.? 21.64 O ACT A1181 B 201 LEU A 141 LEU.? 22.36 OXT ACT A1182 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -30.92 19.75 15.99 -32.39 25.70 15.74 coo 27.00 6.35 51.01 26.30 4.53 50.18 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -29.13 23.30 9.85 -29.08 22.31 11.78 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 142 LYS.? 21.46 CH3 ACT A1182 B 177 GLU A 139 GLU.? 21.64 O ACT A1181 B 201 LEU A 141 LEU.? 22.36 OXT ACT A1182 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -25.15 24.34 9.11 -21.81 19.66 9.96 coo 27.00 6.35 51.01 26.30 4.53 50.18 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -29.13 23.30 9.85 -29.08 22.31 11.78 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS A 149 LYS.? 8.87 O ACT A1181 B 177 GLU A 29 GLU~? 11.10 O ACT A1181 B 201 LEU A 147 LEU^? 15.19 O ACT A1181 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -40.01 25.58 0.52 -39.09 27.65 -5.03 coo 27.00 6.35 51.01 26.30 4.53 50.18 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -32.90 25.17 0.16 -32.14 26.51 1.66 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS B 124 LYS~? 15.51 CA CA B1183 B 177 GLU B 139 GLU.? 13.29 O3 GOL B1182 B 201 LEU B 141 LEU.? 11.01 CA CA B1183 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 coo 27.00 6.35 51.01 26.30 4.53 50.18 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -60.45 -6.61 -10.73 -58.57 -7.78 -11.06 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS B 142 LYS.? 10.67 CA CA B1183 B 177 GLU B 139 GLU.? 13.29 O3 GOL B1182 B 201 LEU B 137 LEU^? 9.63 O2 GOL B1182 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 coo 27.00 6.35 51.01 26.30 4.53 50.18 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -57.25 -1.91 -9.74 -58.40 -2.76 -8.13 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS B 142 LYS.? 10.67 CA CA B1183 B 177 GLU B 139 GLU.? 13.29 O3 GOL B1182 B 201 LEU B 141 LEU.? 11.01 CA CA B1183 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 coo 27.00 6.35 51.01 26.30 4.53 50.18 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -60.45 -6.61 -10.73 -58.57 -7.78 -11.06 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 B 145 LYS B 149 LYS.? 7.98 O3 GOL B1182 B 177 GLU B 140 GLU.? 3.43 CA CA B1183s B 201 LEU B 147 LEU^? -4.90 O2 GOL B1182s coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -50.82 2.31 -15.26 -51.03 5.84 -20.47 coo 27.00 6.35 51.01 26.30 4.53 50.18 -61.69 -2.09 -15.49 -62.76 -1.73 -17.26 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -57.70 1.88 -14.83 -58.68 0.02 -15.15 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 B 145 LYS C 124 LYS~? 15.99 CA CA C1184 B 177 GLU C 139 GLU.? 13.61 CA CA C1184 B 201 LEU C 141 LEU.? 10.84 CA CA C1184 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -59.48 10.16 30.27 -60.09 12.26 35.28 coo 27.00 6.35 51.01 26.30 4.53 50.18 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -60.53 6.49 37.07 -58.53 7.36 37.60 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 B 145 LYS C 142 LYS.? 12.38 CA CA C1184 B 177 GLU C 139 GLU.? 13.61 CA CA C1184 B 201 LEU C 137 LEU^? 10.28 CA CA C1184 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -64.58 4.07 38.03 -66.58 4.11 31.93 coo 27.00 6.35 51.01 26.30 4.53 50.18 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -57.22 1.94 36.20 -58.39 2.78 34.63 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 B 145 LYS C 142 LYS.? 12.38 CA CA C1184 B 177 GLU C 139 GLU.? 13.61 CA CA C1184 B 201 LEU C 141 LEU.? 10.84 CA CA C1184 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -64.58 4.07 38.03 -66.58 4.11 31.93 coo 27.00 6.35 51.01 26.30 4.53 50.18 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -60.53 6.49 37.07 -58.53 7.36 37.60 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 11 3 # 11 B 145 LYS C 149 LYS.? 9.01 CA CA C1184 B 177 GLU C 140 GLU.? 3.48 CA CA C1184s B 201 LEU C 147 LEU^? 5.95 CA CA C1184 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -50.86 -2.28 41.74 -55.49 -4.16 43.55 coo 27.00 6.35 51.01 26.30 4.53 50.18 -61.62 1.99 42.01 -62.64 1.68 43.84 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -57.68 -1.91 41.33 -58.71 -0.07 41.69 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 12 3 # 12 B 145 LYS D 93 LYS.? 12.21 O ACT A1182 B 177 GLU D 119 GLU.? 19.65 O ACT A1182 B 201 LEU D 123 LEU~? 14.95 O ACT A1182 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 27.00 6.35 51.01 26.30 4.53 50.18 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -33.63 -16.15 10.50 -33.77 -15.05 12.40 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 13 3 # 13 B 145 LYS D 124 LYS~? 24.78 O ACT A1182 B 177 GLU D 119 GLU.? 19.65 O ACT A1182 B 201 LEU D 123 LEU~? 14.95 O ACT A1182 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 27.00 6.35 51.01 26.30 4.53 50.18 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -33.63 -16.15 10.50 -33.77 -15.05 12.40 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 14 3 # 14 B 145 LYS D 124 LYS~? 24.78 O ACT A1182 B 177 GLU D 139 GLU.? 21.84 O2 GOL D1181 B 201 LEU D 141 LEU.? 22.36 O ACT A1182 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 27.00 6.35 51.01 26.30 4.53 50.18 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -29.00 -23.23 16.68 -28.82 -22.22 14.77 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 15 3 # 15 B 145 LYS D 142 LYS.? 24.20 CH3 ACT A1182 B 177 GLU D 139 GLU.? 21.84 O2 GOL D1181 B 201 LEU D 141 LEU.? 22.36 O ACT A1182 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -25.06 -24.88 17.65 -21.32 -22.55 15.38 coo 27.00 6.35 51.01 26.30 4.53 50.18 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -29.00 -23.23 16.68 -28.82 -22.22 14.77 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 16 3 # 16 B 145 LYS D 149 LYS.? 13.85 O2 GOL D1181 B 177 GLU D 29 GLU~? 11.05 O2 GOL D1181 B 201 LEU D 147 LEU^? 15.08 O2 GOL D1181 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -40.00 -25.59 26.00 -40.81 -29.12 24.35 coo 27.00 6.35 51.01 26.30 4.53 50.18 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -32.92 -25.16 26.24 -32.16 -26.48 24.73 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 16 hits 1daa_c01 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 646 ASP A 55 ASP.? 17.41 O ACT A1181 A 739 GLY A 122 GLY~? 17.38 OXT ACT A1182 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 11.37 50.89 2.29 11.05 51.63 2.25 -31.93 16.98 20.49 -32.19 17.34 19.79 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 151 HIS.? 15.84 O ACT A1181 A 646 ASP A 152 ASP.? 5.90 O ACT A1181 A 739 GLY A 116 GLY.? 16.42 O ACT A1181 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -46.06 27.03 4.30 -45.69 27.09 6.36 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 11.37 50.89 2.29 11.05 51.63 2.25 -38.20 18.52 6.75 -37.47 18.49 7.12 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 646 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 739 GLY B 122 GLY~? 17.40 O ACT C1183 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 11.37 50.89 2.29 11.05 51.63 2.25 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS B 151 HIS.? 14.53 O3 GOL B1182 A 646 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 739 GLY B 116 GLY.? 11.34 O3 GOL B1182 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 11.37 50.89 2.29 11.05 51.63 2.25 -52.33 -1.19 -6.26 -53.05 -1.53 -6.05 ULMN 3 1ddj_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 646 ASP C 55 ASP.? 19.45 CA CA C1184 A 739 GLY C 122 GLY~? 17.34 OXT ACT C1183 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 11.37 50.89 2.29 11.05 51.63 2.25 -58.64 13.32 25.99 -58.38 12.82 26.62 ULMN 3 1ddj_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS C 151 HIS.? 19.99 CA CA C1184 A 646 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 739 GLY C 116 GLY.? 15.57 CA CA C1184 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 11.37 50.89 2.29 11.05 51.63 2.25 -52.37 1.22 32.72 -53.07 1.55 32.51 ULMN 3 1ddj_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS D 114 HIS^? 15.97 O ACT A1182 A 646 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 739 GLY D 122 GLY~? 17.40 O ACT A1182 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 11.37 50.89 2.29 11.05 51.63 2.25 -32.03 -16.93 5.96 -32.26 -17.35 6.67 ULMN 3 1ddj_c12 PLASMINOGEN user 8 3 # 8 A 603 HIS D 151 HIS.? 15.73 O2 GOL D1181 A 646 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 739 GLY D 116 GLY.? 16.41 O2 GOL D1181 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 11.37 50.89 2.29 11.05 51.63 2.25 -38.19 -18.52 19.73 -37.45 -18.49 19.35 1ddj_c12 source 1ddj PLASMINOGEN : 8 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 646 ASP A 55 ASP.? 17.41 O ACT A1181 B 739 GLY A 122 GLY~? 17.38 OXT ACT A1182 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -31.93 16.98 20.49 -32.19 17.34 19.79 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 646 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 739 GLY B 122 GLY~? 17.40 O ACT C1183 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 646 ASP C 55 ASP.? 19.45 CA CA C1184 B 739 GLY C 122 GLY~? 17.34 OXT ACT C1183 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -58.64 13.32 25.99 -58.38 12.82 26.62 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS D 114 HIS^? 15.97 O ACT A1182 B 646 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 739 GLY D 122 GLY~? 17.40 O ACT A1182 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -32.03 -16.93 5.96 -32.26 -17.35 6.67 1ddj_c13 source 1ddj PLASMINOGEN : 4 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 114 HIS^? 15.94 OXT ACT A1182 C 646 ASP A 55 ASP.? 17.41 O ACT A1181 C 739 GLY A 122 GLY~? 17.38 OXT ACT A1182 coo 15.33 59.81 59.60 13.98 60.99 60.69 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 16.06 55.72 54.73 15.97 56.49 56.70 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 9.38 49.29 65.28 9.01 50.03 65.31 -31.93 16.98 20.49 -32.19 17.34 19.79 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS B 114 HIS^? 14.73 O2 GOL B1182 C 646 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 739 GLY B 122 GLY~? 17.40 O ACT C1183 coo 15.33 59.81 59.60 13.98 60.99 60.69 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 16.06 55.72 54.73 15.97 56.49 56.70 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 9.38 49.29 65.28 9.01 50.03 65.31 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS C 114 HIS^? 15.77 OXT ACT C1183 C 646 ASP C 55 ASP.? 19.45 CA CA C1184 C 739 GLY C 122 GLY~? 17.34 OXT ACT C1183 coo 15.33 59.81 59.60 13.98 60.99 60.69 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 16.06 55.72 54.73 15.97 56.49 56.70 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 9.38 49.29 65.28 9.01 50.03 65.31 -58.64 13.32 25.99 -58.38 12.82 26.62 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS C 151 HIS.? 19.99 CA CA C1184 C 646 ASP C 152 ASP.? 13.45 O3 GOL D1181 C 739 GLY C 116 GLY.? 15.57 CA CA C1184 coo 15.33 59.81 59.60 13.98 60.99 60.69 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 16.06 55.72 54.73 15.97 56.49 56.70 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 9.38 49.29 65.28 9.01 50.03 65.31 -52.37 1.22 32.72 -53.07 1.55 32.51 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS D 114 HIS^? 15.97 O ACT A1182 C 646 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 739 GLY D 122 GLY~? 17.40 O ACT A1182 coo 15.33 59.81 59.60 13.98 60.99 60.69 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 16.06 55.72 54.73 15.97 56.49 56.70 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 9.38 49.29 65.28 9.01 50.03 65.31 -32.03 -16.93 5.96 -32.26 -17.35 6.67 1ddj_c14 source 1ddj PLASMINOGEN : 5 hits 1ddj_c14 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU C 76 GLU.? 18.88 CA CA C1181 A 226 THR C 40 THR~? 15.04 CA CA C1184 A 229 LYS C 35 LYS~? 10.20 CA CA C1184 coo 9.66 102.78 70.07 9.79 101.18 71.42 -62.65 -25.32 14.28 -61.97 -25.69 12.33 coo 7.24 97.46 49.60 8.11 95.69 48.80 -66.85 -8.05 28.72 -64.85 -7.34 28.99 coo 10.53 97.56 43.71 9.33 93.71 47.17 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU D 76 GLU.? 25.58 OXT ACT A1182 A 226 THR D 40 THR~? 17.62 CH3 ACT A1182 A 229 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 9.66 102.78 70.07 9.79 101.18 71.42 -29.91 8.45 37.88 -28.84 10.23 37.63 coo 7.24 97.46 49.60 8.11 95.69 48.80 -23.95 -10.93 26.82 -25.97 -11.31 26.17 coo 10.53 97.56 43.71 9.33 93.71 47.17 -22.65 -18.16 31.19 -20.45 -22.10 27.38 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU C 76 GLU.? 18.88 CA CA C1181 B 226 THR C 40 THR~? 15.04 CA CA C1184 B 229 LYS C 35 LYS~? 10.20 CA CA C1184 coo 15.90 87.61 49.61 13.92 86.96 49.36 -62.65 -25.32 14.28 -61.97 -25.69 12.33 coo 20.74 95.78 68.68 19.29 96.84 69.83 -66.85 -8.05 28.72 -64.85 -7.34 28.99 coo 22.32 101.61 71.64 17.89 98.63 71.55 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU D 76 GLU.? 25.58 OXT ACT A1182 B 226 THR D 40 THR~? 17.62 CH3 ACT A1182 B 229 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 15.90 87.61 49.61 13.92 86.96 49.36 -29.91 8.45 37.88 -28.84 10.23 37.63 coo 20.74 95.78 68.68 19.29 96.84 69.83 -23.95 -10.93 26.82 -25.97 -11.31 26.17 coo 22.32 101.61 71.64 17.89 98.63 71.55 -22.65 -18.16 31.19 -20.45 -22.10 27.38 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU C 76 GLU.? 18.88 CA CA C1181 C 226 THR C 40 THR~? 15.04 CA CA C1184 C 229 LYS C 35 LYS~? 10.20 CA CA C1184 coo 5.43 40.40 61.63 4.27 41.99 60.90 -62.65 -25.32 14.28 -61.97 -25.69 12.33 coo 22.16 45.88 73.63 23.23 47.70 73.25 -66.85 -8.05 28.72 -64.85 -7.34 28.99 coo 28.90 45.91 73.55 25.22 49.72 72.97 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU D 76 GLU.? 25.58 OXT ACT A1182 C 226 THR D 40 THR~? 17.62 CH3 ACT A1182 C 229 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 5.43 40.40 61.63 4.27 41.99 60.90 -29.91 8.45 37.88 -28.84 10.23 37.63 coo 22.16 45.88 73.63 23.23 47.70 73.25 -23.95 -10.93 26.82 -25.97 -11.31 26.17 coo 28.90 45.91 73.55 25.22 49.72 72.97 -22.65 -18.16 31.19 -20.45 -22.10 27.38 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU C 76 GLU.? 18.88 CA CA C1181 D 226 THR C 40 THR~? 15.04 CA CA C1184 D 229 LYS C 35 LYS~? 10.20 CA CA C1184 coo 26.07 55.89 66.14 25.33 56.50 68.01 -62.65 -25.32 14.28 -61.97 -25.69 12.33 coo 11.79 47.62 52.67 10.10 46.51 53.39 -66.85 -8.05 28.72 -64.85 -7.34 28.99 coo 10.05 41.79 49.80 7.94 44.71 53.76 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU D 76 GLU.? 25.58 OXT ACT A1182 D 226 THR D 40 THR~? 17.62 CH3 ACT A1182 D 229 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 26.07 55.89 66.14 25.33 56.50 68.01 -29.91 8.45 37.88 -28.84 10.23 37.63 coo 11.79 47.62 52.67 10.10 46.51 53.39 -23.95 -10.93 26.82 -25.97 -11.31 26.17 coo 10.05 41.79 49.80 7.94 44.71 53.76 -22.65 -18.16 31.19 -20.45 -22.10 27.38 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 200 ASP A 95 ASP~? 18.75 OXT ACT A1182 A 229 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 1.13 77.49 40.64 0.62 75.57 39.98 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 0.84 91.24 49.01 2.91 91.61 49.23 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 10.53 97.56 43.71 9.33 93.71 47.17 -39.21 6.22 27.81 -43.32 9.34 25.63 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 200 ASP A 95 ASP~? 18.75 OXT ACT A1182 B 229 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 9.24 94.26 88.22 8.02 94.07 89.92 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 17.54 90.31 75.01 17.17 92.01 73.80 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 22.32 101.61 71.64 17.89 98.63 71.55 -39.21 6.22 27.81 -43.32 9.34 25.63 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 114 HIS^? 15.94 OXT ACT A1182 C 200 ASP A 95 ASP~? 18.75 OXT ACT A1182 C 229 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 26.77 65.84 83.49 27.06 67.76 84.27 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 19.52 52.01 79.59 20.28 51.65 77.65 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 28.90 45.91 73.55 25.22 49.72 72.97 -39.21 6.22 27.81 -43.32 9.34 25.63 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 114 HIS^? 15.94 OXT ACT A1182 D 200 ASP A 95 ASP~? 18.75 OXT ACT A1182 D 229 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 4.60 52.95 52.50 5.57 51.29 53.40 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 10.05 41.79 49.80 7.94 44.71 53.76 -39.21 6.22 27.81 -43.32 9.34 25.63 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 33 TYR~? 13.22 O ACT A1181 A 138 ARG A 30 ARG.? 15.23 O ACT A1181 A 161 LYS A 35 LYS~? 23.91 O ACT A1181 coo 29.03 88.95 86.80 28.09 90.57 84.75 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 23.31 93.18 82.88 23.00 93.71 79.86 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo 33.83 91.15 88.62 31.07 91.06 83.02 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR B 33 TYR~? -4.73 C1 GOL B1182s A 138 ARG B 30 ARG.? -4.36 CA CA B1183s A 161 LYS B 35 LYS~? 11.04 CA CA B1183 coo 29.03 88.95 86.80 28.09 90.57 84.75 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 23.31 93.18 82.88 23.00 93.71 79.86 -65.37 6.99 -20.70 -65.41 4.49 -18.90 coo 33.83 91.15 88.62 31.07 91.06 83.02 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 133 TYR D 33 TYR~? 12.91 O3 GOL D1181 A 138 ARG D 30 ARG.? 11.01 CA CA C1182 A 161 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 29.03 88.95 86.80 28.09 90.57 84.75 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 23.31 93.18 82.88 23.00 93.71 79.86 -29.54 -28.66 35.64 -30.45 -28.64 38.59 coo 33.83 91.15 88.62 31.07 91.06 83.02 -22.65 -18.16 31.19 -20.45 -22.10 27.38 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 3 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 33 TYR~? 13.22 O ACT A1181 B 138 ARG A 30 ARG.? 15.23 O ACT A1181 B 161 LYS A 35 LYS~? 23.91 O ACT A1181 coo 4.62 122.69 99.88 5.46 122.82 97.24 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 10.44 122.27 94.08 11.02 123.87 91.53 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo -0.17 119.75 99.65 2.51 123.83 95.70 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR B 33 TYR~? -4.73 C1 GOL B1182s B 138 ARG B 30 ARG.? -4.36 CA CA B1183s B 161 LYS B 35 LYS~? 11.04 CA CA B1183 coo 4.62 122.69 99.88 5.46 122.82 97.24 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 10.44 122.27 94.08 11.02 123.87 91.53 -65.37 6.99 -20.70 -65.41 4.49 -18.90 coo -0.17 119.75 99.65 2.51 123.83 95.70 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 133 TYR D 33 TYR~? 12.91 O3 GOL D1181 B 138 ARG D 30 ARG.? 11.01 CA CA C1182 B 161 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 4.62 122.69 99.88 5.46 122.82 97.24 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 10.44 122.27 94.08 11.02 123.87 91.53 -29.54 -28.66 35.64 -30.45 -28.64 38.59 coo -0.17 119.75 99.65 2.51 123.83 95.70 -22.65 -18.16 31.19 -20.45 -22.10 27.38 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 3 hits 1dhp_c01 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 157 TYR~? 5.66 OXT ACT A1181 150 LYS A 158 LYS~? -4.64 O ACT A1181s 186 ASN B 168 ASN~? 15.62 CH3 ACT A1181 coo 32.88 50.55 24.33 31.89 51.78 26.65 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 27.04 52.42 22.30 26.88 49.99 27.00 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 36.98 50.30 37.29 35.85 50.29 35.50 -59.27 19.54 -3.77 -57.59 20.58 -3.04 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 175 TYR~? 24.50 O ACT A1182 150 LYS A 177 LYS.? 21.69 OXT ACT A1181 186 ASN A 68 ASN~? 16.27 OXT ACT A1181 coo 32.88 50.55 24.33 31.89 51.78 26.65 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 27.04 52.42 22.30 26.88 49.99 27.00 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo 36.98 50.30 37.29 35.85 50.29 35.50 -37.69 3.73 -3.29 -39.63 4.05 -4.09 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR B 157 TYR~? 6.24 OXT ACT A1181 150 LYS B 158 LYS~? 6.73 O3 GOL B1182 186 ASN A 168 ASN~? 15.32 OXT ACT A1181 coo 32.88 50.55 24.33 31.89 51.78 26.65 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo 27.04 52.42 22.30 26.88 49.99 27.00 -50.07 10.43 -10.30 -49.56 8.69 -16.32 coo 36.98 50.30 37.29 35.85 50.29 35.50 -31.58 8.23 -11.56 -33.27 7.25 -12.34 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR B 175 TYR~? 10.51 CA CA B1181 150 LYS B 177 LYS.? 12.69 CA CA B1181 186 ASN B 68 ASN~? 15.57 O ACT A1181 coo 32.88 50.55 24.33 31.89 51.78 26.65 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 27.04 52.42 22.30 26.88 49.99 27.00 -68.49 25.09 -2.05 -63.14 26.93 0.36 coo 36.98 50.30 37.29 35.85 50.29 35.50 -53.02 13.76 3.43 -51.10 14.43 2.89 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR C 157 TYR~? 5.26 O3 GOL D1181 150 LYS C 158 LYS~? 13.55 O3 GOL D1181 186 ASN D 168 ASN~? 14.11 O3 GOL D1181 coo 32.88 50.55 24.33 31.89 51.78 26.65 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo 27.04 52.42 22.30 26.88 49.99 27.00 -50.05 -10.42 36.79 -49.63 -8.70 42.89 coo 36.98 50.30 37.29 35.85 50.29 35.50 -31.58 -8.23 38.03 -33.25 -7.24 38.84 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 6 3 # 6 146 TYR C 175 TYR~? 10.79 CA CA C1181 150 LYS C 177 LYS.? 13.52 CA CA C1181 186 ASN C 68 ASN~? 15.25 C2 GOL D1181 coo 32.88 50.55 24.33 31.89 51.78 26.65 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 27.04 52.42 22.30 26.88 49.99 27.00 -68.52 -25.10 28.52 -62.74 -26.81 28.79 coo 36.98 50.30 37.29 35.85 50.29 35.50 -53.02 -13.76 23.01 -51.11 -14.42 23.60 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 7 3 # 7 146 TYR D 157 TYR~? -5.31 C1 GOL D1181s 150 LYS D 158 LYS~? -4.46 O2 GOL D1181s 186 ASN C 168 ASN~? 14.78 C1 GOL D1181 coo 32.88 50.55 24.33 31.89 51.78 26.65 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 27.04 52.42 22.30 26.88 49.99 27.00 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo 36.98 50.30 37.29 35.85 50.29 35.50 -59.24 -19.55 30.22 -57.56 -20.59 29.47 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 7 hits 1dhr_c00 naa= 3 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 1 3 # 1 A 222 TYR A 5 TYR~? 13.40 O1 GOL B1182 A 238 ASP A 6 ASP~? 16.17 CA CA B1181 A 272 TRP A 7 TRP~? 13.17 CA CA B1181 coo -17.92 42.46 111.37 -18.35 40.11 109.91 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo -25.50 44.84 112.68 -25.52 43.37 111.17 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo -27.19 39.29 113.01 -23.27 39.61 112.78 -64.51 23.48 -8.12 -63.01 20.07 -6.83 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 2 3 # 2 A 222 TYR B 5 TYR~? 22.90 O ACT A1181 A 238 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 272 TRP B 7 TRP~? 18.47 OXT ACT A1181 coo -17.92 42.46 111.37 -18.35 40.11 109.91 -20.60 17.75 -11.10 -19.92 17.17 -8.44 coo -25.50 44.84 112.68 -25.52 43.37 111.17 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo -27.19 39.29 113.01 -23.27 39.61 112.78 -26.39 11.02 -16.75 -27.73 11.07 -13.04 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 3 3 # 3 A 222 TYR C 5 TYR~? 20.02 CA CA C1182 A 238 ASP C 6 ASP~? 17.85 CA CA C1182 A 272 TRP C 7 TRP~? 16.43 CA CA C1182 coo -17.92 42.46 111.37 -18.35 40.11 109.91 -20.63 -17.79 37.57 -20.04 -17.26 34.89 coo -25.50 44.84 112.68 -25.52 43.37 111.17 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo -27.19 39.29 113.01 -23.27 39.61 112.78 -26.42 -11.04 43.18 -27.72 -11.10 39.46 ULMN 3 1diz_c00 3-METHYLADENINE DNA GLYCOSYLASE II user 4 3 # 4 A 222 TYR D 5 TYR~? 13.80 CA CA C1181 A 238 ASP D 6 ASP~? 16.12 CA CA C1181 A 272 TRP D 7 TRP~? 13.25 CA CA C1181 coo -17.92 42.46 111.37 -18.35 40.11 109.91 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo -25.50 44.84 112.68 -25.52 43.37 111.17 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo -27.19 39.29 113.01 -23.27 39.61 112.78 -64.48 -23.47 34.59 -63.03 -20.04 33.30 1diz_c00 source 1diz 3-METHYLADENINE DNA GLYCOSYLASE II : 4 hits 1diz_c00 naa= 3 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 1 3 # 1 B 222 TYR A 5 TYR~? 13.40 O1 GOL B1182 B 238 ASP A 6 ASP~? 16.17 CA CA B1181 B 272 TRP A 7 TRP~? 13.17 CA CA B1181 coo 17.91 42.42 121.64 18.26 40.06 123.11 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 25.38 44.99 120.20 25.38 43.50 121.71 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 27.19 39.35 120.02 23.28 39.60 120.23 -64.51 23.48 -8.12 -63.01 20.07 -6.83 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 2 3 # 2 B 222 TYR B 5 TYR~? 22.90 O ACT A1181 B 238 ASP B 6 ASP~? 24.59 OXT ACT A1181 B 272 TRP B 7 TRP~? 18.47 OXT ACT A1181 coo 17.91 42.42 121.64 18.26 40.06 123.11 -20.60 17.75 -11.10 -19.92 17.17 -8.44 coo 25.38 44.99 120.20 25.38 43.50 121.71 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 27.19 39.35 120.02 23.28 39.60 120.23 -26.39 11.02 -16.75 -27.73 11.07 -13.04 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 3 3 # 3 B 222 TYR C 5 TYR~? 20.02 CA CA C1182 B 238 ASP C 6 ASP~? 17.85 CA CA C1182 B 272 TRP C 7 TRP~? 16.43 CA CA C1182 coo 17.91 42.42 121.64 18.26 40.06 123.11 -20.63 -17.79 37.57 -20.04 -17.26 34.89 coo 25.38 44.99 120.20 25.38 43.50 121.71 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 27.19 39.35 120.02 23.28 39.60 120.23 -26.42 -11.04 43.18 -27.72 -11.10 39.46 ULMN 3 1diz_c01 3-METHYLADENINE DNA GLYCOSYLASE II user 4 3 # 4 B 222 TYR D 5 TYR~? 13.80 CA CA C1181 B 238 ASP D 6 ASP~? 16.12 CA CA C1181 B 272 TRP D 7 TRP~? 13.25 CA CA C1181 coo 17.91 42.42 121.64 18.26 40.06 123.11 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 25.38 44.99 120.20 25.38 43.50 121.71 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 27.19 39.35 120.02 23.28 39.60 120.23 -64.48 -23.47 34.59 -63.03 -20.04 33.30 1diz_c01 source 1diz 3-METHYLADENINE DNA GLYCOSYLASE II : 4 hits 1diz_c01 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 33 TYR~? 13.22 O ACT A1181 A 183 LYS A 35 LYS~? 23.91 O ACT A1181 A 278 ASP A 144 ASP.? 22.46 O ACT A1181 coo 19.43 18.53 42.32 17.66 18.80 40.15 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 21.92 15.80 36.19 17.64 19.44 36.35 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo 15.46 19.03 31.40 15.01 18.25 33.31 -24.09 23.13 1.13 -22.88 24.73 0.42 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR A 91 TYR.? 11.44 OXT ACT A1182 A 183 LYS A 93 LYS.? 11.72 OXT ACT A1182 A 278 ASP A 95 ASP~? 18.75 OXT ACT A1182 coo 19.43 18.53 42.32 17.66 18.80 40.15 -35.52 10.03 17.00 -36.51 12.40 15.90 coo 21.92 15.80 36.19 17.64 19.44 36.35 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 15.46 19.03 31.40 15.01 18.25 33.31 -30.02 14.86 26.58 -28.64 13.51 27.46 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR A 157 TYR~? 5.66 OXT ACT A1181 A 183 LYS A 158 LYS~? -4.64 O ACT A1181s A 278 ASP A 152 ASP.? 5.90 O ACT A1181 coo 19.43 18.53 42.32 17.66 18.80 40.15 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 21.92 15.80 36.19 17.64 19.44 36.35 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 15.46 19.03 31.40 15.01 18.25 33.31 -43.60 24.63 -2.03 -43.51 24.01 -4.05 ULMN 3 1do8_c00 MALIC ENZYME user 4 3 # 4 A 112 TYR B 33 TYR~? -4.73 C1 GOL B1182s A 183 LYS B 35 LYS~? 11.04 CA CA B1183 A 278 ASP B 144 ASP.? 6.66 CA CA B1183 coo 19.43 18.53 42.32 17.66 18.80 40.15 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 21.92 15.80 36.19 17.64 19.44 36.35 -68.46 9.78 -10.58 -72.55 6.75 -11.95 coo 15.46 19.03 31.40 15.01 18.25 33.31 -67.28 1.35 -10.84 -69.02 1.72 -11.95 ULMN 3 1do8_c00 MALIC ENZYME user 5 3 # 5 A 112 TYR C 33 TYR~? 11.20 CA CA C1184 A 183 LYS C 35 LYS~? 10.20 CA CA C1184 A 278 ASP C 144 ASP.? 6.69 CA CA C1184 coo 19.43 18.53 42.32 17.66 18.80 40.15 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo 21.92 15.80 36.19 17.64 19.44 36.35 -68.45 -9.84 37.00 -72.38 -5.53 38.73 coo 15.46 19.03 31.40 15.01 18.25 33.31 -67.28 -1.35 37.26 -69.02 -1.78 38.35 ULMN 3 1do8_c00 MALIC ENZYME user 6 3 # 6 A 112 TYR C 91 TYR.? 11.38 OXT ACT C1183 A 183 LYS C 93 LYS.? 19.61 OXT ACT C1183 A 278 ASP C 95 ASP~? 18.98 OXT ACT C1183 coo 19.43 18.53 42.32 17.66 18.80 40.15 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 21.92 15.80 36.19 17.64 19.44 36.35 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 15.46 19.03 31.40 15.01 18.25 33.31 -60.88 17.87 20.49 -62.76 18.57 19.77 ULMN 3 1do8_c00 MALIC ENZYME user 7 3 # 7 A 112 TYR D 33 TYR~? 12.91 O3 GOL D1181 A 183 LYS D 35 LYS~? 23.81 O2 GOL D1181 A 278 ASP D 144 ASP.? 22.37 O2 GOL D1181 coo 19.43 18.53 42.32 17.66 18.80 40.15 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 21.92 15.80 36.19 17.64 19.44 36.35 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo 15.46 19.03 31.40 15.01 18.25 33.31 -24.08 -23.14 25.44 -22.85 -24.74 26.11 ULMN 3 1do8_c00 MALIC ENZYME user 8 3 # 8 A 112 TYR D 157 TYR~? -5.31 C1 GOL D1181s A 183 LYS D 158 LYS~? -4.46 O2 GOL D1181s A 278 ASP D 152 ASP.? 5.75 O2 GOL D1181 coo 19.43 18.53 42.32 17.66 18.80 40.15 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 21.92 15.80 36.19 17.64 19.44 36.35 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo 15.46 19.03 31.40 15.01 18.25 33.31 -43.59 -24.59 28.46 -43.51 -24.00 30.49 1do8_c00 source 1do8 MALIC ENZYME : 8 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 33 TYR~? 13.22 O ACT A1181 B 183 LYS A 35 LYS~? 23.91 O ACT A1181 B 278 ASP A 144 ASP.? 22.46 O ACT A1181 coo 58.62 15.99 58.34 60.98 14.60 58.93 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 60.11 10.60 53.63 62.59 10.74 58.67 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo 66.50 7.32 58.45 66.26 9.42 58.23 -24.09 23.13 1.13 -22.88 24.73 0.42 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR A 91 TYR.? 11.44 OXT ACT A1182 B 183 LYS A 93 LYS.? 11.72 OXT ACT A1182 B 278 ASP A 95 ASP~? 18.75 OXT ACT A1182 coo 58.62 15.99 58.34 60.98 14.60 58.93 -35.52 10.03 17.00 -36.51 12.40 15.90 coo 60.11 10.60 53.63 62.59 10.74 58.67 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 66.50 7.32 58.45 66.26 9.42 58.23 -30.02 14.86 26.58 -28.64 13.51 27.46 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR A 157 TYR~? 5.66 OXT ACT A1181 B 183 LYS A 158 LYS~? -4.64 O ACT A1181s B 278 ASP A 152 ASP.? 5.90 O ACT A1181 coo 58.62 15.99 58.34 60.98 14.60 58.93 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 60.11 10.60 53.63 62.59 10.74 58.67 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 66.50 7.32 58.45 66.26 9.42 58.23 -43.60 24.63 -2.03 -43.51 24.01 -4.05 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR B 33 TYR~? -4.73 C1 GOL B1182s B 183 LYS B 35 LYS~? 11.04 CA CA B1183 B 278 ASP B 144 ASP.? 6.66 CA CA B1183 coo 58.62 15.99 58.34 60.98 14.60 58.93 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 60.11 10.60 53.63 62.59 10.74 58.67 -68.46 9.78 -10.58 -72.55 6.75 -11.95 coo 66.50 7.32 58.45 66.26 9.42 58.23 -67.28 1.35 -10.84 -69.02 1.72 -11.95 ULMN 3 1do8_c01 MALIC ENZYME user 5 3 # 5 B 112 TYR C 5 TYR~? 20.02 CA CA C1182 B 183 LYS D 35 LYS~? 23.81 O2 GOL D1181 B 278 ASP D 144 ASP.? 22.37 O2 GOL D1181 coo 58.62 15.99 58.34 60.98 14.60 58.93 -20.63 -17.79 37.57 -20.04 -17.26 34.89 coo 60.11 10.60 53.63 62.59 10.74 58.67 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo 66.50 7.32 58.45 66.26 9.42 58.23 -24.08 -23.14 25.44 -22.85 -24.74 26.11 ULMN 3 1do8_c01 MALIC ENZYME user 6 3 # 6 B 112 TYR C 33 TYR~? 11.20 CA CA C1184 B 183 LYS C 35 LYS~? 10.20 CA CA C1184 B 278 ASP C 144 ASP.? 6.69 CA CA C1184 coo 58.62 15.99 58.34 60.98 14.60 58.93 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo 60.11 10.60 53.63 62.59 10.74 58.67 -68.45 -9.84 37.00 -72.38 -5.53 38.73 coo 66.50 7.32 58.45 66.26 9.42 58.23 -67.28 -1.35 37.26 -69.02 -1.78 38.35 ULMN 3 1do8_c01 MALIC ENZYME user 7 3 # 7 B 112 TYR C 91 TYR.? 11.38 OXT ACT C1183 B 183 LYS C 93 LYS.? 19.61 OXT ACT C1183 B 278 ASP C 95 ASP~? 18.98 OXT ACT C1183 coo 58.62 15.99 58.34 60.98 14.60 58.93 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 60.11 10.60 53.63 62.59 10.74 58.67 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 66.50 7.32 58.45 66.26 9.42 58.23 -60.88 17.87 20.49 -62.76 18.57 19.77 ULMN 3 1do8_c01 MALIC ENZYME user 8 3 # 8 B 112 TYR D 33 TYR~? 12.91 O3 GOL D1181 B 183 LYS D 35 LYS~? 23.81 O2 GOL D1181 B 278 ASP D 144 ASP.? 22.37 O2 GOL D1181 coo 58.62 15.99 58.34 60.98 14.60 58.93 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 60.11 10.60 53.63 62.59 10.74 58.67 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo 66.50 7.32 58.45 66.26 9.42 58.23 -24.08 -23.14 25.44 -22.85 -24.74 26.11 1do8_c01 source 1do8 MALIC ENZYME : 8 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 33 TYR~? 13.22 O ACT A1181 C 183 LYS A 35 LYS~? 23.91 O ACT A1181 C 278 ASP A 144 ASP.? 22.46 O ACT A1181 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -24.09 23.13 1.13 -22.88 24.73 0.42 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR A 91 TYR.? 11.44 OXT ACT A1182 C 183 LYS A 93 LYS.? 11.72 OXT ACT A1182 C 278 ASP A 95 ASP~? 18.75 OXT ACT A1182 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -35.52 10.03 17.00 -36.51 12.40 15.90 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -30.02 14.86 26.58 -28.64 13.51 27.46 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR A 157 TYR~? 5.66 OXT ACT A1181 C 183 LYS A 158 LYS~? -4.64 O ACT A1181s C 278 ASP A 152 ASP.? 5.90 O ACT A1181 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -43.60 24.63 -2.03 -43.51 24.01 -4.05 ULMN 3 1do8_c02 MALIC ENZYME user 4 3 # 4 C 112 TYR B 33 TYR~? -4.73 C1 GOL B1182s C 183 LYS B 35 LYS~? 11.04 CA CA B1183 C 278 ASP B 144 ASP.? 6.66 CA CA B1183 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -68.46 9.78 -10.58 -72.55 6.75 -11.95 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -67.28 1.35 -10.84 -69.02 1.72 -11.95 ULMN 3 1do8_c02 MALIC ENZYME user 5 3 # 5 C 112 TYR C 33 TYR~? 11.20 CA CA C1184 C 183 LYS C 35 LYS~? 10.20 CA CA C1184 C 278 ASP C 144 ASP.? 6.69 CA CA C1184 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -68.45 -9.84 37.00 -72.38 -5.53 38.73 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -67.28 -1.35 37.26 -69.02 -1.78 38.35 ULMN 3 1do8_c02 MALIC ENZYME user 6 3 # 6 C 112 TYR C 91 TYR.? 11.38 OXT ACT C1183 C 183 LYS C 93 LYS.? 19.61 OXT ACT C1183 C 278 ASP C 95 ASP~? 18.98 OXT ACT C1183 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -60.88 17.87 20.49 -62.76 18.57 19.77 ULMN 3 1do8_c02 MALIC ENZYME user 7 3 # 7 C 112 TYR D 33 TYR~? 12.91 O3 GOL D1181 C 183 LYS D 35 LYS~? 23.81 O2 GOL D1181 C 278 ASP D 144 ASP.? 22.37 O2 GOL D1181 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -24.08 -23.14 25.44 -22.85 -24.74 26.11 ULMN 3 1do8_c02 MALIC ENZYME user 8 3 # 8 C 112 TYR D 157 TYR~? -5.31 C1 GOL D1181s C 183 LYS D 158 LYS~? -4.46 O2 GOL D1181s C 278 ASP D 152 ASP.? 5.75 O2 GOL D1181 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -43.59 -24.59 28.46 -43.51 -24.00 30.49 1do8_c02 source 1do8 MALIC ENZYME : 8 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 33 TYR~? 13.22 O ACT A1181 D 183 LYS A 35 LYS~? 23.91 O ACT A1181 D 278 ASP A 144 ASP.? 22.46 O ACT A1181 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -24.09 23.13 1.13 -22.88 24.73 0.42 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR A 91 TYR.? 11.44 OXT ACT A1182 D 183 LYS A 93 LYS.? 11.72 OXT ACT A1182 D 278 ASP A 95 ASP~? 18.75 OXT ACT A1182 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -35.52 10.03 17.00 -36.51 12.40 15.90 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -30.02 14.86 26.58 -28.64 13.51 27.46 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR A 157 TYR~? 5.66 OXT ACT A1181 D 183 LYS A 158 LYS~? -4.64 O ACT A1181s D 278 ASP A 152 ASP.? 5.90 O ACT A1181 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -43.60 24.63 -2.03 -43.51 24.01 -4.05 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR B 33 TYR~? -4.73 C1 GOL B1182s D 183 LYS B 35 LYS~? 11.04 CA CA B1183 D 278 ASP B 144 ASP.? 6.66 CA CA B1183 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -68.46 9.78 -10.58 -72.55 6.75 -11.95 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -67.28 1.35 -10.84 -69.02 1.72 -11.95 ULMN 3 1do8_c03 MALIC ENZYME user 5 3 # 5 D 112 TYR C 5 TYR~? 20.02 CA CA C1182 D 183 LYS D 35 LYS~? 23.81 O2 GOL D1181 D 278 ASP D 144 ASP.? 22.37 O2 GOL D1181 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -20.63 -17.79 37.57 -20.04 -17.26 34.89 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -24.08 -23.14 25.44 -22.85 -24.74 26.11 ULMN 3 1do8_c03 MALIC ENZYME user 6 3 # 6 D 112 TYR C 33 TYR~? 11.20 CA CA C1184 D 183 LYS C 35 LYS~? 10.20 CA CA C1184 D 278 ASP C 144 ASP.? 6.69 CA CA C1184 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -68.45 -9.84 37.00 -72.38 -5.53 38.73 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -67.28 -1.35 37.26 -69.02 -1.78 38.35 ULMN 3 1do8_c03 MALIC ENZYME user 7 3 # 7 D 112 TYR C 91 TYR.? 11.38 OXT ACT C1183 D 183 LYS C 93 LYS.? 19.61 OXT ACT C1183 D 278 ASP C 95 ASP~? 18.98 OXT ACT C1183 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -60.88 17.87 20.49 -62.76 18.57 19.77 ULMN 3 1do8_c03 MALIC ENZYME user 8 3 # 8 D 112 TYR D 33 TYR~? 12.91 O3 GOL D1181 D 183 LYS D 35 LYS~? 23.81 O2 GOL D1181 D 278 ASP D 144 ASP.? 22.37 O2 GOL D1181 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -24.08 -23.14 25.44 -22.85 -24.74 26.11 1do8_c03 source 1do8 MALIC ENZYME : 8 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 114 HIS^? 15.94 OXT ACT A1182 E 102 ASP A 55 ASP.? 17.41 O ACT A1181 E 193 GLY A 122 GLY~? 17.38 OXT ACT A1182 coo 11.39 26.86 25.95 9.85 26.64 27.36 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 10.90 32.83 25.96 10.83 30.68 25.98 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 4.57 20.60 30.29 4.74 21.36 30.66 -31.93 16.98 20.49 -32.19 17.34 19.79 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS B 114 HIS^? 14.73 O2 GOL B1182 E 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 E 193 GLY B 122 GLY~? 17.40 O ACT C1183 coo 11.39 26.86 25.95 9.85 26.64 27.36 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 10.90 32.83 25.96 10.83 30.68 25.98 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 4.57 20.60 30.29 4.74 21.36 30.66 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS C 114 HIS^? 15.77 OXT ACT C1183 E 102 ASP C 55 ASP.? 19.45 CA CA C1184 E 193 GLY C 122 GLY~? 17.34 OXT ACT C1183 coo 11.39 26.86 25.95 9.85 26.64 27.36 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 10.90 32.83 25.96 10.83 30.68 25.98 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 4.57 20.60 30.29 4.74 21.36 30.66 -58.64 13.32 25.99 -58.38 12.82 26.62 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 4 3 # 4 E 57 HIS D 114 HIS^? 15.97 O ACT A1182 E 102 ASP D 55 ASP.? 17.43 O2 GOL D1181 E 193 GLY D 122 GLY~? 17.40 O ACT A1182 coo 11.39 26.86 25.95 9.85 26.64 27.36 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 10.90 32.83 25.96 10.83 30.68 25.98 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 4.57 20.60 30.29 4.74 21.36 30.66 -32.03 -16.93 5.96 -32.26 -17.35 6.67 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 4 hits 1ds2_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 16 GLY~? 8.84 CH3 ACT A1181 B 144 GLU A 17 GLU~? 13.61 CH3 ACT A1181 B 164 GLU B 27 GLU~? 13.41 O1 GOL B1182 coo 88.87 114.43 152.30 88.45 115.15 152.32 -52.14 19.77 -14.51 -52.26 20.60 -14.34 coo 85.20 111.99 152.05 86.60 110.89 150.91 -53.17 23.87 -17.57 -54.60 25.28 -18.31 coo 88.14 113.46 145.73 86.79 113.92 147.30 -57.79 18.33 -19.74 -56.95 20.26 -20.07 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY A 24 GLY~? 6.98 CH3 ACT A1181 B 144 GLU A 27 GLU~? -12.01 CH3 ACT A1181s B 164 GLU B 17 GLU~? -13.09 CH3 ACT A1181s coo 88.87 114.43 152.30 88.45 115.15 152.32 -38.70 23.07 -14.67 -39.06 23.24 -13.96 coo 85.20 111.99 152.05 86.60 110.89 150.91 -34.14 22.58 -15.68 -34.47 22.99 -17.72 coo 88.14 113.46 145.73 86.79 113.92 147.30 -38.08 19.88 -20.29 -36.49 20.35 -21.57 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 3 3 # 3 B 141 GLY B 16 GLY~? 6.98 OXT ACT A1181 B 144 GLU B 17 GLU~? -13.09 CH3 ACT A1181s B 164 GLU A 27 GLU~? -12.01 CH3 ACT A1181s coo 88.87 114.43 152.30 88.45 115.15 152.32 -38.85 18.09 -15.57 -38.71 17.64 -16.26 coo 85.20 111.99 152.05 86.60 110.89 150.91 -38.08 19.88 -20.29 -36.49 20.35 -21.57 coo 88.14 113.46 145.73 86.79 113.92 147.30 -34.14 22.58 -15.68 -34.47 22.99 -17.72 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 4 3 # 4 B 141 GLY B 24 GLY~? 11.88 C1 GOL B1182 B 144 GLU B 27 GLU~? 13.41 O1 GOL B1182 B 164 GLU A 17 GLU~? 13.61 CH3 ACT A1181 coo 88.87 114.43 152.30 88.45 115.15 152.32 -52.31 16.92 -18.92 -51.97 16.19 -18.78 coo 85.20 111.99 152.05 86.60 110.89 150.91 -57.79 18.33 -19.74 -56.95 20.26 -20.07 coo 88.14 113.46 145.73 86.79 113.92 147.30 -53.17 23.87 -17.57 -54.60 25.28 -18.31 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 5 3 # 5 B 141 GLY C 16 GLY~? 6.74 C3 GOL D1181 B 144 GLU C 17 GLU~? 3.68 CA CA C1182s B 164 GLU D 27 GLU~? 2.91 CA CA C1182s coo 88.87 114.43 152.30 88.45 115.15 152.32 -38.82 -18.07 42.06 -38.69 -17.63 42.74 coo 85.20 111.99 152.05 86.60 110.89 150.91 -38.10 -19.90 46.72 -36.47 -20.40 47.99 coo 88.14 113.46 145.73 86.79 113.92 147.30 -34.10 -22.57 42.20 -34.50 -23.02 44.23 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 6 3 # 6 B 141 GLY C 24 GLY~? 11.82 O1 GOL D1181 B 144 GLU C 27 GLU~? 15.61 O1 GOL D1181 B 164 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 88.87 114.43 152.30 88.45 115.15 152.32 -52.31 -16.92 45.35 -51.96 -16.19 45.23 coo 85.20 111.99 152.05 86.60 110.89 150.91 -57.81 -18.31 46.30 -57.05 -20.28 46.55 coo 88.14 113.46 145.73 86.79 113.92 147.30 -53.10 -23.91 44.12 -54.66 -25.27 44.77 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 7 3 # 7 B 141 GLY D 16 GLY~? 8.64 C1 GOL D1181 B 144 GLU D 17 GLU~? 13.36 O1 GOL D1181 B 164 GLU C 27 GLU~? 15.61 O1 GOL D1181 coo 88.87 114.43 152.30 88.45 115.15 152.32 -52.16 -19.77 41.01 -52.26 -20.58 40.82 coo 85.20 111.99 152.05 86.60 110.89 150.91 -53.10 -23.91 44.12 -54.66 -25.27 44.77 coo 88.14 113.46 145.73 86.79 113.92 147.30 -57.81 -18.31 46.30 -57.05 -20.28 46.55 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 8 3 # 8 B 141 GLY D 24 GLY~? 5.25 CA CA C1182 B 144 GLU D 27 GLU~? 2.91 CA CA C1182s B 164 GLU C 17 GLU~? 3.68 CA CA C1182s coo 88.87 114.43 152.30 88.45 115.15 152.32 -38.72 -23.09 41.13 -39.06 -23.23 40.41 coo 85.20 111.99 152.05 86.60 110.89 150.91 -34.10 -22.57 42.20 -34.50 -23.02 44.23 coo 88.14 113.46 145.73 86.79 113.92 147.30 -38.10 -19.90 46.72 -36.47 -20.40 47.99 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 16 GLY~? 8.84 CH3 ACT A1181 C 144 GLU A 17 GLU~? 13.61 CH3 ACT A1181 C 164 GLU B 27 GLU~? 13.41 O1 GOL B1182 coo 56.28 104.55 135.84 56.09 105.34 136.05 -52.14 19.77 -14.51 -52.26 20.60 -14.34 coo 58.46 103.90 139.48 57.57 102.00 139.16 -53.17 23.87 -17.57 -54.60 25.28 -18.31 coo 51.71 102.03 140.09 53.02 103.62 140.54 -57.79 18.33 -19.74 -56.95 20.26 -20.07 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY A 24 GLY~? 6.98 CH3 ACT A1181 C 144 GLU A 27 GLU~? -12.01 CH3 ACT A1181s C 164 GLU B 17 GLU~? -13.09 CH3 ACT A1181s coo 56.28 104.55 135.84 56.09 105.34 136.05 -38.70 23.07 -14.67 -39.06 23.24 -13.96 coo 58.46 103.90 139.48 57.57 102.00 139.16 -34.14 22.58 -15.68 -34.47 22.99 -17.72 coo 51.71 102.03 140.09 53.02 103.62 140.54 -38.08 19.88 -20.29 -36.49 20.35 -21.57 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 3 3 # 3 C 141 GLY B 16 GLY~? 6.98 OXT ACT A1181 C 144 GLU B 17 GLU~? -13.09 CH3 ACT A1181s C 164 GLU A 27 GLU~? -12.01 CH3 ACT A1181s coo 56.28 104.55 135.84 56.09 105.34 136.05 -38.85 18.09 -15.57 -38.71 17.64 -16.26 coo 58.46 103.90 139.48 57.57 102.00 139.16 -38.08 19.88 -20.29 -36.49 20.35 -21.57 coo 51.71 102.03 140.09 53.02 103.62 140.54 -34.14 22.58 -15.68 -34.47 22.99 -17.72 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 4 3 # 4 C 141 GLY B 24 GLY~? 11.88 C1 GOL B1182 C 144 GLU B 27 GLU~? 13.41 O1 GOL B1182 C 164 GLU A 17 GLU~? 13.61 CH3 ACT A1181 coo 56.28 104.55 135.84 56.09 105.34 136.05 -52.31 16.92 -18.92 -51.97 16.19 -18.78 coo 58.46 103.90 139.48 57.57 102.00 139.16 -57.79 18.33 -19.74 -56.95 20.26 -20.07 coo 51.71 102.03 140.09 53.02 103.62 140.54 -53.17 23.87 -17.57 -54.60 25.28 -18.31 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 5 3 # 5 C 141 GLY C 16 GLY~? 6.74 C3 GOL D1181 C 144 GLU C 17 GLU~? 3.68 CA CA C1182s C 164 GLU D 27 GLU~? 2.91 CA CA C1182s coo 56.28 104.55 135.84 56.09 105.34 136.05 -38.82 -18.07 42.06 -38.69 -17.63 42.74 coo 58.46 103.90 139.48 57.57 102.00 139.16 -38.10 -19.90 46.72 -36.47 -20.40 47.99 coo 51.71 102.03 140.09 53.02 103.62 140.54 -34.10 -22.57 42.20 -34.50 -23.02 44.23 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 6 3 # 6 C 141 GLY C 24 GLY~? 11.82 O1 GOL D1181 C 144 GLU C 27 GLU~? 15.61 O1 GOL D1181 C 164 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 56.28 104.55 135.84 56.09 105.34 136.05 -52.31 -16.92 45.35 -51.96 -16.19 45.23 coo 58.46 103.90 139.48 57.57 102.00 139.16 -57.81 -18.31 46.30 -57.05 -20.28 46.55 coo 51.71 102.03 140.09 53.02 103.62 140.54 -53.10 -23.91 44.12 -54.66 -25.27 44.77 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 7 3 # 7 C 141 GLY D 16 GLY~? 8.64 C1 GOL D1181 C 144 GLU D 17 GLU~? 13.36 O1 GOL D1181 C 164 GLU C 27 GLU~? 15.61 O1 GOL D1181 coo 56.28 104.55 135.84 56.09 105.34 136.05 -52.16 -19.77 41.01 -52.26 -20.58 40.82 coo 58.46 103.90 139.48 57.57 102.00 139.16 -53.10 -23.91 44.12 -54.66 -25.27 44.77 coo 51.71 102.03 140.09 53.02 103.62 140.54 -57.81 -18.31 46.30 -57.05 -20.28 46.55 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 8 3 # 8 C 141 GLY D 24 GLY~? 5.25 CA CA C1182 C 144 GLU D 27 GLU~? 2.91 CA CA C1182s C 164 GLU C 17 GLU~? 3.68 CA CA C1182s coo 56.28 104.55 135.84 56.09 105.34 136.05 -38.72 -23.09 41.13 -39.06 -23.23 40.41 coo 58.46 103.90 139.48 57.57 102.00 139.16 -34.10 -22.57 42.20 -34.50 -23.02 44.23 coo 51.71 102.03 140.09 53.02 103.62 140.54 -38.10 -19.90 46.72 -36.47 -20.40 47.99 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 16 GLY~? 8.84 CH3 ACT A1181 D 144 GLU A 17 GLU~? 13.61 CH3 ACT A1181 D 164 GLU B 27 GLU~? 13.41 O1 GOL B1182 coo 86.19 80.64 132.77 86.38 79.85 132.93 -52.14 19.77 -14.51 -52.26 20.60 -14.34 coo 84.75 81.24 136.88 85.62 83.14 136.43 -53.17 23.87 -17.57 -54.60 25.28 -18.31 coo 91.47 83.05 136.24 90.35 81.38 136.84 -57.79 18.33 -19.74 -56.95 20.26 -20.07 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY A 24 GLY~? 6.98 CH3 ACT A1181 D 144 GLU A 27 GLU~? -12.01 CH3 ACT A1181s D 164 GLU B 17 GLU~? -13.09 CH3 ACT A1181s coo 86.19 80.64 132.77 86.38 79.85 132.93 -38.70 23.07 -14.67 -39.06 23.24 -13.96 coo 84.75 81.24 136.88 85.62 83.14 136.43 -34.14 22.58 -15.68 -34.47 22.99 -17.72 coo 91.47 83.05 136.24 90.35 81.38 136.84 -38.08 19.88 -20.29 -36.49 20.35 -21.57 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 3 3 # 3 D 141 GLY B 16 GLY~? 6.98 OXT ACT A1181 D 144 GLU B 17 GLU~? -13.09 CH3 ACT A1181s D 164 GLU A 27 GLU~? -12.01 CH3 ACT A1181s coo 86.19 80.64 132.77 86.38 79.85 132.93 -38.85 18.09 -15.57 -38.71 17.64 -16.26 coo 84.75 81.24 136.88 85.62 83.14 136.43 -38.08 19.88 -20.29 -36.49 20.35 -21.57 coo 91.47 83.05 136.24 90.35 81.38 136.84 -34.14 22.58 -15.68 -34.47 22.99 -17.72 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 4 3 # 4 D 141 GLY B 24 GLY~? 11.88 C1 GOL B1182 D 144 GLU B 27 GLU~? 13.41 O1 GOL B1182 D 164 GLU A 17 GLU~? 13.61 CH3 ACT A1181 coo 86.19 80.64 132.77 86.38 79.85 132.93 -52.31 16.92 -18.92 -51.97 16.19 -18.78 coo 84.75 81.24 136.88 85.62 83.14 136.43 -57.79 18.33 -19.74 -56.95 20.26 -20.07 coo 91.47 83.05 136.24 90.35 81.38 136.84 -53.17 23.87 -17.57 -54.60 25.28 -18.31 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 5 3 # 5 D 141 GLY B 24 GLY~? 11.88 C1 GOL B1182 D 144 GLU B 27 GLU~? 13.41 O1 GOL B1182 D 164 GLU B 29 GLU~? -3.75 O1 GOL B1182s coo 86.19 80.64 132.77 86.38 79.85 132.93 -52.31 16.92 -18.92 -51.97 16.19 -18.78 coo 84.75 81.24 136.88 85.62 83.14 136.43 -57.79 18.33 -19.74 -56.95 20.26 -20.07 coo 91.47 83.05 136.24 90.35 81.38 136.84 -57.44 9.91 -17.53 -57.08 7.94 -18.23 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 6 3 # 6 D 141 GLY C 16 GLY~? 6.74 C3 GOL D1181 D 144 GLU C 17 GLU~? 3.68 CA CA C1182s D 164 GLU D 27 GLU~? 2.91 CA CA C1182s coo 86.19 80.64 132.77 86.38 79.85 132.93 -38.82 -18.07 42.06 -38.69 -17.63 42.74 coo 84.75 81.24 136.88 85.62 83.14 136.43 -38.10 -19.90 46.72 -36.47 -20.40 47.99 coo 91.47 83.05 136.24 90.35 81.38 136.84 -34.10 -22.57 42.20 -34.50 -23.02 44.23 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 7 3 # 7 D 141 GLY C 24 GLY~? 11.82 O1 GOL D1181 D 144 GLU C 27 GLU~? 15.61 O1 GOL D1181 D 164 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 86.19 80.64 132.77 86.38 79.85 132.93 -52.31 -16.92 45.35 -51.96 -16.19 45.23 coo 84.75 81.24 136.88 85.62 83.14 136.43 -57.81 -18.31 46.30 -57.05 -20.28 46.55 coo 91.47 83.05 136.24 90.35 81.38 136.84 -53.10 -23.91 44.12 -54.66 -25.27 44.77 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 8 3 # 8 D 141 GLY D 16 GLY~? 8.64 C1 GOL D1181 D 144 GLU D 17 GLU~? 13.36 O1 GOL D1181 D 164 GLU C 27 GLU~? 15.61 O1 GOL D1181 coo 86.19 80.64 132.77 86.38 79.85 132.93 -52.16 -19.77 41.01 -52.26 -20.58 40.82 coo 84.75 81.24 136.88 85.62 83.14 136.43 -53.10 -23.91 44.12 -54.66 -25.27 44.77 coo 91.47 83.05 136.24 90.35 81.38 136.84 -57.81 -18.31 46.30 -57.05 -20.28 46.55 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 9 3 # 9 D 141 GLY D 24 GLY~? 5.25 CA CA C1182 D 144 GLU D 27 GLU~? 2.91 CA CA C1182s D 164 GLU C 17 GLU~? 3.68 CA CA C1182s coo 86.19 80.64 132.77 86.38 79.85 132.93 -38.72 -23.09 41.13 -39.06 -23.23 40.41 coo 84.75 81.24 136.88 85.62 83.14 136.43 -34.10 -22.57 42.20 -34.50 -23.02 44.23 coo 91.47 83.05 136.24 90.35 81.38 136.84 -38.10 -19.90 46.72 -36.47 -20.40 47.99 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 9 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 16 GLY~? 8.84 CH3 ACT A1181 E 144 GLU A 17 GLU~? 13.61 CH3 ACT A1181 E 164 GLU B 27 GLU~? 13.41 O1 GOL B1182 coo 90.07 81.07 170.50 90.23 80.26 170.38 -52.14 19.77 -14.51 -52.26 20.60 -14.34 coo 87.05 81.30 167.53 86.38 82.74 168.94 -53.17 23.87 -17.57 -54.60 25.28 -18.31 coo 84.40 80.02 173.80 85.08 79.06 172.03 -57.79 18.33 -19.74 -56.95 20.26 -20.07 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY A 24 GLY~? 6.98 CH3 ACT A1181 E 144 GLU A 27 GLU~? -12.01 CH3 ACT A1181s E 164 GLU B 17 GLU~? -13.09 CH3 ACT A1181s coo 90.07 81.07 170.50 90.23 80.26 170.38 -38.70 23.07 -14.67 -39.06 23.24 -13.96 coo 87.05 81.30 167.53 86.38 82.74 168.94 -34.14 22.58 -15.68 -34.47 22.99 -17.72 coo 84.40 80.02 173.80 85.08 79.06 172.03 -38.08 19.88 -20.29 -36.49 20.35 -21.57 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 3 3 # 3 E 141 GLY B 16 GLY~? 6.98 OXT ACT A1181 E 144 GLU B 17 GLU~? -13.09 CH3 ACT A1181s E 164 GLU A 27 GLU~? -12.01 CH3 ACT A1181s coo 90.07 81.07 170.50 90.23 80.26 170.38 -38.85 18.09 -15.57 -38.71 17.64 -16.26 coo 87.05 81.30 167.53 86.38 82.74 168.94 -38.08 19.88 -20.29 -36.49 20.35 -21.57 coo 84.40 80.02 173.80 85.08 79.06 172.03 -34.14 22.58 -15.68 -34.47 22.99 -17.72 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 4 3 # 4 E 141 GLY B 24 GLY~? 11.88 C1 GOL B1182 E 144 GLU B 27 GLU~? 13.41 O1 GOL B1182 E 164 GLU A 17 GLU~? 13.61 CH3 ACT A1181 coo 90.07 81.07 170.50 90.23 80.26 170.38 -52.31 16.92 -18.92 -51.97 16.19 -18.78 coo 87.05 81.30 167.53 86.38 82.74 168.94 -57.79 18.33 -19.74 -56.95 20.26 -20.07 coo 84.40 80.02 173.80 85.08 79.06 172.03 -53.17 23.87 -17.57 -54.60 25.28 -18.31 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 5 3 # 5 E 141 GLY C 16 GLY~? 6.74 C3 GOL D1181 E 144 GLU C 17 GLU~? 3.68 CA CA C1182s E 164 GLU D 27 GLU~? 2.91 CA CA C1182s coo 90.07 81.07 170.50 90.23 80.26 170.38 -38.82 -18.07 42.06 -38.69 -17.63 42.74 coo 87.05 81.30 167.53 86.38 82.74 168.94 -38.10 -19.90 46.72 -36.47 -20.40 47.99 coo 84.40 80.02 173.80 85.08 79.06 172.03 -34.10 -22.57 42.20 -34.50 -23.02 44.23 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 6 3 # 6 E 141 GLY C 24 GLY~? 11.82 O1 GOL D1181 E 144 GLU C 27 GLU~? 15.61 O1 GOL D1181 E 164 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 90.07 81.07 170.50 90.23 80.26 170.38 -52.31 -16.92 45.35 -51.96 -16.19 45.23 coo 87.05 81.30 167.53 86.38 82.74 168.94 -57.81 -18.31 46.30 -57.05 -20.28 46.55 coo 84.40 80.02 173.80 85.08 79.06 172.03 -53.10 -23.91 44.12 -54.66 -25.27 44.77 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 7 3 # 7 E 141 GLY D 16 GLY~? 8.64 C1 GOL D1181 E 144 GLU D 17 GLU~? 13.36 O1 GOL D1181 E 164 GLU C 27 GLU~? 15.61 O1 GOL D1181 coo 90.07 81.07 170.50 90.23 80.26 170.38 -52.16 -19.77 41.01 -52.26 -20.58 40.82 coo 87.05 81.30 167.53 86.38 82.74 168.94 -53.10 -23.91 44.12 -54.66 -25.27 44.77 coo 84.40 80.02 173.80 85.08 79.06 172.03 -57.81 -18.31 46.30 -57.05 -20.28 46.55 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 8 3 # 8 E 141 GLY D 24 GLY~? 5.25 CA CA C1182 E 144 GLU D 27 GLU~? 2.91 CA CA C1182s E 164 GLU C 17 GLU~? 3.68 CA CA C1182s coo 90.07 81.07 170.50 90.23 80.26 170.38 -38.72 -23.09 41.13 -39.06 -23.23 40.41 coo 87.05 81.30 167.53 86.38 82.74 168.94 -34.10 -22.57 42.20 -34.50 -23.02 44.23 coo 84.40 80.02 173.80 85.08 79.06 172.03 -38.10 -19.90 46.72 -36.47 -20.40 47.99 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 16 GLY~? 8.84 CH3 ACT A1181 F 144 GLU A 17 GLU~? 13.61 CH3 ACT A1181 F 164 GLU B 27 GLU~? 13.41 O1 GOL B1182 coo 57.12 70.68 155.10 57.52 69.95 155.02 -52.14 19.77 -14.51 -52.26 20.60 -14.34 coo 60.62 73.13 154.21 59.05 74.26 153.35 -53.17 23.87 -17.57 -54.60 25.28 -18.31 coo 56.75 71.71 148.46 58.44 71.01 149.54 -57.79 18.33 -19.74 -56.95 20.26 -20.07 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY A 24 GLY~? 6.98 CH3 ACT A1181 F 144 GLU A 27 GLU~? -12.01 CH3 ACT A1181s F 164 GLU B 17 GLU~? -13.09 CH3 ACT A1181s coo 57.12 70.68 155.10 57.52 69.95 155.02 -38.70 23.07 -14.67 -39.06 23.24 -13.96 coo 60.62 73.13 154.21 59.05 74.26 153.35 -34.14 22.58 -15.68 -34.47 22.99 -17.72 coo 56.75 71.71 148.46 58.44 71.01 149.54 -38.08 19.88 -20.29 -36.49 20.35 -21.57 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 3 3 # 3 F 141 GLY B 16 GLY~? 6.98 OXT ACT A1181 F 144 GLU B 17 GLU~? -13.09 CH3 ACT A1181s F 164 GLU A 27 GLU~? -12.01 CH3 ACT A1181s coo 57.12 70.68 155.10 57.52 69.95 155.02 -38.85 18.09 -15.57 -38.71 17.64 -16.26 coo 60.62 73.13 154.21 59.05 74.26 153.35 -38.08 19.88 -20.29 -36.49 20.35 -21.57 coo 56.75 71.71 148.46 58.44 71.01 149.54 -34.14 22.58 -15.68 -34.47 22.99 -17.72 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 4 3 # 4 F 141 GLY B 24 GLY~? 11.88 C1 GOL B1182 F 144 GLU B 27 GLU~? 13.41 O1 GOL B1182 F 164 GLU A 17 GLU~? 13.61 CH3 ACT A1181 coo 57.12 70.68 155.10 57.52 69.95 155.02 -52.31 16.92 -18.92 -51.97 16.19 -18.78 coo 60.62 73.13 154.21 59.05 74.26 153.35 -57.79 18.33 -19.74 -56.95 20.26 -20.07 coo 56.75 71.71 148.46 58.44 71.01 149.54 -53.17 23.87 -17.57 -54.60 25.28 -18.31 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 5 3 # 5 F 141 GLY C 16 GLY~? 6.74 C3 GOL D1181 F 144 GLU C 17 GLU~? 3.68 CA CA C1182s F 164 GLU D 27 GLU~? 2.91 CA CA C1182s coo 57.12 70.68 155.10 57.52 69.95 155.02 -38.82 -18.07 42.06 -38.69 -17.63 42.74 coo 60.62 73.13 154.21 59.05 74.26 153.35 -38.10 -19.90 46.72 -36.47 -20.40 47.99 coo 56.75 71.71 148.46 58.44 71.01 149.54 -34.10 -22.57 42.20 -34.50 -23.02 44.23 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 6 3 # 6 F 141 GLY C 24 GLY~? 11.82 O1 GOL D1181 F 144 GLU C 27 GLU~? 15.61 O1 GOL D1181 F 164 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 57.12 70.68 155.10 57.52 69.95 155.02 -52.31 -16.92 45.35 -51.96 -16.19 45.23 coo 60.62 73.13 154.21 59.05 74.26 153.35 -57.81 -18.31 46.30 -57.05 -20.28 46.55 coo 56.75 71.71 148.46 58.44 71.01 149.54 -53.10 -23.91 44.12 -54.66 -25.27 44.77 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 7 3 # 7 F 141 GLY D 16 GLY~? 8.64 C1 GOL D1181 F 144 GLU D 17 GLU~? 13.36 O1 GOL D1181 F 164 GLU C 27 GLU~? 15.61 O1 GOL D1181 coo 57.12 70.68 155.10 57.52 69.95 155.02 -52.16 -19.77 41.01 -52.26 -20.58 40.82 coo 60.62 73.13 154.21 59.05 74.26 153.35 -53.10 -23.91 44.12 -54.66 -25.27 44.77 coo 56.75 71.71 148.46 58.44 71.01 149.54 -57.81 -18.31 46.30 -57.05 -20.28 46.55 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 8 3 # 8 F 141 GLY D 24 GLY~? 5.25 CA CA C1182 F 144 GLU D 27 GLU~? 2.91 CA CA C1182s F 164 GLU C 17 GLU~? 3.68 CA CA C1182s coo 57.12 70.68 155.10 57.52 69.95 155.02 -38.72 -23.09 41.13 -39.06 -23.23 40.41 coo 60.62 73.13 154.21 59.05 74.26 153.35 -34.10 -22.57 42.20 -34.50 -23.02 44.23 coo 56.75 71.71 148.46 58.44 71.01 149.54 -38.10 -19.90 46.72 -36.47 -20.40 47.99 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c17 naa= 3 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 53 SER^? 12.21 OXT ACT A1182 A 208 ASP A 55 ASP.? 17.41 O ACT A1181 A 236 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 49.19 42.85 125.39 50.92 43.54 123.63 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 57.80 42.94 129.59 56.47 43.28 127.93 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 55.54 41.70 125.00 53.71 42.50 124.53 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER B 53 SER^? 12.05 O ACT C1183 A 208 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 236 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 49.19 42.85 125.39 50.92 43.54 123.63 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 57.80 42.94 129.59 56.47 43.28 127.93 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 55.54 41.70 125.00 53.71 42.50 124.53 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 3 3 # 3 A 80 SER C 53 SER^? 12.05 OXT ACT C1183 A 208 ASP C 55 ASP.? 19.45 CA CA C1184 A 236 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 49.19 42.85 125.39 50.92 43.54 123.63 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 57.80 42.94 129.59 56.47 43.28 127.93 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 55.54 41.70 125.00 53.71 42.50 124.53 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 4 3 # 4 A 80 SER D 53 SER^? 12.18 O ACT A1182 A 208 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 236 HIS D 114 HIS^? 15.97 O ACT A1182 coo 49.19 42.85 125.39 50.92 43.54 123.63 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 57.80 42.94 129.59 56.47 43.28 127.93 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 55.54 41.70 125.00 53.71 42.50 124.53 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1dwo_c00 source 1dwo HYDROXYNITRILE LYASE : 4 hits 1dwo_c00 naa= 3 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 1 3 # 1 B 80 SER A 53 SER^? 12.21 OXT ACT A1182 B 208 ASP A 55 ASP.? 17.41 O ACT A1181 B 236 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 55.25 19.46 97.60 53.04 19.32 98.76 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 57.34 11.46 102.30 56.11 13.10 101.70 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 55.03 16.17 103.08 54.39 17.23 101.45 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 2 3 # 2 B 80 SER B 53 SER^? 12.05 O ACT C1183 B 208 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 236 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 55.25 19.46 97.60 53.04 19.32 98.76 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 57.34 11.46 102.30 56.11 13.10 101.70 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 55.03 16.17 103.08 54.39 17.23 101.45 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 3 3 # 3 B 80 SER C 53 SER^? 12.05 OXT ACT C1183 B 208 ASP C 55 ASP.? 19.45 CA CA C1184 B 236 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 55.25 19.46 97.60 53.04 19.32 98.76 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 57.34 11.46 102.30 56.11 13.10 101.70 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 55.03 16.17 103.08 54.39 17.23 101.45 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 4 3 # 4 B 80 SER D 53 SER^? 12.18 O ACT A1182 B 208 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 236 HIS D 114 HIS^? 15.97 O ACT A1182 coo 55.25 19.46 97.60 53.04 19.32 98.76 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 57.34 11.46 102.30 56.11 13.10 101.70 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 55.03 16.17 103.08 54.39 17.23 101.45 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1dwo_c01 source 1dwo HYDROXYNITRILE LYASE : 4 hits 1dwo_c01 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 9 LYS~? 15.21 O1 GOL B1182 A 215 LYS B 164 LYS~? 10.34 O ACT A1181 A 277 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 0.50 24.09 51.68 1.51 29.34 52.35 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 13.06 30.79 51.73 11.40 35.76 53.48 -54.90 15.84 -3.99 -50.07 17.65 -1.98 coo 13.04 31.88 60.72 10.57 35.34 57.49 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 35 LYS~? 23.91 O ACT A1181 A 215 LYS A 142 LYS.? 21.46 CH3 ACT A1182 A 277 LYS A 130 LYS.? 19.75 CH3 ACT A1182 coo 0.50 24.09 51.68 1.51 29.34 52.35 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo 13.06 30.79 51.73 11.40 35.76 53.48 -25.15 24.34 9.11 -21.81 19.66 9.96 coo 13.04 31.88 60.72 10.57 35.34 57.49 -19.41 16.20 13.18 -20.24 16.85 17.21 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS A 35 LYS~? 23.91 O ACT A1181 A 215 LYS A 164 LYS~? 11.79 OXT ACT A1181 A 277 LYS A 158 LYS~? -4.64 O ACT A1181s coo 0.50 24.09 51.68 1.51 29.34 52.35 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo 13.06 30.79 51.73 11.40 35.76 53.48 -35.84 9.74 -8.05 -40.64 7.29 -8.85 coo 13.04 31.88 60.72 10.57 35.34 57.49 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS A 117 LYS.? 20.14 O ACT A1181 A 215 LYS B 72 LYS.? 19.60 OXT ACT C1183 A 277 LYS B 75 LYS.? 22.83 O ACT A1181 coo 0.50 24.09 51.68 1.51 29.34 52.35 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 13.06 30.79 51.73 11.40 35.76 53.48 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 13.04 31.88 60.72 10.57 35.34 57.49 -57.47 22.90 13.02 -52.58 24.12 11.55 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS A 142 LYS.? 21.46 CH3 ACT A1182 A 215 LYS A 117 LYS.? 20.14 O ACT A1181 A 277 LYS A 149 LYS.? 8.87 O ACT A1181 coo 0.50 24.09 51.68 1.51 29.34 52.35 -25.15 24.34 9.11 -21.81 19.66 9.96 coo 13.06 30.79 51.73 11.40 35.76 53.48 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 13.04 31.88 60.72 10.57 35.34 57.49 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 A 131 LYS A 164 LYS~? 11.79 OXT ACT A1181 A 215 LYS B 158 LYS~? 6.73 O3 GOL B1182 A 277 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 0.50 24.09 51.68 1.51 29.34 52.35 -35.84 9.74 -8.05 -40.64 7.29 -8.85 coo 13.06 30.79 51.73 11.40 35.76 53.48 -50.07 10.43 -10.30 -49.56 8.69 -16.32 coo 13.04 31.88 60.72 10.57 35.34 57.49 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 A 131 LYS B 9 LYS~? 18.37 O ACT A1181 A 215 LYS A 164 LYS~? 11.79 OXT ACT A1181 A 277 LYS A 158 LYS~? -4.64 O ACT A1181s coo 0.50 24.09 51.68 1.51 29.34 52.35 -27.67 18.71 -15.51 -26.70 22.99 -17.12 coo 13.06 30.79 51.73 11.40 35.76 53.48 -35.84 9.74 -8.05 -40.64 7.29 -8.85 coo 13.04 31.88 60.72 10.57 35.34 57.49 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 A 131 LYS B 35 LYS~? 11.04 CA CA B1183 A 215 LYS A 2 LYS^? 14.71 CA CA B1181 A 277 LYS B 177 LYS.? 12.69 CA CA B1181 coo 0.50 24.09 51.68 1.51 29.34 52.35 -68.46 9.78 -10.58 -72.55 6.75 -11.95 coo 13.06 30.79 51.73 11.40 35.76 53.48 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo 13.04 31.88 60.72 10.57 35.34 57.49 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 A 131 LYS B 117 LYS.? 17.47 O3 GOL B1182 A 215 LYS A 72 LYS.? 19.74 O ACT A1182 A 277 LYS A 75 LYS.? 21.85 O3 GOL B1182 coo 0.50 24.09 51.68 1.51 29.34 52.35 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 13.06 30.79 51.73 11.40 35.76 53.48 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 13.04 31.88 60.72 10.57 35.34 57.49 -33.45 -8.66 -7.93 -38.30 -6.69 -11.44 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 A 131 LYS B 164 LYS~? 10.34 O ACT A1181 A 215 LYS A 158 LYS~? -4.64 O ACT A1181s A 277 LYS A 149 LYS.? 8.87 O ACT A1181 coo 0.50 24.09 51.68 1.51 29.34 52.35 -54.90 15.84 -3.99 -50.07 17.65 -1.98 coo 13.06 30.79 51.73 11.40 35.76 53.48 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 13.04 31.88 60.72 10.57 35.34 57.49 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 A 131 LYS C 9 LYS~? 14.61 CA CA C1182 A 215 LYS D 164 LYS~? 10.47 O3 GOL D1181 A 277 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 0.50 24.09 51.68 1.51 29.34 52.35 -27.74 -18.74 41.99 -22.99 -22.90 41.19 coo 13.06 30.79 51.73 11.40 35.76 53.48 -35.86 -9.73 34.54 -40.60 -7.29 35.38 coo 13.04 31.88 60.72 10.57 35.34 57.49 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 A 131 LYS C 117 LYS.? 21.58 CA CA C1184 A 215 LYS D 72 LYS.? 18.40 OXT ACT A1182 A 277 LYS D 75 LYS.? 24.88 O3 GOL D1181 coo 0.50 24.09 51.68 1.51 29.34 52.35 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 13.06 30.79 51.73 11.40 35.76 53.48 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 13.04 31.88 60.72 10.57 35.34 57.49 -33.47 8.69 34.45 -37.51 6.70 37.91 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 A 131 LYS C 130 LYS.? 19.26 CH3 ACT C1183 A 215 LYS C 124 LYS~? 15.99 CA CA C1184 A 277 LYS C 93 LYS.? 19.61 OXT ACT C1183 coo 0.50 24.09 51.68 1.51 29.34 52.35 -71.03 6.26 28.36 -70.68 9.47 26.70 coo 13.06 30.79 51.73 11.40 35.76 53.48 -59.48 10.16 30.27 -60.09 12.26 35.28 coo 13.04 31.88 60.72 10.57 35.34 57.49 -54.93 14.23 21.55 -53.38 19.08 19.32 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 A 131 LYS C 164 LYS~? 9.98 C2 GOL D1181 A 215 LYS D 158 LYS~? -4.46 O2 GOL D1181s A 277 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 0.50 24.09 51.68 1.51 29.34 52.35 -54.90 -15.84 30.45 -50.06 -17.66 28.47 coo 13.06 30.79 51.73 11.40 35.76 53.48 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo 13.04 31.88 60.72 10.57 35.34 57.49 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 A 131 LYS D 9 LYS~? 18.78 CA CA C1184 A 215 LYS C 164 LYS~? 9.98 C2 GOL D1181 A 277 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 0.50 24.09 51.68 1.51 29.34 52.35 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 13.06 30.79 51.73 11.40 35.76 53.48 -54.90 -15.84 30.45 -50.06 -17.66 28.47 coo 13.04 31.88 60.72 10.57 35.34 57.49 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 A 131 LYS D 35 LYS~? 23.81 O2 GOL D1181 A 215 LYS D 142 LYS.? 24.20 CH3 ACT A1182 A 277 LYS D 130 LYS.? 19.81 CH3 ACT A1182 coo 0.50 24.09 51.68 1.51 29.34 52.35 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo 13.06 30.79 51.73 11.40 35.76 53.48 -25.06 -24.88 17.65 -21.32 -22.55 15.38 coo 13.04 31.88 60.72 10.57 35.34 57.49 -19.48 -16.44 13.55 -20.26 -16.74 8.72 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 A 131 LYS D 35 LYS~? 23.81 O2 GOL D1181 A 215 LYS D 164 LYS~? 10.47 O3 GOL D1181 A 277 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 0.50 24.09 51.68 1.51 29.34 52.35 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo 13.06 30.79 51.73 11.40 35.76 53.48 -35.86 -9.73 34.54 -40.60 -7.29 35.38 coo 13.04 31.88 60.72 10.57 35.34 57.49 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 A 131 LYS D 117 LYS.? 19.88 O2 GOL D1181 A 215 LYS C 72 LYS.? 18.71 O ACT C1183 A 277 LYS C 75 LYS.? 21.97 O2 GOL D1181 coo 0.50 24.09 51.68 1.51 29.34 52.35 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 13.06 30.79 51.73 11.40 35.76 53.48 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 13.04 31.88 60.72 10.57 35.34 57.49 -57.40 -22.87 13.44 -53.97 -26.42 17.14 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 A 131 LYS D 142 LYS.? 24.20 CH3 ACT A1182 A 215 LYS D 117 LYS.? 19.88 O2 GOL D1181 A 277 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 0.50 24.09 51.68 1.51 29.34 52.35 -25.06 -24.88 17.65 -21.32 -22.55 15.38 coo 13.06 30.79 51.73 11.40 35.76 53.48 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 13.04 31.88 60.72 10.57 35.34 57.49 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 A 131 LYS D 164 LYS~? 10.47 O3 GOL D1181 A 215 LYS C 158 LYS~? 13.55 O3 GOL D1181 A 277 LYS C 149 LYS.? 9.01 CA CA C1184 coo 0.50 24.09 51.68 1.51 29.34 52.35 -35.86 -9.73 34.54 -40.60 -7.29 35.38 coo 13.06 30.79 51.73 11.40 35.76 53.48 -50.05 -10.42 36.79 -49.63 -8.70 42.89 coo 13.04 31.88 60.72 10.57 35.34 57.49 -50.86 -2.28 41.74 -55.49 -4.16 43.55 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 20 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 9 LYS~? 15.21 O1 GOL B1182 B 215 LYS B 164 LYS~? 10.34 O ACT A1181 B 277 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 6.78 45.91 16.15 7.82 40.81 15.84 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 17.88 38.77 19.81 16.38 34.23 17.24 -54.90 15.84 -3.99 -50.07 17.65 -1.98 coo 20.33 37.78 11.20 16.77 34.53 13.47 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 35 LYS~? 23.91 O ACT A1181 B 215 LYS A 142 LYS.? 21.46 CH3 ACT A1182 B 277 LYS A 130 LYS.? 19.75 CH3 ACT A1182 coo 6.78 45.91 16.15 7.82 40.81 15.84 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo 17.88 38.77 19.81 16.38 34.23 17.24 -25.15 24.34 9.11 -21.81 19.66 9.96 coo 20.33 37.78 11.20 16.77 34.53 13.47 -19.41 16.20 13.18 -20.24 16.85 17.21 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS A 142 LYS.? 21.46 CH3 ACT A1182 B 215 LYS A 117 LYS.? 20.14 O ACT A1181 B 277 LYS A 149 LYS.? 8.87 O ACT A1181 coo 6.78 45.91 16.15 7.82 40.81 15.84 -25.15 24.34 9.11 -21.81 19.66 9.96 coo 17.88 38.77 19.81 16.38 34.23 17.24 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 20.33 37.78 11.20 16.77 34.53 13.47 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS A 164 LYS~? 11.79 OXT ACT A1181 B 215 LYS B 158 LYS~? 6.73 O3 GOL B1182 B 277 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 6.78 45.91 16.15 7.82 40.81 15.84 -35.84 9.74 -8.05 -40.64 7.29 -8.85 coo 17.88 38.77 19.81 16.38 34.23 17.24 -50.07 10.43 -10.30 -49.56 8.69 -16.32 coo 20.33 37.78 11.20 16.77 34.53 13.47 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 B 131 LYS B 9 LYS~? 18.37 O ACT A1181 B 215 LYS A 164 LYS~? 11.79 OXT ACT A1181 B 277 LYS A 158 LYS~? -4.64 O ACT A1181s coo 6.78 45.91 16.15 7.82 40.81 15.84 -27.67 18.71 -15.51 -26.70 22.99 -17.12 coo 17.88 38.77 19.81 16.38 34.23 17.24 -35.84 9.74 -8.05 -40.64 7.29 -8.85 coo 20.33 37.78 11.20 16.77 34.53 13.47 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 B 131 LYS B 164 LYS~? 10.34 O ACT A1181 B 215 LYS A 158 LYS~? -4.64 O ACT A1181s B 277 LYS A 149 LYS.? 8.87 O ACT A1181 coo 6.78 45.91 16.15 7.82 40.81 15.84 -54.90 15.84 -3.99 -50.07 17.65 -1.98 coo 17.88 38.77 19.81 16.38 34.23 17.24 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 20.33 37.78 11.20 16.77 34.53 13.47 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 B 131 LYS C 9 LYS~? 14.61 CA CA C1182 B 215 LYS D 164 LYS~? 10.47 O3 GOL D1181 B 277 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 6.78 45.91 16.15 7.82 40.81 15.84 -27.74 -18.74 41.99 -22.99 -22.90 41.19 coo 17.88 38.77 19.81 16.38 34.23 17.24 -35.86 -9.73 34.54 -40.60 -7.29 35.38 coo 20.33 37.78 11.20 16.77 34.53 13.47 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 B 131 LYS C 164 LYS~? 9.98 C2 GOL D1181 B 215 LYS D 158 LYS~? -4.46 O2 GOL D1181s B 277 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 6.78 45.91 16.15 7.82 40.81 15.84 -54.90 -15.84 30.45 -50.06 -17.66 28.47 coo 17.88 38.77 19.81 16.38 34.23 17.24 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo 20.33 37.78 11.20 16.77 34.53 13.47 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 B 131 LYS D 9 LYS~? 18.78 CA CA C1184 B 215 LYS C 164 LYS~? 9.98 C2 GOL D1181 B 277 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 6.78 45.91 16.15 7.82 40.81 15.84 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 17.88 38.77 19.81 16.38 34.23 17.24 -54.90 -15.84 30.45 -50.06 -17.66 28.47 coo 20.33 37.78 11.20 16.77 34.53 13.47 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 B 131 LYS D 35 LYS~? 23.81 O2 GOL D1181 B 215 LYS D 142 LYS.? 24.20 CH3 ACT A1182 B 277 LYS D 130 LYS.? 19.81 CH3 ACT A1182 coo 6.78 45.91 16.15 7.82 40.81 15.84 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo 17.88 38.77 19.81 16.38 34.23 17.24 -25.06 -24.88 17.65 -21.32 -22.55 15.38 coo 20.33 37.78 11.20 16.77 34.53 13.47 -19.48 -16.44 13.55 -20.26 -16.74 8.72 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 B 131 LYS D 142 LYS.? 24.20 CH3 ACT A1182 B 215 LYS D 117 LYS.? 19.88 O2 GOL D1181 B 277 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 6.78 45.91 16.15 7.82 40.81 15.84 -25.06 -24.88 17.65 -21.32 -22.55 15.38 coo 17.88 38.77 19.81 16.38 34.23 17.24 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 20.33 37.78 11.20 16.77 34.53 13.47 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 B 131 LYS D 164 LYS~? 10.47 O3 GOL D1181 B 215 LYS C 158 LYS~? 13.55 O3 GOL D1181 B 277 LYS C 149 LYS.? 9.01 CA CA C1184 coo 6.78 45.91 16.15 7.82 40.81 15.84 -35.86 -9.73 34.54 -40.60 -7.29 35.38 coo 17.88 38.77 19.81 16.38 34.23 17.24 -50.05 -10.42 36.79 -49.63 -8.70 42.89 coo 20.33 37.78 11.20 16.77 34.53 13.47 -50.86 -2.28 41.74 -55.49 -4.16 43.55 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 12 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 40 ASP A 156 ASP~? 10.59 O ACT A1181 A 103 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 157 TYR~? 5.66 OXT ACT A1181 A 40 ASP A 152 ASP.? 5.90 O ACT A1181 A 103 ASP A 156 ASP~? 10.59 O ACT A1181 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 40 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 103 ASP A 156 ASP~? 10.59 O ACT A1181 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 157 TYR~? 6.24 OXT ACT A1181 A 40 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 103 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 40 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 103 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR C 157 TYR~? 5.26 O3 GOL D1181 A 40 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 103 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 40 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 103 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR D 157 TYR~? -5.31 C1 GOL D1181s A 40 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 103 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 8 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 64 TYR~? 13.66 OXT ACT A1181 B 40 ASP A 156 ASP~? 10.59 O ACT A1181 B 103 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 157 TYR~? 5.66 OXT ACT A1181 B 40 ASP A 152 ASP.? 5.90 O ACT A1181 B 103 ASP A 156 ASP~? 10.59 O ACT A1181 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 64 TYR~? 13.94 OXT ACT A1181 B 40 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 103 ASP A 156 ASP~? 10.59 O ACT A1181 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 157 TYR~? 6.24 OXT ACT A1181 B 40 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 103 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR C 64 TYR~? 13.24 O3 GOL D1181 B 40 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 103 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR C 157 TYR~? 5.26 O3 GOL D1181 B 40 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 103 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR D 64 TYR~? 12.19 O3 GOL D1181 B 40 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 103 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR D 157 TYR~? -5.31 C1 GOL D1181s B 40 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 103 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 8 hits 1e3v_c03 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 34 ALA~? 17.95 O ACT A1181 A 136 TYR B 5 TYR~? 22.90 O ACT A1181 A 140 LYS B 9 LYS~? 18.37 O ACT A1181 coo 55.90 7.49 23.83 56.71 8.23 22.76 -25.61 17.94 -7.13 -25.09 18.62 -8.43 coo 59.38 10.02 17.51 59.95 9.89 20.21 -20.60 17.75 -11.10 -19.92 17.17 -8.44 coo 59.52 3.69 18.67 62.31 6.19 22.58 -27.67 18.71 -15.51 -26.70 22.99 -17.12 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA B 34 ALA~? 8.65 O1 GOL B1182 A 136 TYR A 5 TYR~? 13.40 O1 GOL B1182 A 140 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo 55.90 7.49 23.83 56.71 8.23 22.76 -65.40 11.95 -11.28 -65.85 13.06 -12.24 coo 59.38 10.02 17.51 59.95 9.89 20.21 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 59.52 3.69 18.67 62.31 6.19 22.58 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 3 3 # 3 A 107 ALA C 34 ALA~? 12.61 CA CA C1184 A 136 TYR D 5 TYR~? 13.80 CA CA C1181 A 140 LYS D 9 LYS~? 18.78 CA CA C1184 coo 55.90 7.49 23.83 56.71 8.23 22.76 -65.39 -11.97 37.73 -65.91 -13.10 38.66 coo 59.38 10.02 17.51 59.95 9.89 20.21 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 59.52 3.69 18.67 62.31 6.19 22.58 -63.24 -19.53 41.29 -64.69 -19.90 45.47 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 3 hits 1e7q_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 35 SER A 88 SER.? 4.86 OXT ACT A1182 A 218 ASP D 84 ASP^? 8.02 O ACT A1182 coo 47.22 22.34 8.57 45.16 22.02 9.13 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 43.58 20.85 5.15 44.62 23.01 5.76 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 44.05 16.99 12.67 44.05 18.89 11.74 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP A 152 ASP.? 5.90 O ACT A1181 A 35 SER A 153 SER.? 8.36 O ACT A1181 A 218 ASP A 156 ASP~? 10.59 O ACT A1181 coo 47.22 22.34 8.57 45.16 22.02 9.13 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 43.58 20.85 5.15 44.62 23.01 5.76 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 44.05 16.99 12.67 44.05 18.89 11.74 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 3 3 # 3 A 32 ASP B 84 ASP^? 7.80 O ACT C1183 A 35 SER B 88 SER.? 4.64 O ACT C1183 A 218 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 47.22 22.34 8.57 45.16 22.02 9.13 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 43.58 20.85 5.15 44.62 23.01 5.76 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 44.05 16.99 12.67 44.05 18.89 11.74 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 4 3 # 4 A 32 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 35 SER B 153 SER.? 13.04 OXT ACT A1181 A 218 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 47.22 22.34 8.57 45.16 22.02 9.13 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 43.58 20.85 5.15 44.62 23.01 5.76 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo 44.05 16.99 12.67 44.05 18.89 11.74 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 5 3 # 5 A 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 35 SER C 88 SER.? 4.69 OXT ACT C1183 A 218 ASP B 84 ASP^? 7.80 O ACT C1183 coo 47.22 22.34 8.57 45.16 22.02 9.13 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 43.58 20.85 5.15 44.62 23.01 5.76 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 44.05 16.99 12.67 44.05 18.89 11.74 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 6 3 # 6 A 32 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 35 SER C 153 SER.? 12.45 O3 GOL D1181 A 218 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 47.22 22.34 8.57 45.16 22.02 9.13 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 43.58 20.85 5.15 44.62 23.01 5.76 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo 44.05 16.99 12.67 44.05 18.89 11.74 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 7 3 # 7 A 32 ASP D 84 ASP^? 8.02 O ACT A1182 A 35 SER D 88 SER.? 4.67 O ACT A1182 A 218 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 47.22 22.34 8.57 45.16 22.02 9.13 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 43.58 20.85 5.15 44.62 23.01 5.76 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 44.05 16.99 12.67 44.05 18.89 11.74 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 8 3 # 8 A 32 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 35 SER D 153 SER.? 8.24 O2 GOL D1181 A 218 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 47.22 22.34 8.57 45.16 22.02 9.13 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 43.58 20.85 5.15 44.62 23.01 5.76 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo 44.05 16.99 12.67 44.05 18.89 11.74 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1eag_c04 source 1eag PEPTIDE INHIBITOR : 8 hits 1eag_c04 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS B 2 LYS^? 23.29 OXT ACT A1181 A 207 LYS A 177 LYS.? 21.69 OXT ACT A1181 A 366 ASP B 6 ASP~? 24.59 OXT ACT A1181 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -21.58 16.53 -17.87 -19.92 17.81 -18.11 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS C 2 LYS^? 15.05 CA CA C1182 A 207 LYS D 177 LYS.? 22.56 O3 GOL D1181 A 366 ASP C 6 ASP~? 17.85 CA CA C1182 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -21.58 -16.53 44.38 -19.90 -17.78 44.62 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS D 2 LYS.? 16.82 CA CA C1181 A 207 LYS C 177 LYS.? 13.52 CA CA C1181 A 366 ASP D 6 ASP~? 16.12 CA CA C1181 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -68.52 -25.10 28.52 -62.74 -26.81 28.79 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -69.27 -22.53 40.17 -70.96 -22.24 41.39 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 3 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS B 2 LYS^? 23.29 OXT ACT A1181 B 207 LYS A 177 LYS.? 21.69 OXT ACT A1181 B 366 ASP B 6 ASP~? 24.59 OXT ACT A1181 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -21.58 16.53 -17.87 -19.92 17.81 -18.11 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS B 2 LYS^? 23.29 OXT ACT A1181 C 207 LYS A 177 LYS.? 21.69 OXT ACT A1181 C 366 ASP B 6 ASP~? 24.59 OXT ACT A1181 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -21.58 16.53 -17.87 -19.92 17.81 -18.11 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS C 2 LYS^? 15.05 CA CA C1182 C 207 LYS D 177 LYS.? 22.56 O3 GOL D1181 C 366 ASP C 6 ASP~? 17.85 CA CA C1182 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -21.58 -16.53 44.38 -19.90 -17.78 44.62 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 3 3 # 3 C 205 LYS D 2 LYS.? 16.82 CA CA C1181 C 207 LYS C 177 LYS.? 13.52 CA CA C1181 C 366 ASP D 6 ASP~? 16.12 CA CA C1181 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -68.52 -25.10 28.52 -62.74 -26.81 28.79 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -69.27 -22.53 40.17 -70.96 -22.24 41.39 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 3 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS B 2 LYS^? 23.29 OXT ACT A1181 D 207 LYS A 177 LYS.? 21.69 OXT ACT A1181 D 366 ASP B 6 ASP~? 24.59 OXT ACT A1181 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -21.58 16.53 -17.87 -19.92 17.81 -18.11 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c07 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 177 ASP A 55 ASP.? 17.41 O ACT A1181 A 203 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 8.74 45.76 47.19 9.33 46.93 45.56 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 11.68 42.31 52.96 12.05 43.92 51.65 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 18.07 52.81 49.62 14.17 49.99 48.07 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 177 ASP A 55 ASP.? 17.41 O ACT A1181 A 203 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 8.74 45.76 47.19 9.33 46.93 45.56 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 11.68 42.31 52.96 12.05 43.92 51.65 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 18.07 52.81 49.62 14.17 49.99 48.07 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS A 151 HIS.? 15.84 O ACT A1181 A 177 ASP A 152 ASP.? 5.90 O ACT A1181 A 203 LYS A 117 LYS.? 20.14 O ACT A1181 coo 8.74 45.76 47.19 9.33 46.93 45.56 -46.06 27.03 4.30 -45.69 27.09 6.36 coo 11.68 42.31 52.96 12.05 43.92 51.65 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 18.07 52.81 49.62 14.17 49.99 48.07 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 4 3 # 4 A 99 HIS B 59 HIS~? 15.18 O ACT C1183 A 177 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 203 LYS A 72 LYS.? 19.74 O ACT A1182 coo 8.74 45.76 47.19 9.33 46.93 45.56 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 11.68 42.31 52.96 12.05 43.92 51.65 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 18.07 52.81 49.62 14.17 49.99 48.07 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 5 3 # 5 A 99 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 177 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 203 LYS B 93 LYS.? 14.57 O ACT C1183 coo 8.74 45.76 47.19 9.33 46.93 45.56 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 11.68 42.31 52.96 12.05 43.92 51.65 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 18.07 52.81 49.62 14.17 49.99 48.07 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 6 3 # 6 A 99 HIS B 151 HIS.? 14.53 O3 GOL B1182 A 177 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 203 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 8.74 45.76 47.19 9.33 46.93 45.56 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 11.68 42.31 52.96 12.05 43.92 51.65 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 18.07 52.81 49.62 14.17 49.99 48.07 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 7 3 # 7 A 99 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 177 ASP C 55 ASP.? 19.45 CA CA C1184 A 203 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 8.74 45.76 47.19 9.33 46.93 45.56 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 11.68 42.31 52.96 12.05 43.92 51.65 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 18.07 52.81 49.62 14.17 49.99 48.07 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 8 3 # 8 A 99 HIS C 151 HIS.? 19.99 CA CA C1184 A 177 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 203 LYS C 117 LYS.? 21.58 CA CA C1184 coo 8.74 45.76 47.19 9.33 46.93 45.56 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 11.68 42.31 52.96 12.05 43.92 51.65 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 18.07 52.81 49.62 14.17 49.99 48.07 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 9 3 # 9 A 99 HIS D 114 HIS^? 15.97 O ACT A1182 A 177 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 203 LYS D 93 LYS.? 12.21 O ACT A1182 coo 8.74 45.76 47.19 9.33 46.93 45.56 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 11.68 42.31 52.96 12.05 43.92 51.65 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 18.07 52.81 49.62 14.17 49.99 48.07 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 10 3 # 10 A 99 HIS D 151 HIS.? 15.73 O2 GOL D1181 A 177 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 203 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 8.74 45.76 47.19 9.33 46.93 45.56 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo 11.68 42.31 52.96 12.05 43.92 51.65 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 18.07 52.81 49.62 14.17 49.99 48.07 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1ecx_c02 source 1ecx AMINOTRANSFERASE : 10 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 177 ASP A 55 ASP.? 17.41 O ACT A1181 B 203 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 14.87 88.04 21.51 13.64 87.90 19.81 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 15.87 92.46 27.37 14.46 91.76 25.94 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 3.60 91.42 23.52 8.20 89.55 22.63 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 177 ASP A 55 ASP.? 17.41 O ACT A1181 B 203 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 14.87 88.04 21.51 13.64 87.90 19.81 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 15.87 92.46 27.37 14.46 91.76 25.94 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 3.60 91.42 23.52 8.20 89.55 22.63 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS A 151 HIS.? 15.84 O ACT A1181 B 177 ASP A 152 ASP.? 5.90 O ACT A1181 B 203 LYS A 117 LYS.? 20.14 O ACT A1181 coo 14.87 88.04 21.51 13.64 87.90 19.81 -46.06 27.03 4.30 -45.69 27.09 6.36 coo 15.87 92.46 27.37 14.46 91.76 25.94 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 3.60 91.42 23.52 8.20 89.55 22.63 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS B 59 HIS~? 15.18 O ACT C1183 B 177 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 203 LYS A 72 LYS.? 19.74 O ACT A1182 coo 14.87 88.04 21.51 13.64 87.90 19.81 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 15.87 92.46 27.37 14.46 91.76 25.94 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 3.60 91.42 23.52 8.20 89.55 22.63 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 5 3 # 5 B 99 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 177 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 203 LYS B 93 LYS.? 14.57 O ACT C1183 coo 14.87 88.04 21.51 13.64 87.90 19.81 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 15.87 92.46 27.37 14.46 91.76 25.94 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 3.60 91.42 23.52 8.20 89.55 22.63 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 6 3 # 6 B 99 HIS B 151 HIS.? 14.53 O3 GOL B1182 B 177 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 203 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 14.87 88.04 21.51 13.64 87.90 19.81 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 15.87 92.46 27.37 14.46 91.76 25.94 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 3.60 91.42 23.52 8.20 89.55 22.63 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 7 3 # 7 B 99 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 177 ASP C 55 ASP.? 19.45 CA CA C1184 B 203 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 14.87 88.04 21.51 13.64 87.90 19.81 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 15.87 92.46 27.37 14.46 91.76 25.94 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 3.60 91.42 23.52 8.20 89.55 22.63 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 8 3 # 8 B 99 HIS C 151 HIS.? 19.99 CA CA C1184 B 177 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 203 LYS C 117 LYS.? 21.58 CA CA C1184 coo 14.87 88.04 21.51 13.64 87.90 19.81 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 15.87 92.46 27.37 14.46 91.76 25.94 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 3.60 91.42 23.52 8.20 89.55 22.63 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 9 3 # 9 B 99 HIS D 114 HIS^? 15.97 O ACT A1182 B 177 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 203 LYS D 93 LYS.? 12.21 O ACT A1182 coo 14.87 88.04 21.51 13.64 87.90 19.81 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 15.87 92.46 27.37 14.46 91.76 25.94 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 3.60 91.42 23.52 8.20 89.55 22.63 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 10 3 # 10 B 99 HIS D 151 HIS.? 15.73 O2 GOL D1181 B 177 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 203 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 14.87 88.04 21.51 13.64 87.90 19.81 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo 15.87 92.46 27.37 14.46 91.76 25.94 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 3.60 91.42 23.52 8.20 89.55 22.63 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1ecx_c03 source 1ecx AMINOTRANSFERASE : 10 hits 1ecx_c03 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 84 ASP^? 7.98 OXT ACT A1182 P 35 SER A 88 SER.? 4.86 OXT ACT A1182 P 215 ASP D 84 ASP^? 8.02 O ACT A1182 coo 10.15 33.41 11.98 7.98 33.66 12.07 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 7.57 37.60 10.00 8.86 37.02 12.03 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 4.04 29.97 8.82 4.78 31.15 10.46 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP A 152 ASP.? 5.90 O ACT A1181 P 35 SER A 153 SER.? 8.36 O ACT A1181 P 215 ASP A 156 ASP~? 10.59 O ACT A1181 coo 10.15 33.41 11.98 7.98 33.66 12.07 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 7.57 37.60 10.00 8.86 37.02 12.03 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 4.04 29.97 8.82 4.78 31.15 10.46 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 3 3 # 3 P 32 ASP B 84 ASP^? 7.80 O ACT C1183 P 35 SER B 88 SER.? 4.64 O ACT C1183 P 215 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 10.15 33.41 11.98 7.98 33.66 12.07 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 7.57 37.60 10.00 8.86 37.02 12.03 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 4.04 29.97 8.82 4.78 31.15 10.46 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 4 3 # 4 P 32 ASP B 152 ASP.? 8.52 O3 GOL B1182 P 35 SER B 153 SER.? 13.04 OXT ACT A1181 P 215 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 10.15 33.41 11.98 7.98 33.66 12.07 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 7.57 37.60 10.00 8.86 37.02 12.03 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo 4.04 29.97 8.82 4.78 31.15 10.46 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 5 3 # 5 P 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 P 35 SER C 88 SER.? 4.69 OXT ACT C1183 P 215 ASP B 84 ASP^? 7.80 O ACT C1183 coo 10.15 33.41 11.98 7.98 33.66 12.07 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 7.57 37.60 10.00 8.86 37.02 12.03 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 4.04 29.97 8.82 4.78 31.15 10.46 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 6 3 # 6 P 32 ASP C 152 ASP.? 13.45 O3 GOL D1181 P 35 SER C 153 SER.? 12.45 O3 GOL D1181 P 215 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 10.15 33.41 11.98 7.98 33.66 12.07 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 7.57 37.60 10.00 8.86 37.02 12.03 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo 4.04 29.97 8.82 4.78 31.15 10.46 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 7 3 # 7 P 32 ASP D 84 ASP^? 8.02 O ACT A1182 P 35 SER A 88 SER.? 4.86 OXT ACT A1182 P 215 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 10.15 33.41 11.98 7.98 33.66 12.07 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 7.57 37.60 10.00 8.86 37.02 12.03 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 4.04 29.97 8.82 4.78 31.15 10.46 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 8 3 # 8 P 32 ASP D 84 ASP^? 8.02 O ACT A1182 P 35 SER D 88 SER.? 4.67 O ACT A1182 P 215 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 10.15 33.41 11.98 7.98 33.66 12.07 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 7.57 37.60 10.00 8.86 37.02 12.03 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 4.04 29.97 8.82 4.78 31.15 10.46 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 9 3 # 9 P 32 ASP D 152 ASP.? 5.75 O2 GOL D1181 P 35 SER D 153 SER.? 8.24 O2 GOL D1181 P 215 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 10.15 33.41 11.98 7.98 33.66 12.07 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 7.57 37.60 10.00 8.86 37.02 12.03 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo 4.04 29.97 8.82 4.78 31.15 10.46 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 9 hits 1eed_c04 naa= 3 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 A 107 ASP A 55 ASP.? 17.41 O ACT A1181 A 246 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 275 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo 28.44 37.56 46.79 26.87 37.11 48.10 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 22.84 50.35 52.24 23.24 48.32 52.90 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 26.67 42.94 48.26 27.49 41.07 48.73 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 A 107 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 246 ASP B 84 ASP^? 7.80 O ACT C1183 A 275 HIS B 59 HIS~? 15.18 O ACT C1183 coo 28.44 37.56 46.79 26.87 37.11 48.10 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 22.84 50.35 52.24 23.24 48.32 52.90 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 26.67 42.94 48.26 27.49 41.07 48.73 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1ehy_c00 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 A 107 ASP C 55 ASP.? 19.45 CA CA C1184 A 246 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 275 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo 28.44 37.56 46.79 26.87 37.11 48.10 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 22.84 50.35 52.24 23.24 48.32 52.90 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 26.67 42.94 48.26 27.49 41.07 48.73 -46.89 1.05 23.56 -47.29 3.11 23.40 1ehy_c00 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 3 hits 1ehy_c00 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 152 ASP.? 5.90 O ACT A1181 B 246 ASP B 73 ASP.? 22.00 OXT ACT C1183 B 275 HIS A 151 HIS.? 15.84 O ACT A1181 coo 34.84 56.77 81.62 34.95 54.74 82.03 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 43.18 49.30 68.39 44.75 49.87 69.78 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 38.73 55.10 77.62 36.80 55.01 78.46 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 246 ASP A 73 ASP.? 22.06 O ACT A1182 B 275 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 34.84 56.77 81.62 34.95 54.74 82.03 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 43.18 49.30 68.39 44.75 49.87 69.78 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 38.73 55.10 77.62 36.80 55.01 78.46 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 B 107 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 246 ASP D 73 ASP.? 21.98 OXT ACT A1182 B 275 HIS C 151 HIS.? 19.99 CA CA C1184 coo 34.84 56.77 81.62 34.95 54.74 82.03 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 43.18 49.30 68.39 44.75 49.87 69.78 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 38.73 55.10 77.62 36.80 55.01 78.46 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 B 107 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 246 ASP C 73 ASP.? 22.09 O ACT C1183 B 275 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 34.84 56.77 81.62 34.95 54.74 82.03 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 43.18 49.30 68.39 44.75 49.87 69.78 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 38.73 55.10 77.62 36.80 55.01 78.46 -45.79 -27.28 22.21 -45.52 -27.23 20.13 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 4 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 152 ASP.? 5.90 O ACT A1181 C 246 ASP B 73 ASP.? 22.00 OXT ACT C1183 C 275 HIS A 151 HIS.? 15.84 O ACT A1181 coo 1.90 35.26 72.76 3.20 35.74 71.18 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 12.03 20.33 71.56 10.48 19.25 70.56 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 3.92 29.96 71.75 4.22 31.96 72.31 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 246 ASP B 144 ASP.? 6.66 CA CA B1183 C 275 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 1.90 35.26 72.76 3.20 35.74 71.18 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 12.03 20.33 71.56 10.48 19.25 70.56 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 3.92 29.96 71.75 4.22 31.96 72.31 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 C 107 ASP B 152 ASP.? 8.52 O3 GOL B1182 C 246 ASP A 73 ASP.? 22.06 O ACT A1182 C 275 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 1.90 35.26 72.76 3.20 35.74 71.18 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 12.03 20.33 71.56 10.48 19.25 70.56 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 3.92 29.96 71.75 4.22 31.96 72.31 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 C 107 ASP C 55 ASP.? 19.45 CA CA C1184 C 246 ASP C 144 ASP.? 6.69 CA CA C1184 C 275 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 1.90 35.26 72.76 3.20 35.74 71.18 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 12.03 20.33 71.56 10.48 19.25 70.56 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 3.92 29.96 71.75 4.22 31.96 72.31 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 5 3 # 5 C 107 ASP C 152 ASP.? 13.45 O3 GOL D1181 C 246 ASP D 73 ASP.? 21.98 OXT ACT A1182 C 275 HIS C 151 HIS.? 19.99 CA CA C1184 coo 1.90 35.26 72.76 3.20 35.74 71.18 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 12.03 20.33 71.56 10.48 19.25 70.56 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 3.92 29.96 71.75 4.22 31.96 72.31 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 6 3 # 6 C 107 ASP D 152 ASP.? 5.75 O2 GOL D1181 C 246 ASP C 73 ASP.? 22.09 O ACT C1183 C 275 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 1.90 35.26 72.76 3.20 35.74 71.18 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 12.03 20.33 71.56 10.48 19.25 70.56 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 3.92 29.96 71.75 4.22 31.96 72.31 -45.79 -27.28 22.21 -45.52 -27.23 20.13 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 6 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 152 ASP.? 5.90 O ACT A1181 D 246 ASP B 73 ASP.? 22.00 OXT ACT C1183 D 275 HIS A 151 HIS.? 15.84 O ACT A1181 coo 37.41 19.89 81.58 37.64 21.98 81.53 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 23.50 26.43 88.52 24.76 26.47 90.29 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 33.16 21.44 85.29 34.07 21.53 83.40 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP B 152 ASP.? 8.52 O3 GOL B1182 D 246 ASP A 73 ASP.? 22.06 O ACT A1182 D 275 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 37.41 19.89 81.58 37.64 21.98 81.53 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 23.50 26.43 88.52 24.76 26.47 90.29 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 33.16 21.44 85.29 34.07 21.53 83.40 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 D 107 ASP C 152 ASP.? 13.45 O3 GOL D1181 D 246 ASP D 73 ASP.? 21.98 OXT ACT A1182 D 275 HIS C 151 HIS.? 19.99 CA CA C1184 coo 37.41 19.89 81.58 37.64 21.98 81.53 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 23.50 26.43 88.52 24.76 26.47 90.29 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 33.16 21.44 85.29 34.07 21.53 83.40 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 D 107 ASP D 152 ASP.? 5.75 O2 GOL D1181 D 246 ASP C 73 ASP.? 22.09 O ACT C1183 D 275 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 37.41 19.89 81.58 37.64 21.98 81.53 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 23.50 26.43 88.52 24.76 26.47 90.29 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 33.16 21.44 85.29 34.07 21.53 83.40 -45.79 -27.28 22.21 -45.52 -27.23 20.13 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 4 hits 1ehy_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 197 ASP A 55 ASP.? 17.41 O ACT A1181 A 223 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 197 ASP A 55 ASP.? 17.41 O ACT A1181 A 223 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 197 ASP A 55 ASP.? 17.41 O ACT A1181 A 223 LYS A 149 LYS.? 8.87 O ACT A1181 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS A 151 HIS.? 15.84 O ACT A1181 A 197 ASP A 152 ASP.? 5.90 O ACT A1181 A 223 LYS A 117 LYS.? 20.14 O ACT A1181 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -46.06 27.03 4.30 -45.69 27.09 6.36 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 A 114 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 197 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 223 LYS B 93 LYS.? 14.57 O ACT C1183 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 A 114 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 197 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 223 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 A 114 HIS B 151 HIS.? 14.53 O3 GOL B1182 A 197 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 223 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 A 114 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 197 ASP C 55 ASP.? 19.45 CA CA C1184 A 223 LYS C 93 LYS.? 19.61 OXT ACT C1183 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -54.93 14.23 21.55 -53.38 19.08 19.32 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 A 114 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 197 ASP C 55 ASP.? 19.45 CA CA C1184 A 223 LYS C 149 LYS.? 9.01 CA CA C1184 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 A 114 HIS C 151 HIS.? 19.99 CA CA C1184 A 197 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 223 LYS C 117 LYS.? 21.58 CA CA C1184 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -44.62 2.10 41.60 -44.48 3.82 40.41 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 A 114 HIS D 114 HIS^? 15.97 O ACT A1182 A 197 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 223 LYS D 93 LYS.? 12.21 O ACT A1182 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 A 114 HIS D 114 HIS^? 15.97 O ACT A1182 A 197 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 223 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 13 3 # 13 A 114 HIS D 151 HIS.? 15.73 O2 GOL D1181 A 197 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 223 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 13 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 197 ASP A 55 ASP.? 17.41 O ACT A1181 B 223 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 197 ASP A 55 ASP.? 17.41 O ACT A1181 B 223 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 197 ASP A 55 ASP.? 17.41 O ACT A1181 B 223 LYS A 149 LYS.? 8.87 O ACT A1181 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS A 151 HIS.? 15.84 O ACT A1181 B 197 ASP A 152 ASP.? 5.90 O ACT A1181 B 223 LYS A 117 LYS.? 20.14 O ACT A1181 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -46.06 27.03 4.30 -45.69 27.09 6.36 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 B 114 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 197 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 223 LYS B 93 LYS.? 14.57 O ACT C1183 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 B 114 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 197 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 223 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 B 114 HIS B 151 HIS.? 14.53 O3 GOL B1182 B 197 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 223 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 B 114 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 197 ASP C 55 ASP.? 19.45 CA CA C1184 B 223 LYS C 93 LYS.? 19.61 OXT ACT C1183 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -54.93 14.23 21.55 -53.38 19.08 19.32 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 B 114 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 197 ASP C 55 ASP.? 19.45 CA CA C1184 B 223 LYS C 149 LYS.? 9.01 CA CA C1184 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 B 114 HIS C 151 HIS.? 19.99 CA CA C1184 B 197 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 223 LYS C 117 LYS.? 21.58 CA CA C1184 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -44.62 2.10 41.60 -44.48 3.82 40.41 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 B 114 HIS D 59 HIS~? 14.28 O ACT A1182 B 197 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 223 LYS C 72 LYS.? 18.71 O ACT C1183 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 B 114 HIS D 114 HIS^? 15.97 O ACT A1182 B 197 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 223 LYS D 93 LYS.? 12.21 O ACT A1182 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 13 3 # 13 B 114 HIS D 114 HIS^? 15.97 O ACT A1182 B 197 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 223 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 14 3 # 14 B 114 HIS D 151 HIS.? 15.73 O2 GOL D1181 B 197 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 223 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 14 hits 1elq_c03 naa= 3 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 3 # 1 150 ASP A 55 ASP.? 17.41 O ACT A1181 153 ARG A 58 ARG~? 14.46 O ACT A1181 177 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo 6.83 2.75 19.17 7.40 0.75 19.11 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 3 # 2 150 ASP A 55 ASP.? 17.41 O ACT A1181 153 ARG A 58 ARG~? 14.46 O ACT A1181 177 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 6.83 2.75 19.17 7.40 0.75 19.11 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 3 3 # 3 150 ASP B 55 ASP.? 14.29 O3 GOL B1182 153 ARG B 58 ARG~? 12.97 O3 GOL B1182 177 HIS B 59 HIS~? 15.18 O ACT C1183 coo 6.83 2.75 19.17 7.40 0.75 19.11 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 4 3 # 4 150 ASP B 55 ASP.? 14.29 O3 GOL B1182 153 ARG B 58 ARG~? 12.97 O3 GOL B1182 177 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 6.83 2.75 19.17 7.40 0.75 19.11 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 5 3 # 5 150 ASP C 55 ASP.? 19.45 CA CA C1184 153 ARG C 58 ARG~? 18.42 O3 GOL D1181 177 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo 6.83 2.75 19.17 7.40 0.75 19.11 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -46.89 1.05 23.56 -47.29 3.11 23.40 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 6 3 # 6 150 ASP C 55 ASP.? 19.45 CA CA C1184 153 ARG C 58 ARG~? 18.42 O3 GOL D1181 177 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 6.83 2.75 19.17 7.40 0.75 19.11 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 7 3 # 7 150 ASP D 55 ASP.? 17.43 O2 GOL D1181 153 ARG D 58 ARG~? 14.52 O2 GOL D1181 177 HIS D 114 HIS^? 15.97 O ACT A1182 coo 6.83 2.75 19.17 7.40 0.75 19.11 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1emd_c01 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 7 hits 1emd_c01 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 38 ALA~? 22.67 OXT ACT A1181 A 257 ALA A 34 ALA~? 17.95 O ACT A1181 A 328 ASP A 144 ASP.? 22.46 O ACT A1181 coo 39.84 24.12 8.44 38.50 24.23 9.11 -22.35 13.14 -5.03 -21.40 14.08 -5.75 coo 43.22 26.73 5.37 41.81 27.09 5.79 -25.61 17.94 -7.13 -25.09 18.62 -8.43 coo 38.17 34.10 6.67 37.72 32.06 6.84 -24.09 23.13 1.13 -22.88 24.73 0.42 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA B 38 ALA~? 12.14 CA CA B1181 A 257 ALA B 34 ALA~? 8.65 O1 GOL B1182 A 328 ASP B 144 ASP.? 6.66 CA CA B1183 coo 39.84 24.12 8.44 38.50 24.23 9.11 -68.47 11.61 -6.00 -69.42 12.03 -7.12 coo 43.22 26.73 5.37 41.81 27.09 5.79 -65.40 11.95 -11.28 -65.85 13.06 -12.24 coo 38.17 34.10 6.67 37.72 32.06 6.84 -67.28 1.35 -10.84 -69.02 1.72 -11.95 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA C 38 ALA~? 12.06 CA CA C1181 A 257 ALA C 34 ALA~? 12.61 CA CA C1184 A 328 ASP C 144 ASP.? 6.69 CA CA C1184 coo 39.84 24.12 8.44 38.50 24.23 9.11 -68.47 -11.63 32.46 -69.41 -12.04 33.57 coo 43.22 26.73 5.37 41.81 27.09 5.79 -65.39 -11.97 37.73 -65.91 -13.10 38.66 coo 38.17 34.10 6.67 37.72 32.06 6.84 -67.28 -1.35 37.26 -69.02 -1.78 38.35 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA D 38 ALA~? 21.45 O3 GOL D1181 A 257 ALA D 34 ALA~? 16.85 CA CA C1182 A 328 ASP D 144 ASP.? 22.37 O2 GOL D1181 coo 39.84 24.12 8.44 38.50 24.23 9.11 -22.38 -13.17 31.47 -21.46 -14.12 32.22 coo 43.22 26.73 5.37 41.81 27.09 5.79 -25.61 -17.93 33.60 -25.08 -18.60 34.88 coo 38.17 34.10 6.67 37.72 32.06 6.84 -24.08 -23.14 25.44 -22.85 -24.74 26.11 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 4 hits 1eo7_c00 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER A 172 SER~? 20.14 OXT ACT A1181 A 140 TYR A 175 TYR~? 24.50 O ACT A1182 A 144 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 34.67 35.79 48.83 33.57 37.88 49.47 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 29.60 38.99 53.89 30.10 37.88 51.36 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 32.73 32.94 54.42 29.29 32.83 50.35 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER B 31 SER~? 8.40 O1 GOL B1182 A 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 A 144 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo 34.67 35.79 48.83 33.57 37.88 49.47 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 29.60 38.99 53.89 30.10 37.88 51.36 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 32.73 32.94 54.42 29.29 32.83 50.35 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 A 116 SER B 31 SER~? 8.40 O1 GOL B1182 A 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 A 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 34.67 35.79 48.83 33.57 37.88 49.47 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 29.60 38.99 53.89 30.10 37.88 51.36 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 32.73 32.94 54.42 29.29 32.83 50.35 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 A 116 SER B 32 SER~? 5.72 CA CA B1183 A 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 A 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 34.67 35.79 48.83 33.57 37.88 49.47 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 29.60 38.99 53.89 30.10 37.88 51.36 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 32.73 32.94 54.42 29.29 32.83 50.35 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 A 116 SER B 172 SER~? 11.09 CA CA B1181 A 140 TYR B 175 TYR~? 10.51 CA CA B1181 A 144 LYS B 177 LYS.? 12.69 CA CA B1181 coo 34.67 35.79 48.83 33.57 37.88 49.47 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 29.60 38.99 53.89 30.10 37.88 51.36 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 32.73 32.94 54.42 29.29 32.83 50.35 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 A 116 SER C 31 SER.? 11.23 CA CA C1184 A 140 TYR D 5 TYR~? 13.80 CA CA C1181 A 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 34.67 35.79 48.83 33.57 37.88 49.47 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 29.60 38.99 53.89 30.10 37.88 51.36 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 32.73 32.94 54.42 29.29 32.83 50.35 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 A 116 SER C 32 SER~? 5.57 CA CA C1184 A 140 TYR D 5 TYR~? 13.80 CA CA C1181 A 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 34.67 35.79 48.83 33.57 37.88 49.47 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 29.60 38.99 53.89 30.10 37.88 51.36 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 32.73 32.94 54.42 29.29 32.83 50.35 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 A 116 SER C 172 SER~? 11.19 CA CA C1181 A 140 TYR C 175 TYR~? 10.79 CA CA C1181 A 144 LYS C 177 LYS.? 13.52 CA CA C1181 coo 34.67 35.79 48.83 33.57 37.88 49.47 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 29.60 38.99 53.89 30.10 37.88 51.36 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 32.73 32.94 54.42 29.29 32.83 50.35 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 A 116 SER D 172 SER~? 19.02 O3 GOL D1181 A 140 TYR D 175 TYR.? 24.43 OXT ACT A1182 A 144 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 34.67 35.79 48.83 33.57 37.88 49.47 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 29.60 38.99 53.89 30.10 37.88 51.36 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 32.73 32.94 54.42 29.29 32.83 50.35 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 9 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER A 172 SER~? 20.14 OXT ACT A1181 B 140 TYR A 175 TYR~? 24.50 O ACT A1182 B 144 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 30.90 35.65 89.60 29.85 37.72 88.83 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 24.43 38.83 86.53 27.07 38.03 86.12 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 25.13 32.62 89.49 27.74 32.61 84.91 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 B 116 SER B 31 SER~? 8.40 O1 GOL B1182 B 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 B 144 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo 30.90 35.65 89.60 29.85 37.72 88.83 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 24.43 38.83 86.53 27.07 38.03 86.12 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 25.13 32.62 89.49 27.74 32.61 84.91 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 B 116 SER B 31 SER~? 8.40 O1 GOL B1182 B 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 B 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 30.90 35.65 89.60 29.85 37.72 88.83 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 24.43 38.83 86.53 27.07 38.03 86.12 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 25.13 32.62 89.49 27.74 32.61 84.91 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 B 116 SER B 32 SER~? 5.72 CA CA B1183 B 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 B 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 30.90 35.65 89.60 29.85 37.72 88.83 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 24.43 38.83 86.53 27.07 38.03 86.12 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 25.13 32.62 89.49 27.74 32.61 84.91 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 B 116 SER B 172 SER~? 11.09 CA CA B1181 B 140 TYR B 175 TYR~? 10.51 CA CA B1181 B 144 LYS B 177 LYS.? 12.69 CA CA B1181 coo 30.90 35.65 89.60 29.85 37.72 88.83 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 24.43 38.83 86.53 27.07 38.03 86.12 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 25.13 32.62 89.49 27.74 32.61 84.91 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 B 116 SER C 31 SER.? 11.23 CA CA C1184 B 140 TYR D 5 TYR~? 13.80 CA CA C1181 B 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 30.90 35.65 89.60 29.85 37.72 88.83 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 24.43 38.83 86.53 27.07 38.03 86.12 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 25.13 32.62 89.49 27.74 32.61 84.91 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 B 116 SER C 32 SER~? 5.57 CA CA C1184 B 140 TYR D 5 TYR~? 13.80 CA CA C1181 B 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 30.90 35.65 89.60 29.85 37.72 88.83 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 24.43 38.83 86.53 27.07 38.03 86.12 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 25.13 32.62 89.49 27.74 32.61 84.91 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 B 116 SER C 172 SER~? 11.19 CA CA C1181 B 140 TYR C 175 TYR~? 10.79 CA CA C1181 B 144 LYS C 177 LYS.? 13.52 CA CA C1181 coo 30.90 35.65 89.60 29.85 37.72 88.83 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 24.43 38.83 86.53 27.07 38.03 86.12 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 25.13 32.62 89.49 27.74 32.61 84.91 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 B 116 SER D 172 SER~? 19.02 O3 GOL D1181 B 140 TYR D 175 TYR.? 24.43 OXT ACT A1182 B 144 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 30.90 35.65 89.60 29.85 37.72 88.83 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 24.43 38.83 86.53 27.07 38.03 86.12 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 25.13 32.62 89.49 27.74 32.61 84.91 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 9 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER A 172 SER~? 20.14 OXT ACT A1181 C 140 TYR A 175 TYR~? 24.50 O ACT A1182 C 144 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER B 31 SER~? 8.40 O1 GOL B1182 C 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 C 144 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 C 116 SER B 31 SER~? 8.40 O1 GOL B1182 C 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 C 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 C 116 SER B 32 SER~? 5.72 CA CA B1183 C 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 C 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 C 116 SER B 172 SER~? 11.09 CA CA B1181 C 140 TYR B 175 TYR~? 10.51 CA CA B1181 C 144 LYS B 177 LYS.? 12.69 CA CA B1181 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -65.36 23.11 4.03 -63.61 22.29 6.06 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 C 116 SER C 31 SER.? 11.23 CA CA C1184 C 140 TYR D 5 TYR~? 13.80 CA CA C1181 C 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 C 116 SER C 32 SER~? 5.57 CA CA C1184 C 140 TYR D 5 TYR~? 13.80 CA CA C1181 C 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 C 116 SER C 172 SER~? 11.19 CA CA C1181 C 140 TYR C 175 TYR~? 10.79 CA CA C1181 C 144 LYS C 177 LYS.? 13.52 CA CA C1181 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 C 116 SER D 172 SER~? 19.02 O3 GOL D1181 C 140 TYR D 175 TYR.? 24.43 OXT ACT A1182 C 144 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo -8.28 37.01 91.79 -6.99 36.16 94.13 -25.75 0.70 38.70 -27.49 2.18 37.04 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 9 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER A 172 SER~? 20.14 OXT ACT A1181 D 140 TYR A 175 TYR~? 24.50 O ACT A1182 D 144 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 D 116 SER B 31 SER~? 8.40 O1 GOL B1182 D 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 D 144 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 D 116 SER B 31 SER~? 8.40 O1 GOL B1182 D 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 D 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 D 116 SER B 32 SER~? 5.72 CA CA B1183 D 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 D 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 D 116 SER B 172 SER~? 11.09 CA CA B1181 D 140 TYR B 175 TYR~? 10.51 CA CA B1181 D 144 LYS B 177 LYS.? 12.69 CA CA B1181 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -65.36 23.11 4.03 -63.61 22.29 6.06 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 D 116 SER C 31 SER.? 11.23 CA CA C1184 D 140 TYR D 5 TYR~? 13.80 CA CA C1181 D 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 D 116 SER C 32 SER~? 5.57 CA CA C1184 D 140 TYR D 5 TYR~? 13.80 CA CA C1181 D 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 D 116 SER C 172 SER~? 11.19 CA CA C1181 D 140 TYR C 175 TYR~? 10.79 CA CA C1181 D 144 LYS C 177 LYS.? 13.52 CA CA C1181 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 D 116 SER D 172 SER~? 19.02 O3 GOL D1181 D 140 TYR D 175 TYR.? 24.43 OXT ACT A1182 D 144 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo -23.30 35.33 62.20 -25.10 34.24 64.06 -25.75 0.70 38.70 -27.49 2.18 37.04 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 9 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER A 172 SER~? 20.14 OXT ACT A1181 E 140 TYR A 175 TYR~? 24.50 O ACT A1182 E 144 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 E 116 SER B 31 SER~? 8.40 O1 GOL B1182 E 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 E 144 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 E 116 SER B 31 SER~? 8.40 O1 GOL B1182 E 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 E 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 E 116 SER B 32 SER~? 5.72 CA CA B1183 E 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 E 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 E 116 SER B 172 SER~? 11.09 CA CA B1181 E 140 TYR B 175 TYR~? 10.51 CA CA B1181 E 144 LYS B 177 LYS.? 12.69 CA CA B1181 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 E 116 SER C 31 SER.? 11.23 CA CA C1184 E 140 TYR D 5 TYR~? 13.80 CA CA C1181 E 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 E 116 SER C 32 SER~? 5.57 CA CA C1184 E 140 TYR D 5 TYR~? 13.80 CA CA C1181 E 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 E 116 SER C 172 SER~? 11.19 CA CA C1181 E 140 TYR C 175 TYR~? 10.79 CA CA C1181 E 144 LYS C 177 LYS.? 13.52 CA CA C1181 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 E 116 SER D 172 SER~? 19.02 O3 GOL D1181 E 140 TYR D 175 TYR.? 24.43 OXT ACT A1182 E 144 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 0.04 36.70 38.68 -2.21 35.46 37.50 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 9 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER A 172 SER~? 20.14 OXT ACT A1181 F 140 TYR A 175 TYR~? 24.50 O ACT A1182 F 144 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 55.30 92.46 56.72 55.15 90.39 55.38 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 54.49 89.31 49.65 53.35 90.16 52.06 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 56.78 95.62 51.15 51.59 95.31 52.37 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER B 31 SER~? 8.40 O1 GOL B1182 F 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 F 144 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo 55.30 92.46 56.72 55.15 90.39 55.38 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 54.49 89.31 49.65 53.35 90.16 52.06 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 56.78 95.62 51.15 51.59 95.31 52.37 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 F 116 SER B 31 SER~? 8.40 O1 GOL B1182 F 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 F 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 55.30 92.46 56.72 55.15 90.39 55.38 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 54.49 89.31 49.65 53.35 90.16 52.06 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 56.78 95.62 51.15 51.59 95.31 52.37 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 F 116 SER B 32 SER~? 5.72 CA CA B1183 F 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 F 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 55.30 92.46 56.72 55.15 90.39 55.38 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 54.49 89.31 49.65 53.35 90.16 52.06 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 56.78 95.62 51.15 51.59 95.31 52.37 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 F 116 SER B 172 SER~? 11.09 CA CA B1181 F 140 TYR B 175 TYR~? 10.51 CA CA B1181 F 144 LYS B 177 LYS.? 12.69 CA CA B1181 coo 55.30 92.46 56.72 55.15 90.39 55.38 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 54.49 89.31 49.65 53.35 90.16 52.06 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 56.78 95.62 51.15 51.59 95.31 52.37 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 F 116 SER C 31 SER.? 11.23 CA CA C1184 F 140 TYR D 5 TYR~? 13.80 CA CA C1181 F 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 55.30 92.46 56.72 55.15 90.39 55.38 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 54.49 89.31 49.65 53.35 90.16 52.06 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 56.78 95.62 51.15 51.59 95.31 52.37 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 F 116 SER C 32 SER~? 5.57 CA CA C1184 F 140 TYR D 5 TYR~? 13.80 CA CA C1181 F 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 55.30 92.46 56.72 55.15 90.39 55.38 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 54.49 89.31 49.65 53.35 90.16 52.06 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 56.78 95.62 51.15 51.59 95.31 52.37 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 F 116 SER C 172 SER~? 11.19 CA CA C1181 F 140 TYR C 175 TYR~? 10.79 CA CA C1181 F 144 LYS C 177 LYS.? 13.52 CA CA C1181 coo 55.30 92.46 56.72 55.15 90.39 55.38 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 54.49 89.31 49.65 53.35 90.16 52.06 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 56.78 95.62 51.15 51.59 95.31 52.37 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 F 116 SER D 172 SER~? 19.02 O3 GOL D1181 F 140 TYR D 175 TYR.? 24.43 OXT ACT A1182 F 144 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 55.30 92.46 56.72 55.15 90.39 55.38 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 54.49 89.31 49.65 53.35 90.16 52.06 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 56.78 95.62 51.15 51.59 95.31 52.37 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 9 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER A 172 SER~? 20.14 OXT ACT A1181 G 140 TYR A 175 TYR~? 24.50 O ACT A1182 G 144 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 76.25 95.63 21.56 75.29 93.40 21.36 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 69.78 91.62 20.06 71.51 92.68 22.02 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 71.19 98.21 18.32 70.69 97.75 23.67 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 G 116 SER B 31 SER~? 8.40 O1 GOL B1182 G 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 G 144 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo 76.25 95.63 21.56 75.29 93.40 21.36 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 69.78 91.62 20.06 71.51 92.68 22.02 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 71.19 98.21 18.32 70.69 97.75 23.67 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 G 116 SER B 31 SER~? 8.40 O1 GOL B1182 G 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 G 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 76.25 95.63 21.56 75.29 93.40 21.36 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 69.78 91.62 20.06 71.51 92.68 22.02 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 71.19 98.21 18.32 70.69 97.75 23.67 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 G 116 SER B 32 SER~? 5.72 CA CA B1183 G 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 G 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 76.25 95.63 21.56 75.29 93.40 21.36 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 69.78 91.62 20.06 71.51 92.68 22.02 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 71.19 98.21 18.32 70.69 97.75 23.67 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 G 116 SER B 172 SER~? 11.09 CA CA B1181 G 140 TYR B 175 TYR~? 10.51 CA CA B1181 G 144 LYS B 177 LYS.? 12.69 CA CA B1181 coo 76.25 95.63 21.56 75.29 93.40 21.36 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 69.78 91.62 20.06 71.51 92.68 22.02 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 71.19 98.21 18.32 70.69 97.75 23.67 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 G 116 SER C 31 SER.? 11.23 CA CA C1184 G 140 TYR D 5 TYR~? 13.80 CA CA C1181 G 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 76.25 95.63 21.56 75.29 93.40 21.36 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 69.78 91.62 20.06 71.51 92.68 22.02 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 71.19 98.21 18.32 70.69 97.75 23.67 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 G 116 SER C 32 SER~? 5.57 CA CA C1184 G 140 TYR D 5 TYR~? 13.80 CA CA C1181 G 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 76.25 95.63 21.56 75.29 93.40 21.36 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 69.78 91.62 20.06 71.51 92.68 22.02 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 71.19 98.21 18.32 70.69 97.75 23.67 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 G 116 SER C 172 SER~? 11.19 CA CA C1181 G 140 TYR C 175 TYR~? 10.79 CA CA C1181 G 144 LYS C 177 LYS.? 13.52 CA CA C1181 coo 76.25 95.63 21.56 75.29 93.40 21.36 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 69.78 91.62 20.06 71.51 92.68 22.02 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 71.19 98.21 18.32 70.69 97.75 23.67 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 G 116 SER D 172 SER~? 19.02 O3 GOL D1181 G 140 TYR D 175 TYR.? 24.43 OXT ACT A1182 G 144 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 76.25 95.63 21.56 75.29 93.40 21.36 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 69.78 91.62 20.06 71.51 92.68 22.02 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 71.19 98.21 18.32 70.69 97.75 23.67 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 9 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER A 172 SER~? 20.14 OXT ACT A1181 H 140 TYR A 175 TYR~? 24.50 O ACT A1182 H 144 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 15.45 90.62 47.70 16.55 88.57 46.97 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 21.92 87.58 44.67 19.30 88.41 44.23 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 21.26 93.70 47.67 18.47 93.68 43.08 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER B 31 SER~? 8.40 O1 GOL B1182 H 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 H 144 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo 15.45 90.62 47.70 16.55 88.57 46.97 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 21.92 87.58 44.67 19.30 88.41 44.23 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 21.26 93.70 47.67 18.47 93.68 43.08 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 H 116 SER B 31 SER~? 8.40 O1 GOL B1182 H 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 H 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 15.45 90.62 47.70 16.55 88.57 46.97 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 21.92 87.58 44.67 19.30 88.41 44.23 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 21.26 93.70 47.67 18.47 93.68 43.08 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 H 116 SER B 32 SER~? 5.72 CA CA B1183 H 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 H 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 15.45 90.62 47.70 16.55 88.57 46.97 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 21.92 87.58 44.67 19.30 88.41 44.23 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 21.26 93.70 47.67 18.47 93.68 43.08 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 H 116 SER B 172 SER~? 11.09 CA CA B1181 H 140 TYR B 175 TYR~? 10.51 CA CA B1181 H 144 LYS B 177 LYS.? 12.69 CA CA B1181 coo 15.45 90.62 47.70 16.55 88.57 46.97 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 21.92 87.58 44.67 19.30 88.41 44.23 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 21.26 93.70 47.67 18.47 93.68 43.08 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 H 116 SER C 31 SER.? 11.23 CA CA C1184 H 140 TYR D 5 TYR~? 13.80 CA CA C1181 H 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 15.45 90.62 47.70 16.55 88.57 46.97 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 21.92 87.58 44.67 19.30 88.41 44.23 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 21.26 93.70 47.67 18.47 93.68 43.08 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 H 116 SER C 32 SER~? 5.57 CA CA C1184 H 140 TYR D 5 TYR~? 13.80 CA CA C1181 H 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 15.45 90.62 47.70 16.55 88.57 46.97 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 21.92 87.58 44.67 19.30 88.41 44.23 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 21.26 93.70 47.67 18.47 93.68 43.08 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 H 116 SER C 172 SER~? 11.19 CA CA C1181 H 140 TYR C 175 TYR~? 10.79 CA CA C1181 H 144 LYS C 177 LYS.? 13.52 CA CA C1181 coo 15.45 90.62 47.70 16.55 88.57 46.97 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 21.92 87.58 44.67 19.30 88.41 44.23 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 21.26 93.70 47.67 18.47 93.68 43.08 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 H 116 SER D 172 SER~? 19.02 O3 GOL D1181 H 140 TYR D 175 TYR.? 24.43 OXT ACT A1182 H 144 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 15.45 90.62 47.70 16.55 88.57 46.97 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 21.92 87.58 44.67 19.30 88.41 44.23 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 21.26 93.70 47.67 18.47 93.68 43.08 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 9 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER A 172 SER~? 20.14 OXT ACT A1181 I 140 TYR A 175 TYR~? 24.50 O ACT A1182 I 144 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 11.78 90.82 7.18 12.84 88.72 7.93 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 16.78 87.76 12.19 16.39 88.69 9.59 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 13.67 93.83 12.65 17.08 93.94 8.58 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 I 116 SER B 31 SER~? 8.40 O1 GOL B1182 I 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 I 144 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo 11.78 90.82 7.18 12.84 88.72 7.93 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 16.78 87.76 12.19 16.39 88.69 9.59 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 13.67 93.83 12.65 17.08 93.94 8.58 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 I 116 SER B 31 SER~? 8.40 O1 GOL B1182 I 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 I 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 11.78 90.82 7.18 12.84 88.72 7.93 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 16.78 87.76 12.19 16.39 88.69 9.59 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 13.67 93.83 12.65 17.08 93.94 8.58 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 I 116 SER B 32 SER~? 5.72 CA CA B1183 I 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 I 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 11.78 90.82 7.18 12.84 88.72 7.93 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 16.78 87.76 12.19 16.39 88.69 9.59 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 13.67 93.83 12.65 17.08 93.94 8.58 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 I 116 SER B 172 SER~? 11.09 CA CA B1181 I 140 TYR B 175 TYR~? 10.51 CA CA B1181 I 144 LYS B 177 LYS.? 12.69 CA CA B1181 coo 11.78 90.82 7.18 12.84 88.72 7.93 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 16.78 87.76 12.19 16.39 88.69 9.59 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 13.67 93.83 12.65 17.08 93.94 8.58 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 I 116 SER C 31 SER.? 11.23 CA CA C1184 I 140 TYR D 5 TYR~? 13.80 CA CA C1181 I 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 11.78 90.82 7.18 12.84 88.72 7.93 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 16.78 87.76 12.19 16.39 88.69 9.59 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 13.67 93.83 12.65 17.08 93.94 8.58 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 I 116 SER C 32 SER~? 5.57 CA CA C1184 I 140 TYR D 5 TYR~? 13.80 CA CA C1181 I 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 11.78 90.82 7.18 12.84 88.72 7.93 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 16.78 87.76 12.19 16.39 88.69 9.59 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 13.67 93.83 12.65 17.08 93.94 8.58 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 I 116 SER C 172 SER~? 11.19 CA CA C1181 I 140 TYR C 175 TYR~? 10.79 CA CA C1181 I 144 LYS C 177 LYS.? 13.52 CA CA C1181 coo 11.78 90.82 7.18 12.84 88.72 7.93 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 16.78 87.76 12.19 16.39 88.69 9.59 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 13.67 93.83 12.65 17.08 93.94 8.58 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 I 116 SER D 172 SER~? 19.02 O3 GOL D1181 I 140 TYR D 175 TYR.? 24.43 OXT ACT A1182 I 144 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 11.78 90.82 7.18 12.84 88.72 7.93 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 16.78 87.76 12.19 16.39 88.69 9.59 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 13.67 93.83 12.65 17.08 93.94 8.58 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 9 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER A 172 SER~? 20.14 OXT ACT A1181 J 140 TYR A 175 TYR~? 24.50 O ACT A1182 J 144 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER B 31 SER~? 8.40 O1 GOL B1182 J 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 J 144 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 J 116 SER B 31 SER~? 8.40 O1 GOL B1182 J 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 J 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 J 116 SER B 32 SER~? 5.72 CA CA B1183 J 140 TYR A 5 TYR~? 13.40 O1 GOL B1182 J 144 LYS B 35 LYS~? 11.04 CA CA B1183 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 J 116 SER B 172 SER~? 11.09 CA CA B1181 J 140 TYR B 175 TYR~? 10.51 CA CA B1181 J 144 LYS B 177 LYS.? 12.69 CA CA B1181 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 J 116 SER C 31 SER.? 11.23 CA CA C1184 J 140 TYR D 5 TYR~? 13.80 CA CA C1181 J 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 J 116 SER C 32 SER~? 5.57 CA CA C1184 J 140 TYR D 5 TYR~? 13.80 CA CA C1181 J 144 LYS C 35 LYS~? 10.20 CA CA C1184 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 J 116 SER C 172 SER~? 11.19 CA CA C1181 J 140 TYR C 175 TYR~? 10.79 CA CA C1181 J 144 LYS C 177 LYS.? 13.52 CA CA C1181 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 J 116 SER D 172 SER~? 19.02 O3 GOL D1181 J 140 TYR D 175 TYR.? 24.43 OXT ACT A1182 J 144 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 9 hits 1eq2_c09 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 40 THR~? 17.59 CH3 ACT A1182 A 159 LYS A 35 LYS~? 23.91 O ACT A1181 A 193 GLU A 29 GLU~? 11.10 O ACT A1181 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -23.93 10.90 -0.33 -25.94 11.33 0.34 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -32.63 23.57 -6.21 -33.51 24.93 -4.84 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 125 THR~? 19.90 OXT ACT A1182 A 159 LYS A 142 LYS.? 21.46 CH3 ACT A1182 A 193 GLU A 139 GLU.? 21.64 O ACT A1181 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -27.86 19.04 18.16 -27.51 19.22 20.30 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -25.15 24.34 9.11 -21.81 19.66 9.96 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -34.64 27.04 8.52 -35.38 28.56 9.82 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR B 40 THR~? 13.23 O2 GOL B1182 A 159 LYS B 35 LYS~? 11.04 CA CA B1183 A 193 GLU B 143 GLU.? -7.19 CA CA B1183s coo -2.58 16.31 54.79 -4.02 14.93 55.64 -66.85 8.08 -2.24 -64.82 7.37 -2.52 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -68.46 9.78 -10.58 -72.55 6.75 -11.95 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -68.55 -1.90 -14.29 -70.34 -1.88 -15.47 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR C 40 THR~? 15.04 CA CA C1184 A 159 LYS C 35 LYS~? 10.20 CA CA C1184 A 193 GLU C 143 GLU.? 3.32 CA CA C1184s coo -2.58 16.31 54.79 -4.02 14.93 55.64 -66.85 -8.05 28.72 -64.85 -7.34 28.99 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -68.45 -9.84 37.00 -72.38 -5.53 38.73 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -67.43 0.61 42.53 -66.07 0.84 44.19 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR D 40 THR~? 17.62 CH3 ACT A1182 A 159 LYS D 35 LYS~? 23.81 O2 GOL D1181 A 193 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -23.95 -10.93 26.82 -25.97 -11.31 26.17 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -32.61 -23.54 32.68 -33.42 -24.92 31.28 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR D 125 THR~? 20.00 O ACT A1182 A 159 LYS D 142 LYS.? 24.20 CH3 ACT A1182 A 193 GLU D 139 GLU.? 21.84 O2 GOL D1181 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -27.89 -19.06 8.30 -27.52 -19.27 6.15 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -25.06 -24.88 17.65 -21.32 -22.55 15.38 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -34.44 -26.82 17.86 -34.96 -28.12 16.26 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 6 hits 1et0_c02 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 29 GLU~? 11.10 O ACT A1181 A 260 ARG A 58 ARG~? 14.46 O ACT A1181 A 270 LYS A 149 LYS.? 8.87 O ACT A1181 coo 50.99 29.43 12.86 52.11 29.45 14.65 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 39.80 27.50 22.98 42.20 26.56 21.34 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 48.83 21.70 19.50 47.44 24.99 15.25 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 29 GLU~? 11.10 O ACT A1181 A 260 ARG A 58 ARG~? 14.46 O ACT A1181 A 270 LYS A 158 LYS~? -4.64 O ACT A1181s coo 50.99 29.43 12.86 52.11 29.45 14.65 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 39.80 27.50 22.98 42.20 26.56 21.34 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 48.83 21.70 19.50 47.44 24.99 15.25 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU A 139 GLU.? 21.64 O ACT A1181 A 260 ARG A 58 ARG~? 14.46 O ACT A1181 A 270 LYS A 149 LYS.? 8.87 O ACT A1181 coo 50.99 29.43 12.86 52.11 29.45 14.65 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 39.80 27.50 22.98 42.20 26.56 21.34 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 48.83 21.70 19.50 47.44 24.99 15.25 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU B 17 GLU~? -13.09 CH3 ACT A1181s A 260 ARG A 30 ARG.? 15.23 O ACT A1181 A 270 LYS B 9 LYS~? 18.37 O ACT A1181 coo 50.99 29.43 12.86 52.11 29.45 14.65 -38.08 19.88 -20.29 -36.49 20.35 -21.57 coo 39.80 27.50 22.98 42.20 26.56 21.34 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo 48.83 21.70 19.50 47.44 24.99 15.25 -27.67 18.71 -15.51 -26.70 22.99 -17.12 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU B 139 GLU.? 13.29 O3 GOL B1182 A 260 ARG B 58 ARG~? 12.97 O3 GOL B1182 A 270 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 50.99 29.43 12.86 52.11 29.45 14.65 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 39.80 27.50 22.98 42.20 26.56 21.34 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 48.83 21.70 19.50 47.44 24.99 15.25 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU C 17 GLU~? 3.68 CA CA C1182s A 260 ARG D 30 ARG.? 11.01 CA CA C1182 A 270 LYS C 9 LYS~? 14.61 CA CA C1182 coo 50.99 29.43 12.86 52.11 29.45 14.65 -38.10 -19.90 46.72 -36.47 -20.40 47.99 coo 39.80 27.50 22.98 42.20 26.56 21.34 -29.54 -28.66 35.64 -30.45 -28.64 38.59 coo 48.83 21.70 19.50 47.44 24.99 15.25 -27.74 -18.74 41.99 -22.99 -22.90 41.19 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU C 139 GLU.? 13.61 CA CA C1184 A 260 ARG C 58 ARG~? 18.42 O3 GOL D1181 A 270 LYS C 149 LYS.? 9.01 CA CA C1184 coo 50.99 29.43 12.86 52.11 29.45 14.65 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 39.80 27.50 22.98 42.20 26.56 21.34 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 48.83 21.70 19.50 47.44 24.99 15.25 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 8 3 # 8 A 34 GLU D 29 GLU~? 11.05 O2 GOL D1181 A 260 ARG D 58 ARG~? 14.52 O2 GOL D1181 A 270 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 50.99 29.43 12.86 52.11 29.45 14.65 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo 39.80 27.50 22.98 42.20 26.56 21.34 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 48.83 21.70 19.50 47.44 24.99 15.25 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 9 3 # 9 A 34 GLU D 29 GLU~? 11.05 O2 GOL D1181 A 260 ARG D 58 ARG~? 14.52 O2 GOL D1181 A 270 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 50.99 29.43 12.86 52.11 29.45 14.65 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo 39.80 27.50 22.98 42.20 26.56 21.34 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 48.83 21.70 19.50 47.44 24.99 15.25 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 10 3 # 10 A 34 GLU D 139 GLU.? 21.84 O2 GOL D1181 A 260 ARG D 58 ARG~? 14.52 O2 GOL D1181 A 270 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 50.99 29.43 12.86 52.11 29.45 14.65 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 39.80 27.50 22.98 42.20 26.56 21.34 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 48.83 21.70 19.50 47.44 24.99 15.25 -40.00 -25.59 26.00 -40.81 -29.12 24.35 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 10 hits 1euy_c00 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 14 ASP~? 14.99 CH3 ACT A1181 C 117 GLU A 10 GLU~? 17.55 CA CA B1181 C 131 GLU A 17 GLU~? 13.61 CH3 ACT A1181 coo 68.01 56.37 72.57 68.42 56.10 70.51 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 66.59 62.50 67.44 67.57 60.64 67.12 -63.89 24.62 -14.30 -65.11 25.98 -13.14 coo 69.24 52.27 71.96 69.91 50.26 71.89 -53.17 23.87 -17.57 -54.60 25.28 -18.31 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 3 # 2 C 95 ASP A 55 ASP.? 17.41 O ACT A1181 C 117 GLU A 150 GLU.? 17.29 O ACT A1181 C 131 GLU A 119 GLU.? 19.75 OXT ACT A1182 coo 68.01 56.37 72.57 68.42 56.10 70.51 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 66.59 62.50 67.44 67.57 60.64 67.12 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 69.24 52.27 71.96 69.91 50.26 71.89 -40.83 18.78 13.92 -42.39 17.53 13.21 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 3 3 # 3 C 95 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 117 GLU B 150 GLU.? 13.13 O3 GOL B1182 C 131 GLU B 119 GLU.? 18.74 O3 GOL B1182 coo 68.01 56.37 72.57 68.42 56.10 70.51 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 66.59 62.50 67.44 67.57 60.64 67.12 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 69.24 52.27 71.96 69.91 50.26 71.89 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 4 3 # 4 C 95 ASP C 55 ASP.? 19.45 CA CA C1184 C 117 GLU C 150 GLU.? 16.95 CA CA C1184 C 131 GLU C 119 GLU.? 19.60 OXT ACT C1183 coo 68.01 56.37 72.57 68.42 56.10 70.51 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 66.59 62.50 67.44 67.57 60.64 67.12 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 69.24 52.27 71.96 69.91 50.26 71.89 -49.67 7.91 30.13 -48.14 6.69 29.28 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 5 3 # 5 C 95 ASP D 14 ASP~? 14.81 O1 GOL D1181 C 117 GLU C 27 GLU~? 15.61 O1 GOL D1181 C 131 GLU D 10 GLU~? 18.53 CA CA C1181 coo 68.01 56.37 72.57 68.42 56.10 70.51 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 66.59 62.50 67.44 67.57 60.64 67.12 -57.81 -18.31 46.30 -57.05 -20.28 46.55 coo 69.24 52.27 71.96 69.91 50.26 71.89 -62.08 -25.49 39.96 -63.41 -27.01 39.21 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 6 3 # 6 C 95 ASP D 14 ASP~? 14.81 O1 GOL D1181 C 117 GLU D 17 GLU~? 13.36 O1 GOL D1181 C 131 GLU D 10 GLU~? 18.53 CA CA C1181 coo 68.01 56.37 72.57 68.42 56.10 70.51 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 66.59 62.50 67.44 67.57 60.64 67.12 -53.10 -23.91 44.12 -54.66 -25.27 44.77 coo 69.24 52.27 71.96 69.91 50.26 71.89 -62.08 -25.49 39.96 -63.41 -27.01 39.21 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 7 3 # 7 C 95 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 117 GLU D 150 GLU.? 17.20 O2 GOL D1181 C 131 GLU D 119 GLU.? 19.65 O ACT A1182 coo 68.01 56.37 72.57 68.42 56.10 70.51 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 66.59 62.50 67.44 67.57 60.64 67.12 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 69.24 52.27 71.96 69.91 50.26 71.89 -40.78 -18.80 12.54 -42.26 -17.44 13.18 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 7 hits 1f6d_c02 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 59 HIS~? 15.34 OXT ACT A1182 C 62 LYS A 93 LYS.? 11.72 OXT ACT A1182 F 35 ASP A 55 ASP.? 17.41 O ACT A1181 coo 15.40 22.79 16.66 13.93 24.10 15.98 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 19.95 18.98 4.81 18.82 20.94 10.49 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 16.32 15.30 17.19 17.71 14.73 18.69 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS A 114 HIS^? 15.94 OXT ACT A1182 C 62 LYS A 93 LYS.? 11.72 OXT ACT A1182 F 35 ASP A 55 ASP.? 17.41 O ACT A1181 coo 15.40 22.79 16.66 13.93 24.10 15.98 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 19.95 18.98 4.81 18.82 20.94 10.49 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 16.32 15.30 17.19 17.71 14.73 18.69 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS A 114 HIS^? 15.94 OXT ACT A1182 C 62 LYS A 149 LYS.? 8.87 O ACT A1181 F 35 ASP A 55 ASP.? 17.41 O ACT A1181 coo 15.40 22.79 16.66 13.93 24.10 15.98 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 19.95 18.98 4.81 18.82 20.94 10.49 -40.01 25.58 0.52 -39.09 27.65 -5.03 coo 16.32 15.30 17.19 17.71 14.73 18.69 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS A 151 HIS.? 15.84 O ACT A1181 C 62 LYS A 117 LYS.? 20.14 O ACT A1181 F 35 ASP A 152 ASP.? 5.90 O ACT A1181 coo 15.40 22.79 16.66 13.93 24.10 15.98 -46.06 27.03 4.30 -45.69 27.09 6.36 coo 19.95 18.98 4.81 18.82 20.94 10.49 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 16.32 15.30 17.19 17.71 14.73 18.69 -43.60 24.63 -2.03 -43.51 24.01 -4.05 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 5 3 # 5 A 105 HIS B 114 HIS^? 14.73 O2 GOL B1182 C 62 LYS B 93 LYS.? 14.57 O ACT C1183 F 35 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 15.40 22.79 16.66 13.93 24.10 15.98 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 19.95 18.98 4.81 18.82 20.94 10.49 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 16.32 15.30 17.19 17.71 14.73 18.69 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 6 3 # 6 A 105 HIS B 114 HIS^? 14.73 O2 GOL B1182 C 62 LYS B 149 LYS.? 7.98 O3 GOL B1182 F 35 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 15.40 22.79 16.66 13.93 24.10 15.98 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 19.95 18.98 4.81 18.82 20.94 10.49 -50.82 2.31 -15.26 -51.03 5.84 -20.47 coo 16.32 15.30 17.19 17.71 14.73 18.69 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 7 3 # 7 A 105 HIS B 151 HIS.? 14.53 O3 GOL B1182 C 62 LYS B 117 LYS.? 17.47 O3 GOL B1182 F 35 ASP B 152 ASP.? 8.52 O3 GOL B1182 coo 15.40 22.79 16.66 13.93 24.10 15.98 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 19.95 18.98 4.81 18.82 20.94 10.49 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 16.32 15.30 17.19 17.71 14.73 18.69 -47.04 4.74 -15.30 -47.17 6.82 -15.76 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 8 3 # 8 A 105 HIS C 114 HIS^? 15.77 OXT ACT C1183 C 62 LYS C 93 LYS.? 19.61 OXT ACT C1183 F 35 ASP C 55 ASP.? 19.45 CA CA C1184 coo 15.40 22.79 16.66 13.93 24.10 15.98 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 19.95 18.98 4.81 18.82 20.94 10.49 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 16.32 15.30 17.19 17.71 14.73 18.69 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 9 3 # 9 A 105 HIS C 114 HIS^? 15.77 OXT ACT C1183 C 62 LYS C 149 LYS.? 9.01 CA CA C1184 F 35 ASP C 55 ASP.? 19.45 CA CA C1184 coo 15.40 22.79 16.66 13.93 24.10 15.98 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 19.95 18.98 4.81 18.82 20.94 10.49 -50.86 -2.28 41.74 -55.49 -4.16 43.55 coo 16.32 15.30 17.19 17.71 14.73 18.69 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 10 3 # 10 A 105 HIS C 151 HIS.? 19.99 CA CA C1184 C 62 LYS C 117 LYS.? 21.58 CA CA C1184 F 35 ASP C 152 ASP.? 13.45 O3 GOL D1181 coo 15.40 22.79 16.66 13.93 24.10 15.98 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 19.95 18.98 4.81 18.82 20.94 10.49 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 16.32 15.30 17.19 17.71 14.73 18.69 -47.03 -4.77 41.79 -47.13 -6.84 42.24 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 11 3 # 11 A 105 HIS D 114 HIS^? 15.97 O ACT A1182 C 62 LYS D 93 LYS.? 12.21 O ACT A1182 F 35 ASP D 55 ASP.? 17.43 O2 GOL D1181 coo 15.40 22.79 16.66 13.93 24.10 15.98 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 19.95 18.98 4.81 18.82 20.94 10.49 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 16.32 15.30 17.19 17.71 14.73 18.69 -40.72 -16.97 16.40 -41.69 -17.43 18.23 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 12 3 # 12 A 105 HIS D 114 HIS^? 15.97 O ACT A1182 C 62 LYS D 149 LYS.? 13.85 O2 GOL D1181 F 35 ASP D 55 ASP.? 17.43 O2 GOL D1181 coo 15.40 22.79 16.66 13.93 24.10 15.98 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 19.95 18.98 4.81 18.82 20.94 10.49 -40.00 -25.59 26.00 -40.81 -29.12 24.35 coo 16.32 15.30 17.19 17.71 14.73 18.69 -40.72 -16.97 16.40 -41.69 -17.43 18.23 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 13 3 # 13 A 105 HIS D 151 HIS.? 15.73 O2 GOL D1181 C 62 LYS D 117 LYS.? 19.88 O2 GOL D1181 F 35 ASP D 152 ASP.? 5.75 O2 GOL D1181 coo 15.40 22.79 16.66 13.93 24.10 15.98 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo 19.95 18.98 4.81 18.82 20.94 10.49 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 16.32 15.30 17.19 17.71 14.73 18.69 -43.59 -24.59 28.46 -43.51 -24.00 30.49 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 13 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 93 LYS.? 11.72 OXT ACT A1182 C 105 HIS A 59 HIS~? 15.34 OXT ACT A1182 D 35 ASP A 55 ASP.? 17.41 O ACT A1181 coo 38.76 28.25 7.87 36.33 26.41 13.58 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 34.93 19.72 17.37 34.72 18.17 15.98 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 41.01 23.02 20.83 40.65 24.26 22.55 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS A 93 LYS.? 11.72 OXT ACT A1182 C 105 HIS A 114 HIS^? 15.94 OXT ACT A1182 D 35 ASP A 55 ASP.? 17.41 O ACT A1181 coo 38.76 28.25 7.87 36.33 26.41 13.58 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 34.93 19.72 17.37 34.72 18.17 15.98 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 41.01 23.02 20.83 40.65 24.26 22.55 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS A 117 LYS.? 20.14 O ACT A1181 C 105 HIS A 151 HIS.? 15.84 O ACT A1181 D 35 ASP A 152 ASP.? 5.90 O ACT A1181 coo 38.76 28.25 7.87 36.33 26.41 13.58 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 34.93 19.72 17.37 34.72 18.17 15.98 -46.06 27.03 4.30 -45.69 27.09 6.36 coo 41.01 23.02 20.83 40.65 24.26 22.55 -43.60 24.63 -2.03 -43.51 24.01 -4.05 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS A 149 LYS.? 8.87 O ACT A1181 C 105 HIS A 114 HIS^? 15.94 OXT ACT A1182 D 35 ASP A 55 ASP.? 17.41 O ACT A1181 coo 38.76 28.25 7.87 36.33 26.41 13.58 -40.01 25.58 0.52 -39.09 27.65 -5.03 coo 34.93 19.72 17.37 34.72 18.17 15.98 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 41.01 23.02 20.83 40.65 24.26 22.55 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 5 3 # 5 B 62 LYS B 93 LYS.? 14.57 O ACT C1183 C 105 HIS B 114 HIS^? 14.73 O2 GOL B1182 D 35 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 38.76 28.25 7.87 36.33 26.41 13.58 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 34.93 19.72 17.37 34.72 18.17 15.98 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 41.01 23.02 20.83 40.65 24.26 22.55 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 6 3 # 6 B 62 LYS B 117 LYS.? 17.47 O3 GOL B1182 C 105 HIS B 151 HIS.? 14.53 O3 GOL B1182 D 35 ASP B 152 ASP.? 8.52 O3 GOL B1182 coo 38.76 28.25 7.87 36.33 26.41 13.58 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 34.93 19.72 17.37 34.72 18.17 15.98 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 41.01 23.02 20.83 40.65 24.26 22.55 -47.04 4.74 -15.30 -47.17 6.82 -15.76 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 7 3 # 7 B 62 LYS B 149 LYS.? 7.98 O3 GOL B1182 C 105 HIS B 114 HIS^? 14.73 O2 GOL B1182 D 35 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 38.76 28.25 7.87 36.33 26.41 13.58 -50.82 2.31 -15.26 -51.03 5.84 -20.47 coo 34.93 19.72 17.37 34.72 18.17 15.98 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 41.01 23.02 20.83 40.65 24.26 22.55 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 8 3 # 8 B 62 LYS C 93 LYS.? 19.61 OXT ACT C1183 C 105 HIS C 114 HIS^? 15.77 OXT ACT C1183 D 35 ASP C 55 ASP.? 19.45 CA CA C1184 coo 38.76 28.25 7.87 36.33 26.41 13.58 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 34.93 19.72 17.37 34.72 18.17 15.98 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 41.01 23.02 20.83 40.65 24.26 22.55 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 9 3 # 9 B 62 LYS C 117 LYS.? 21.58 CA CA C1184 C 105 HIS C 151 HIS.? 19.99 CA CA C1184 D 35 ASP C 152 ASP.? 13.45 O3 GOL D1181 coo 38.76 28.25 7.87 36.33 26.41 13.58 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 34.93 19.72 17.37 34.72 18.17 15.98 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 41.01 23.02 20.83 40.65 24.26 22.55 -47.03 -4.77 41.79 -47.13 -6.84 42.24 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 10 3 # 10 B 62 LYS C 149 LYS.? 9.01 CA CA C1184 C 105 HIS C 114 HIS^? 15.77 OXT ACT C1183 D 35 ASP C 55 ASP.? 19.45 CA CA C1184 coo 38.76 28.25 7.87 36.33 26.41 13.58 -50.86 -2.28 41.74 -55.49 -4.16 43.55 coo 34.93 19.72 17.37 34.72 18.17 15.98 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 41.01 23.02 20.83 40.65 24.26 22.55 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 11 3 # 11 B 62 LYS D 93 LYS.? 12.21 O ACT A1182 C 105 HIS D 114 HIS^? 15.97 O ACT A1182 D 35 ASP D 55 ASP.? 17.43 O2 GOL D1181 coo 38.76 28.25 7.87 36.33 26.41 13.58 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 34.93 19.72 17.37 34.72 18.17 15.98 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 41.01 23.02 20.83 40.65 24.26 22.55 -40.72 -16.97 16.40 -41.69 -17.43 18.23 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 12 3 # 12 B 62 LYS D 117 LYS.? 19.88 O2 GOL D1181 C 105 HIS D 151 HIS.? 15.73 O2 GOL D1181 D 35 ASP D 152 ASP.? 5.75 O2 GOL D1181 coo 38.76 28.25 7.87 36.33 26.41 13.58 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 34.93 19.72 17.37 34.72 18.17 15.98 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo 41.01 23.02 20.83 40.65 24.26 22.55 -43.59 -24.59 28.46 -43.51 -24.00 30.49 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 13 3 # 13 B 62 LYS D 149 LYS.? 13.85 O2 GOL D1181 C 105 HIS D 114 HIS^? 15.97 O ACT A1182 D 35 ASP D 55 ASP.? 17.43 O2 GOL D1181 coo 38.76 28.25 7.87 36.33 26.41 13.58 -40.00 -25.59 26.00 -40.81 -29.12 24.35 coo 34.93 19.72 17.37 34.72 18.17 15.98 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 41.01 23.02 20.83 40.65 24.26 22.55 -40.72 -16.97 16.40 -41.69 -17.43 18.23 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 13 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 93 LYS.? 11.72 OXT ACT A1182 B 105 HIS A 59 HIS~? 15.34 OXT ACT A1182 E 35 ASP A 55 ASP.? 17.41 O ACT A1181 coo 20.51 39.76 8.83 21.23 37.38 14.18 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 27.18 37.56 20.68 29.07 38.28 20.13 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 19.97 40.39 22.03 18.53 39.30 23.18 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS A 93 LYS.? 11.72 OXT ACT A1182 B 105 HIS A 114 HIS^? 15.94 OXT ACT A1182 E 35 ASP A 55 ASP.? 17.41 O ACT A1181 coo 20.51 39.76 8.83 21.23 37.38 14.18 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 27.18 37.56 20.68 29.07 38.28 20.13 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 19.97 40.39 22.03 18.53 39.30 23.18 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS A 149 LYS.? 8.87 O ACT A1181 B 105 HIS A 114 HIS^? 15.94 OXT ACT A1182 E 35 ASP A 55 ASP.? 17.41 O ACT A1181 coo 20.51 39.76 8.83 21.23 37.38 14.18 -40.01 25.58 0.52 -39.09 27.65 -5.03 coo 27.18 37.56 20.68 29.07 38.28 20.13 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 19.97 40.39 22.03 18.53 39.30 23.18 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 4 3 # 4 A 62 LYS B 93 LYS.? 14.57 O ACT C1183 B 105 HIS B 59 HIS~? 15.18 O ACT C1183 E 35 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 20.51 39.76 8.83 21.23 37.38 14.18 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 27.18 37.56 20.68 29.07 38.28 20.13 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 19.97 40.39 22.03 18.53 39.30 23.18 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 5 3 # 5 A 62 LYS B 93 LYS.? 14.57 O ACT C1183 B 105 HIS B 114 HIS^? 14.73 O2 GOL B1182 E 35 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 20.51 39.76 8.83 21.23 37.38 14.18 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 27.18 37.56 20.68 29.07 38.28 20.13 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 19.97 40.39 22.03 18.53 39.30 23.18 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 6 3 # 6 A 62 LYS B 149 LYS.? 7.98 O3 GOL B1182 B 105 HIS B 114 HIS^? 14.73 O2 GOL B1182 E 35 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 20.51 39.76 8.83 21.23 37.38 14.18 -50.82 2.31 -15.26 -51.03 5.84 -20.47 coo 27.18 37.56 20.68 29.07 38.28 20.13 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 19.97 40.39 22.03 18.53 39.30 23.18 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 7 3 # 7 A 62 LYS C 93 LYS.? 19.61 OXT ACT C1183 B 105 HIS C 59 HIS~? 15.17 OXT ACT C1183 E 35 ASP C 55 ASP.? 19.45 CA CA C1184 coo 20.51 39.76 8.83 21.23 37.38 14.18 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 27.18 37.56 20.68 29.07 38.28 20.13 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 19.97 40.39 22.03 18.53 39.30 23.18 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 8 3 # 8 A 62 LYS C 93 LYS.? 19.61 OXT ACT C1183 B 105 HIS C 114 HIS^? 15.77 OXT ACT C1183 E 35 ASP C 55 ASP.? 19.45 CA CA C1184 coo 20.51 39.76 8.83 21.23 37.38 14.18 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 27.18 37.56 20.68 29.07 38.28 20.13 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 19.97 40.39 22.03 18.53 39.30 23.18 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 9 3 # 9 A 62 LYS C 149 LYS.? 9.01 CA CA C1184 B 105 HIS C 114 HIS^? 15.77 OXT ACT C1183 E 35 ASP C 55 ASP.? 19.45 CA CA C1184 coo 20.51 39.76 8.83 21.23 37.38 14.18 -50.86 -2.28 41.74 -55.49 -4.16 43.55 coo 27.18 37.56 20.68 29.07 38.28 20.13 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 19.97 40.39 22.03 18.53 39.30 23.18 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 10 3 # 10 A 62 LYS D 93 LYS.? 12.21 O ACT A1182 B 105 HIS D 114 HIS^? 15.97 O ACT A1182 E 35 ASP D 55 ASP.? 17.43 O2 GOL D1181 coo 20.51 39.76 8.83 21.23 37.38 14.18 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 27.18 37.56 20.68 29.07 38.28 20.13 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 19.97 40.39 22.03 18.53 39.30 23.18 -40.72 -16.97 16.40 -41.69 -17.43 18.23 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 11 3 # 11 A 62 LYS D 149 LYS.? 13.85 O2 GOL D1181 B 105 HIS D 114 HIS^? 15.97 O ACT A1182 E 35 ASP D 55 ASP.? 17.43 O2 GOL D1181 coo 20.51 39.76 8.83 21.23 37.38 14.18 -40.00 -25.59 26.00 -40.81 -29.12 24.35 coo 27.18 37.56 20.68 29.07 38.28 20.13 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 19.97 40.39 22.03 18.53 39.30 23.18 -40.72 -16.97 16.40 -41.69 -17.43 18.23 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 11 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 11 PHE~? 14.32 C1 GOL B1182 A 210 ASP A 6 ASP~? 16.17 CA CA B1181 A 244 LYS B 35 LYS~? 11.04 CA CA B1183 coo 9.23 46.77 25.11 11.48 48.39 24.76 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 10.51 37.86 19.71 9.07 39.38 20.04 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo -1.20 42.34 17.67 3.19 45.13 19.06 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 11 PHE~? 14.32 C1 GOL B1182 A 210 ASP A 6 ASP~? 16.17 CA CA B1181 A 244 LYS B 177 LYS.? 12.69 CA CA B1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 10.51 37.86 19.71 9.07 39.38 20.04 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo -1.20 42.34 17.67 3.19 45.13 19.06 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 18 PHE~? 7.18 CH3 ACT A1181 A 210 ASP A 152 ASP.? 5.90 O ACT A1181 A 244 LYS B 164 LYS~? 10.34 O ACT A1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -49.53 25.29 -10.30 -47.93 26.67 -8.41 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 210 ASP A 55 ASP.? 17.41 O ACT A1181 A 244 LYS A 149 LYS.? 8.87 O ACT A1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 10.51 37.86 19.71 9.07 39.38 20.04 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE A 85 PHE.? 8.27 OXT ACT A1182 A 210 ASP A 55 ASP.? 17.41 O ACT A1181 A 244 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 9.23 46.77 25.11 11.48 48.39 24.76 -32.11 8.47 13.22 -30.83 9.73 15.38 coo 10.51 37.86 19.71 9.07 39.38 20.04 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE A 134 PHE^? 18.18 O ACT A1181 A 210 ASP A 144 ASP.? 22.46 O ACT A1181 A 244 LYS A 130 LYS.? 19.75 CH3 ACT A1182 coo 9.23 46.77 25.11 11.48 48.39 24.76 -28.37 13.63 1.61 -29.29 13.61 -1.07 coo 10.51 37.86 19.71 9.07 39.38 20.04 -24.09 23.13 1.13 -22.88 24.73 0.42 coo -1.20 42.34 17.67 3.19 45.13 19.06 -19.41 16.20 13.18 -20.24 16.85 17.21 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE A 163 PHE~? 15.05 OXT ACT A1181 A 210 ASP A 156 ASP~? 10.59 O ACT A1181 A 244 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 9.23 46.77 25.11 11.48 48.39 24.76 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo 10.51 37.86 19.71 9.07 39.38 20.04 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -1.20 42.34 17.67 3.19 45.13 19.06 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE B 11 PHE~? 13.58 OXT ACT A1181 A 210 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 244 LYS A 35 LYS~? 23.91 O ACT A1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 10.51 37.86 19.71 9.07 39.38 20.04 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE B 11 PHE~? 13.58 OXT ACT A1181 A 210 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 244 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 10.51 37.86 19.71 9.07 39.38 20.04 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE B 18 PHE~? 12.22 OXT ACT A1181 A 210 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 244 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -41.22 12.14 -19.23 -42.79 9.87 -19.80 coo 10.51 37.86 19.71 9.07 39.38 20.04 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -1.20 42.34 17.67 3.19 45.13 19.06 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 210 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 244 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 9.23 46.77 25.11 11.48 48.39 24.76 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 10.51 37.86 19.71 9.07 39.38 20.04 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -1.20 42.34 17.67 3.19 45.13 19.06 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE B 90 PHE.? 6.30 O ACT C1183 A 210 ASP B 95 ASP.? 16.79 O ACT C1183 A 244 LYS B 124 LYS~? 15.51 CA CA B1183 coo 9.23 46.77 25.11 11.48 48.39 24.76 -61.00 -7.10 11.28 -61.80 -6.20 13.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo -1.20 42.34 17.67 3.19 45.13 19.06 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE B 134 PHE^? 10.29 O2 GOL B1182 A 210 ASP B 144 ASP.? 6.66 CA CA B1183 A 244 LYS B 130 LYS.? 19.82 CH3 ACT C1183 coo 9.23 46.77 25.11 11.48 48.39 24.76 -62.26 5.34 -3.80 -61.37 7.78 -4.90 coo 10.51 37.86 19.71 9.07 39.38 20.04 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo -1.20 42.34 17.67 3.19 45.13 19.06 -71.06 -6.27 -2.00 -70.24 -10.95 -0.22 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 112 PHE B 163 PHE~? 14.45 C3 GOL B1182 A 210 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 244 LYS A 158 LYS~? -4.64 O ACT A1181s coo 9.23 46.77 25.11 11.48 48.39 24.76 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 A 112 PHE C 11 PHE~? 12.63 O3 GOL D1181 A 210 ASP C 6 ASP~? 17.85 CA CA C1182 A 244 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 10.51 37.86 19.71 9.07 39.38 20.04 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo -1.20 42.34 17.67 3.19 45.13 19.06 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 A 112 PHE C 11 PHE~? 12.63 O3 GOL D1181 A 210 ASP C 6 ASP~? 17.85 CA CA C1182 A 244 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 10.51 37.86 19.71 9.07 39.38 20.04 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo -1.20 42.34 17.67 3.19 45.13 19.06 -22.65 -4.76 42.92 -27.69 -1.89 42.71 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 A 112 PHE C 18 PHE~? 12.17 O3 GOL D1181 A 210 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 244 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -41.21 -12.14 45.70 -42.78 -9.88 46.28 coo 10.51 37.86 19.71 9.07 39.38 20.04 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 A 112 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 210 ASP C 55 ASP.? 19.45 CA CA C1184 A 244 LYS C 149 LYS.? 9.01 CA CA C1184 coo 9.23 46.77 25.11 11.48 48.39 24.76 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 10.51 37.86 19.71 9.07 39.38 20.04 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -1.20 42.34 17.67 3.19 45.13 19.06 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 A 112 PHE C 90 PHE.? 6.24 OXT ACT C1183 A 210 ASP C 95 ASP~? 18.98 OXT ACT C1183 A 244 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 9.23 46.77 25.11 11.48 48.39 24.76 -61.01 7.09 15.23 -61.82 6.22 12.71 coo 10.51 37.86 19.71 9.07 39.38 20.04 -60.88 17.87 20.49 -62.76 18.57 19.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 A 112 PHE C 90 PHE.? 6.24 OXT ACT C1183 A 210 ASP C 95 ASP~? 18.98 OXT ACT C1183 A 244 LYS C 124 LYS~? 15.99 CA CA C1184 coo 9.23 46.77 25.11 11.48 48.39 24.76 -61.01 7.09 15.23 -61.82 6.22 12.71 coo 10.51 37.86 19.71 9.07 39.38 20.04 -60.88 17.87 20.49 -62.76 18.57 19.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 A 112 PHE C 134 PHE^? 13.25 CA CA C1184 A 210 ASP C 144 ASP.? 6.69 CA CA C1184 A 244 LYS C 130 LYS.? 19.26 CH3 ACT C1183 coo 9.23 46.77 25.11 11.48 48.39 24.76 -62.23 -5.37 30.24 -61.37 -7.83 31.34 coo 10.51 37.86 19.71 9.07 39.38 20.04 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo -1.20 42.34 17.67 3.19 45.13 19.06 -71.03 6.26 28.36 -70.68 9.47 26.70 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 A 112 PHE C 163 PHE~? 16.31 C1 GOL D1181 A 210 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 244 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 9.23 46.77 25.11 11.48 48.39 24.76 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo 10.51 37.86 19.71 9.07 39.38 20.04 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 A 112 PHE D 11 PHE~? 14.07 C1 GOL D1181 A 210 ASP D 6 ASP~? 16.12 CA CA C1181 A 244 LYS C 35 LYS~? 10.20 CA CA C1184 coo 9.23 46.77 25.11 11.48 48.39 24.76 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 10.51 37.86 19.71 9.07 39.38 20.04 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo -1.20 42.34 17.67 3.19 45.13 19.06 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 A 112 PHE D 11 PHE~? 14.07 C1 GOL D1181 A 210 ASP D 6 ASP~? 16.12 CA CA C1181 A 244 LYS C 177 LYS.? 13.52 CA CA C1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 10.51 37.86 19.71 9.07 39.38 20.04 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo -1.20 42.34 17.67 3.19 45.13 19.06 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 A 112 PHE D 18 PHE~? 7.09 O1 GOL D1181 A 210 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 244 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -49.53 -25.28 36.78 -47.96 -26.67 34.88 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -1.20 42.34 17.67 3.19 45.13 19.06 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 A 112 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 210 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 244 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 10.51 37.86 19.71 9.07 39.38 20.04 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 27 3 # 27 A 112 PHE D 134 PHE^? 17.04 O3 GOL D1181 A 210 ASP D 144 ASP.? 22.37 O2 GOL D1181 A 244 LYS D 130 LYS.? 19.81 CH3 ACT A1182 coo 9.23 46.77 25.11 11.48 48.39 24.76 -28.39 -13.60 24.85 -29.22 -13.68 27.54 coo 10.51 37.86 19.71 9.07 39.38 20.04 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 -19.48 -16.44 13.55 -20.26 -16.74 8.72 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 28 3 # 28 A 112 PHE D 163 PHE~? 13.40 O3 GOL D1181 A 210 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 244 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 9.23 46.77 25.11 11.48 48.39 24.76 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo 10.51 37.86 19.71 9.07 39.38 20.04 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -1.20 42.34 17.67 3.19 45.13 19.06 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 28 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 11 PHE~? 14.32 C1 GOL B1182 B 210 ASP A 6 ASP~? 16.17 CA CA B1181 B 244 LYS B 35 LYS~? 11.04 CA CA B1183 coo 8.76 47.85 34.91 11.08 46.36 35.41 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 9.06 56.85 40.30 7.71 55.27 39.90 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo -2.38 51.82 41.62 2.07 49.19 40.42 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 11 PHE~? 14.32 C1 GOL B1182 B 210 ASP A 6 ASP~? 16.17 CA CA B1181 B 244 LYS B 177 LYS.? 12.69 CA CA B1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 9.06 56.85 40.30 7.71 55.27 39.90 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo -2.38 51.82 41.62 2.07 49.19 40.42 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 18 PHE~? 7.18 CH3 ACT A1181 B 210 ASP A 152 ASP.? 5.90 O ACT A1181 B 244 LYS B 164 LYS~? 10.34 O ACT A1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -49.53 25.29 -10.30 -47.93 26.67 -8.41 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -2.38 51.82 41.62 2.07 49.19 40.42 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 61 PHE~? 13.18 OXT ACT A1181 B 210 ASP A 55 ASP.? 17.41 O ACT A1181 B 244 LYS A 149 LYS.? 8.87 O ACT A1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 9.06 56.85 40.30 7.71 55.27 39.90 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE A 85 PHE.? 8.27 OXT ACT A1182 B 210 ASP A 55 ASP.? 17.41 O ACT A1181 B 244 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 8.76 47.85 34.91 11.08 46.36 35.41 -32.11 8.47 13.22 -30.83 9.73 15.38 coo 9.06 56.85 40.30 7.71 55.27 39.90 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE A 163 PHE~? 15.05 OXT ACT A1181 B 210 ASP A 156 ASP~? 10.59 O ACT A1181 B 244 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 8.76 47.85 34.91 11.08 46.36 35.41 -36.26 8.81 -3.56 -35.28 6.20 -3.15 coo 9.06 56.85 40.30 7.71 55.27 39.90 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -2.38 51.82 41.62 2.07 49.19 40.42 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE B 11 PHE~? 13.58 OXT ACT A1181 B 210 ASP B 6 ASP~? 24.59 OXT ACT A1181 B 244 LYS A 35 LYS~? 23.91 O ACT A1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 9.06 56.85 40.30 7.71 55.27 39.90 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo -2.38 51.82 41.62 2.07 49.19 40.42 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE B 11 PHE~? 13.58 OXT ACT A1181 B 210 ASP B 6 ASP~? 24.59 OXT ACT A1181 B 244 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 9.06 56.85 40.30 7.71 55.27 39.90 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo -2.38 51.82 41.62 2.07 49.19 40.42 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE B 18 PHE~? 12.22 OXT ACT A1181 B 210 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 244 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -41.22 12.14 -19.23 -42.79 9.87 -19.80 coo 9.06 56.85 40.30 7.71 55.27 39.90 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE B 61 PHE~? 12.02 O3 GOL B1182 B 210 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 244 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 8.76 47.85 34.91 11.08 46.36 35.41 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 9.06 56.85 40.30 7.71 55.27 39.90 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -2.38 51.82 41.62 2.07 49.19 40.42 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE B 90 PHE.? 6.30 O ACT C1183 B 210 ASP B 95 ASP.? 16.79 O ACT C1183 B 244 LYS B 124 LYS~? 15.51 CA CA B1183 coo 8.76 47.85 34.91 11.08 46.36 35.41 -61.00 -7.10 11.28 -61.80 -6.20 13.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo -2.38 51.82 41.62 2.07 49.19 40.42 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE B 134 PHE^? 10.29 O2 GOL B1182 B 210 ASP B 144 ASP.? 6.66 CA CA B1183 B 244 LYS B 130 LYS.? 19.82 CH3 ACT C1183 coo 8.76 47.85 34.91 11.08 46.36 35.41 -62.26 5.34 -3.80 -61.37 7.78 -4.90 coo 9.06 56.85 40.30 7.71 55.27 39.90 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo -2.38 51.82 41.62 2.07 49.19 40.42 -71.06 -6.27 -2.00 -70.24 -10.95 -0.22 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 112 PHE B 163 PHE~? 14.45 C3 GOL B1182 B 210 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 244 LYS A 158 LYS~? -4.64 O ACT A1181s coo 8.76 47.85 34.91 11.08 46.36 35.41 -54.45 12.00 -1.40 -55.38 12.66 1.16 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -2.38 51.82 41.62 2.07 49.19 40.42 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 112 PHE C 11 PHE~? 12.63 O3 GOL D1181 B 210 ASP C 6 ASP~? 17.85 CA CA C1182 B 244 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 9.06 56.85 40.30 7.71 55.27 39.90 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo -2.38 51.82 41.62 2.07 49.19 40.42 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 B 112 PHE C 11 PHE~? 12.63 O3 GOL D1181 B 210 ASP C 6 ASP~? 17.85 CA CA C1182 B 244 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 9.06 56.85 40.30 7.71 55.27 39.90 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo -2.38 51.82 41.62 2.07 49.19 40.42 -22.65 -4.76 42.92 -27.69 -1.89 42.71 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 B 112 PHE C 18 PHE~? 12.17 O3 GOL D1181 B 210 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 244 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -41.21 -12.14 45.70 -42.78 -9.88 46.28 coo 9.06 56.85 40.30 7.71 55.27 39.90 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 B 112 PHE C 61 PHE~? 15.37 O3 GOL D1181 B 210 ASP C 55 ASP.? 19.45 CA CA C1184 B 244 LYS C 149 LYS.? 9.01 CA CA C1184 coo 8.76 47.85 34.91 11.08 46.36 35.41 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 9.06 56.85 40.30 7.71 55.27 39.90 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -2.38 51.82 41.62 2.07 49.19 40.42 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 18 3 # 18 B 112 PHE C 90 PHE.? 6.24 OXT ACT C1183 B 210 ASP C 95 ASP~? 18.98 OXT ACT C1183 B 244 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 8.76 47.85 34.91 11.08 46.36 35.41 -61.01 7.09 15.23 -61.82 6.22 12.71 coo 9.06 56.85 40.30 7.71 55.27 39.90 -60.88 17.87 20.49 -62.76 18.57 19.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 19 3 # 19 B 112 PHE C 90 PHE.? 6.24 OXT ACT C1183 B 210 ASP C 95 ASP~? 18.98 OXT ACT C1183 B 244 LYS C 124 LYS~? 15.99 CA CA C1184 coo 8.76 47.85 34.91 11.08 46.36 35.41 -61.01 7.09 15.23 -61.82 6.22 12.71 coo 9.06 56.85 40.30 7.71 55.27 39.90 -60.88 17.87 20.49 -62.76 18.57 19.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 20 3 # 20 B 112 PHE C 134 PHE^? 13.25 CA CA C1184 B 210 ASP C 144 ASP.? 6.69 CA CA C1184 B 244 LYS C 130 LYS.? 19.26 CH3 ACT C1183 coo 8.76 47.85 34.91 11.08 46.36 35.41 -62.23 -5.37 30.24 -61.37 -7.83 31.34 coo 9.06 56.85 40.30 7.71 55.27 39.90 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo -2.38 51.82 41.62 2.07 49.19 40.42 -71.03 6.26 28.36 -70.68 9.47 26.70 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 21 3 # 21 B 112 PHE C 163 PHE~? 16.31 C1 GOL D1181 B 210 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 244 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 8.76 47.85 34.91 11.08 46.36 35.41 -54.46 -12.01 27.88 -55.42 -12.67 25.34 coo 9.06 56.85 40.30 7.71 55.27 39.90 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -2.38 51.82 41.62 2.07 49.19 40.42 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 22 3 # 22 B 112 PHE D 11 PHE~? 14.07 C1 GOL D1181 B 210 ASP D 6 ASP~? 16.12 CA CA C1181 B 244 LYS C 35 LYS~? 10.20 CA CA C1184 coo 8.76 47.85 34.91 11.08 46.36 35.41 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 9.06 56.85 40.30 7.71 55.27 39.90 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo -2.38 51.82 41.62 2.07 49.19 40.42 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 23 3 # 23 B 112 PHE D 11 PHE~? 14.07 C1 GOL D1181 B 210 ASP D 6 ASP~? 16.12 CA CA C1181 B 244 LYS C 177 LYS.? 13.52 CA CA C1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 9.06 56.85 40.30 7.71 55.27 39.90 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo -2.38 51.82 41.62 2.07 49.19 40.42 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 24 3 # 24 B 112 PHE D 18 PHE~? 7.09 O1 GOL D1181 B 210 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 244 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -49.53 -25.28 36.78 -47.96 -26.67 34.88 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -2.38 51.82 41.62 2.07 49.19 40.42 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 25 3 # 25 B 112 PHE D 61 PHE~? 11.72 O3 GOL D1181 B 210 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 244 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 9.06 56.85 40.30 7.71 55.27 39.90 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 26 3 # 26 B 112 PHE D 134 PHE^? 17.04 O3 GOL D1181 B 210 ASP D 144 ASP.? 22.37 O2 GOL D1181 B 244 LYS D 130 LYS.? 19.81 CH3 ACT A1182 coo 8.76 47.85 34.91 11.08 46.36 35.41 -28.39 -13.60 24.85 -29.22 -13.68 27.54 coo 9.06 56.85 40.30 7.71 55.27 39.90 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo -2.38 51.82 41.62 2.07 49.19 40.42 -19.48 -16.44 13.55 -20.26 -16.74 8.72 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 27 3 # 27 B 112 PHE D 163 PHE~? 13.40 O3 GOL D1181 B 210 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 244 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 8.76 47.85 34.91 11.08 46.36 35.41 -36.27 -8.83 30.01 -35.31 -6.24 29.63 coo 9.06 56.85 40.30 7.71 55.27 39.90 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -2.38 51.82 41.62 2.07 49.19 40.42 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 27 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 210 ASP A 55 ASP.? 17.41 O ACT A1181 A 244 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 11.28 44.53 18.60 9.91 46.00 19.20 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 10.51 37.86 19.71 9.07 39.38 20.04 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 210 ASP A 55 ASP.? 17.41 O ACT A1181 A 244 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 11.28 44.53 18.60 9.91 46.00 19.20 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 10.51 37.86 19.71 9.07 39.38 20.04 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 210 ASP A 55 ASP.? 17.41 O ACT A1181 A 244 LYS A 149 LYS.? 8.87 O ACT A1181 coo 11.28 44.53 18.60 9.91 46.00 19.20 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 10.51 37.86 19.71 9.07 39.38 20.04 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS A 151 HIS.? 15.84 O ACT A1181 A 210 ASP A 152 ASP.? 5.90 O ACT A1181 A 244 LYS A 117 LYS.? 20.14 O ACT A1181 coo 11.28 44.53 18.60 9.91 46.00 19.20 -46.06 27.03 4.30 -45.69 27.09 6.36 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 136 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 210 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 244 LYS B 93 LYS.? 14.57 O ACT C1183 coo 11.28 44.53 18.60 9.91 46.00 19.20 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 10.51 37.86 19.71 9.07 39.38 20.04 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -1.20 42.34 17.67 3.19 45.13 19.06 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 136 HIS B 151 HIS.? 14.53 O3 GOL B1182 A 210 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 244 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 11.28 44.53 18.60 9.91 46.00 19.20 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 10.51 37.86 19.71 9.07 39.38 20.04 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -1.20 42.34 17.67 3.19 45.13 19.06 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 136 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 210 ASP C 55 ASP.? 19.45 CA CA C1184 A 244 LYS C 93 LYS.? 19.61 OXT ACT C1183 coo 11.28 44.53 18.60 9.91 46.00 19.20 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 10.51 37.86 19.71 9.07 39.38 20.04 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -1.20 42.34 17.67 3.19 45.13 19.06 -54.93 14.23 21.55 -53.38 19.08 19.32 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 136 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 210 ASP C 55 ASP.? 19.45 CA CA C1184 A 244 LYS C 149 LYS.? 9.01 CA CA C1184 coo 11.28 44.53 18.60 9.91 46.00 19.20 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 10.51 37.86 19.71 9.07 39.38 20.04 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -1.20 42.34 17.67 3.19 45.13 19.06 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 136 HIS C 151 HIS.? 19.99 CA CA C1184 A 210 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 244 LYS C 117 LYS.? 21.58 CA CA C1184 coo 11.28 44.53 18.60 9.91 46.00 19.20 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 10.51 37.86 19.71 9.07 39.38 20.04 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 136 HIS D 114 HIS^? 15.97 O ACT A1182 A 210 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 244 LYS D 93 LYS.? 12.21 O ACT A1182 coo 11.28 44.53 18.60 9.91 46.00 19.20 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 10.51 37.86 19.71 9.07 39.38 20.04 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 136 HIS D 114 HIS^? 15.97 O ACT A1182 A 210 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 244 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 11.28 44.53 18.60 9.91 46.00 19.20 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 10.51 37.86 19.71 9.07 39.38 20.04 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 136 HIS D 151 HIS.? 15.73 O2 GOL D1181 A 210 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 244 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 11.28 44.53 18.60 9.91 46.00 19.20 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo 10.51 37.86 19.71 9.07 39.38 20.04 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -1.20 42.34 17.67 3.19 45.13 19.06 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 12 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 210 ASP A 55 ASP.? 17.41 O ACT A1181 B 244 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 10.08 50.18 41.78 8.91 48.61 41.04 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 9.06 56.85 40.30 7.71 55.27 39.90 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 210 ASP A 55 ASP.? 17.41 O ACT A1181 B 244 LYS A 149 LYS.? 8.87 O ACT A1181 coo 10.08 50.18 41.78 8.91 48.61 41.04 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 9.06 56.85 40.30 7.71 55.27 39.90 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS A 151 HIS.? 15.84 O ACT A1181 B 210 ASP A 152 ASP.? 5.90 O ACT A1181 B 244 LYS A 117 LYS.? 20.14 O ACT A1181 coo 10.08 50.18 41.78 8.91 48.61 41.04 -46.06 27.03 4.30 -45.69 27.09 6.36 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 136 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 210 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 244 LYS B 93 LYS.? 14.57 O ACT C1183 coo 10.08 50.18 41.78 8.91 48.61 41.04 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 9.06 56.85 40.30 7.71 55.27 39.90 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -2.38 51.82 41.62 2.07 49.19 40.42 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 136 HIS B 151 HIS.? 14.53 O3 GOL B1182 B 210 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 244 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 10.08 50.18 41.78 8.91 48.61 41.04 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 9.06 56.85 40.30 7.71 55.27 39.90 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -2.38 51.82 41.62 2.07 49.19 40.42 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 136 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 210 ASP C 55 ASP.? 19.45 CA CA C1184 B 244 LYS C 93 LYS.? 19.61 OXT ACT C1183 coo 10.08 50.18 41.78 8.91 48.61 41.04 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 9.06 56.85 40.30 7.71 55.27 39.90 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -2.38 51.82 41.62 2.07 49.19 40.42 -54.93 14.23 21.55 -53.38 19.08 19.32 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 136 HIS C 151 HIS.? 19.99 CA CA C1184 B 210 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 244 LYS C 117 LYS.? 21.58 CA CA C1184 coo 10.08 50.18 41.78 8.91 48.61 41.04 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 9.06 56.85 40.30 7.71 55.27 39.90 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 136 HIS D 114 HIS^? 15.97 O ACT A1182 B 210 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 244 LYS D 93 LYS.? 12.21 O ACT A1182 coo 10.08 50.18 41.78 8.91 48.61 41.04 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 9.06 56.85 40.30 7.71 55.27 39.90 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 136 HIS D 151 HIS.? 15.73 O2 GOL D1181 B 210 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 244 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 10.08 50.18 41.78 8.91 48.61 41.04 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo 9.06 56.85 40.30 7.71 55.27 39.90 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -2.38 51.82 41.62 2.07 49.19 40.42 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 9 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 33 TYR~? 13.22 O ACT A1181 A 142 LEU A 147 LEU^? 15.19 O ACT A1181 A 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -32.90 25.17 0.16 -32.14 26.51 1.66 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 33 TYR~? 13.22 O ACT A1181 A 142 LEU A 162 LEU~? 9.74 O ACT A1181 A 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -35.38 15.50 -4.49 -35.01 17.64 -4.54 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR A 33 TYR~? 13.22 O ACT A1181 A 142 LEU A 165 LEU~? 12.03 OXT ACT A1181 A 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -32.81 13.49 -8.77 -31.34 14.80 -9.66 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR A 157 TYR~? 5.66 OXT ACT A1181 A 142 LEU B 154 LEU~? 9.57 OXT ACT A1181 A 165 LYS A 158 LYS~? -4.64 O ACT A1181s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -45.25 9.80 -14.25 -43.98 11.23 -15.30 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR A 157 TYR~? 5.66 OXT ACT A1181 A 142 LEU B 159 LEU~? 9.18 O3 GOL B1182 A 165 LYS A 158 LYS~? -4.64 O ACT A1181s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -50.12 7.79 -6.19 -50.39 5.62 -6.50 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR A 175 TYR~? 24.50 O ACT A1182 A 142 LEU A 170 LEU~? 19.30 O ACT A1182 A 165 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -27.47 5.97 -6.00 -26.81 4.66 -4.41 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s A 142 LEU B 147 LEU^? -4.90 O2 GOL B1182s A 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -57.70 1.88 -14.83 -58.68 0.02 -15.15 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 A 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s A 142 LEU B 162 LEU~? 5.46 C3 GOL B1182 A 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -55.25 10.28 -7.94 -55.75 9.53 -9.90 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 A 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s A 142 LEU B 165 LEU~? 9.28 C1 GOL B1182 A 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -57.94 14.99 -7.70 -59.59 15.24 -9.13 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 A 137 TYR B 157 TYR~? 6.24 OXT ACT A1181 A 142 LEU A 154 LEU~? 3.93 O ACT A1181 A 165 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -45.58 21.65 -6.34 -46.95 22.06 -8.00 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 A 137 TYR B 157 TYR~? 6.24 OXT ACT A1181 A 142 LEU A 159 LEU~? 10.10 O ACT A1181 A 165 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -40.53 14.98 -1.43 -40.24 16.08 0.45 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 A 137 TYR B 175 TYR~? 10.51 CA CA B1181 A 142 LEU B 170 LEU~? 11.52 CA CA B1181 A 165 LYS B 177 LYS.? 12.69 CA CA B1181 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -65.36 23.11 4.03 -63.61 22.29 6.06 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -63.31 15.07 0.21 -63.98 13.98 1.99 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 A 137 TYR C 33 TYR~? 11.20 CA CA C1184 A 142 LEU C 147 LEU^? 5.95 CA CA C1184 A 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -57.68 -1.91 41.33 -58.71 -0.07 41.69 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 A 137 TYR C 33 TYR~? 11.20 CA CA C1184 A 142 LEU C 162 LEU~? 14.12 CA CA C1184 A 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -55.28 -10.26 34.41 -55.73 -9.48 36.37 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 A 137 TYR C 33 TYR~? 11.20 CA CA C1184 A 142 LEU C 165 LEU~? 15.02 C1 GOL D1181 A 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -57.96 -15.03 34.16 -59.58 -15.24 35.60 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 A 137 TYR C 157 TYR~? 5.26 O3 GOL D1181 A 142 LEU D 154 LEU~? -3.89 O2 GOL D1181s A 165 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -45.57 -21.64 32.82 -46.97 -22.12 34.46 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 A 137 TYR C 157 TYR~? 5.26 O3 GOL D1181 A 142 LEU D 159 LEU~? 9.28 O3 GOL D1181 A 165 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -40.54 -14.98 27.89 -40.25 -16.05 25.99 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 A 137 TYR C 175 TYR~? 10.79 CA CA C1181 A 142 LEU C 170 LEU~? 11.77 CA CA C1181 A 165 LYS C 177 LYS.? 13.52 CA CA C1181 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -63.20 -15.10 26.22 -63.88 -14.01 24.45 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 A 137 TYR D 33 TYR~? 12.91 O3 GOL D1181 A 142 LEU D 147 LEU^? 15.08 O2 GOL D1181 A 165 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -32.92 -25.16 26.24 -32.16 -26.48 24.73 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 A 137 TYR D 33 TYR~? 12.91 O3 GOL D1181 A 142 LEU D 162 LEU~? 8.64 O3 GOL D1181 A 165 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -35.40 -15.52 30.95 -35.00 -17.67 31.02 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 A 137 TYR D 33 TYR~? 12.91 O3 GOL D1181 A 142 LEU D 165 LEU~? 10.81 O3 GOL D1181 A 165 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -32.84 -13.46 35.23 -31.36 -14.76 36.14 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 A 137 TYR D 157 TYR~? -5.31 C1 GOL D1181s A 142 LEU C 154 LEU~? 9.28 O3 GOL D1181 A 165 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -45.25 -9.79 40.76 -43.93 -11.17 41.77 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 A 137 TYR D 157 TYR~? -5.31 C1 GOL D1181s A 142 LEU C 159 LEU~? 13.80 O3 GOL D1181 A 165 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -50.12 -7.78 32.65 -50.39 -5.65 32.94 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 A 137 TYR D 175 TYR.? 24.43 OXT ACT A1182 A 142 LEU D 170 LEU~? 19.27 OXT ACT A1182 A 165 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -25.75 0.70 38.70 -27.49 2.18 37.04 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -27.49 -6.00 32.43 -26.81 -4.65 30.88 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 24 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 33 TYR~? 13.22 O ACT A1181 B 142 LEU A 147 LEU^? 15.19 O ACT A1181 B 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -32.90 25.17 0.16 -32.14 26.51 1.66 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 33 TYR~? 13.22 O ACT A1181 B 142 LEU A 162 LEU~? 9.74 O ACT A1181 B 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -35.38 15.50 -4.49 -35.01 17.64 -4.54 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR A 33 TYR~? 13.22 O ACT A1181 B 142 LEU A 165 LEU~? 12.03 OXT ACT A1181 B 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -32.81 13.49 -8.77 -31.34 14.80 -9.66 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR A 91 TYR.? 11.44 OXT ACT A1182 B 142 LEU A 51 LEU^? 7.18 CH3 ACT A1182 B 165 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -29.07 7.28 10.42 -27.57 6.02 11.41 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR A 157 TYR~? 5.66 OXT ACT A1181 B 142 LEU B 154 LEU~? 9.57 OXT ACT A1181 B 165 LYS A 158 LYS~? -4.64 O ACT A1181s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -45.25 9.80 -14.25 -43.98 11.23 -15.30 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR A 157 TYR~? 5.66 OXT ACT A1181 B 142 LEU B 159 LEU~? 9.18 O3 GOL B1182 B 165 LYS A 158 LYS~? -4.64 O ACT A1181s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -50.12 7.79 -6.19 -50.39 5.62 -6.50 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 137 TYR A 175 TYR~? 24.50 O ACT A1182 B 142 LEU A 170 LEU~? 19.30 O ACT A1182 B 165 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -27.47 5.97 -6.00 -26.81 4.66 -4.41 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 B 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s B 142 LEU B 147 LEU^? -4.90 O2 GOL B1182s B 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -57.70 1.88 -14.83 -58.68 0.02 -15.15 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 B 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s B 142 LEU B 162 LEU~? 5.46 C3 GOL B1182 B 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -55.25 10.28 -7.94 -55.75 9.53 -9.90 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 B 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s B 142 LEU B 165 LEU~? 9.28 C1 GOL B1182 B 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -57.94 14.99 -7.70 -59.59 15.24 -9.13 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 B 137 TYR B 157 TYR~? 6.24 OXT ACT A1181 B 142 LEU A 154 LEU~? 3.93 O ACT A1181 B 165 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -45.58 21.65 -6.34 -46.95 22.06 -8.00 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 B 137 TYR B 157 TYR~? 6.24 OXT ACT A1181 B 142 LEU A 159 LEU~? 10.10 O ACT A1181 B 165 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -40.53 14.98 -1.43 -40.24 16.08 0.45 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 B 137 TYR B 175 TYR~? 10.51 CA CA B1181 B 142 LEU B 170 LEU~? 11.52 CA CA B1181 B 165 LYS B 177 LYS.? 12.69 CA CA B1181 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -65.36 23.11 4.03 -63.61 22.29 6.06 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -63.31 15.07 0.21 -63.98 13.98 1.99 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 B 137 TYR C 33 TYR~? 11.20 CA CA C1184 B 142 LEU C 147 LEU^? 5.95 CA CA C1184 B 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -57.68 -1.91 41.33 -58.71 -0.07 41.69 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 B 137 TYR C 33 TYR~? 11.20 CA CA C1184 B 142 LEU C 162 LEU~? 14.12 CA CA C1184 B 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -55.28 -10.26 34.41 -55.73 -9.48 36.37 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 B 137 TYR C 33 TYR~? 11.20 CA CA C1184 B 142 LEU C 165 LEU~? 15.02 C1 GOL D1181 B 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -57.96 -15.03 34.16 -59.58 -15.24 35.60 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 B 137 TYR C 157 TYR~? 5.26 O3 GOL D1181 B 142 LEU D 154 LEU~? -3.89 O2 GOL D1181s B 165 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -45.57 -21.64 32.82 -46.97 -22.12 34.46 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 B 137 TYR C 157 TYR~? 5.26 O3 GOL D1181 B 142 LEU D 159 LEU~? 9.28 O3 GOL D1181 B 165 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -40.54 -14.98 27.89 -40.25 -16.05 25.99 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 B 137 TYR C 175 TYR~? 10.79 CA CA C1181 B 142 LEU C 170 LEU~? 11.77 CA CA C1181 B 165 LYS C 177 LYS.? 13.52 CA CA C1181 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -63.20 -15.10 26.22 -63.88 -14.01 24.45 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 B 137 TYR D 33 TYR~? 12.91 O3 GOL D1181 B 142 LEU D 147 LEU^? 15.08 O2 GOL D1181 B 165 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -32.92 -25.16 26.24 -32.16 -26.48 24.73 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 B 137 TYR D 33 TYR~? 12.91 O3 GOL D1181 B 142 LEU D 162 LEU~? 8.64 O3 GOL D1181 B 165 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -35.40 -15.52 30.95 -35.00 -17.67 31.02 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 B 137 TYR D 33 TYR~? 12.91 O3 GOL D1181 B 142 LEU D 165 LEU~? 10.81 O3 GOL D1181 B 165 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -32.84 -13.46 35.23 -31.36 -14.76 36.14 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 B 137 TYR D 157 TYR~? -5.31 C1 GOL D1181s B 142 LEU C 154 LEU~? 9.28 O3 GOL D1181 B 165 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -45.25 -9.79 40.76 -43.93 -11.17 41.77 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 B 137 TYR D 157 TYR~? -5.31 C1 GOL D1181s B 142 LEU C 159 LEU~? 13.80 O3 GOL D1181 B 165 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -50.12 -7.78 32.65 -50.39 -5.65 32.94 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 25 3 # 25 B 137 TYR D 175 TYR.? 24.43 OXT ACT A1182 B 142 LEU D 170 LEU~? 19.27 OXT ACT A1182 B 165 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -25.75 0.70 38.70 -27.49 2.18 37.04 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -27.49 -6.00 32.43 -26.81 -4.65 30.88 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 25 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 33 TYR~? 13.22 O ACT A1181 C 142 LEU A 26 LEU~? 8.46 O ACT A1181 C 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -35.11 20.39 -10.59 -34.03 19.20 -9.13 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 33 TYR~? 13.22 O ACT A1181 C 142 LEU A 147 LEU^? 15.19 O ACT A1181 C 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -32.90 25.17 0.16 -32.14 26.51 1.66 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR A 33 TYR~? 13.22 O ACT A1181 C 142 LEU A 162 LEU~? 9.74 O ACT A1181 C 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -35.38 15.50 -4.49 -35.01 17.64 -4.54 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR A 33 TYR~? 13.22 O ACT A1181 C 142 LEU A 165 LEU~? 12.03 OXT ACT A1181 C 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -32.81 13.49 -8.77 -31.34 14.80 -9.66 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR A 91 TYR.? 11.44 OXT ACT A1182 C 142 LEU A 51 LEU^? 7.18 CH3 ACT A1182 C 165 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -29.07 7.28 10.42 -27.57 6.02 11.41 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 137 TYR A 157 TYR~? 5.66 OXT ACT A1181 C 142 LEU B 154 LEU~? 9.57 OXT ACT A1181 C 165 LYS A 158 LYS~? -4.64 O ACT A1181s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -45.25 9.80 -14.25 -43.98 11.23 -15.30 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 137 TYR A 157 TYR~? 5.66 OXT ACT A1181 C 142 LEU B 159 LEU~? 9.18 O3 GOL B1182 C 165 LYS A 158 LYS~? -4.64 O ACT A1181s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -50.12 7.79 -6.19 -50.39 5.62 -6.50 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 C 137 TYR A 175 TYR~? 24.50 O ACT A1182 C 142 LEU A 170 LEU~? 19.30 O ACT A1182 C 165 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -27.47 5.97 -6.00 -26.81 4.66 -4.41 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 C 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s C 142 LEU B 26 LEU~? 5.85 C1 GOL B1182 C 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -55.85 13.90 -14.75 -57.02 12.86 -13.20 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 C 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s C 142 LEU B 147 LEU^? -4.90 O2 GOL B1182s C 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -57.70 1.88 -14.83 -58.68 0.02 -15.15 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 C 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s C 142 LEU B 162 LEU~? 5.46 C3 GOL B1182 C 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -55.25 10.28 -7.94 -55.75 9.53 -9.90 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 C 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s C 142 LEU B 165 LEU~? 9.28 C1 GOL B1182 C 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -57.94 14.99 -7.70 -59.59 15.24 -9.13 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 C 137 TYR B 157 TYR~? 6.24 OXT ACT A1181 C 142 LEU A 154 LEU~? 3.93 O ACT A1181 C 165 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -45.58 21.65 -6.34 -46.95 22.06 -8.00 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 C 137 TYR B 157 TYR~? 6.24 OXT ACT A1181 C 142 LEU A 159 LEU~? 10.10 O ACT A1181 C 165 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -40.53 14.98 -1.43 -40.24 16.08 0.45 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 C 137 TYR B 175 TYR~? 10.51 CA CA B1181 C 142 LEU B 170 LEU~? 11.52 CA CA B1181 C 165 LYS B 177 LYS.? 12.69 CA CA B1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -65.36 23.11 4.03 -63.61 22.29 6.06 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -63.31 15.07 0.21 -63.98 13.98 1.99 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 C 137 TYR C 33 TYR~? 11.20 CA CA C1184 C 142 LEU C 26 LEU~? 14.05 C1 GOL D1181 C 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -55.92 -14.00 41.24 -57.21 -13.07 39.65 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 C 137 TYR C 33 TYR~? 11.20 CA CA C1184 C 142 LEU C 147 LEU^? 5.95 CA CA C1184 C 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -57.68 -1.91 41.33 -58.71 -0.07 41.69 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 C 137 TYR C 33 TYR~? 11.20 CA CA C1184 C 142 LEU C 162 LEU~? 14.12 CA CA C1184 C 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -55.28 -10.26 34.41 -55.73 -9.48 36.37 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 C 137 TYR C 33 TYR~? 11.20 CA CA C1184 C 142 LEU C 165 LEU~? 15.02 C1 GOL D1181 C 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -57.96 -15.03 34.16 -59.58 -15.24 35.60 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 C 137 TYR C 157 TYR~? 5.26 O3 GOL D1181 C 142 LEU D 154 LEU~? -3.89 O2 GOL D1181s C 165 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -45.57 -21.64 32.82 -46.97 -22.12 34.46 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 C 137 TYR C 157 TYR~? 5.26 O3 GOL D1181 C 142 LEU D 159 LEU~? 9.28 O3 GOL D1181 C 165 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -40.54 -14.98 27.89 -40.25 -16.05 25.99 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 C 137 TYR C 175 TYR~? 10.79 CA CA C1181 C 142 LEU C 170 LEU~? 11.77 CA CA C1181 C 165 LYS C 177 LYS.? 13.52 CA CA C1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -63.20 -15.10 26.22 -63.88 -14.01 24.45 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 C 137 TYR D 33 TYR~? 12.91 O3 GOL D1181 C 142 LEU D 147 LEU^? 15.08 O2 GOL D1181 C 165 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -32.92 -25.16 26.24 -32.16 -26.48 24.73 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 C 137 TYR D 33 TYR~? 12.91 O3 GOL D1181 C 142 LEU D 162 LEU~? 8.64 O3 GOL D1181 C 165 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -35.40 -15.52 30.95 -35.00 -17.67 31.02 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 25 3 # 25 C 137 TYR D 33 TYR~? 12.91 O3 GOL D1181 C 142 LEU D 165 LEU~? 10.81 O3 GOL D1181 C 165 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -32.84 -13.46 35.23 -31.36 -14.76 36.14 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 26 3 # 26 C 137 TYR D 157 TYR~? -5.31 C1 GOL D1181s C 142 LEU C 154 LEU~? 9.28 O3 GOL D1181 C 165 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -45.25 -9.79 40.76 -43.93 -11.17 41.77 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 27 3 # 27 C 137 TYR D 157 TYR~? -5.31 C1 GOL D1181s C 142 LEU C 159 LEU~? 13.80 O3 GOL D1181 C 165 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -50.12 -7.78 32.65 -50.39 -5.65 32.94 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 28 3 # 28 C 137 TYR D 175 TYR.? 24.43 OXT ACT A1182 C 142 LEU D 170 LEU~? 19.27 OXT ACT A1182 C 165 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -25.75 0.70 38.70 -27.49 2.18 37.04 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -27.49 -6.00 32.43 -26.81 -4.65 30.88 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 28 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 33 TYR~? 13.22 O ACT A1181 D 142 LEU A 147 LEU^? 15.19 O ACT A1181 D 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -32.90 25.17 0.16 -32.14 26.51 1.66 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 33 TYR~? 13.22 O ACT A1181 D 142 LEU A 162 LEU~? 9.74 O ACT A1181 D 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -35.38 15.50 -4.49 -35.01 17.64 -4.54 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR A 33 TYR~? 13.22 O ACT A1181 D 142 LEU A 165 LEU~? 12.03 OXT ACT A1181 D 165 LYS A 35 LYS~? 23.91 O ACT A1181 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -32.81 13.49 -8.77 -31.34 14.80 -9.66 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR A 91 TYR.? 11.44 OXT ACT A1182 D 142 LEU A 51 LEU^? 7.18 CH3 ACT A1182 D 165 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -29.07 7.28 10.42 -27.57 6.02 11.41 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR A 157 TYR~? 5.66 OXT ACT A1181 D 142 LEU B 154 LEU~? 9.57 OXT ACT A1181 D 165 LYS A 158 LYS~? -4.64 O ACT A1181s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -45.25 9.80 -14.25 -43.98 11.23 -15.30 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR A 157 TYR~? 5.66 OXT ACT A1181 D 142 LEU B 159 LEU~? 9.18 O3 GOL B1182 D 165 LYS A 158 LYS~? -4.64 O ACT A1181s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -50.12 7.79 -6.19 -50.39 5.62 -6.50 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 137 TYR A 175 TYR~? 24.50 O ACT A1182 D 142 LEU A 170 LEU~? 19.30 O ACT A1182 D 165 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -27.47 5.97 -6.00 -26.81 4.66 -4.41 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 D 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s D 142 LEU B 147 LEU^? -4.90 O2 GOL B1182s D 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -57.70 1.88 -14.83 -58.68 0.02 -15.15 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 D 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s D 142 LEU B 162 LEU~? 5.46 C3 GOL B1182 D 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -55.25 10.28 -7.94 -55.75 9.53 -9.90 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 D 137 TYR B 33 TYR~? -4.73 C1 GOL B1182s D 142 LEU B 165 LEU~? 9.28 C1 GOL B1182 D 165 LYS B 35 LYS~? 11.04 CA CA B1183 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -57.94 14.99 -7.70 -59.59 15.24 -9.13 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 D 137 TYR B 157 TYR~? 6.24 OXT ACT A1181 D 142 LEU A 154 LEU~? 3.93 O ACT A1181 D 165 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -45.58 21.65 -6.34 -46.95 22.06 -8.00 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 D 137 TYR B 157 TYR~? 6.24 OXT ACT A1181 D 142 LEU A 159 LEU~? 10.10 O ACT A1181 D 165 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -40.53 14.98 -1.43 -40.24 16.08 0.45 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 D 137 TYR B 175 TYR~? 10.51 CA CA B1181 D 142 LEU B 170 LEU~? 11.52 CA CA B1181 D 165 LYS B 177 LYS.? 12.69 CA CA B1181 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -65.36 23.11 4.03 -63.61 22.29 6.06 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -63.31 15.07 0.21 -63.98 13.98 1.99 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 D 137 TYR C 33 TYR~? 11.20 CA CA C1184 D 142 LEU C 147 LEU^? 5.95 CA CA C1184 D 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -57.68 -1.91 41.33 -58.71 -0.07 41.69 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 D 137 TYR C 33 TYR~? 11.20 CA CA C1184 D 142 LEU C 162 LEU~? 14.12 CA CA C1184 D 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -55.28 -10.26 34.41 -55.73 -9.48 36.37 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 D 137 TYR C 33 TYR~? 11.20 CA CA C1184 D 142 LEU C 165 LEU~? 15.02 C1 GOL D1181 D 165 LYS C 35 LYS~? 10.20 CA CA C1184 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -57.96 -15.03 34.16 -59.58 -15.24 35.60 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 D 137 TYR C 157 TYR~? 5.26 O3 GOL D1181 D 142 LEU D 154 LEU~? -3.89 O2 GOL D1181s D 165 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -45.57 -21.64 32.82 -46.97 -22.12 34.46 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 D 137 TYR C 157 TYR~? 5.26 O3 GOL D1181 D 142 LEU D 159 LEU~? 9.28 O3 GOL D1181 D 165 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -40.54 -14.98 27.89 -40.25 -16.05 25.99 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 D 137 TYR C 175 TYR~? 10.79 CA CA C1181 D 142 LEU C 170 LEU~? 11.77 CA CA C1181 D 165 LYS C 177 LYS.? 13.52 CA CA C1181 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -63.20 -15.10 26.22 -63.88 -14.01 24.45 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 D 137 TYR D 33 TYR~? 12.91 O3 GOL D1181 D 142 LEU D 147 LEU^? 15.08 O2 GOL D1181 D 165 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -32.92 -25.16 26.24 -32.16 -26.48 24.73 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 D 137 TYR D 33 TYR~? 12.91 O3 GOL D1181 D 142 LEU D 162 LEU~? 8.64 O3 GOL D1181 D 165 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -35.40 -15.52 30.95 -35.00 -17.67 31.02 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 D 137 TYR D 33 TYR~? 12.91 O3 GOL D1181 D 142 LEU D 165 LEU~? 10.81 O3 GOL D1181 D 165 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -32.84 -13.46 35.23 -31.36 -14.76 36.14 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 D 137 TYR D 157 TYR~? -5.31 C1 GOL D1181s D 142 LEU C 154 LEU~? 9.28 O3 GOL D1181 D 165 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -45.25 -9.79 40.76 -43.93 -11.17 41.77 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 D 137 TYR D 157 TYR~? -5.31 C1 GOL D1181s D 142 LEU C 159 LEU~? 13.80 O3 GOL D1181 D 165 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -50.12 -7.78 32.65 -50.39 -5.65 32.94 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 25 3 # 25 D 137 TYR D 175 TYR.? 24.43 OXT ACT A1182 D 142 LEU D 170 LEU~? 19.27 OXT ACT A1182 D 165 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -25.75 0.70 38.70 -27.49 2.18 37.04 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -27.49 -6.00 32.43 -26.81 -4.65 30.88 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 25 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 99 SER~? 12.20 OXT ACT A1182 A 48 THR A 102 THR~? 11.01 OXT ACT A1182 A 165 LYS A 130 LYS.? 19.75 CH3 ACT A1182 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -27.81 9.50 21.53 -30.13 10.20 21.65 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -24.41 5.58 21.31 -25.97 4.66 22.51 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -19.41 16.20 13.18 -20.24 16.85 17.21 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER B 99 SER~? 12.12 O ACT C1183 A 48 THR B 102 THR~? 11.18 CH3 ACT C1183 A 165 LYS B 130 LYS.? 19.82 CH3 ACT C1183 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -62.79 -11.40 7.59 -60.42 -11.55 7.06 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -66.17 -9.62 11.24 -64.70 -10.41 12.61 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -71.06 -6.27 -2.00 -70.24 -10.95 -0.22 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER C 99 SER~? 11.91 OXT ACT C1183 A 48 THR C 102 THR~? 11.11 OXT ACT C1183 A 165 LYS C 130 LYS.? 19.26 CH3 ACT C1183 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -62.74 11.40 18.89 -60.36 11.40 19.38 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -66.13 9.63 15.26 -64.66 10.40 13.87 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -71.03 6.26 28.36 -70.68 9.47 26.70 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER D 99 SER~? 12.19 O ACT A1182 A 48 THR D 102 THR~? 11.03 O ACT A1182 A 165 LYS D 130 LYS.? 19.81 CH3 ACT A1182 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -27.80 -9.54 4.93 -30.15 -10.16 4.86 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -24.39 -5.56 5.17 -25.97 -4.66 3.97 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -19.48 -16.44 13.55 -20.26 -16.74 8.72 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 99 SER~? 12.20 OXT ACT A1182 B 48 THR A 102 THR~? 11.01 OXT ACT A1182 B 165 LYS A 130 LYS.? 19.75 CH3 ACT A1182 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -27.81 9.50 21.53 -30.13 10.20 21.65 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -24.41 5.58 21.31 -25.97 4.66 22.51 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -19.41 16.20 13.18 -20.24 16.85 17.21 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 99 SER~? 12.12 O ACT C1183 B 48 THR B 102 THR~? 11.18 CH3 ACT C1183 B 165 LYS B 130 LYS.? 19.82 CH3 ACT C1183 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -62.79 -11.40 7.59 -60.42 -11.55 7.06 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -66.17 -9.62 11.24 -64.70 -10.41 12.61 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -71.06 -6.27 -2.00 -70.24 -10.95 -0.22 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER C 99 SER~? 11.91 OXT ACT C1183 B 48 THR C 102 THR~? 11.11 OXT ACT C1183 B 165 LYS C 130 LYS.? 19.26 CH3 ACT C1183 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -62.74 11.40 18.89 -60.36 11.40 19.38 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -66.13 9.63 15.26 -64.66 10.40 13.87 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -71.03 6.26 28.36 -70.68 9.47 26.70 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 47 SER D 99 SER~? 12.19 O ACT A1182 B 48 THR D 102 THR~? 11.03 O ACT A1182 B 165 LYS D 130 LYS.? 19.81 CH3 ACT A1182 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -27.80 -9.54 4.93 -30.15 -10.16 4.86 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -24.39 -5.56 5.17 -25.97 -4.66 3.97 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -19.48 -16.44 13.55 -20.26 -16.74 8.72 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 99 SER~? 12.20 OXT ACT A1182 C 48 THR A 102 THR~? 11.01 OXT ACT A1182 C 165 LYS A 130 LYS.? 19.75 CH3 ACT A1182 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -27.81 9.50 21.53 -30.13 10.20 21.65 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -24.41 5.58 21.31 -25.97 4.66 22.51 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -19.41 16.20 13.18 -20.24 16.85 17.21 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER B 99 SER~? 12.12 O ACT C1183 C 48 THR B 102 THR~? 11.18 CH3 ACT C1183 C 165 LYS B 130 LYS.? 19.82 CH3 ACT C1183 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -62.79 -11.40 7.59 -60.42 -11.55 7.06 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -66.17 -9.62 11.24 -64.70 -10.41 12.61 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -71.06 -6.27 -2.00 -70.24 -10.95 -0.22 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER C 99 SER~? 11.91 OXT ACT C1183 C 48 THR C 102 THR~? 11.11 OXT ACT C1183 C 165 LYS C 130 LYS.? 19.26 CH3 ACT C1183 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -62.74 11.40 18.89 -60.36 11.40 19.38 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -66.13 9.63 15.26 -64.66 10.40 13.87 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -71.03 6.26 28.36 -70.68 9.47 26.70 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER D 99 SER~? 12.19 O ACT A1182 C 48 THR D 102 THR~? 11.03 O ACT A1182 C 165 LYS D 130 LYS.? 19.81 CH3 ACT A1182 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -27.80 -9.54 4.93 -30.15 -10.16 4.86 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -24.39 -5.56 5.17 -25.97 -4.66 3.97 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -19.48 -16.44 13.55 -20.26 -16.74 8.72 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 99 SER~? 12.20 OXT ACT A1182 D 48 THR A 102 THR~? 11.01 OXT ACT A1182 D 165 LYS A 130 LYS.? 19.75 CH3 ACT A1182 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -27.81 9.50 21.53 -30.13 10.20 21.65 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -24.41 5.58 21.31 -25.97 4.66 22.51 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -19.41 16.20 13.18 -20.24 16.85 17.21 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER B 99 SER~? 12.12 O ACT C1183 D 48 THR B 102 THR~? 11.18 CH3 ACT C1183 D 165 LYS B 130 LYS.? 19.82 CH3 ACT C1183 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -62.79 -11.40 7.59 -60.42 -11.55 7.06 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -66.17 -9.62 11.24 -64.70 -10.41 12.61 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -71.06 -6.27 -2.00 -70.24 -10.95 -0.22 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER C 99 SER~? 11.91 OXT ACT C1183 D 48 THR C 102 THR~? 11.11 OXT ACT C1183 D 165 LYS C 130 LYS.? 19.26 CH3 ACT C1183 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -62.74 11.40 18.89 -60.36 11.40 19.38 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -66.13 9.63 15.26 -64.66 10.40 13.87 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -71.03 6.26 28.36 -70.68 9.47 26.70 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER D 99 SER~? 12.19 O ACT A1182 D 48 THR D 102 THR~? 11.03 O ACT A1182 D 165 LYS D 130 LYS.? 19.81 CH3 ACT A1182 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -27.80 -9.54 4.93 -30.15 -10.16 4.86 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -24.39 -5.56 5.17 -25.97 -4.66 3.97 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -19.48 -16.44 13.55 -20.26 -16.74 8.72 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c07 naa= 3 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 1 3 # 1 96 SER C 32 SER~? 5.57 CA CA C1184 272 CYH C 145 CYH.? 5.42 CA CA C1184 312 GLU C 143 GLU.? 3.32 CA CA C1184s coo 27.57 5.78 14.13 25.30 6.31 13.99 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 18.48 7.50 15.98 21.17 6.92 15.38 -62.51 -1.53 37.02 -61.06 0.37 38.52 coo 22.30 10.15 12.52 24.07 9.52 13.47 -67.43 0.61 42.53 -66.07 0.84 44.19 1fnb_c00 source 1fnb FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN RE: 1 hits 1fnb_c00 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 25 TRP~? -4.63 O ACT A1181s A 317 GLU A 29 GLU~? 11.10 O ACT A1181 A 365 ARG B 13 ARG~? 17.43 OXT ACT A1181 coo 79.91 26.87 38.77 78.95 23.18 37.81 -39.57 21.42 -9.88 -37.14 20.90 -6.80 coo 85.55 26.30 41.25 85.59 24.97 39.65 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 83.47 25.30 27.10 83.44 27.82 25.29 -32.45 21.03 -20.61 -29.60 19.86 -21.02 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP B 25 TRP~? -6.17 O3 GOL B1182s A 317 GLU B 29 GLU~? -3.75 O1 GOL B1182s A 365 ARG A 13 ARG~? 17.46 CH3 ACT A1181 coo 79.91 26.87 38.77 78.95 23.18 37.81 -51.25 13.14 -15.70 -53.64 10.62 -13.83 coo 85.55 26.30 41.25 85.59 24.97 39.65 -57.44 9.91 -17.53 -57.08 7.94 -18.23 coo 83.47 25.30 27.10 83.44 27.82 25.29 -58.47 23.67 -18.83 -59.87 25.50 -16.74 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 3 3 # 3 A 314 TRP D 25 TRP~? -4.53 O2 GOL D1181s A 317 GLU D 29 GLU~? 11.05 O2 GOL D1181 A 365 ARG C 13 ARG~? 8.07 CA CA C1182 coo 79.91 26.87 38.77 78.95 23.18 37.81 -39.59 -21.43 36.34 -37.18 -20.87 33.24 coo 85.55 26.30 41.25 85.59 24.97 39.65 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo 83.47 25.30 27.10 83.44 27.82 25.29 -32.51 -20.88 47.20 -29.56 -20.08 47.23 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 3 hits 1g8o_c01 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 29 GLU~? 11.10 O ACT A1181 A 47 ASP A 144 ASP.? 22.46 O ACT A1181 A 161 TYR A 33 TYR~? 13.22 O ACT A1181 coo 37.12 18.35 73.76 37.09 16.69 72.44 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 29.81 8.06 73.13 30.21 10.11 72.95 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 37.29 15.56 67.90 37.37 13.79 70.08 -29.65 19.68 -6.55 -29.87 20.32 -9.24 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU D 29 GLU~? 11.05 O2 GOL D1181 A 47 ASP D 144 ASP.? 22.37 O2 GOL D1181 A 161 TYR D 33 TYR~? 12.91 O3 GOL D1181 coo 37.12 18.35 73.76 37.09 16.69 72.44 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo 29.81 8.06 73.13 30.21 10.11 72.95 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 37.29 15.56 67.90 37.37 13.79 70.08 -29.64 -19.70 33.03 -29.80 -20.31 35.72 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 2 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 29 GLU~? 11.10 O ACT A1181 B 47 ASP A 144 ASP.? 22.46 O ACT A1181 B 161 TYR A 33 TYR~? 13.22 O ACT A1181 coo 53.87 35.49 53.22 55.44 35.72 54.61 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 63.47 43.65 53.95 61.45 43.07 54.06 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 56.38 35.81 59.19 58.25 35.77 57.10 -29.65 19.68 -6.55 -29.87 20.32 -9.24 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU D 29 GLU~? 11.05 O2 GOL D1181 B 47 ASP D 144 ASP.? 22.37 O2 GOL D1181 B 161 TYR D 33 TYR~? 12.91 O3 GOL D1181 coo 53.87 35.49 53.22 55.44 35.72 54.61 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo 63.47 43.65 53.95 61.45 43.07 54.06 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 56.38 35.81 59.19 58.25 35.77 57.10 -29.64 -19.70 33.03 -29.80 -20.31 35.72 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 2 hits 1geq_c03 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 55 ASP.? 17.41 O ACT A1181 A 64 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 155 ASN B 68 ASN~? 15.57 O ACT A1181 coo 3.12 38.70 24.20 3.24 38.59 26.33 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 1.90 38.00 29.77 3.91 38.35 29.95 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 9.89 36.55 37.38 9.27 37.99 36.08 -53.02 13.76 3.43 -51.10 14.43 2.89 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 64 HIS B 59 HIS~? 15.18 O ACT C1183 A 155 ASN A 68 ASN~? 16.27 OXT ACT A1181 coo 3.12 38.70 24.20 3.24 38.59 26.33 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 1.90 38.00 29.77 3.91 38.35 29.95 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 9.89 36.55 37.38 9.27 37.99 36.08 -37.69 3.73 -3.29 -39.63 4.05 -4.09 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP C 55 ASP.? 19.45 CA CA C1184 A 64 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 155 ASN D 68 ASN~? 14.78 O3 GOL D1181 coo 3.12 38.70 24.20 3.24 38.59 26.33 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 1.90 38.00 29.77 3.91 38.35 29.95 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 9.89 36.55 37.38 9.27 37.99 36.08 -37.72 -3.74 29.70 -39.65 -4.05 30.55 1gns_c00 source 1gns SUBTILISIN BPN' : 3 hits 1gns_c00 naa= 3 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 B 106 ASN A 63 ASN~? 15.00 O ACT A1182 B 108 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 144 ASP A 156 ASP~? 10.59 O ACT A1181 coo 36.64 101.02 13.15 38.55 101.84 12.78 -42.85 5.00 4.60 -43.72 3.09 4.23 coo 41.00 107.18 12.86 42.70 107.82 11.96 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 31.60 110.69 6.14 29.69 109.74 5.94 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 B 106 ASN A 63 ASN~? 15.00 O ACT A1182 B 108 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 144 ASP B 84 ASP^? 7.80 O ACT C1183 coo 36.64 101.02 13.15 38.55 101.84 12.78 -42.85 5.00 4.60 -43.72 3.09 4.23 coo 41.00 107.18 12.86 42.70 107.82 11.96 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 31.60 110.69 6.14 29.69 109.74 5.94 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 B 106 ASN A 63 ASN~? 15.00 O ACT A1182 B 108 HIS B 59 HIS~? 15.18 O ACT C1183 B 144 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 36.64 101.02 13.15 38.55 101.84 12.78 -42.85 5.00 4.60 -43.72 3.09 4.23 coo 41.00 107.18 12.86 42.70 107.82 11.96 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 31.60 110.69 6.14 29.69 109.74 5.94 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 3 # 4 B 106 ASN B 63 ASN~? 14.86 OXT ACT C1183 B 108 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 144 ASP A 156 ASP~? 10.59 O ACT A1181 coo 36.64 101.02 13.15 38.55 101.84 12.78 -47.83 6.22 5.31 -46.99 7.23 6.98 coo 41.00 107.18 12.86 42.70 107.82 11.96 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 31.60 110.69 6.14 29.69 109.74 5.94 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 3 # 5 B 106 ASN B 63 ASN~? 14.86 OXT ACT C1183 B 108 HIS B 59 HIS~? 15.18 O ACT C1183 B 144 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 36.64 101.02 13.15 38.55 101.84 12.78 -47.83 6.22 5.31 -46.99 7.23 6.98 coo 41.00 107.18 12.86 42.70 107.82 11.96 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 31.60 110.69 6.14 29.69 109.74 5.94 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 3 # 6 B 106 ASN B 63 ASN~? 14.86 OXT ACT C1183 B 108 HIS B 59 HIS~? 15.18 O ACT C1183 B 144 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 36.64 101.02 13.15 38.55 101.84 12.78 -47.83 6.22 5.31 -46.99 7.23 6.98 coo 41.00 107.18 12.86 42.70 107.82 11.96 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 31.60 110.69 6.14 29.69 109.74 5.94 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 7 3 # 7 B 106 ASN C 63 ASN~? 14.81 O ACT C1183 B 108 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 144 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 36.64 101.02 13.15 38.55 101.84 12.78 -47.81 -6.22 21.11 -47.01 -7.28 19.44 coo 41.00 107.18 12.86 42.70 107.82 11.96 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 31.60 110.69 6.14 29.69 109.74 5.94 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 8 3 # 8 B 106 ASN C 63 ASN~? 14.81 O ACT C1183 B 108 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 144 ASP D 84 ASP^? 8.02 O ACT A1182 coo 36.64 101.02 13.15 38.55 101.84 12.78 -47.81 -6.22 21.11 -47.01 -7.28 19.44 coo 41.00 107.18 12.86 42.70 107.82 11.96 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 31.60 110.69 6.14 29.69 109.74 5.94 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 9 3 # 9 B 106 ASN C 63 ASN~? 14.81 O ACT C1183 B 108 HIS D 59 HIS~? 14.28 O ACT A1182 B 144 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 36.64 101.02 13.15 38.55 101.84 12.78 -47.81 -6.22 21.11 -47.01 -7.28 19.44 coo 41.00 107.18 12.86 42.70 107.82 11.96 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 31.60 110.69 6.14 29.69 109.74 5.94 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 10 3 # 10 B 106 ASN D 63 ASN~? 14.84 OXT ACT A1182 B 108 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 144 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 36.64 101.02 13.15 38.55 101.84 12.78 -42.87 -5.02 21.89 -43.66 -3.06 22.11 coo 41.00 107.18 12.86 42.70 107.82 11.96 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 31.60 110.69 6.14 29.69 109.74 5.94 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 11 3 # 11 B 106 ASN D 63 ASN~? 14.84 OXT ACT A1182 B 108 HIS D 59 HIS~? 14.28 O ACT A1182 B 144 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 36.64 101.02 13.15 38.55 101.84 12.78 -42.87 -5.02 21.89 -43.66 -3.06 22.11 coo 41.00 107.18 12.86 42.70 107.82 11.96 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 31.60 110.69 6.14 29.69 109.74 5.94 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1grc_c03 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 12 3 # 12 B 106 ASN D 63 ASN~? 14.84 OXT ACT A1182 B 108 HIS D 59 HIS~? 14.28 O ACT A1182 B 144 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 36.64 101.02 13.15 38.55 101.84 12.78 -42.87 -5.02 21.89 -43.66 -3.06 22.11 coo 41.00 107.18 12.86 42.70 107.82 11.96 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 31.60 110.69 6.14 29.69 109.74 5.94 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1grc_c03 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 12 hits 1grc_c03 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 18 PHE~? 7.18 CH3 ACT A1181 A 298 ASP A 14 ASP~? 14.99 CH3 ACT A1181 A 329 LYS B 164 LYS~? 10.34 O ACT A1181 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -49.53 25.29 -10.30 -47.93 26.67 -8.41 coo 2.59 0.29 25.55 4.65 0.18 25.07 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 12.42 6.10 23.27 9.95 1.57 20.16 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 298 ASP A 55 ASP.? 17.41 O ACT A1181 A 329 LYS A 149 LYS.? 8.87 O ACT A1181 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 2.59 0.29 25.55 4.65 0.18 25.07 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 12.42 6.10 23.27 9.95 1.57 20.16 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 298 ASP A 156 ASP~? 10.59 O ACT A1181 A 329 LYS A 149 LYS.? 8.87 O ACT A1181 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 2.59 0.29 25.55 4.65 0.18 25.07 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 12.42 6.10 23.27 9.95 1.57 20.16 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE A 138 PHE.? 14.29 O ACT A1181 A 298 ASP A 55 ASP.? 17.41 O ACT A1181 A 329 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 2.59 0.29 25.55 4.65 0.18 25.07 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 12.42 6.10 23.27 9.95 1.57 20.16 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE B 18 PHE~? 12.22 OXT ACT A1181 A 298 ASP B 14 ASP~? 13.85 OXT ACT A1181 A 329 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -41.22 12.14 -19.23 -42.79 9.87 -19.80 coo 2.59 0.29 25.55 4.65 0.18 25.07 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo 12.42 6.10 23.27 9.95 1.57 20.16 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 298 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 329 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 2.59 0.29 25.55 4.65 0.18 25.07 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 12.42 6.10 23.27 9.95 1.57 20.16 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 298 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 329 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 2.59 0.29 25.55 4.65 0.18 25.07 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 12.42 6.10 23.27 9.95 1.57 20.16 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE B 138 PHE.? 9.75 O3 GOL B1182 A 298 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 329 LYS B 124 LYS~? 15.51 CA CA B1183 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 2.59 0.29 25.55 4.65 0.18 25.07 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 12.42 6.10 23.27 9.95 1.57 20.16 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 A 189 PHE C 18 PHE~? 12.17 O3 GOL D1181 A 298 ASP C 14 ASP~? 9.29 CA CA C1182 A 329 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -41.21 -12.14 45.70 -42.78 -9.88 46.28 coo 2.59 0.29 25.55 4.65 0.18 25.07 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 12.42 6.10 23.27 9.95 1.57 20.16 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 A 189 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 298 ASP C 55 ASP.? 19.45 CA CA C1184 A 329 LYS C 149 LYS.? 9.01 CA CA C1184 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 2.59 0.29 25.55 4.65 0.18 25.07 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 12.42 6.10 23.27 9.95 1.57 20.16 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 A 189 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 298 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 329 LYS C 149 LYS.? 9.01 CA CA C1184 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 2.59 0.29 25.55 4.65 0.18 25.07 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 12.42 6.10 23.27 9.95 1.57 20.16 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 A 189 PHE C 138 PHE.? 14.85 CA CA C1184 A 298 ASP C 55 ASP.? 19.45 CA CA C1184 A 329 LYS C 124 LYS~? 15.99 CA CA C1184 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 2.59 0.29 25.55 4.65 0.18 25.07 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 12.42 6.10 23.27 9.95 1.57 20.16 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 A 189 PHE D 18 PHE~? 7.09 O1 GOL D1181 A 298 ASP D 14 ASP~? 14.81 O1 GOL D1181 A 329 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -49.53 -25.28 36.78 -47.96 -26.67 34.88 coo 2.59 0.29 25.55 4.65 0.18 25.07 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 12.42 6.10 23.27 9.95 1.57 20.16 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 A 189 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 298 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 329 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 2.59 0.29 25.55 4.65 0.18 25.07 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 12.42 6.10 23.27 9.95 1.57 20.16 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 A 189 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 298 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 329 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 2.59 0.29 25.55 4.65 0.18 25.07 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 12.42 6.10 23.27 9.95 1.57 20.16 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 A 189 PHE D 138 PHE.? 14.22 O2 GOL D1181 A 298 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 329 LYS D 124 LYS~? 24.78 O ACT A1182 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 2.59 0.29 25.55 4.65 0.18 25.07 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 12.42 6.10 23.27 9.95 1.57 20.16 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 18 PHE~? 7.18 CH3 ACT A1181 B 298 ASP A 14 ASP~? 14.99 CH3 ACT A1181 B 329 LYS B 164 LYS~? 10.34 O ACT A1181 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -49.53 25.29 -10.30 -47.93 26.67 -8.41 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 61 PHE~? 13.18 OXT ACT A1181 B 298 ASP A 55 ASP.? 17.41 O ACT A1181 B 329 LYS A 149 LYS.? 8.87 O ACT A1181 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 61 PHE~? 13.18 OXT ACT A1181 B 298 ASP A 156 ASP~? 10.59 O ACT A1181 B 329 LYS A 149 LYS.? 8.87 O ACT A1181 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE A 138 PHE.? 14.29 O ACT A1181 B 298 ASP A 55 ASP.? 17.41 O ACT A1181 B 329 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE B 18 PHE~? 12.22 OXT ACT A1181 B 298 ASP B 14 ASP~? 13.85 OXT ACT A1181 B 329 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -41.22 12.14 -19.23 -42.79 9.87 -19.80 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE B 61 PHE~? 12.02 O3 GOL B1182 B 298 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 329 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE B 61 PHE~? 12.02 O3 GOL B1182 B 298 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 329 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE B 138 PHE.? 9.75 O3 GOL B1182 B 298 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 329 LYS B 124 LYS~? 15.51 CA CA B1183 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 B 189 PHE C 18 PHE~? 12.17 O3 GOL D1181 B 298 ASP C 14 ASP~? 9.29 CA CA C1182 B 329 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -41.21 -12.14 45.70 -42.78 -9.88 46.28 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 B 189 PHE C 61 PHE~? 15.37 O3 GOL D1181 B 298 ASP C 55 ASP.? 19.45 CA CA C1184 B 329 LYS C 149 LYS.? 9.01 CA CA C1184 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 B 189 PHE C 61 PHE~? 15.37 O3 GOL D1181 B 298 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 329 LYS C 149 LYS.? 9.01 CA CA C1184 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 B 189 PHE C 138 PHE.? 14.85 CA CA C1184 B 298 ASP C 55 ASP.? 19.45 CA CA C1184 B 329 LYS C 124 LYS~? 15.99 CA CA C1184 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 B 189 PHE D 18 PHE~? 7.09 O1 GOL D1181 B 298 ASP D 14 ASP~? 14.81 O1 GOL D1181 B 329 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -49.53 -25.28 36.78 -47.96 -26.67 34.88 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 B 189 PHE D 61 PHE~? 11.72 O3 GOL D1181 B 298 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 329 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 B 189 PHE D 61 PHE~? 11.72 O3 GOL D1181 B 298 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 329 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 B 189 PHE D 138 PHE.? 14.22 O2 GOL D1181 B 298 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 329 LYS D 124 LYS~? 24.78 O ACT A1182 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 18 PHE~? 7.18 CH3 ACT A1181 C 298 ASP A 14 ASP~? 14.99 CH3 ACT A1181 C 329 LYS B 164 LYS~? 10.34 O ACT A1181 coo 17.41 60.57 64.39 18.40 58.12 65.34 -49.53 25.29 -10.30 -47.93 26.67 -8.41 coo 24.10 66.43 63.33 24.18 64.30 63.40 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 27.64 56.61 58.17 22.18 57.92 60.36 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 61 PHE~? 13.18 OXT ACT A1181 C 298 ASP A 55 ASP.? 17.41 O ACT A1181 C 329 LYS A 149 LYS.? 8.87 O ACT A1181 coo 17.41 60.57 64.39 18.40 58.12 65.34 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 24.10 66.43 63.33 24.18 64.30 63.40 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 27.64 56.61 58.17 22.18 57.92 60.36 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 61 PHE~? 13.18 OXT ACT A1181 C 298 ASP A 156 ASP~? 10.59 O ACT A1181 C 329 LYS A 149 LYS.? 8.87 O ACT A1181 coo 17.41 60.57 64.39 18.40 58.12 65.34 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 24.10 66.43 63.33 24.18 64.30 63.40 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 27.64 56.61 58.17 22.18 57.92 60.36 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE A 138 PHE.? 14.29 O ACT A1181 C 298 ASP A 55 ASP.? 17.41 O ACT A1181 C 329 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 17.41 60.57 64.39 18.40 58.12 65.34 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 24.10 66.43 63.33 24.18 64.30 63.40 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 27.64 56.61 58.17 22.18 57.92 60.36 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE B 18 PHE~? 12.22 OXT ACT A1181 C 298 ASP B 14 ASP~? 13.85 OXT ACT A1181 C 329 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 17.41 60.57 64.39 18.40 58.12 65.34 -41.22 12.14 -19.23 -42.79 9.87 -19.80 coo 24.10 66.43 63.33 24.18 64.30 63.40 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo 27.64 56.61 58.17 22.18 57.92 60.36 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE B 61 PHE~? 12.02 O3 GOL B1182 C 298 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 329 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 17.41 60.57 64.39 18.40 58.12 65.34 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 24.10 66.43 63.33 24.18 64.30 63.40 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 27.64 56.61 58.17 22.18 57.92 60.36 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE B 61 PHE~? 12.02 O3 GOL B1182 C 298 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 329 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 17.41 60.57 64.39 18.40 58.12 65.34 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 24.10 66.43 63.33 24.18 64.30 63.40 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 27.64 56.61 58.17 22.18 57.92 60.36 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE B 138 PHE.? 9.75 O3 GOL B1182 C 298 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 329 LYS B 124 LYS~? 15.51 CA CA B1183 coo 17.41 60.57 64.39 18.40 58.12 65.34 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 24.10 66.43 63.33 24.18 64.30 63.40 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 27.64 56.61 58.17 22.18 57.92 60.36 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 C 189 PHE C 18 PHE~? 12.17 O3 GOL D1181 C 298 ASP C 14 ASP~? 9.29 CA CA C1182 C 329 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 17.41 60.57 64.39 18.40 58.12 65.34 -41.21 -12.14 45.70 -42.78 -9.88 46.28 coo 24.10 66.43 63.33 24.18 64.30 63.40 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 27.64 56.61 58.17 22.18 57.92 60.36 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 C 189 PHE C 61 PHE~? 15.37 O3 GOL D1181 C 298 ASP C 55 ASP.? 19.45 CA CA C1184 C 329 LYS C 149 LYS.? 9.01 CA CA C1184 coo 17.41 60.57 64.39 18.40 58.12 65.34 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 24.10 66.43 63.33 24.18 64.30 63.40 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 27.64 56.61 58.17 22.18 57.92 60.36 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 C 189 PHE C 61 PHE~? 15.37 O3 GOL D1181 C 298 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 329 LYS C 149 LYS.? 9.01 CA CA C1184 coo 17.41 60.57 64.39 18.40 58.12 65.34 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 24.10 66.43 63.33 24.18 64.30 63.40 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 27.64 56.61 58.17 22.18 57.92 60.36 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 C 189 PHE C 138 PHE.? 14.85 CA CA C1184 C 298 ASP C 55 ASP.? 19.45 CA CA C1184 C 329 LYS C 124 LYS~? 15.99 CA CA C1184 coo 17.41 60.57 64.39 18.40 58.12 65.34 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 24.10 66.43 63.33 24.18 64.30 63.40 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 27.64 56.61 58.17 22.18 57.92 60.36 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 C 189 PHE D 18 PHE~? 7.09 O1 GOL D1181 C 298 ASP D 14 ASP~? 14.81 O1 GOL D1181 C 329 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 17.41 60.57 64.39 18.40 58.12 65.34 -49.53 -25.28 36.78 -47.96 -26.67 34.88 coo 24.10 66.43 63.33 24.18 64.30 63.40 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 27.64 56.61 58.17 22.18 57.92 60.36 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 C 189 PHE D 61 PHE~? 11.72 O3 GOL D1181 C 298 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 329 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 17.41 60.57 64.39 18.40 58.12 65.34 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 24.10 66.43 63.33 24.18 64.30 63.40 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 27.64 56.61 58.17 22.18 57.92 60.36 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 C 189 PHE D 61 PHE~? 11.72 O3 GOL D1181 C 298 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 329 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 17.41 60.57 64.39 18.40 58.12 65.34 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 24.10 66.43 63.33 24.18 64.30 63.40 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 27.64 56.61 58.17 22.18 57.92 60.36 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 C 189 PHE D 138 PHE.? 14.22 O2 GOL D1181 C 298 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 329 LYS D 124 LYS~? 24.78 O ACT A1182 coo 17.41 60.57 64.39 18.40 58.12 65.34 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 24.10 66.43 63.33 24.18 64.30 63.40 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 27.64 56.61 58.17 22.18 57.92 60.36 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 18 PHE~? 7.18 CH3 ACT A1181 D 298 ASP A 14 ASP~? 14.99 CH3 ACT A1181 D 329 LYS B 164 LYS~? 10.34 O ACT A1181 coo 35.44 53.35 83.81 35.65 54.53 81.28 -49.53 25.29 -10.30 -47.93 26.67 -8.41 coo 29.72 46.46 83.60 30.79 47.36 81.99 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 36.89 44.91 74.55 37.33 48.94 79.01 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 61 PHE~? 13.18 OXT ACT A1181 D 298 ASP A 55 ASP.? 17.41 O ACT A1181 D 329 LYS A 149 LYS.? 8.87 O ACT A1181 coo 35.44 53.35 83.81 35.65 54.53 81.28 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 29.72 46.46 83.60 30.79 47.36 81.99 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 36.89 44.91 74.55 37.33 48.94 79.01 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 61 PHE~? 13.18 OXT ACT A1181 D 298 ASP A 156 ASP~? 10.59 O ACT A1181 D 329 LYS A 149 LYS.? 8.87 O ACT A1181 coo 35.44 53.35 83.81 35.65 54.53 81.28 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 29.72 46.46 83.60 30.79 47.36 81.99 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 36.89 44.91 74.55 37.33 48.94 79.01 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE A 138 PHE.? 14.29 O ACT A1181 D 298 ASP A 55 ASP.? 17.41 O ACT A1181 D 329 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 35.44 53.35 83.81 35.65 54.53 81.28 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 29.72 46.46 83.60 30.79 47.36 81.99 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 36.89 44.91 74.55 37.33 48.94 79.01 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE B 18 PHE~? 12.22 OXT ACT A1181 D 298 ASP B 14 ASP~? 13.85 OXT ACT A1181 D 329 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 35.44 53.35 83.81 35.65 54.53 81.28 -41.22 12.14 -19.23 -42.79 9.87 -19.80 coo 29.72 46.46 83.60 30.79 47.36 81.99 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo 36.89 44.91 74.55 37.33 48.94 79.01 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE B 61 PHE~? 12.02 O3 GOL B1182 D 298 ASP B 55 ASP.? 14.29 O3 GOL B1182 D 329 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 35.44 53.35 83.81 35.65 54.53 81.28 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 29.72 46.46 83.60 30.79 47.36 81.99 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 36.89 44.91 74.55 37.33 48.94 79.01 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE B 61 PHE~? 12.02 O3 GOL B1182 D 298 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 329 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 35.44 53.35 83.81 35.65 54.53 81.28 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 29.72 46.46 83.60 30.79 47.36 81.99 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 36.89 44.91 74.55 37.33 48.94 79.01 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE B 138 PHE.? 9.75 O3 GOL B1182 D 298 ASP B 55 ASP.? 14.29 O3 GOL B1182 D 329 LYS B 124 LYS~? 15.51 CA CA B1183 coo 35.44 53.35 83.81 35.65 54.53 81.28 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 29.72 46.46 83.60 30.79 47.36 81.99 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 36.89 44.91 74.55 37.33 48.94 79.01 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 9 3 # 9 D 189 PHE C 18 PHE~? 12.17 O3 GOL D1181 D 298 ASP C 14 ASP~? 9.29 CA CA C1182 D 329 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 35.44 53.35 83.81 35.65 54.53 81.28 -41.21 -12.14 45.70 -42.78 -9.88 46.28 coo 29.72 46.46 83.60 30.79 47.36 81.99 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 36.89 44.91 74.55 37.33 48.94 79.01 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 10 3 # 10 D 189 PHE C 61 PHE~? 15.37 O3 GOL D1181 D 298 ASP C 55 ASP.? 19.45 CA CA C1184 D 329 LYS C 149 LYS.? 9.01 CA CA C1184 coo 35.44 53.35 83.81 35.65 54.53 81.28 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 29.72 46.46 83.60 30.79 47.36 81.99 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 36.89 44.91 74.55 37.33 48.94 79.01 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 11 3 # 11 D 189 PHE C 61 PHE~? 15.37 O3 GOL D1181 D 298 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 329 LYS C 149 LYS.? 9.01 CA CA C1184 coo 35.44 53.35 83.81 35.65 54.53 81.28 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 29.72 46.46 83.60 30.79 47.36 81.99 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 36.89 44.91 74.55 37.33 48.94 79.01 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 12 3 # 12 D 189 PHE C 138 PHE.? 14.85 CA CA C1184 D 298 ASP C 55 ASP.? 19.45 CA CA C1184 D 329 LYS C 124 LYS~? 15.99 CA CA C1184 coo 35.44 53.35 83.81 35.65 54.53 81.28 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 29.72 46.46 83.60 30.79 47.36 81.99 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 36.89 44.91 74.55 37.33 48.94 79.01 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 13 3 # 13 D 189 PHE D 18 PHE~? 7.09 O1 GOL D1181 D 298 ASP D 14 ASP~? 14.81 O1 GOL D1181 D 329 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 35.44 53.35 83.81 35.65 54.53 81.28 -49.53 -25.28 36.78 -47.96 -26.67 34.88 coo 29.72 46.46 83.60 30.79 47.36 81.99 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 36.89 44.91 74.55 37.33 48.94 79.01 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 14 3 # 14 D 189 PHE D 61 PHE~? 11.72 O3 GOL D1181 D 298 ASP D 55 ASP.? 17.43 O2 GOL D1181 D 329 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 35.44 53.35 83.81 35.65 54.53 81.28 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 29.72 46.46 83.60 30.79 47.36 81.99 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 36.89 44.91 74.55 37.33 48.94 79.01 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 15 3 # 15 D 189 PHE D 61 PHE~? 11.72 O3 GOL D1181 D 298 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 329 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 35.44 53.35 83.81 35.65 54.53 81.28 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 29.72 46.46 83.60 30.79 47.36 81.99 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 36.89 44.91 74.55 37.33 48.94 79.01 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 16 3 # 16 D 189 PHE D 138 PHE.? 14.22 O2 GOL D1181 D 298 ASP D 55 ASP.? 17.43 O2 GOL D1181 D 329 LYS D 124 LYS~? 24.78 O ACT A1182 coo 35.44 53.35 83.81 35.65 54.53 81.28 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 29.72 46.46 83.60 30.79 47.36 81.99 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 36.89 44.91 74.55 37.33 48.94 79.01 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 16 hits 1gtx_c03 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER A 172 SER~? 20.14 OXT ACT A1181 A 164 TYR A 175 TYR~? 24.50 O ACT A1182 A 168 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 32.37 52.40 49.35 31.32 53.88 47.74 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 29.69 55.04 42.83 31.98 53.56 43.49 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 26.96 50.99 47.03 31.03 48.83 44.33 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 A 151 SER B 31 SER~? 8.40 O1 GOL B1182 A 164 TYR A 5 TYR~? 13.40 O1 GOL B1182 A 168 LYS B 35 LYS~? 11.04 CA CA B1183 coo 32.37 52.40 49.35 31.32 53.88 47.74 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 29.69 55.04 42.83 31.98 53.56 43.49 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 26.96 50.99 47.03 31.03 48.83 44.33 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 A 151 SER B 32 SER~? 5.72 CA CA B1183 A 164 TYR A 5 TYR~? 13.40 O1 GOL B1182 A 168 LYS B 35 LYS~? 11.04 CA CA B1183 coo 32.37 52.40 49.35 31.32 53.88 47.74 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 29.69 55.04 42.83 31.98 53.56 43.49 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 26.96 50.99 47.03 31.03 48.83 44.33 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 A 151 SER B 172 SER~? 11.09 CA CA B1181 A 164 TYR B 175 TYR~? 10.51 CA CA B1181 A 168 LYS B 177 LYS.? 12.69 CA CA B1181 coo 32.37 52.40 49.35 31.32 53.88 47.74 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 29.69 55.04 42.83 31.98 53.56 43.49 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 26.96 50.99 47.03 31.03 48.83 44.33 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 A 151 SER C 31 SER.? 11.23 CA CA C1184 A 164 TYR D 5 TYR~? 13.80 CA CA C1181 A 168 LYS C 35 LYS~? 10.20 CA CA C1184 coo 32.37 52.40 49.35 31.32 53.88 47.74 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 29.69 55.04 42.83 31.98 53.56 43.49 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 26.96 50.99 47.03 31.03 48.83 44.33 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 6 3 # 6 A 151 SER C 32 SER~? 5.57 CA CA C1184 A 164 TYR D 5 TYR~? 13.80 CA CA C1181 A 168 LYS C 35 LYS~? 10.20 CA CA C1184 coo 32.37 52.40 49.35 31.32 53.88 47.74 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 29.69 55.04 42.83 31.98 53.56 43.49 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 26.96 50.99 47.03 31.03 48.83 44.33 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 7 3 # 7 A 151 SER C 172 SER~? 11.19 CA CA C1181 A 164 TYR C 175 TYR~? 10.79 CA CA C1181 A 168 LYS C 177 LYS.? 13.52 CA CA C1181 coo 32.37 52.40 49.35 31.32 53.88 47.74 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 29.69 55.04 42.83 31.98 53.56 43.49 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 26.96 50.99 47.03 31.03 48.83 44.33 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 8 3 # 8 A 151 SER D 172 SER~? 19.02 O3 GOL D1181 A 164 TYR D 175 TYR.? 24.43 OXT ACT A1182 A 168 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 32.37 52.40 49.35 31.32 53.88 47.74 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 29.69 55.04 42.83 31.98 53.56 43.49 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 26.96 50.99 47.03 31.03 48.83 44.33 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 8 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER A 172 SER~? 20.14 OXT ACT A1181 B 164 TYR A 175 TYR~? 24.50 O ACT A1182 B 168 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 13.08 50.93 56.67 13.12 48.99 55.27 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 11.52 46.03 51.32 10.06 47.90 52.76 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 15.72 50.86 51.22 10.77 52.35 51.39 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 B 151 SER B 31 SER~? 8.40 O1 GOL B1182 B 164 TYR A 5 TYR~? 13.40 O1 GOL B1182 B 168 LYS B 35 LYS~? 11.04 CA CA B1183 coo 13.08 50.93 56.67 13.12 48.99 55.27 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 11.52 46.03 51.32 10.06 47.90 52.76 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 15.72 50.86 51.22 10.77 52.35 51.39 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 B 151 SER B 32 SER~? 5.72 CA CA B1183 B 164 TYR A 5 TYR~? 13.40 O1 GOL B1182 B 168 LYS B 35 LYS~? 11.04 CA CA B1183 coo 13.08 50.93 56.67 13.12 48.99 55.27 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 11.52 46.03 51.32 10.06 47.90 52.76 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 15.72 50.86 51.22 10.77 52.35 51.39 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 B 151 SER B 172 SER~? 11.09 CA CA B1181 B 164 TYR B 175 TYR~? 10.51 CA CA B1181 B 168 LYS B 177 LYS.? 12.69 CA CA B1181 coo 13.08 50.93 56.67 13.12 48.99 55.27 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 11.52 46.03 51.32 10.06 47.90 52.76 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 15.72 50.86 51.22 10.77 52.35 51.39 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 B 151 SER C 31 SER.? 11.23 CA CA C1184 B 164 TYR D 5 TYR~? 13.80 CA CA C1181 B 168 LYS C 35 LYS~? 10.20 CA CA C1184 coo 13.08 50.93 56.67 13.12 48.99 55.27 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 11.52 46.03 51.32 10.06 47.90 52.76 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 15.72 50.86 51.22 10.77 52.35 51.39 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 6 3 # 6 B 151 SER C 32 SER~? 5.57 CA CA C1184 B 164 TYR D 5 TYR~? 13.80 CA CA C1181 B 168 LYS C 35 LYS~? 10.20 CA CA C1184 coo 13.08 50.93 56.67 13.12 48.99 55.27 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 11.52 46.03 51.32 10.06 47.90 52.76 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 15.72 50.86 51.22 10.77 52.35 51.39 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 7 3 # 7 B 151 SER C 172 SER~? 11.19 CA CA C1181 B 164 TYR C 175 TYR~? 10.79 CA CA C1181 B 168 LYS C 177 LYS.? 13.52 CA CA C1181 coo 13.08 50.93 56.67 13.12 48.99 55.27 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 11.52 46.03 51.32 10.06 47.90 52.76 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 15.72 50.86 51.22 10.77 52.35 51.39 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 8 3 # 8 B 151 SER D 172 SER~? 19.02 O3 GOL D1181 B 164 TYR D 175 TYR.? 24.43 OXT ACT A1182 B 168 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 13.08 50.93 56.67 13.12 48.99 55.27 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 11.52 46.03 51.32 10.06 47.90 52.76 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 15.72 50.86 51.22 10.77 52.35 51.39 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 8 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER A 172 SER~? 20.14 OXT ACT A1181 C 164 TYR A 175 TYR~? 24.50 O ACT A1182 C 168 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 11.22 34.38 82.32 11.07 36.29 83.78 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 8.83 39.27 87.38 7.60 37.43 85.69 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 12.98 34.46 88.14 8.11 32.96 87.14 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 C 151 SER B 31 SER~? 8.40 O1 GOL B1182 C 164 TYR A 5 TYR~? 13.40 O1 GOL B1182 C 168 LYS B 35 LYS~? 11.04 CA CA B1183 coo 11.22 34.38 82.32 11.07 36.29 83.78 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 8.83 39.27 87.38 7.60 37.43 85.69 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 12.98 34.46 88.14 8.11 32.96 87.14 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 C 151 SER B 32 SER~? 5.72 CA CA B1183 C 164 TYR A 5 TYR~? 13.40 O1 GOL B1182 C 168 LYS B 35 LYS~? 11.04 CA CA B1183 coo 11.22 34.38 82.32 11.07 36.29 83.78 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 8.83 39.27 87.38 7.60 37.43 85.69 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 12.98 34.46 88.14 8.11 32.96 87.14 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 C 151 SER B 172 SER~? 11.09 CA CA B1181 C 164 TYR B 175 TYR~? 10.51 CA CA B1181 C 168 LYS B 177 LYS.? 12.69 CA CA B1181 coo 11.22 34.38 82.32 11.07 36.29 83.78 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 8.83 39.27 87.38 7.60 37.43 85.69 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 12.98 34.46 88.14 8.11 32.96 87.14 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 C 151 SER C 31 SER.? 11.23 CA CA C1184 C 164 TYR D 5 TYR~? 13.80 CA CA C1181 C 168 LYS C 35 LYS~? 10.20 CA CA C1184 coo 11.22 34.38 82.32 11.07 36.29 83.78 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 8.83 39.27 87.38 7.60 37.43 85.69 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 12.98 34.46 88.14 8.11 32.96 87.14 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 6 3 # 6 C 151 SER C 32 SER~? 5.57 CA CA C1184 C 164 TYR D 5 TYR~? 13.80 CA CA C1181 C 168 LYS C 35 LYS~? 10.20 CA CA C1184 coo 11.22 34.38 82.32 11.07 36.29 83.78 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 8.83 39.27 87.38 7.60 37.43 85.69 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 12.98 34.46 88.14 8.11 32.96 87.14 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 7 3 # 7 C 151 SER C 172 SER~? 11.19 CA CA C1181 C 164 TYR C 175 TYR~? 10.79 CA CA C1181 C 168 LYS C 177 LYS.? 13.52 CA CA C1181 coo 11.22 34.38 82.32 11.07 36.29 83.78 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 8.83 39.27 87.38 7.60 37.43 85.69 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 12.98 34.46 88.14 8.11 32.96 87.14 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 8 3 # 8 C 151 SER D 172 SER~? 19.02 O3 GOL D1181 C 164 TYR D 175 TYR.? 24.43 OXT ACT A1182 C 168 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 11.22 34.38 82.32 11.07 36.29 83.78 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 8.83 39.27 87.38 7.60 37.43 85.69 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 12.98 34.46 88.14 8.11 32.96 87.14 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 8 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER A 172 SER~? 20.14 OXT ACT A1181 D 164 TYR A 175 TYR~? 24.50 O ACT A1182 D 168 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 29.15 32.90 92.57 27.86 31.44 94.02 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 25.49 30.28 98.59 27.88 31.73 98.26 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 23.46 34.31 94.02 27.08 36.46 97.29 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 D 151 SER B 31 SER~? 8.40 O1 GOL B1182 D 164 TYR A 5 TYR~? 13.40 O1 GOL B1182 D 168 LYS B 35 LYS~? 11.04 CA CA B1183 coo 29.15 32.90 92.57 27.86 31.44 94.02 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 25.49 30.28 98.59 27.88 31.73 98.26 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 23.46 34.31 94.02 27.08 36.46 97.29 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 D 151 SER B 32 SER~? 5.72 CA CA B1183 D 164 TYR A 5 TYR~? 13.40 O1 GOL B1182 D 168 LYS B 35 LYS~? 11.04 CA CA B1183 coo 29.15 32.90 92.57 27.86 31.44 94.02 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 25.49 30.28 98.59 27.88 31.73 98.26 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 23.46 34.31 94.02 27.08 36.46 97.29 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 D 151 SER B 172 SER~? 11.09 CA CA B1181 D 164 TYR B 175 TYR~? 10.51 CA CA B1181 D 168 LYS B 177 LYS.? 12.69 CA CA B1181 coo 29.15 32.90 92.57 27.86 31.44 94.02 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 25.49 30.28 98.59 27.88 31.73 98.26 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 23.46 34.31 94.02 27.08 36.46 97.29 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 D 151 SER C 31 SER.? 11.23 CA CA C1184 D 164 TYR D 5 TYR~? 13.80 CA CA C1181 D 168 LYS C 35 LYS~? 10.20 CA CA C1184 coo 29.15 32.90 92.57 27.86 31.44 94.02 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 25.49 30.28 98.59 27.88 31.73 98.26 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 23.46 34.31 94.02 27.08 36.46 97.29 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 6 3 # 6 D 151 SER C 32 SER~? 5.57 CA CA C1184 D 164 TYR D 5 TYR~? 13.80 CA CA C1181 D 168 LYS C 35 LYS~? 10.20 CA CA C1184 coo 29.15 32.90 92.57 27.86 31.44 94.02 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 25.49 30.28 98.59 27.88 31.73 98.26 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 23.46 34.31 94.02 27.08 36.46 97.29 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 7 3 # 7 D 151 SER C 172 SER~? 11.19 CA CA C1181 D 164 TYR C 175 TYR~? 10.79 CA CA C1181 D 168 LYS C 177 LYS.? 13.52 CA CA C1181 coo 29.15 32.90 92.57 27.86 31.44 94.02 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 25.49 30.28 98.59 27.88 31.73 98.26 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 23.46 34.31 94.02 27.08 36.46 97.29 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 8 3 # 8 D 151 SER D 172 SER~? 19.02 O3 GOL D1181 D 164 TYR D 175 TYR.? 24.43 OXT ACT A1182 D 168 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 29.15 32.90 92.57 27.86 31.44 94.02 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 25.49 30.28 98.59 27.88 31.73 98.26 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 23.46 34.31 94.02 27.08 36.46 97.29 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 8 hits 1gz6_c03 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 95 ASP~? 18.75 OXT ACT A1182 A 327 GLU B 10 GLU~? 20.86 OXT ACT A1181 A 339 ARG B 13 ARG~? 17.43 OXT ACT A1181 coo 85.81 57.99 116.01 86.03 55.86 115.89 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 75.11 41.01 160.30 76.65 40.06 161.41 -27.02 16.65 -20.13 -25.98 15.39 -21.46 coo 82.23 40.35 159.87 85.09 40.67 161.01 -32.45 21.03 -20.61 -29.60 19.86 -21.02 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 95 ASP~? 18.75 OXT ACT A1182 A 327 GLU B 17 GLU~? -13.09 CH3 ACT A1181s A 339 ARG B 13 ARG~? 17.43 OXT ACT A1181 coo 85.81 57.99 116.01 86.03 55.86 115.89 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 75.11 41.01 160.30 76.65 40.06 161.41 -38.08 19.88 -20.29 -36.49 20.35 -21.57 coo 82.23 40.35 159.87 85.09 40.67 161.01 -32.45 21.03 -20.61 -29.60 19.86 -21.02 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 144 ASP.? 22.46 O ACT A1181 A 327 GLU C 150 GLU.? 16.95 CA CA C1184 A 339 ARG C 58 ARG~? 18.42 O3 GOL D1181 coo 85.81 57.99 116.01 86.03 55.86 115.89 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 75.11 41.01 160.30 76.65 40.06 161.41 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 82.23 40.35 159.87 85.09 40.67 161.01 -48.43 -0.71 31.25 -46.65 0.17 33.60 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP B 95 ASP.? 16.79 O ACT C1183 A 327 GLU A 10 GLU~? 17.55 CA CA B1181 A 339 ARG A 13 ARG~? 17.46 CH3 ACT A1181 coo 85.81 57.99 116.01 86.03 55.86 115.89 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 75.11 41.01 160.30 76.65 40.06 161.41 -63.89 24.62 -14.30 -65.11 25.98 -13.14 coo 82.23 40.35 159.87 85.09 40.67 161.01 -58.47 23.67 -18.83 -59.87 25.50 -16.74 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP B 95 ASP.? 16.79 O ACT C1183 A 327 GLU A 17 GLU~? 13.61 CH3 ACT A1181 A 339 ARG A 13 ARG~? 17.46 CH3 ACT A1181 coo 85.81 57.99 116.01 86.03 55.86 115.89 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 75.11 41.01 160.30 76.65 40.06 161.41 -53.17 23.87 -17.57 -54.60 25.28 -18.31 coo 82.23 40.35 159.87 85.09 40.67 161.01 -58.47 23.67 -18.83 -59.87 25.50 -16.74 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP B 95 ASP.? 16.79 O ACT C1183 A 327 GLU C 10 GLU~? 13.45 CA CA C1182 A 339 ARG C 13 ARG~? 8.07 CA CA C1182 coo 85.81 57.99 116.01 86.03 55.86 115.89 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 75.11 41.01 160.30 76.65 40.06 161.41 -27.27 -16.59 46.83 -26.38 -15.22 48.19 coo 82.23 40.35 159.87 85.09 40.67 161.01 -32.51 -20.88 47.20 -29.56 -20.08 47.23 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP C 95 ASP~? 18.98 OXT ACT C1183 A 327 GLU D 10 GLU~? 18.53 CA CA C1181 A 339 ARG D 13 ARG~? 18.52 O1 GOL D1181 coo 85.81 57.99 116.01 86.03 55.86 115.89 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 -62.08 -25.49 39.96 -63.41 -27.01 39.21 coo 82.23 40.35 159.87 85.09 40.67 161.01 -58.59 -23.71 45.22 -61.26 -24.52 43.91 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP C 95 ASP~? 18.98 OXT ACT C1183 A 327 GLU D 17 GLU~? 13.36 O1 GOL D1181 A 339 ARG D 13 ARG~? 18.52 O1 GOL D1181 coo 85.81 57.99 116.01 86.03 55.86 115.89 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 -53.10 -23.91 44.12 -54.66 -25.27 44.77 coo 82.23 40.35 159.87 85.09 40.67 161.01 -58.59 -23.71 45.22 -61.26 -24.52 43.91 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP D 144 ASP.? 22.37 O2 GOL D1181 A 327 GLU B 150 GLU.? 13.13 O3 GOL B1182 A 339 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 85.81 57.99 116.01 86.03 55.86 115.89 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 75.11 41.01 160.30 76.65 40.06 161.41 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 82.23 40.35 159.87 85.09 40.67 161.01 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 9 hits 1hto_c00 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 200 ASP A 55 ASP.? 17.41 O ACT A1181 A 226 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 23.24 46.58 4.39 24.43 46.59 2.66 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 34.47 51.09 7.19 28.58 51.18 7.53 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS A 151 HIS.? 15.84 O ACT A1181 A 200 ASP A 152 ASP.? 5.90 O ACT A1181 A 226 LYS A 117 LYS.? 20.14 O ACT A1181 coo 23.24 46.58 4.39 24.43 46.59 2.66 -46.06 27.03 4.30 -45.69 27.09 6.36 coo 24.51 43.28 11.18 25.17 44.50 9.58 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 200 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 226 LYS B 93 LYS.? 14.57 O ACT C1183 coo 23.24 46.58 4.39 24.43 46.59 2.66 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 24.51 43.28 11.18 25.17 44.50 9.58 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 34.47 51.09 7.19 28.58 51.18 7.53 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1i29_c01 CSDB user 4 3 # 4 A 123 HIS B 151 HIS.? 14.53 O3 GOL B1182 A 200 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 226 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 23.24 46.58 4.39 24.43 46.59 2.66 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 24.51 43.28 11.18 25.17 44.50 9.58 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 34.47 51.09 7.19 28.58 51.18 7.53 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1i29_c01 CSDB user 5 3 # 5 A 123 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 200 ASP C 55 ASP.? 19.45 CA CA C1184 A 226 LYS C 93 LYS.? 19.61 OXT ACT C1183 coo 23.24 46.58 4.39 24.43 46.59 2.66 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 24.51 43.28 11.18 25.17 44.50 9.58 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 34.47 51.09 7.19 28.58 51.18 7.53 -54.93 14.23 21.55 -53.38 19.08 19.32 ULMN 3 1i29_c01 CSDB user 6 3 # 6 A 123 HIS C 151 HIS.? 19.99 CA CA C1184 A 200 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 226 LYS C 117 LYS.? 21.58 CA CA C1184 coo 23.24 46.58 4.39 24.43 46.59 2.66 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 24.51 43.28 11.18 25.17 44.50 9.58 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 34.47 51.09 7.19 28.58 51.18 7.53 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1i29_c01 CSDB user 7 3 # 7 A 123 HIS D 59 HIS~? 14.28 O ACT A1182 A 200 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 226 LYS C 72 LYS.? 18.71 O ACT C1183 coo 23.24 46.58 4.39 24.43 46.59 2.66 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 34.47 51.09 7.19 28.58 51.18 7.53 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1i29_c01 CSDB user 8 3 # 8 A 123 HIS D 114 HIS^? 15.97 O ACT A1182 A 200 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 226 LYS D 93 LYS.? 12.21 O ACT A1182 coo 23.24 46.58 4.39 24.43 46.59 2.66 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 34.47 51.09 7.19 28.58 51.18 7.53 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1i29_c01 CSDB user 9 3 # 9 A 123 HIS D 151 HIS.? 15.73 O2 GOL D1181 A 200 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 226 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 23.24 46.58 4.39 24.43 46.59 2.66 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo 24.51 43.28 11.18 25.17 44.50 9.58 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 34.47 51.09 7.19 28.58 51.18 7.53 -38.62 -20.39 16.44 -44.46 -21.28 15.46 1i29_c01 source 1i29 CSDB : 9 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 52 VAL^? 10.46 OXT ACT A1182 A 200 ASP A 55 ASP.? 17.41 O ACT A1181 A 226 LYS A 149 LYS.? 8.87 O ACT A1181 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -32.94 8.41 7.70 -33.51 7.90 5.60 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 34.47 51.09 7.19 28.58 51.18 7.53 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 52 VAL^? 10.46 OXT ACT A1182 A 200 ASP A 55 ASP.? 17.41 O ACT A1181 A 226 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -32.94 8.41 7.70 -33.51 7.90 5.60 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 34.47 51.09 7.19 28.58 51.18 7.53 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 115 VAL^? 15.97 O ACT A1181 A 200 ASP A 152 ASP.? 5.90 O ACT A1181 A 226 LYS B 164 LYS~? 10.34 O ACT A1181 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -36.13 15.59 5.61 -36.83 14.64 3.78 coo 24.51 43.28 11.18 25.17 44.50 9.58 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 34.47 51.09 7.19 28.58 51.18 7.53 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL B 52 VAL^? 10.37 O ACT C1183 A 200 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 226 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -57.65 1.84 3.37 -57.03 3.95 3.09 coo 24.51 43.28 11.18 25.17 44.50 9.58 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 34.47 51.09 7.19 28.58 51.18 7.53 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL B 115 VAL^? 11.10 O3 GOL B1182 A 200 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 226 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -54.47 1.00 -3.95 -53.73 3.06 -3.76 coo 24.51 43.28 11.18 25.17 44.50 9.58 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 34.47 51.09 7.19 28.58 51.18 7.53 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL C 52 VAL^? 10.37 OXT ACT C1183 A 200 ASP C 55 ASP.? 19.45 CA CA C1184 A 226 LYS C 149 LYS.? 9.01 CA CA C1184 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -57.64 -1.82 23.07 -57.06 -3.94 23.43 coo 24.51 43.28 11.18 25.17 44.50 9.58 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 34.47 51.09 7.19 28.58 51.18 7.53 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL C 115 VAL^? 15.88 CA CA C1184 A 200 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 226 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -54.45 -0.99 30.41 -53.78 -3.10 30.27 coo 24.51 43.28 11.18 25.17 44.50 9.58 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 34.47 51.09 7.19 28.58 51.18 7.53 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL D 52 VAL^? 10.48 O ACT A1182 A 200 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 226 LYS C 72 LYS.? 18.71 O ACT C1183 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -32.95 -8.43 18.76 -33.52 -7.91 20.86 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 34.47 51.09 7.19 28.58 51.18 7.53 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL D 52 VAL^? 10.48 O ACT A1182 A 200 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 226 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -32.95 -8.43 18.76 -33.52 -7.91 20.86 coo 24.51 43.28 11.18 25.17 44.50 9.58 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 34.47 51.09 7.19 28.58 51.18 7.53 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL D 115 VAL^? 15.36 O3 GOL D1181 A 200 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 226 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -36.13 -15.57 20.89 -36.85 -14.63 22.69 coo 24.51 43.28 11.18 25.17 44.50 9.58 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 34.47 51.09 7.19 28.58 51.18 7.53 -54.90 -15.84 30.45 -50.06 -17.66 28.47 1i29_c03 source 1i29 CSDB : 10 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 72 LYS.? 19.74 O ACT A1182 A 74 LYS D 93 LYS.? 12.21 O ACT A1182 A 165 GLU A 76 GLU.? 24.24 O ACT A1182 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -29.57 -9.56 -10.67 -29.13 -11.11 -9.28 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS C 72 LYS.? 18.71 O ACT C1183 A 74 LYS C 75 LYS.? 21.97 O2 GOL D1181 A 165 GLU C 167 GLU~? 15.18 C1 GOL D1181 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -57.40 -22.87 13.44 -53.97 -26.42 17.14 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -56.84 -16.73 27.22 -55.09 -16.98 26.08 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS C 72 LYS.? 18.71 O ACT C1183 A 74 LYS C 75 LYS.? 21.97 O2 GOL D1181 A 165 GLU D 150 GLU.? 17.20 O2 GOL D1181 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -57.40 -22.87 13.44 -53.97 -26.42 17.14 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -42.98 -24.43 20.59 -42.64 -25.02 18.59 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS C 75 LYS.? 21.97 O2 GOL D1181 A 74 LYS C 72 LYS.? 18.71 O ACT C1183 A 165 GLU C 167 GLU~? 15.18 C1 GOL D1181 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -57.40 -22.87 13.44 -53.97 -26.42 17.14 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -56.84 -16.73 27.22 -55.09 -16.98 26.08 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS C 75 LYS.? 21.97 O2 GOL D1181 A 74 LYS C 72 LYS.? 18.71 O ACT C1183 A 165 GLU D 150 GLU.? 17.20 O2 GOL D1181 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -57.40 -22.87 13.44 -53.97 -26.42 17.14 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -42.98 -24.43 20.59 -42.64 -25.02 18.59 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS D 93 LYS.? 12.21 O ACT A1182 A 74 LYS A 72 LYS.? 19.74 O ACT A1182 A 165 GLU A 76 GLU.? 24.24 O ACT A1182 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -29.57 -9.56 -10.67 -29.13 -11.11 -9.28 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 6 hits 1idt_c00 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 57 SER.? 18.23 O ACT A1181 A 173 ARG B 77 ARG.? 16.85 CA CA B1181 A 211 ASP A 55 ASP.? 17.41 O ACT A1181 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -45.76 15.37 8.19 -46.87 17.43 8.67 coo 18.77 77.82 11.69 20.55 80.22 10.73 -57.98 19.33 8.28 -57.78 17.70 5.69 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER B 57 SER.? 17.44 O3 GOL B1182 A 173 ARG A 77 ARG.? 18.54 O ACT A1182 A 211 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 coo 18.77 77.82 11.69 20.55 80.22 10.73 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER C 57 SER.? 20.56 O3 GOL D1181 A 173 ARG D 77 ARG.? 18.56 OXT ACT A1182 A 211 ASP C 55 ASP.? 19.45 CA CA C1184 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -44.87 1.18 29.24 -43.70 2.34 31.00 coo 18.77 77.82 11.69 20.55 80.22 10.73 -32.91 2.84 33.04 -33.00 -0.18 32.51 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1ig8_c00 HEXOKINASE PII user 4 3 # 4 A 158 SER D 57 SER.? 18.28 O2 GOL D1181 A 173 ARG C 77 ARG.? 17.10 CA CA C1181 A 211 ASP D 55 ASP.? 17.43 O2 GOL D1181 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -45.75 -15.36 18.26 -46.91 -17.39 17.79 coo 18.77 77.82 11.69 20.55 80.22 10.73 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -40.72 -16.97 16.40 -41.69 -17.43 18.23 1ig8_c00 source 1ig8 HEXOKINASE PII : 4 hits 1ig8_c00 naa= 3 ULMN 3 1iph_c00 CATALASE HPII user 1 3 # 1 A 128 HIS A 43 HIS~? 14.01 CH3 ACT A1182 A 167 SER A 42 SER~? 22.64 CH3 ACT A1182 A 201 ASN A 109 ASN.? 14.39 CH3 ACT A1182 coo 12.95 4.49 19.05 14.87 4.39 19.77 -21.65 8.05 3.64 -22.04 7.30 5.57 coo 10.44 7.96 22.51 12.16 7.57 20.82 -19.46 8.46 -2.16 -18.17 10.05 -3.40 coo 19.43 6.74 22.83 19.09 5.15 21.60 -18.98 4.63 8.19 -18.49 6.24 6.88 ULMN 3 1iph_c00 CATALASE HPII user 2 3 # 2 A 128 HIS A 43 HIS~? 14.01 CH3 ACT A1182 A 167 SER A 49 SER^? 7.92 CH3 ACT A1182 A 201 ASN A 46 ASN~? 20.18 CH3 ACT A1182 coo 12.95 4.49 19.05 14.87 4.39 19.77 -21.65 8.05 3.64 -22.04 7.30 5.57 coo 10.44 7.96 22.51 12.16 7.57 20.82 -24.82 3.72 6.45 -24.44 3.87 8.86 coo 19.43 6.74 22.83 19.09 5.15 21.60 -16.92 5.08 1.56 -15.60 6.18 0.30 ULMN 3 1iph_c00 CATALASE HPII user 3 3 # 3 A 128 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 167 SER A 56 SER.? 20.33 OXT ACT A1182 A 201 ASN A 86 ASN.? 11.67 OXT ACT A1182 coo 12.95 4.49 19.05 14.87 4.39 19.77 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 10.44 7.96 22.51 12.16 7.57 20.82 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 19.43 6.74 22.83 19.09 5.15 21.60 -38.42 8.17 12.63 -38.52 10.18 11.86 ULMN 3 1iph_c00 CATALASE HPII user 4 3 # 4 A 128 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 167 SER A 56 SER.? 20.33 OXT ACT A1182 A 201 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo 12.95 4.49 19.05 14.87 4.39 19.77 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 10.44 7.96 22.51 12.16 7.57 20.82 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 19.43 6.74 22.83 19.09 5.15 21.60 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1iph_c00 CATALASE HPII user 5 3 # 5 A 128 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 167 SER A 57 SER.? 18.23 O ACT A1181 A 201 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo 12.95 4.49 19.05 14.87 4.39 19.77 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 10.44 7.96 22.51 12.16 7.57 20.82 -45.76 15.37 8.19 -46.87 17.43 8.67 coo 19.43 6.74 22.83 19.09 5.15 21.60 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1iph_c00 CATALASE HPII user 6 3 # 6 A 128 HIS B 43 HIS~? 14.15 CH3 ACT C1183 A 167 SER B 42 SER~? 9.53 CA CA B1181 A 201 ASN B 109 ASN.? 14.52 CH3 ACT C1183 coo 12.95 4.49 19.05 14.87 4.39 19.77 -68.93 5.59 2.00 -68.67 4.03 3.39 coo 10.44 7.96 22.51 12.16 7.57 20.82 -71.32 10.68 -0.61 -72.48 11.28 -2.66 coo 19.43 6.74 22.83 19.09 5.15 21.60 -71.64 2.73 6.90 -72.13 3.19 4.89 ULMN 3 1iph_c00 CATALASE HPII user 7 3 # 7 A 128 HIS B 43 HIS~? 14.15 CH3 ACT C1183 A 167 SER B 49 SER^? 8.06 CH3 ACT C1183 A 201 ASN B 46 ASN~? 10.46 CA CA B1181 coo 12.95 4.49 19.05 14.87 4.39 19.77 -68.93 5.59 2.00 -68.67 4.03 3.39 coo 10.44 7.96 22.51 12.16 7.57 20.82 -65.82 4.78 7.06 -66.17 2.51 7.90 coo 19.43 6.74 22.83 19.09 5.15 21.60 -74.04 8.69 3.83 -75.20 9.76 2.34 ULMN 3 1iph_c00 CATALASE HPII user 8 3 # 8 A 128 HIS B 59 HIS~? 15.18 O ACT C1183 A 167 SER B 56 SER.? 19.73 O3 GOL B1182 A 201 ASN A 63 ASN~? 15.00 O ACT A1182 coo 12.95 4.49 19.05 14.87 4.39 19.77 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 10.44 7.96 22.51 12.16 7.57 20.82 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 19.43 6.74 22.83 19.09 5.15 21.60 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1iph_c00 CATALASE HPII user 9 3 # 9 A 128 HIS B 59 HIS~? 15.18 O ACT C1183 A 167 SER B 56 SER.? 19.73 O3 GOL B1182 A 201 ASN B 86 ASN.? 11.57 O ACT C1183 coo 12.95 4.49 19.05 14.87 4.39 19.77 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 10.44 7.96 22.51 12.16 7.57 20.82 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 19.43 6.74 22.83 19.09 5.15 21.60 -52.20 -2.48 5.54 -51.99 -2.60 3.42 ULMN 3 1iph_c00 CATALASE HPII user 10 3 # 10 A 128 HIS B 59 HIS~? 15.18 O ACT C1183 A 167 SER B 57 SER.? 17.44 O3 GOL B1182 A 201 ASN A 63 ASN~? 15.00 O ACT A1182 coo 12.95 4.49 19.05 14.87 4.39 19.77 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 10.44 7.96 22.51 12.16 7.57 20.82 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 coo 19.43 6.74 22.83 19.09 5.15 21.60 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1iph_c00 CATALASE HPII user 11 3 # 11 A 128 HIS C 43 HIS~? 14.16 CH3 ACT C1183 A 167 SER C 42 SER~? 9.40 CA CA C1181 A 201 ASN C 109 ASN.? 14.51 CH3 ACT C1183 coo 12.95 4.49 19.05 14.87 4.39 19.77 -69.05 -5.52 24.49 -68.63 -4.06 23.04 coo 10.44 7.96 22.51 12.16 7.57 20.82 -71.30 -10.68 27.08 -72.47 -11.31 29.07 coo 19.43 6.74 22.83 19.09 5.15 21.60 -71.64 -2.74 19.53 -72.13 -3.21 21.54 ULMN 3 1iph_c00 CATALASE HPII user 12 3 # 12 A 128 HIS C 43 HIS~? 14.16 CH3 ACT C1183 A 167 SER C 49 SER^? 8.04 CH3 ACT C1183 A 201 ASN C 46 ASN~? 10.53 CA CA C1181 coo 12.95 4.49 19.05 14.87 4.39 19.77 -69.05 -5.52 24.49 -68.63 -4.06 23.04 coo 10.44 7.96 22.51 12.16 7.57 20.82 -65.83 -4.76 19.39 -66.15 -2.47 18.58 coo 19.43 6.74 22.83 19.09 5.15 21.60 -74.04 -8.67 22.63 -75.10 -9.60 24.27 ULMN 3 1iph_c00 CATALASE HPII user 13 3 # 13 A 128 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 167 SER C 56 SER.? 20.22 OXT ACT C1183 A 201 ASN C 86 ASN.? 11.54 OXT ACT C1183 coo 12.95 4.49 19.05 14.87 4.39 19.77 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 10.44 7.96 22.51 12.16 7.57 20.82 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 19.43 6.74 22.83 19.09 5.15 21.60 -52.20 2.48 20.90 -52.01 2.64 23.02 ULMN 3 1iph_c00 CATALASE HPII user 14 3 # 14 A 128 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 167 SER C 56 SER.? 20.22 OXT ACT C1183 A 201 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo 12.95 4.49 19.05 14.87 4.39 19.77 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 10.44 7.96 22.51 12.16 7.57 20.82 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 19.43 6.74 22.83 19.09 5.15 21.60 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1iph_c00 CATALASE HPII user 15 3 # 15 A 128 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 167 SER C 57 SER.? 20.56 O3 GOL D1181 A 201 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo 12.95 4.49 19.05 14.87 4.39 19.77 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 10.44 7.96 22.51 12.16 7.57 20.82 -44.87 1.18 29.24 -43.70 2.34 31.00 coo 19.43 6.74 22.83 19.09 5.15 21.60 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1iph_c00 CATALASE HPII user 16 3 # 16 A 128 HIS D 43 HIS~? 14.01 CH3 ACT A1182 A 167 SER D 42 SER~? 22.67 CH3 ACT A1182 A 201 ASN D 109 ASN.? 14.36 CH3 ACT A1182 coo 12.95 4.49 19.05 14.87 4.39 19.77 -21.76 -7.99 22.88 -22.00 -7.32 20.90 coo 10.44 7.96 22.51 12.16 7.57 20.82 -19.49 -8.50 28.63 -18.22 -10.13 29.88 coo 19.43 6.74 22.83 19.09 5.15 21.60 -18.98 -4.62 18.28 -18.54 -6.24 19.59 ULMN 3 1iph_c00 CATALASE HPII user 17 3 # 17 A 128 HIS D 43 HIS~? 14.01 CH3 ACT A1182 A 167 SER D 49 SER^? 7.93 CH3 ACT A1182 A 201 ASN D 46 ASN~? 18.62 CH3 ACT A1182 coo 12.95 4.49 19.05 14.87 4.39 19.77 -21.76 -7.99 22.88 -22.00 -7.32 20.90 coo 10.44 7.96 22.51 12.16 7.57 20.82 -24.82 -3.74 20.02 -24.43 -3.84 17.62 coo 19.43 6.74 22.83 19.09 5.15 21.60 -16.96 -5.07 24.82 -15.16 -4.92 23.63 ULMN 3 1iph_c00 CATALASE HPII user 18 3 # 18 A 128 HIS D 59 HIS~? 14.28 O ACT A1182 A 167 SER D 56 SER.? 20.40 O ACT A1182 A 201 ASN D 86 ASN.? 11.74 O ACT A1182 coo 12.95 4.49 19.05 14.87 4.39 19.77 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 10.44 7.96 22.51 12.16 7.57 20.82 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 19.43 6.74 22.83 19.09 5.15 21.60 -38.34 -8.19 13.90 -38.52 -10.20 14.65 1iph_c00 source 1iph CATALASE HPII : 18 hits 1iph_c00 naa= 3 ULMN 3 1iph_c01 CATALASE HPII user 1 3 # 1 B 128 HIS A 43 HIS~? 14.01 CH3 ACT A1182 B 167 SER A 42 SER~? 22.64 CH3 ACT A1182 B 201 ASN A 109 ASN.? 14.39 CH3 ACT A1182 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -21.65 8.05 3.64 -22.04 7.30 5.57 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -19.46 8.46 -2.16 -18.17 10.05 -3.40 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -18.98 4.63 8.19 -18.49 6.24 6.88 ULMN 3 1iph_c01 CATALASE HPII user 2 3 # 2 B 128 HIS A 43 HIS~? 14.01 CH3 ACT A1182 B 167 SER A 49 SER^? 7.92 CH3 ACT A1182 B 201 ASN A 46 ASN~? 20.18 CH3 ACT A1182 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -21.65 8.05 3.64 -22.04 7.30 5.57 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -24.82 3.72 6.45 -24.44 3.87 8.86 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -16.92 5.08 1.56 -15.60 6.18 0.30 ULMN 3 1iph_c01 CATALASE HPII user 3 3 # 3 B 128 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 167 SER A 56 SER.? 20.33 OXT ACT A1182 B 201 ASN A 86 ASN.? 11.67 OXT ACT A1182 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -44.08 14.33 11.46 -44.92 16.36 12.58 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -38.42 8.17 12.63 -38.52 10.18 11.86 ULMN 3 1iph_c01 CATALASE HPII user 4 3 # 4 B 128 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 167 SER A 56 SER.? 20.33 OXT ACT A1182 B 201 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -44.08 14.33 11.46 -44.92 16.36 12.58 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1iph_c01 CATALASE HPII user 5 3 # 5 B 128 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 167 SER A 57 SER.? 18.23 O ACT A1181 B 201 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -45.76 15.37 8.19 -46.87 17.43 8.67 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1iph_c01 CATALASE HPII user 6 3 # 6 B 128 HIS B 43 HIS~? 14.15 CH3 ACT C1183 B 167 SER B 42 SER~? 9.53 CA CA B1181 B 201 ASN B 109 ASN.? 14.52 CH3 ACT C1183 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -68.93 5.59 2.00 -68.67 4.03 3.39 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -71.32 10.68 -0.61 -72.48 11.28 -2.66 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -71.64 2.73 6.90 -72.13 3.19 4.89 ULMN 3 1iph_c01 CATALASE HPII user 7 3 # 7 B 128 HIS B 43 HIS~? 14.15 CH3 ACT C1183 B 167 SER B 49 SER^? 8.06 CH3 ACT C1183 B 201 ASN B 46 ASN~? 10.46 CA CA B1181 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -68.93 5.59 2.00 -68.67 4.03 3.39 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -65.82 4.78 7.06 -66.17 2.51 7.90 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -74.04 8.69 3.83 -75.20 9.76 2.34 ULMN 3 1iph_c01 CATALASE HPII user 8 3 # 8 B 128 HIS B 59 HIS~? 15.18 O ACT C1183 B 167 SER B 56 SER.? 19.73 O3 GOL B1182 B 201 ASN A 63 ASN~? 15.00 O ACT A1182 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1iph_c01 CATALASE HPII user 9 3 # 9 B 128 HIS B 59 HIS~? 15.18 O ACT C1183 B 167 SER B 56 SER.? 19.73 O3 GOL B1182 B 201 ASN B 86 ASN.? 11.57 O ACT C1183 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -52.20 -2.48 5.54 -51.99 -2.60 3.42 ULMN 3 1iph_c01 CATALASE HPII user 10 3 # 10 B 128 HIS B 59 HIS~? 15.18 O ACT C1183 B 167 SER B 57 SER.? 17.44 O3 GOL B1182 B 201 ASN A 63 ASN~? 15.00 O ACT A1182 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1iph_c01 CATALASE HPII user 11 3 # 11 B 128 HIS C 43 HIS~? 14.16 CH3 ACT C1183 B 167 SER C 42 SER~? 9.40 CA CA C1181 B 201 ASN C 109 ASN.? 14.51 CH3 ACT C1183 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -69.05 -5.52 24.49 -68.63 -4.06 23.04 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -71.30 -10.68 27.08 -72.47 -11.31 29.07 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -71.64 -2.74 19.53 -72.13 -3.21 21.54 ULMN 3 1iph_c01 CATALASE HPII user 12 3 # 12 B 128 HIS C 43 HIS~? 14.16 CH3 ACT C1183 B 167 SER C 49 SER^? 8.04 CH3 ACT C1183 B 201 ASN C 46 ASN~? 10.53 CA CA C1181 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -69.05 -5.52 24.49 -68.63 -4.06 23.04 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -65.83 -4.76 19.39 -66.15 -2.47 18.58 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -74.04 -8.67 22.63 -75.10 -9.60 24.27 ULMN 3 1iph_c01 CATALASE HPII user 13 3 # 13 B 128 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 167 SER C 56 SER.? 20.22 OXT ACT C1183 B 201 ASN C 86 ASN.? 11.54 OXT ACT C1183 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -46.89 1.05 23.56 -47.29 3.11 23.40 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -46.48 3.79 27.00 -45.42 5.54 28.32 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -52.20 2.48 20.90 -52.01 2.64 23.02 ULMN 3 1iph_c01 CATALASE HPII user 14 3 # 14 B 128 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 167 SER C 56 SER.? 20.22 OXT ACT C1183 B 201 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -46.89 1.05 23.56 -47.29 3.11 23.40 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -46.48 3.79 27.00 -45.42 5.54 28.32 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1iph_c01 CATALASE HPII user 15 3 # 15 B 128 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 167 SER C 57 SER.? 20.56 O3 GOL D1181 B 201 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -46.89 1.05 23.56 -47.29 3.11 23.40 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -44.87 1.18 29.24 -43.70 2.34 31.00 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1iph_c01 CATALASE HPII user 16 3 # 16 B 128 HIS D 43 HIS~? 14.01 CH3 ACT A1182 B 167 SER D 42 SER~? 22.67 CH3 ACT A1182 B 201 ASN D 109 ASN.? 14.36 CH3 ACT A1182 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -21.76 -7.99 22.88 -22.00 -7.32 20.90 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -19.49 -8.50 28.63 -18.22 -10.13 29.88 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -18.98 -4.62 18.28 -18.54 -6.24 19.59 ULMN 3 1iph_c01 CATALASE HPII user 17 3 # 17 B 128 HIS D 43 HIS~? 14.01 CH3 ACT A1182 B 167 SER D 49 SER^? 7.93 CH3 ACT A1182 B 201 ASN D 46 ASN~? 18.62 CH3 ACT A1182 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -21.76 -7.99 22.88 -22.00 -7.32 20.90 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -24.82 -3.74 20.02 -24.43 -3.84 17.62 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -16.96 -5.07 24.82 -15.16 -4.92 23.63 ULMN 3 1iph_c01 CATALASE HPII user 18 3 # 18 B 128 HIS D 59 HIS~? 14.28 O ACT A1182 B 167 SER D 56 SER.? 20.40 O ACT A1182 B 201 ASN D 86 ASN.? 11.74 O ACT A1182 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -38.34 -8.19 13.90 -38.52 -10.20 14.65 1iph_c01 source 1iph CATALASE HPII : 18 hits 1iph_c01 naa= 3 ULMN 3 1iph_c02 CATALASE HPII user 1 3 # 1 C 128 HIS A 43 HIS~? 14.01 CH3 ACT A1182 C 167 SER A 42 SER~? 22.64 CH3 ACT A1182 C 201 ASN A 109 ASN.? 14.39 CH3 ACT A1182 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -21.65 8.05 3.64 -22.04 7.30 5.57 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -19.46 8.46 -2.16 -18.17 10.05 -3.40 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -18.98 4.63 8.19 -18.49 6.24 6.88 ULMN 3 1iph_c02 CATALASE HPII user 2 3 # 2 C 128 HIS A 43 HIS~? 14.01 CH3 ACT A1182 C 167 SER A 49 SER^? 7.92 CH3 ACT A1182 C 201 ASN A 46 ASN~? 20.18 CH3 ACT A1182 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -21.65 8.05 3.64 -22.04 7.30 5.57 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -24.82 3.72 6.45 -24.44 3.87 8.86 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -16.92 5.08 1.56 -15.60 6.18 0.30 ULMN 3 1iph_c02 CATALASE HPII user 3 3 # 3 C 128 HIS A 59 HIS~? 15.34 OXT ACT A1182 C 167 SER A 56 SER.? 20.33 OXT ACT A1182 C 201 ASN A 86 ASN.? 11.67 OXT ACT A1182 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -44.08 14.33 11.46 -44.92 16.36 12.58 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -38.42 8.17 12.63 -38.52 10.18 11.86 ULMN 3 1iph_c02 CATALASE HPII user 4 3 # 4 C 128 HIS A 59 HIS~? 15.34 OXT ACT A1182 C 167 SER A 56 SER.? 20.33 OXT ACT A1182 C 201 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -44.08 14.33 11.46 -44.92 16.36 12.58 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1iph_c02 CATALASE HPII user 5 3 # 5 C 128 HIS A 59 HIS~? 15.34 OXT ACT A1182 C 167 SER A 57 SER.? 18.23 O ACT A1181 C 201 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -45.76 15.37 8.19 -46.87 17.43 8.67 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1iph_c02 CATALASE HPII user 6 3 # 6 C 128 HIS B 43 HIS~? 14.15 CH3 ACT C1183 C 167 SER B 42 SER~? 9.53 CA CA B1181 C 201 ASN B 109 ASN.? 14.52 CH3 ACT C1183 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -68.93 5.59 2.00 -68.67 4.03 3.39 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -71.32 10.68 -0.61 -72.48 11.28 -2.66 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -71.64 2.73 6.90 -72.13 3.19 4.89 ULMN 3 1iph_c02 CATALASE HPII user 7 3 # 7 C 128 HIS B 43 HIS~? 14.15 CH3 ACT C1183 C 167 SER B 49 SER^? 8.06 CH3 ACT C1183 C 201 ASN B 46 ASN~? 10.46 CA CA B1181 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -68.93 5.59 2.00 -68.67 4.03 3.39 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -65.82 4.78 7.06 -66.17 2.51 7.90 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -74.04 8.69 3.83 -75.20 9.76 2.34 ULMN 3 1iph_c02 CATALASE HPII user 8 3 # 8 C 128 HIS B 59 HIS~? 15.18 O ACT C1183 C 167 SER B 56 SER.? 19.73 O3 GOL B1182 C 201 ASN A 63 ASN~? 15.00 O ACT A1182 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1iph_c02 CATALASE HPII user 9 3 # 9 C 128 HIS B 59 HIS~? 15.18 O ACT C1183 C 167 SER B 56 SER.? 19.73 O3 GOL B1182 C 201 ASN B 86 ASN.? 11.57 O ACT C1183 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -52.20 -2.48 5.54 -51.99 -2.60 3.42 ULMN 3 1iph_c02 CATALASE HPII user 10 3 # 10 C 128 HIS B 59 HIS~? 15.18 O ACT C1183 C 167 SER B 57 SER.? 17.44 O3 GOL B1182 C 201 ASN A 63 ASN~? 15.00 O ACT A1182 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1iph_c02 CATALASE HPII user 11 3 # 11 C 128 HIS C 43 HIS~? 14.16 CH3 ACT C1183 C 167 SER C 42 SER~? 9.40 CA CA C1181 C 201 ASN C 109 ASN.? 14.51 CH3 ACT C1183 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -69.05 -5.52 24.49 -68.63 -4.06 23.04 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -71.30 -10.68 27.08 -72.47 -11.31 29.07 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -71.64 -2.74 19.53 -72.13 -3.21 21.54 ULMN 3 1iph_c02 CATALASE HPII user 12 3 # 12 C 128 HIS C 43 HIS~? 14.16 CH3 ACT C1183 C 167 SER C 49 SER^? 8.04 CH3 ACT C1183 C 201 ASN C 46 ASN~? 10.53 CA CA C1181 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -69.05 -5.52 24.49 -68.63 -4.06 23.04 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -65.83 -4.76 19.39 -66.15 -2.47 18.58 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -74.04 -8.67 22.63 -75.10 -9.60 24.27 ULMN 3 1iph_c02 CATALASE HPII user 13 3 # 13 C 128 HIS C 59 HIS~? 15.17 OXT ACT C1183 C 167 SER C 56 SER.? 20.22 OXT ACT C1183 C 201 ASN C 86 ASN.? 11.54 OXT ACT C1183 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -46.89 1.05 23.56 -47.29 3.11 23.40 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -46.48 3.79 27.00 -45.42 5.54 28.32 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -52.20 2.48 20.90 -52.01 2.64 23.02 ULMN 3 1iph_c02 CATALASE HPII user 14 3 # 14 C 128 HIS C 59 HIS~? 15.17 OXT ACT C1183 C 167 SER C 56 SER.? 20.22 OXT ACT C1183 C 201 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -46.89 1.05 23.56 -47.29 3.11 23.40 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -46.48 3.79 27.00 -45.42 5.54 28.32 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1iph_c02 CATALASE HPII user 15 3 # 15 C 128 HIS C 59 HIS~? 15.17 OXT ACT C1183 C 167 SER C 57 SER.? 20.56 O3 GOL D1181 C 201 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -46.89 1.05 23.56 -47.29 3.11 23.40 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -44.87 1.18 29.24 -43.70 2.34 31.00 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1iph_c02 CATALASE HPII user 16 3 # 16 C 128 HIS D 43 HIS~? 14.01 CH3 ACT A1182 C 167 SER D 42 SER~? 22.67 CH3 ACT A1182 C 201 ASN D 109 ASN.? 14.36 CH3 ACT A1182 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -21.76 -7.99 22.88 -22.00 -7.32 20.90 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -19.49 -8.50 28.63 -18.22 -10.13 29.88 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -18.98 -4.62 18.28 -18.54 -6.24 19.59 ULMN 3 1iph_c02 CATALASE HPII user 17 3 # 17 C 128 HIS D 43 HIS~? 14.01 CH3 ACT A1182 C 167 SER D 49 SER^? 7.93 CH3 ACT A1182 C 201 ASN D 46 ASN~? 18.62 CH3 ACT A1182 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -21.76 -7.99 22.88 -22.00 -7.32 20.90 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -24.82 -3.74 20.02 -24.43 -3.84 17.62 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -16.96 -5.07 24.82 -15.16 -4.92 23.63 ULMN 3 1iph_c02 CATALASE HPII user 18 3 # 18 C 128 HIS D 59 HIS~? 14.28 O ACT A1182 C 167 SER D 56 SER.? 20.40 O ACT A1182 C 201 ASN D 86 ASN.? 11.74 O ACT A1182 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -38.34 -8.19 13.90 -38.52 -10.20 14.65 1iph_c02 source 1iph CATALASE HPII : 18 hits 1iph_c02 naa= 3 ULMN 3 1iph_c03 CATALASE HPII user 1 3 # 1 D 128 HIS A 43 HIS~? 14.01 CH3 ACT A1182 D 167 SER A 42 SER~? 22.64 CH3 ACT A1182 D 201 ASN A 109 ASN.? 14.39 CH3 ACT A1182 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -21.65 8.05 3.64 -22.04 7.30 5.57 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -19.46 8.46 -2.16 -18.17 10.05 -3.40 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -18.98 4.63 8.19 -18.49 6.24 6.88 ULMN 3 1iph_c03 CATALASE HPII user 2 3 # 2 D 128 HIS A 43 HIS~? 14.01 CH3 ACT A1182 D 167 SER A 49 SER^? 7.92 CH3 ACT A1182 D 201 ASN A 46 ASN~? 20.18 CH3 ACT A1182 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -21.65 8.05 3.64 -22.04 7.30 5.57 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -24.82 3.72 6.45 -24.44 3.87 8.86 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -16.92 5.08 1.56 -15.60 6.18 0.30 ULMN 3 1iph_c03 CATALASE HPII user 3 3 # 3 D 128 HIS A 59 HIS~? 15.34 OXT ACT A1182 D 167 SER A 56 SER.? 20.33 OXT ACT A1182 D 201 ASN A 86 ASN.? 11.67 OXT ACT A1182 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -38.42 8.17 12.63 -38.52 10.18 11.86 ULMN 3 1iph_c03 CATALASE HPII user 4 3 # 4 D 128 HIS A 59 HIS~? 15.34 OXT ACT A1182 D 167 SER A 56 SER.? 20.33 OXT ACT A1182 D 201 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1iph_c03 CATALASE HPII user 5 3 # 5 D 128 HIS A 59 HIS~? 15.34 OXT ACT A1182 D 167 SER A 57 SER.? 18.23 O ACT A1181 D 201 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -45.76 15.37 8.19 -46.87 17.43 8.67 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1iph_c03 CATALASE HPII user 6 3 # 6 D 128 HIS B 43 HIS~? 14.15 CH3 ACT C1183 D 167 SER B 42 SER~? 9.53 CA CA B1181 D 201 ASN B 109 ASN.? 14.52 CH3 ACT C1183 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -68.93 5.59 2.00 -68.67 4.03 3.39 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -71.32 10.68 -0.61 -72.48 11.28 -2.66 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -71.64 2.73 6.90 -72.13 3.19 4.89 ULMN 3 1iph_c03 CATALASE HPII user 7 3 # 7 D 128 HIS B 43 HIS~? 14.15 CH3 ACT C1183 D 167 SER B 49 SER^? 8.06 CH3 ACT C1183 D 201 ASN B 46 ASN~? 10.46 CA CA B1181 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -68.93 5.59 2.00 -68.67 4.03 3.39 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -65.82 4.78 7.06 -66.17 2.51 7.90 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -74.04 8.69 3.83 -75.20 9.76 2.34 ULMN 3 1iph_c03 CATALASE HPII user 8 3 # 8 D 128 HIS B 59 HIS~? 15.18 O ACT C1183 D 167 SER B 56 SER.? 19.73 O3 GOL B1182 D 201 ASN A 63 ASN~? 15.00 O ACT A1182 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1iph_c03 CATALASE HPII user 9 3 # 9 D 128 HIS B 59 HIS~? 15.18 O ACT C1183 D 167 SER B 56 SER.? 19.73 O3 GOL B1182 D 201 ASN B 86 ASN.? 11.57 O ACT C1183 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -52.20 -2.48 5.54 -51.99 -2.60 3.42 ULMN 3 1iph_c03 CATALASE HPII user 10 3 # 10 D 128 HIS B 59 HIS~? 15.18 O ACT C1183 D 167 SER B 57 SER.? 17.44 O3 GOL B1182 D 201 ASN A 63 ASN~? 15.00 O ACT A1182 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1iph_c03 CATALASE HPII user 11 3 # 11 D 128 HIS C 43 HIS~? 14.16 CH3 ACT C1183 D 167 SER C 42 SER~? 9.40 CA CA C1181 D 201 ASN C 109 ASN.? 14.51 CH3 ACT C1183 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -69.05 -5.52 24.49 -68.63 -4.06 23.04 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -71.30 -10.68 27.08 -72.47 -11.31 29.07 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -71.64 -2.74 19.53 -72.13 -3.21 21.54 ULMN 3 1iph_c03 CATALASE HPII user 12 3 # 12 D 128 HIS C 43 HIS~? 14.16 CH3 ACT C1183 D 167 SER C 49 SER^? 8.04 CH3 ACT C1183 D 201 ASN C 46 ASN~? 10.53 CA CA C1181 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -69.05 -5.52 24.49 -68.63 -4.06 23.04 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -65.83 -4.76 19.39 -66.15 -2.47 18.58 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -74.04 -8.67 22.63 -75.10 -9.60 24.27 ULMN 3 1iph_c03 CATALASE HPII user 13 3 # 13 D 128 HIS C 59 HIS~? 15.17 OXT ACT C1183 D 167 SER C 56 SER.? 20.22 OXT ACT C1183 D 201 ASN C 86 ASN.? 11.54 OXT ACT C1183 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -52.20 2.48 20.90 -52.01 2.64 23.02 ULMN 3 1iph_c03 CATALASE HPII user 14 3 # 14 D 128 HIS C 59 HIS~? 15.17 OXT ACT C1183 D 167 SER C 56 SER.? 20.22 OXT ACT C1183 D 201 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1iph_c03 CATALASE HPII user 15 3 # 15 D 128 HIS C 59 HIS~? 15.17 OXT ACT C1183 D 167 SER C 57 SER.? 20.56 O3 GOL D1181 D 201 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -44.87 1.18 29.24 -43.70 2.34 31.00 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1iph_c03 CATALASE HPII user 16 3 # 16 D 128 HIS D 43 HIS~? 14.01 CH3 ACT A1182 D 167 SER D 42 SER~? 22.67 CH3 ACT A1182 D 201 ASN D 109 ASN.? 14.36 CH3 ACT A1182 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -21.76 -7.99 22.88 -22.00 -7.32 20.90 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -19.49 -8.50 28.63 -18.22 -10.13 29.88 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -18.98 -4.62 18.28 -18.54 -6.24 19.59 ULMN 3 1iph_c03 CATALASE HPII user 17 3 # 17 D 128 HIS D 43 HIS~? 14.01 CH3 ACT A1182 D 167 SER D 49 SER^? 7.93 CH3 ACT A1182 D 201 ASN D 46 ASN~? 18.62 CH3 ACT A1182 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -21.76 -7.99 22.88 -22.00 -7.32 20.90 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -24.82 -3.74 20.02 -24.43 -3.84 17.62 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -16.96 -5.07 24.82 -15.16 -4.92 23.63 ULMN 3 1iph_c03 CATALASE HPII user 18 3 # 18 D 128 HIS D 59 HIS~? 14.28 O ACT A1182 D 167 SER D 56 SER.? 20.40 O ACT A1182 D 201 ASN D 86 ASN.? 11.74 O ACT A1182 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -38.34 -8.19 13.90 -38.52 -10.20 14.65 1iph_c03 source 1iph CATALASE HPII : 18 hits 1iph_c03 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 84 ASP^? 7.98 OXT ACT A1182 A1134 ALA A 87 ALA.? 6.96 OXT ACT A1182 A1137 ASN A 86 ASN.? 11.67 OXT ACT A1182 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -36.44 3.40 10.01 -38.05 4.61 10.68 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -37.93 4.41 14.70 -38.35 3.33 13.74 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -38.42 8.17 12.63 -38.52 10.18 11.86 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP B 84 ASP^? 7.80 O ACT C1183 A1134 ALA B 87 ALA.? 6.83 O ACT C1183 A1137 ASN B 86 ASN.? 11.57 O ACT C1183 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -54.22 1.68 8.96 -52.58 0.65 8.12 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -52.69 -3.08 9.85 -52.24 -1.81 10.51 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -52.20 -2.48 5.54 -51.99 -2.60 3.42 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 3 3 # 3 A1132 ASP B 95 ASP.? 16.79 O ACT C1183 A1134 ALA B 96 ALA.? 19.63 O ACT C1183 A1137 ASN B 97 ASN~? 15.65 O ACT C1183 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -62.34 -18.67 5.39 -62.96 -19.17 6.71 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -64.58 -14.76 3.84 -63.20 -13.18 4.05 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 4 3 # 4 A1132 ASP C 84 ASP^? 7.78 OXT ACT C1183 A1134 ALA C 87 ALA.? 6.87 OXT ACT C1183 A1137 ASN C 86 ASN.? 11.54 OXT ACT C1183 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -52.69 3.10 16.59 -52.21 1.83 15.91 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -52.20 2.48 20.90 -52.01 2.64 23.02 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 5 3 # 5 A1132 ASP C 95 ASP~? 18.98 OXT ACT C1183 A1134 ALA C 96 ALA~? 16.84 OXT ACT C1183 A1137 ASN C 94 ASN.? 20.53 OXT ACT C1183 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -60.88 17.87 20.49 -62.76 18.57 19.77 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -62.09 13.83 23.14 -62.11 13.46 24.60 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -57.57 16.60 24.50 -56.01 17.74 25.39 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 6 3 # 6 A1132 ASP C 95 ASP~? 18.98 OXT ACT C1183 A1134 ALA C 96 ALA~? 16.84 OXT ACT C1183 A1137 ASN C 97 ASN~? 20.34 OXT ACT C1183 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -60.88 17.87 20.49 -62.76 18.57 19.77 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -62.09 13.83 23.14 -62.11 13.46 24.60 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -66.13 16.32 22.33 -66.34 16.55 24.44 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 7 3 # 7 A1132 ASP D 84 ASP^? 8.02 O ACT A1182 A1134 ALA D 87 ALA.? 6.96 O ACT A1182 A1137 ASN D 86 ASN.? 11.74 O ACT A1182 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -37.91 -4.38 11.75 -38.33 -3.29 12.71 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -38.34 -8.19 13.90 -38.52 -10.20 14.65 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 7 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 55 ASP.? 17.41 O ACT A1181 A 204 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 279 TYR A 91 TYR.? 11.44 OXT ACT A1182 coo 5.85 5.60 30.32 5.00 7.49 29.88 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 7.79 1.83 27.81 9.08 3.25 26.92 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 8.22 7.77 18.64 7.58 8.47 21.28 -35.52 10.03 17.00 -36.51 12.40 15.90 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 204 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 279 TYR B 91 TYR.? 11.41 O ACT C1183 coo 5.85 5.60 30.32 5.00 7.49 29.88 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 7.79 1.83 27.81 9.08 3.25 26.92 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 8.22 7.77 18.64 7.58 8.47 21.28 -54.93 -7.42 5.60 -53.90 -7.36 2.99 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP C 55 ASP.? 19.45 CA CA C1184 A 204 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 279 TYR C 91 TYR.? 11.38 OXT ACT C1183 coo 5.85 5.60 30.32 5.00 7.49 29.88 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 7.79 1.83 27.81 9.08 3.25 26.92 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 8.22 7.77 18.64 7.58 8.47 21.28 -54.93 7.42 20.88 -53.88 7.33 23.48 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 4 3 # 4 A 202 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 204 GLU D 119 GLU.? 19.65 O ACT A1182 A 279 TYR D 91 TYR.? 11.52 O ACT A1182 coo 5.85 5.60 30.32 5.00 7.49 29.88 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 7.79 1.83 27.81 9.08 3.25 26.92 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 8.22 7.77 18.64 7.58 8.47 21.28 -35.52 -10.04 9.46 -36.46 -12.45 10.54 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 4 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 61 GLU A 139 GLU.? 21.64 O ACT A1181 A 162 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -40.83 18.78 13.92 -42.39 17.53 13.21 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -34.64 27.04 8.52 -35.38 28.56 9.82 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 61 GLU B 139 GLU.? 13.29 O3 GOL B1182 A 162 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 61 GLU C 139 GLU.? 13.61 CA CA C1184 A 162 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -49.67 7.91 30.13 -48.14 6.69 29.28 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -54.75 6.31 40.61 -53.48 6.42 38.96 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 4 3 # 4 A 14 GLU D 119 GLU.? 19.65 O ACT A1182 A 61 GLU D 139 GLU.? 21.84 O2 GOL D1181 A 162 HIS D 114 HIS^? 15.97 O ACT A1182 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 4 hits 1j53_c00 naa= 3 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN A 39 GLN~? 23.73 CH3 ACT A1182 A 79 PHE A 134 PHE^? 18.18 O ACT A1181 A 80 THR A 40 THR~? 17.59 CH3 ACT A1182 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -20.25 15.54 -1.05 -20.17 17.31 0.14 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -28.37 13.63 1.61 -29.29 13.61 -1.07 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -23.93 10.90 -0.33 -25.94 11.33 0.34 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 2 3 # 2 A 78 GLN B 39 GLN~? 11.27 CA CA B1183 A 79 PHE B 134 PHE^? 10.29 O2 GOL B1182 A 80 THR B 40 THR~? 13.23 O2 GOL B1182 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -70.82 6.88 -6.62 -70.59 5.36 -8.10 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -62.26 5.34 -3.80 -61.37 7.78 -4.90 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -66.85 8.08 -2.24 -64.82 7.37 -2.52 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 3 3 # 3 A 78 GLN C 39 GLN~? 11.29 CA CA C1184 A 79 PHE C 134 PHE^? 13.25 CA CA C1184 A 80 THR C 40 THR~? 15.04 CA CA C1184 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -70.79 -6.86 33.04 -70.58 -5.33 34.49 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -62.23 -5.37 30.24 -61.37 -7.83 31.34 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -66.85 -8.05 28.72 -64.85 -7.34 28.99 ULMN 3 1j7g_c00 D-TYROSYL-TRNA(TYR) DEACYLASE user 4 3 # 4 A 78 GLN D 39 GLN~? 23.71 CH3 ACT A1182 A 79 PHE D 134 PHE^? 17.04 O3 GOL D1181 A 80 THR D 40 THR~? 17.62 CH3 ACT A1182 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -20.15 -15.54 27.47 -20.25 -17.32 26.30 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -28.39 -13.60 24.85 -29.22 -13.68 27.54 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -23.95 -10.93 26.82 -25.97 -11.31 26.17 1j7g_c00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 4 hits 1j7g_c00 naa= 3 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 1 3 # 1 A 202 SER C 53 SER^? 12.05 OXT ACT C1183 A 308 ASP C 55 ASP.? 19.45 CA CA C1184 A 338 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 37.44 15.05 21.90 37.18 17.02 20.71 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 45.75 18.77 19.41 43.72 18.70 19.99 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 41.13 18.39 17.83 39.67 17.70 19.17 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 2 3 # 2 A 202 SER D 53 SER^? 12.18 O ACT A1182 A 308 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 338 HIS D 114 HIS^? 15.97 O ACT A1182 coo 37.44 15.05 21.90 37.18 17.02 20.71 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 45.75 18.77 19.41 43.72 18.70 19.99 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 41.13 18.39 17.83 39.67 17.70 19.17 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1jkm_c00 source 1jkm BREFELDIN A ESTERASE : 2 hits 1jkm_c00 naa= 3 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 1 3 # 1 B 202 SER C 53 SER^? 12.05 OXT ACT C1183 B 308 ASP C 55 ASP.? 19.45 CA CA C1184 B 338 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 67.81 2.11 21.29 69.09 3.00 23.04 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 64.20 9.21 26.15 65.67 7.96 25.24 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 66.92 5.20 26.82 67.69 4.22 25.14 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 2 3 # 2 B 202 SER D 53 SER^? 12.18 O ACT A1182 B 308 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 338 HIS D 114 HIS^? 15.97 O ACT A1182 coo 67.81 2.11 21.29 69.09 3.00 23.04 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 64.20 9.21 26.15 65.67 7.96 25.24 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 66.92 5.20 26.82 67.69 4.22 25.14 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1jkm_c01 source 1jkm BREFELDIN A ESTERASE : 2 hits 1jkm_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 56 LYS A 124 LYS~? 24.92 OXT ACT A1182 A 258 ARG A 58 ARG~? 14.46 O ACT A1181 coo 42.33 1.56 26.99 42.38 2.91 28.66 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -30.92 19.75 15.99 -32.39 25.70 15.74 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 56 LYS B 124 LYS~? 15.51 CA CA B1183 A 258 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 42.33 1.56 26.99 42.38 2.91 28.66 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU D 119 GLU.? 19.65 O ACT A1182 A 56 LYS D 124 LYS~? 24.78 O ACT A1182 A 258 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 42.33 1.56 26.99 42.38 2.91 28.66 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -43.20 -16.00 21.95 -43.92 -18.81 20.94 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 3 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 119 GLU.? 19.75 OXT ACT A1182 B 56 LYS A 124 LYS~? 24.92 OXT ACT A1182 B 258 ARG A 58 ARG~? 14.46 O ACT A1181 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -30.92 19.75 15.99 -32.39 25.70 15.74 coo 2.64 1.83 34.81 1.56 1.13 32.02 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 29 GLU~? -3.75 O1 GOL B1182s B 56 LYS B 149 LYS.? 7.98 O3 GOL B1182 B 258 ARG B 30 ARG.? -4.36 CA CA B1183s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -57.44 9.91 -17.53 -57.08 7.94 -18.23 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -50.82 2.31 -15.26 -51.03 5.84 -20.47 coo 2.64 1.83 34.81 1.56 1.13 32.02 -65.37 6.99 -20.70 -65.41 4.49 -18.90 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU B 119 GLU.? 18.74 O3 GOL B1182 B 56 LYS B 124 LYS~? 15.51 CA CA B1183 B 258 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 coo 2.64 1.83 34.81 1.56 1.13 32.02 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU D 119 GLU.? 19.65 O ACT A1182 B 56 LYS D 124 LYS~? 24.78 O ACT A1182 B 258 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 2.64 1.83 34.81 1.56 1.13 32.02 -43.20 -16.00 21.95 -43.92 -18.81 20.94 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 119 GLU.? 19.75 OXT ACT A1182 C 56 LYS A 124 LYS~? 24.92 OXT ACT A1182 C 258 ARG A 58 ARG~? 14.46 O ACT A1181 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -30.92 19.75 15.99 -32.39 25.70 15.74 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 29 GLU~? -3.75 O1 GOL B1182s C 56 LYS B 149 LYS.? 7.98 O3 GOL B1182 C 258 ARG B 30 ARG.? -4.36 CA CA B1183s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -57.44 9.91 -17.53 -57.08 7.94 -18.23 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -50.82 2.31 -15.26 -51.03 5.84 -20.47 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -65.37 6.99 -20.70 -65.41 4.49 -18.90 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU B 119 GLU.? 18.74 O3 GOL B1182 C 56 LYS B 124 LYS~? 15.51 CA CA B1183 C 258 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU D 119 GLU.? 19.65 O ACT A1182 C 56 LYS D 124 LYS~? 24.78 O ACT A1182 C 258 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -43.20 -16.00 21.95 -43.92 -18.81 20.94 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 119 GLU.? 19.75 OXT ACT A1182 D 56 LYS A 124 LYS~? 24.92 OXT ACT A1182 D 258 ARG A 58 ARG~? 14.46 O ACT A1181 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -30.92 19.75 15.99 -32.39 25.70 15.74 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 29 GLU~? -3.75 O1 GOL B1182s D 56 LYS B 149 LYS.? 7.98 O3 GOL B1182 D 258 ARG B 30 ARG.? -4.36 CA CA B1183s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -57.44 9.91 -17.53 -57.08 7.94 -18.23 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -50.82 2.31 -15.26 -51.03 5.84 -20.47 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -65.37 6.99 -20.70 -65.41 4.49 -18.90 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU B 119 GLU.? 18.74 O3 GOL B1182 D 56 LYS B 124 LYS~? 15.51 CA CA B1183 D 258 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU D 119 GLU.? 19.65 O ACT A1182 D 56 LYS D 124 LYS~? 24.78 O ACT A1182 D 258 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -43.20 -16.00 21.95 -43.92 -18.81 20.94 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 95 ASP~? 18.75 OXT ACT A1182 262 LYS A 93 LYS.? 11.72 OXT ACT A1182 336 ARG D 77 ARG.? 18.56 OXT ACT A1182 coo 61.88 50.78 12.96 63.84 50.60 13.71 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 63.59 44.40 18.32 63.20 49.74 17.95 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 72.60 57.42 15.86 71.61 56.68 18.70 -32.91 2.84 33.04 -33.00 -0.18 32.51 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP A 156 ASP~? 10.59 O ACT A1181 262 LYS A 158 LYS~? -4.64 O ACT A1181s 336 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 61.88 50.78 12.96 63.84 50.60 13.71 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 63.59 44.40 18.32 63.20 49.74 17.95 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 72.60 57.42 15.86 71.61 56.68 18.70 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP A 156 ASP~? 10.59 O ACT A1181 262 LYS B 164 LYS~? 10.34 O ACT A1181 336 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 61.88 50.78 12.96 63.84 50.60 13.71 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 63.59 44.40 18.32 63.20 49.74 17.95 -54.90 15.84 -3.99 -50.07 17.65 -1.98 coo 72.60 57.42 15.86 71.61 56.68 18.70 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP B 156 ASP~? 13.25 OXT ACT A1181 262 LYS A 164 LYS~? 11.79 OXT ACT A1181 336 ARG A 58 ARG~? 14.46 O ACT A1181 coo 61.88 50.78 12.96 63.84 50.60 13.71 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 63.59 44.40 18.32 63.20 49.74 17.95 -35.84 9.74 -8.05 -40.64 7.29 -8.85 coo 72.60 57.42 15.86 71.61 56.68 18.70 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP B 156 ASP~? 13.25 OXT ACT A1181 262 LYS B 158 LYS~? 6.73 O3 GOL B1182 336 ARG A 58 ARG~? 14.46 O ACT A1181 coo 61.88 50.78 12.96 63.84 50.60 13.71 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 63.59 44.40 18.32 63.20 49.74 17.95 -50.07 10.43 -10.30 -49.56 8.69 -16.32 coo 72.60 57.42 15.86 71.61 56.68 18.70 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 6 3 # 6 255 ASP C 6 ASP~? 17.85 CA CA C1182 262 LYS C 9 LYS~? 14.61 CA CA C1182 336 ARG C -1 ARG.? 22.70 CA CA C1182 coo 61.88 50.78 12.96 63.84 50.60 13.71 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 63.59 44.40 18.32 63.20 49.74 17.95 -27.74 -18.74 41.99 -22.99 -22.90 41.19 coo 72.60 57.42 15.86 71.61 56.68 18.70 -23.32 -3.70 47.99 -26.29 -3.39 47.24 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 7 3 # 7 255 ASP C 95 ASP~? 18.98 OXT ACT C1183 262 LYS C 93 LYS.? 19.61 OXT ACT C1183 336 ARG B 77 ARG.? 16.85 CA CA B1181 coo 61.88 50.78 12.96 63.84 50.60 13.71 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 63.59 44.40 18.32 63.20 49.74 17.95 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 72.60 57.42 15.86 71.61 56.68 18.70 -57.98 19.33 8.28 -57.78 17.70 5.69 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 8 3 # 8 255 ASP C 156 ASP~? 12.06 O3 GOL D1181 262 LYS C 158 LYS~? 13.55 O3 GOL D1181 336 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 61.88 50.78 12.96 63.84 50.60 13.71 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 63.59 44.40 18.32 63.20 49.74 17.95 -50.05 -10.42 36.79 -49.63 -8.70 42.89 coo 72.60 57.42 15.86 71.61 56.68 18.70 -43.20 -16.00 21.95 -43.92 -18.81 20.94 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 9 3 # 9 255 ASP C 156 ASP~? 12.06 O3 GOL D1181 262 LYS D 164 LYS~? 10.47 O3 GOL D1181 336 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 61.88 50.78 12.96 63.84 50.60 13.71 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 63.59 44.40 18.32 63.20 49.74 17.95 -35.86 -9.73 34.54 -40.60 -7.29 35.38 coo 72.60 57.42 15.86 71.61 56.68 18.70 -43.20 -16.00 21.95 -43.92 -18.81 20.94 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 9 hits 1lam_c00 naa= 3 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 1 3 # 1 166 ASP A 55 ASP.? 17.41 O ACT A1181 169 ARG A 58 ARG~? 14.46 O ACT A1181 193 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo 20.88 15.91 3.60 20.25 17.72 4.50 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 18.81 19.85 7.63 17.55 19.89 5.97 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 2 3 # 2 166 ASP A 55 ASP.? 17.41 O ACT A1181 169 ARG A 58 ARG~? 14.46 O ACT A1181 193 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 20.88 15.91 3.60 20.25 17.72 4.50 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 18.81 19.85 7.63 17.55 19.89 5.97 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 3 3 # 3 166 ASP B 55 ASP.? 14.29 O3 GOL B1182 169 ARG B 58 ARG~? 12.97 O3 GOL B1182 193 HIS B 59 HIS~? 15.18 O ACT C1183 coo 20.88 15.91 3.60 20.25 17.72 4.50 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 18.81 19.85 7.63 17.55 19.89 5.97 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 4 3 # 4 166 ASP B 55 ASP.? 14.29 O3 GOL B1182 169 ARG B 58 ARG~? 12.97 O3 GOL B1182 193 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 20.88 15.91 3.60 20.25 17.72 4.50 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 18.81 19.85 7.63 17.55 19.89 5.97 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 5 3 # 5 166 ASP C 55 ASP.? 19.45 CA CA C1184 169 ARG C 58 ARG~? 18.42 O3 GOL D1181 193 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo 20.88 15.91 3.60 20.25 17.72 4.50 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 18.81 19.85 7.63 17.55 19.89 5.97 -46.89 1.05 23.56 -47.29 3.11 23.40 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 6 3 # 6 166 ASP C 55 ASP.? 19.45 CA CA C1184 169 ARG C 58 ARG~? 18.42 O3 GOL D1181 193 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 20.88 15.91 3.60 20.25 17.72 4.50 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 18.81 19.85 7.63 17.55 19.89 5.97 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 7 3 # 7 166 ASP D 55 ASP.? 17.43 O2 GOL D1181 169 ARG D 58 ARG~? 14.52 O2 GOL D1181 193 HIS D 114 HIS^? 15.97 O ACT A1182 coo 20.88 15.91 3.60 20.25 17.72 4.50 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 18.81 19.85 7.63 17.55 19.89 5.97 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1ldm_c01 source 1ldm M4 LACTATE DEHYDROGENASE : 7 hits 1ldm_c01 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 96 ALA~? 16.98 OXT ACT A1182 A 317 GLY A 122 GLY~? 17.38 OXT ACT A1182 A 318 ASP A 95 ASP~? 18.75 OXT ACT A1182 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -28.64 14.50 22.33 -28.62 15.76 21.46 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -31.93 16.98 20.49 -32.19 17.34 19.79 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -30.02 14.86 26.58 -28.64 13.51 27.46 1lij_c01 source 1lij ADENOSINE KINASE : 1 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 96 ALA~? 16.98 OXT ACT A1182 A 317 GLY A 122 GLY~? 17.38 OXT ACT A1182 A 318 ASP A 95 ASP~? 18.75 OXT ACT A1182 coo 27.04 23.54 41.85 25.72 24.19 42.18 -28.64 14.50 22.33 -28.62 15.76 21.46 coo 27.87 23.16 38.17 28.43 22.97 38.87 -31.93 16.98 20.49 -32.19 17.34 19.79 coo 32.11 22.71 40.58 33.42 24.22 39.78 -30.02 14.86 26.58 -28.64 13.51 27.46 1lio_c01 source 1lio ADENOSINE KINASE : 1 hits 1lio_c01 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 9 LYS~? 15.21 O1 GOL B1182 A 202 SER B 31 SER~? 8.40 O1 GOL B1182 A 226 SER B 32 SER~? 5.72 CA CA B1183 coo 1.62 6.10 69.30 3.81 1.25 65.91 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 4.43 1.89 61.79 4.31 0.09 63.40 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS A 72 LYS.? 19.74 O ACT A1182 A 202 SER D 89 SER.? 7.37 O ACT A1182 A 226 SER D 88 SER.? 4.67 O ACT A1182 coo 1.62 6.10 69.30 3.81 1.25 65.91 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 4.43 1.89 61.79 4.31 0.09 63.40 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 3 3 # 3 A 123 LYS A 93 LYS.? 11.72 OXT ACT A1182 A 202 SER A 88 SER.? 4.86 OXT ACT A1182 A 226 SER A 89 SER.? 7.33 OXT ACT A1182 coo 1.62 6.10 69.30 3.81 1.25 65.91 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 4.43 1.89 61.79 4.31 0.09 63.40 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -34.05 3.70 20.21 -34.55 1.39 20.81 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 4 3 # 4 A 123 LYS A 93 LYS.? 11.72 OXT ACT A1182 A 202 SER A 89 SER.? 7.33 OXT ACT A1182 A 226 SER A 88 SER.? 4.86 OXT ACT A1182 coo 1.62 6.10 69.30 3.81 1.25 65.91 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 4.43 1.89 61.79 4.31 0.09 63.40 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 5 3 # 5 A 123 LYS B 72 LYS.? 19.60 OXT ACT C1183 A 202 SER C 89 SER.? 7.45 OXT ACT C1183 A 226 SER C 88 SER.? 4.69 OXT ACT C1183 coo 1.62 6.10 69.30 3.81 1.25 65.91 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 4.43 1.89 61.79 4.31 0.09 63.40 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 6 3 # 6 A 123 LYS B 93 LYS.? 14.57 O ACT C1183 A 202 SER B 89 SER.? 7.47 O ACT C1183 A 226 SER B 88 SER.? 4.64 O ACT C1183 coo 1.62 6.10 69.30 3.81 1.25 65.91 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 4.43 1.89 61.79 4.31 0.09 63.40 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 7 3 # 7 A 123 LYS C 72 LYS.? 18.71 O ACT C1183 A 202 SER B 89 SER.? 7.47 O ACT C1183 A 226 SER B 88 SER.? 4.64 O ACT C1183 coo 1.62 6.10 69.30 3.81 1.25 65.91 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 4.43 1.89 61.79 4.31 0.09 63.40 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 8 3 # 8 A 123 LYS C 93 LYS.? 19.61 OXT ACT C1183 A 202 SER C 89 SER.? 7.45 OXT ACT C1183 A 226 SER C 88 SER.? 4.69 OXT ACT C1183 coo 1.62 6.10 69.30 3.81 1.25 65.91 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 4.43 1.89 61.79 4.31 0.09 63.40 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 9 3 # 9 A 123 LYS D 9 LYS~? 18.78 CA CA C1184 A 202 SER C 31 SER.? 11.23 CA CA C1184 A 226 SER C 32 SER~? 5.57 CA CA C1184 coo 1.62 6.10 69.30 3.81 1.25 65.91 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 4.43 1.89 61.79 4.31 0.09 63.40 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 10 3 # 10 A 123 LYS D 72 LYS.? 18.40 OXT ACT A1182 A 202 SER A 89 SER.? 7.33 OXT ACT A1182 A 226 SER A 88 SER.? 4.86 OXT ACT A1182 coo 1.62 6.10 69.30 3.81 1.25 65.91 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 4.43 1.89 61.79 4.31 0.09 63.40 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 11 3 # 11 A 123 LYS D 93 LYS.? 12.21 O ACT A1182 A 202 SER D 89 SER.? 7.37 O ACT A1182 A 226 SER D 88 SER.? 4.67 O ACT A1182 coo 1.62 6.10 69.30 3.81 1.25 65.91 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 4.43 1.89 61.79 4.31 0.09 63.40 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -34.51 -3.89 10.07 -32.18 -4.55 9.73 1m21_c00 source 1m21 PEPTIDE AMIDASE : 11 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 9 LYS~? 15.21 O1 GOL B1182 B 202 SER B 31 SER~? 8.40 O1 GOL B1182 B 226 SER B 32 SER~? 5.72 CA CA B1183 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 32.81 4.27 10.70 32.87 6.07 12.31 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 28.77 6.36 12.44 30.83 7.25 11.75 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS A 72 LYS.? 19.74 O ACT A1182 B 202 SER D 89 SER.? 7.37 O ACT A1182 B 226 SER D 88 SER.? 4.67 O ACT A1182 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 32.81 4.27 10.70 32.87 6.07 12.31 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 28.77 6.36 12.44 30.83 7.25 11.75 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 3 3 # 3 B 123 LYS A 93 LYS.? 11.72 OXT ACT A1182 B 202 SER A 88 SER.? 4.86 OXT ACT A1182 B 226 SER A 89 SER.? 7.33 OXT ACT A1182 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 32.81 4.27 10.70 32.87 6.07 12.31 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 28.77 6.36 12.44 30.83 7.25 11.75 -34.05 3.70 20.21 -34.55 1.39 20.81 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 4 3 # 4 B 123 LYS A 93 LYS.? 11.72 OXT ACT A1182 B 202 SER A 89 SER.? 7.33 OXT ACT A1182 B 226 SER A 88 SER.? 4.86 OXT ACT A1182 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 32.81 4.27 10.70 32.87 6.07 12.31 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 28.77 6.36 12.44 30.83 7.25 11.75 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 5 3 # 5 B 123 LYS B 72 LYS.? 19.60 OXT ACT C1183 B 202 SER C 89 SER.? 7.45 OXT ACT C1183 B 226 SER C 88 SER.? 4.69 OXT ACT C1183 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 32.81 4.27 10.70 32.87 6.07 12.31 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 28.77 6.36 12.44 30.83 7.25 11.75 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 6 3 # 6 B 123 LYS B 93 LYS.? 14.57 O ACT C1183 B 202 SER B 89 SER.? 7.47 O ACT C1183 B 226 SER B 88 SER.? 4.64 O ACT C1183 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 32.81 4.27 10.70 32.87 6.07 12.31 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 28.77 6.36 12.44 30.83 7.25 11.75 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 7 3 # 7 B 123 LYS C 72 LYS.? 18.71 O ACT C1183 B 202 SER B 89 SER.? 7.47 O ACT C1183 B 226 SER B 88 SER.? 4.64 O ACT C1183 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 32.81 4.27 10.70 32.87 6.07 12.31 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 28.77 6.36 12.44 30.83 7.25 11.75 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 8 3 # 8 B 123 LYS C 93 LYS.? 19.61 OXT ACT C1183 B 202 SER C 89 SER.? 7.45 OXT ACT C1183 B 226 SER C 88 SER.? 4.69 OXT ACT C1183 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 32.81 4.27 10.70 32.87 6.07 12.31 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 28.77 6.36 12.44 30.83 7.25 11.75 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 9 3 # 9 B 123 LYS D 9 LYS~? 18.78 CA CA C1184 B 202 SER C 31 SER.? 11.23 CA CA C1184 B 226 SER C 32 SER~? 5.57 CA CA C1184 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 32.81 4.27 10.70 32.87 6.07 12.31 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 28.77 6.36 12.44 30.83 7.25 11.75 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 10 3 # 10 B 123 LYS D 72 LYS.? 18.40 OXT ACT A1182 B 202 SER A 89 SER.? 7.33 OXT ACT A1182 B 226 SER A 88 SER.? 4.86 OXT ACT A1182 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 32.81 4.27 10.70 32.87 6.07 12.31 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 28.77 6.36 12.44 30.83 7.25 11.75 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 11 3 # 11 B 123 LYS D 93 LYS.? 12.21 O ACT A1182 B 202 SER D 89 SER.? 7.37 O ACT A1182 B 226 SER D 88 SER.? 4.67 O ACT A1182 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 32.81 4.27 10.70 32.87 6.07 12.31 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 28.77 6.36 12.44 30.83 7.25 11.75 -34.51 -3.89 10.07 -32.18 -4.55 9.73 1m21_c01 source 1m21 PEPTIDE AMIDASE : 11 hits 1m21_c01 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 152 ASP.? 5.90 O ACT A1181 A 265 GLU A 17 GLU~? 13.61 CH3 ACT A1181 A 369 ASP A 156 ASP~? 10.59 O ACT A1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 17.36 23.57 72.04 18.68 21.92 71.98 -53.17 23.87 -17.57 -54.60 25.28 -18.31 coo 12.19 31.08 87.29 11.13 32.66 86.38 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 152 ASP.? 5.90 O ACT A1181 A 265 GLU A 27 GLU~? -12.01 CH3 ACT A1181s A 369 ASP A 156 ASP~? 10.59 O ACT A1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.14 22.58 -15.68 -34.47 22.99 -17.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 152 ASP.? 5.90 O ACT A1181 A 265 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 369 ASP A 156 ASP~? 10.59 O ACT A1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 156 ASP~? 10.59 O ACT A1181 A 265 GLU A 17 GLU~? 13.61 CH3 ACT A1181 A 369 ASP A 152 ASP.? 5.90 O ACT A1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 -53.17 23.87 -17.57 -54.60 25.28 -18.31 coo 12.19 31.08 87.29 11.13 32.66 86.38 -43.60 24.63 -2.03 -43.51 24.01 -4.05 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 156 ASP~? 10.59 O ACT A1181 A 265 GLU A 27 GLU~? -12.01 CH3 ACT A1181s A 369 ASP A 152 ASP.? 5.90 O ACT A1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.14 22.58 -15.68 -34.47 22.99 -17.72 coo 12.19 31.08 87.29 11.13 32.66 86.38 -43.60 24.63 -2.03 -43.51 24.01 -4.05 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 156 ASP~? 10.59 O ACT A1181 A 265 GLU A 29 GLU~? 11.10 O ACT A1181 A 369 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP A 156 ASP~? 10.59 O ACT A1181 A 265 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 369 ASP A 152 ASP.? 5.90 O ACT A1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 12.19 31.08 87.29 11.13 32.66 86.38 -43.60 24.63 -2.03 -43.51 24.01 -4.05 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 265 GLU B 17 GLU~? -13.09 CH3 ACT A1181s A 369 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 17.36 23.57 72.04 18.68 21.92 71.98 -38.08 19.88 -20.29 -36.49 20.35 -21.57 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 265 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 369 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 17.36 23.57 72.04 18.68 21.92 71.98 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 265 GLU B 17 GLU~? -13.09 CH3 ACT A1181s A 369 ASP B 152 ASP.? 8.52 O3 GOL B1182 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 -38.08 19.88 -20.29 -36.49 20.35 -21.57 coo 12.19 31.08 87.29 11.13 32.66 86.38 -47.04 4.74 -15.30 -47.17 6.82 -15.76 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 265 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 369 ASP B 152 ASP.? 8.52 O3 GOL B1182 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 12.19 31.08 87.29 11.13 32.66 86.38 -47.04 4.74 -15.30 -47.17 6.82 -15.76 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 265 GLU C 17 GLU~? 3.68 CA CA C1182s A 369 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 17.36 23.57 72.04 18.68 21.92 71.98 -38.10 -19.90 46.72 -36.47 -20.40 47.99 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 265 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 369 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 17.36 23.57 72.04 18.68 21.92 71.98 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 265 GLU C 17 GLU~? 3.68 CA CA C1182s A 369 ASP C 152 ASP.? 13.45 O3 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 -38.10 -19.90 46.72 -36.47 -20.40 47.99 coo 12.19 31.08 87.29 11.13 32.66 86.38 -47.03 -4.77 41.79 -47.13 -6.84 42.24 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 265 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 369 ASP C 152 ASP.? 13.45 O3 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 -47.03 -4.77 41.79 -47.13 -6.84 42.24 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 265 GLU D 17 GLU~? 13.36 O1 GOL D1181 A 369 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 17.36 23.57 72.04 18.68 21.92 71.98 -53.10 -23.91 44.12 -54.66 -25.27 44.77 coo 12.19 31.08 87.29 11.13 32.66 86.38 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 265 GLU D 27 GLU~? 2.91 CA CA C1182s A 369 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.10 -22.57 42.20 -34.50 -23.02 44.23 coo 12.19 31.08 87.29 11.13 32.66 86.38 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 265 GLU D 119 GLU.? 19.65 O ACT A1182 A 369 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 265 GLU D 17 GLU~? 13.36 O1 GOL D1181 A 369 ASP D 152 ASP.? 5.75 O2 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 -53.10 -23.91 44.12 -54.66 -25.27 44.77 coo 12.19 31.08 87.29 11.13 32.66 86.38 -43.59 -24.59 28.46 -43.51 -24.00 30.49 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 265 GLU D 27 GLU~? 2.91 CA CA C1182s A 369 ASP D 152 ASP.? 5.75 O2 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 -34.10 -22.57 42.20 -34.50 -23.02 44.23 coo 12.19 31.08 87.29 11.13 32.66 86.38 -43.59 -24.59 28.46 -43.51 -24.00 30.49 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 265 GLU D 29 GLU~? 11.05 O2 GOL D1181 A 369 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 22 3 # 22 A 241 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 265 GLU D 119 GLU.? 19.65 O ACT A1182 A 369 ASP D 152 ASP.? 5.75 O2 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 -43.59 -24.59 28.46 -43.51 -24.00 30.49 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 22 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 156 ASP~? 10.59 O ACT A1181 A 279 GLU A 139 GLU.? 21.64 O ACT A1181 A 369 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 16.54 46.37 63.94 14.77 45.79 62.95 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 73 ASP.? 22.00 OXT ACT C1183 A 279 GLU A 121 GLU~? 23.87 OXT ACT A1182 A 369 ASP C 95 ASP~? 18.98 OXT ACT C1183 coo 11.74 38.14 80.19 10.63 36.40 80.65 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 16.54 46.37 63.94 14.77 45.79 62.95 -33.98 22.68 21.15 -32.78 23.95 19.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 -60.88 17.87 20.49 -62.76 18.57 19.77 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 279 GLU B 139 GLU.? 13.29 O3 GOL B1182 A 369 ASP A 156 ASP~? 10.59 O ACT A1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 16.54 46.37 63.94 14.77 45.79 62.95 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 12.19 31.08 87.29 11.13 32.66 86.38 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP C 73 ASP.? 22.09 O ACT C1183 A 279 GLU D 139 GLU.? 21.84 O2 GOL D1181 A 369 ASP B 95 ASP.? 16.79 O ACT C1183 coo 11.74 38.14 80.19 10.63 36.40 80.65 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 16.54 46.37 63.94 14.77 45.79 62.95 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 12.19 31.08 87.29 11.13 32.66 86.38 -58.00 -16.84 6.87 -57.88 -17.33 8.94 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 279 GLU C 139 GLU.? 13.61 CA CA C1184 A 369 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 16.54 46.37 63.94 14.77 45.79 62.95 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP D 73 ASP.? 21.98 OXT ACT A1182 A 279 GLU C 121 GLU~? 20.76 CA CA C1184 A 369 ASP A 95 ASP~? 18.75 OXT ACT A1182 coo 11.74 38.14 80.19 10.63 36.40 80.65 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 16.54 46.37 63.94 14.77 45.79 62.95 -56.38 16.29 30.73 -57.04 15.33 32.51 coo 12.19 31.08 87.29 11.13 32.66 86.38 -30.02 14.86 26.58 -28.64 13.51 27.46 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP D 73 ASP.? 21.98 OXT ACT A1182 A 279 GLU C 139 GLU.? 13.61 CA CA C1184 A 369 ASP A 95 ASP~? 18.75 OXT ACT A1182 coo 11.74 38.14 80.19 10.63 36.40 80.65 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 16.54 46.37 63.94 14.77 45.79 62.95 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -30.02 14.86 26.58 -28.64 13.51 27.46 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP D 84 ASP^? 8.02 O ACT A1182 A 279 GLU D 167 GLU~? 14.12 O3 GOL D1181 A 369 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 11.74 38.14 80.19 10.63 36.40 80.65 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 16.54 46.37 63.94 14.77 45.79 62.95 -33.98 -6.43 34.19 -35.73 -5.26 33.93 coo 12.19 31.08 87.29 11.13 32.66 86.38 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 279 GLU D 139 GLU.? 21.84 O2 GOL D1181 A 369 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 11.74 38.14 80.19 10.63 36.40 80.65 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 16.54 46.37 63.94 14.77 45.79 62.95 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 12.19 31.08 87.29 11.13 32.66 86.38 -44.46 -7.83 33.81 -43.76 -5.84 33.54 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 9 hits 1m53_c06 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP A 84 ASP^? 7.98 OXT ACT A1182 B 168 ASN A 63 ASN~? 15.00 O ACT A1182 B 241 HIS B 59 HIS~? 15.18 O ACT C1183 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -36.44 3.40 10.01 -38.05 4.61 10.68 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -42.85 5.00 4.60 -43.72 3.09 4.23 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 B 10 ASP B 84 ASP^? 7.80 O ACT C1183 B 168 ASN B 63 ASN~? 14.86 OXT ACT C1183 B 241 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -54.22 1.68 8.96 -52.58 0.65 8.12 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -47.83 6.22 5.31 -46.99 7.23 6.98 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 3 3 # 3 B 10 ASP D 84 ASP^? 8.02 O ACT A1182 B 168 ASN D 63 ASN~? 14.84 OXT ACT A1182 B 241 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -42.87 -5.02 21.89 -43.66 -3.06 22.11 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -46.89 1.05 23.56 -47.29 3.11 23.40 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 3 hits 1mas_c01 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS B 2 LYS^? 23.29 OXT ACT A1181 166 LYS A 177 LYS.? 21.69 OXT ACT A1181 324 SER A 31 SER.? 13.84 O ACT A1181 coo 25.93 8.11 25.51 26.40 7.80 19.66 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 27.27 1.43 25.09 29.18 5.25 22.89 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo 46.32 14.55 19.93 45.95 12.72 21.27 -28.88 24.94 -3.50 -30.71 23.40 -2.97 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS B 177 LYS.? 12.69 CA CA B1181 166 LYS A 2 LYS^? 14.71 CA CA B1181 324 SER A 153 SER.? 8.36 O ACT A1181 coo 25.93 8.11 25.51 26.40 7.80 19.66 -68.49 25.09 -2.05 -63.14 26.93 0.36 coo 27.27 1.43 25.09 29.18 5.25 22.89 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo 46.32 14.55 19.93 45.95 12.72 21.27 -48.21 23.38 -2.65 -49.08 24.42 -4.65 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS C 2 LYS^? 15.05 CA CA C1182 166 LYS D 177 LYS.? 22.56 O3 GOL D1181 324 SER D 31 SER.? 13.74 O2 GOL D1181 coo 25.93 8.11 25.51 26.40 7.80 19.66 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 27.27 1.43 25.09 29.18 5.25 22.89 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 46.32 14.55 19.93 45.95 12.72 21.27 -28.89 -24.92 29.95 -30.70 -23.38 29.44 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS C 177 LYS.? 13.52 CA CA C1181 166 LYS D 2 LYS.? 16.82 CA CA C1181 324 SER D 153 SER.? 8.24 O2 GOL D1181 coo 25.93 8.11 25.51 26.40 7.80 19.66 -68.52 -25.10 28.52 -62.74 -26.81 28.79 coo 27.27 1.43 25.09 29.18 5.25 22.89 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo 46.32 14.55 19.93 45.95 12.72 21.27 -48.20 -23.41 29.14 -49.00 -24.50 31.12 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 4 hits 1mdr_c01 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 84 ASP^? 7.98 OXT ACT A1182 35 SER A 88 SER.? 4.86 OXT ACT A1182 215 ASP D 84 ASP^? 8.02 O ACT A1182 coo 20.97 14.47 32.28 19.66 15.96 31.62 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 16.04 14.72 33.82 17.27 13.71 31.95 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 20.65 22.00 33.80 20.06 20.56 32.39 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 3 # 2 32 ASP A 152 ASP.? 5.90 O ACT A1181 35 SER A 153 SER.? 8.36 O ACT A1181 215 ASP A 156 ASP~? 10.59 O ACT A1181 coo 20.97 14.47 32.28 19.66 15.96 31.62 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 16.04 14.72 33.82 17.27 13.71 31.95 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 20.65 22.00 33.80 20.06 20.56 32.39 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 3 3 # 3 32 ASP B 84 ASP^? 7.80 O ACT C1183 35 SER B 88 SER.? 4.64 O ACT C1183 215 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 20.97 14.47 32.28 19.66 15.96 31.62 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 16.04 14.72 33.82 17.27 13.71 31.95 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 20.65 22.00 33.80 20.06 20.56 32.39 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 4 3 # 4 32 ASP B 152 ASP.? 8.52 O3 GOL B1182 35 SER B 153 SER.? 13.04 OXT ACT A1181 215 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 20.97 14.47 32.28 19.66 15.96 31.62 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 16.04 14.72 33.82 17.27 13.71 31.95 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo 20.65 22.00 33.80 20.06 20.56 32.39 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 5 3 # 5 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 35 SER C 88 SER.? 4.69 OXT ACT C1183 215 ASP B 84 ASP^? 7.80 O ACT C1183 coo 20.97 14.47 32.28 19.66 15.96 31.62 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 16.04 14.72 33.82 17.27 13.71 31.95 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 20.65 22.00 33.80 20.06 20.56 32.39 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 6 3 # 6 32 ASP C 152 ASP.? 13.45 O3 GOL D1181 35 SER C 153 SER.? 12.45 O3 GOL D1181 215 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 20.97 14.47 32.28 19.66 15.96 31.62 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 16.04 14.72 33.82 17.27 13.71 31.95 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo 20.65 22.00 33.80 20.06 20.56 32.39 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 7 3 # 7 32 ASP D 84 ASP^? 8.02 O ACT A1182 35 SER D 88 SER.? 4.67 O ACT A1182 215 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 20.97 14.47 32.28 19.66 15.96 31.62 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 16.04 14.72 33.82 17.27 13.71 31.95 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 20.65 22.00 33.80 20.06 20.56 32.39 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 8 3 # 8 32 ASP D 152 ASP.? 5.75 O2 GOL D1181 35 SER D 153 SER.? 8.24 O2 GOL D1181 215 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 20.97 14.47 32.28 19.66 15.96 31.62 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 16.04 14.72 33.82 17.27 13.71 31.95 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo 20.65 22.00 33.80 20.06 20.56 32.39 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 8 hits 1mpp_c04 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY B 116 GLY.? 11.34 O3 GOL B1182 A 501 ASP C 84 ASP^? 7.78 OXT ACT C1183 B 367 TYR A 5 TYR~? 13.40 O1 GOL B1182 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -52.33 -1.19 -6.26 -53.05 -1.53 -6.05 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -70.28 15.77 -12.22 -70.83 13.52 -10.65 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY C 116 GLY.? 15.57 CA CA C1184 A 501 ASP B 84 ASP^? 7.80 O ACT C1183 B 367 TYR D 5 TYR~? 13.80 CA CA C1181 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -52.37 1.22 32.72 -53.07 1.55 32.51 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -70.23 -15.79 38.72 -70.77 -13.51 37.21 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY D 116 GLY.? 16.41 O2 GOL D1181 A 501 ASP B 95 ASP.? 16.79 O ACT C1183 B 367 TYR A 91 TYR.? 11.44 OXT ACT A1182 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -38.19 -18.52 19.73 -37.45 -18.49 19.35 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -35.52 10.03 17.00 -36.51 12.40 15.90 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 3 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY B 116 GLY.? 11.34 O3 GOL B1182 D 501 ASP C 84 ASP^? 7.78 OXT ACT C1183 E 367 TYR A 5 TYR~? 13.40 O1 GOL B1182 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -52.33 -1.19 -6.26 -53.05 -1.53 -6.05 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -70.28 15.77 -12.22 -70.83 13.52 -10.65 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY C 116 GLY.? 15.57 CA CA C1184 D 501 ASP B 84 ASP^? 7.80 O ACT C1183 E 367 TYR D 5 TYR~? 13.80 CA CA C1181 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -52.37 1.22 32.72 -53.07 1.55 32.51 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -70.23 -15.79 38.72 -70.77 -13.51 37.21 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY D 116 GLY.? 16.41 O2 GOL D1181 D 501 ASP B 95 ASP.? 16.79 O ACT C1183 E 367 TYR A 91 TYR.? 11.44 OXT ACT A1182 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -38.19 -18.52 19.73 -37.45 -18.49 19.35 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -35.52 10.03 17.00 -36.51 12.40 15.90 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 3 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 156 ASP~? 10.59 O ACT A1181 A 55 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 84 LYS B 164 LYS~? 10.34 O ACT A1181 coo 11.09 42.89 24.44 11.32 42.06 22.49 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 4.60 40.33 20.42 7.25 39.50 20.05 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 9.71 44.83 15.47 10.13 41.43 19.93 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 55 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 84 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 11.09 42.89 24.44 11.32 42.06 22.49 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 4.60 40.33 20.42 7.25 39.50 20.05 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 9.71 44.83 15.47 10.13 41.43 19.93 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 55 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 84 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 11.09 42.89 24.44 11.32 42.06 22.49 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 4.60 40.33 20.42 7.25 39.50 20.05 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 9.71 44.83 15.47 10.13 41.43 19.93 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 55 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 84 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 11.09 42.89 24.44 11.32 42.06 22.49 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 4.60 40.33 20.42 7.25 39.50 20.05 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 9.71 44.83 15.47 10.13 41.43 19.93 -54.90 -15.84 30.45 -50.06 -17.66 28.47 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 4 hits 1mrq_c02 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 A 217 SER B 31 SER~? 8.40 O1 GOL B1182 A 241 SER B 32 SER~? 5.72 CA CA B1183 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS A 72 LYS.? 19.74 O ACT A1182 A 217 SER D 89 SER.? 7.37 O ACT A1182 A 241 SER D 88 SER.? 4.67 O ACT A1182 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 A 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 A 217 SER A 89 SER.? 7.33 OXT ACT A1182 A 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 A 142 LYS A 117 LYS.? 20.14 O ACT A1181 A 217 SER A 56 SER.? 20.33 OXT ACT A1182 A 241 SER A 57 SER.? 18.23 O ACT A1181 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 A 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 A 217 SER C 89 SER.? 7.45 OXT ACT C1183 A 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 A 142 LYS B 93 LYS.? 14.57 O ACT C1183 A 217 SER B 89 SER.? 7.47 O ACT C1183 A 241 SER B 88 SER.? 4.64 O ACT C1183 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 A 142 LYS B 117 LYS.? 17.47 O3 GOL B1182 A 217 SER B 56 SER.? 19.73 O3 GOL B1182 A 241 SER B 57 SER.? 17.44 O3 GOL B1182 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 A 142 LYS C 72 LYS.? 18.71 O ACT C1183 A 217 SER B 89 SER.? 7.47 O ACT C1183 A 241 SER B 88 SER.? 4.64 O ACT C1183 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 A 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 A 217 SER C 89 SER.? 7.45 OXT ACT C1183 A 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 A 142 LYS C 117 LYS.? 21.58 CA CA C1184 A 217 SER C 56 SER.? 20.22 OXT ACT C1183 A 241 SER C 57 SER.? 20.56 O3 GOL D1181 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 A 142 LYS D 9 LYS~? 18.78 CA CA C1184 A 217 SER C 31 SER.? 11.23 CA CA C1184 A 241 SER C 32 SER~? 5.57 CA CA C1184 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 A 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 A 217 SER A 89 SER.? 7.33 OXT ACT A1182 A 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 A 142 LYS D 93 LYS.? 12.21 O ACT A1182 A 217 SER D 89 SER.? 7.37 O ACT A1182 A 241 SER D 88 SER.? 4.67 O ACT A1182 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 A 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 A 217 SER D 56 SER.? 20.40 O ACT A1182 A 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 14 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 B 217 SER B 31 SER~? 8.40 O1 GOL B1182 B 241 SER B 32 SER~? 5.72 CA CA B1183 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS A 72 LYS.? 19.74 O ACT A1182 B 217 SER D 89 SER.? 7.37 O ACT A1182 B 241 SER D 88 SER.? 4.67 O ACT A1182 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 B 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 B 217 SER A 89 SER.? 7.33 OXT ACT A1182 B 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -36.14 12.80 22.42 -38.75 8.18 20.02 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -34.05 3.70 20.21 -34.55 1.39 20.81 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 B 142 LYS A 117 LYS.? 20.14 O ACT A1181 B 217 SER A 56 SER.? 20.33 OXT ACT A1182 B 241 SER A 57 SER.? 18.23 O ACT A1181 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -38.62 20.41 10.01 -44.40 21.40 11.23 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -44.08 14.33 11.46 -44.92 16.36 12.58 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 B 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 B 217 SER C 89 SER.? 7.45 OXT ACT C1183 B 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -51.55 16.08 13.28 -45.97 15.76 16.18 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -56.55 7.81 13.84 -56.09 7.66 11.51 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 B 142 LYS B 93 LYS.? 14.57 O ACT C1183 B 217 SER B 89 SER.? 7.47 O ACT C1183 B 241 SER B 88 SER.? 4.64 O ACT C1183 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 B 142 LYS B 117 LYS.? 17.47 O3 GOL B1182 B 217 SER B 56 SER.? 19.73 O3 GOL B1182 B 241 SER B 57 SER.? 17.44 O3 GOL B1182 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 B 142 LYS C 72 LYS.? 18.71 O ACT C1183 B 217 SER B 89 SER.? 7.47 O ACT C1183 B 241 SER B 88 SER.? 4.64 O ACT C1183 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 B 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 B 217 SER C 89 SER.? 7.45 OXT ACT C1183 B 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -54.93 14.23 21.55 -53.38 19.08 19.32 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -56.55 7.81 13.84 -56.09 7.66 11.51 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 B 142 LYS C 117 LYS.? 21.58 CA CA C1184 B 217 SER C 56 SER.? 20.22 OXT ACT C1183 B 241 SER C 57 SER.? 20.56 O3 GOL D1181 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -51.85 4.98 33.11 -46.06 6.47 33.64 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -46.48 3.79 27.00 -45.42 5.54 28.32 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 B 142 LYS D 9 LYS~? 18.78 CA CA C1184 B 217 SER C 31 SER.? 11.23 CA CA C1184 B 241 SER C 32 SER~? 5.57 CA CA C1184 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 B 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 B 217 SER A 89 SER.? 7.33 OXT ACT A1182 B 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -39.21 6.22 27.81 -43.32 9.34 25.63 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -34.05 3.70 20.21 -34.55 1.39 20.81 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 B 142 LYS D 93 LYS.? 12.21 O ACT A1182 B 217 SER D 89 SER.? 7.37 O ACT A1182 B 241 SER D 88 SER.? 4.67 O ACT A1182 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 B 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 B 217 SER D 56 SER.? 20.40 O ACT A1182 B 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 14 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 C 217 SER B 31 SER~? 8.40 O1 GOL B1182 C 241 SER B 32 SER~? 5.72 CA CA B1183 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS A 72 LYS.? 19.74 O ACT A1182 C 217 SER D 89 SER.? 7.37 O ACT A1182 C 241 SER D 88 SER.? 4.67 O ACT A1182 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 C 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 C 217 SER A 89 SER.? 7.33 OXT ACT A1182 C 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -36.14 12.80 22.42 -38.75 8.18 20.02 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -34.05 3.70 20.21 -34.55 1.39 20.81 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 C 142 LYS A 117 LYS.? 20.14 O ACT A1181 C 217 SER A 56 SER.? 20.33 OXT ACT A1182 C 241 SER A 57 SER.? 18.23 O ACT A1181 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -38.62 20.41 10.01 -44.40 21.40 11.23 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -44.08 14.33 11.46 -44.92 16.36 12.58 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 C 142 LYS B 93 LYS.? 14.57 O ACT C1183 C 217 SER B 89 SER.? 7.47 O ACT C1183 C 241 SER B 88 SER.? 4.64 O ACT C1183 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 C 142 LYS B 117 LYS.? 17.47 O3 GOL B1182 C 217 SER B 56 SER.? 19.73 O3 GOL B1182 C 241 SER B 57 SER.? 17.44 O3 GOL B1182 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 C 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 C 217 SER C 89 SER.? 7.45 OXT ACT C1183 C 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -54.93 14.23 21.55 -53.38 19.08 19.32 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -56.55 7.81 13.84 -56.09 7.66 11.51 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 C 142 LYS C 117 LYS.? 21.58 CA CA C1184 C 217 SER C 56 SER.? 20.22 OXT ACT C1183 C 241 SER C 57 SER.? 20.56 O3 GOL D1181 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -51.85 4.98 33.11 -46.06 6.47 33.64 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -46.48 3.79 27.00 -45.42 5.54 28.32 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 C 142 LYS D 9 LYS~? 18.78 CA CA C1184 C 217 SER C 31 SER.? 11.23 CA CA C1184 C 241 SER C 32 SER~? 5.57 CA CA C1184 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 C 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 C 217 SER A 89 SER.? 7.33 OXT ACT A1182 C 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -39.21 6.22 27.81 -43.32 9.34 25.63 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -34.05 3.70 20.21 -34.55 1.39 20.81 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 C 142 LYS D 93 LYS.? 12.21 O ACT A1182 C 217 SER D 89 SER.? 7.37 O ACT A1182 C 241 SER D 88 SER.? 4.67 O ACT A1182 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 C 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 C 217 SER D 56 SER.? 20.40 O ACT A1182 C 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 12 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 D 217 SER B 31 SER~? 8.40 O1 GOL B1182 D 241 SER B 32 SER~? 5.72 CA CA B1183 coo 32.93 17.78 71.88 30.89 13.50 67.83 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 34.38 11.17 66.10 32.18 12.14 65.65 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 31.34 7.96 67.74 31.44 9.08 65.62 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS A 72 LYS.? 19.74 O ACT A1182 D 217 SER D 89 SER.? 7.37 O ACT A1182 D 241 SER D 88 SER.? 4.67 O ACT A1182 coo 32.93 17.78 71.88 30.89 13.50 67.83 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 34.38 11.17 66.10 32.18 12.14 65.65 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 31.34 7.96 67.74 31.44 9.08 65.62 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 D 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 D 217 SER A 89 SER.? 7.33 OXT ACT A1182 D 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 32.93 17.78 71.88 30.89 13.50 67.83 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 34.38 11.17 66.10 32.18 12.14 65.65 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 31.34 7.96 67.74 31.44 9.08 65.62 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 D 142 LYS A 117 LYS.? 20.14 O ACT A1181 D 217 SER A 56 SER.? 20.33 OXT ACT A1182 D 241 SER A 57 SER.? 18.23 O ACT A1181 coo 32.93 17.78 71.88 30.89 13.50 67.83 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 34.38 11.17 66.10 32.18 12.14 65.65 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 31.34 7.96 67.74 31.44 9.08 65.62 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 D 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 D 217 SER C 89 SER.? 7.45 OXT ACT C1183 D 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 32.93 17.78 71.88 30.89 13.50 67.83 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 34.38 11.17 66.10 32.18 12.14 65.65 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 31.34 7.96 67.74 31.44 9.08 65.62 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 D 142 LYS B 93 LYS.? 14.57 O ACT C1183 D 217 SER B 89 SER.? 7.47 O ACT C1183 D 241 SER B 88 SER.? 4.64 O ACT C1183 coo 32.93 17.78 71.88 30.89 13.50 67.83 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 34.38 11.17 66.10 32.18 12.14 65.65 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 31.34 7.96 67.74 31.44 9.08 65.62 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 D 142 LYS B 117 LYS.? 17.47 O3 GOL B1182 D 217 SER B 56 SER.? 19.73 O3 GOL B1182 D 241 SER B 57 SER.? 17.44 O3 GOL B1182 coo 32.93 17.78 71.88 30.89 13.50 67.83 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 34.38 11.17 66.10 32.18 12.14 65.65 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 31.34 7.96 67.74 31.44 9.08 65.62 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 D 142 LYS C 72 LYS.? 18.71 O ACT C1183 D 217 SER B 89 SER.? 7.47 O ACT C1183 D 241 SER B 88 SER.? 4.64 O ACT C1183 coo 32.93 17.78 71.88 30.89 13.50 67.83 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 34.38 11.17 66.10 32.18 12.14 65.65 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 31.34 7.96 67.74 31.44 9.08 65.62 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 D 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 D 217 SER C 89 SER.? 7.45 OXT ACT C1183 D 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 32.93 17.78 71.88 30.89 13.50 67.83 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 34.38 11.17 66.10 32.18 12.14 65.65 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 31.34 7.96 67.74 31.44 9.08 65.62 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 D 142 LYS C 117 LYS.? 21.58 CA CA C1184 D 217 SER C 56 SER.? 20.22 OXT ACT C1183 D 241 SER C 57 SER.? 20.56 O3 GOL D1181 coo 32.93 17.78 71.88 30.89 13.50 67.83 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 34.38 11.17 66.10 32.18 12.14 65.65 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 31.34 7.96 67.74 31.44 9.08 65.62 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 D 142 LYS D 9 LYS~? 18.78 CA CA C1184 D 217 SER C 31 SER.? 11.23 CA CA C1184 D 241 SER C 32 SER~? 5.57 CA CA C1184 coo 32.93 17.78 71.88 30.89 13.50 67.83 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 34.38 11.17 66.10 32.18 12.14 65.65 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 31.34 7.96 67.74 31.44 9.08 65.62 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 D 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 D 217 SER A 89 SER.? 7.33 OXT ACT A1182 D 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 32.93 17.78 71.88 30.89 13.50 67.83 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 34.38 11.17 66.10 32.18 12.14 65.65 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 31.34 7.96 67.74 31.44 9.08 65.62 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 D 142 LYS D 93 LYS.? 12.21 O ACT A1182 D 217 SER D 89 SER.? 7.37 O ACT A1182 D 241 SER D 88 SER.? 4.67 O ACT A1182 coo 32.93 17.78 71.88 30.89 13.50 67.83 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 34.38 11.17 66.10 32.18 12.14 65.65 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 31.34 7.96 67.74 31.44 9.08 65.62 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 D 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 D 217 SER D 56 SER.? 20.40 O ACT A1182 D 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo 32.93 17.78 71.88 30.89 13.50 67.83 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 34.38 11.17 66.10 32.18 12.14 65.65 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 31.34 7.96 67.74 31.44 9.08 65.62 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 14 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 E 217 SER B 31 SER~? 8.40 O1 GOL B1182 E 241 SER B 32 SER~? 5.72 CA CA B1183 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS A 72 LYS.? 19.74 O ACT A1182 E 217 SER D 89 SER.? 7.37 O ACT A1182 E 241 SER D 88 SER.? 4.67 O ACT A1182 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 E 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 E 217 SER A 89 SER.? 7.33 OXT ACT A1182 E 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 E 142 LYS A 117 LYS.? 20.14 O ACT A1181 E 217 SER A 56 SER.? 20.33 OXT ACT A1182 E 241 SER A 57 SER.? 18.23 O ACT A1181 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 E 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 E 217 SER C 89 SER.? 7.45 OXT ACT C1183 E 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 E 142 LYS B 93 LYS.? 14.57 O ACT C1183 E 217 SER B 89 SER.? 7.47 O ACT C1183 E 241 SER B 88 SER.? 4.64 O ACT C1183 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 E 142 LYS C 72 LYS.? 18.71 O ACT C1183 E 217 SER B 89 SER.? 7.47 O ACT C1183 E 241 SER B 88 SER.? 4.64 O ACT C1183 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 E 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 E 217 SER C 89 SER.? 7.45 OXT ACT C1183 E 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 E 142 LYS D 9 LYS~? 18.78 CA CA C1184 E 217 SER C 31 SER.? 11.23 CA CA C1184 E 241 SER C 32 SER~? 5.57 CA CA C1184 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 E 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 E 217 SER A 89 SER.? 7.33 OXT ACT A1182 E 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 E 142 LYS D 93 LYS.? 12.21 O ACT A1182 E 217 SER D 89 SER.? 7.37 O ACT A1182 E 241 SER D 88 SER.? 4.67 O ACT A1182 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 E 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 E 217 SER D 56 SER.? 20.40 O ACT A1182 E 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 12 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 F 217 SER B 31 SER~? 8.40 O1 GOL B1182 F 241 SER B 32 SER~? 5.72 CA CA B1183 coo 85.78 13.19 64.96 85.47 13.47 58.63 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 87.43 17.13 57.15 85.84 15.39 56.76 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 89.69 13.60 54.86 87.60 14.67 54.46 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS A 72 LYS.? 19.74 O ACT A1182 F 217 SER D 89 SER.? 7.37 O ACT A1182 F 241 SER D 88 SER.? 4.67 O ACT A1182 coo 85.78 13.19 64.96 85.47 13.47 58.63 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 87.43 17.13 57.15 85.84 15.39 56.76 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 89.69 13.60 54.86 87.60 14.67 54.46 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 F 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 F 217 SER A 89 SER.? 7.33 OXT ACT A1182 F 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 85.78 13.19 64.96 85.47 13.47 58.63 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 87.43 17.13 57.15 85.84 15.39 56.76 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 89.69 13.60 54.86 87.60 14.67 54.46 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 F 142 LYS A 117 LYS.? 20.14 O ACT A1181 F 217 SER A 56 SER.? 20.33 OXT ACT A1182 F 241 SER A 57 SER.? 18.23 O ACT A1181 coo 85.78 13.19 64.96 85.47 13.47 58.63 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 87.43 17.13 57.15 85.84 15.39 56.76 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 89.69 13.60 54.86 87.60 14.67 54.46 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 F 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 F 217 SER C 89 SER.? 7.45 OXT ACT C1183 F 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 85.78 13.19 64.96 85.47 13.47 58.63 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 87.43 17.13 57.15 85.84 15.39 56.76 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 89.69 13.60 54.86 87.60 14.67 54.46 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 F 142 LYS B 93 LYS.? 14.57 O ACT C1183 F 217 SER B 89 SER.? 7.47 O ACT C1183 F 241 SER B 88 SER.? 4.64 O ACT C1183 coo 85.78 13.19 64.96 85.47 13.47 58.63 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 87.43 17.13 57.15 85.84 15.39 56.76 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 89.69 13.60 54.86 87.60 14.67 54.46 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 F 142 LYS B 117 LYS.? 17.47 O3 GOL B1182 F 217 SER B 56 SER.? 19.73 O3 GOL B1182 F 241 SER B 57 SER.? 17.44 O3 GOL B1182 coo 85.78 13.19 64.96 85.47 13.47 58.63 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 87.43 17.13 57.15 85.84 15.39 56.76 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 89.69 13.60 54.86 87.60 14.67 54.46 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 F 142 LYS C 72 LYS.? 18.71 O ACT C1183 F 217 SER B 89 SER.? 7.47 O ACT C1183 F 241 SER B 88 SER.? 4.64 O ACT C1183 coo 85.78 13.19 64.96 85.47 13.47 58.63 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 87.43 17.13 57.15 85.84 15.39 56.76 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 89.69 13.60 54.86 87.60 14.67 54.46 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 F 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 F 217 SER C 89 SER.? 7.45 OXT ACT C1183 F 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 85.78 13.19 64.96 85.47 13.47 58.63 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 87.43 17.13 57.15 85.84 15.39 56.76 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 89.69 13.60 54.86 87.60 14.67 54.46 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 F 142 LYS C 117 LYS.? 21.58 CA CA C1184 F 217 SER C 56 SER.? 20.22 OXT ACT C1183 F 241 SER C 57 SER.? 20.56 O3 GOL D1181 coo 85.78 13.19 64.96 85.47 13.47 58.63 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 87.43 17.13 57.15 85.84 15.39 56.76 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 89.69 13.60 54.86 87.60 14.67 54.46 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 F 142 LYS D 9 LYS~? 18.78 CA CA C1184 F 217 SER C 31 SER.? 11.23 CA CA C1184 F 241 SER C 32 SER~? 5.57 CA CA C1184 coo 85.78 13.19 64.96 85.47 13.47 58.63 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 87.43 17.13 57.15 85.84 15.39 56.76 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 89.69 13.60 54.86 87.60 14.67 54.46 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 F 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 F 217 SER A 89 SER.? 7.33 OXT ACT A1182 F 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 85.78 13.19 64.96 85.47 13.47 58.63 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 87.43 17.13 57.15 85.84 15.39 56.76 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 89.69 13.60 54.86 87.60 14.67 54.46 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 F 142 LYS D 93 LYS.? 12.21 O ACT A1182 F 217 SER D 89 SER.? 7.37 O ACT A1182 F 241 SER D 88 SER.? 4.67 O ACT A1182 coo 85.78 13.19 64.96 85.47 13.47 58.63 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 87.43 17.13 57.15 85.84 15.39 56.76 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 89.69 13.60 54.86 87.60 14.67 54.46 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 F 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 F 217 SER D 56 SER.? 20.40 O ACT A1182 F 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo 85.78 13.19 64.96 85.47 13.47 58.63 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 87.43 17.13 57.15 85.84 15.39 56.76 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 89.69 13.60 54.86 87.60 14.67 54.46 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 14 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 G 217 SER B 31 SER~? 8.40 O1 GOL B1182 G 241 SER B 32 SER~? 5.72 CA CA B1183 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS A 72 LYS.? 19.74 O ACT A1182 G 217 SER D 89 SER.? 7.37 O ACT A1182 G 241 SER D 88 SER.? 4.67 O ACT A1182 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 G 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 G 217 SER A 89 SER.? 7.33 OXT ACT A1182 G 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 G 142 LYS A 117 LYS.? 20.14 O ACT A1181 G 217 SER A 56 SER.? 20.33 OXT ACT A1182 G 241 SER A 57 SER.? 18.23 O ACT A1181 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 G 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 G 217 SER C 89 SER.? 7.45 OXT ACT C1183 G 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 G 142 LYS B 93 LYS.? 14.57 O ACT C1183 G 217 SER B 89 SER.? 7.47 O ACT C1183 G 241 SER B 88 SER.? 4.64 O ACT C1183 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 G 142 LYS B 117 LYS.? 17.47 O3 GOL B1182 G 217 SER B 56 SER.? 19.73 O3 GOL B1182 G 241 SER B 57 SER.? 17.44 O3 GOL B1182 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 G 142 LYS C 72 LYS.? 18.71 O ACT C1183 G 217 SER B 89 SER.? 7.47 O ACT C1183 G 241 SER B 88 SER.? 4.64 O ACT C1183 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 G 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 G 217 SER C 89 SER.? 7.45 OXT ACT C1183 G 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 G 142 LYS C 117 LYS.? 21.58 CA CA C1184 G 217 SER C 56 SER.? 20.22 OXT ACT C1183 G 241 SER C 57 SER.? 20.56 O3 GOL D1181 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 G 142 LYS D 9 LYS~? 18.78 CA CA C1184 G 217 SER C 31 SER.? 11.23 CA CA C1184 G 241 SER C 32 SER~? 5.57 CA CA C1184 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 G 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 G 217 SER A 89 SER.? 7.33 OXT ACT A1182 G 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 G 142 LYS D 93 LYS.? 12.21 O ACT A1182 G 217 SER D 89 SER.? 7.37 O ACT A1182 G 241 SER D 88 SER.? 4.67 O ACT A1182 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 G 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 G 217 SER D 56 SER.? 20.40 O ACT A1182 G 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 14 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 H 217 SER B 31 SER~? 8.40 O1 GOL B1182 H 241 SER B 32 SER~? 5.72 CA CA B1183 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS A 72 LYS.? 19.74 O ACT A1182 H 217 SER D 89 SER.? 7.37 O ACT A1182 H 241 SER D 88 SER.? 4.67 O ACT A1182 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 H 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 H 217 SER A 89 SER.? 7.33 OXT ACT A1182 H 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 H 142 LYS A 117 LYS.? 20.14 O ACT A1181 H 217 SER A 56 SER.? 20.33 OXT ACT A1182 H 241 SER A 57 SER.? 18.23 O ACT A1181 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 H 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 H 217 SER C 89 SER.? 7.45 OXT ACT C1183 H 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 H 142 LYS B 93 LYS.? 14.57 O ACT C1183 H 217 SER B 89 SER.? 7.47 O ACT C1183 H 241 SER B 88 SER.? 4.64 O ACT C1183 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 H 142 LYS C 72 LYS.? 18.71 O ACT C1183 H 217 SER B 89 SER.? 7.47 O ACT C1183 H 241 SER B 88 SER.? 4.64 O ACT C1183 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 H 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 H 217 SER C 89 SER.? 7.45 OXT ACT C1183 H 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 H 142 LYS D 9 LYS~? 18.78 CA CA C1184 H 217 SER C 31 SER.? 11.23 CA CA C1184 H 241 SER C 32 SER~? 5.57 CA CA C1184 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 H 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 H 217 SER A 89 SER.? 7.33 OXT ACT A1182 H 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 H 142 LYS D 93 LYS.? 12.21 O ACT A1182 H 217 SER D 89 SER.? 7.37 O ACT A1182 H 241 SER D 88 SER.? 4.67 O ACT A1182 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 H 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 H 217 SER D 56 SER.? 20.40 O ACT A1182 H 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 12 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 I 217 SER B 31 SER~? 8.40 O1 GOL B1182 I 241 SER B 32 SER~? 5.72 CA CA B1183 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 2.83 88.63 29.54 1.30 86.82 30.03 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 2.37 88.32 34.25 2.82 86.58 32.61 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS A 72 LYS.? 19.74 O ACT A1182 I 217 SER D 89 SER.? 7.37 O ACT A1182 I 241 SER D 88 SER.? 4.67 O ACT A1182 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 2.83 88.63 29.54 1.30 86.82 30.03 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 2.37 88.32 34.25 2.82 86.58 32.61 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 I 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 I 217 SER A 89 SER.? 7.33 OXT ACT A1182 I 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 2.83 88.63 29.54 1.30 86.82 30.03 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 2.37 88.32 34.25 2.82 86.58 32.61 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 I 142 LYS A 117 LYS.? 20.14 O ACT A1181 I 217 SER A 56 SER.? 20.33 OXT ACT A1182 I 241 SER A 57 SER.? 18.23 O ACT A1181 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 2.83 88.63 29.54 1.30 86.82 30.03 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 2.37 88.32 34.25 2.82 86.58 32.61 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 I 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 I 217 SER C 89 SER.? 7.45 OXT ACT C1183 I 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 2.83 88.63 29.54 1.30 86.82 30.03 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 2.37 88.32 34.25 2.82 86.58 32.61 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 I 142 LYS B 93 LYS.? 14.57 O ACT C1183 I 217 SER B 89 SER.? 7.47 O ACT C1183 I 241 SER B 88 SER.? 4.64 O ACT C1183 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 2.83 88.63 29.54 1.30 86.82 30.03 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 2.37 88.32 34.25 2.82 86.58 32.61 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 I 142 LYS B 117 LYS.? 17.47 O3 GOL B1182 I 217 SER B 56 SER.? 19.73 O3 GOL B1182 I 241 SER B 57 SER.? 17.44 O3 GOL B1182 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 2.83 88.63 29.54 1.30 86.82 30.03 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 2.37 88.32 34.25 2.82 86.58 32.61 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 I 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 I 217 SER C 89 SER.? 7.45 OXT ACT C1183 I 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 2.83 88.63 29.54 1.30 86.82 30.03 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 2.37 88.32 34.25 2.82 86.58 32.61 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 I 142 LYS C 117 LYS.? 21.58 CA CA C1184 I 217 SER C 56 SER.? 20.22 OXT ACT C1183 I 241 SER C 57 SER.? 20.56 O3 GOL D1181 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 2.83 88.63 29.54 1.30 86.82 30.03 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 2.37 88.32 34.25 2.82 86.58 32.61 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 I 142 LYS D 9 LYS~? 18.78 CA CA C1184 I 217 SER C 31 SER.? 11.23 CA CA C1184 I 241 SER C 32 SER~? 5.57 CA CA C1184 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 2.83 88.63 29.54 1.30 86.82 30.03 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 2.37 88.32 34.25 2.82 86.58 32.61 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 I 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 I 217 SER A 89 SER.? 7.33 OXT ACT A1182 I 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 2.83 88.63 29.54 1.30 86.82 30.03 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 2.37 88.32 34.25 2.82 86.58 32.61 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 I 142 LYS D 93 LYS.? 12.21 O ACT A1182 I 217 SER D 89 SER.? 7.37 O ACT A1182 I 241 SER D 88 SER.? 4.67 O ACT A1182 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 2.83 88.63 29.54 1.30 86.82 30.03 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 2.37 88.32 34.25 2.82 86.58 32.61 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 I 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 I 217 SER D 56 SER.? 20.40 O ACT A1182 I 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 2.83 88.63 29.54 1.30 86.82 30.03 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 2.37 88.32 34.25 2.82 86.58 32.61 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 13 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 J 217 SER B 31 SER~? 8.40 O1 GOL B1182 J 241 SER B 32 SER~? 5.72 CA CA B1183 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS A 72 LYS.? 19.74 O ACT A1182 J 217 SER D 89 SER.? 7.37 O ACT A1182 J 241 SER D 88 SER.? 4.67 O ACT A1182 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 J 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 J 217 SER A 88 SER.? 4.86 OXT ACT A1182 J 241 SER A 89 SER.? 7.33 OXT ACT A1182 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -36.14 12.80 22.42 -38.75 8.18 20.02 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -34.67 3.69 16.47 -32.74 5.08 16.23 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -34.05 3.70 20.21 -34.55 1.39 20.81 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 J 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 J 217 SER A 89 SER.? 7.33 OXT ACT A1182 J 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -36.14 12.80 22.42 -38.75 8.18 20.02 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -34.05 3.70 20.21 -34.55 1.39 20.81 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 J 142 LYS A 117 LYS.? 20.14 O ACT A1181 J 217 SER A 56 SER.? 20.33 OXT ACT A1182 J 241 SER A 57 SER.? 18.23 O ACT A1181 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -38.62 20.41 10.01 -44.40 21.40 11.23 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -44.08 14.33 11.46 -44.92 16.36 12.58 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 J 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 J 217 SER C 89 SER.? 7.45 OXT ACT C1183 J 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -51.55 16.08 13.28 -45.97 15.76 16.18 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -56.55 7.81 13.84 -56.09 7.66 11.51 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 J 142 LYS B 93 LYS.? 14.57 O ACT C1183 J 217 SER B 89 SER.? 7.47 O ACT C1183 J 241 SER B 88 SER.? 4.64 O ACT C1183 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 J 142 LYS B 117 LYS.? 17.47 O3 GOL B1182 J 217 SER B 56 SER.? 19.73 O3 GOL B1182 J 241 SER B 57 SER.? 17.44 O3 GOL B1182 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 J 142 LYS C 72 LYS.? 18.71 O ACT C1183 J 217 SER B 89 SER.? 7.47 O ACT C1183 J 241 SER B 88 SER.? 4.64 O ACT C1183 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 J 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 J 217 SER C 89 SER.? 7.45 OXT ACT C1183 J 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -54.93 14.23 21.55 -53.38 19.08 19.32 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -56.55 7.81 13.84 -56.09 7.66 11.51 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 J 142 LYS C 117 LYS.? 21.58 CA CA C1184 J 217 SER C 56 SER.? 20.22 OXT ACT C1183 J 241 SER C 57 SER.? 20.56 O3 GOL D1181 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -51.85 4.98 33.11 -46.06 6.47 33.64 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -46.48 3.79 27.00 -45.42 5.54 28.32 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 J 142 LYS D 9 LYS~? 18.78 CA CA C1184 J 217 SER C 31 SER.? 11.23 CA CA C1184 J 241 SER C 32 SER~? 5.57 CA CA C1184 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 J 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 J 217 SER A 89 SER.? 7.33 OXT ACT A1182 J 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -39.21 6.22 27.81 -43.32 9.34 25.63 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -34.05 3.70 20.21 -34.55 1.39 20.81 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 J 142 LYS D 93 LYS.? 12.21 O ACT A1182 J 217 SER D 89 SER.? 7.37 O ACT A1182 J 241 SER D 88 SER.? 4.67 O ACT A1182 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 15 3 # 15 J 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 J 217 SER D 56 SER.? 20.40 O ACT A1182 J 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 15 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 K 217 SER B 31 SER~? 8.40 O1 GOL B1182 K 241 SER B 32 SER~? 5.72 CA CA B1183 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS A 72 LYS.? 19.74 O ACT A1182 K 217 SER D 89 SER.? 7.37 O ACT A1182 K 241 SER D 88 SER.? 4.67 O ACT A1182 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 K 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 K 217 SER A 89 SER.? 7.33 OXT ACT A1182 K 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -36.14 12.80 22.42 -38.75 8.18 20.02 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -34.05 3.70 20.21 -34.55 1.39 20.81 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 K 142 LYS A 117 LYS.? 20.14 O ACT A1181 K 217 SER A 56 SER.? 20.33 OXT ACT A1182 K 241 SER A 57 SER.? 18.23 O ACT A1181 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -38.62 20.41 10.01 -44.40 21.40 11.23 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -44.08 14.33 11.46 -44.92 16.36 12.58 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 K 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 K 217 SER C 89 SER.? 7.45 OXT ACT C1183 K 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -51.55 16.08 13.28 -45.97 15.76 16.18 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -56.55 7.81 13.84 -56.09 7.66 11.51 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 K 142 LYS B 93 LYS.? 14.57 O ACT C1183 K 217 SER B 89 SER.? 7.47 O ACT C1183 K 241 SER B 88 SER.? 4.64 O ACT C1183 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 K 142 LYS B 117 LYS.? 17.47 O3 GOL B1182 K 217 SER B 56 SER.? 19.73 O3 GOL B1182 K 241 SER B 57 SER.? 17.44 O3 GOL B1182 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 K 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 K 217 SER C 89 SER.? 7.45 OXT ACT C1183 K 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -54.93 14.23 21.55 -53.38 19.08 19.32 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -56.55 7.81 13.84 -56.09 7.66 11.51 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 K 142 LYS C 117 LYS.? 21.58 CA CA C1184 K 217 SER C 56 SER.? 20.22 OXT ACT C1183 K 241 SER C 57 SER.? 20.56 O3 GOL D1181 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -51.85 4.98 33.11 -46.06 6.47 33.64 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -46.48 3.79 27.00 -45.42 5.54 28.32 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 K 142 LYS D 9 LYS~? 18.78 CA CA C1184 K 217 SER C 31 SER.? 11.23 CA CA C1184 K 241 SER C 32 SER~? 5.57 CA CA C1184 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 K 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 K 217 SER A 89 SER.? 7.33 OXT ACT A1182 K 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -39.21 6.22 27.81 -43.32 9.34 25.63 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -34.05 3.70 20.21 -34.55 1.39 20.81 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 K 142 LYS D 93 LYS.? 12.21 O ACT A1182 K 217 SER D 89 SER.? 7.37 O ACT A1182 K 241 SER D 88 SER.? 4.67 O ACT A1182 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 K 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 K 217 SER D 56 SER.? 20.40 O ACT A1182 K 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 13 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 L 217 SER B 31 SER~? 8.40 O1 GOL B1182 L 241 SER B 32 SER~? 5.72 CA CA B1183 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS A 72 LYS.? 19.74 O ACT A1182 L 217 SER D 89 SER.? 7.37 O ACT A1182 L 241 SER D 88 SER.? 4.67 O ACT A1182 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 L 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 L 217 SER A 89 SER.? 7.33 OXT ACT A1182 L 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 L 142 LYS A 117 LYS.? 20.14 O ACT A1181 L 217 SER A 56 SER.? 20.33 OXT ACT A1182 L 241 SER A 57 SER.? 18.23 O ACT A1181 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 L 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 L 217 SER C 89 SER.? 7.45 OXT ACT C1183 L 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 L 142 LYS B 93 LYS.? 14.57 O ACT C1183 L 217 SER B 89 SER.? 7.47 O ACT C1183 L 241 SER B 88 SER.? 4.64 O ACT C1183 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 L 142 LYS C 72 LYS.? 18.71 O ACT C1183 L 217 SER B 89 SER.? 7.47 O ACT C1183 L 241 SER B 88 SER.? 4.64 O ACT C1183 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 L 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 L 217 SER C 89 SER.? 7.45 OXT ACT C1183 L 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 L 142 LYS D 9 LYS~? 18.78 CA CA C1184 L 217 SER C 31 SER.? 11.23 CA CA C1184 L 241 SER C 32 SER~? 5.57 CA CA C1184 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 L 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 L 217 SER A 89 SER.? 7.33 OXT ACT A1182 L 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 L 142 LYS D 93 LYS.? 12.21 O ACT A1182 L 217 SER D 89 SER.? 7.37 O ACT A1182 L 241 SER D 88 SER.? 4.67 O ACT A1182 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 L 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 L 217 SER D 56 SER.? 20.40 O ACT A1182 L 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 12 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 M 217 SER B 31 SER~? 8.40 O1 GOL B1182 M 241 SER B 32 SER~? 5.72 CA CA B1183 coo 57.83 99.61 24.25 54.90 95.14 20.60 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 51.07 94.66 21.52 53.18 93.49 22.20 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 51.67 94.23 16.93 51.60 92.47 18.57 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS A 72 LYS.? 19.74 O ACT A1182 M 217 SER D 89 SER.? 7.37 O ACT A1182 M 241 SER D 88 SER.? 4.67 O ACT A1182 coo 57.83 99.61 24.25 54.90 95.14 20.60 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 51.07 94.66 21.52 53.18 93.49 22.20 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 51.67 94.23 16.93 51.60 92.47 18.57 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 M 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 M 217 SER A 89 SER.? 7.33 OXT ACT A1182 M 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 57.83 99.61 24.25 54.90 95.14 20.60 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 51.07 94.66 21.52 53.18 93.49 22.20 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 51.67 94.23 16.93 51.60 92.47 18.57 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 M 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 M 217 SER C 89 SER.? 7.45 OXT ACT C1183 M 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 57.83 99.61 24.25 54.90 95.14 20.60 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 51.07 94.66 21.52 53.18 93.49 22.20 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 51.67 94.23 16.93 51.60 92.47 18.57 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 M 142 LYS B 93 LYS.? 14.57 O ACT C1183 M 217 SER B 89 SER.? 7.47 O ACT C1183 M 241 SER B 88 SER.? 4.64 O ACT C1183 coo 57.83 99.61 24.25 54.90 95.14 20.60 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 51.07 94.66 21.52 53.18 93.49 22.20 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 51.67 94.23 16.93 51.60 92.47 18.57 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 M 142 LYS C 72 LYS.? 18.71 O ACT C1183 M 217 SER B 89 SER.? 7.47 O ACT C1183 M 241 SER B 88 SER.? 4.64 O ACT C1183 coo 57.83 99.61 24.25 54.90 95.14 20.60 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 51.07 94.66 21.52 53.18 93.49 22.20 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 51.67 94.23 16.93 51.60 92.47 18.57 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 M 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 M 217 SER C 89 SER.? 7.45 OXT ACT C1183 M 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 57.83 99.61 24.25 54.90 95.14 20.60 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 51.07 94.66 21.52 53.18 93.49 22.20 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 51.67 94.23 16.93 51.60 92.47 18.57 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 M 142 LYS D 9 LYS~? 18.78 CA CA C1184 M 217 SER C 31 SER.? 11.23 CA CA C1184 M 241 SER C 32 SER~? 5.57 CA CA C1184 coo 57.83 99.61 24.25 54.90 95.14 20.60 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 51.07 94.66 21.52 53.18 93.49 22.20 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 51.67 94.23 16.93 51.60 92.47 18.57 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 M 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 M 217 SER A 89 SER.? 7.33 OXT ACT A1182 M 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 57.83 99.61 24.25 54.90 95.14 20.60 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 51.07 94.66 21.52 53.18 93.49 22.20 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 51.67 94.23 16.93 51.60 92.47 18.57 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 M 142 LYS D 93 LYS.? 12.21 O ACT A1182 M 217 SER D 89 SER.? 7.37 O ACT A1182 M 241 SER D 88 SER.? 4.67 O ACT A1182 coo 57.83 99.61 24.25 54.90 95.14 20.60 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 51.07 94.66 21.52 53.18 93.49 22.20 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 51.67 94.23 16.93 51.60 92.47 18.57 -34.51 -3.89 10.07 -32.18 -4.55 9.73 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 10 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 N 217 SER B 31 SER~? 8.40 O1 GOL B1182 N 241 SER B 32 SER~? 5.72 CA CA B1183 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 82.47 71.15 2.07 80.82 69.44 2.28 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS A 72 LYS.? 19.74 O ACT A1182 N 217 SER D 89 SER.? 7.37 O ACT A1182 N 241 SER D 88 SER.? 4.67 O ACT A1182 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 82.47 71.15 2.07 80.82 69.44 2.28 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 N 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 N 217 SER A 89 SER.? 7.33 OXT ACT A1182 N 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 82.47 71.15 2.07 80.82 69.44 2.28 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 N 142 LYS A 117 LYS.? 20.14 O ACT A1181 N 217 SER A 56 SER.? 20.33 OXT ACT A1182 N 241 SER A 57 SER.? 18.23 O ACT A1181 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 82.47 71.15 2.07 80.82 69.44 2.28 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 N 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 N 217 SER C 89 SER.? 7.45 OXT ACT C1183 N 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 82.47 71.15 2.07 80.82 69.44 2.28 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 N 142 LYS B 93 LYS.? 14.57 O ACT C1183 N 217 SER B 89 SER.? 7.47 O ACT C1183 N 241 SER B 88 SER.? 4.64 O ACT C1183 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 82.47 71.15 2.07 80.82 69.44 2.28 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 N 142 LYS B 117 LYS.? 17.47 O3 GOL B1182 N 217 SER B 56 SER.? 19.73 O3 GOL B1182 N 241 SER B 57 SER.? 17.44 O3 GOL B1182 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 82.47 71.15 2.07 80.82 69.44 2.28 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 N 142 LYS C 72 LYS.? 18.71 O ACT C1183 N 217 SER B 89 SER.? 7.47 O ACT C1183 N 241 SER B 88 SER.? 4.64 O ACT C1183 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 82.47 71.15 2.07 80.82 69.44 2.28 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 N 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 N 217 SER C 89 SER.? 7.45 OXT ACT C1183 N 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 82.47 71.15 2.07 80.82 69.44 2.28 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 N 142 LYS C 117 LYS.? 21.58 CA CA C1184 N 217 SER C 56 SER.? 20.22 OXT ACT C1183 N 241 SER C 57 SER.? 20.56 O3 GOL D1181 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 82.47 71.15 2.07 80.82 69.44 2.28 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 N 142 LYS D 9 LYS~? 18.78 CA CA C1184 N 217 SER C 31 SER.? 11.23 CA CA C1184 N 241 SER C 32 SER~? 5.57 CA CA C1184 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 82.47 71.15 2.07 80.82 69.44 2.28 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 N 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 N 217 SER A 89 SER.? 7.33 OXT ACT A1182 N 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 82.47 71.15 2.07 80.82 69.44 2.28 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 N 142 LYS D 93 LYS.? 12.21 O ACT A1182 N 217 SER D 89 SER.? 7.37 O ACT A1182 N 241 SER D 88 SER.? 4.67 O ACT A1182 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 82.47 71.15 2.07 80.82 69.44 2.28 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 N 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 N 217 SER D 56 SER.? 20.40 O ACT A1182 N 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 82.47 71.15 2.07 80.82 69.44 2.28 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 14 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 O 217 SER B 31 SER~? 8.40 O1 GOL B1182 O 241 SER B 32 SER~? 5.72 CA CA B1183 coo 81.67 70.12 58.71 78.82 64.87 57.22 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 81.62 62.23 55.05 79.32 62.93 55.20 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 79.39 59.54 58.42 78.72 60.00 56.11 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS A 72 LYS.? 19.74 O ACT A1182 O 217 SER D 89 SER.? 7.37 O ACT A1182 O 241 SER D 88 SER.? 4.67 O ACT A1182 coo 81.67 70.12 58.71 78.82 64.87 57.22 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 81.62 62.23 55.05 79.32 62.93 55.20 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 79.39 59.54 58.42 78.72 60.00 56.11 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 O 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 O 217 SER A 89 SER.? 7.33 OXT ACT A1182 O 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 81.67 70.12 58.71 78.82 64.87 57.22 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 81.62 62.23 55.05 79.32 62.93 55.20 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 79.39 59.54 58.42 78.72 60.00 56.11 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 O 142 LYS A 117 LYS.? 20.14 O ACT A1181 O 217 SER A 56 SER.? 20.33 OXT ACT A1182 O 241 SER A 57 SER.? 18.23 O ACT A1181 coo 81.67 70.12 58.71 78.82 64.87 57.22 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 81.62 62.23 55.05 79.32 62.93 55.20 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 79.39 59.54 58.42 78.72 60.00 56.11 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 O 142 LYS B 72 LYS.? 19.60 OXT ACT C1183 O 217 SER C 89 SER.? 7.45 OXT ACT C1183 O 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 81.67 70.12 58.71 78.82 64.87 57.22 -51.55 16.08 13.28 -45.97 15.76 16.18 coo 81.62 62.23 55.05 79.32 62.93 55.20 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 79.39 59.54 58.42 78.72 60.00 56.11 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 O 142 LYS B 93 LYS.? 14.57 O ACT C1183 O 217 SER B 89 SER.? 7.47 O ACT C1183 O 241 SER B 88 SER.? 4.64 O ACT C1183 coo 81.67 70.12 58.71 78.82 64.87 57.22 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 81.62 62.23 55.05 79.32 62.93 55.20 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 79.39 59.54 58.42 78.72 60.00 56.11 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 O 142 LYS B 117 LYS.? 17.47 O3 GOL B1182 O 217 SER B 56 SER.? 19.73 O3 GOL B1182 O 241 SER B 57 SER.? 17.44 O3 GOL B1182 coo 81.67 70.12 58.71 78.82 64.87 57.22 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 81.62 62.23 55.05 79.32 62.93 55.20 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 79.39 59.54 58.42 78.72 60.00 56.11 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 O 142 LYS C 72 LYS.? 18.71 O ACT C1183 O 217 SER B 89 SER.? 7.47 O ACT C1183 O 241 SER B 88 SER.? 4.64 O ACT C1183 coo 81.67 70.12 58.71 78.82 64.87 57.22 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo 81.62 62.23 55.05 79.32 62.93 55.20 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 79.39 59.54 58.42 78.72 60.00 56.11 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 O 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 O 217 SER C 89 SER.? 7.45 OXT ACT C1183 O 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 81.67 70.12 58.71 78.82 64.87 57.22 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 81.62 62.23 55.05 79.32 62.93 55.20 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 79.39 59.54 58.42 78.72 60.00 56.11 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 O 142 LYS C 117 LYS.? 21.58 CA CA C1184 O 217 SER C 56 SER.? 20.22 OXT ACT C1183 O 241 SER C 57 SER.? 20.56 O3 GOL D1181 coo 81.67 70.12 58.71 78.82 64.87 57.22 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 81.62 62.23 55.05 79.32 62.93 55.20 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 79.39 59.54 58.42 78.72 60.00 56.11 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 O 142 LYS D 9 LYS~? 18.78 CA CA C1184 O 217 SER C 31 SER.? 11.23 CA CA C1184 O 241 SER C 32 SER~? 5.57 CA CA C1184 coo 81.67 70.12 58.71 78.82 64.87 57.22 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 81.62 62.23 55.05 79.32 62.93 55.20 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 79.39 59.54 58.42 78.72 60.00 56.11 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 O 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 O 217 SER A 89 SER.? 7.33 OXT ACT A1182 O 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 81.67 70.12 58.71 78.82 64.87 57.22 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 81.62 62.23 55.05 79.32 62.93 55.20 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 79.39 59.54 58.42 78.72 60.00 56.11 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 13 3 # 13 O 142 LYS D 93 LYS.? 12.21 O ACT A1182 O 217 SER D 89 SER.? 7.37 O ACT A1182 O 241 SER D 88 SER.? 4.67 O ACT A1182 coo 81.67 70.12 58.71 78.82 64.87 57.22 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 81.62 62.23 55.05 79.32 62.93 55.20 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 79.39 59.54 58.42 78.72 60.00 56.11 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 14 3 # 14 O 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 O 217 SER D 56 SER.? 20.40 O ACT A1182 O 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo 81.67 70.12 58.71 78.82 64.87 57.22 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 81.62 62.23 55.05 79.32 62.93 55.20 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 79.39 59.54 58.42 78.72 60.00 56.11 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 14 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 9 LYS~? 15.21 O1 GOL B1182 P 217 SER B 31 SER~? 8.40 O1 GOL B1182 P 241 SER B 32 SER~? 5.72 CA CA B1183 coo 37.29 55.72 69.54 38.73 59.85 65.07 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 35.55 61.40 62.96 37.72 60.41 62.66 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 38.60 64.77 64.10 38.63 63.28 62.26 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS A 72 LYS.? 19.74 O ACT A1182 P 217 SER D 89 SER.? 7.37 O ACT A1182 P 241 SER D 88 SER.? 4.67 O ACT A1182 coo 37.29 55.72 69.54 38.73 59.85 65.07 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 35.55 61.40 62.96 37.72 60.41 62.66 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 38.60 64.77 64.10 38.63 63.28 62.26 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 P 142 LYS A 93 LYS.? 11.72 OXT ACT A1182 P 217 SER A 89 SER.? 7.33 OXT ACT A1182 P 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 37.29 55.72 69.54 38.73 59.85 65.07 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 35.55 61.40 62.96 37.72 60.41 62.66 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 38.60 64.77 64.10 38.63 63.28 62.26 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 P 142 LYS A 117 LYS.? 20.14 O ACT A1181 P 217 SER A 56 SER.? 20.33 OXT ACT A1182 P 241 SER A 57 SER.? 18.23 O ACT A1181 coo 37.29 55.72 69.54 38.73 59.85 65.07 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 35.55 61.40 62.96 37.72 60.41 62.66 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 38.60 64.77 64.10 38.63 63.28 62.26 -45.76 15.37 8.19 -46.87 17.43 8.67 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 P 142 LYS B 93 LYS.? 14.57 O ACT C1183 P 217 SER B 89 SER.? 7.47 O ACT C1183 P 241 SER B 88 SER.? 4.64 O ACT C1183 coo 37.29 55.72 69.54 38.73 59.85 65.07 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 35.55 61.40 62.96 37.72 60.41 62.66 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 38.60 64.77 64.10 38.63 63.28 62.26 -56.11 -4.45 10.90 -58.45 -5.07 10.53 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 P 142 LYS B 117 LYS.? 17.47 O3 GOL B1182 P 217 SER B 56 SER.? 19.73 O3 GOL B1182 P 241 SER B 57 SER.? 17.44 O3 GOL B1182 coo 37.29 55.72 69.54 38.73 59.85 65.07 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 35.55 61.40 62.96 37.72 60.41 62.66 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 38.60 64.77 64.10 38.63 63.28 62.26 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 7 3 # 7 P 142 LYS C 93 LYS.? 19.61 OXT ACT C1183 P 217 SER C 89 SER.? 7.45 OXT ACT C1183 P 241 SER C 88 SER.? 4.69 OXT ACT C1183 coo 37.29 55.72 69.54 38.73 59.85 65.07 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 35.55 61.40 62.96 37.72 60.41 62.66 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 38.60 64.77 64.10 38.63 63.28 62.26 -56.10 4.45 15.54 -58.39 5.12 16.05 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 8 3 # 8 P 142 LYS C 117 LYS.? 21.58 CA CA C1184 P 217 SER C 56 SER.? 20.22 OXT ACT C1183 P 241 SER C 57 SER.? 20.56 O3 GOL D1181 coo 37.29 55.72 69.54 38.73 59.85 65.07 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 35.55 61.40 62.96 37.72 60.41 62.66 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 38.60 64.77 64.10 38.63 63.28 62.26 -44.87 1.18 29.24 -43.70 2.34 31.00 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 9 3 # 9 P 142 LYS D 9 LYS~? 18.78 CA CA C1184 P 217 SER C 31 SER.? 11.23 CA CA C1184 P 241 SER C 32 SER~? 5.57 CA CA C1184 coo 37.29 55.72 69.54 38.73 59.85 65.07 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 35.55 61.40 62.96 37.72 60.41 62.66 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 38.60 64.77 64.10 38.63 63.28 62.26 -65.86 -7.98 41.44 -65.87 -6.54 43.37 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 10 3 # 10 P 142 LYS D 72 LYS.? 18.40 OXT ACT A1182 P 217 SER A 89 SER.? 7.33 OXT ACT A1182 P 241 SER A 88 SER.? 4.86 OXT ACT A1182 coo 37.29 55.72 69.54 38.73 59.85 65.07 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 35.55 61.40 62.96 37.72 60.41 62.66 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 38.60 64.77 64.10 38.63 63.28 62.26 -34.67 3.69 16.47 -32.74 5.08 16.23 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 11 3 # 11 P 142 LYS D 93 LYS.? 12.21 O ACT A1182 P 217 SER D 89 SER.? 7.37 O ACT A1182 P 241 SER D 88 SER.? 4.67 O ACT A1182 coo 37.29 55.72 69.54 38.73 59.85 65.07 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 35.55 61.40 62.96 37.72 60.41 62.66 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 38.60 64.77 64.10 38.63 63.28 62.26 -34.51 -3.89 10.07 -32.18 -4.55 9.73 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 12 3 # 12 P 142 LYS D 117 LYS.? 19.88 O2 GOL D1181 P 217 SER D 56 SER.? 20.40 O ACT A1182 P 241 SER D 57 SER.? 18.28 O2 GOL D1181 coo 37.29 55.72 69.54 38.73 59.85 65.07 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 35.55 61.40 62.96 37.72 60.41 62.66 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 38.60 64.77 64.10 38.63 63.28 62.26 -45.75 -15.36 18.26 -46.91 -17.39 17.79 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 12 hits 1mt5_c15 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 2 LYS^? 14.71 CA CA B1181 A 169 LYS B 177 LYS.? 12.69 CA CA B1181 A 327 GLU A 10 GLU~? 17.55 CA CA B1181 coo 20.73 15.53 25.54 22.09 15.64 19.40 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo 24.31 10.25 23.71 29.02 12.05 20.75 -68.49 25.09 -2.05 -63.14 26.93 0.36 coo 21.86 20.40 18.59 22.12 18.33 18.33 -63.89 24.62 -14.30 -65.11 25.98 -13.14 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS B 2 LYS^? 23.29 OXT ACT A1181 A 169 LYS A 177 LYS.? 21.69 OXT ACT A1181 A 327 GLU B 10 GLU~? 20.86 OXT ACT A1181 coo 20.73 15.53 25.54 22.09 15.64 19.40 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 24.31 10.25 23.71 29.02 12.05 20.75 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo 21.86 20.40 18.59 22.12 18.33 18.33 -27.02 16.65 -20.13 -25.98 15.39 -21.46 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS C 2 LYS^? 15.05 CA CA C1182 A 169 LYS D 177 LYS.? 22.56 O3 GOL D1181 A 327 GLU C 10 GLU~? 13.45 CA CA C1182 coo 20.73 15.53 25.54 22.09 15.64 19.40 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 24.31 10.25 23.71 29.02 12.05 20.75 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 21.86 20.40 18.59 22.12 18.33 18.33 -27.27 -16.59 46.83 -26.38 -15.22 48.19 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 4 3 # 4 A 167 LYS D 2 LYS.? 16.82 CA CA C1181 A 169 LYS C 177 LYS.? 13.52 CA CA C1181 A 327 GLU D 10 GLU~? 18.53 CA CA C1181 coo 20.73 15.53 25.54 22.09 15.64 19.40 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo 24.31 10.25 23.71 29.02 12.05 20.75 -68.52 -25.10 28.52 -62.74 -26.81 28.79 coo 21.86 20.40 18.59 22.12 18.33 18.33 -62.08 -25.49 39.96 -63.41 -27.01 39.21 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 4 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 2 LYS^? 14.71 CA CA B1181 B 169 LYS B 177 LYS.? 12.69 CA CA B1181 B 327 GLU A 10 GLU~? 17.55 CA CA B1181 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -68.49 25.09 -2.05 -63.14 26.93 0.36 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -63.89 24.62 -14.30 -65.11 25.98 -13.14 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS B 2 LYS^? 23.29 OXT ACT A1181 B 169 LYS A 177 LYS.? 21.69 OXT ACT A1181 B 327 GLU B 10 GLU~? 20.86 OXT ACT A1181 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -27.02 16.65 -20.13 -25.98 15.39 -21.46 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS C 2 LYS^? 15.05 CA CA C1182 B 169 LYS D 177 LYS.? 22.56 O3 GOL D1181 B 327 GLU C 10 GLU~? 13.45 CA CA C1182 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -27.27 -16.59 46.83 -26.38 -15.22 48.19 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 4 3 # 4 B 167 LYS D 2 LYS.? 16.82 CA CA C1181 B 169 LYS C 177 LYS.? 13.52 CA CA C1181 B 327 GLU D 10 GLU~? 18.53 CA CA C1181 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -68.52 -25.10 28.52 -62.74 -26.81 28.79 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -62.08 -25.49 39.96 -63.41 -27.01 39.21 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 4 hits 1muc_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 197 ASP A 55 ASP.? 17.41 O ACT A1181 A 223 ALA A 87 ALA.? 6.96 OXT ACT A1182 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -37.93 4.41 14.70 -38.35 3.33 13.74 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 197 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 223 ALA B 87 ALA.? 6.83 O ACT C1183 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -52.69 -3.08 9.85 -52.24 -1.81 10.51 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 197 ASP C 55 ASP.? 19.45 CA CA C1184 A 223 ALA C 87 ALA.? 6.87 OXT ACT C1183 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -52.69 3.10 16.59 -52.21 1.83 15.91 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS D 114 HIS^? 15.97 O ACT A1182 A 197 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 223 ALA D 87 ALA.? 6.96 O ACT A1182 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -37.91 -4.38 11.75 -38.33 -3.29 12.71 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 4 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 197 ASP A 55 ASP.? 17.41 O ACT A1181 B 223 ALA A 87 ALA.? 6.96 OXT ACT A1182 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -37.93 4.41 14.70 -38.35 3.33 13.74 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 197 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 223 ALA B 87 ALA.? 6.83 O ACT C1183 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -52.69 -3.08 9.85 -52.24 -1.81 10.51 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 197 ASP C 55 ASP.? 19.45 CA CA C1184 B 223 ALA C 87 ALA.? 6.87 OXT ACT C1183 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -52.69 3.10 16.59 -52.21 1.83 15.91 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS D 114 HIS^? 15.97 O ACT A1182 B 197 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 223 ALA D 87 ALA.? 6.96 O ACT A1182 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -37.91 -4.38 11.75 -38.33 -3.29 12.71 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 4 hits 1n2t_c03 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 150 GLU.? 17.29 O ACT A1181 B 128 HIS A 114 HIS^? 15.94 OXT ACT A1182 C 263 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo 6.12 5.94 82.00 7.16 6.32 83.81 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 12.51 16.35 80.99 13.16 14.90 82.37 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 11.58 14.94 93.26 12.25 14.03 91.50 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU B 150 GLU.? 13.13 O3 GOL B1182 B 128 HIS B 114 HIS^? 14.73 O2 GOL B1182 C 263 HIS B 59 HIS~? 15.18 O ACT C1183 coo 6.12 5.94 82.00 7.16 6.32 83.81 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 12.51 16.35 80.99 13.16 14.90 82.37 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 11.58 14.94 93.26 12.25 14.03 91.50 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU C 150 GLU.? 16.95 CA CA C1184 B 128 HIS C 114 HIS^? 15.77 OXT ACT C1183 C 263 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo 6.12 5.94 82.00 7.16 6.32 83.81 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 12.51 16.35 80.99 13.16 14.90 82.37 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 11.58 14.94 93.26 12.25 14.03 91.50 -46.89 1.05 23.56 -47.29 3.11 23.40 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 B 59 GLU D 150 GLU.? 17.20 O2 GOL D1181 B 128 HIS D 114 HIS^? 15.97 O ACT A1182 C 263 HIS D 59 HIS~? 14.28 O ACT A1182 coo 6.12 5.94 82.00 7.16 6.32 83.81 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 12.51 16.35 80.99 13.16 14.90 82.37 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 11.58 14.94 93.26 12.25 14.03 91.50 -44.08 -8.12 17.12 -43.68 -6.15 16.50 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 4 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 59 HIS~? 15.34 OXT ACT A1182 D 59 GLU A 150 GLU.? 17.29 O ACT A1181 D 128 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS B 59 HIS~? 15.18 O ACT C1183 D 59 GLU B 150 GLU.? 13.13 O3 GOL B1182 D 128 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS C 59 HIS~? 15.17 OXT ACT C1183 D 59 GLU C 150 GLU.? 16.95 CA CA C1184 D 128 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS D 59 HIS~? 14.28 O ACT A1182 D 59 GLU D 150 GLU.? 17.20 O2 GOL D1181 D 128 HIS D 114 HIS^? 15.97 O ACT A1182 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 4 hits 1ni4_c01 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 9 LYS~? 15.21 O1 GOL B1182 631 LYS B 142 LYS.? 10.67 CA CA B1183 708 LYS A 2 LYS^? 14.71 CA CA B1181 coo 8.61 33.06 11.15 10.12 29.19 8.82 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 coo 18.16 32.86 9.85 16.06 28.20 13.56 -70.83 25.29 -8.78 -66.22 27.65 -9.14 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 9 LYS~? 15.21 O1 GOL B1182 631 LYS B 149 LYS.? 7.98 O3 GOL B1182 708 LYS A 2 LYS^? 14.71 CA CA B1181 coo 8.61 33.06 11.15 10.12 29.19 8.82 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -50.82 2.31 -15.26 -51.03 5.84 -20.47 coo 18.16 32.86 9.85 16.06 28.20 13.56 -70.83 25.29 -8.78 -66.22 27.65 -9.14 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS A 72 LYS.? 19.74 O ACT A1182 631 LYS B 158 LYS~? 6.73 O3 GOL B1182 708 LYS D 93 LYS.? 12.21 O ACT A1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -50.07 10.43 -10.30 -49.56 8.69 -16.32 coo 18.16 32.86 9.85 16.06 28.20 13.56 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS A 93 LYS.? 11.72 OXT ACT A1182 631 LYS A 142 LYS.? 21.46 CH3 ACT A1182 708 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -36.14 12.80 22.42 -38.75 8.18 20.02 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -25.15 24.34 9.11 -21.81 19.66 9.96 coo 18.16 32.86 9.85 16.06 28.20 13.56 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 5 3 # 5 549 LYS A 93 LYS.? 11.72 OXT ACT A1182 631 LYS C 117 LYS.? 21.58 CA CA C1184 708 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -36.14 12.80 22.42 -38.75 8.18 20.02 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -51.85 4.98 33.11 -46.06 6.47 33.64 coo 18.16 32.86 9.85 16.06 28.20 13.56 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 6 3 # 6 549 LYS A 117 LYS.? 20.14 O ACT A1181 631 LYS B 164 LYS~? 10.34 O ACT A1181 708 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -38.62 20.41 10.01 -44.40 21.40 11.23 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -54.90 15.84 -3.99 -50.07 17.65 -1.98 coo 18.16 32.86 9.85 16.06 28.20 13.56 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 7 3 # 7 549 LYS A 117 LYS.? 20.14 O ACT A1181 631 LYS D 72 LYS.? 18.40 OXT ACT A1182 708 LYS A 149 LYS.? 8.87 O ACT A1181 coo 8.61 33.06 11.15 10.12 29.19 8.82 -38.62 20.41 10.01 -44.40 21.40 11.23 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 18.16 32.86 9.85 16.06 28.20 13.56 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 8 3 # 8 549 LYS A 124 LYS~? 24.92 OXT ACT A1182 631 LYS A 35 LYS~? 23.91 O ACT A1181 708 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -30.92 19.75 15.99 -32.39 25.70 15.74 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo 18.16 32.86 9.85 16.06 28.20 13.56 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 9 3 # 9 549 LYS A 124 LYS~? 24.92 OXT ACT A1182 631 LYS D 75 LYS.? 24.88 O3 GOL D1181 708 LYS A 142 LYS.? 21.46 CH3 ACT A1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -30.92 19.75 15.99 -32.39 25.70 15.74 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -33.47 8.69 34.45 -37.51 6.70 37.91 coo 18.16 32.86 9.85 16.06 28.20 13.56 -25.15 24.34 9.11 -21.81 19.66 9.96 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 10 3 # 10 549 LYS A 158 LYS~? -4.64 O ACT A1181s 631 LYS B 149 LYS.? 7.98 O3 GOL B1182 708 LYS A 149 LYS.? 8.87 O ACT A1181 coo 8.61 33.06 11.15 10.12 29.19 8.82 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -50.82 2.31 -15.26 -51.03 5.84 -20.47 coo 18.16 32.86 9.85 16.06 28.20 13.56 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 11 3 # 11 549 LYS B 9 LYS~? 18.37 O ACT A1181 631 LYS A 149 LYS.? 8.87 O ACT A1181 708 LYS B 2 LYS^? 23.29 OXT ACT A1181 coo 8.61 33.06 11.15 10.12 29.19 8.82 -27.67 18.71 -15.51 -26.70 22.99 -17.12 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -40.01 25.58 0.52 -39.09 27.65 -5.03 coo 18.16 32.86 9.85 16.06 28.20 13.56 -20.20 10.38 -18.51 -23.30 13.86 -21.27 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 12 3 # 12 549 LYS B 72 LYS.? 19.60 OXT ACT C1183 631 LYS A 158 LYS~? -4.64 O ACT A1181s 708 LYS C 93 LYS.? 19.61 OXT ACT C1183 coo 8.61 33.06 11.15 10.12 29.19 8.82 -51.55 16.08 13.28 -45.97 15.76 16.18 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 18.16 32.86 9.85 16.06 28.20 13.56 -54.93 14.23 21.55 -53.38 19.08 19.32 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 13 3 # 13 549 LYS B 93 LYS.? 14.57 O ACT C1183 631 LYS B 142 LYS.? 10.67 CA CA B1183 708 LYS C 72 LYS.? 18.71 O ACT C1183 coo 8.61 33.06 11.15 10.12 29.19 8.82 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 coo 18.16 32.86 9.85 16.06 28.20 13.56 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 14 3 # 14 549 LYS B 93 LYS.? 14.57 O ACT C1183 631 LYS D 117 LYS.? 19.88 O2 GOL D1181 708 LYS B 124 LYS~? 15.51 CA CA B1183 coo 8.61 33.06 11.15 10.12 29.19 8.82 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo 18.16 32.86 9.85 16.06 28.20 13.56 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 15 3 # 15 549 LYS B 117 LYS.? 17.47 O3 GOL B1182 631 LYS A 164 LYS~? 11.79 OXT ACT A1181 708 LYS B 124 LYS~? 15.51 CA CA B1183 coo 8.61 33.06 11.15 10.12 29.19 8.82 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -35.84 9.74 -8.05 -40.64 7.29 -8.85 coo 18.16 32.86 9.85 16.06 28.20 13.56 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 16 3 # 16 549 LYS B 124 LYS~? 15.51 CA CA B1183 631 LYS B 35 LYS~? 11.04 CA CA B1183 708 LYS B 93 LYS.? 14.57 O ACT C1183 coo 8.61 33.06 11.15 10.12 29.19 8.82 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -68.46 9.78 -10.58 -72.55 6.75 -11.95 coo 18.16 32.86 9.85 16.06 28.20 13.56 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 17 3 # 17 549 LYS B 124 LYS~? 15.51 CA CA B1183 631 LYS C 75 LYS.? 21.97 O2 GOL D1181 708 LYS B 142 LYS.? 10.67 CA CA B1183 coo 8.61 33.06 11.15 10.12 29.19 8.82 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -57.40 -22.87 13.44 -53.97 -26.42 17.14 coo 18.16 32.86 9.85 16.06 28.20 13.56 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 18 3 # 18 549 LYS B 142 LYS.? 10.67 CA CA B1183 631 LYS A 9 LYS~? 15.21 O1 GOL B1182 708 LYS B 124 LYS~? 15.51 CA CA B1183 coo 8.61 33.06 11.15 10.12 29.19 8.82 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 18.16 32.86 9.85 16.06 28.20 13.56 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 19 3 # 19 549 LYS B 158 LYS~? 6.73 O3 GOL B1182 631 LYS A 149 LYS.? 8.87 O ACT A1181 708 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -50.07 10.43 -10.30 -49.56 8.69 -16.32 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -40.01 25.58 0.52 -39.09 27.65 -5.03 coo 18.16 32.86 9.85 16.06 28.20 13.56 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 20 3 # 20 549 LYS C 9 LYS~? 14.61 CA CA C1182 631 LYS D 149 LYS.? 13.85 O2 GOL D1181 708 LYS C 2 LYS^? 15.05 CA CA C1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -27.74 -18.74 41.99 -22.99 -22.90 41.19 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -40.00 -25.59 26.00 -40.81 -29.12 24.35 coo 18.16 32.86 9.85 16.06 28.20 13.56 -20.31 -10.65 45.10 -24.59 -14.66 46.53 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 21 3 # 21 549 LYS C 72 LYS.? 18.71 O ACT C1183 631 LYS D 158 LYS~? -4.46 O2 GOL D1181s 708 LYS B 93 LYS.? 14.57 O ACT C1183 coo 8.61 33.06 11.15 10.12 29.19 8.82 -51.58 -16.11 13.18 -47.22 -15.59 10.10 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo 18.16 32.86 9.85 16.06 28.20 13.56 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 22 3 # 22 549 LYS C 93 LYS.? 19.61 OXT ACT C1183 631 LYS A 117 LYS.? 20.14 O ACT A1181 708 LYS C 124 LYS~? 15.99 CA CA C1184 coo 8.61 33.06 11.15 10.12 29.19 8.82 -54.93 14.23 21.55 -53.38 19.08 19.32 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -38.62 20.41 10.01 -44.40 21.40 11.23 coo 18.16 32.86 9.85 16.06 28.20 13.56 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 23 3 # 23 549 LYS C 93 LYS.? 19.61 OXT ACT C1183 631 LYS C 142 LYS.? 12.38 CA CA C1184 708 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 8.61 33.06 11.15 10.12 29.19 8.82 -54.93 14.23 21.55 -53.38 19.08 19.32 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -64.58 4.07 38.03 -66.58 4.11 31.93 coo 18.16 32.86 9.85 16.06 28.20 13.56 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 24 3 # 24 549 LYS C 117 LYS.? 21.58 CA CA C1184 631 LYS D 164 LYS~? 10.47 O3 GOL D1181 708 LYS C 124 LYS~? 15.99 CA CA C1184 coo 8.61 33.06 11.15 10.12 29.19 8.82 -51.85 4.98 33.11 -46.06 6.47 33.64 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -35.86 -9.73 34.54 -40.60 -7.29 35.38 coo 18.16 32.86 9.85 16.06 28.20 13.56 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 25 3 # 25 549 LYS C 124 LYS~? 15.99 CA CA C1184 631 LYS B 75 LYS.? 22.83 O ACT A1181 708 LYS C 142 LYS.? 12.38 CA CA C1184 coo 8.61 33.06 11.15 10.12 29.19 8.82 -59.48 10.16 30.27 -60.09 12.26 35.28 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -57.47 22.90 13.02 -52.58 24.12 11.55 coo 18.16 32.86 9.85 16.06 28.20 13.56 -64.58 4.07 38.03 -66.58 4.11 31.93 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 26 3 # 26 549 LYS C 124 LYS~? 15.99 CA CA C1184 631 LYS C 35 LYS~? 10.20 CA CA C1184 708 LYS C 93 LYS.? 19.61 OXT ACT C1183 coo 8.61 33.06 11.15 10.12 29.19 8.82 -59.48 10.16 30.27 -60.09 12.26 35.28 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -68.45 -9.84 37.00 -72.38 -5.53 38.73 coo 18.16 32.86 9.85 16.06 28.20 13.56 -54.93 14.23 21.55 -53.38 19.08 19.32 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 27 3 # 27 549 LYS C 142 LYS.? 12.38 CA CA C1184 631 LYS D 9 LYS~? 18.78 CA CA C1184 708 LYS C 124 LYS~? 15.99 CA CA C1184 coo 8.61 33.06 11.15 10.12 29.19 8.82 -64.58 4.07 38.03 -66.58 4.11 31.93 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 18.16 32.86 9.85 16.06 28.20 13.56 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 28 3 # 28 549 LYS C 158 LYS~? 13.55 O3 GOL D1181 631 LYS D 149 LYS.? 13.85 O2 GOL D1181 708 LYS C 149 LYS.? 9.01 CA CA C1184 coo 8.61 33.06 11.15 10.12 29.19 8.82 -50.05 -10.42 36.79 -49.63 -8.70 42.89 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -40.00 -25.59 26.00 -40.81 -29.12 24.35 coo 18.16 32.86 9.85 16.06 28.20 13.56 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 29 3 # 29 549 LYS D 9 LYS~? 18.78 CA CA C1184 631 LYS C 142 LYS.? 12.38 CA CA C1184 708 LYS D 2 LYS.? 16.82 CA CA C1181 coo 8.61 33.06 11.15 10.12 29.19 8.82 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -64.58 4.07 38.03 -66.58 4.11 31.93 coo 18.16 32.86 9.85 16.06 28.20 13.56 -70.92 -25.33 35.01 -67.02 -26.54 39.55 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 30 3 # 30 549 LYS D 9 LYS~? 18.78 CA CA C1184 631 LYS C 149 LYS.? 9.01 CA CA C1184 708 LYS D 2 LYS.? 16.82 CA CA C1181 coo 8.61 33.06 11.15 10.12 29.19 8.82 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -50.86 -2.28 41.74 -55.49 -4.16 43.55 coo 18.16 32.86 9.85 16.06 28.20 13.56 -70.92 -25.33 35.01 -67.02 -26.54 39.55 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 31 3 # 31 549 LYS D 72 LYS.? 18.40 OXT ACT A1182 631 LYS C 158 LYS~? 13.55 O3 GOL D1181 708 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -39.21 6.22 27.81 -43.32 9.34 25.63 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -50.05 -10.42 36.79 -49.63 -8.70 42.89 coo 18.16 32.86 9.85 16.06 28.20 13.56 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 32 3 # 32 549 LYS D 93 LYS.? 12.21 O ACT A1182 631 LYS B 117 LYS.? 17.47 O3 GOL B1182 708 LYS D 124 LYS~? 24.78 O ACT A1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 coo 18.16 32.86 9.85 16.06 28.20 13.56 -30.92 -19.78 10.48 -31.91 -25.53 10.85 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 33 3 # 33 549 LYS D 93 LYS.? 12.21 O ACT A1182 631 LYS D 142 LYS.? 24.20 CH3 ACT A1182 708 LYS A 72 LYS.? 19.74 O ACT A1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -25.06 -24.88 17.65 -21.32 -22.55 15.38 coo 18.16 32.86 9.85 16.06 28.20 13.56 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 34 3 # 34 549 LYS D 117 LYS.? 19.88 O2 GOL D1181 631 LYS A 72 LYS.? 19.74 O ACT A1182 708 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 8.61 33.06 11.15 10.12 29.19 8.82 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 18.16 32.86 9.85 16.06 28.20 13.56 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 35 3 # 35 549 LYS D 117 LYS.? 19.88 O2 GOL D1181 631 LYS C 164 LYS~? 9.98 C2 GOL D1181 708 LYS D 124 LYS~? 24.78 O ACT A1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -38.62 -20.39 16.44 -44.46 -21.28 15.46 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -54.90 -15.84 30.45 -50.06 -17.66 28.47 coo 18.16 32.86 9.85 16.06 28.20 13.56 -30.92 -19.78 10.48 -31.91 -25.53 10.85 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 36 3 # 36 549 LYS D 124 LYS~? 24.78 O ACT A1182 631 LYS A 75 LYS.? 21.85 O3 GOL B1182 708 LYS D 142 LYS.? 24.20 CH3 ACT A1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -33.45 -8.66 -7.93 -38.30 -6.69 -11.44 coo 18.16 32.86 9.85 16.06 28.20 13.56 -25.06 -24.88 17.65 -21.32 -22.55 15.38 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 37 3 # 37 549 LYS D 124 LYS~? 24.78 O ACT A1182 631 LYS D 35 LYS~? 23.81 O2 GOL D1181 708 LYS D 93 LYS.? 12.21 O ACT A1182 coo 8.61 33.06 11.15 10.12 29.19 8.82 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo 18.16 32.86 9.85 16.06 28.20 13.56 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 38 3 # 38 549 LYS D 158 LYS~? -4.46 O2 GOL D1181s 631 LYS C 149 LYS.? 9.01 CA CA C1184 708 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 8.61 33.06 11.15 10.12 29.19 8.82 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -50.86 -2.28 41.74 -55.49 -4.16 43.55 coo 18.16 32.86 9.85 16.06 28.20 13.56 -40.00 -25.59 26.00 -40.81 -29.12 24.35 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 38 hits 1nsf_c00 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER C 56 SER.? 20.22 OXT ACT C1183 A 154 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 261 ARG C 58 ARG~? 18.42 O3 GOL D1181 coo 16.10 74.10 3.11 17.18 73.52 5.20 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 16.07 84.71 8.14 15.20 82.81 8.14 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 10.59 77.85 4.81 13.09 76.36 5.76 -48.43 -0.71 31.25 -46.65 0.17 33.60 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 1 hits 1o98_c00 naa= 3 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 A 1 CYH A 145 CYH.? 18.06 O ACT A1181 A 903 GLU B 167 GLU~? 15.72 O ACT A1181 A 972 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 88.42 112.53 24.94 87.72 110.88 27.11 -28.16 21.72 2.56 -30.09 23.43 3.54 coo 61.58 117.15 13.99 62.31 115.51 15.12 -56.85 16.74 -0.78 -55.11 17.01 0.42 coo 60.18 107.64 21.53 58.13 110.55 17.14 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 A 1 CYH B 145 CYH.? 5.45 CA CA B1183 A 903 GLU A 167 GLU~? 17.93 OXT ACT A1181 A 972 LYS A 75 LYS.? 21.85 O3 GOL B1182 coo 88.42 112.53 24.94 87.72 110.88 27.11 -62.49 1.50 -10.58 -60.97 -0.38 -12.04 coo 61.58 117.15 13.99 62.31 115.51 15.12 -32.78 4.71 -6.52 -34.47 3.65 -5.83 coo 60.18 107.64 21.53 58.13 110.55 17.14 -33.45 -8.66 -7.93 -38.30 -6.69 -11.44 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 A 1 CYH C 145 CYH.? 5.42 CA CA C1184 A 903 GLU D 167 GLU~? 14.12 O3 GOL D1181 A 972 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 88.42 112.53 24.94 87.72 110.88 27.11 -62.51 -1.53 37.02 -61.06 0.37 38.52 coo 61.58 117.15 13.99 62.31 115.51 15.12 -33.98 -6.43 34.19 -35.73 -5.26 33.93 coo 60.18 107.64 21.53 58.13 110.55 17.14 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 A 1 CYH D 145 CYH.? 17.92 O2 GOL D1181 A 903 GLU C 167 GLU~? 15.18 C1 GOL D1181 A 972 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 88.42 112.53 24.94 87.72 110.88 27.11 -28.17 -21.73 23.90 -30.12 -23.42 22.95 coo 61.58 117.15 13.99 62.31 115.51 15.12 -56.84 -16.73 27.22 -55.09 -16.98 26.08 coo 60.18 107.64 21.53 58.13 110.55 17.14 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1ofd_c02 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 4 hits 1ofd_c02 naa= 3 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 B 1 CYH A 145 CYH.? 18.06 O ACT A1181 B 903 GLU B 167 GLU~? 15.72 O ACT A1181 B 972 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 31.47 38.87 24.90 30.94 36.98 26.93 -28.16 21.72 2.56 -30.09 23.43 3.54 coo 4.13 40.53 14.21 5.06 38.89 15.19 -56.85 16.74 -0.78 -55.11 17.01 0.42 coo 4.08 30.40 21.12 1.62 33.28 16.83 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 B 1 CYH B 145 CYH.? 5.45 CA CA B1183 B 903 GLU A 167 GLU~? 17.93 OXT ACT A1181 B 972 LYS A 75 LYS.? 21.85 O3 GOL B1182 coo 31.47 38.87 24.90 30.94 36.98 26.93 -62.49 1.50 -10.58 -60.97 -0.38 -12.04 coo 4.13 40.53 14.21 5.06 38.89 15.19 -32.78 4.71 -6.52 -34.47 3.65 -5.83 coo 4.08 30.40 21.12 1.62 33.28 16.83 -33.45 -8.66 -7.93 -38.30 -6.69 -11.44 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 3 3 # 3 B 1 CYH C 145 CYH.? 5.42 CA CA C1184 B 903 GLU D 167 GLU~? 14.12 O3 GOL D1181 B 972 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 31.47 38.87 24.90 30.94 36.98 26.93 -62.51 -1.53 37.02 -61.06 0.37 38.52 coo 4.13 40.53 14.21 5.06 38.89 15.19 -33.98 -6.43 34.19 -35.73 -5.26 33.93 coo 4.08 30.40 21.12 1.62 33.28 16.83 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 4 3 # 4 B 1 CYH D 145 CYH.? 17.92 O2 GOL D1181 B 903 GLU C 167 GLU~? 15.18 C1 GOL D1181 B 972 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 31.47 38.87 24.90 30.94 36.98 26.93 -28.17 -21.73 23.90 -30.12 -23.42 22.95 coo 4.13 40.53 14.21 5.06 38.89 15.19 -56.84 -16.73 27.22 -55.09 -16.98 26.08 coo 4.08 30.40 21.12 1.62 33.28 16.83 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1ofd_c03 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 4 hits 1ofd_c03 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS A 9 LYS~? 15.21 O1 GOL B1182 A 208 GLN B 161 GLN~? 9.27 C3 GOL B1182 A 209 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -52.63 15.11 -10.15 -52.19 15.21 -12.23 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 A 175 LYS A 158 LYS~? -4.64 O ACT A1181s A 208 GLN B 161 GLN~? 9.27 C3 GOL B1182 A 209 LYS B 164 LYS~? 10.34 O ACT A1181 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -52.63 15.11 -10.15 -52.19 15.21 -12.23 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 A 175 LYS B 9 LYS~? 18.37 O ACT A1181 A 208 GLN A 161 GLN~? 4.67 OXT ACT A1181 A 209 LYS A 158 LYS~? -4.64 O ACT A1181s coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -27.67 18.71 -15.51 -26.70 22.99 -17.12 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -38.30 15.63 -9.77 -38.66 17.57 -10.57 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 A 175 LYS B 158 LYS~? 6.73 O3 GOL B1182 A 208 GLN A 161 GLN~? 4.67 OXT ACT A1181 A 209 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -50.07 10.43 -10.30 -49.56 8.69 -16.32 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -38.30 15.63 -9.77 -38.66 17.57 -10.57 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 A 175 LYS C 9 LYS~? 14.61 CA CA C1182 A 208 GLN D 161 GLN~? -3.82 O3 GOL D1181s A 209 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -27.74 -18.74 41.99 -22.99 -22.90 41.19 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -38.29 -15.65 36.22 -38.71 -17.60 37.01 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 A 175 LYS C 158 LYS~? 13.55 O3 GOL D1181 A 208 GLN D 161 GLN~? -3.82 O3 GOL D1181s A 209 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -50.05 -10.42 36.79 -49.63 -8.70 42.89 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -38.29 -15.65 36.22 -38.71 -17.60 37.01 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 A 175 LYS D 9 LYS~? 18.78 CA CA C1184 A 208 GLN C 161 GLN~? 9.18 C1 GOL D1181 A 209 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -52.62 -15.10 36.59 -52.24 -15.21 38.68 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 A 175 LYS D 158 LYS~? -4.46 O2 GOL D1181s A 208 GLN C 161 GLN~? 9.18 C1 GOL D1181 A 209 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -52.62 -15.10 36.59 -52.24 -15.21 38.68 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -54.90 -15.84 30.45 -50.06 -17.66 28.47 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 8 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS A 9 LYS~? 15.21 O1 GOL B1182 B 208 GLN A 15 GLN~? 11.07 C3 GOL B1182 B 209 LYS B 164 LYS~? 10.34 O ACT A1181 coo 105.03 46.01 19.55 106.59 42.35 15.55 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 113.93 46.99 13.56 113.37 48.52 14.95 -53.85 19.12 -9.94 -54.79 17.30 -9.37 coo 115.66 49.12 8.60 111.19 49.52 4.73 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS A 9 LYS~? 15.21 O1 GOL B1182 B 208 GLN B 161 GLN~? 9.27 C3 GOL B1182 B 209 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 105.03 46.01 19.55 106.59 42.35 15.55 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 113.93 46.99 13.56 113.37 48.52 14.95 -52.63 15.11 -10.15 -52.19 15.21 -12.23 coo 115.66 49.12 8.60 111.19 49.52 4.73 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 B 175 LYS A 9 LYS~? 15.21 O1 GOL B1182 B 208 GLN B 161 GLN~? 9.27 C3 GOL B1182 B 209 LYS B 164 LYS~? 10.34 O ACT A1181 coo 105.03 46.01 19.55 106.59 42.35 15.55 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 113.93 46.99 13.56 113.37 48.52 14.95 -52.63 15.11 -10.15 -52.19 15.21 -12.23 coo 115.66 49.12 8.60 111.19 49.52 4.73 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 B 175 LYS B 9 LYS~? 18.37 O ACT A1181 B 208 GLN A 161 GLN~? 4.67 OXT ACT A1181 B 209 LYS A 158 LYS~? -4.64 O ACT A1181s coo 105.03 46.01 19.55 106.59 42.35 15.55 -27.67 18.71 -15.51 -26.70 22.99 -17.12 coo 113.93 46.99 13.56 113.37 48.52 14.95 -38.30 15.63 -9.77 -38.66 17.57 -10.57 coo 115.66 49.12 8.60 111.19 49.52 4.73 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 B 175 LYS B 9 LYS~? 18.37 O ACT A1181 B 208 GLN A 161 GLN~? 4.67 OXT ACT A1181 B 209 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 105.03 46.01 19.55 106.59 42.35 15.55 -27.67 18.71 -15.51 -26.70 22.99 -17.12 coo 113.93 46.99 13.56 113.37 48.52 14.95 -38.30 15.63 -9.77 -38.66 17.57 -10.57 coo 115.66 49.12 8.60 111.19 49.52 4.73 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 B 175 LYS B 9 LYS~? 18.37 O ACT A1181 B 208 GLN B 15 GLN~? 8.49 OXT ACT A1181 B 209 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 105.03 46.01 19.55 106.59 42.35 15.55 -27.67 18.71 -15.51 -26.70 22.99 -17.12 coo 113.93 46.99 13.56 113.37 48.52 14.95 -37.01 14.07 -13.41 -36.09 14.23 -11.49 coo 115.66 49.12 8.60 111.19 49.52 4.73 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 B 175 LYS C 9 LYS~? 14.61 CA CA C1182 B 208 GLN C 15 GLN~? 7.40 O3 GOL D1181 B 209 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 105.03 46.01 19.55 106.59 42.35 15.55 -27.74 -18.74 41.99 -22.99 -22.90 41.19 coo 113.93 46.99 13.56 113.37 48.52 14.95 -36.99 -14.05 39.90 -36.11 -14.23 37.95 coo 115.66 49.12 8.60 111.19 49.52 4.73 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 B 175 LYS C 9 LYS~? 14.61 CA CA C1182 B 208 GLN D 161 GLN~? -3.82 O3 GOL D1181s B 209 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 105.03 46.01 19.55 106.59 42.35 15.55 -27.74 -18.74 41.99 -22.99 -22.90 41.19 coo 113.93 46.99 13.56 113.37 48.52 14.95 -38.29 -15.65 36.22 -38.71 -17.60 37.01 coo 115.66 49.12 8.60 111.19 49.52 4.73 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 9 3 # 9 B 175 LYS C 9 LYS~? 14.61 CA CA C1182 B 208 GLN D 161 GLN~? -3.82 O3 GOL D1181s B 209 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 105.03 46.01 19.55 106.59 42.35 15.55 -27.74 -18.74 41.99 -22.99 -22.90 41.19 coo 113.93 46.99 13.56 113.37 48.52 14.95 -38.29 -15.65 36.22 -38.71 -17.60 37.01 coo 115.66 49.12 8.60 111.19 49.52 4.73 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 10 3 # 10 B 175 LYS D 9 LYS~? 18.78 CA CA C1184 B 208 GLN C 161 GLN~? 9.18 C1 GOL D1181 B 209 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 105.03 46.01 19.55 106.59 42.35 15.55 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 113.93 46.99 13.56 113.37 48.52 14.95 -52.62 -15.10 36.59 -52.24 -15.21 38.68 coo 115.66 49.12 8.60 111.19 49.52 4.73 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 11 3 # 11 B 175 LYS D 9 LYS~? 18.78 CA CA C1184 B 208 GLN C 161 GLN~? 9.18 C1 GOL D1181 B 209 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 105.03 46.01 19.55 106.59 42.35 15.55 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 113.93 46.99 13.56 113.37 48.52 14.95 -52.62 -15.10 36.59 -52.24 -15.21 38.68 coo 115.66 49.12 8.60 111.19 49.52 4.73 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 12 3 # 12 B 175 LYS D 9 LYS~? 18.78 CA CA C1184 B 208 GLN D 15 GLN~? 10.48 C1 GOL D1181 B 209 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 105.03 46.01 19.55 106.59 42.35 15.55 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 113.93 46.99 13.56 113.37 48.52 14.95 -53.83 -19.14 36.40 -54.76 -17.32 35.80 coo 115.66 49.12 8.60 111.19 49.52 4.73 -54.90 -15.84 30.45 -50.06 -17.66 28.47 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 12 hits 1ohh_c07 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS A 9 LYS~? 15.21 O1 GOL B1182 C 208 GLN B 161 GLN~? 9.27 C3 GOL B1182 C 209 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -63.23 19.50 -14.81 -65.35 21.15 -20.54 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -52.63 15.11 -10.15 -52.19 15.21 -12.23 coo 113.62 1.19 33.65 109.52 3.92 36.47 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 C 175 LYS B 9 LYS~? 18.37 O ACT A1181 C 208 GLN A 161 GLN~? 4.67 OXT ACT A1181 C 209 LYS A 158 LYS~? -4.64 O ACT A1181s coo 100.54 -2.78 25.52 103.29 2.02 24.05 -27.67 18.71 -15.51 -26.70 22.99 -17.12 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -38.30 15.63 -9.77 -38.66 17.57 -10.57 coo 113.62 1.19 33.65 109.52 3.92 36.47 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 C 175 LYS B 142 LYS.? 10.67 CA CA B1183 C 208 GLN B 39 GLN~? 11.27 CA CA B1183 C 209 LYS B 35 LYS~? 11.04 CA CA B1183 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -70.82 6.88 -6.62 -70.59 5.36 -8.10 coo 113.62 1.19 33.65 109.52 3.92 36.47 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 C 175 LYS C 9 LYS~? 14.61 CA CA C1182 C 208 GLN D 161 GLN~? -3.82 O3 GOL D1181s C 209 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 100.54 -2.78 25.52 103.29 2.02 24.05 -27.74 -18.74 41.99 -22.99 -22.90 41.19 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -38.29 -15.65 36.22 -38.71 -17.60 37.01 coo 113.62 1.19 33.65 109.52 3.92 36.47 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 C 175 LYS C 142 LYS.? 12.38 CA CA C1184 C 208 GLN C 39 GLN~? 11.29 CA CA C1184 C 209 LYS C 35 LYS~? 10.20 CA CA C1184 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -64.58 4.07 38.03 -66.58 4.11 31.93 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -70.79 -6.86 33.04 -70.58 -5.33 34.49 coo 113.62 1.19 33.65 109.52 3.92 36.47 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 C 175 LYS D 9 LYS~? 18.78 CA CA C1184 C 208 GLN C 161 GLN~? 9.18 C1 GOL D1181 C 209 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -52.62 -15.10 36.59 -52.24 -15.21 38.68 coo 113.62 1.19 33.65 109.52 3.92 36.47 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 6 hits 1ohh_c08 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 55 ASP.? 17.41 O ACT A1181 A 146 TYR A 91 TYR.? 11.44 OXT ACT A1182 A 177 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 1.87 119.38 16.45 1.41 122.11 16.84 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 156 ASP~? 10.59 O ACT A1181 A 146 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 1.87 119.38 16.45 1.41 122.11 16.84 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 146 TYR B 91 TYR.? 11.41 O ACT C1183 A 177 LYS B 93 LYS.? 14.57 O ACT C1183 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 1.87 119.38 16.45 1.41 122.11 16.84 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 146 TYR B 157 TYR~? 6.24 OXT ACT A1181 A 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 1.87 119.38 16.45 1.41 122.11 16.84 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 146 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 177 LYS B 164 LYS~? 10.34 O ACT A1181 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 1.87 119.38 16.45 1.41 122.11 16.84 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 A 24 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 146 TYR C 157 TYR~? 5.26 O3 GOL D1181 A 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 1.87 119.38 16.45 1.41 122.11 16.84 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 A 24 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 146 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 177 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 1.87 119.38 16.45 1.41 122.11 16.84 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 A 24 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 146 TYR D 91 TYR.? 11.52 O ACT A1182 A 177 LYS D 93 LYS.? 12.21 O ACT A1182 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 1.87 119.38 16.45 1.41 122.11 16.84 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 A 24 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 146 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 1.87 119.38 16.45 1.41 122.11 16.84 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -35.86 -9.73 34.54 -40.60 -7.29 35.38 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 55 ASP.? 17.41 O ACT A1181 B 146 TYR A 91 TYR.? 11.44 OXT ACT A1182 B 177 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 156 ASP~? 10.59 O ACT A1181 B 146 TYR A 64 TYR~? 13.66 OXT ACT A1181 B 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 146 TYR B 91 TYR.? 11.41 O ACT C1183 B 177 LYS B 93 LYS.? 14.57 O ACT C1183 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 146 TYR B 157 TYR~? 6.24 OXT ACT A1181 B 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 146 TYR B 64 TYR~? 13.94 OXT ACT A1181 B 177 LYS B 164 LYS~? 10.34 O ACT A1181 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 B 24 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 146 TYR C 157 TYR~? 5.26 O3 GOL D1181 B 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 B 24 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 146 TYR C 64 TYR~? 13.24 O3 GOL D1181 B 177 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 B 24 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 146 TYR D 91 TYR.? 11.52 O ACT A1182 B 177 LYS D 93 LYS.? 12.21 O ACT A1182 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 B 24 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 146 TYR D 64 TYR~? 12.19 O3 GOL D1181 B 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -35.86 -9.73 34.54 -40.60 -7.29 35.38 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 55 ASP.? 17.41 O ACT A1181 C 146 TYR A 91 TYR.? 11.44 OXT ACT A1182 C 177 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 156 ASP~? 10.59 O ACT A1181 C 146 TYR A 64 TYR~? 13.66 OXT ACT A1181 C 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 146 TYR B 91 TYR.? 11.41 O ACT C1183 C 177 LYS B 93 LYS.? 14.57 O ACT C1183 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP B 152 ASP.? 8.52 O3 GOL B1182 C 146 TYR B 157 TYR~? 6.24 OXT ACT A1181 C 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 146 TYR B 64 TYR~? 13.94 OXT ACT A1181 C 177 LYS B 164 LYS~? 10.34 O ACT A1181 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 C 24 ASP C 152 ASP.? 13.45 O3 GOL D1181 C 146 TYR C 157 TYR~? 5.26 O3 GOL D1181 C 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 C 24 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 146 TYR C 64 TYR~? 13.24 O3 GOL D1181 C 177 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 C 24 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 146 TYR D 91 TYR.? 11.52 O ACT A1182 C 177 LYS D 93 LYS.? 12.21 O ACT A1182 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 C 24 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 146 TYR D 64 TYR~? 12.19 O3 GOL D1181 C 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -35.86 -9.73 34.54 -40.60 -7.29 35.38 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 55 ASP.? 17.41 O ACT A1181 D 146 TYR A 91 TYR.? 11.44 OXT ACT A1182 D 177 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 156 ASP~? 10.59 O ACT A1181 D 146 TYR A 64 TYR~? 13.66 OXT ACT A1181 D 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP B 55 ASP.? 14.29 O3 GOL B1182 D 146 TYR B 91 TYR.? 11.41 O ACT C1183 D 177 LYS B 93 LYS.? 14.57 O ACT C1183 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP B 152 ASP.? 8.52 O3 GOL B1182 D 146 TYR B 157 TYR~? 6.24 OXT ACT A1181 D 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 146 TYR B 64 TYR~? 13.94 OXT ACT A1181 D 177 LYS B 164 LYS~? 10.34 O ACT A1181 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 D 24 ASP C 152 ASP.? 13.45 O3 GOL D1181 D 146 TYR C 157 TYR~? 5.26 O3 GOL D1181 D 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 D 24 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 146 TYR C 64 TYR~? 13.24 O3 GOL D1181 D 177 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 D 24 ASP D 55 ASP.? 17.43 O2 GOL D1181 D 146 TYR D 91 TYR.? 11.52 O ACT A1182 D 177 LYS D 93 LYS.? 12.21 O ACT A1182 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 D 24 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 146 TYR D 64 TYR~? 12.19 O3 GOL D1181 D 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -35.86 -9.73 34.54 -40.60 -7.29 35.38 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 55 ASP.? 17.41 O ACT A1181 E 146 TYR A 91 TYR.? 11.44 OXT ACT A1182 E 177 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 156 ASP~? 10.59 O ACT A1181 E 146 TYR A 64 TYR~? 13.66 OXT ACT A1181 E 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP B 55 ASP.? 14.29 O3 GOL B1182 E 146 TYR B 91 TYR.? 11.41 O ACT C1183 E 177 LYS B 93 LYS.? 14.57 O ACT C1183 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP B 152 ASP.? 8.52 O3 GOL B1182 E 146 TYR B 157 TYR~? 6.24 OXT ACT A1181 E 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP B 156 ASP~? 13.25 OXT ACT A1181 E 146 TYR B 64 TYR~? 13.94 OXT ACT A1181 E 177 LYS B 164 LYS~? 10.34 O ACT A1181 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 E 24 ASP C 152 ASP.? 13.45 O3 GOL D1181 E 146 TYR C 157 TYR~? 5.26 O3 GOL D1181 E 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 E 24 ASP C 156 ASP~? 12.06 O3 GOL D1181 E 146 TYR C 64 TYR~? 13.24 O3 GOL D1181 E 177 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 E 24 ASP D 55 ASP.? 17.43 O2 GOL D1181 E 146 TYR D 91 TYR.? 11.52 O ACT A1182 E 177 LYS D 93 LYS.? 12.21 O ACT A1182 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 E 24 ASP D 156 ASP~? 10.44 C2 GOL D1181 E 146 TYR D 64 TYR~? 12.19 O3 GOL D1181 E 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -35.86 -9.73 34.54 -40.60 -7.29 35.38 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 55 ASP.? 17.41 O ACT A1181 F 146 TYR A 91 TYR.? 11.44 OXT ACT A1182 F 177 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 156 ASP~? 10.59 O ACT A1181 F 146 TYR A 64 TYR~? 13.66 OXT ACT A1181 F 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP B 55 ASP.? 14.29 O3 GOL B1182 F 146 TYR B 91 TYR.? 11.41 O ACT C1183 F 177 LYS B 93 LYS.? 14.57 O ACT C1183 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP B 152 ASP.? 8.52 O3 GOL B1182 F 146 TYR B 157 TYR~? 6.24 OXT ACT A1181 F 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP B 156 ASP~? 13.25 OXT ACT A1181 F 146 TYR B 64 TYR~? 13.94 OXT ACT A1181 F 177 LYS B 164 LYS~? 10.34 O ACT A1181 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 F 24 ASP C 152 ASP.? 13.45 O3 GOL D1181 F 146 TYR C 157 TYR~? 5.26 O3 GOL D1181 F 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 F 24 ASP C 156 ASP~? 12.06 O3 GOL D1181 F 146 TYR C 64 TYR~? 13.24 O3 GOL D1181 F 177 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 F 24 ASP D 55 ASP.? 17.43 O2 GOL D1181 F 146 TYR D 91 TYR.? 11.52 O ACT A1182 F 177 LYS D 93 LYS.? 12.21 O ACT A1182 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 F 24 ASP D 156 ASP~? 10.44 C2 GOL D1181 F 146 TYR D 64 TYR~? 12.19 O3 GOL D1181 F 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -35.86 -9.73 34.54 -40.60 -7.29 35.38 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 55 ASP.? 17.41 O ACT A1181 G 146 TYR A 91 TYR.? 11.44 OXT ACT A1182 G 177 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 156 ASP~? 10.59 O ACT A1181 G 146 TYR A 64 TYR~? 13.66 OXT ACT A1181 G 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP B 55 ASP.? 14.29 O3 GOL B1182 G 146 TYR B 91 TYR.? 11.41 O ACT C1183 G 177 LYS B 93 LYS.? 14.57 O ACT C1183 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP B 152 ASP.? 8.52 O3 GOL B1182 G 146 TYR B 157 TYR~? 6.24 OXT ACT A1181 G 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP B 156 ASP~? 13.25 OXT ACT A1181 G 146 TYR B 64 TYR~? 13.94 OXT ACT A1181 G 177 LYS B 164 LYS~? 10.34 O ACT A1181 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 G 24 ASP C 152 ASP.? 13.45 O3 GOL D1181 G 146 TYR C 157 TYR~? 5.26 O3 GOL D1181 G 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 G 24 ASP C 156 ASP~? 12.06 O3 GOL D1181 G 146 TYR C 64 TYR~? 13.24 O3 GOL D1181 G 177 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 G 24 ASP D 55 ASP.? 17.43 O2 GOL D1181 G 146 TYR D 91 TYR.? 11.52 O ACT A1182 G 177 LYS D 93 LYS.? 12.21 O ACT A1182 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 G 24 ASP D 156 ASP~? 10.44 C2 GOL D1181 G 146 TYR D 64 TYR~? 12.19 O3 GOL D1181 G 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -35.86 -9.73 34.54 -40.60 -7.29 35.38 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 55 ASP.? 17.41 O ACT A1181 H 146 TYR A 91 TYR.? 11.44 OXT ACT A1182 H 177 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 156 ASP~? 10.59 O ACT A1181 H 146 TYR A 64 TYR~? 13.66 OXT ACT A1181 H 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP B 55 ASP.? 14.29 O3 GOL B1182 H 146 TYR B 91 TYR.? 11.41 O ACT C1183 H 177 LYS B 93 LYS.? 14.57 O ACT C1183 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP B 152 ASP.? 8.52 O3 GOL B1182 H 146 TYR B 157 TYR~? 6.24 OXT ACT A1181 H 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP B 156 ASP~? 13.25 OXT ACT A1181 H 146 TYR B 64 TYR~? 13.94 OXT ACT A1181 H 177 LYS B 164 LYS~? 10.34 O ACT A1181 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 H 24 ASP C 152 ASP.? 13.45 O3 GOL D1181 H 146 TYR C 157 TYR~? 5.26 O3 GOL D1181 H 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 H 24 ASP C 156 ASP~? 12.06 O3 GOL D1181 H 146 TYR C 64 TYR~? 13.24 O3 GOL D1181 H 177 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 H 24 ASP D 55 ASP.? 17.43 O2 GOL D1181 H 146 TYR D 91 TYR.? 11.52 O ACT A1182 H 177 LYS D 93 LYS.? 12.21 O ACT A1182 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 H 24 ASP D 156 ASP~? 10.44 C2 GOL D1181 H 146 TYR D 64 TYR~? 12.19 O3 GOL D1181 H 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -35.86 -9.73 34.54 -40.60 -7.29 35.38 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 55 ASP.? 17.41 O ACT A1181 I 146 TYR A 91 TYR.? 11.44 OXT ACT A1182 I 177 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 156 ASP~? 10.59 O ACT A1181 I 146 TYR A 64 TYR~? 13.66 OXT ACT A1181 I 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP B 55 ASP.? 14.29 O3 GOL B1182 I 146 TYR B 91 TYR.? 11.41 O ACT C1183 I 177 LYS B 93 LYS.? 14.57 O ACT C1183 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP B 152 ASP.? 8.52 O3 GOL B1182 I 146 TYR B 157 TYR~? 6.24 OXT ACT A1181 I 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP B 156 ASP~? 13.25 OXT ACT A1181 I 146 TYR B 64 TYR~? 13.94 OXT ACT A1181 I 177 LYS B 164 LYS~? 10.34 O ACT A1181 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 I 24 ASP C 152 ASP.? 13.45 O3 GOL D1181 I 146 TYR C 157 TYR~? 5.26 O3 GOL D1181 I 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 I 24 ASP C 156 ASP~? 12.06 O3 GOL D1181 I 146 TYR C 64 TYR~? 13.24 O3 GOL D1181 I 177 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 I 24 ASP D 55 ASP.? 17.43 O2 GOL D1181 I 146 TYR D 91 TYR.? 11.52 O ACT A1182 I 177 LYS D 93 LYS.? 12.21 O ACT A1182 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 I 24 ASP D 156 ASP~? 10.44 C2 GOL D1181 I 146 TYR D 64 TYR~? 12.19 O3 GOL D1181 I 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -35.86 -9.73 34.54 -40.60 -7.29 35.38 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 55 ASP.? 17.41 O ACT A1181 J 146 TYR A 91 TYR.? 11.44 OXT ACT A1182 J 177 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -35.52 10.03 17.00 -36.51 12.40 15.90 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 156 ASP~? 10.59 O ACT A1181 J 146 TYR A 64 TYR~? 13.66 OXT ACT A1181 J 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP B 55 ASP.? 14.29 O3 GOL B1182 J 146 TYR B 91 TYR.? 11.41 O ACT C1183 J 177 LYS B 93 LYS.? 14.57 O ACT C1183 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -54.77 -14.10 4.84 -51.86 -13.62 10.10 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP B 152 ASP.? 8.52 O3 GOL B1182 J 146 TYR B 157 TYR~? 6.24 OXT ACT A1181 J 177 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP B 156 ASP~? 13.25 OXT ACT A1181 J 146 TYR B 64 TYR~? 13.94 OXT ACT A1181 J 177 LYS B 164 LYS~? 10.34 O ACT A1181 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 J 24 ASP C 152 ASP.? 13.45 O3 GOL D1181 J 146 TYR C 157 TYR~? 5.26 O3 GOL D1181 J 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 J 24 ASP C 156 ASP~? 12.06 O3 GOL D1181 J 146 TYR C 64 TYR~? 13.24 O3 GOL D1181 J 177 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 J 24 ASP D 55 ASP.? 17.43 O2 GOL D1181 J 146 TYR D 91 TYR.? 11.52 O ACT A1182 J 177 LYS D 93 LYS.? 12.21 O ACT A1182 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -36.07 -12.96 3.87 -39.26 -8.07 6.08 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 J 24 ASP D 156 ASP~? 10.44 C2 GOL D1181 J 146 TYR D 64 TYR~? 12.19 O3 GOL D1181 J 177 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -35.86 -9.73 34.54 -40.60 -7.29 35.38 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 9 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 14 ASP~? 14.99 CH3 ACT A1181 A 96 GLU B 167 GLU~? 15.72 O ACT A1181 A 132 LYS B 164 LYS~? 10.34 O ACT A1181 coo 31.23 12.29 16.44 30.82 11.56 18.39 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 26.82 3.20 24.36 27.99 4.86 24.98 -56.85 16.74 -0.78 -55.11 17.01 0.42 coo 29.99 0.62 22.18 30.38 6.69 20.81 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 73 ASP.? 22.06 O ACT A1182 A 96 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 132 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 31.23 12.29 16.44 30.82 11.56 18.39 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 26.82 3.20 24.36 27.99 4.86 24.98 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 29.99 0.62 22.18 30.38 6.69 20.81 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP A 156 ASP~? 10.59 O ACT A1181 A 96 GLU A 150 GLU.? 17.29 O ACT A1181 A 132 LYS A 149 LYS.? 8.87 O ACT A1181 coo 31.23 12.29 16.44 30.82 11.56 18.39 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 26.82 3.20 24.36 27.99 4.86 24.98 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 29.99 0.62 22.18 30.38 6.69 20.81 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP B 73 ASP.? 22.00 OXT ACT C1183 A 96 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 132 LYS A 117 LYS.? 20.14 O ACT A1181 coo 31.23 12.29 16.44 30.82 11.56 18.39 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 26.82 3.20 24.36 27.99 4.86 24.98 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 29.99 0.62 22.18 30.38 6.69 20.81 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 96 GLU B 150 GLU.? 13.13 O3 GOL B1182 A 132 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 31.23 12.29 16.44 30.82 11.56 18.39 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 26.82 3.20 24.36 27.99 4.86 24.98 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 29.99 0.62 22.18 30.38 6.69 20.81 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP C 14 ASP~? 9.29 CA CA C1182 A 96 GLU D 167 GLU~? 14.12 O3 GOL D1181 A 132 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 31.23 12.29 16.44 30.82 11.56 18.39 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 26.82 3.20 24.36 27.99 4.86 24.98 -33.98 -6.43 34.19 -35.73 -5.26 33.93 coo 29.99 0.62 22.18 30.38 6.69 20.81 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1onr_c00 TRANSALDOLASE B user 7 3 # 7 A 17 ASP C 73 ASP.? 22.09 O ACT C1183 A 96 GLU D 119 GLU.? 19.65 O ACT A1182 A 132 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 31.23 12.29 16.44 30.82 11.56 18.39 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 26.82 3.20 24.36 27.99 4.86 24.98 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 29.99 0.62 22.18 30.38 6.69 20.81 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 1onr_c00 TRANSALDOLASE B user 8 3 # 8 A 17 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 96 GLU C 150 GLU.? 16.95 CA CA C1184 A 132 LYS C 149 LYS.? 9.01 CA CA C1184 coo 31.23 12.29 16.44 30.82 11.56 18.39 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 26.82 3.20 24.36 27.99 4.86 24.98 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 29.99 0.62 22.18 30.38 6.69 20.81 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1onr_c00 TRANSALDOLASE B user 9 3 # 9 A 17 ASP D 14 ASP~? 14.81 O1 GOL D1181 A 96 GLU C 167 GLU~? 15.18 C1 GOL D1181 A 132 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 31.23 12.29 16.44 30.82 11.56 18.39 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 26.82 3.20 24.36 27.99 4.86 24.98 -56.84 -16.73 27.22 -55.09 -16.98 26.08 coo 29.99 0.62 22.18 30.38 6.69 20.81 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1onr_c00 TRANSALDOLASE B user 10 3 # 10 A 17 ASP D 73 ASP.? 21.98 OXT ACT A1182 A 96 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 132 LYS C 117 LYS.? 21.58 CA CA C1184 coo 31.23 12.29 16.44 30.82 11.56 18.39 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 26.82 3.20 24.36 27.99 4.86 24.98 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 29.99 0.62 22.18 30.38 6.69 20.81 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1onr_c00 TRANSALDOLASE B user 11 3 # 11 A 17 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 96 GLU D 150 GLU.? 17.20 O2 GOL D1181 A 132 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 31.23 12.29 16.44 30.82 11.56 18.39 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 26.82 3.20 24.36 27.99 4.86 24.98 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 29.99 0.62 22.18 30.38 6.69 20.81 -40.00 -25.59 26.00 -40.81 -29.12 24.35 1onr_c00 source 1onr TRANSALDOLASE B : 11 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 14 ASP~? 14.99 CH3 ACT A1181 B 96 GLU B 167 GLU~? 15.72 O ACT A1181 B 132 LYS B 164 LYS~? 10.34 O ACT A1181 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 26.69 48.45 7.18 27.85 50.13 7.74 -56.85 16.74 -0.78 -55.11 17.01 0.42 coo 29.82 45.80 5.07 30.26 51.81 3.56 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 73 ASP.? 22.06 O ACT A1182 B 96 GLU B 119 GLU.? 18.74 O3 GOL B1182 B 132 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 26.69 48.45 7.18 27.85 50.13 7.74 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 29.82 45.80 5.07 30.26 51.81 3.56 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP A 156 ASP~? 10.59 O ACT A1181 B 96 GLU A 150 GLU.? 17.29 O ACT A1181 B 132 LYS A 149 LYS.? 8.87 O ACT A1181 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 26.69 48.45 7.18 27.85 50.13 7.74 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 29.82 45.80 5.07 30.26 51.81 3.56 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP B 73 ASP.? 22.00 OXT ACT C1183 B 96 GLU A 119 GLU.? 19.75 OXT ACT A1182 B 132 LYS A 117 LYS.? 20.14 O ACT A1181 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 26.69 48.45 7.18 27.85 50.13 7.74 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 29.82 45.80 5.07 30.26 51.81 3.56 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 96 GLU B 150 GLU.? 13.13 O3 GOL B1182 B 132 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 26.69 48.45 7.18 27.85 50.13 7.74 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 29.82 45.80 5.07 30.26 51.81 3.56 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP C 14 ASP~? 9.29 CA CA C1182 B 96 GLU D 167 GLU~? 14.12 O3 GOL D1181 B 132 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 26.69 48.45 7.18 27.85 50.13 7.74 -33.98 -6.43 34.19 -35.73 -5.26 33.93 coo 29.82 45.80 5.07 30.26 51.81 3.56 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1onr_c01 TRANSALDOLASE B user 7 3 # 7 B 17 ASP C 73 ASP.? 22.09 O ACT C1183 B 96 GLU D 119 GLU.? 19.65 O ACT A1182 B 132 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 26.69 48.45 7.18 27.85 50.13 7.74 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 29.82 45.80 5.07 30.26 51.81 3.56 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 1onr_c01 TRANSALDOLASE B user 8 3 # 8 B 17 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 96 GLU C 150 GLU.? 16.95 CA CA C1184 B 132 LYS C 149 LYS.? 9.01 CA CA C1184 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 26.69 48.45 7.18 27.85 50.13 7.74 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 29.82 45.80 5.07 30.26 51.81 3.56 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1onr_c01 TRANSALDOLASE B user 9 3 # 9 B 17 ASP D 14 ASP~? 14.81 O1 GOL D1181 B 96 GLU C 167 GLU~? 15.18 C1 GOL D1181 B 132 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 26.69 48.45 7.18 27.85 50.13 7.74 -56.84 -16.73 27.22 -55.09 -16.98 26.08 coo 29.82 45.80 5.07 30.26 51.81 3.56 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1onr_c01 TRANSALDOLASE B user 10 3 # 10 B 17 ASP D 73 ASP.? 21.98 OXT ACT A1182 B 96 GLU C 119 GLU.? 19.60 OXT ACT C1183 B 132 LYS C 117 LYS.? 21.58 CA CA C1184 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 26.69 48.45 7.18 27.85 50.13 7.74 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 29.82 45.80 5.07 30.26 51.81 3.56 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1onr_c01 TRANSALDOLASE B user 11 3 # 11 B 17 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 96 GLU D 150 GLU.? 17.20 O2 GOL D1181 B 132 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 26.69 48.45 7.18 27.85 50.13 7.74 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 29.82 45.80 5.07 30.26 51.81 3.56 -40.00 -25.59 26.00 -40.81 -29.12 24.35 1onr_c01 source 1onr TRANSALDOLASE B : 11 hits 1onr_c01 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 42 SER~? 22.64 CH3 ACT A1182 A 239 VAL A 44 VAL~? 15.48 CH3 ACT A1182 A 413 ASN A 46 ASN~? 20.18 CH3 ACT A1182 coo 80.14 40.76 52.28 77.73 40.59 51.94 -19.46 8.46 -2.16 -18.17 10.05 -3.40 coo 75.67 35.37 52.30 76.00 35.96 50.23 -22.59 4.76 0.20 -24.62 4.47 -0.57 coo 81.75 35.21 52.13 80.92 37.12 51.69 -16.92 5.08 1.56 -15.60 6.18 0.30 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER A 89 SER.? 7.33 OXT ACT A1182 A 239 VAL D 82 VAL^? 8.84 OXT ACT A1182 A 413 ASN D 70 ASN~? 11.36 OXT ACT A1182 coo 80.14 40.76 52.28 77.73 40.59 51.94 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 75.67 35.37 52.30 76.00 35.96 50.23 -30.32 -2.20 21.21 -31.39 -3.09 22.93 coo 81.75 35.21 52.13 80.92 37.12 51.69 -33.95 2.02 25.56 -31.86 1.70 25.35 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER A 172 SER~? 20.14 OXT ACT A1181 A 239 VAL A 178 VAL^? 23.68 OXT ACT A1181 A 413 ASN A 176 ASN.? 29.75 CH3 ACT A1182 coo 80.14 40.76 52.28 77.73 40.59 51.94 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 75.67 35.37 52.30 76.00 35.96 50.23 -21.43 7.83 -14.70 -22.98 9.33 -14.16 coo 81.75 35.21 52.13 80.92 37.12 51.69 -19.36 1.51 -14.26 -19.79 -0.51 -14.77 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 4 3 # 4 A 170 SER B 42 SER~? 9.53 CA CA B1181 A 239 VAL B 44 VAL~? 12.02 CA CA B1181 A 413 ASN B 46 ASN~? 10.46 CA CA B1181 coo 80.14 40.76 52.28 77.73 40.59 51.94 -71.32 10.68 -0.61 -72.48 11.28 -2.66 coo 75.67 35.37 52.30 76.00 35.96 50.23 -68.22 9.96 3.77 -66.16 10.79 3.82 coo 81.75 35.21 52.13 80.92 37.12 51.69 -74.04 8.69 3.83 -75.20 9.76 2.34 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 5 3 # 5 A 170 SER B 89 SER.? 7.47 O ACT C1183 A 239 VAL C 82 VAL^? 8.90 O ACT C1183 A 413 ASN C 70 ASN~? 11.43 O ACT C1183 coo 80.14 40.76 52.28 77.73 40.59 51.94 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 75.67 35.37 52.30 76.00 35.96 50.23 -60.40 -6.50 18.34 -59.35 -7.77 19.81 coo 81.75 35.21 52.13 80.92 37.12 51.69 -56.89 -12.17 16.15 -58.98 -11.84 16.38 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 6 3 # 6 A 170 SER C 42 SER~? 9.40 CA CA C1181 A 239 VAL C 44 VAL~? 12.15 CA CA C1181 A 413 ASN C 46 ASN~? 10.53 CA CA C1181 coo 80.14 40.76 52.28 77.73 40.59 51.94 -71.30 -10.68 27.08 -72.47 -11.31 29.07 coo 75.67 35.37 52.30 76.00 35.96 50.23 -68.22 -9.96 22.69 -66.14 -10.80 22.63 coo 81.75 35.21 52.13 80.92 37.12 51.69 -74.04 -8.67 22.63 -75.10 -9.60 24.27 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 7 3 # 7 A 170 SER C 89 SER.? 7.45 OXT ACT C1183 A 239 VAL B 82 VAL^? 8.90 OXT ACT C1183 A 413 ASN B 70 ASN~? 11.40 OXT ACT C1183 coo 80.14 40.76 52.28 77.73 40.59 51.94 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 75.67 35.37 52.30 76.00 35.96 50.23 -60.38 6.53 8.14 -59.34 7.83 6.68 coo 81.75 35.21 52.13 80.92 37.12 51.69 -56.88 12.21 10.31 -58.96 11.82 10.06 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 8 3 # 8 A 170 SER D 42 SER~? 22.67 CH3 ACT A1182 A 239 VAL D 44 VAL~? 15.50 CH3 ACT A1182 A 413 ASN D 46 ASN~? 18.62 CH3 ACT A1182 coo 80.14 40.76 52.28 77.73 40.59 51.94 -19.49 -8.50 28.63 -18.22 -10.13 29.88 coo 75.67 35.37 52.30 76.00 35.96 50.23 -22.58 -4.76 26.27 -24.63 -4.50 27.05 coo 81.75 35.21 52.13 80.92 37.12 51.69 -16.96 -5.07 24.82 -15.16 -4.92 23.63 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 9 3 # 9 A 170 SER D 89 SER.? 7.37 O ACT A1182 A 239 VAL A 82 VAL^? 8.88 O ACT A1182 A 413 ASN A 70 ASN~? 11.41 O ACT A1182 coo 80.14 40.76 52.28 77.73 40.59 51.94 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 75.67 35.37 52.30 76.00 35.96 50.23 -30.31 2.23 5.24 -31.41 3.04 3.49 coo 81.75 35.21 52.13 80.92 37.12 51.69 -33.93 -2.05 0.89 -31.84 -1.69 1.12 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 10 3 # 10 A 170 SER D 172 SER~? 19.02 O3 GOL D1181 A 239 VAL D 178 VAL^? 21.47 CA CA C1182 A 413 ASN D 176 ASN.? 28.38 CH3 ACT A1182 coo 80.14 40.76 52.28 77.73 40.59 51.94 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 75.67 35.37 52.30 76.00 35.96 50.23 -21.39 -7.86 41.14 -22.96 -9.33 40.54 coo 81.75 35.21 52.13 80.92 37.12 51.69 -19.41 -1.59 41.01 -18.50 -0.80 39.26 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 10 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 42 SER~? 22.64 CH3 ACT A1182 B 239 VAL A 44 VAL~? 15.48 CH3 ACT A1182 B 413 ASN A 46 ASN~? 20.18 CH3 ACT A1182 coo 25.22 6.41 2.90 27.67 6.33 3.11 -19.46 8.46 -2.16 -18.17 10.05 -3.40 coo 29.71 1.00 2.66 29.43 1.57 4.74 -22.59 4.76 0.20 -24.62 4.47 -0.57 coo 23.72 0.88 2.95 24.56 2.79 3.34 -16.92 5.08 1.56 -15.60 6.18 0.30 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER A 89 SER.? 7.33 OXT ACT A1182 B 239 VAL D 82 VAL^? 8.84 OXT ACT A1182 B 413 ASN D 70 ASN~? 11.36 OXT ACT A1182 coo 25.22 6.41 2.90 27.67 6.33 3.11 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 29.71 1.00 2.66 29.43 1.57 4.74 -30.32 -2.20 21.21 -31.39 -3.09 22.93 coo 23.72 0.88 2.95 24.56 2.79 3.34 -33.95 2.02 25.56 -31.86 1.70 25.35 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 3 3 # 3 B 170 SER B 42 SER~? 9.53 CA CA B1181 B 239 VAL B 44 VAL~? 12.02 CA CA B1181 B 413 ASN B 46 ASN~? 10.46 CA CA B1181 coo 25.22 6.41 2.90 27.67 6.33 3.11 -71.32 10.68 -0.61 -72.48 11.28 -2.66 coo 29.71 1.00 2.66 29.43 1.57 4.74 -68.22 9.96 3.77 -66.16 10.79 3.82 coo 23.72 0.88 2.95 24.56 2.79 3.34 -74.04 8.69 3.83 -75.20 9.76 2.34 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 4 3 # 4 B 170 SER B 89 SER.? 7.47 O ACT C1183 B 239 VAL C 82 VAL^? 8.90 O ACT C1183 B 413 ASN C 70 ASN~? 11.43 O ACT C1183 coo 25.22 6.41 2.90 27.67 6.33 3.11 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 29.71 1.00 2.66 29.43 1.57 4.74 -60.40 -6.50 18.34 -59.35 -7.77 19.81 coo 23.72 0.88 2.95 24.56 2.79 3.34 -56.89 -12.17 16.15 -58.98 -11.84 16.38 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 5 3 # 5 B 170 SER C 42 SER~? 9.40 CA CA C1181 B 239 VAL C 44 VAL~? 12.15 CA CA C1181 B 413 ASN C 46 ASN~? 10.53 CA CA C1181 coo 25.22 6.41 2.90 27.67 6.33 3.11 -71.30 -10.68 27.08 -72.47 -11.31 29.07 coo 29.71 1.00 2.66 29.43 1.57 4.74 -68.22 -9.96 22.69 -66.14 -10.80 22.63 coo 23.72 0.88 2.95 24.56 2.79 3.34 -74.04 -8.67 22.63 -75.10 -9.60 24.27 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 6 3 # 6 B 170 SER C 89 SER.? 7.45 OXT ACT C1183 B 239 VAL B 82 VAL^? 8.90 OXT ACT C1183 B 413 ASN B 70 ASN~? 11.40 OXT ACT C1183 coo 25.22 6.41 2.90 27.67 6.33 3.11 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 29.71 1.00 2.66 29.43 1.57 4.74 -60.38 6.53 8.14 -59.34 7.83 6.68 coo 23.72 0.88 2.95 24.56 2.79 3.34 -56.88 12.21 10.31 -58.96 11.82 10.06 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 7 3 # 7 B 170 SER D 42 SER~? 22.67 CH3 ACT A1182 B 239 VAL D 44 VAL~? 15.50 CH3 ACT A1182 B 413 ASN D 46 ASN~? 18.62 CH3 ACT A1182 coo 25.22 6.41 2.90 27.67 6.33 3.11 -19.49 -8.50 28.63 -18.22 -10.13 29.88 coo 29.71 1.00 2.66 29.43 1.57 4.74 -22.58 -4.76 26.27 -24.63 -4.50 27.05 coo 23.72 0.88 2.95 24.56 2.79 3.34 -16.96 -5.07 24.82 -15.16 -4.92 23.63 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 8 3 # 8 B 170 SER D 89 SER.? 7.37 O ACT A1182 B 239 VAL A 82 VAL^? 8.88 O ACT A1182 B 413 ASN A 70 ASN~? 11.41 O ACT A1182 coo 25.22 6.41 2.90 27.67 6.33 3.11 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 29.71 1.00 2.66 29.43 1.57 4.74 -30.31 2.23 5.24 -31.41 3.04 3.49 coo 23.72 0.88 2.95 24.56 2.79 3.34 -33.93 -2.05 0.89 -31.84 -1.69 1.12 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 9 3 # 9 B 170 SER D 172 SER~? 19.02 O3 GOL D1181 B 239 VAL D 178 VAL^? 21.47 CA CA C1182 B 413 ASN D 176 ASN.? 28.38 CH3 ACT A1182 coo 25.22 6.41 2.90 27.67 6.33 3.11 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 29.71 1.00 2.66 29.43 1.57 4.74 -21.39 -7.86 41.14 -22.96 -9.33 40.54 coo 23.72 0.88 2.95 24.56 2.79 3.34 -19.41 -1.59 41.01 -18.50 -0.80 39.26 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 9 hits 1oqz_c01 naa= 3 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 53 SER^? 12.21 OXT ACT A1182 A 708 ASP A 55 ASP.? 17.41 O ACT A1181 A 740 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -35.29 10.69 9.61 -33.77 12.39 10.51 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 53 SER^? 12.05 O ACT C1183 A 708 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 740 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER C 53 SER^? 12.05 OXT ACT C1183 A 708 ASP C 55 ASP.? 19.45 CA CA C1184 A 740 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -55.28 0.90 24.40 -56.83 2.38 25.58 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 A 630 SER D 53 SER^? 12.18 O ACT A1182 A 708 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 740 HIS D 114 HIS^? 15.97 O ACT A1182 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1pfq_c00 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 4 hits 1pfq_c00 naa= 3 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 53 SER^? 12.21 OXT ACT A1182 B 708 ASP A 55 ASP.? 17.41 O ACT A1181 B 740 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 4.44 13.29 37.64 6.01 11.66 38.49 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 6.39 7.18 30.33 6.92 8.20 32.17 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 8.57 10.09 34.47 7.10 10.73 35.82 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 53 SER^? 12.05 O ACT C1183 B 708 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 740 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 4.44 13.29 37.64 6.01 11.66 38.49 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 6.39 7.18 30.33 6.92 8.20 32.17 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 8.57 10.09 34.47 7.10 10.73 35.82 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER C 53 SER^? 12.05 OXT ACT C1183 B 708 ASP C 55 ASP.? 19.45 CA CA C1184 B 740 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 4.44 13.29 37.64 6.01 11.66 38.49 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 6.39 7.18 30.33 6.92 8.20 32.17 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 8.57 10.09 34.47 7.10 10.73 35.82 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER D 53 SER^? 12.18 O ACT A1182 B 708 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 740 HIS D 114 HIS^? 15.97 O ACT A1182 coo 4.44 13.29 37.64 6.01 11.66 38.49 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 6.39 7.18 30.33 6.92 8.20 32.17 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 8.57 10.09 34.47 7.10 10.73 35.82 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1pfq_c01 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 4 hits 1pfq_c01 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER D 56 SER.? 20.40 O ACT A1182 A 709 ASP D 84 ASP^? 8.02 O ACT A1182 A 740 HIS D 59 HIS~? 14.28 O ACT A1182 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -44.08 -8.12 17.12 -43.68 -6.15 16.50 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER D 57 SER.? 18.28 O2 GOL D1181 A 709 ASP D 84 ASP^? 8.02 O ACT A1182 A 740 HIS D 59 HIS~? 14.28 O ACT A1182 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -45.75 -15.36 18.26 -46.91 -17.39 17.79 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -44.08 -8.12 17.12 -43.68 -6.15 16.50 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 56 SER.? 20.33 OXT ACT A1182 B 709 ASP A 84 ASP^? 7.98 OXT ACT A1182 B 740 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo 4.44 13.29 37.64 6.01 11.66 38.49 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 10.26 2.81 31.69 11.64 4.30 32.43 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 8.57 10.09 34.47 7.10 10.73 35.82 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER A 57 SER.? 18.23 O ACT A1181 B 709 ASP A 84 ASP^? 7.98 OXT ACT A1182 B 740 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo 4.44 13.29 37.64 6.01 11.66 38.49 -45.76 15.37 8.19 -46.87 17.43 8.67 coo 10.26 2.81 31.69 11.64 4.30 32.43 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 8.57 10.09 34.47 7.10 10.73 35.82 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER B 56 SER.? 19.73 O3 GOL B1182 B 709 ASP B 84 ASP^? 7.80 O ACT C1183 B 740 HIS B 59 HIS~? 15.18 O ACT C1183 coo 4.44 13.29 37.64 6.01 11.66 38.49 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 10.26 2.81 31.69 11.64 4.30 32.43 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 8.57 10.09 34.47 7.10 10.73 35.82 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER B 57 SER.? 17.44 O3 GOL B1182 B 709 ASP B 84 ASP^? 7.80 O ACT C1183 B 740 HIS B 59 HIS~? 15.18 O ACT C1183 coo 4.44 13.29 37.64 6.01 11.66 38.49 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 coo 10.26 2.81 31.69 11.64 4.30 32.43 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 8.57 10.09 34.47 7.10 10.73 35.82 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 B 630 SER C 56 SER.? 20.22 OXT ACT C1183 B 709 ASP C 84 ASP^? 7.78 OXT ACT C1183 B 740 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo 4.44 13.29 37.64 6.01 11.66 38.49 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 10.26 2.81 31.69 11.64 4.30 32.43 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 8.57 10.09 34.47 7.10 10.73 35.82 -46.89 1.05 23.56 -47.29 3.11 23.40 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 B 630 SER C 57 SER.? 20.56 O3 GOL D1181 B 709 ASP C 84 ASP^? 7.78 OXT ACT C1183 B 740 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo 4.44 13.29 37.64 6.01 11.66 38.49 -44.87 1.18 29.24 -43.70 2.34 31.00 coo 10.26 2.81 31.69 11.64 4.30 32.43 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 8.57 10.09 34.47 7.10 10.73 35.82 -46.89 1.05 23.56 -47.29 3.11 23.40 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 B 630 SER D 56 SER.? 20.40 O ACT A1182 B 709 ASP D 84 ASP^? 8.02 O ACT A1182 B 740 HIS D 59 HIS~? 14.28 O ACT A1182 coo 4.44 13.29 37.64 6.01 11.66 38.49 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 10.26 2.81 31.69 11.64 4.30 32.43 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 8.57 10.09 34.47 7.10 10.73 35.82 -44.08 -8.12 17.12 -43.68 -6.15 16.50 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 8 3 # 8 B 630 SER D 57 SER.? 18.28 O2 GOL D1181 B 709 ASP D 84 ASP^? 8.02 O ACT A1182 B 740 HIS D 59 HIS~? 14.28 O ACT A1182 coo 4.44 13.29 37.64 6.01 11.66 38.49 -45.75 -15.36 18.26 -46.91 -17.39 17.79 coo 10.26 2.81 31.69 11.64 4.30 32.43 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 8.57 10.09 34.47 7.10 10.73 35.82 -44.08 -8.12 17.12 -43.68 -6.15 16.50 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 8 hits 1pfq_c03 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 96 ALA~? 16.98 OXT ACT A1182 A 126 LEU A 100 LEU~? 15.28 CH3 ACT A1182 A 158 GLU A 104 GLU~? 15.66 CH3 ACT A1182 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -28.64 14.50 22.33 -28.62 15.76 21.46 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -24.18 12.19 19.74 -23.04 13.28 18.29 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -20.64 9.26 17.21 -19.66 10.90 18.17 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA C 96 ALA~? 16.84 OXT ACT C1183 A 126 LEU C 100 LEU~? 15.16 CH3 ACT C1183 A 158 GLU C 104 GLU~? 15.46 CH3 ACT C1183 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -62.09 13.83 23.14 -62.11 13.46 24.60 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -66.41 10.56 22.00 -67.73 9.48 23.31 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -69.83 7.02 20.20 -71.35 7.54 21.51 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 96 ALA~? 16.98 OXT ACT A1182 B 126 LEU A 100 LEU~? 15.28 CH3 ACT A1182 B 158 GLU A 104 GLU~? 15.66 CH3 ACT A1182 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -28.64 14.50 22.33 -28.62 15.76 21.46 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -24.18 12.19 19.74 -23.04 13.28 18.29 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -20.64 9.26 17.21 -19.66 10.90 18.17 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA C 96 ALA~? 16.84 OXT ACT C1183 B 126 LEU C 100 LEU~? 15.16 CH3 ACT C1183 B 158 GLU C 104 GLU~? 15.46 CH3 ACT C1183 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -62.09 13.83 23.14 -62.11 13.46 24.60 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -66.41 10.56 22.00 -67.73 9.48 23.31 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -69.83 7.02 20.20 -71.35 7.54 21.51 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 96 ALA~? 16.98 OXT ACT A1182 C 126 LEU A 100 LEU~? 15.28 CH3 ACT A1182 C 158 GLU A 104 GLU~? 15.66 CH3 ACT A1182 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -28.64 14.50 22.33 -28.62 15.76 21.46 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -24.18 12.19 19.74 -23.04 13.28 18.29 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -20.64 9.26 17.21 -19.66 10.90 18.17 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA C 96 ALA~? 16.84 OXT ACT C1183 C 126 LEU C 100 LEU~? 15.16 CH3 ACT C1183 C 158 GLU C 104 GLU~? 15.46 CH3 ACT C1183 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -62.09 13.83 23.14 -62.11 13.46 24.60 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -66.41 10.56 22.00 -67.73 9.48 23.31 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -69.83 7.02 20.20 -71.35 7.54 21.51 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 144 ASP.? 22.46 O ACT A1181 A 270 LYS A 35 LYS~? 23.91 O ACT A1181 A 382 MET A 111 MET^? 15.46 CH3 ACT A1182 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -24.09 23.13 1.13 -22.88 24.73 0.42 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -24.57 9.65 7.75 -24.52 11.07 3.80 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP B 144 ASP.? 6.66 CA CA B1183 A 270 LYS B 35 LYS~? 11.04 CA CA B1183 A 382 MET B 111 MET^? 15.47 O2 GOL B1182 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -68.46 9.78 -10.58 -72.55 6.75 -11.95 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -66.03 1.17 2.20 -66.07 4.25 -0.63 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP C 95 ASP~? 18.98 OXT ACT C1183 A 270 LYS C 93 LYS.? 19.61 OXT ACT C1183 A 382 MET C 105 MET~? 11.25 CH3 ACT C1183 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -60.88 17.87 20.49 -62.76 18.57 19.77 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -54.93 14.23 21.55 -53.38 19.08 19.32 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -70.36 6.56 14.22 -68.22 8.22 11.76 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP C 144 ASP.? 6.69 CA CA C1184 A 270 LYS C 35 LYS~? 10.20 CA CA C1184 A 382 MET C 111 MET^? 15.48 CH3 ACT C1183 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -68.45 -9.84 37.00 -72.38 -5.53 38.73 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -66.04 -1.16 24.25 -66.10 -4.26 27.10 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 5 3 # 5 A 248 ASP D 144 ASP.? 22.37 O2 GOL D1181 A 270 LYS D 35 LYS~? 23.81 O2 GOL D1181 A 382 MET D 111 MET^? 15.49 CH3 ACT A1182 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -24.56 -9.67 18.69 -24.51 -11.07 22.67 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 6 3 # 6 A 248 ASP D 144 ASP.? 22.37 O2 GOL D1181 A 270 LYS D 142 LYS.? 24.20 CH3 ACT A1182 A 382 MET D 111 MET^? 15.49 CH3 ACT A1182 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -25.06 -24.88 17.65 -21.32 -22.55 15.38 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -24.56 -9.67 18.69 -24.51 -11.07 22.67 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 6 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 144 ASP.? 22.46 O ACT A1181 B 270 LYS A 35 LYS~? 23.91 O ACT A1181 B 382 MET A 111 MET^? 15.46 CH3 ACT A1182 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -24.09 23.13 1.13 -22.88 24.73 0.42 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -24.57 9.65 7.75 -24.52 11.07 3.80 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP A 144 ASP.? 22.46 O ACT A1181 B 270 LYS A 142 LYS.? 21.46 CH3 ACT A1182 B 382 MET A 111 MET^? 15.46 CH3 ACT A1182 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -24.09 23.13 1.13 -22.88 24.73 0.42 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -25.15 24.34 9.11 -21.81 19.66 9.96 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -24.57 9.65 7.75 -24.52 11.07 3.80 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 3 3 # 3 B 248 ASP B 144 ASP.? 6.66 CA CA B1183 B 270 LYS B 35 LYS~? 11.04 CA CA B1183 B 382 MET B 111 MET^? 15.47 O2 GOL B1182 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -68.46 9.78 -10.58 -72.55 6.75 -11.95 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -66.03 1.17 2.20 -66.07 4.25 -0.63 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 4 3 # 4 B 248 ASP B 144 ASP.? 6.66 CA CA B1183 B 270 LYS B 142 LYS.? 10.67 CA CA B1183 B 382 MET B 111 MET^? 15.47 O2 GOL B1182 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -66.03 1.17 2.20 -66.07 4.25 -0.63 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 5 3 # 5 B 248 ASP C 144 ASP.? 6.69 CA CA C1184 B 270 LYS C 35 LYS~? 10.20 CA CA C1184 B 382 MET C 111 MET^? 15.48 CH3 ACT C1183 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -68.45 -9.84 37.00 -72.38 -5.53 38.73 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -66.04 -1.16 24.25 -66.10 -4.26 27.10 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 6 3 # 6 B 248 ASP C 144 ASP.? 6.69 CA CA C1184 B 270 LYS C 142 LYS.? 12.38 CA CA C1184 B 382 MET C 111 MET^? 15.48 CH3 ACT C1183 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -64.58 4.07 38.03 -66.58 4.11 31.93 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -66.04 -1.16 24.25 -66.10 -4.26 27.10 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 7 3 # 7 B 248 ASP D 144 ASP.? 22.37 O2 GOL D1181 B 270 LYS D 35 LYS~? 23.81 O2 GOL D1181 B 382 MET D 111 MET^? 15.49 CH3 ACT A1182 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -24.56 -9.67 18.69 -24.51 -11.07 22.67 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 8 3 # 8 B 248 ASP D 144 ASP.? 22.37 O2 GOL D1181 B 270 LYS D 142 LYS.? 24.20 CH3 ACT A1182 B 382 MET D 111 MET^? 15.49 CH3 ACT A1182 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -25.06 -24.88 17.65 -21.32 -22.55 15.38 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -24.56 -9.67 18.69 -24.51 -11.07 22.67 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 8 hits 1pjq_c03 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 53 SER^? 12.21 OXT ACT A1182 B 69 ALA A 87 ALA.? 6.96 OXT ACT A1182 B 241 ASN A 86 ASN.? 11.67 OXT ACT A1182 coo 13.24 41.94 33.13 13.08 39.54 33.17 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 9.15 37.89 36.69 10.55 37.76 37.22 -37.93 4.41 14.70 -38.35 3.33 13.74 coo 10.91 43.03 38.47 11.81 41.82 36.93 -38.42 8.17 12.63 -38.52 10.18 11.86 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER A 99 SER~? 12.20 OXT ACT A1182 B 69 ALA A 96 ALA~? 16.98 OXT ACT A1182 B 241 ASN A 97 ASN~? 20.44 OXT ACT A1182 coo 13.24 41.94 33.13 13.08 39.54 33.17 -27.81 9.50 21.53 -30.13 10.20 21.65 coo 9.15 37.89 36.69 10.55 37.76 37.22 -28.64 14.50 22.33 -28.62 15.76 21.46 coo 10.91 43.03 38.47 11.81 41.82 36.93 -24.46 14.50 24.96 -23.77 16.46 24.44 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER A 99 SER~? 12.20 OXT ACT A1182 B 69 ALA A 101 ALA~? 15.42 CH3 ACT A1182 B 241 ASN A 97 ASN~? 20.44 OXT ACT A1182 coo 13.24 41.94 33.13 13.08 39.54 33.17 -27.81 9.50 21.53 -30.13 10.20 21.65 coo 9.15 37.89 36.69 10.55 37.76 37.22 -22.27 8.71 21.69 -22.00 8.86 23.18 coo 10.91 43.03 38.47 11.81 41.82 36.93 -24.46 14.50 24.96 -23.77 16.46 24.44 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER A 172 SER~? 20.14 OXT ACT A1181 B 69 ALA A 169 ALA~? 17.78 OXT ACT A1181 B 241 ASN A 168 ASN~? 15.32 OXT ACT A1181 coo 13.24 41.94 33.13 13.08 39.54 33.17 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 9.15 37.89 36.69 10.55 37.76 37.22 -27.60 9.14 -9.68 -27.49 10.41 -8.90 coo 10.91 43.03 38.47 11.81 41.82 36.93 -31.58 8.23 -11.56 -33.27 7.25 -12.34 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 5 3 # 5 B 1 SER B 53 SER^? 12.05 O ACT C1183 B 69 ALA B 87 ALA.? 6.83 O ACT C1183 B 241 ASN B 86 ASN.? 11.57 O ACT C1183 coo 13.24 41.94 33.13 13.08 39.54 33.17 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 9.15 37.89 36.69 10.55 37.76 37.22 -52.69 -3.08 9.85 -52.24 -1.81 10.51 coo 10.91 43.03 38.47 11.81 41.82 36.93 -52.20 -2.48 5.54 -51.99 -2.60 3.42 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 6 3 # 6 B 1 SER B 99 SER~? 12.12 O ACT C1183 B 69 ALA B 96 ALA.? 19.63 O ACT C1183 B 241 ASN B 97 ASN~? 15.65 O ACT C1183 coo 13.24 41.94 33.13 13.08 39.54 33.17 -62.79 -11.40 7.59 -60.42 -11.55 7.06 coo 9.15 37.89 36.69 10.55 37.76 37.22 -62.34 -18.67 5.39 -62.96 -19.17 6.71 coo 10.91 43.03 38.47 11.81 41.82 36.93 -64.58 -14.76 3.84 -63.20 -13.18 4.05 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 7 3 # 7 B 1 SER B 99 SER~? 12.12 O ACT C1183 B 69 ALA B 101 ALA~? 15.53 CH3 ACT C1183 B 241 ASN B 97 ASN~? 15.65 O ACT C1183 coo 13.24 41.94 33.13 13.08 39.54 33.17 -62.79 -11.40 7.59 -60.42 -11.55 7.06 coo 9.15 37.89 36.69 10.55 37.76 37.22 -68.31 -11.14 8.47 -68.68 -12.57 8.87 coo 10.91 43.03 38.47 11.81 41.82 36.93 -64.58 -14.76 3.84 -63.20 -13.18 4.05 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 8 3 # 8 B 1 SER B 172 SER~? 11.09 CA CA B1181 B 69 ALA B 169 ALA~? 12.65 CA CA B1181 B 241 ASN B 168 ASN~? 15.62 CH3 ACT A1181 coo 13.24 41.94 33.13 13.08 39.54 33.17 -65.24 21.33 -1.59 -63.69 21.95 -3.31 coo 9.15 37.89 36.69 10.55 37.76 37.22 -63.20 17.37 -4.05 -63.27 16.15 -4.99 coo 10.91 43.03 38.47 11.81 41.82 36.93 -59.27 19.54 -3.77 -57.59 20.58 -3.04 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 9 3 # 9 B 1 SER C 53 SER^? 12.05 OXT ACT C1183 B 69 ALA C 87 ALA.? 6.87 OXT ACT C1183 B 241 ASN C 86 ASN.? 11.54 OXT ACT C1183 coo 13.24 41.94 33.13 13.08 39.54 33.17 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 9.15 37.89 36.69 10.55 37.76 37.22 -52.69 3.10 16.59 -52.21 1.83 15.91 coo 10.91 43.03 38.47 11.81 41.82 36.93 -52.20 2.48 20.90 -52.01 2.64 23.02 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 10 3 # 10 B 1 SER C 99 SER~? 11.91 OXT ACT C1183 B 69 ALA C 96 ALA~? 16.84 OXT ACT C1183 B 241 ASN C 97 ASN~? 20.34 OXT ACT C1183 coo 13.24 41.94 33.13 13.08 39.54 33.17 -62.74 11.40 18.89 -60.36 11.40 19.38 coo 9.15 37.89 36.69 10.55 37.76 37.22 -62.09 13.83 23.14 -62.11 13.46 24.60 coo 10.91 43.03 38.47 11.81 41.82 36.93 -66.13 16.32 22.33 -66.34 16.55 24.44 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 11 3 # 11 B 1 SER C 99 SER~? 11.91 OXT ACT C1183 B 69 ALA C 101 ALA~? 15.51 CH3 ACT C1183 B 241 ASN C 97 ASN~? 20.34 OXT ACT C1183 coo 13.24 41.94 33.13 13.08 39.54 33.17 -62.74 11.40 18.89 -60.36 11.40 19.38 coo 9.15 37.89 36.69 10.55 37.76 37.22 -68.27 11.18 18.01 -68.57 12.62 17.61 coo 10.91 43.03 38.47 11.81 41.82 36.93 -66.13 16.32 22.33 -66.34 16.55 24.44 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 12 3 # 12 B 1 SER C 172 SER~? 11.19 CA CA C1181 B 69 ALA C 169 ALA~? 12.75 CA CA C1181 B 241 ASN C 168 ASN~? 14.78 C1 GOL D1181 coo 13.24 41.94 33.13 13.08 39.54 33.17 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 9.15 37.89 36.69 10.55 37.76 37.22 -63.19 -17.38 30.51 -63.27 -16.18 31.48 coo 10.91 43.03 38.47 11.81 41.82 36.93 -59.24 -19.55 30.22 -57.56 -20.59 29.47 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 13 3 # 13 B 1 SER D 53 SER^? 12.18 O ACT A1182 B 69 ALA D 87 ALA.? 6.96 O ACT A1182 B 241 ASN D 86 ASN.? 11.74 O ACT A1182 coo 13.24 41.94 33.13 13.08 39.54 33.17 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 9.15 37.89 36.69 10.55 37.76 37.22 -37.91 -4.38 11.75 -38.33 -3.29 12.71 coo 10.91 43.03 38.47 11.81 41.82 36.93 -38.34 -8.19 13.90 -38.52 -10.20 14.65 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 14 3 # 14 B 1 SER D 99 SER~? 12.19 O ACT A1182 B 69 ALA D 101 ALA~? 15.44 CH3 ACT A1182 B 241 ASN D 97 ASN~? 15.89 O ACT A1182 coo 13.24 41.94 33.13 13.08 39.54 33.17 -27.80 -9.54 4.93 -30.15 -10.16 4.86 coo 9.15 37.89 36.69 10.55 37.76 37.22 -22.24 -8.69 4.80 -21.96 -8.85 3.32 coo 10.91 43.03 38.47 11.81 41.82 36.93 -26.32 -14.61 3.13 -27.44 -14.01 4.83 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 15 3 # 15 B 1 SER D 172 SER~? 19.02 O3 GOL D1181 B 69 ALA D 169 ALA~? 16.50 O3 GOL D1181 B 241 ASN D 168 ASN~? 14.11 O3 GOL D1181 coo 13.24 41.94 33.13 13.08 39.54 33.17 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 9.15 37.89 36.69 10.55 37.76 37.22 -27.60 -9.12 36.16 -27.49 -10.39 35.36 coo 10.91 43.03 38.47 11.81 41.82 36.93 -31.58 -8.23 38.03 -33.25 -7.24 38.84 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 15 hits 1pnl_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 77 ARG.? 18.54 O ACT A1182 A 479 PHE A 171 PHE~? 20.27 O ACT A1182 A 483 GLU A 167 GLU~? 17.93 OXT ACT A1181 coo 17.33 52.29 2.24 18.71 54.03 0.18 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo 20.06 57.44 1.28 18.39 56.19 3.12 -29.04 2.00 -8.65 -29.75 0.52 -6.40 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 -32.78 4.71 -6.52 -34.47 3.65 -5.83 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 1 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 77 ARG.? 18.54 O ACT A1182 B 479 PHE A 171 PHE~? 20.27 O ACT A1182 B 483 GLU A 167 GLU~? 17.93 OXT ACT A1181 coo -26.72 93.28 20.13 -28.02 93.55 17.39 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo -29.34 90.48 15.69 -27.62 89.95 17.80 -29.04 2.00 -8.65 -29.75 0.52 -6.40 coo -26.63 95.49 14.65 -25.77 93.77 13.77 -32.78 4.71 -6.52 -34.47 3.65 -5.83 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 1 hits 1pow_c03 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 68 ASN~? 16.27 OXT ACT A1181 A 192 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 195 HIS B 59 HIS~? 15.18 O ACT C1183 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -37.69 3.73 -3.29 -39.63 4.05 -4.09 coo 2.03 47.14 19.75 1.72 46.26 21.64 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN B 68 ASN~? 15.57 O ACT A1181 A 192 ASP A 55 ASP.? 17.41 O ACT A1181 A 195 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -53.02 13.76 3.43 -51.10 14.43 2.89 coo 2.03 47.14 19.75 1.72 46.26 21.64 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 A 74 ASN D 68 ASN~? 14.78 O3 GOL D1181 A 192 ASP C 55 ASP.? 19.45 CA CA C1184 A 195 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -37.72 -3.74 29.70 -39.65 -4.05 30.55 coo 2.03 47.14 19.75 1.72 46.26 21.64 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -46.89 1.05 23.56 -47.29 3.11 23.40 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 3 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 68 ASN~? 16.27 OXT ACT A1181 B 192 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 195 HIS B 59 HIS~? 15.18 O ACT C1183 coo -1.08 51.41 10.34 0.65 52.62 10.17 -37.69 3.73 -3.29 -39.63 4.05 -4.09 coo 11.36 52.33 5.59 10.18 53.87 6.47 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 7.99 56.74 7.55 6.88 55.39 8.70 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN B 68 ASN~? 15.57 O ACT A1181 B 192 ASP A 55 ASP.? 17.41 O ACT A1181 B 195 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo -1.08 51.41 10.34 0.65 52.62 10.17 -53.02 13.76 3.43 -51.10 14.43 2.89 coo 11.36 52.33 5.59 10.18 53.87 6.47 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 7.99 56.74 7.55 6.88 55.39 8.70 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 B 74 ASN D 68 ASN~? 14.78 O3 GOL D1181 B 192 ASP C 55 ASP.? 19.45 CA CA C1184 B 195 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo -1.08 51.41 10.34 0.65 52.62 10.17 -37.72 -3.74 29.70 -39.65 -4.05 30.55 coo 11.36 52.33 5.59 10.18 53.87 6.47 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 7.99 56.74 7.55 6.88 55.39 8.70 -46.89 1.05 23.56 -47.29 3.11 23.40 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 3 hits 1pp4_c03 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 67 ARG A 58 ARG~? 14.46 O ACT A1181 A 86 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo 18.15 3.28 18.56 20.10 2.92 19.20 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 21.52 6.83 26.64 21.22 5.53 23.85 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 67 ARG A 58 ARG~? 14.46 O ACT A1181 A 86 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 18.15 3.28 18.56 20.10 2.92 19.20 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 21.52 6.83 26.64 21.22 5.53 23.85 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1pyl_c00 RIBONUCLEASE user 3 3 # 3 A 56 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 67 ARG B 58 ARG~? 12.97 O3 GOL B1182 A 86 HIS B 59 HIS~? 15.18 O ACT C1183 coo 18.15 3.28 18.56 20.10 2.92 19.20 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 21.52 6.83 26.64 21.22 5.53 23.85 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1pyl_c00 RIBONUCLEASE user 4 3 # 4 A 56 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 67 ARG B 58 ARG~? 12.97 O3 GOL B1182 A 86 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 18.15 3.28 18.56 20.10 2.92 19.20 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 21.52 6.83 26.64 21.22 5.53 23.85 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1pyl_c00 RIBONUCLEASE user 5 3 # 5 A 56 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 67 ARG C 58 ARG~? 18.42 O3 GOL D1181 A 86 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo 18.15 3.28 18.56 20.10 2.92 19.20 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 21.52 6.83 26.64 21.22 5.53 23.85 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -46.89 1.05 23.56 -47.29 3.11 23.40 ULMN 3 1pyl_c00 RIBONUCLEASE user 6 3 # 6 A 56 GLU C 119 GLU.? 19.60 OXT ACT C1183 A 67 ARG C 58 ARG~? 18.42 O3 GOL D1181 A 86 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 18.15 3.28 18.56 20.10 2.92 19.20 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 21.52 6.83 26.64 21.22 5.53 23.85 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1pyl_c00 RIBONUCLEASE user 7 3 # 7 A 56 GLU D 119 GLU.? 19.65 O ACT A1182 A 67 ARG D 58 ARG~? 14.52 O2 GOL D1181 A 86 HIS D 114 HIS^? 15.97 O ACT A1182 coo 18.15 3.28 18.56 20.10 2.92 19.20 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 21.52 6.83 26.64 21.22 5.53 23.85 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1pyl_c00 source 1pyl RIBONUCLEASE : 7 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 119 GLU.? 19.75 OXT ACT A1182 B 67 ARG A 58 ARG~? 14.46 O ACT A1181 B 86 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU A 119 GLU.? 19.75 OXT ACT A1182 B 67 ARG A 58 ARG~? 14.46 O ACT A1181 B 86 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1pyl_c01 RIBONUCLEASE user 3 3 # 3 B 56 GLU B 119 GLU.? 18.74 O3 GOL B1182 B 67 ARG B 58 ARG~? 12.97 O3 GOL B1182 B 86 HIS B 59 HIS~? 15.18 O ACT C1183 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 1pyl_c01 RIBONUCLEASE user 4 3 # 4 B 56 GLU B 119 GLU.? 18.74 O3 GOL B1182 B 67 ARG B 58 ARG~? 12.97 O3 GOL B1182 B 86 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1pyl_c01 RIBONUCLEASE user 5 3 # 5 B 56 GLU C 119 GLU.? 19.60 OXT ACT C1183 B 67 ARG C 58 ARG~? 18.42 O3 GOL D1181 B 86 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -46.89 1.05 23.56 -47.29 3.11 23.40 ULMN 3 1pyl_c01 RIBONUCLEASE user 6 3 # 6 B 56 GLU C 119 GLU.? 19.60 OXT ACT C1183 B 67 ARG C 58 ARG~? 18.42 O3 GOL D1181 B 86 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -49.67 7.91 30.13 -48.14 6.69 29.28 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1pyl_c01 RIBONUCLEASE user 7 3 # 7 B 56 GLU D 119 GLU.? 19.65 O ACT A1182 B 67 ARG D 58 ARG~? 14.52 O2 GOL D1181 B 86 HIS D 114 HIS^? 15.97 O ACT A1182 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1pyl_c01 source 1pyl RIBONUCLEASE : 7 hits 1pyl_c01 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 36 LEU~? 19.03 O ACT A1181 A 58 ASP A 144 ASP.? 22.46 O ACT A1181 A 120 LYS A 142 LYS.? 21.46 CH3 ACT A1182 coo 34.02 69.29 75.26 34.82 67.82 76.74 -25.97 17.47 -1.20 -25.68 19.48 -0.33 coo 34.46 72.45 78.57 32.82 72.75 77.28 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 28.96 77.64 81.19 29.05 74.53 77.51 -25.15 24.34 9.11 -21.81 19.66 9.96 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU A 98 LEU~? 16.25 OXT ACT A1182 A 58 ASP A 95 ASP~? 18.75 OXT ACT A1182 A 120 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 34.02 69.29 75.26 34.82 67.82 76.74 -27.39 9.92 25.94 -26.97 9.12 27.93 coo 34.46 72.45 78.57 32.82 72.75 77.28 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 28.96 77.64 81.19 29.05 74.53 77.51 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 A 48 LEU A 155 LEU~? 8.86 O ACT A1181 A 58 ASP A 156 ASP~? 10.59 O ACT A1181 A 120 LYS B 164 LYS~? 10.34 O ACT A1181 coo 34.02 69.29 75.26 34.82 67.82 76.74 -43.73 20.49 -0.69 -42.12 20.15 0.73 coo 34.46 72.45 78.57 32.82 72.75 77.28 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 28.96 77.64 81.19 29.05 74.53 77.51 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 A 48 LEU A 160 LEU~? 8.80 OXT ACT A1181 A 58 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 120 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 34.02 69.29 75.26 34.82 67.82 76.74 -41.85 11.99 -5.74 -43.38 10.84 -4.79 coo 34.46 72.45 78.57 32.82 72.75 77.28 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 28.96 77.64 81.19 29.05 74.53 77.51 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 A 48 LEU B 36 LEU~? 8.31 O2 GOL B1182 A 58 ASP B 144 ASP.? 6.66 CA CA B1183 A 120 LYS B 142 LYS.? 10.67 CA CA B1183 coo 34.02 69.29 75.26 34.82 67.82 76.74 -65.15 6.57 -9.02 -64.58 4.62 -8.22 coo 34.46 72.45 78.57 32.82 72.75 77.28 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 28.96 77.64 81.19 29.05 74.53 77.51 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 6 3 # 6 A 48 LEU B 98 LEU~? 16.43 O ACT C1183 A 58 ASP B 95 ASP.? 16.79 O ACT C1183 A 120 LYS C 72 LYS.? 18.71 O ACT C1183 coo 34.02 69.29 75.26 34.82 67.82 76.74 -63.33 -15.45 9.54 -63.70 -17.43 10.36 coo 34.46 72.45 78.57 32.82 72.75 77.28 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 28.96 77.64 81.19 29.05 74.53 77.51 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 7 3 # 7 A 48 LEU B 98 LEU~? 16.43 O ACT C1183 A 58 ASP B 95 ASP.? 16.79 O ACT C1183 A 120 LYS C 75 LYS.? 21.97 O2 GOL D1181 coo 34.02 69.29 75.26 34.82 67.82 76.74 -63.33 -15.45 9.54 -63.70 -17.43 10.36 coo 34.46 72.45 78.57 32.82 72.75 77.28 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 28.96 77.64 81.19 29.05 74.53 77.51 -57.40 -22.87 13.44 -53.97 -26.42 17.14 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 8 3 # 8 A 48 LEU B 155 LEU~? 8.74 O3 GOL B1182 A 58 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 120 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 34.02 69.29 75.26 34.82 67.82 76.74 -46.89 4.99 -11.02 -48.49 3.73 -10.16 coo 34.46 72.45 78.57 32.82 72.75 77.28 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 28.96 77.64 81.19 29.05 74.53 77.51 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 9 3 # 9 A 48 LEU B 160 LEU~? 9.59 OXT ACT A1181 A 58 ASP A 156 ASP~? 10.59 O ACT A1181 A 120 LYS A 158 LYS~? -4.64 O ACT A1181s coo 34.02 69.29 75.26 34.82 67.82 76.74 -48.88 12.92 -5.16 -47.30 12.65 -3.74 coo 34.46 72.45 78.57 32.82 72.75 77.28 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 28.96 77.64 81.19 29.05 74.53 77.51 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 10 3 # 10 A 48 LEU C 36 LEU~? 8.84 CA CA C1184 A 58 ASP C 144 ASP.? 6.69 CA CA C1184 A 120 LYS C 142 LYS.? 12.38 CA CA C1184 coo 34.02 69.29 75.26 34.82 67.82 76.74 -65.19 -6.55 35.50 -64.61 -4.63 34.62 coo 34.46 72.45 78.57 32.82 72.75 77.28 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 28.96 77.64 81.19 29.05 74.53 77.51 -64.58 4.07 38.03 -66.58 4.11 31.93 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 11 3 # 11 A 48 LEU C 98 LEU~? 16.39 OXT ACT C1183 A 58 ASP C 95 ASP~? 18.98 OXT ACT C1183 A 120 LYS B 75 LYS.? 22.83 O ACT A1181 coo 34.02 69.29 75.26 34.82 67.82 76.74 -63.32 15.67 17.65 -63.68 17.13 16.05 coo 34.46 72.45 78.57 32.82 72.75 77.28 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 28.96 77.64 81.19 29.05 74.53 77.51 -57.47 22.90 13.02 -52.58 24.12 11.55 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 12 3 # 12 A 48 LEU C 155 LEU~? 14.36 O3 GOL D1181 A 58 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 120 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 34.02 69.29 75.26 34.82 67.82 76.74 -46.93 -4.99 37.50 -48.50 -3.75 36.63 coo 34.46 72.45 78.57 32.82 72.75 77.28 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 28.96 77.64 81.19 29.05 74.53 77.51 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 13 3 # 13 A 48 LEU C 160 LEU~? 8.91 O3 GOL D1181 A 58 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 120 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 34.02 69.29 75.26 34.82 67.82 76.74 -48.88 -12.94 31.66 -47.29 -12.69 30.23 coo 34.46 72.45 78.57 32.82 72.75 77.28 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 28.96 77.64 81.19 29.05 74.53 77.51 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 14 3 # 14 A 48 LEU D 36 LEU~? 18.59 O3 GOL D1181 A 58 ASP D 144 ASP.? 22.37 O2 GOL D1181 A 120 LYS D 142 LYS.? 24.20 CH3 ACT A1182 coo 34.02 69.29 75.26 34.82 67.82 76.74 -25.97 -17.48 27.72 -25.71 -19.44 26.74 coo 34.46 72.45 78.57 32.82 72.75 77.28 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 28.96 77.64 81.19 29.05 74.53 77.51 -25.06 -24.88 17.65 -21.32 -22.55 15.38 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 15 3 # 15 A 48 LEU D 155 LEU~? 8.85 O2 GOL D1181 A 58 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 120 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 34.02 69.29 75.26 34.82 67.82 76.74 -43.78 -20.51 27.17 -42.15 -20.14 25.71 coo 34.46 72.45 78.57 32.82 72.75 77.28 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 28.96 77.64 81.19 29.05 74.53 77.51 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 16 3 # 16 A 48 LEU D 160 LEU~? 7.46 O3 GOL D1181 A 58 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 120 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 34.02 69.29 75.26 34.82 67.82 76.74 -41.83 -11.95 32.17 -43.38 -10.80 31.19 coo 34.46 72.45 78.57 32.82 72.75 77.28 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 28.96 77.64 81.19 29.05 74.53 77.51 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 16 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 36 LEU~? 19.03 O ACT A1181 B 58 ASP A 144 ASP.? 22.46 O ACT A1181 B 120 LYS A 142 LYS.? 21.46 CH3 ACT A1182 coo 54.50 104.32 58.69 55.83 105.69 59.81 -25.97 17.47 -1.20 -25.68 19.48 -0.33 coo 57.63 101.19 59.83 56.60 100.89 57.99 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 61.58 95.88 55.22 58.18 99.30 54.71 -25.15 24.34 9.11 -21.81 19.66 9.96 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU A 98 LEU~? 16.25 OXT ACT A1182 B 58 ASP A 95 ASP~? 18.75 OXT ACT A1182 B 120 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo 54.50 104.32 58.69 55.83 105.69 59.81 -27.39 9.92 25.94 -26.97 9.12 27.93 coo 57.63 101.19 59.83 56.60 100.89 57.99 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 61.58 95.88 55.22 58.18 99.30 54.71 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 B 48 LEU A 155 LEU~? 8.86 O ACT A1181 B 58 ASP A 156 ASP~? 10.59 O ACT A1181 B 120 LYS B 164 LYS~? 10.34 O ACT A1181 coo 54.50 104.32 58.69 55.83 105.69 59.81 -43.73 20.49 -0.69 -42.12 20.15 0.73 coo 57.63 101.19 59.83 56.60 100.89 57.99 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 61.58 95.88 55.22 58.18 99.30 54.71 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 B 48 LEU A 160 LEU~? 8.80 OXT ACT A1181 B 58 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 120 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 54.50 104.32 58.69 55.83 105.69 59.81 -41.85 11.99 -5.74 -43.38 10.84 -4.79 coo 57.63 101.19 59.83 56.60 100.89 57.99 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 61.58 95.88 55.22 58.18 99.30 54.71 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 B 48 LEU B 36 LEU~? 8.31 O2 GOL B1182 B 58 ASP B 144 ASP.? 6.66 CA CA B1183 B 120 LYS B 142 LYS.? 10.67 CA CA B1183 coo 54.50 104.32 58.69 55.83 105.69 59.81 -65.15 6.57 -9.02 -64.58 4.62 -8.22 coo 57.63 101.19 59.83 56.60 100.89 57.99 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 61.58 95.88 55.22 58.18 99.30 54.71 -64.62 -4.19 -11.77 -67.07 -4.36 -7.79 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 6 3 # 6 B 48 LEU B 98 LEU~? 16.43 O ACT C1183 B 58 ASP B 95 ASP.? 16.79 O ACT C1183 B 120 LYS C 72 LYS.? 18.71 O ACT C1183 coo 54.50 104.32 58.69 55.83 105.69 59.81 -63.33 -15.45 9.54 -63.70 -17.43 10.36 coo 57.63 101.19 59.83 56.60 100.89 57.99 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 61.58 95.88 55.22 58.18 99.30 54.71 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 7 3 # 7 B 48 LEU B 98 LEU~? 16.43 O ACT C1183 B 58 ASP B 95 ASP.? 16.79 O ACT C1183 B 120 LYS C 75 LYS.? 21.97 O2 GOL D1181 coo 54.50 104.32 58.69 55.83 105.69 59.81 -63.33 -15.45 9.54 -63.70 -17.43 10.36 coo 57.63 101.19 59.83 56.60 100.89 57.99 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 61.58 95.88 55.22 58.18 99.30 54.71 -57.40 -22.87 13.44 -53.97 -26.42 17.14 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 8 3 # 8 B 48 LEU B 155 LEU~? 8.74 O3 GOL B1182 B 58 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 120 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 54.50 104.32 58.69 55.83 105.69 59.81 -46.89 4.99 -11.02 -48.49 3.73 -10.16 coo 57.63 101.19 59.83 56.60 100.89 57.99 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 61.58 95.88 55.22 58.18 99.30 54.71 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 9 3 # 9 B 48 LEU B 160 LEU~? 9.59 OXT ACT A1181 B 58 ASP A 156 ASP~? 10.59 O ACT A1181 B 120 LYS A 158 LYS~? -4.64 O ACT A1181s coo 54.50 104.32 58.69 55.83 105.69 59.81 -48.88 12.92 -5.16 -47.30 12.65 -3.74 coo 57.63 101.19 59.83 56.60 100.89 57.99 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 61.58 95.88 55.22 58.18 99.30 54.71 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 10 3 # 10 B 48 LEU C 36 LEU~? 8.84 CA CA C1184 B 58 ASP C 144 ASP.? 6.69 CA CA C1184 B 120 LYS C 142 LYS.? 12.38 CA CA C1184 coo 54.50 104.32 58.69 55.83 105.69 59.81 -65.19 -6.55 35.50 -64.61 -4.63 34.62 coo 57.63 101.19 59.83 56.60 100.89 57.99 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 61.58 95.88 55.22 58.18 99.30 54.71 -64.58 4.07 38.03 -66.58 4.11 31.93 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 11 3 # 11 B 48 LEU C 98 LEU~? 16.39 OXT ACT C1183 B 58 ASP C 95 ASP~? 18.98 OXT ACT C1183 B 120 LYS B 75 LYS.? 22.83 O ACT A1181 coo 54.50 104.32 58.69 55.83 105.69 59.81 -63.32 15.67 17.65 -63.68 17.13 16.05 coo 57.63 101.19 59.83 56.60 100.89 57.99 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 61.58 95.88 55.22 58.18 99.30 54.71 -57.47 22.90 13.02 -52.58 24.12 11.55 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 12 3 # 12 B 48 LEU C 155 LEU~? 14.36 O3 GOL D1181 B 58 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 120 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 54.50 104.32 58.69 55.83 105.69 59.81 -46.93 -4.99 37.50 -48.50 -3.75 36.63 coo 57.63 101.19 59.83 56.60 100.89 57.99 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 61.58 95.88 55.22 58.18 99.30 54.71 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 13 3 # 13 B 48 LEU D 36 LEU~? 18.59 O3 GOL D1181 B 58 ASP D 144 ASP.? 22.37 O2 GOL D1181 B 120 LYS D 142 LYS.? 24.20 CH3 ACT A1182 coo 54.50 104.32 58.69 55.83 105.69 59.81 -25.97 -17.48 27.72 -25.71 -19.44 26.74 coo 57.63 101.19 59.83 56.60 100.89 57.99 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 61.58 95.88 55.22 58.18 99.30 54.71 -25.06 -24.88 17.65 -21.32 -22.55 15.38 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 14 3 # 14 B 48 LEU D 155 LEU~? 8.85 O2 GOL D1181 B 58 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 120 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 54.50 104.32 58.69 55.83 105.69 59.81 -43.78 -20.51 27.17 -42.15 -20.14 25.71 coo 57.63 101.19 59.83 56.60 100.89 57.99 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 61.58 95.88 55.22 58.18 99.30 54.71 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 15 3 # 15 B 48 LEU D 160 LEU~? 7.46 O3 GOL D1181 B 58 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 120 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 54.50 104.32 58.69 55.83 105.69 59.81 -41.83 -11.95 32.17 -43.38 -10.80 31.19 coo 57.63 101.19 59.83 56.60 100.89 57.99 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 61.58 95.88 55.22 58.18 99.30 54.71 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 15 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 55 ASP.? 17.41 O ACT A1181 A 68 ALA A 54 ALA^? 15.02 OXT ACT A1182 A 72 LEU A 62 LEU~? 11.91 OXT ACT A1182 coo 46.76 7.59 18.65 45.27 6.01 18.52 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 48.88 4.35 16.59 48.73 5.09 15.20 -38.22 13.01 8.71 -39.06 12.37 7.62 coo 53.89 6.25 15.09 52.88 7.92 14.14 -39.55 8.38 6.71 -38.08 7.45 8.12 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 95 ASP~? 18.75 OXT ACT A1182 A 68 ALA A 96 ALA~? 16.98 OXT ACT A1182 A 72 LEU A 100 LEU~? 15.28 CH3 ACT A1182 coo 46.76 7.59 18.65 45.27 6.01 18.52 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 48.88 4.35 16.59 48.73 5.09 15.20 -28.64 14.50 22.33 -28.62 15.76 21.46 coo 53.89 6.25 15.09 52.88 7.92 14.14 -24.18 12.19 19.74 -23.04 13.28 18.29 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 68 ALA B 54 ALA^? 14.74 O ACT C1183 A 72 LEU B 62 LEU~? 11.69 O ACT C1183 coo 46.76 7.59 18.65 45.27 6.01 18.52 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 48.88 4.35 16.59 48.73 5.09 15.20 -52.33 -0.83 -0.35 -51.49 0.42 -0.07 coo 53.89 6.25 15.09 52.88 7.92 14.14 -51.17 2.84 3.08 -52.53 1.95 4.64 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP B 95 ASP.? 16.79 O ACT C1183 A 68 ALA B 96 ALA.? 19.63 O ACT C1183 A 72 LEU B 98 LEU~? 16.43 O ACT C1183 coo 46.76 7.59 18.65 45.27 6.01 18.52 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 48.88 4.35 16.59 48.73 5.09 15.20 -62.34 -18.67 5.39 -62.96 -19.17 6.71 coo 53.89 6.25 15.09 52.88 7.92 14.14 -63.33 -15.45 9.54 -63.70 -17.43 10.36 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP C 55 ASP.? 19.45 CA CA C1184 A 68 ALA C 54 ALA^? 14.74 OXT ACT C1183 A 72 LEU C 62 LEU~? 11.74 OXT ACT C1183 coo 46.76 7.59 18.65 45.27 6.01 18.52 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 48.88 4.35 16.59 48.73 5.09 15.20 -52.34 0.82 26.82 -51.53 -0.42 26.55 coo 53.89 6.25 15.09 52.88 7.92 14.14 -51.11 -2.83 23.37 -52.52 -2.00 21.86 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP C 95 ASP~? 18.98 OXT ACT C1183 A 68 ALA C 96 ALA~? 16.84 OXT ACT C1183 A 72 LEU C 100 LEU~? 15.16 CH3 ACT C1183 coo 46.76 7.59 18.65 45.27 6.01 18.52 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 48.88 4.35 16.59 48.73 5.09 15.20 -62.09 13.83 23.14 -62.11 13.46 24.60 coo 53.89 6.25 15.09 52.88 7.92 14.14 -66.41 10.56 22.00 -67.73 9.48 23.31 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 7 3 # 7 A 67 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 68 ALA D 54 ALA^? 15.02 O ACT A1182 A 72 LEU D 62 LEU~? 11.93 O ACT A1182 coo 46.76 7.59 18.65 45.27 6.01 18.52 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 48.88 4.35 16.59 48.73 5.09 15.20 -38.21 -12.99 17.72 -39.03 -12.34 18.84 coo 53.89 6.25 15.09 52.88 7.92 14.14 -39.56 -8.35 19.75 -38.00 -7.51 18.39 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 7 hits 1q6l_c05 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER A 153 SER.? 8.36 O ACT A1181 A 310 GLU A 150 GLU.? 17.29 O ACT A1181 A 399 HIS A 151 HIS.? 15.84 O ACT A1181 coo 2.67 37.96 55.23 1.78 40.01 56.16 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 6.61 38.44 63.61 6.69 38.31 61.50 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 4.95 41.82 59.53 3.85 40.70 58.14 -46.06 27.03 4.30 -45.69 27.09 6.36 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 1 hits 1qe3_c00 naa= 3 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 1 3 # 1 A 554 SER A 53 SER^? 12.21 OXT ACT A1182 A 641 ASP A 55 ASP.? 17.41 O ACT A1181 A 680 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 34.48 40.33 79.08 36.40 39.98 80.55 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 40.64 47.22 77.43 39.90 45.49 78.43 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 38.53 44.50 81.45 37.60 42.73 80.84 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 2 3 # 2 A 554 SER B 53 SER^? 12.05 O ACT C1183 A 641 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 680 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 34.48 40.33 79.08 36.40 39.98 80.55 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 40.64 47.22 77.43 39.90 45.49 78.43 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 38.53 44.50 81.45 37.60 42.73 80.84 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 3 3 # 3 A 554 SER C 53 SER^? 12.05 OXT ACT C1183 A 641 ASP C 55 ASP.? 19.45 CA CA C1184 A 680 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 34.48 40.33 79.08 36.40 39.98 80.55 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 40.64 47.22 77.43 39.90 45.49 78.43 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 38.53 44.50 81.45 37.60 42.73 80.84 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 4 3 # 4 A 554 SER D 53 SER^? 12.18 O ACT A1182 A 641 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 680 HIS D 114 HIS^? 15.97 O ACT A1182 coo 34.48 40.33 79.08 36.40 39.98 80.55 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 40.64 47.22 77.43 39.90 45.49 78.43 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 38.53 44.50 81.45 37.60 42.73 80.84 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1qfm_c00 source 1qfm PROLYL OLIGOPEPTIDASE : 4 hits 1qfm_c00 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 236 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 55.45 46.76 42.08 57.34 46.16 42.75 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 48.87 29.19 44.63 49.10 27.34 43.63 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 47.58 17.35 41.83 51.40 20.85 40.83 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS B 59 HIS~? 15.18 O ACT C1183 A 236 ASP A 55 ASP.? 17.41 O ACT A1181 A 261 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 55.45 46.76 42.08 57.34 46.16 42.75 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 48.87 29.19 44.63 49.10 27.34 43.63 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 47.58 17.35 41.83 51.40 20.85 40.83 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 155 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 236 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 261 LYS D 124 LYS~? 24.78 O ACT A1182 coo 55.45 46.76 42.08 57.34 46.16 42.75 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 48.87 29.19 44.63 49.10 27.34 43.63 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 47.58 17.35 41.83 51.40 20.85 40.83 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 236 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS B 59 HIS~? 15.18 O ACT C1183 B 236 ASP A 55 ASP.? 17.41 O ACT A1181 B 261 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 155 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 236 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 261 LYS D 124 LYS~? 24.78 O ACT A1182 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 59 HIS~? 15.34 OXT ACT A1182 C 236 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 55.11 47.10 12.61 53.44 47.85 11.58 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 45.78 31.11 9.51 44.25 30.06 10.53 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 37.54 22.37 12.10 37.83 27.55 13.24 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS B 59 HIS~? 15.18 O ACT C1183 C 236 ASP A 55 ASP.? 17.41 O ACT A1181 C 261 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 55.11 47.10 12.61 53.44 47.85 11.58 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 45.78 31.11 9.51 44.25 30.06 10.53 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 37.54 22.37 12.10 37.83 27.55 13.24 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 155 HIS C 59 HIS~? 15.17 OXT ACT C1183 C 236 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 261 LYS D 124 LYS~? 24.78 O ACT A1182 coo 55.11 47.10 12.61 53.44 47.85 11.58 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 45.78 31.11 9.51 44.25 30.06 10.53 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 37.54 22.37 12.10 37.83 27.55 13.24 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 59 HIS~? 15.34 OXT ACT A1182 D 236 ASP B 55 ASP.? 14.29 O3 GOL B1182 D 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS B 59 HIS~? 15.18 O ACT C1183 D 236 ASP A 55 ASP.? 17.41 O ACT A1181 D 261 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 155 HIS C 59 HIS~? 15.17 OXT ACT C1183 D 236 ASP D 55 ASP.? 17.43 O2 GOL D1181 D 261 LYS D 124 LYS~? 24.78 O ACT A1182 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 59 HIS~? 15.34 OXT ACT A1182 E 236 ASP B 55 ASP.? 14.29 O3 GOL B1182 E 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS B 59 HIS~? 15.18 O ACT C1183 E 236 ASP A 55 ASP.? 17.41 O ACT A1181 E 261 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 155 HIS C 59 HIS~? 15.17 OXT ACT C1183 E 236 ASP D 55 ASP.? 17.43 O2 GOL D1181 E 261 LYS D 124 LYS~? 24.78 O ACT A1182 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 59 HIS~? 15.34 OXT ACT A1182 F 236 ASP B 55 ASP.? 14.29 O3 GOL B1182 F 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS B 59 HIS~? 15.18 O ACT C1183 F 236 ASP A 55 ASP.? 17.41 O ACT A1181 F 261 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 155 HIS C 59 HIS~? 15.17 OXT ACT C1183 F 236 ASP D 55 ASP.? 17.43 O2 GOL D1181 F 261 LYS D 124 LYS~? 24.78 O ACT A1182 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 59 HIS~? 15.34 OXT ACT A1182 G 236 ASP B 55 ASP.? 14.29 O3 GOL B1182 G 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS B 59 HIS~? 15.18 O ACT C1183 G 236 ASP A 55 ASP.? 17.41 O ACT A1181 G 261 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 155 HIS C 59 HIS~? 15.17 OXT ACT C1183 G 236 ASP D 55 ASP.? 17.43 O2 GOL D1181 G 261 LYS D 124 LYS~? 24.78 O ACT A1182 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 59 HIS~? 15.34 OXT ACT A1182 H 236 ASP B 55 ASP.? 14.29 O3 GOL B1182 H 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS B 59 HIS~? 15.18 O ACT C1183 H 236 ASP A 55 ASP.? 17.41 O ACT A1181 H 261 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 155 HIS C 59 HIS~? 15.17 OXT ACT C1183 H 236 ASP D 55 ASP.? 17.43 O2 GOL D1181 H 261 LYS D 124 LYS~? 24.78 O ACT A1182 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 5 TYR~? 13.40 O1 GOL B1182 A 236 ASP A 6 ASP~? 16.17 CA CA B1181 A 261 LYS B 177 LYS.? 12.69 CA CA B1181 coo 55.48 26.51 40.65 55.39 23.99 39.43 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 48.87 29.19 44.63 49.10 27.34 43.63 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 47.58 17.35 41.83 51.40 20.85 40.83 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 236 ASP A 156 ASP~? 10.59 O ACT A1181 A 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 55.48 26.51 40.65 55.39 23.99 39.43 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 48.87 29.19 44.63 49.10 27.34 43.63 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 47.58 17.35 41.83 51.40 20.85 40.83 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 55.48 26.51 40.65 55.39 23.99 39.43 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 47.58 17.35 41.83 51.40 20.85 40.83 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 236 ASP A 156 ASP~? 10.59 O ACT A1181 A 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 55.48 26.51 40.65 55.39 23.99 39.43 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 48.87 29.19 44.63 49.10 27.34 43.63 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 47.58 17.35 41.83 51.40 20.85 40.83 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 55.48 26.51 40.65 55.39 23.99 39.43 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 47.58 17.35 41.83 51.40 20.85 40.83 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR B 91 TYR.? 11.41 O ACT C1183 A 236 ASP B 95 ASP.? 16.79 O ACT C1183 A 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 55.48 26.51 40.65 55.39 23.99 39.43 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 48.87 29.19 44.63 49.10 27.34 43.63 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 47.58 17.35 41.83 51.40 20.85 40.83 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 55.48 26.51 40.65 55.39 23.99 39.43 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 47.58 17.35 41.83 51.40 20.85 40.83 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 55.48 26.51 40.65 55.39 23.99 39.43 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 48.87 29.19 44.63 49.10 27.34 43.63 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 47.58 17.35 41.83 51.40 20.85 40.83 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR D 5 TYR~? 13.80 CA CA C1181 A 236 ASP D 6 ASP~? 16.12 CA CA C1181 A 261 LYS C 177 LYS.? 13.52 CA CA C1181 coo 55.48 26.51 40.65 55.39 23.99 39.43 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 48.87 29.19 44.63 49.10 27.34 43.63 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 47.58 17.35 41.83 51.40 20.85 40.83 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 55.48 26.51 40.65 55.39 23.99 39.43 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 47.58 17.35 41.83 51.40 20.85 40.83 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 55.48 26.51 40.65 55.39 23.99 39.43 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 48.87 29.19 44.63 49.10 27.34 43.63 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 47.58 17.35 41.83 51.40 20.85 40.83 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 5 TYR~? 13.40 O1 GOL B1182 B 236 ASP A 6 ASP~? 16.17 CA CA B1181 B 261 LYS B 177 LYS.? 12.69 CA CA B1181 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 B 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 B 236 ASP A 156 ASP~? 10.59 O ACT A1181 B 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 91 TYR.? 11.41 O ACT C1183 B 236 ASP B 95 ASP.? 16.79 O ACT C1183 B 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 B 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR D 5 TYR~? 13.80 CA CA C1181 B 236 ASP D 6 ASP~? 16.12 CA CA C1181 B 261 LYS C 177 LYS.? 13.52 CA CA C1181 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 B 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -40.69 -17.70 31.92 -41.11 -24.00 32.63 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 5 TYR~? 13.40 O1 GOL B1182 C 236 ASP A 6 ASP~? 16.17 CA CA B1181 C 261 LYS B 177 LYS.? 12.69 CA CA B1181 coo 39.51 34.34 13.63 37.63 32.61 14.79 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 45.78 31.11 9.51 44.25 30.06 10.53 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 37.54 22.37 12.10 37.83 27.55 13.24 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 C 236 ASP A 156 ASP~? 10.59 O ACT A1181 C 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 39.51 34.34 13.63 37.63 32.61 14.79 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 45.78 31.11 9.51 44.25 30.06 10.53 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 37.54 22.37 12.10 37.83 27.55 13.24 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 C 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 39.51 34.34 13.63 37.63 32.61 14.79 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 37.54 22.37 12.10 37.83 27.55 13.24 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 C 236 ASP A 156 ASP~? 10.59 O ACT A1181 C 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 39.51 34.34 13.63 37.63 32.61 14.79 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 45.78 31.11 9.51 44.25 30.06 10.53 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 37.54 22.37 12.10 37.83 27.55 13.24 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 C 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 39.51 34.34 13.63 37.63 32.61 14.79 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 37.54 22.37 12.10 37.83 27.55 13.24 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 163 TYR B 91 TYR.? 11.41 O ACT C1183 C 236 ASP B 95 ASP.? 16.79 O ACT C1183 C 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 39.51 34.34 13.63 37.63 32.61 14.79 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 45.78 31.11 9.51 44.25 30.06 10.53 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 37.54 22.37 12.10 37.83 27.55 13.24 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 C 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 39.51 34.34 13.63 37.63 32.61 14.79 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 37.54 22.37 12.10 37.83 27.55 13.24 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 C 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 39.51 34.34 13.63 37.63 32.61 14.79 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 45.78 31.11 9.51 44.25 30.06 10.53 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 37.54 22.37 12.10 37.83 27.55 13.24 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 C 163 TYR D 5 TYR~? 13.80 CA CA C1181 C 236 ASP D 6 ASP~? 16.12 CA CA C1181 C 261 LYS C 177 LYS.? 13.52 CA CA C1181 coo 39.51 34.34 13.63 37.63 32.61 14.79 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 45.78 31.11 9.51 44.25 30.06 10.53 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 37.54 22.37 12.10 37.83 27.55 13.24 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 C 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 C 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 39.51 34.34 13.63 37.63 32.61 14.79 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 37.54 22.37 12.10 37.83 27.55 13.24 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 C 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 C 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 39.51 34.34 13.63 37.63 32.61 14.79 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 45.78 31.11 9.51 44.25 30.06 10.53 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 37.54 22.37 12.10 37.83 27.55 13.24 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 5 TYR~? 13.40 O1 GOL B1182 D 236 ASP A 6 ASP~? 16.17 CA CA B1181 D 261 LYS B 177 LYS.? 12.69 CA CA B1181 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 D 236 ASP A 156 ASP~? 10.59 O ACT A1181 D 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 D 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 D 236 ASP A 156 ASP~? 10.59 O ACT A1181 D 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 D 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 163 TYR B 91 TYR.? 11.41 O ACT C1183 D 236 ASP B 95 ASP.? 16.79 O ACT C1183 D 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 D 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 D 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 D 163 TYR D 5 TYR~? 13.80 CA CA C1181 D 236 ASP D 6 ASP~? 16.12 CA CA C1181 D 261 LYS C 177 LYS.? 13.52 CA CA C1181 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 D 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 D 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 D 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 D 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 5 TYR~? 13.40 O1 GOL B1182 E 236 ASP A 6 ASP~? 16.17 CA CA B1181 E 261 LYS B 177 LYS.? 12.69 CA CA B1181 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 E 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 E 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 E 236 ASP A 156 ASP~? 10.59 O ACT A1181 E 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 91 TYR.? 11.41 O ACT C1183 E 236 ASP B 95 ASP.? 16.79 O ACT C1183 E 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 E 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 E 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR D 5 TYR~? 13.80 CA CA C1181 E 236 ASP D 6 ASP~? 16.12 CA CA C1181 E 261 LYS C 177 LYS.? 13.52 CA CA C1181 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 E 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 E 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -40.69 -17.70 31.92 -41.11 -24.00 32.63 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 5 TYR~? 13.40 O1 GOL B1182 F 236 ASP A 6 ASP~? 16.17 CA CA B1181 F 261 LYS B 177 LYS.? 12.69 CA CA B1181 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 F 236 ASP A 156 ASP~? 10.59 O ACT A1181 F 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 F 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 F 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 F 236 ASP A 156 ASP~? 10.59 O ACT A1181 F 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 F 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 F 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR B 91 TYR.? 11.41 O ACT C1183 F 236 ASP B 95 ASP.? 16.79 O ACT C1183 F 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 F 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 F 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 F 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 F 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR D 5 TYR~? 13.80 CA CA C1181 F 236 ASP D 6 ASP~? 16.12 CA CA C1181 F 261 LYS C 177 LYS.? 13.52 CA CA C1181 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 F 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 F 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 F 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 F 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 5 TYR~? 13.40 O1 GOL B1182 G 236 ASP A 6 ASP~? 16.17 CA CA B1181 G 261 LYS B 177 LYS.? 12.69 CA CA B1181 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 G 236 ASP A 156 ASP~? 10.59 O ACT A1181 G 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 G 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 G 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 G 236 ASP A 156 ASP~? 10.59 O ACT A1181 G 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 G 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 G 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 163 TYR B 91 TYR.? 11.41 O ACT C1183 G 236 ASP B 95 ASP.? 16.79 O ACT C1183 G 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 G 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 G 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 G 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 G 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 G 163 TYR D 5 TYR~? 13.80 CA CA C1181 G 236 ASP D 6 ASP~? 16.12 CA CA C1181 G 261 LYS C 177 LYS.? 13.52 CA CA C1181 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 G 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 G 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 G 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 G 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 G 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 G 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -50.05 -10.42 36.79 -49.63 -8.70 42.89 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 5 TYR~? 13.40 O1 GOL B1182 H 236 ASP A 6 ASP~? 16.17 CA CA B1181 H 261 LYS B 177 LYS.? 12.69 CA CA B1181 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 H 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 H 261 LYS A 158 LYS~? -4.64 O ACT A1181s coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 H 236 ASP A 156 ASP~? 10.59 O ACT A1181 H 261 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 163 TYR B 91 TYR.? 11.41 O ACT C1183 H 236 ASP B 95 ASP.? 16.79 O ACT C1183 H 261 LYS B 124 LYS~? 15.51 CA CA B1183 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 H 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 H 261 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 163 TYR D 5 TYR~? 13.80 CA CA C1181 H 236 ASP D 6 ASP~? 16.12 CA CA C1181 H 261 LYS C 177 LYS.? 13.52 CA CA C1181 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 H 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 H 261 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -40.69 -17.70 31.92 -41.11 -24.00 32.63 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 7 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 30 ARG.? 15.23 O ACT A1181 C 163 TYR A 33 TYR~? 13.22 O ACT A1181 C 236 ASP A 144 ASP.? 22.46 O ACT A1181 coo 39.01 29.77 22.02 37.48 31.30 19.84 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo 39.51 34.34 13.63 37.63 32.61 14.79 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 45.78 31.11 9.51 44.25 30.06 10.53 -24.09 23.13 1.13 -22.88 24.73 0.42 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 58 ARG~? 14.46 O ACT A1181 C 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 C 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 39.01 29.77 22.02 37.48 31.30 19.84 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 39.51 34.34 13.63 37.63 32.61 14.79 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG A 58 ARG~? 14.46 O ACT A1181 C 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 C 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 39.01 29.77 22.02 37.48 31.30 19.84 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 39.51 34.34 13.63 37.63 32.61 14.79 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 C 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 C 236 ASP A 156 ASP~? 10.59 O ACT A1181 coo 39.01 29.77 22.02 37.48 31.30 19.84 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 39.51 34.34 13.63 37.63 32.61 14.79 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 45.78 31.11 9.51 44.25 30.06 10.53 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 C 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 C 236 ASP A 156 ASP~? 10.59 O ACT A1181 coo 39.01 29.77 22.02 37.48 31.30 19.84 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 39.51 34.34 13.63 37.63 32.61 14.79 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 45.78 31.11 9.51 44.25 30.06 10.53 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 110 ARG C 58 ARG~? 18.42 O3 GOL D1181 C 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 C 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 39.01 29.77 22.02 37.48 31.30 19.84 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 39.51 34.34 13.63 37.63 32.61 14.79 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 45.78 31.11 9.51 44.25 30.06 10.53 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 110 ARG D 30 ARG.? 11.01 CA CA C1182 C 163 TYR D 33 TYR~? 12.91 O3 GOL D1181 C 236 ASP D 144 ASP.? 22.37 O2 GOL D1181 coo 39.01 29.77 22.02 37.48 31.30 19.84 -29.54 -28.66 35.64 -30.45 -28.64 38.59 coo 39.51 34.34 13.63 37.63 32.61 14.79 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 45.78 31.11 9.51 44.25 30.06 10.53 -24.08 -23.14 25.44 -22.85 -24.74 26.11 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 C 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 C 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 39.01 29.77 22.02 37.48 31.30 19.84 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 39.51 34.34 13.63 37.63 32.61 14.79 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 C 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 C 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 39.01 29.77 22.02 37.48 31.30 19.84 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 39.51 34.34 13.63 37.63 32.61 14.79 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 45.78 31.11 9.51 44.25 30.06 10.53 -44.46 -7.83 33.81 -43.76 -5.84 33.54 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 30 ARG.? 15.23 O ACT A1181 D 163 TYR A 33 TYR~? 13.22 O ACT A1181 D 236 ASP A 144 ASP.? 22.46 O ACT A1181 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -24.09 23.13 1.13 -22.88 24.73 0.42 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 58 ARG~? 14.46 O ACT A1181 D 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 D 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG A 58 ARG~? 14.46 O ACT A1181 D 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 D 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 D 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 D 236 ASP A 156 ASP~? 10.59 O ACT A1181 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 D 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 D 236 ASP A 156 ASP~? 10.59 O ACT A1181 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 110 ARG C 58 ARG~? 18.42 O3 GOL D1181 D 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 D 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 110 ARG D 30 ARG.? 11.01 CA CA C1182 D 163 TYR D 33 TYR~? 12.91 O3 GOL D1181 D 236 ASP D 144 ASP.? 22.37 O2 GOL D1181 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -29.54 -28.66 35.64 -30.45 -28.64 38.59 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -24.08 -23.14 25.44 -22.85 -24.74 26.11 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 D 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 D 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 D 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 D 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -44.46 -7.83 33.81 -43.76 -5.84 33.54 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 33 TYR~? 13.22 O ACT A1181 A 236 ASP A 144 ASP.? 22.46 O ACT A1181 C 110 ARG A 30 ARG.? 15.23 O ACT A1181 coo 55.48 26.51 40.65 55.39 23.99 39.43 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 48.87 29.19 44.63 49.10 27.34 43.63 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 52.39 23.42 32.10 54.51 23.27 34.29 -29.59 28.63 -9.22 -30.43 28.64 -12.20 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 236 ASP A 156 ASP~? 10.59 O ACT A1181 C 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 55.48 26.51 40.65 55.39 23.99 39.43 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 48.87 29.19 44.63 49.10 27.34 43.63 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 52.39 23.42 32.10 54.51 23.27 34.29 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 110 ARG A 58 ARG~? 14.46 O ACT A1181 coo 55.48 26.51 40.65 55.39 23.99 39.43 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 52.39 23.42 32.10 54.51 23.27 34.29 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 236 ASP A 156 ASP~? 10.59 O ACT A1181 C 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 55.48 26.51 40.65 55.39 23.99 39.43 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 48.87 29.19 44.63 49.10 27.34 43.63 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 52.39 23.42 32.10 54.51 23.27 34.29 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 110 ARG A 58 ARG~? 14.46 O ACT A1181 coo 55.48 26.51 40.65 55.39 23.99 39.43 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 52.39 23.42 32.10 54.51 23.27 34.29 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 55.48 26.51 40.65 55.39 23.99 39.43 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 52.39 23.42 32.10 54.51 23.27 34.29 -43.20 -16.00 21.95 -43.92 -18.81 20.94 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR D 33 TYR~? 12.91 O3 GOL D1181 A 236 ASP D 144 ASP.? 22.37 O2 GOL D1181 C 110 ARG D 30 ARG.? 11.01 CA CA C1182 coo 55.48 26.51 40.65 55.39 23.99 39.43 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 48.87 29.19 44.63 49.10 27.34 43.63 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 52.39 23.42 32.10 54.51 23.27 34.29 -29.54 -28.66 35.64 -30.45 -28.64 38.59 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 55.48 26.51 40.65 55.39 23.99 39.43 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 48.87 29.19 44.63 49.10 27.34 43.63 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 52.39 23.42 32.10 54.51 23.27 34.29 -43.20 -16.00 21.95 -43.92 -18.81 20.94 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 110 ARG C 58 ARG~? 18.42 O3 GOL D1181 coo 55.48 26.51 40.65 55.39 23.99 39.43 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 48.87 29.19 44.63 49.10 27.34 43.63 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 52.39 23.42 32.10 54.51 23.27 34.29 -48.43 -0.71 31.25 -46.65 0.17 33.60 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 33 TYR~? 13.22 O ACT A1181 B 236 ASP A 144 ASP.? 22.46 O ACT A1181 D 110 ARG A 30 ARG.? 15.23 O ACT A1181 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -29.59 28.63 -9.22 -30.43 28.64 -12.20 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 B 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 110 ARG A 58 ARG~? 14.46 O ACT A1181 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 B 236 ASP A 156 ASP~? 10.59 O ACT A1181 D 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR D 33 TYR~? 12.91 O3 GOL D1181 B 236 ASP D 144 ASP.? 22.37 O2 GOL D1181 D 110 ARG D 30 ARG.? 11.01 CA CA C1182 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -29.54 -28.66 35.64 -30.45 -28.64 38.59 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 B 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -43.20 -16.00 21.95 -43.92 -18.81 20.94 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 30 ARG.? 15.23 O ACT A1181 G 163 TYR A 33 TYR~? 13.22 O ACT A1181 G 236 ASP A 144 ASP.? 22.46 O ACT A1181 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -24.09 23.13 1.13 -22.88 24.73 0.42 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 58 ARG~? 14.46 O ACT A1181 G 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 G 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG A 58 ARG~? 14.46 O ACT A1181 G 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 G 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 G 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 G 236 ASP A 156 ASP~? 10.59 O ACT A1181 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 G 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 G 236 ASP A 156 ASP~? 10.59 O ACT A1181 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 110 ARG C 58 ARG~? 18.42 O3 GOL D1181 G 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 G 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 110 ARG D 30 ARG.? 11.01 CA CA C1182 G 163 TYR D 33 TYR~? 12.91 O3 GOL D1181 G 236 ASP D 144 ASP.? 22.37 O2 GOL D1181 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -29.54 -28.66 35.64 -30.45 -28.64 38.59 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -24.08 -23.14 25.44 -22.85 -24.74 26.11 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 G 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 G 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 G 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 G 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -44.46 -7.83 33.81 -43.76 -5.84 33.54 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 30 ARG.? 15.23 O ACT A1181 H 163 TYR A 33 TYR~? 13.22 O ACT A1181 H 236 ASP A 144 ASP.? 22.46 O ACT A1181 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -24.09 23.13 1.13 -22.88 24.73 0.42 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG A 58 ARG~? 14.46 O ACT A1181 H 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 H 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 H 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 H 236 ASP A 156 ASP~? 10.59 O ACT A1181 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG D 30 ARG.? 11.01 CA CA C1182 H 163 TYR D 33 TYR~? 12.91 O3 GOL D1181 H 236 ASP D 144 ASP.? 22.37 O2 GOL D1181 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -29.54 -28.66 35.64 -30.45 -28.64 38.59 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -24.08 -23.14 25.44 -22.85 -24.74 26.11 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 H 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 H 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -44.46 -7.83 33.81 -43.76 -5.84 33.54 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 33 TYR~? 13.22 O ACT A1181 E 236 ASP A 144 ASP.? 22.46 O ACT A1181 G 110 ARG A 30 ARG.? 15.23 O ACT A1181 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -29.59 28.63 -9.22 -30.43 28.64 -12.20 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 E 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 G 110 ARG A 58 ARG~? 14.46 O ACT A1181 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 E 236 ASP A 156 ASP~? 10.59 O ACT A1181 G 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR D 33 TYR~? 12.91 O3 GOL D1181 E 236 ASP D 144 ASP.? 22.37 O2 GOL D1181 G 110 ARG D 30 ARG.? 11.01 CA CA C1182 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -29.54 -28.66 35.64 -30.45 -28.64 38.59 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 E 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 G 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -43.20 -16.00 21.95 -43.92 -18.81 20.94 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 33 TYR~? 13.22 O ACT A1181 F 236 ASP A 144 ASP.? 22.46 O ACT A1181 H 110 ARG A 30 ARG.? 15.23 O ACT A1181 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -29.59 28.63 -9.22 -30.43 28.64 -12.20 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 F 236 ASP A 156 ASP~? 10.59 O ACT A1181 H 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 64 TYR~? 13.66 OXT ACT A1181 F 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 H 110 ARG A 58 ARG~? 14.46 O ACT A1181 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 F 236 ASP A 156 ASP~? 10.59 O ACT A1181 H 110 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR B 64 TYR~? 13.94 OXT ACT A1181 F 236 ASP B 156 ASP~? 13.25 OXT ACT A1181 H 110 ARG A 58 ARG~? 14.46 O ACT A1181 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR C 64 TYR~? 13.24 O3 GOL D1181 F 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 H 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -43.20 -16.00 21.95 -43.92 -18.81 20.94 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR D 33 TYR~? 12.91 O3 GOL D1181 F 236 ASP D 144 ASP.? 22.37 O2 GOL D1181 H 110 ARG D 30 ARG.? 11.01 CA CA C1182 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -29.54 -28.66 35.64 -30.45 -28.64 38.59 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 F 236 ASP C 156 ASP~? 12.06 O3 GOL D1181 H 110 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -43.20 -16.00 21.95 -43.92 -18.81 20.94 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR D 64 TYR~? 12.19 O3 GOL D1181 F 236 ASP D 156 ASP~? 10.44 C2 GOL D1181 H 110 ARG C 58 ARG~? 18.42 O3 GOL D1181 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -48.43 -0.71 31.25 -46.65 0.17 33.60 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 73 ASP.? 22.06 O ACT A1182 A 261 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 329 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 28.46 69.88 26.74 30.40 70.70 26.53 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 34.02 79.89 42.60 34.73 78.01 41.86 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 37.87 70.12 31.80 36.61 69.74 30.15 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 156 ASP~? 10.59 O ACT A1181 A 261 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 329 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 28.46 69.88 26.74 30.40 70.70 26.53 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 34.02 79.89 42.60 34.73 78.01 41.86 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 84 ASP^? 7.80 O ACT C1183 A 261 ASP C 55 ASP.? 19.45 CA CA C1184 A 329 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 28.46 69.88 26.74 30.40 70.70 26.53 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 34.02 79.89 42.60 34.73 78.01 41.86 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 37.87 70.12 31.80 36.61 69.74 30.15 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 261 ASP A 55 ASP.? 17.41 O ACT A1181 A 329 ASP A 156 ASP~? 10.59 O ACT A1181 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 34.02 79.89 42.60 34.73 78.01 41.86 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 261 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 329 ASP B 84 ASP^? 7.80 O ACT C1183 coo 28.46 69.88 26.74 30.40 70.70 26.53 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 34.02 79.89 42.60 34.73 78.01 41.86 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 37.87 70.12 31.80 36.61 69.74 30.15 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 261 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 329 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 28.46 69.88 26.74 30.40 70.70 26.53 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 34.02 79.89 42.60 34.73 78.01 41.86 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP D 73 ASP.? 21.98 OXT ACT A1182 A 261 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 329 ASP C 55 ASP.? 19.45 CA CA C1184 coo 28.46 69.88 26.74 30.40 70.70 26.53 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 34.02 79.89 42.60 34.73 78.01 41.86 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 37.87 70.12 31.80 36.61 69.74 30.15 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 261 ASP C 55 ASP.? 19.45 CA CA C1184 A 329 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 28.46 69.88 26.74 30.40 70.70 26.53 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 34.02 79.89 42.60 34.73 78.01 41.86 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.46 -7.83 33.81 -43.76 -5.84 33.54 1qho_c05 source 1qho ALPHA-AMYLASE : 8 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 73 ASP.? 22.06 O ACT A1182 A 260 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 329 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 28.46 69.88 26.74 30.40 70.70 26.53 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 30.73 81.29 37.61 31.23 82.07 35.69 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 37.87 70.12 31.80 36.61 69.74 30.15 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 152 ASP.? 5.90 O ACT A1181 A 260 ASP A 55 ASP.? 17.41 O ACT A1181 A 329 ASP A 156 ASP~? 10.59 O ACT A1181 coo 28.46 69.88 26.74 30.40 70.70 26.53 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 30.73 81.29 37.61 31.23 82.07 35.69 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 260 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 329 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 28.46 69.88 26.74 30.40 70.70 26.53 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 30.73 81.29 37.61 31.23 82.07 35.69 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 260 ASP C 55 ASP.? 19.45 CA CA C1184 A 329 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 28.46 69.88 26.74 30.40 70.70 26.53 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 30.73 81.29 37.61 31.23 82.07 35.69 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 37.87 70.12 31.80 36.61 69.74 30.15 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP D 73 ASP.? 21.98 OXT ACT A1182 A 260 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 329 ASP C 55 ASP.? 19.45 CA CA C1184 coo 28.46 69.88 26.74 30.40 70.70 26.53 -38.49 8.41 31.97 -37.49 9.71 33.33 coo 30.73 81.29 37.61 31.23 82.07 35.69 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 260 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 329 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 28.46 69.88 26.74 30.40 70.70 26.53 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 30.73 81.29 37.61 31.23 82.07 35.69 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1qho_c07 source 1qho ALPHA-AMYLASE : 6 hits 1qho_c07 naa= 3 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 53 SER^? 12.21 OXT ACT A1182 A 207 ASP A 55 ASP.? 17.41 O ACT A1181 A 235 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 15.54 46.73 17.13 17.06 48.44 16.17 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 23.60 50.31 20.82 21.66 50.51 20.06 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 20.17 51.16 17.08 18.31 50.28 17.44 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER B 53 SER^? 12.05 O ACT C1183 A 207 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 235 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 15.54 46.73 17.13 17.06 48.44 16.17 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 23.60 50.31 20.82 21.66 50.51 20.06 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 20.17 51.16 17.08 18.31 50.28 17.44 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 3 3 # 3 A 80 SER C 53 SER^? 12.05 OXT ACT C1183 A 207 ASP C 55 ASP.? 19.45 CA CA C1184 A 235 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 15.54 46.73 17.13 17.06 48.44 16.17 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 23.60 50.31 20.82 21.66 50.51 20.06 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 20.17 51.16 17.08 18.31 50.28 17.44 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 4 3 # 4 A 80 SER D 53 SER^? 12.18 O ACT A1182 A 207 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 235 HIS D 114 HIS^? 15.97 O ACT A1182 coo 15.54 46.73 17.13 17.06 48.44 16.17 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 23.60 50.31 20.82 21.66 50.51 20.06 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 20.17 51.16 17.08 18.31 50.28 17.44 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1qj4_c00 source 1qj4 HYDROXYNITRILE LYASE : 4 hits 1qj4_c00 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA D 54 ALA^? 15.02 O ACT A1182 A 148 HIS D 59 HIS~? 14.28 O ACT A1182 A 163 ASP D 84 ASP^? 8.02 O ACT A1182 coo 1.42 19.18 21.84 1.11 19.57 23.28 -38.21 -12.99 17.72 -39.03 -12.34 18.84 coo 0.71 19.67 27.92 2.43 19.16 26.83 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 7.15 16.22 27.50 6.15 18.00 27.94 -36.44 -3.37 16.46 -38.06 -4.61 15.80 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA D 54 ALA^? 15.02 O ACT A1182 B 148 HIS D 59 HIS~? 14.28 O ACT A1182 B 163 ASP D 84 ASP^? 8.02 O ACT A1182 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -38.21 -12.99 17.72 -39.03 -12.34 18.84 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -36.44 -3.37 16.46 -38.06 -4.61 15.80 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA D 54 ALA^? 15.02 O ACT A1182 C 148 HIS D 59 HIS~? 14.28 O ACT A1182 C 163 ASP D 84 ASP^? 8.02 O ACT A1182 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -38.21 -12.99 17.72 -39.03 -12.34 18.84 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -36.44 -3.37 16.46 -38.06 -4.61 15.80 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA D 54 ALA^? 15.02 O ACT A1182 D 148 HIS D 59 HIS~? 14.28 O ACT A1182 D 163 ASP D 84 ASP^? 8.02 O ACT A1182 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -38.21 -12.99 17.72 -39.03 -12.34 18.84 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -36.44 -3.37 16.46 -38.06 -4.61 15.80 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c03 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA D 54 ALA^? 15.02 O ACT A1182 F 148 HIS D 59 HIS~? 14.28 O ACT A1182 F 163 ASP D 84 ASP^? 8.02 O ACT A1182 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -38.21 -12.99 17.72 -39.03 -12.34 18.84 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -36.44 -3.37 16.46 -38.06 -4.61 15.80 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c05 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA D 54 ALA^? 15.02 O ACT A1182 H 148 HIS D 59 HIS~? 14.28 O ACT A1182 H 163 ASP D 84 ASP^? 8.02 O ACT A1182 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -38.21 -12.99 17.72 -39.03 -12.34 18.84 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -36.44 -3.37 16.46 -38.06 -4.61 15.80 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c07 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 646 ASP A 55 ASP.? 17.41 O ACT A1181 A 741 SER B 67 SER~? 15.74 OXT ACT C1183 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -51.74 11.42 7.51 -49.69 11.53 6.21 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS B 59 HIS~? 15.18 O ACT C1183 A 646 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 741 SER A 67 SER~? 15.83 O ACT A1182 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -39.02 0.91 0.50 -41.06 2.13 -0.03 ULMN 3 1qrz_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 646 ASP C 55 ASP.? 19.45 CA CA C1184 A 741 SER D 67 SER~? 15.83 OXT ACT A1182 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -46.89 1.05 23.56 -47.29 3.11 23.40 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -39.02 -0.93 25.94 -41.07 -2.17 26.53 ULMN 3 1qrz_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS D 59 HIS~? 14.28 O ACT A1182 A 646 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 741 SER C 67 SER~? 15.70 O ACT C1183 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -51.74 -11.42 18.94 -49.72 -11.51 20.26 1qrz_c12 source 1qrz PLASMINOGEN : 4 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 646 ASP A 55 ASP.? 17.41 O ACT A1181 B 741 SER B 67 SER~? 15.74 OXT ACT C1183 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -51.74 11.42 7.51 -49.69 11.53 6.21 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 59 HIS~? 15.18 O ACT C1183 B 646 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 741 SER A 67 SER~? 15.83 O ACT A1182 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -39.02 0.91 0.50 -41.06 2.13 -0.03 ULMN 3 1qrz_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 646 ASP C 55 ASP.? 19.45 CA CA C1184 B 741 SER D 67 SER~? 15.83 OXT ACT A1182 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -46.89 1.05 23.56 -47.29 3.11 23.40 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -39.02 -0.93 25.94 -41.07 -2.17 26.53 ULMN 3 1qrz_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS D 59 HIS~? 14.28 O ACT A1182 B 646 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 741 SER C 67 SER~? 15.70 O ACT C1183 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -51.74 -11.42 18.94 -49.72 -11.51 20.26 1qrz_c13 source 1qrz PLASMINOGEN : 4 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 59 HIS~? 15.34 OXT ACT A1182 C 646 ASP A 55 ASP.? 17.41 O ACT A1181 C 741 SER B 67 SER~? 15.74 OXT ACT C1183 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -51.74 11.42 7.51 -49.69 11.53 6.21 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS B 59 HIS~? 15.18 O ACT C1183 C 646 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 741 SER A 67 SER~? 15.83 O ACT A1182 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -39.02 0.91 0.50 -41.06 2.13 -0.03 ULMN 3 1qrz_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS C 59 HIS~? 15.17 OXT ACT C1183 C 646 ASP C 55 ASP.? 19.45 CA CA C1184 C 741 SER D 67 SER~? 15.83 OXT ACT A1182 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -39.02 -0.93 25.94 -41.07 -2.17 26.53 ULMN 3 1qrz_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS D 59 HIS~? 14.28 O ACT A1182 C 646 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 741 SER C 67 SER~? 15.70 O ACT C1183 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -51.74 -11.42 18.94 -49.72 -11.51 20.26 1qrz_c14 source 1qrz PLASMINOGEN : 4 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 59 HIS~? 15.34 OXT ACT A1182 D 646 ASP A 55 ASP.? 17.41 O ACT A1181 D 741 SER B 67 SER~? 15.74 OXT ACT C1183 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -51.74 11.42 7.51 -49.69 11.53 6.21 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS B 59 HIS~? 15.18 O ACT C1183 D 646 ASP B 55 ASP.? 14.29 O3 GOL B1182 D 741 SER A 67 SER~? 15.83 O ACT A1182 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -39.02 0.91 0.50 -41.06 2.13 -0.03 ULMN 3 1qrz_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS C 59 HIS~? 15.17 OXT ACT C1183 D 646 ASP C 55 ASP.? 19.45 CA CA C1184 D 741 SER D 67 SER~? 15.83 OXT ACT A1182 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -46.89 1.05 23.56 -47.29 3.11 23.40 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -39.02 -0.93 25.94 -41.07 -2.17 26.53 ULMN 3 1qrz_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS D 59 HIS~? 14.28 O ACT A1182 D 646 ASP D 55 ASP.? 17.43 O2 GOL D1181 D 741 SER C 67 SER~? 15.70 O ACT C1183 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -51.74 -11.42 18.94 -49.72 -11.51 20.26 1qrz_c15 source 1qrz PLASMINOGEN : 4 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS D 59 HIS~? 14.28 O ACT A1182 A 646 ASP D 84 ASP^? 8.02 O ACT A1182 A 739 GLY D 116 GLY.? 16.41 O2 GOL D1181 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -38.19 -18.52 19.73 -37.45 -18.49 19.35 1qrz_c20 source 1qrz PLASMINOGEN : 1 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS D 59 HIS~? 14.28 O ACT A1182 B 646 ASP D 84 ASP^? 8.02 O ACT A1182 B 739 GLY D 116 GLY.? 16.41 O2 GOL D1181 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -38.19 -18.52 19.73 -37.45 -18.49 19.35 1qrz_c21 source 1qrz PLASMINOGEN : 1 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS D 59 HIS~? 14.28 O ACT A1182 C 646 ASP D 84 ASP^? 8.02 O ACT A1182 C 739 GLY D 116 GLY.? 16.41 O2 GOL D1181 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 7.82 1.25 3.03 7.30 1.31 3.65 -38.19 -18.52 19.73 -37.45 -18.49 19.35 1qrz_c22 source 1qrz PLASMINOGEN : 1 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS D 59 HIS~? 14.28 O ACT A1182 D 646 ASP D 84 ASP^? 8.02 O ACT A1182 D 739 GLY D 116 GLY.? 16.41 O2 GOL D1181 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -38.19 -18.52 19.73 -37.45 -18.49 19.35 1qrz_c23 source 1qrz PLASMINOGEN : 1 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 11 PHE~? 14.32 C1 GOL B1182 A 201 ASP A 14 ASP~? 14.99 CH3 ACT A1181 A 227 LYS A 2 LYS^? 14.71 CA CA B1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 25.52 45.12 37.98 23.98 46.65 37.85 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 12.68 46.83 36.69 18.26 48.67 34.51 -70.83 25.29 -8.78 -66.22 27.65 -9.14 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 18 PHE~? 7.18 CH3 ACT A1181 A 201 ASP A 14 ASP~? 14.99 CH3 ACT A1181 A 227 LYS B 164 LYS~? 10.34 O ACT A1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -49.53 25.29 -10.30 -47.93 26.67 -8.41 coo 25.52 45.12 37.98 23.98 46.65 37.85 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 12.68 46.83 36.69 18.26 48.67 34.51 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 201 ASP A 156 ASP~? 10.59 O ACT A1181 A 227 LYS A 117 LYS.? 20.14 O ACT A1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 25.52 45.12 37.98 23.98 46.65 37.85 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 12.68 46.83 36.69 18.26 48.67 34.51 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 201 ASP A 156 ASP~? 10.59 O ACT A1181 A 227 LYS A 149 LYS.? 8.87 O ACT A1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 25.52 45.12 37.98 23.98 46.65 37.85 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 12.68 46.83 36.69 18.26 48.67 34.51 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 201 ASP A 156 ASP~? 10.59 O ACT A1181 A 227 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 25.52 45.12 37.98 23.98 46.65 37.85 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 12.68 46.83 36.69 18.26 48.67 34.51 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE A 138 PHE.? 14.29 O ACT A1181 A 201 ASP A 55 ASP.? 17.41 O ACT A1181 A 227 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 23.39 49.81 32.16 21.33 51.68 32.26 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 25.52 45.12 37.98 23.98 46.65 37.85 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 12.68 46.83 36.69 18.26 48.67 34.51 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE B 4 PHE~? 20.64 OXT ACT A1181 A 201 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 227 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -22.20 13.21 -10.55 -24.23 13.70 -8.68 coo 25.52 45.12 37.98 23.98 46.65 37.85 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 12.68 46.83 36.69 18.26 48.67 34.51 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1qz9_c02 KYNURENINASE user 8 3 # 8 A 129 PHE B 11 PHE~? 13.58 OXT ACT A1181 A 201 ASP B 14 ASP~? 13.85 OXT ACT A1181 A 227 LYS B 2 LYS^? 23.29 OXT ACT A1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 25.52 45.12 37.98 23.98 46.65 37.85 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo 12.68 46.83 36.69 18.26 48.67 34.51 -20.20 10.38 -18.51 -23.30 13.86 -21.27 ULMN 3 1qz9_c02 KYNURENINASE user 9 3 # 9 A 129 PHE B 18 PHE~? 12.22 OXT ACT A1181 A 201 ASP B 14 ASP~? 13.85 OXT ACT A1181 A 227 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -41.22 12.14 -19.23 -42.79 9.87 -19.80 coo 25.52 45.12 37.98 23.98 46.65 37.85 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo 12.68 46.83 36.69 18.26 48.67 34.51 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 1qz9_c02 KYNURENINASE user 10 3 # 10 A 129 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 201 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 227 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo 23.39 49.81 32.16 21.33 51.68 32.26 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 12.68 46.83 36.69 18.26 48.67 34.51 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 1qz9_c02 KYNURENINASE user 11 3 # 11 A 129 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 201 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 227 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 23.39 49.81 32.16 21.33 51.68 32.26 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 12.68 46.83 36.69 18.26 48.67 34.51 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 1qz9_c02 KYNURENINASE user 12 3 # 12 A 129 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 201 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 227 LYS B 164 LYS~? 10.34 O ACT A1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 12.68 46.83 36.69 18.26 48.67 34.51 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 1qz9_c02 KYNURENINASE user 13 3 # 13 A 129 PHE B 138 PHE.? 9.75 O3 GOL B1182 A 201 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 227 LYS B 124 LYS~? 15.51 CA CA B1183 coo 23.39 49.81 32.16 21.33 51.68 32.26 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 25.52 45.12 37.98 23.98 46.65 37.85 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 12.68 46.83 36.69 18.26 48.67 34.51 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 1qz9_c02 KYNURENINASE user 14 3 # 14 A 129 PHE C 4 PHE~? 19.56 CA CA C1182 A 201 ASP C 6 ASP~? 17.85 CA CA C1182 A 227 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -22.18 -13.20 37.01 -24.26 -13.66 35.19 coo 25.52 45.12 37.98 23.98 46.65 37.85 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 12.68 46.83 36.69 18.26 48.67 34.51 -22.65 -4.76 42.92 -27.69 -1.89 42.71 ULMN 3 1qz9_c02 KYNURENINASE user 15 3 # 15 A 129 PHE C 11 PHE~? 12.63 O3 GOL D1181 A 201 ASP C 14 ASP~? 9.29 CA CA C1182 A 227 LYS C 2 LYS^? 15.05 CA CA C1182 coo 23.39 49.81 32.16 21.33 51.68 32.26 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 25.52 45.12 37.98 23.98 46.65 37.85 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 12.68 46.83 36.69 18.26 48.67 34.51 -20.31 -10.65 45.10 -24.59 -14.66 46.53 ULMN 3 1qz9_c02 KYNURENINASE user 16 3 # 16 A 129 PHE C 18 PHE~? 12.17 O3 GOL D1181 A 201 ASP C 14 ASP~? 9.29 CA CA C1182 A 227 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -41.21 -12.14 45.70 -42.78 -9.88 46.28 coo 25.52 45.12 37.98 23.98 46.65 37.85 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 12.68 46.83 36.69 18.26 48.67 34.51 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1qz9_c02 KYNURENINASE user 17 3 # 17 A 129 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 201 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 227 LYS C 117 LYS.? 21.58 CA CA C1184 coo 23.39 49.81 32.16 21.33 51.68 32.26 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 12.68 46.83 36.69 18.26 48.67 34.51 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 1qz9_c02 KYNURENINASE user 18 3 # 18 A 129 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 201 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 227 LYS C 149 LYS.? 9.01 CA CA C1184 coo 23.39 49.81 32.16 21.33 51.68 32.26 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 12.68 46.83 36.69 18.26 48.67 34.51 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 1qz9_c02 KYNURENINASE user 19 3 # 19 A 129 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 201 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 227 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 25.52 45.12 37.98 23.98 46.65 37.85 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 12.68 46.83 36.69 18.26 48.67 34.51 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1qz9_c02 KYNURENINASE user 20 3 # 20 A 129 PHE C 138 PHE.? 14.85 CA CA C1184 A 201 ASP C 55 ASP.? 19.45 CA CA C1184 A 227 LYS C 124 LYS~? 15.99 CA CA C1184 coo 23.39 49.81 32.16 21.33 51.68 32.26 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 25.52 45.12 37.98 23.98 46.65 37.85 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 12.68 46.83 36.69 18.26 48.67 34.51 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 1qz9_c02 KYNURENINASE user 21 3 # 21 A 129 PHE D 11 PHE~? 14.07 C1 GOL D1181 A 201 ASP D 14 ASP~? 14.81 O1 GOL D1181 A 227 LYS D 2 LYS.? 16.82 CA CA C1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 25.52 45.12 37.98 23.98 46.65 37.85 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 12.68 46.83 36.69 18.26 48.67 34.51 -70.92 -25.33 35.01 -67.02 -26.54 39.55 ULMN 3 1qz9_c02 KYNURENINASE user 22 3 # 22 A 129 PHE D 18 PHE~? 7.09 O1 GOL D1181 A 201 ASP D 14 ASP~? 14.81 O1 GOL D1181 A 227 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -49.53 -25.28 36.78 -47.96 -26.67 34.88 coo 25.52 45.12 37.98 23.98 46.65 37.85 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 12.68 46.83 36.69 18.26 48.67 34.51 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 1qz9_c02 KYNURENINASE user 23 3 # 23 A 129 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 201 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 227 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 25.52 45.12 37.98 23.98 46.65 37.85 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 12.68 46.83 36.69 18.26 48.67 34.51 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 1qz9_c02 KYNURENINASE user 24 3 # 24 A 129 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 201 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 227 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 25.52 45.12 37.98 23.98 46.65 37.85 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 12.68 46.83 36.69 18.26 48.67 34.51 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 1qz9_c02 KYNURENINASE user 25 3 # 25 A 129 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 201 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 227 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 23.39 49.81 32.16 21.33 51.68 32.26 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 25.52 45.12 37.98 23.98 46.65 37.85 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 12.68 46.83 36.69 18.26 48.67 34.51 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 1qz9_c02 KYNURENINASE user 26 3 # 26 A 129 PHE D 138 PHE.? 14.22 O2 GOL D1181 A 201 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 227 LYS D 124 LYS~? 24.78 O ACT A1182 coo 23.39 49.81 32.16 21.33 51.68 32.26 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 25.52 45.12 37.98 23.98 46.65 37.85 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 12.68 46.83 36.69 18.26 48.67 34.51 -30.92 -19.78 10.48 -31.91 -25.53 10.85 1qz9_c02 source 1qz9 KYNURENINASE : 26 hits 1qz9_c02 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 610 HIS D 114 HIS^? 15.97 O ACT A1182 A 661 HIS D 59 HIS~? 14.28 O ACT A1182 coo 75.99 81.56 1.86 73.91 81.34 2.28 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 71.04 78.84 0.46 71.54 76.90 1.02 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 75.40 81.38 12.06 74.88 79.42 12.63 -44.08 -8.12 17.12 -43.68 -6.15 16.50 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 1 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 610 HIS D 114 HIS^? 15.97 O ACT A1182 C 661 HIS D 59 HIS~? 14.28 O ACT A1182 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -44.08 -8.12 17.12 -43.68 -6.15 16.50 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 1 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 84 ASP A 55 ASP.? 17.41 O ACT A1181 B 140 GLY A 122 GLY~? 17.38 OXT ACT A1182 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -31.93 16.98 20.49 -32.19 17.34 19.79 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 84 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 140 GLY B 122 GLY~? 17.40 O ACT C1183 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 ULMN 3 1rgq_c01 NS4A PEPTIDE user 3 3 # 3 B 60 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 84 ASP C 55 ASP.? 19.45 CA CA C1184 B 140 GLY C 122 GLY~? 17.34 OXT ACT C1183 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -58.64 13.32 25.99 -58.38 12.82 26.62 ULMN 3 1rgq_c01 NS4A PEPTIDE user 4 3 # 4 B 60 HIS D 114 HIS^? 15.97 O ACT A1182 B 84 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 140 GLY D 122 GLY~? 17.40 O ACT A1182 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -32.03 -16.93 5.96 -32.26 -17.35 6.67 1rgq_c01 source 1rgq NS4A PEPTIDE : 4 hits 1rgq_c01 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 152 ASP.? 5.90 O ACT A1181 35 SER A 153 SER.? 8.36 O ACT A1181 215 ASP A 156 ASP~? 10.59 O ACT A1181 coo 11.85 17.24 72.81 11.09 15.37 72.36 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 12.20 12.71 75.45 13.69 13.84 74.03 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 5.22 15.03 71.43 7.19 14.88 70.83 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP B 152 ASP.? 8.52 O3 GOL B1182 35 SER B 153 SER.? 13.04 OXT ACT A1181 215 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 11.85 17.24 72.81 11.09 15.37 72.36 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 12.20 12.71 75.45 13.69 13.84 74.03 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo 5.22 15.03 71.43 7.19 14.88 70.83 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 3 # 3 32 ASP C 152 ASP.? 13.45 O3 GOL D1181 35 SER C 153 SER.? 12.45 O3 GOL D1181 215 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 11.85 17.24 72.81 11.09 15.37 72.36 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 12.20 12.71 75.45 13.69 13.84 74.03 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo 5.22 15.03 71.43 7.19 14.88 70.83 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 4 3 # 4 32 ASP D 152 ASP.? 5.75 O2 GOL D1181 35 SER D 153 SER.? 8.24 O2 GOL D1181 215 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 11.85 17.24 72.81 11.09 15.37 72.36 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 12.20 12.71 75.45 13.69 13.84 74.03 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo 5.22 15.03 71.43 7.19 14.88 70.83 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 4 hits 1rne_c04 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 29 GLU~? 11.10 O ACT A1181 A 288 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 329 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 29.27 18.78 14.99 27.16 18.62 14.76 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 49.52 10.06 10.36 50.99 9.65 8.92 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 57.80 12.92 13.83 53.77 8.42 12.15 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU A 119 GLU.? 19.75 OXT ACT A1182 A 288 HIS B 59 HIS~? 15.18 O ACT C1183 A 329 LYS A 72 LYS.? 19.74 O ACT A1182 coo 29.27 18.78 14.99 27.16 18.62 14.76 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 49.52 10.06 10.36 50.99 9.65 8.92 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 57.80 12.92 13.83 53.77 8.42 12.15 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU A 140 GLU.? 22.35 O ACT A1181 A 288 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 329 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 29.27 18.78 14.99 27.16 18.62 14.76 -27.69 26.26 5.34 -26.17 27.35 4.33 coo 49.52 10.06 10.36 50.99 9.65 8.92 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 57.80 12.92 13.83 53.77 8.42 12.15 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU A 167 GLU~? 17.93 OXT ACT A1181 A 288 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 329 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 29.27 18.78 14.99 27.16 18.62 14.76 -32.78 4.71 -6.52 -34.47 3.65 -5.83 coo 49.52 10.06 10.36 50.99 9.65 8.92 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 57.80 12.92 13.83 53.77 8.42 12.15 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 A 137 GLU B 119 GLU.? 18.74 O3 GOL B1182 A 288 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 329 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 29.27 18.78 14.99 27.16 18.62 14.76 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 49.52 10.06 10.36 50.99 9.65 8.92 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 57.80 12.92 13.83 53.77 8.42 12.15 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 A 137 GLU B 167 GLU~? 15.72 O ACT A1181 A 288 HIS B 59 HIS~? 15.18 O ACT C1183 A 329 LYS A 72 LYS.? 19.74 O ACT A1182 coo 29.27 18.78 14.99 27.16 18.62 14.76 -56.85 16.74 -0.78 -55.11 17.01 0.42 coo 49.52 10.06 10.36 50.99 9.65 8.92 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 57.80 12.92 13.83 53.77 8.42 12.15 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 A 137 GLU C 167 GLU~? 15.18 C1 GOL D1181 A 288 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 329 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 29.27 18.78 14.99 27.16 18.62 14.76 -56.84 -16.73 27.22 -55.09 -16.98 26.08 coo 49.52 10.06 10.36 50.99 9.65 8.92 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 57.80 12.92 13.83 53.77 8.42 12.15 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 A 137 GLU D 119 GLU.? 19.65 O ACT A1182 A 288 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 329 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 29.27 18.78 14.99 27.16 18.62 14.76 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 49.52 10.06 10.36 50.99 9.65 8.92 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 57.80 12.92 13.83 53.77 8.42 12.15 -39.21 6.22 27.81 -43.32 9.34 25.63 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 8 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 29 GLU~? 11.10 O ACT A1181 B 288 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 329 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 119 GLU.? 19.75 OXT ACT A1182 B 288 HIS B 59 HIS~? 15.18 O ACT C1183 B 329 LYS A 72 LYS.? 19.74 O ACT A1182 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -40.83 18.78 13.92 -42.39 17.53 13.21 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU B 119 GLU.? 18.74 O3 GOL B1182 B 288 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 329 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU D 119 GLU.? 19.65 O ACT A1182 B 288 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 329 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -40.78 -18.80 12.54 -42.26 -17.44 13.18 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU D 167 GLU~? 14.12 O3 GOL D1181 B 288 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 329 LYS C 124 LYS~? 15.99 CA CA C1184 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -33.98 -6.43 34.19 -35.73 -5.26 33.93 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -59.48 10.16 30.27 -60.09 12.26 35.28 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 5 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 102 ASP A 55 ASP.? 17.41 O ACT A1181 B 195 SER A 53 SER^? 12.21 OXT ACT A1182 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -35.29 10.69 9.61 -33.77 12.39 10.51 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 102 ASP A 55 ASP.? 17.41 O ACT A1181 B 195 SER A 53 SER^? 12.21 OXT ACT A1182 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -35.29 10.69 9.61 -33.77 12.39 10.51 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS B 59 HIS~? 15.18 O ACT C1183 B 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 195 SER B 53 SER^? 12.05 O ACT C1183 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -55.28 -0.85 2.05 -56.85 -2.35 0.91 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 195 SER B 53 SER^? 12.05 O ACT C1183 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -55.28 -0.85 2.05 -56.85 -2.35 0.91 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 3 # 5 B 57 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 102 ASP C 55 ASP.? 19.45 CA CA C1184 B 195 SER C 53 SER^? 12.05 OXT ACT C1183 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -46.89 1.05 23.56 -47.29 3.11 23.40 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -55.28 0.90 24.40 -56.83 2.38 25.58 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 6 3 # 6 B 57 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 102 ASP C 55 ASP.? 19.45 CA CA C1184 B 195 SER C 53 SER^? 12.05 OXT ACT C1183 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -55.28 0.90 24.40 -56.83 2.38 25.58 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 7 3 # 7 B 57 HIS D 114 HIS^? 15.97 O ACT A1182 B 102 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 195 SER D 53 SER^? 12.18 O ACT A1182 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -35.31 -10.69 16.86 -33.78 -12.33 15.90 1rtf_c03 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 7 hits 1rtf_c03 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 102 ASP A 55 ASP.? 17.41 O ACT A1181 B 193 GLY A 122 GLY~? 17.38 OXT ACT A1182 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -31.93 16.98 20.49 -32.19 17.34 19.79 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 193 GLY B 122 GLY~? 17.40 O ACT C1183 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 102 ASP C 55 ASP.? 19.45 CA CA C1184 B 193 GLY C 122 GLY~? 17.34 OXT ACT C1183 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -58.64 13.32 25.99 -58.38 12.82 26.62 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS D 114 HIS^? 15.97 O ACT A1182 B 102 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 193 GLY D 122 GLY~? 17.40 O ACT A1182 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -32.03 -16.93 5.96 -32.26 -17.35 6.67 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 4 hits 1rtf_c06 naa= 3 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 1 3 # 1 A 104 ILE A 118 ILE.? 19.55 OXT ACT A1182 A 106 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 142 ASP A 55 ASP.? 17.41 O ACT A1181 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -34.85 20.28 13.02 -33.45 20.18 12.88 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 2 3 # 2 A 104 ILE B 118 ILE.? 16.04 CA CA B1183 A 106 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 142 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -55.60 -7.68 -5.36 -57.00 -7.51 -5.37 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 3 3 # 3 A 104 ILE C 118 ILE.? 16.09 CA CA C1184 A 106 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 142 ASP C 55 ASP.? 19.45 CA CA C1184 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -55.61 7.67 31.78 -57.02 7.49 31.77 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 4 3 # 4 A 104 ILE D 118 ILE.? 19.64 O ACT A1182 A 106 HIS D 114 HIS^? 15.97 O ACT A1182 A 142 ASP D 55 ASP.? 17.43 O2 GOL D1181 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -34.85 -20.32 13.47 -33.43 -20.23 13.59 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -40.72 -16.97 16.40 -41.69 -17.43 18.23 1s3i_c00 source 1s3i 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE : 4 hits 1s3i_c00 naa= 3 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 55 ASP.? 17.41 O ACT A1181 64 HIS A 59 HIS~? 15.34 OXT ACT A1182 221 SER A 53 SER^? 12.21 OXT ACT A1182 coo 80.16 73.25 62.48 80.01 71.25 61.82 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 78.27 67.69 61.83 79.58 67.76 60.19 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 83.63 66.07 58.16 81.31 66.75 57.98 -35.29 10.69 9.61 -33.77 12.39 10.51 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 55 ASP.? 17.41 O ACT A1181 64 HIS A 114 HIS^? 15.94 OXT ACT A1182 221 SER A 53 SER^? 12.21 OXT ACT A1182 coo 80.16 73.25 62.48 80.01 71.25 61.82 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 78.27 67.69 61.83 79.58 67.76 60.19 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 83.63 66.07 58.16 81.31 66.75 57.98 -35.29 10.69 9.61 -33.77 12.39 10.51 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP B 55 ASP.? 14.29 O3 GOL B1182 64 HIS B 59 HIS~? 15.18 O ACT C1183 221 SER B 53 SER^? 12.05 O ACT C1183 coo 80.16 73.25 62.48 80.01 71.25 61.82 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 78.27 67.69 61.83 79.58 67.76 60.19 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 83.63 66.07 58.16 81.31 66.75 57.98 -55.28 -0.85 2.05 -56.85 -2.35 0.91 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP B 55 ASP.? 14.29 O3 GOL B1182 64 HIS B 114 HIS^? 14.73 O2 GOL B1182 221 SER B 53 SER^? 12.05 O ACT C1183 coo 80.16 73.25 62.48 80.01 71.25 61.82 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 78.27 67.69 61.83 79.58 67.76 60.19 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 83.63 66.07 58.16 81.31 66.75 57.98 -55.28 -0.85 2.05 -56.85 -2.35 0.91 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 5 3 # 5 32 ASP C 55 ASP.? 19.45 CA CA C1184 64 HIS C 59 HIS~? 15.17 OXT ACT C1183 221 SER C 53 SER^? 12.05 OXT ACT C1183 coo 80.16 73.25 62.48 80.01 71.25 61.82 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 78.27 67.69 61.83 79.58 67.76 60.19 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 83.63 66.07 58.16 81.31 66.75 57.98 -55.28 0.90 24.40 -56.83 2.38 25.58 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 6 3 # 6 32 ASP C 55 ASP.? 19.45 CA CA C1184 64 HIS C 114 HIS^? 15.77 OXT ACT C1183 221 SER C 53 SER^? 12.05 OXT ACT C1183 coo 80.16 73.25 62.48 80.01 71.25 61.82 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 78.27 67.69 61.83 79.58 67.76 60.19 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 83.63 66.07 58.16 81.31 66.75 57.98 -55.28 0.90 24.40 -56.83 2.38 25.58 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 7 3 # 7 32 ASP D 55 ASP.? 17.43 O2 GOL D1181 64 HIS D 114 HIS^? 15.97 O ACT A1182 221 SER D 53 SER^? 12.18 O ACT A1182 coo 80.16 73.25 62.48 80.01 71.25 61.82 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 78.27 67.69 61.83 79.58 67.76 60.19 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 83.63 66.07 58.16 81.31 66.75 57.98 -35.31 -10.69 16.86 -33.78 -12.33 15.90 1sca_c00 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 7 hits 1sca_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 55 ASP.? 17.41 O ACT A1181 64 HIS A 59 HIS~? 15.34 OXT ACT A1182 155 ASN B 68 ASN~? 15.57 O ACT A1181 coo 80.16 73.25 62.48 80.01 71.25 61.82 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 78.27 67.69 61.83 79.58 67.76 60.19 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 80.34 61.88 52.75 81.25 63.19 54.35 -53.02 13.76 3.43 -51.10 14.43 2.89 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP B 55 ASP.? 14.29 O3 GOL B1182 64 HIS B 59 HIS~? 15.18 O ACT C1183 155 ASN A 68 ASN~? 16.27 OXT ACT A1181 coo 80.16 73.25 62.48 80.01 71.25 61.82 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 78.27 67.69 61.83 79.58 67.76 60.19 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 80.34 61.88 52.75 81.25 63.19 54.35 -37.69 3.73 -3.29 -39.63 4.05 -4.09 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP C 55 ASP.? 19.45 CA CA C1184 64 HIS C 59 HIS~? 15.17 OXT ACT C1183 155 ASN D 68 ASN~? 14.78 O3 GOL D1181 coo 80.16 73.25 62.48 80.01 71.25 61.82 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 78.27 67.69 61.83 79.58 67.76 60.19 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 80.34 61.88 52.75 81.25 63.19 54.35 -37.72 -3.74 29.70 -39.65 -4.05 30.55 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 3 hits 1sca_c01 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 37 SER A 88 SER.? 4.86 OXT ACT A1182 A 214 ASP D 84 ASP^? 8.02 O ACT A1182 coo 51.75 60.57 19.10 52.05 60.90 21.19 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 51.10 65.11 20.73 52.62 63.74 19.42 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 48.59 58.89 25.78 50.13 59.74 24.61 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1sme_c04 PLASMEPSIN II user 2 3 # 2 A 34 ASP A 152 ASP.? 5.90 O ACT A1181 A 37 SER A 153 SER.? 8.36 O ACT A1181 A 214 ASP A 156 ASP~? 10.59 O ACT A1181 coo 51.75 60.57 19.10 52.05 60.90 21.19 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 51.10 65.11 20.73 52.62 63.74 19.42 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 48.59 58.89 25.78 50.13 59.74 24.61 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1sme_c04 PLASMEPSIN II user 3 3 # 3 A 34 ASP B 84 ASP^? 7.80 O ACT C1183 A 37 SER B 88 SER.? 4.64 O ACT C1183 A 214 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 51.75 60.57 19.10 52.05 60.90 21.19 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 51.10 65.11 20.73 52.62 63.74 19.42 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 48.59 58.89 25.78 50.13 59.74 24.61 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1sme_c04 PLASMEPSIN II user 4 3 # 4 A 34 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 37 SER B 153 SER.? 13.04 OXT ACT A1181 A 214 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 51.75 60.57 19.10 52.05 60.90 21.19 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 51.10 65.11 20.73 52.62 63.74 19.42 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo 48.59 58.89 25.78 50.13 59.74 24.61 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1sme_c04 PLASMEPSIN II user 5 3 # 5 A 34 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 37 SER C 88 SER.? 4.69 OXT ACT C1183 A 214 ASP B 84 ASP^? 7.80 O ACT C1183 coo 51.75 60.57 19.10 52.05 60.90 21.19 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 51.10 65.11 20.73 52.62 63.74 19.42 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 48.59 58.89 25.78 50.13 59.74 24.61 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1sme_c04 PLASMEPSIN II user 6 3 # 6 A 34 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 37 SER C 153 SER.? 12.45 O3 GOL D1181 A 214 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 51.75 60.57 19.10 52.05 60.90 21.19 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 51.10 65.11 20.73 52.62 63.74 19.42 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo 48.59 58.89 25.78 50.13 59.74 24.61 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1sme_c04 PLASMEPSIN II user 7 3 # 7 A 34 ASP D 84 ASP^? 8.02 O ACT A1182 A 37 SER D 88 SER.? 4.67 O ACT A1182 A 214 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 51.75 60.57 19.10 52.05 60.90 21.19 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 51.10 65.11 20.73 52.62 63.74 19.42 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 48.59 58.89 25.78 50.13 59.74 24.61 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1sme_c04 PLASMEPSIN II user 8 3 # 8 A 34 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 37 SER D 153 SER.? 8.24 O2 GOL D1181 A 214 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 51.75 60.57 19.10 52.05 60.90 21.19 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 51.10 65.11 20.73 52.62 63.74 19.42 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo 48.59 58.89 25.78 50.13 59.74 24.61 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1sme_c04 source 1sme PLASMEPSIN II : 8 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 84 ASP^? 7.98 OXT ACT A1182 B 37 SER A 88 SER.? 4.86 OXT ACT A1182 B 214 ASP D 84 ASP^? 8.02 O ACT A1182 coo 17.69 97.58 52.73 17.33 97.19 54.77 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 20.67 100.44 55.84 20.21 98.51 54.45 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 12.41 98.71 58.47 14.37 98.17 58.05 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP A 152 ASP.? 5.90 O ACT A1181 B 37 SER A 153 SER.? 8.36 O ACT A1181 B 214 ASP A 156 ASP~? 10.59 O ACT A1181 coo 17.69 97.58 52.73 17.33 97.19 54.77 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 20.67 100.44 55.84 20.21 98.51 54.45 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 12.41 98.71 58.47 14.37 98.17 58.05 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1sme_c05 PLASMEPSIN II user 3 3 # 3 B 34 ASP B 84 ASP^? 7.80 O ACT C1183 B 37 SER B 88 SER.? 4.64 O ACT C1183 B 214 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 17.69 97.58 52.73 17.33 97.19 54.77 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 20.67 100.44 55.84 20.21 98.51 54.45 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 12.41 98.71 58.47 14.37 98.17 58.05 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1sme_c05 PLASMEPSIN II user 4 3 # 4 B 34 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 37 SER B 153 SER.? 13.04 OXT ACT A1181 B 214 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 17.69 97.58 52.73 17.33 97.19 54.77 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 20.67 100.44 55.84 20.21 98.51 54.45 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo 12.41 98.71 58.47 14.37 98.17 58.05 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1sme_c05 PLASMEPSIN II user 5 3 # 5 B 34 ASP C 84 ASP^? 7.78 OXT ACT C1183 B 37 SER C 88 SER.? 4.69 OXT ACT C1183 B 214 ASP B 84 ASP^? 7.80 O ACT C1183 coo 17.69 97.58 52.73 17.33 97.19 54.77 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 20.67 100.44 55.84 20.21 98.51 54.45 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 12.41 98.71 58.47 14.37 98.17 58.05 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1sme_c05 PLASMEPSIN II user 6 3 # 6 B 34 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 37 SER C 153 SER.? 12.45 O3 GOL D1181 B 214 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 17.69 97.58 52.73 17.33 97.19 54.77 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 20.67 100.44 55.84 20.21 98.51 54.45 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo 12.41 98.71 58.47 14.37 98.17 58.05 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 1sme_c05 PLASMEPSIN II user 7 3 # 7 B 34 ASP D 84 ASP^? 8.02 O ACT A1182 B 37 SER D 88 SER.? 4.67 O ACT A1182 B 214 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 17.69 97.58 52.73 17.33 97.19 54.77 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 20.67 100.44 55.84 20.21 98.51 54.45 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 12.41 98.71 58.47 14.37 98.17 58.05 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1sme_c05 PLASMEPSIN II user 8 3 # 8 B 34 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 37 SER D 153 SER.? 8.24 O2 GOL D1181 B 214 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 17.69 97.58 52.73 17.33 97.19 54.77 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 20.67 100.44 55.84 20.21 98.51 54.45 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo 12.41 98.71 58.47 14.37 98.17 58.05 -46.26 -16.01 28.32 -46.92 -16.52 26.38 1sme_c05 source 1sme PLASMEPSIN II : 8 hits 1sme_c05 naa= 3 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 A 87 ARG A 58 ARG~? 14.46 O ACT A1181 A 89 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 119 ASN A 63 ASN~? 15.00 O ACT A1182 coo 28.44 23.52 73.95 30.13 24.84 76.11 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 21.34 20.13 69.47 22.14 19.11 71.12 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 19.69 29.00 71.61 19.80 26.98 72.20 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 A 87 ARG A 58 ARG~? 14.46 O ACT A1181 A 89 HIS A 59 HIS~? 15.34 OXT ACT A1182 A 119 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo 28.44 23.52 73.95 30.13 24.84 76.11 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 21.34 20.13 69.47 22.14 19.11 71.12 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 19.69 29.00 71.61 19.80 26.98 72.20 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 A 87 ARG A 58 ARG~? 14.46 O ACT A1181 A 89 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 119 ASN A 86 ASN.? 11.67 OXT ACT A1182 coo 28.44 23.52 73.95 30.13 24.84 76.11 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 21.34 20.13 69.47 22.14 19.11 71.12 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 19.69 29.00 71.61 19.80 26.98 72.20 -38.42 8.17 12.63 -38.52 10.18 11.86 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 A 87 ARG B 58 ARG~? 12.97 O3 GOL B1182 A 89 HIS B 59 HIS~? 15.18 O ACT C1183 A 119 ASN A 63 ASN~? 15.00 O ACT A1182 coo 28.44 23.52 73.95 30.13 24.84 76.11 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 21.34 20.13 69.47 22.14 19.11 71.12 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 19.69 29.00 71.61 19.80 26.98 72.20 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 5 3 # 5 A 87 ARG B 58 ARG~? 12.97 O3 GOL B1182 A 89 HIS B 59 HIS~? 15.18 O ACT C1183 A 119 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo 28.44 23.52 73.95 30.13 24.84 76.11 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 21.34 20.13 69.47 22.14 19.11 71.12 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 19.69 29.00 71.61 19.80 26.98 72.20 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 6 3 # 6 A 87 ARG B 58 ARG~? 12.97 O3 GOL B1182 A 89 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 119 ASN B 86 ASN.? 11.57 O ACT C1183 coo 28.44 23.52 73.95 30.13 24.84 76.11 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 21.34 20.13 69.47 22.14 19.11 71.12 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 19.69 29.00 71.61 19.80 26.98 72.20 -52.20 -2.48 5.54 -51.99 -2.60 3.42 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 7 3 # 7 A 87 ARG C 58 ARG~? 18.42 O3 GOL D1181 A 89 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 119 ASN C 63 ASN~? 14.81 O ACT C1183 coo 28.44 23.52 73.95 30.13 24.84 76.11 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 21.34 20.13 69.47 22.14 19.11 71.12 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 19.69 29.00 71.61 19.80 26.98 72.20 -47.81 -6.22 21.11 -47.01 -7.28 19.44 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 8 3 # 8 A 87 ARG C 58 ARG~? 18.42 O3 GOL D1181 A 89 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 119 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo 28.44 23.52 73.95 30.13 24.84 76.11 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 21.34 20.13 69.47 22.14 19.11 71.12 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 19.69 29.00 71.61 19.80 26.98 72.20 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 9 3 # 9 A 87 ARG C 58 ARG~? 18.42 O3 GOL D1181 A 89 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 119 ASN C 86 ASN.? 11.54 OXT ACT C1183 coo 28.44 23.52 73.95 30.13 24.84 76.11 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 21.34 20.13 69.47 22.14 19.11 71.12 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 19.69 29.00 71.61 19.80 26.98 72.20 -52.20 2.48 20.90 -52.01 2.64 23.02 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 10 3 # 10 A 87 ARG D 58 ARG~? 14.52 O2 GOL D1181 A 89 HIS D 114 HIS^? 15.97 O ACT A1182 A 119 ASN D 86 ASN.? 11.74 O ACT A1182 coo 28.44 23.52 73.95 30.13 24.84 76.11 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 21.34 20.13 69.47 22.14 19.11 71.12 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 19.69 29.00 71.61 19.80 26.98 72.20 -38.34 -8.19 13.90 -38.52 -10.20 14.65 1smn_c00 source 1smn EXTRACELLULAR ENDONUCLEASE : 10 hits 1smn_c00 naa= 3 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 B 87 ARG A 58 ARG~? 14.46 O ACT A1181 B 89 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 119 ASN A 63 ASN~? 15.00 O ACT A1182 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -43.27 15.99 4.53 -43.95 18.83 5.47 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 B 87 ARG A 58 ARG~? 14.46 O ACT A1181 B 89 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 119 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -43.27 15.99 4.53 -43.95 18.83 5.47 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -43.78 10.05 10.24 -43.35 10.65 12.21 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 B 87 ARG A 58 ARG~? 14.46 O ACT A1181 B 89 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 119 ASN A 86 ASN.? 11.67 OXT ACT A1182 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -43.27 15.99 4.53 -43.95 18.83 5.47 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -38.42 8.17 12.63 -38.52 10.18 11.86 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 4 3 # 4 B 87 ARG B 58 ARG~? 12.97 O3 GOL B1182 B 89 HIS B 59 HIS~? 15.18 O ACT C1183 B 119 ASN A 63 ASN~? 15.00 O ACT A1182 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 5 3 # 5 B 87 ARG B 58 ARG~? 12.97 O3 GOL B1182 B 89 HIS B 59 HIS~? 15.18 O ACT C1183 B 119 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 6 3 # 6 B 87 ARG B 58 ARG~? 12.97 O3 GOL B1182 B 89 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 119 ASN B 86 ASN.? 11.57 O ACT C1183 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -52.20 -2.48 5.54 -51.99 -2.60 3.42 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 7 3 # 7 B 87 ARG C 58 ARG~? 18.42 O3 GOL D1181 B 89 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 119 ASN C 63 ASN~? 14.81 O ACT C1183 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -46.89 1.05 23.56 -47.29 3.11 23.40 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -47.81 -6.22 21.11 -47.01 -7.28 19.44 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 8 3 # 8 B 87 ARG C 58 ARG~? 18.42 O3 GOL D1181 B 89 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 119 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -46.89 1.05 23.56 -47.29 3.11 23.40 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 9 3 # 9 B 87 ARG C 58 ARG~? 18.42 O3 GOL D1181 B 89 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 119 ASN C 86 ASN.? 11.54 OXT ACT C1183 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -56.52 2.47 29.05 -54.69 3.49 29.13 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -52.20 2.48 20.90 -52.01 2.64 23.02 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 10 3 # 10 B 87 ARG D 58 ARG~? 14.52 O2 GOL D1181 B 89 HIS D 114 HIS^? 15.97 O ACT A1182 B 119 ASN D 86 ASN.? 11.74 O ACT A1182 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -38.34 -8.19 13.90 -38.52 -10.20 14.65 1smn_c01 source 1smn EXTRACELLULAR ENDONUCLEASE : 10 hits 1smn_c01 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 6 ASP~? 16.17 CA CA B1181 E 168 LYS A 2 LYS^? 14.71 CA CA B1181 E 201 THR B 179 THR^? 6.91 CA CA B1181 coo 5.36 16.20 22.10 3.88 17.00 23.31 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 5.06 22.32 18.11 1.02 22.08 22.74 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -73.24 20.81 -4.92 -74.72 22.26 -5.56 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 6 ASP~? 24.59 OXT ACT A1181 E 168 LYS B 2 LYS^? 23.29 OXT ACT A1181 E 201 THR A 179 THR^? 28.89 OXT ACT A1181 coo 5.36 16.20 22.10 3.88 17.00 23.31 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 5.06 22.32 18.11 1.02 22.08 22.74 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -18.20 8.65 -12.85 -16.17 9.02 -13.57 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP C 6 ASP~? 17.85 CA CA C1182 E 168 LYS C 2 LYS^? 15.05 CA CA C1182 E 201 THR D 179 THR^? 25.87 CA CA C1182 coo 5.36 16.20 22.10 3.88 17.00 23.31 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 5.06 22.32 18.11 1.02 22.08 22.74 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -18.18 -8.72 39.22 -16.52 -8.31 40.56 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP D 6 ASP~? 16.12 CA CA C1181 E 168 LYS D 2 LYS.? 16.82 CA CA C1181 E 201 THR C 179 THR.? 6.44 CA CA C1181 coo 5.36 16.20 22.10 3.88 17.00 23.31 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 5.06 22.32 18.11 1.02 22.08 22.74 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -73.10 -20.61 31.39 -74.58 -22.14 31.75 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 4 hits 1stc_c02 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 6 ASP~? 16.17 CA CA B1181 E 168 LYS A 2 LYS^? 14.71 CA CA B1181 E 171 ASN A 3 ASN^? 12.04 CA CA B1181 coo 5.36 16.20 22.10 3.88 17.00 23.31 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 5.06 22.32 18.11 1.02 22.08 22.74 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo 6.68 21.78 22.39 5.28 20.74 23.60 -72.70 21.43 -11.05 -73.07 19.35 -11.09 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP A 95 ASP~? 18.75 OXT ACT A1182 E 168 LYS A 93 LYS.? 11.72 OXT ACT A1182 E 171 ASN A 94 ASN.? 20.31 OXT ACT A1182 coo 5.36 16.20 22.10 3.88 17.00 23.31 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 5.06 22.32 18.11 1.02 22.08 22.74 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 6.68 21.78 22.39 5.28 20.74 23.60 -34.68 14.84 26.15 -33.66 16.63 26.68 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP B 6 ASP~? 24.59 OXT ACT A1181 E 168 LYS B 2 LYS^? 23.29 OXT ACT A1181 E 171 ASN B 3 ASN^? 25.47 OXT ACT A1181 coo 5.36 16.20 22.10 3.88 17.00 23.31 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 5.06 22.32 18.11 1.02 22.08 22.74 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 6.68 21.78 22.39 5.28 20.74 23.60 -18.33 14.30 -16.20 -18.26 15.53 -14.45 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP C 6 ASP~? 17.85 CA CA C1182 E 168 LYS C 2 LYS^? 15.05 CA CA C1182 E 171 ASN C 3 ASN^? 20.98 CA CA C1182 coo 5.36 16.20 22.10 3.88 17.00 23.31 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 5.06 22.32 18.11 1.02 22.08 22.74 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 6.68 21.78 22.39 5.28 20.74 23.60 -18.27 -14.28 42.59 -18.15 -15.35 40.76 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 5 3 # 5 E 166 ASP C 95 ASP~? 18.98 OXT ACT C1183 E 168 LYS C 93 LYS.? 19.61 OXT ACT C1183 E 171 ASN C 94 ASN.? 20.53 OXT ACT C1183 coo 5.36 16.20 22.10 3.88 17.00 23.31 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 5.06 22.32 18.11 1.02 22.08 22.74 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 6.68 21.78 22.39 5.28 20.74 23.60 -57.57 16.60 24.50 -56.01 17.74 25.39 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 6 3 # 6 E 166 ASP D 6 ASP~? 16.12 CA CA C1181 E 168 LYS D 2 LYS.? 16.82 CA CA C1181 E 171 ASN D 3 ASN~? 12.07 CA CA C1181 coo 5.36 16.20 22.10 3.88 17.00 23.31 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 5.06 22.32 18.11 1.02 22.08 22.74 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo 6.68 21.78 22.39 5.28 20.74 23.60 -72.61 -21.52 37.54 -72.85 -19.41 37.73 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 6 hits 1stc_c03 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 16 GLY~? 8.84 CH3 ACT A1181 B 17 GLN A 21 GLN~? 9.37 CH3 ACT A1181 B 140 GLU A 17 GLU~? 13.61 CH3 ACT A1181 coo 61.49 19.86 5.96 61.52 19.46 5.16 -52.14 19.77 -14.51 -52.26 20.60 -14.34 coo 63.76 11.90 7.93 65.18 13.07 6.77 -46.14 27.82 -14.56 -47.41 29.11 -13.48 coo 66.44 19.00 7.38 67.69 17.67 8.37 -53.17 23.87 -17.57 -54.60 25.28 -18.31 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY A 24 GLY~? 6.98 CH3 ACT A1181 B 17 GLN B 15 GLN~? 8.49 OXT ACT A1181 B 140 GLU A 27 GLU~? -12.01 CH3 ACT A1181s coo 61.49 19.86 5.96 61.52 19.46 5.16 -38.70 23.07 -14.67 -39.06 23.24 -13.96 coo 63.76 11.90 7.93 65.18 13.07 6.77 -37.01 14.07 -13.41 -36.09 14.23 -11.49 coo 66.44 19.00 7.38 67.69 17.67 8.37 -34.14 22.58 -15.68 -34.47 22.99 -17.72 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY A 24 GLY~? 6.98 CH3 ACT A1181 B 17 GLN B 15 GLN~? 8.49 OXT ACT A1181 B 140 GLU B 17 GLU~? -13.09 CH3 ACT A1181s coo 61.49 19.86 5.96 61.52 19.46 5.16 -38.70 23.07 -14.67 -39.06 23.24 -13.96 coo 63.76 11.90 7.93 65.18 13.07 6.77 -37.01 14.07 -13.41 -36.09 14.23 -11.49 coo 66.44 19.00 7.38 67.69 17.67 8.37 -38.08 19.88 -20.29 -36.49 20.35 -21.57 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 4 3 # 4 A 261 GLY B 16 GLY~? 6.98 OXT ACT A1181 B 17 GLN B 21 GLN~? 14.95 OXT ACT A1181 B 140 GLU B 17 GLU~? -13.09 CH3 ACT A1181s coo 61.49 19.86 5.96 61.52 19.46 5.16 -38.85 18.09 -15.57 -38.71 17.64 -16.26 coo 63.76 11.90 7.93 65.18 13.07 6.77 -44.65 14.99 -23.33 -43.37 13.47 -24.10 coo 66.44 19.00 7.38 67.69 17.67 8.37 -38.08 19.88 -20.29 -36.49 20.35 -21.57 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 5 3 # 5 A 261 GLY B 24 GLY~? 11.88 C1 GOL B1182 B 17 GLN A 15 GLN~? 11.07 C3 GOL B1182 B 140 GLU A 17 GLU~? 13.61 CH3 ACT A1181 coo 61.49 19.86 5.96 61.52 19.46 5.16 -52.31 16.92 -18.92 -51.97 16.19 -18.78 coo 63.76 11.90 7.93 65.18 13.07 6.77 -53.85 19.12 -9.94 -54.79 17.30 -9.37 coo 66.44 19.00 7.38 67.69 17.67 8.37 -53.17 23.87 -17.57 -54.60 25.28 -18.31 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 6 3 # 6 A 261 GLY C 16 GLY~? 6.74 C3 GOL D1181 B 17 GLN C 21 GLN~? 10.67 CA CA C1182 B 140 GLU C 17 GLU~? 3.68 CA CA C1182s coo 61.49 19.86 5.96 61.52 19.46 5.16 -38.82 -18.07 42.06 -38.69 -17.63 42.74 coo 63.76 11.90 7.93 65.18 13.07 6.77 -42.83 -16.22 49.17 -41.46 -14.68 49.75 coo 66.44 19.00 7.38 67.69 17.67 8.37 -38.10 -19.90 46.72 -36.47 -20.40 47.99 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 7 3 # 7 A 261 GLY C 24 GLY~? 11.82 O1 GOL D1181 B 17 GLN D 15 GLN~? 10.48 C1 GOL D1181 B 140 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 61.49 19.86 5.96 61.52 19.46 5.16 -52.31 -16.92 45.35 -51.96 -16.19 45.23 coo 63.76 11.90 7.93 65.18 13.07 6.77 -53.83 -19.14 36.40 -54.76 -17.32 35.80 coo 66.44 19.00 7.38 67.69 17.67 8.37 -53.10 -23.91 44.12 -54.66 -25.27 44.77 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 8 3 # 8 A 261 GLY D 16 GLY~? 8.64 C1 GOL D1181 B 17 GLN D 21 GLN~? 9.15 O1 GOL D1181 B 140 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 61.49 19.86 5.96 61.52 19.46 5.16 -52.16 -19.77 41.01 -52.26 -20.58 40.82 coo 63.76 11.90 7.93 65.18 13.07 6.77 -46.13 -27.82 41.08 -47.36 -29.14 39.96 coo 66.44 19.00 7.38 67.69 17.67 8.37 -53.10 -23.91 44.12 -54.66 -25.27 44.77 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 9 3 # 9 A 261 GLY D 24 GLY~? 5.25 CA CA C1182 B 17 GLN C 15 GLN~? 7.40 O3 GOL D1181 B 140 GLU C 17 GLU~? 3.68 CA CA C1182s coo 61.49 19.86 5.96 61.52 19.46 5.16 -38.72 -23.09 41.13 -39.06 -23.23 40.41 coo 63.76 11.90 7.93 65.18 13.07 6.77 -36.99 -14.05 39.90 -36.11 -14.23 37.95 coo 66.44 19.00 7.38 67.69 17.67 8.37 -38.10 -19.90 46.72 -36.47 -20.40 47.99 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 10 3 # 10 A 261 GLY D 24 GLY~? 5.25 CA CA C1182 B 17 GLN C 15 GLN~? 7.40 O3 GOL D1181 B 140 GLU D 27 GLU~? 2.91 CA CA C1182s coo 61.49 19.86 5.96 61.52 19.46 5.16 -38.72 -23.09 41.13 -39.06 -23.23 40.41 coo 63.76 11.90 7.93 65.18 13.07 6.77 -36.99 -14.05 39.90 -36.11 -14.23 37.95 coo 66.44 19.00 7.38 67.69 17.67 8.37 -34.10 -22.57 42.20 -34.50 -23.02 44.23 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 10 hits 1t4c_c02 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 88 SER.? 4.86 OXT ACT A1182 A 90 SER A 89 SER.? 7.33 OXT ACT A1182 A 145 LYS A 93 LYS.? 11.72 OXT ACT A1182 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 1.47 40.03 18.48 2.45 41.37 16.68 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 7.35 44.71 16.29 4.71 40.98 14.52 -36.14 12.80 22.42 -38.75 8.18 20.02 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER A 88 SER.? 4.86 OXT ACT A1182 A 90 SER A 89 SER.? 7.33 OXT ACT A1182 A 145 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 1.47 40.03 18.48 2.45 41.37 16.68 -34.05 3.70 20.21 -34.55 1.39 20.81 coo 7.35 44.71 16.29 4.71 40.98 14.52 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 3 3 # 3 A 88 SER B 32 SER~? 5.72 CA CA B1183 A 90 SER B 31 SER~? 8.40 O1 GOL B1182 A 145 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 1.47 40.03 18.48 2.45 41.37 16.68 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 7.35 44.71 16.29 4.71 40.98 14.52 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 4 3 # 4 A 88 SER B 88 SER.? 4.64 O ACT C1183 A 90 SER B 89 SER.? 7.47 O ACT C1183 A 145 LYS C 72 LYS.? 18.71 O ACT C1183 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 1.47 40.03 18.48 2.45 41.37 16.68 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 7.35 44.71 16.29 4.71 40.98 14.52 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 5 3 # 5 A 88 SER C 32 SER~? 5.57 CA CA C1184 A 90 SER C 31 SER.? 11.23 CA CA C1184 A 145 LYS D 9 LYS~? 18.78 CA CA C1184 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 1.47 40.03 18.48 2.45 41.37 16.68 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 7.35 44.71 16.29 4.71 40.98 14.52 -63.24 -19.53 41.29 -64.69 -19.90 45.47 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 6 3 # 6 A 88 SER C 88 SER.? 4.69 OXT ACT C1183 A 90 SER C 89 SER.? 7.45 OXT ACT C1183 A 145 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 1.47 40.03 18.48 2.45 41.37 16.68 -56.55 7.81 13.84 -56.09 7.66 11.51 coo 7.35 44.71 16.29 4.71 40.98 14.52 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 7 3 # 7 A 88 SER D 88 SER.? 4.67 O ACT A1182 A 90 SER D 89 SER.? 7.37 O ACT A1182 A 145 LYS A 72 LYS.? 19.74 O ACT A1182 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 1.47 40.03 18.48 2.45 41.37 16.68 -34.06 -3.63 6.31 -34.52 -1.34 5.65 coo 7.35 44.71 16.29 4.71 40.98 14.52 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 7 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER B 32 SER~? 5.72 CA CA B1183 B 90 SER B 31 SER~? 8.40 O1 GOL B1182 B 145 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo 61.01 10.03 12.97 58.78 10.97 12.69 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 56.85 12.22 16.37 55.62 11.34 14.45 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 49.80 9.51 14.88 53.14 11.99 12.77 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 2 3 # 2 B 88 SER B 88 SER.? 4.64 O ACT C1183 B 90 SER B 89 SER.? 7.47 O ACT C1183 B 145 LYS C 72 LYS.? 18.71 O ACT C1183 coo 61.01 10.03 12.97 58.78 10.97 12.69 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 56.85 12.22 16.37 55.62 11.34 14.45 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 49.80 9.51 14.88 53.14 11.99 12.77 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 3 3 # 3 B 88 SER C 32 SER~? 5.57 CA CA C1184 B 90 SER C 31 SER.? 11.23 CA CA C1184 B 145 LYS D 9 LYS~? 18.78 CA CA C1184 coo 61.01 10.03 12.97 58.78 10.97 12.69 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 56.85 12.22 16.37 55.62 11.34 14.45 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 49.80 9.51 14.88 53.14 11.99 12.77 -63.24 -19.53 41.29 -64.69 -19.90 45.47 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 3 hits 1t7d_c01 naa= 3 ULMN 3 1tah_c00 LIPASE user 1 3 # 1 B 87 SER C 53 SER^? 12.05 OXT ACT C1183 B 263 ASP C 55 ASP.? 19.45 CA CA C1184 B 285 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1tah_c00 LIPASE user 2 3 # 2 B 87 SER D 53 SER^? 12.18 O ACT A1182 B 263 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 285 HIS D 114 HIS^? 15.97 O ACT A1182 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1tah_c00 source 1tah LIPASE : 2 hits 1tah_c00 naa= 3 ULMN 3 1tah_c01 LIPASE user 1 3 # 1 A 87 SER C 53 SER^? 12.05 OXT ACT C1183 A 263 ASP C 55 ASP.? 19.45 CA CA C1184 A 285 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1tah_c01 LIPASE user 2 3 # 2 A 87 SER D 53 SER^? 12.18 O ACT A1182 A 263 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 285 HIS D 114 HIS^? 15.97 O ACT A1182 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1tah_c01 source 1tah LIPASE : 2 hits 1tah_c01 naa= 3 ULMN 3 1tah_c02 LIPASE user 1 3 # 1 C 87 SER C 53 SER^? 12.05 OXT ACT C1183 C 263 ASP C 55 ASP.? 19.45 CA CA C1184 C 285 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -55.28 0.90 24.40 -56.83 2.38 25.58 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1tah_c02 LIPASE user 2 3 # 2 C 87 SER D 53 SER^? 12.18 O ACT A1182 C 263 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 285 HIS D 114 HIS^? 15.97 O ACT A1182 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1tah_c02 source 1tah LIPASE : 2 hits 1tah_c02 naa= 3 ULMN 3 1tah_c03 LIPASE user 1 3 # 1 D 87 SER C 53 SER^? 12.05 OXT ACT C1183 D 263 ASP C 55 ASP.? 19.45 CA CA C1184 D 285 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -55.28 0.90 24.40 -56.83 2.38 25.58 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1tah_c03 LIPASE user 2 3 # 2 D 87 SER D 53 SER^? 12.18 O ACT A1182 D 263 ASP D 55 ASP.? 17.43 O2 GOL D1181 D 285 HIS D 114 HIS^? 15.97 O ACT A1182 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1tah_c03 source 1tah LIPASE : 2 hits 1tah_c03 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS D 59 HIS~? 14.28 O ACT A1182 A 174 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 404 TYR C 64 TYR~? 13.24 O3 GOL D1181 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -49.46 -10.91 25.49 -49.72 -13.40 26.79 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS D 59 HIS~? 14.28 O ACT A1182 C 174 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 404 TYR C 64 TYR~? 13.24 O3 GOL D1181 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -49.46 -10.91 25.49 -49.72 -13.40 26.79 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS D 59 HIS~? 14.28 O ACT A1182 E 174 ASP D 55 ASP.? 17.43 O2 GOL D1181 E 404 TYR C 64 TYR~? 13.24 O3 GOL D1181 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -49.46 -10.91 25.49 -49.72 -13.40 26.79 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 59 HIS~? 15.34 OXT ACT A1182 G 174 ASP A 55 ASP.? 17.41 O ACT A1181 G 404 TYR B 64 TYR~? 13.94 OXT ACT A1181 coo 60.48-101.16 45.95 60.56-101.20 43.85 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 58.10-108.15 40.62 59.57-106.86 41.51 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -49.49 10.87 0.95 -49.71 13.38 -0.30 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS B 59 HIS~? 15.18 O ACT C1183 G 174 ASP B 55 ASP.? 14.29 O3 GOL B1182 G 404 TYR A 64 TYR~? 13.66 OXT ACT A1181 coo 60.48-101.16 45.95 60.56-101.20 43.85 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 58.10-108.15 40.62 59.57-106.86 41.51 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -41.23 7.24 -1.52 -40.97 7.41 -4.31 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS C 59 HIS~? 15.17 OXT ACT C1183 G 174 ASP C 55 ASP.? 19.45 CA CA C1184 G 404 TYR D 64 TYR~? 12.19 O3 GOL D1181 coo 60.48-101.16 45.95 60.56-101.20 43.85 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 58.10-108.15 40.62 59.57-106.86 41.51 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -41.23 -7.21 27.99 -40.99 -7.39 30.78 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 G 144 HIS D 59 HIS~? 14.28 O ACT A1182 G 174 ASP D 55 ASP.? 17.43 O2 GOL D1181 G 404 TYR C 64 TYR~? 13.24 O3 GOL D1181 coo 60.48-101.16 45.95 60.56-101.20 43.85 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 58.10-108.15 40.62 59.57-106.86 41.51 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -49.46 -10.91 25.49 -49.72 -13.40 26.79 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS D 59 HIS~? 14.28 O ACT A1182 I 174 ASP D 55 ASP.? 17.43 O2 GOL D1181 I 404 TYR C 64 TYR~? 13.24 O3 GOL D1181 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -49.46 -10.91 25.49 -49.72 -13.40 26.79 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 59 HIS~? 15.34 OXT ACT A1182 K 174 ASP A 55 ASP.? 17.41 O ACT A1181 K 404 TYR B 64 TYR~? 13.94 OXT ACT A1181 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 102.36 30.86 6.31 102.45 29.08 5.12 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -49.49 10.87 0.95 -49.71 13.38 -0.30 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS B 59 HIS~? 15.18 O ACT C1183 K 174 ASP B 55 ASP.? 14.29 O3 GOL B1182 K 404 TYR A 64 TYR~? 13.66 OXT ACT A1181 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 102.36 30.86 6.31 102.45 29.08 5.12 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -41.23 7.24 -1.52 -40.97 7.41 -4.31 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS C 59 HIS~? 15.17 OXT ACT C1183 K 174 ASP C 55 ASP.? 19.45 CA CA C1184 K 404 TYR D 64 TYR~? 12.19 O3 GOL D1181 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 102.36 30.86 6.31 102.45 29.08 5.12 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -41.23 -7.21 27.99 -40.99 -7.39 30.78 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 K 144 HIS D 59 HIS~? 14.28 O ACT A1182 K 174 ASP D 55 ASP.? 17.43 O2 GOL D1181 K 404 TYR C 64 TYR~? 13.24 O3 GOL D1181 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 102.36 30.86 6.31 102.45 29.08 5.12 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -49.46 -10.91 25.49 -49.72 -13.40 26.79 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c11 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 96 ALA~? 16.98 OXT ACT A1182 A 251 GLY A 122 GLY~? 17.38 OXT ACT A1182 A 252 ASP A 95 ASP~? 18.75 OXT ACT A1182 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -28.64 14.50 22.33 -28.62 15.76 21.46 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -31.93 16.98 20.49 -32.19 17.34 19.79 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -30.02 14.86 26.58 -28.64 13.51 27.46 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 1 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 96 ALA~? 16.98 OXT ACT A1182 B 251 GLY A 122 GLY~? 17.38 OXT ACT A1182 B 252 ASP A 95 ASP~? 18.75 OXT ACT A1182 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -28.64 14.50 22.33 -28.62 15.76 21.46 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -31.93 16.98 20.49 -32.19 17.34 19.79 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -30.02 14.86 26.58 -28.64 13.51 27.46 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 1 hits 1tz3_c03 naa= 3 ULMN 3 1uaq_c00 CYTOSINE DEAMINASE user 1 3 # 1 A 64 GLU C 143 GLU.? 3.32 CA CA C1184s A 89 SER C 32 SER~? 5.57 CA CA C1184 A 91 CYH C 145 CYH.? 5.42 CA CA C1184 coo -18.27 -3.12 10.92 -16.30 -3.26 10.07 -67.43 0.61 42.53 -66.07 0.84 44.19 coo -16.83 -3.83 3.62 -17.28 -5.61 2.05 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo -13.84 -8.33 7.58 -13.00 -8.13 10.24 -62.51 -1.53 37.02 -61.06 0.37 38.52 1uaq_c00 source 1uaq CYTOSINE DEAMINASE : 1 hits 1uaq_c00 naa= 3 ULMN 3 1uaq_c01 CYTOSINE DEAMINASE user 1 3 # 1 B 64 GLU C 143 GLU.? 3.32 CA CA C1184s B 89 SER C 32 SER~? 5.57 CA CA C1184 B 91 CYH C 145 CYH.? 5.42 CA CA C1184 coo -13.67 -17.67 21.70 -15.74 -17.78 22.24 -67.43 0.61 42.53 -66.07 0.84 44.19 coo -17.71 -23.81 20.93 -18.57 -24.92 18.94 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo -20.38 -18.31 18.13 -20.06 -15.64 18.96 -62.51 -1.53 37.02 -61.06 0.37 38.52 1uaq_c01 source 1uaq CYTOSINE DEAMINASE : 1 hits 1uaq_c01 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 151 HIS.? 15.84 O ACT A1181 89 GLU A 150 GLU.? 17.29 O ACT A1181 243 ASN B 168 ASN~? 15.62 CH3 ACT A1181 coo 5.83 15.74 17.38 6.41 17.70 17.86 -46.06 27.03 4.30 -45.69 27.09 6.36 coo 3.11 16.19 13.44 4.96 17.09 13.42 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 0.53 21.81 31.33 1.05 20.47 29.70 -59.27 19.54 -3.77 -57.59 20.58 -3.04 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS B 151 HIS.? 14.53 O3 GOL B1182 89 GLU B 150 GLU.? 13.13 O3 GOL B1182 243 ASN A 168 ASN~? 15.32 OXT ACT A1181 coo 5.83 15.74 17.38 6.41 17.70 17.86 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 3.11 16.19 13.44 4.96 17.09 13.42 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 0.53 21.81 31.33 1.05 20.47 29.70 -31.58 8.23 -11.56 -33.27 7.25 -12.34 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS C 151 HIS.? 19.99 CA CA C1184 89 GLU C 150 GLU.? 16.95 CA CA C1184 243 ASN D 168 ASN~? 14.11 O3 GOL D1181 coo 5.83 15.74 17.38 6.41 17.70 17.86 -44.62 2.10 41.60 -44.48 3.82 40.41 coo 3.11 16.19 13.44 4.96 17.09 13.42 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 0.53 21.81 31.33 1.05 20.47 29.70 -31.58 -8.23 38.03 -33.25 -7.24 38.84 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 4 3 # 4 86 HIS D 151 HIS.? 15.73 O2 GOL D1181 89 GLU D 150 GLU.? 17.20 O2 GOL D1181 243 ASN C 168 ASN~? 14.78 C1 GOL D1181 coo 5.83 15.74 17.38 6.41 17.70 17.86 -45.79 -27.28 22.21 -45.52 -27.23 20.13 coo 3.11 16.19 13.44 4.96 17.09 13.42 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 0.53 21.81 31.33 1.05 20.47 29.70 -59.24 -19.55 30.22 -57.56 -20.59 29.47 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 4 hits 1ula_c00 naa= 3 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 A 85 GLU A 140 GLU.? 22.35 O ACT A1181 A 87 ASP A 144 ASP.? 22.46 O ACT A1181 A 89 GLU A 143 GLU.? 25.89 CH3 ACT A1182 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -27.69 26.26 5.34 -26.17 27.35 4.33 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -21.50 21.88 6.93 -19.95 23.25 7.45 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 A 85 GLU A 143 GLU.? 25.89 CH3 ACT A1182 A 87 ASP A 144 ASP.? 22.46 O ACT A1181 A 89 GLU A 140 GLU.? 22.35 O ACT A1181 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -21.50 21.88 6.93 -19.95 23.25 7.45 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -27.69 26.26 5.34 -26.17 27.35 4.33 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 3 3 # 3 A 85 GLU D 10 GLU~? 18.53 CA CA C1181 A 87 ASP D 14 ASP~? 14.81 O1 GOL D1181 A 89 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -62.08 -25.49 39.96 -63.41 -27.01 39.21 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -53.10 -23.91 44.12 -54.66 -25.27 44.77 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 4 3 # 4 A 85 GLU D 17 GLU~? 13.36 O1 GOL D1181 A 87 ASP D 14 ASP~? 14.81 O1 GOL D1181 A 89 GLU D 10 GLU~? 18.53 CA CA C1181 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -53.10 -23.91 44.12 -54.66 -25.27 44.77 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -62.08 -25.49 39.96 -63.41 -27.01 39.21 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 5 3 # 5 A 85 GLU D 143 GLU.? 26.04 CH3 ACT A1182 A 87 ASP D 144 ASP.? 22.37 O2 GOL D1181 A 89 GLU D 140 GLU.? 20.95 O2 GOL D1181 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -21.61 -22.24 19.24 -19.70 -23.15 19.54 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -27.73 -26.26 21.28 -26.82 -26.69 23.16 1un1_c00 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 5 hits 1un1_c00 naa= 3 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 B 85 GLU A 140 GLU.? 22.35 O ACT A1181 B 87 ASP A 144 ASP.? 22.46 O ACT A1181 B 89 GLU A 143 GLU.? 25.89 CH3 ACT A1182 coo 19.32 178.30 3.72 20.56 176.87 2.77 -27.69 26.26 5.34 -26.17 27.35 4.33 coo 22.91 179.81 6.56 22.10 178.65 5.00 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 26.74 177.55 7.48 27.16 177.47 5.41 -21.50 21.88 6.93 -19.95 23.25 7.45 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 B 85 GLU A 143 GLU.? 25.89 CH3 ACT A1182 B 87 ASP A 144 ASP.? 22.46 O ACT A1181 B 89 GLU A 140 GLU.? 22.35 O ACT A1181 coo 19.32 178.30 3.72 20.56 176.87 2.77 -21.50 21.88 6.93 -19.95 23.25 7.45 coo 22.91 179.81 6.56 22.10 178.65 5.00 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 26.74 177.55 7.48 27.16 177.47 5.41 -27.69 26.26 5.34 -26.17 27.35 4.33 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 3 3 # 3 B 85 GLU D 10 GLU~? 18.53 CA CA C1181 B 87 ASP D 14 ASP~? 14.81 O1 GOL D1181 B 89 GLU D 17 GLU~? 13.36 O1 GOL D1181 coo 19.32 178.30 3.72 20.56 176.87 2.77 -62.08 -25.49 39.96 -63.41 -27.01 39.21 coo 22.91 179.81 6.56 22.10 178.65 5.00 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 26.74 177.55 7.48 27.16 177.47 5.41 -53.10 -23.91 44.12 -54.66 -25.27 44.77 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 4 3 # 4 B 85 GLU D 17 GLU~? 13.36 O1 GOL D1181 B 87 ASP D 14 ASP~? 14.81 O1 GOL D1181 B 89 GLU D 10 GLU~? 18.53 CA CA C1181 coo 19.32 178.30 3.72 20.56 176.87 2.77 -53.10 -23.91 44.12 -54.66 -25.27 44.77 coo 22.91 179.81 6.56 22.10 178.65 5.00 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 26.74 177.55 7.48 27.16 177.47 5.41 -62.08 -25.49 39.96 -63.41 -27.01 39.21 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 5 3 # 5 B 85 GLU D 143 GLU.? 26.04 CH3 ACT A1182 B 87 ASP D 144 ASP.? 22.37 O2 GOL D1181 B 89 GLU D 140 GLU.? 20.95 O2 GOL D1181 coo 19.32 178.30 3.72 20.56 176.87 2.77 -21.61 -22.24 19.24 -19.70 -23.15 19.54 coo 22.91 179.81 6.56 22.10 178.65 5.00 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 26.74 177.55 7.48 27.16 177.47 5.41 -27.73 -26.26 21.28 -26.82 -26.69 23.16 1un1_c01 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 5 hits 1un1_c01 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 156 ASP~? 10.59 O ACT A1181 218 GLU B 121 GLU~? 20.57 CA CA B1183 329 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 70.09 11.71 8.46 70.56 12.89 6.77 -56.51 -16.27 -4.35 -57.29 -15.23 -6.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 156 ASP~? 10.59 O ACT A1181 218 GLU B 143 GLU.? -7.19 CA CA B1183s 329 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 70.09 11.71 8.46 70.56 12.89 6.77 -68.55 -1.90 -14.29 -70.34 -1.88 -15.47 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP B 73 ASP.? 22.00 OXT ACT C1183 218 GLU B 104 GLU~? 15.50 CH3 ACT C1183 329 ASP C 95 ASP~? 18.98 OXT ACT C1183 coo 49.16 35.16 15.19 51.08 34.43 15.65 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 70.09 11.71 8.46 70.56 12.89 6.77 -69.87 -6.96 6.25 -71.31 -7.55 4.87 coo 59.16 37.82 13.95 57.63 37.03 15.12 -60.88 17.87 20.49 -62.76 18.57 19.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 73 ASP.? 22.00 OXT ACT C1183 218 GLU C 150 GLU.? 16.95 CA CA C1184 329 ASP C 95 ASP~? 18.98 OXT ACT C1183 coo 49.16 35.16 15.19 51.08 34.43 15.65 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 70.09 11.71 8.46 70.56 12.89 6.77 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 -60.88 17.87 20.49 -62.76 18.57 19.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 156 ASP~? 13.25 OXT ACT A1181 218 GLU A 121 GLU~? 23.87 OXT ACT A1182 329 ASP A 156 ASP~? 10.59 O ACT A1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 70.09 11.71 8.46 70.56 12.89 6.77 -33.98 22.68 21.15 -32.78 23.95 19.94 coo 59.16 37.82 13.95 57.63 37.03 15.12 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 156 ASP~? 13.25 OXT ACT A1181 218 GLU A 143 GLU.? 25.89 CH3 ACT A1182 329 ASP A 156 ASP~? 10.59 O ACT A1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 70.09 11.71 8.46 70.56 12.89 6.77 -21.50 21.88 6.93 -19.95 23.25 7.45 coo 59.16 37.82 13.95 57.63 37.03 15.12 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP C 73 ASP.? 22.09 O ACT C1183 218 GLU C 104 GLU~? 15.46 CH3 ACT C1183 329 ASP B 95 ASP.? 16.79 O ACT C1183 coo 49.16 35.16 15.19 51.08 34.43 15.65 -52.43 -20.77 12.85 -53.47 -22.46 12.11 coo 70.09 11.71 8.46 70.56 12.89 6.77 -69.83 7.02 20.20 -71.35 7.54 21.51 coo 59.16 37.82 13.95 57.63 37.03 15.12 -58.00 -16.84 6.87 -57.88 -17.33 8.94 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP C 156 ASP~? 12.06 O3 GOL D1181 218 GLU D 121 GLU~? 23.78 O ACT A1182 329 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 70.09 11.71 8.46 70.56 12.89 6.77 -33.90 -22.59 5.14 -32.85 -23.80 6.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP C 156 ASP~? 12.06 O3 GOL D1181 218 GLU D 143 GLU.? 26.04 CH3 ACT A1182 329 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 70.09 11.71 8.46 70.56 12.89 6.77 -21.61 -22.24 19.24 -19.70 -23.15 19.54 coo 59.16 37.82 13.95 57.63 37.03 15.12 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP D 156 ASP~? 10.44 C2 GOL D1181 218 GLU C 121 GLU~? 20.76 CA CA C1184 329 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 -56.38 16.29 30.73 -57.04 15.33 32.51 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.46 -7.83 33.81 -43.76 -5.84 33.54 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 10 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 84 ASP^? 7.98 OXT ACT A1182 242 GLU A 150 GLU.? 17.29 O ACT A1181 329 ASP D 84 ASP^? 8.02 O ACT A1182 coo 49.16 35.16 15.19 51.08 34.43 15.65 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 30.42 34.74 5.00 29.09 35.09 3.38 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 59.16 37.82 13.95 57.63 37.03 15.12 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 95 ASP~? 18.75 OXT ACT A1182 242 GLU A 139 GLU.? 21.64 O ACT A1181 329 ASP D 73 ASP.? 21.98 OXT ACT A1182 coo 49.16 35.16 15.19 51.08 34.43 15.65 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 30.42 34.74 5.00 29.09 35.09 3.38 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 -38.49 8.41 31.97 -37.49 9.71 33.33 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 156 ASP~? 10.59 O ACT A1181 242 GLU B 76 GLU.? 18.73 CA CA B1181 329 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 30.42 34.74 5.00 29.09 35.09 3.38 -61.39 25.88 12.33 -62.09 25.88 14.33 coo 59.16 37.82 13.95 57.63 37.03 15.12 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 156 ASP~? 10.59 O ACT A1181 242 GLU B 150 GLU.? 13.13 O3 GOL B1182 329 ASP A 152 ASP.? 5.90 O ACT A1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 59.16 37.82 13.95 57.63 37.03 15.12 -43.60 24.63 -2.03 -43.51 24.01 -4.05 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 73 ASP.? 22.00 OXT ACT C1183 242 GLU A 139 GLU.? 21.64 O ACT A1181 329 ASP C 95 ASP~? 18.98 OXT ACT C1183 coo 49.16 35.16 15.19 51.08 34.43 15.65 -52.42 20.74 13.73 -53.54 22.42 14.42 coo 30.42 34.74 5.00 29.09 35.09 3.38 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 -60.88 17.87 20.49 -62.76 18.57 19.77 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 84 ASP^? 7.80 O ACT C1183 242 GLU B 139 GLU.? 13.29 O3 GOL B1182 329 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 49.16 35.16 15.19 51.08 34.43 15.65 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 30.42 34.74 5.00 29.09 35.09 3.38 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 84 ASP^? 7.80 O ACT C1183 242 GLU B 150 GLU.? 13.13 O3 GOL B1182 329 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 49.16 35.16 15.19 51.08 34.43 15.65 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 59.16 37.82 13.95 57.63 37.03 15.12 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 95 ASP.? 16.79 O ACT C1183 242 GLU B 139 GLU.? 13.29 O3 GOL B1182 329 ASP C 73 ASP.? 22.09 O ACT C1183 coo 49.16 35.16 15.19 51.08 34.43 15.65 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 30.42 34.74 5.00 29.09 35.09 3.38 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.43 -20.77 12.85 -53.47 -22.46 12.11 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 156 ASP~? 13.25 OXT ACT A1181 242 GLU A 76 GLU.? 24.24 O ACT A1182 329 ASP A 156 ASP~? 10.59 O ACT A1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 30.42 34.74 5.00 29.09 35.09 3.38 -29.57 -9.56 -10.67 -29.13 -11.11 -9.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP B 156 ASP~? 13.25 OXT ACT A1181 242 GLU A 150 GLU.? 17.29 O ACT A1181 329 ASP B 152 ASP.? 8.52 O3 GOL B1182 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 30.42 34.74 5.00 29.09 35.09 3.38 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 59.16 37.82 13.95 57.63 37.03 15.12 -47.04 4.74 -15.30 -47.17 6.82 -15.76 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP C 84 ASP^? 7.78 OXT ACT C1183 242 GLU C 150 GLU.? 16.95 CA CA C1184 329 ASP B 84 ASP^? 7.80 O ACT C1183 coo 49.16 35.16 15.19 51.08 34.43 15.65 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP C 156 ASP~? 12.06 O3 GOL D1181 242 GLU D 76 GLU.? 25.58 OXT ACT A1182 329 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -29.91 8.45 37.88 -28.84 10.23 37.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 -46.26 -16.01 28.32 -46.92 -16.52 26.38 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP C 156 ASP~? 12.06 O3 GOL D1181 242 GLU D 150 GLU.? 17.20 O2 GOL D1181 329 ASP C 152 ASP.? 13.45 O3 GOL D1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 59.16 37.82 13.95 57.63 37.03 15.12 -47.03 -4.77 41.79 -47.13 -6.84 42.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP D 84 ASP^? 8.02 O ACT A1182 242 GLU D 150 GLU.? 17.20 O2 GOL D1181 329 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 49.16 35.16 15.19 51.08 34.43 15.65 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 30.42 34.74 5.00 29.09 35.09 3.38 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 59.16 37.82 13.95 57.63 37.03 15.12 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP D 156 ASP~? 10.44 C2 GOL D1181 242 GLU C 150 GLU.? 16.95 CA CA C1184 329 ASP D 152 ASP.? 5.75 O2 GOL D1181 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 59.16 37.82 13.95 57.63 37.03 15.12 -43.59 -24.59 28.46 -43.51 -24.00 30.49 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 15 hits 1uok_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN B 94 ASN.? 19.97 O ACT C1183 457 GLY B 122 GLY~? 17.40 O ACT C1183 459 GLU B 121 GLU~? 20.57 CA CA B1183 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -55.90 -18.81 5.77 -53.88 -19.30 6.35 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -56.51 -16.27 -4.35 -57.29 -15.23 -6.03 1vom_c00 source 1vom MYOSIN : 1 hits 1vom_c00 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 33 TYR~? 13.22 O ACT A1181 A 317 GLU A 29 GLU~? 11.10 O ACT A1181 A 365 ARG B 13 ARG~? 17.43 OXT ACT A1181 coo 1.77 6.56 57.05 3.05 7.44 59.37 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 3.06 2.85 52.79 4.83 3.89 53.24 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 3.82 17.09 49.56 4.09 14.32 50.84 -32.45 21.03 -20.61 -29.60 19.86 -21.02 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR B 33 TYR~? -4.73 C1 GOL B1182s A 317 GLU B 29 GLU~? -3.75 O1 GOL B1182s A 365 ARG A 13 ARG~? 17.46 CH3 ACT A1181 coo 1.77 6.56 57.05 3.05 7.44 59.37 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 3.06 2.85 52.79 4.83 3.89 53.24 -57.44 9.91 -17.53 -57.08 7.94 -18.23 coo 3.82 17.09 49.56 4.09 14.32 50.84 -58.47 23.67 -18.83 -59.87 25.50 -16.74 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR D 33 TYR~? 12.91 O3 GOL D1181 A 317 GLU D 29 GLU~? 11.05 O2 GOL D1181 A 365 ARG C 13 ARG~? 8.07 CA CA C1182 coo 1.77 6.56 57.05 3.05 7.44 59.37 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 3.06 2.85 52.79 4.83 3.89 53.24 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo 3.82 17.09 49.56 4.09 14.32 50.84 -32.51 -20.88 47.20 -29.56 -20.08 47.23 1vzx_c02 source 1vzx 2.04.01.0087 : 3 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 33 TYR~? 13.22 O ACT A1181 B1317 GLU A 29 GLU~? 11.10 O ACT A1181 B1365 ARG B 13 ARG~? 17.43 OXT ACT A1181 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -32.63 23.57 -6.21 -33.51 24.93 -4.84 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -32.45 21.03 -20.61 -29.60 19.86 -21.02 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR B 33 TYR~? -4.73 C1 GOL B1182s B1317 GLU B 29 GLU~? -3.75 O1 GOL B1182s B1365 ARG A 13 ARG~? 17.46 CH3 ACT A1181 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -57.44 9.91 -17.53 -57.08 7.94 -18.23 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -58.47 23.67 -18.83 -59.87 25.50 -16.74 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR D 33 TYR~? 12.91 O3 GOL D1181 B1317 GLU D 29 GLU~? 11.05 O2 GOL D1181 B1365 ARG C 13 ARG~? 8.07 CA CA C1182 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -32.61 -23.54 32.68 -33.42 -24.92 31.28 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -32.51 -20.88 47.20 -29.56 -20.08 47.23 1vzx_c03 source 1vzx 2.04.01.0087 : 3 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 33 TYR~? 13.22 O ACT A1181 A 40 ASP A 144 ASP.? 22.46 O ACT A1181 A 103 LEU A 146 LEU^? 13.59 O ACT A1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 7.55 25.51 14.34 9.65 25.73 14.24 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 11.83 18.73 16.99 10.99 19.71 15.26 -31.13 19.53 -0.53 -32.02 18.95 -2.45 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 40 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 103 LEU A 62 LEU~? 11.91 OXT ACT A1182 coo 12.09 16.13 10.57 11.28 18.80 10.73 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 7.55 25.51 14.34 9.65 25.73 14.24 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 11.83 18.73 16.99 10.99 19.71 15.26 -39.55 8.38 6.71 -38.08 7.45 8.12 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 40 ASP A 156 ASP~? 10.59 O ACT A1181 A 103 LEU A 160 LEU~? 8.80 OXT ACT A1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 7.55 25.51 14.34 9.65 25.73 14.24 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 11.83 18.73 16.99 10.99 19.71 15.26 -41.85 11.99 -5.74 -43.38 10.84 -4.79 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR A 91 TYR.? 11.44 OXT ACT A1182 A 40 ASP A 55 ASP.? 17.41 O ACT A1181 A 103 LEU A 123 LEU~? 14.88 OXT ACT A1182 coo 12.09 16.13 10.57 11.28 18.80 10.73 -35.52 10.03 17.00 -36.51 12.40 15.90 coo 7.55 25.51 14.34 9.65 25.73 14.24 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 11.83 18.73 16.99 10.99 19.71 15.26 -33.56 16.12 15.97 -33.69 15.04 14.07 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR A 107 TYR~? -4.55 CH3 ACT A1182s A 40 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 103 LEU A 51 LEU^? 7.18 CH3 ACT A1182 coo 12.09 16.13 10.57 11.28 18.80 10.73 -24.81 2.99 13.30 -27.48 2.42 13.94 coo 7.55 25.51 14.34 9.65 25.73 14.24 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 11.83 18.73 16.99 10.99 19.71 15.26 -29.07 7.28 10.42 -27.57 6.02 11.41 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR A 157 TYR~? 5.66 OXT ACT A1181 A 40 ASP A 152 ASP.? 5.90 O ACT A1181 A 103 LEU A 159 LEU~? 10.10 O ACT A1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 7.55 25.51 14.34 9.65 25.73 14.24 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 11.83 18.73 16.99 10.99 19.71 15.26 -40.53 14.98 -1.43 -40.24 16.08 0.45 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR B 33 TYR~? -4.73 C1 GOL B1182s A 40 ASP B 144 ASP.? 6.66 CA CA B1183 A 103 LEU B 146 LEU^? -4.12 O2 GOL B1182s coo 12.09 16.13 10.57 11.28 18.80 10.73 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 7.55 25.51 14.34 9.65 25.73 14.24 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 11.83 18.73 16.99 10.99 19.71 15.26 -59.25 4.86 -9.92 -58.23 6.70 -10.06 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 40 ASP B 84 ASP^? 7.80 O ACT C1183 A 103 LEU B 62 LEU~? 11.69 O ACT C1183 coo 12.09 16.13 10.57 11.28 18.80 10.73 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 7.55 25.51 14.34 9.65 25.73 14.24 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 11.83 18.73 16.99 10.99 19.71 15.26 -51.17 2.84 3.08 -52.53 1.95 4.64 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 40 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 103 LEU B 160 LEU~? 9.59 OXT ACT A1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 7.55 25.51 14.34 9.65 25.73 14.24 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 11.83 18.73 16.99 10.99 19.71 15.26 -48.88 12.92 -5.16 -47.30 12.65 -3.74 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR B 91 TYR.? 11.41 O ACT C1183 A 40 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 103 LEU B 123 LEU~? 14.76 O ACT C1183 coo 12.09 16.13 10.57 11.28 18.80 10.73 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 7.55 25.51 14.34 9.65 25.73 14.24 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 11.83 18.73 16.99 10.99 19.71 15.26 -56.96 -8.84 -0.37 -56.82 -6.67 -0.15 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR B 107 TYR~? -4.64 CH3 ACT C1183s A 40 ASP B 84 ASP^? 7.80 O ACT C1183 A 103 LEU B 51 LEU^? 7.28 CH3 ACT C1183 coo 12.09 16.13 10.57 11.28 18.80 10.73 -65.76 -1.20 10.47 -63.11 -1.54 11.28 coo 7.55 25.51 14.34 9.65 25.73 14.24 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 11.83 18.73 16.99 10.99 19.71 15.26 -61.53 -0.27 5.43 -63.08 -0.69 6.89 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 12 3 # 12 A 16 TYR B 157 TYR~? 6.24 OXT ACT A1181 A 40 ASP A 156 ASP~? 10.59 O ACT A1181 A 103 LEU A 160 LEU~? 8.80 OXT ACT A1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo 7.55 25.51 14.34 9.65 25.73 14.24 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 11.83 18.73 16.99 10.99 19.71 15.26 -41.85 11.99 -5.74 -43.38 10.84 -4.79 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 13 3 # 13 A 16 TYR B 157 TYR~? 6.24 OXT ACT A1181 A 40 ASP A 156 ASP~? 10.59 O ACT A1181 A 103 LEU B 159 LEU~? 9.18 O3 GOL B1182 coo 12.09 16.13 10.57 11.28 18.80 10.73 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo 7.55 25.51 14.34 9.65 25.73 14.24 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 11.83 18.73 16.99 10.99 19.71 15.26 -50.12 7.79 -6.19 -50.39 5.62 -6.50 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 14 3 # 14 A 16 TYR B 157 TYR~? 6.24 OXT ACT A1181 A 40 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 103 LEU B 159 LEU~? 9.18 O3 GOL B1182 coo 12.09 16.13 10.57 11.28 18.80 10.73 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo 7.55 25.51 14.34 9.65 25.73 14.24 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 11.83 18.73 16.99 10.99 19.71 15.26 -50.12 7.79 -6.19 -50.39 5.62 -6.50 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 15 3 # 15 A 16 TYR C 33 TYR~? 11.20 CA CA C1184 A 40 ASP C 144 ASP.? 6.69 CA CA C1184 A 103 LEU C 146 LEU^? 9.32 CA CA C1184 coo 12.09 16.13 10.57 11.28 18.80 10.73 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo 7.55 25.51 14.34 9.65 25.73 14.24 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 11.83 18.73 16.99 10.99 19.71 15.26 -59.22 -4.94 36.47 -58.09 -6.73 36.70 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 16 3 # 16 A 16 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 40 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 103 LEU C 160 LEU~? 8.91 O3 GOL D1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 7.55 25.51 14.34 9.65 25.73 14.24 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 11.83 18.73 16.99 10.99 19.71 15.26 -48.88 -12.94 31.66 -47.29 -12.69 30.23 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 17 3 # 17 A 16 TYR C 91 TYR.? 11.38 OXT ACT C1183 A 40 ASP C 55 ASP.? 19.45 CA CA C1184 A 103 LEU C 123 LEU~? 14.68 OXT ACT C1183 coo 12.09 16.13 10.57 11.28 18.80 10.73 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 7.55 25.51 14.34 9.65 25.73 14.24 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 11.83 18.73 16.99 10.99 19.71 15.26 -56.96 8.82 26.82 -56.82 6.64 26.57 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 18 3 # 18 A 16 TYR C 107 TYR~? -4.63 CH3 ACT C1183s A 40 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 103 LEU C 51 LEU^? 7.28 CH3 ACT C1183 coo 12.09 16.13 10.57 11.28 18.80 10.73 -65.75 1.19 15.99 -63.10 1.53 15.19 coo 7.55 25.51 14.34 9.65 25.73 14.24 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 11.83 18.73 16.99 10.99 19.71 15.26 -61.54 0.26 21.05 -63.07 0.75 19.58 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 19 3 # 19 A 16 TYR C 157 TYR~? 5.26 O3 GOL D1181 A 40 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 103 LEU C 159 LEU~? 13.80 O3 GOL D1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo 7.55 25.51 14.34 9.65 25.73 14.24 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 11.83 18.73 16.99 10.99 19.71 15.26 -50.12 -7.78 32.65 -50.39 -5.65 32.94 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 20 3 # 20 A 16 TYR C 157 TYR~? 5.26 O3 GOL D1181 A 40 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 103 LEU C 159 LEU~? 13.80 O3 GOL D1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo 7.55 25.51 14.34 9.65 25.73 14.24 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 11.83 18.73 16.99 10.99 19.71 15.26 -50.12 -7.78 32.65 -50.39 -5.65 32.94 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 21 3 # 21 A 16 TYR C 157 TYR~? 5.26 O3 GOL D1181 A 40 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 103 LEU D 160 LEU~? 7.46 O3 GOL D1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo 7.55 25.51 14.34 9.65 25.73 14.24 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 11.83 18.73 16.99 10.99 19.71 15.26 -41.83 -11.95 32.17 -43.38 -10.80 31.19 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 22 3 # 22 A 16 TYR D 33 TYR~? 12.91 O3 GOL D1181 A 40 ASP D 144 ASP.? 22.37 O2 GOL D1181 A 103 LEU D 146 LEU^? 13.45 O3 GOL D1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 7.55 25.51 14.34 9.65 25.73 14.24 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 11.83 18.73 16.99 10.99 19.71 15.26 -31.14 -19.51 26.95 -31.88 -19.07 28.95 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 23 3 # 23 A 16 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 40 ASP D 84 ASP^? 8.02 O ACT A1182 A 103 LEU D 62 LEU~? 11.93 O ACT A1182 coo 12.09 16.13 10.57 11.28 18.80 10.73 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 7.55 25.51 14.34 9.65 25.73 14.24 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 11.83 18.73 16.99 10.99 19.71 15.26 -39.56 -8.35 19.75 -38.00 -7.51 18.39 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 24 3 # 24 A 16 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 40 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 103 LEU D 160 LEU~? 7.46 O3 GOL D1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 7.55 25.51 14.34 9.65 25.73 14.24 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 11.83 18.73 16.99 10.99 19.71 15.26 -41.83 -11.95 32.17 -43.38 -10.80 31.19 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 25 3 # 25 A 16 TYR D 91 TYR.? 11.52 O ACT A1182 A 40 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 103 LEU D 123 LEU~? 14.95 O ACT A1182 coo 12.09 16.13 10.57 11.28 18.80 10.73 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo 7.55 25.51 14.34 9.65 25.73 14.24 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 11.83 18.73 16.99 10.99 19.71 15.26 -33.63 -16.15 10.50 -33.77 -15.05 12.40 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 26 3 # 26 A 16 TYR D 107 TYR~? -4.59 CH3 ACT A1182s A 40 ASP D 84 ASP^? 8.02 O ACT A1182 A 103 LEU D 51 LEU^? 7.25 CH3 ACT A1182 coo 12.09 16.13 10.57 11.28 18.80 10.73 -24.79 -2.98 13.13 -27.46 -2.42 12.49 coo 7.55 25.51 14.34 9.65 25.73 14.24 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 11.83 18.73 16.99 10.99 19.71 15.26 -29.09 -7.29 16.02 -27.53 -6.11 15.07 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 27 3 # 27 A 16 TYR D 157 TYR~? -5.31 C1 GOL D1181s A 40 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 103 LEU C 160 LEU~? 8.91 O3 GOL D1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 7.55 25.51 14.34 9.65 25.73 14.24 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 11.83 18.73 16.99 10.99 19.71 15.26 -48.88 -12.94 31.66 -47.29 -12.69 30.23 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 28 3 # 28 A 16 TYR D 157 TYR~? -5.31 C1 GOL D1181s A 40 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 103 LEU D 159 LEU~? 9.28 O3 GOL D1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 7.55 25.51 14.34 9.65 25.73 14.24 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 11.83 18.73 16.99 10.99 19.71 15.26 -40.54 -14.98 27.89 -40.25 -16.05 25.99 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 29 3 # 29 A 16 TYR D 157 TYR~? -5.31 C1 GOL D1181s A 40 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 103 LEU D 159 LEU~? 9.28 O3 GOL D1181 coo 12.09 16.13 10.57 11.28 18.80 10.73 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 7.55 25.51 14.34 9.65 25.73 14.24 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 11.83 18.73 16.99 10.99 19.71 15.26 -40.54 -14.98 27.89 -40.25 -16.05 25.99 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 29 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 33 TYR~? 13.22 O ACT A1181 B 40 ASP A 144 ASP.? 22.46 O ACT A1181 B 103 LEU A 36 LEU~? 19.03 O ACT A1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 9.39 10.77 34.53 11.50 10.63 34.41 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 12.89 17.60 31.13 12.34 16.51 32.90 -25.97 17.47 -1.20 -25.68 19.48 -0.33 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 33 TYR~? 13.22 O ACT A1181 B 40 ASP A 144 ASP.? 22.46 O ACT A1181 B 103 LEU A 146 LEU^? 13.59 O ACT A1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 9.39 10.77 34.53 11.50 10.63 34.41 -24.09 23.13 1.13 -22.88 24.73 0.42 coo 12.89 17.60 31.13 12.34 16.51 32.90 -31.13 19.53 -0.53 -32.02 18.95 -2.45 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR A 64 TYR~? 13.66 OXT ACT A1181 B 40 ASP A 156 ASP~? 10.59 O ACT A1181 B 103 LEU A 160 LEU~? 8.80 OXT ACT A1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 9.39 10.77 34.53 11.50 10.63 34.41 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 12.89 17.60 31.13 12.34 16.51 32.90 -41.85 11.99 -5.74 -43.38 10.84 -4.79 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR A 91 TYR.? 11.44 OXT ACT A1182 B 40 ASP A 55 ASP.? 17.41 O ACT A1181 B 103 LEU A 123 LEU~? 14.88 OXT ACT A1182 coo 14.25 20.09 37.35 13.48 17.40 37.38 -35.52 10.03 17.00 -36.51 12.40 15.90 coo 9.39 10.77 34.53 11.50 10.63 34.41 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 12.89 17.60 31.13 12.34 16.51 32.90 -33.56 16.12 15.97 -33.69 15.04 14.07 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR A 107 TYR~? -4.55 CH3 ACT A1182s B 40 ASP A 84 ASP^? 7.98 OXT ACT A1182 B 103 LEU A 51 LEU^? 7.18 CH3 ACT A1182 coo 14.25 20.09 37.35 13.48 17.40 37.38 -24.81 2.99 13.30 -27.48 2.42 13.94 coo 9.39 10.77 34.53 11.50 10.63 34.41 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 12.89 17.60 31.13 12.34 16.51 32.90 -29.07 7.28 10.42 -27.57 6.02 11.41 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR A 157 TYR~? 5.66 OXT ACT A1181 B 40 ASP A 152 ASP.? 5.90 O ACT A1181 B 103 LEU A 159 LEU~? 10.10 O ACT A1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 9.39 10.77 34.53 11.50 10.63 34.41 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 12.89 17.60 31.13 12.34 16.51 32.90 -40.53 14.98 -1.43 -40.24 16.08 0.45 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR A 157 TYR~? 5.66 OXT ACT A1181 B 40 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 103 LEU A 159 LEU~? 10.10 O ACT A1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 9.39 10.77 34.53 11.50 10.63 34.41 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 12.89 17.60 31.13 12.34 16.51 32.90 -40.53 14.98 -1.43 -40.24 16.08 0.45 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR A 157 TYR~? 5.66 OXT ACT A1181 B 40 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 103 LEU B 160 LEU~? 9.59 OXT ACT A1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 9.39 10.77 34.53 11.50 10.63 34.41 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 12.89 17.60 31.13 12.34 16.51 32.90 -48.88 12.92 -5.16 -47.30 12.65 -3.74 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR B 33 TYR~? -4.73 C1 GOL B1182s B 40 ASP B 144 ASP.? 6.66 CA CA B1183 B 103 LEU B 146 LEU^? -4.12 O2 GOL B1182s coo 14.25 20.09 37.35 13.48 17.40 37.38 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 9.39 10.77 34.53 11.50 10.63 34.41 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 12.89 17.60 31.13 12.34 16.51 32.90 -59.25 4.86 -9.92 -58.23 6.70 -10.06 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR B 64 TYR~? 13.94 OXT ACT A1181 B 40 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 103 LEU B 160 LEU~? 9.59 OXT ACT A1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 9.39 10.77 34.53 11.50 10.63 34.41 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 12.89 17.60 31.13 12.34 16.51 32.90 -48.88 12.92 -5.16 -47.30 12.65 -3.74 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR B 91 TYR.? 11.41 O ACT C1183 B 40 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 103 LEU B 123 LEU~? 14.76 O ACT C1183 coo 14.25 20.09 37.35 13.48 17.40 37.38 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 9.39 10.77 34.53 11.50 10.63 34.41 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 12.89 17.60 31.13 12.34 16.51 32.90 -56.96 -8.84 -0.37 -56.82 -6.67 -0.15 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 12 3 # 12 B 16 TYR B 107 TYR~? -4.64 CH3 ACT C1183s B 40 ASP B 84 ASP^? 7.80 O ACT C1183 B 103 LEU B 51 LEU^? 7.28 CH3 ACT C1183 coo 14.25 20.09 37.35 13.48 17.40 37.38 -65.76 -1.20 10.47 -63.11 -1.54 11.28 coo 9.39 10.77 34.53 11.50 10.63 34.41 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 12.89 17.60 31.13 12.34 16.51 32.90 -61.53 -0.27 5.43 -63.08 -0.69 6.89 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 13 3 # 13 B 16 TYR B 157 TYR~? 6.24 OXT ACT A1181 B 40 ASP A 156 ASP~? 10.59 O ACT A1181 B 103 LEU A 160 LEU~? 8.80 OXT ACT A1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo 9.39 10.77 34.53 11.50 10.63 34.41 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 12.89 17.60 31.13 12.34 16.51 32.90 -41.85 11.99 -5.74 -43.38 10.84 -4.79 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 14 3 # 14 B 16 TYR B 157 TYR~? 6.24 OXT ACT A1181 B 40 ASP A 156 ASP~? 10.59 O ACT A1181 B 103 LEU B 159 LEU~? 9.18 O3 GOL B1182 coo 14.25 20.09 37.35 13.48 17.40 37.38 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo 9.39 10.77 34.53 11.50 10.63 34.41 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 12.89 17.60 31.13 12.34 16.51 32.90 -50.12 7.79 -6.19 -50.39 5.62 -6.50 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 15 3 # 15 B 16 TYR B 157 TYR~? 6.24 OXT ACT A1181 B 40 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 103 LEU B 159 LEU~? 9.18 O3 GOL B1182 coo 14.25 20.09 37.35 13.48 17.40 37.38 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo 9.39 10.77 34.53 11.50 10.63 34.41 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 12.89 17.60 31.13 12.34 16.51 32.90 -50.12 7.79 -6.19 -50.39 5.62 -6.50 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 16 3 # 16 B 16 TYR C 33 TYR~? 11.20 CA CA C1184 B 40 ASP C 144 ASP.? 6.69 CA CA C1184 B 103 LEU C 146 LEU^? 9.32 CA CA C1184 coo 14.25 20.09 37.35 13.48 17.40 37.38 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo 9.39 10.77 34.53 11.50 10.63 34.41 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 12.89 17.60 31.13 12.34 16.51 32.90 -59.22 -4.94 36.47 -58.09 -6.73 36.70 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 17 3 # 17 B 16 TYR C 64 TYR~? 13.24 O3 GOL D1181 B 40 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 103 LEU C 160 LEU~? 8.91 O3 GOL D1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 9.39 10.77 34.53 11.50 10.63 34.41 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 12.89 17.60 31.13 12.34 16.51 32.90 -48.88 -12.94 31.66 -47.29 -12.69 30.23 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 18 3 # 18 B 16 TYR C 91 TYR.? 11.38 OXT ACT C1183 B 40 ASP C 55 ASP.? 19.45 CA CA C1184 B 103 LEU C 123 LEU~? 14.68 OXT ACT C1183 coo 14.25 20.09 37.35 13.48 17.40 37.38 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 9.39 10.77 34.53 11.50 10.63 34.41 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 12.89 17.60 31.13 12.34 16.51 32.90 -56.96 8.82 26.82 -56.82 6.64 26.57 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 19 3 # 19 B 16 TYR C 107 TYR~? -4.63 CH3 ACT C1183s B 40 ASP C 84 ASP^? 7.78 OXT ACT C1183 B 103 LEU C 51 LEU^? 7.28 CH3 ACT C1183 coo 14.25 20.09 37.35 13.48 17.40 37.38 -65.75 1.19 15.99 -63.10 1.53 15.19 coo 9.39 10.77 34.53 11.50 10.63 34.41 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 12.89 17.60 31.13 12.34 16.51 32.90 -61.54 0.26 21.05 -63.07 0.75 19.58 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 20 3 # 20 B 16 TYR C 157 TYR~? 5.26 O3 GOL D1181 B 40 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 103 LEU C 159 LEU~? 13.80 O3 GOL D1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo 9.39 10.77 34.53 11.50 10.63 34.41 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 12.89 17.60 31.13 12.34 16.51 32.90 -50.12 -7.78 32.65 -50.39 -5.65 32.94 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 21 3 # 21 B 16 TYR C 157 TYR~? 5.26 O3 GOL D1181 B 40 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 103 LEU C 159 LEU~? 13.80 O3 GOL D1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo 9.39 10.77 34.53 11.50 10.63 34.41 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 12.89 17.60 31.13 12.34 16.51 32.90 -50.12 -7.78 32.65 -50.39 -5.65 32.94 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 22 3 # 22 B 16 TYR C 157 TYR~? 5.26 O3 GOL D1181 B 40 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 103 LEU D 160 LEU~? 7.46 O3 GOL D1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo 9.39 10.77 34.53 11.50 10.63 34.41 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 12.89 17.60 31.13 12.34 16.51 32.90 -41.83 -11.95 32.17 -43.38 -10.80 31.19 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 23 3 # 23 B 16 TYR D 33 TYR~? 12.91 O3 GOL D1181 B 40 ASP D 144 ASP.? 22.37 O2 GOL D1181 B 103 LEU D 146 LEU^? 13.45 O3 GOL D1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 9.39 10.77 34.53 11.50 10.63 34.41 -24.08 -23.14 25.44 -22.85 -24.74 26.11 coo 12.89 17.60 31.13 12.34 16.51 32.90 -31.14 -19.51 26.95 -31.88 -19.07 28.95 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 24 3 # 24 B 16 TYR D 64 TYR~? 12.19 O3 GOL D1181 B 40 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 103 LEU D 160 LEU~? 7.46 O3 GOL D1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 9.39 10.77 34.53 11.50 10.63 34.41 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 12.89 17.60 31.13 12.34 16.51 32.90 -41.83 -11.95 32.17 -43.38 -10.80 31.19 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 25 3 # 25 B 16 TYR D 91 TYR.? 11.52 O ACT A1182 B 40 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 103 LEU D 123 LEU~? 14.95 O ACT A1182 coo 14.25 20.09 37.35 13.48 17.40 37.38 -35.52 -10.04 9.46 -36.46 -12.45 10.54 coo 9.39 10.77 34.53 11.50 10.63 34.41 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 12.89 17.60 31.13 12.34 16.51 32.90 -33.63 -16.15 10.50 -33.77 -15.05 12.40 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 26 3 # 26 B 16 TYR D 107 TYR~? -4.59 CH3 ACT A1182s B 40 ASP D 84 ASP^? 8.02 O ACT A1182 B 103 LEU D 51 LEU^? 7.25 CH3 ACT A1182 coo 14.25 20.09 37.35 13.48 17.40 37.38 -24.79 -2.98 13.13 -27.46 -2.42 12.49 coo 9.39 10.77 34.53 11.50 10.63 34.41 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 12.89 17.60 31.13 12.34 16.51 32.90 -29.09 -7.29 16.02 -27.53 -6.11 15.07 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 27 3 # 27 B 16 TYR D 157 TYR~? -5.31 C1 GOL D1181s B 40 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 103 LEU C 160 LEU~? 8.91 O3 GOL D1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 9.39 10.77 34.53 11.50 10.63 34.41 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 12.89 17.60 31.13 12.34 16.51 32.90 -48.88 -12.94 31.66 -47.29 -12.69 30.23 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 28 3 # 28 B 16 TYR D 157 TYR~? -5.31 C1 GOL D1181s B 40 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 103 LEU D 159 LEU~? 9.28 O3 GOL D1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 9.39 10.77 34.53 11.50 10.63 34.41 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 12.89 17.60 31.13 12.34 16.51 32.90 -40.54 -14.98 27.89 -40.25 -16.05 25.99 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 29 3 # 29 B 16 TYR D 157 TYR~? -5.31 C1 GOL D1181s B 40 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 103 LEU D 159 LEU~? 9.28 O3 GOL D1181 coo 14.25 20.09 37.35 13.48 17.40 37.38 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 9.39 10.77 34.53 11.50 10.63 34.41 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 12.89 17.60 31.13 12.34 16.51 32.90 -40.54 -14.98 27.89 -40.25 -16.05 25.99 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 29 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS D 59 HIS~? 14.28 O ACT A1182 A 169 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 288 GLU D 150 GLU.? 17.20 O2 GOL D1181 coo 67.72 35.99 30.87 69.77 36.13 31.33 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 73.17 30.66 22.56 72.87 30.30 20.46 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 74.06 28.51 15.92 73.77 29.56 17.73 -42.98 -24.43 20.59 -42.64 -25.02 18.59 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 1 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 20 ALA~? 7.25 CH3 ACT A1181 B 182 GLY A 24 GLY~? 6.98 CH3 ACT A1181 B 183 GLY B 16 GLY~? 6.98 OXT ACT A1181 coo 38.36-101.47-135.52 39.62-101.29-136.35 -46.52 21.79 -16.07 -47.44 21.93 -17.26 coo 41.93-102.35-126.87 41.52-101.89-126.30 -38.70 23.07 -14.67 -39.06 23.24 -13.96 coo 38.37-101.99-128.11 38.63-102.24-127.37 -38.85 18.09 -15.57 -38.71 17.64 -16.26 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 20 ALA~? 7.25 CH3 ACT A1181 B 182 GLY B 16 GLY~? 6.98 OXT ACT A1181 B 183 GLY A 24 GLY~? 6.98 CH3 ACT A1181 coo 38.36-101.47-135.52 39.62-101.29-136.35 -46.52 21.79 -16.07 -47.44 21.93 -17.26 coo 41.93-102.35-126.87 41.52-101.89-126.30 -38.85 18.09 -15.57 -38.71 17.64 -16.26 coo 38.37-101.99-128.11 38.63-102.24-127.37 -38.70 23.07 -14.67 -39.06 23.24 -13.96 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA A 20 ALA~? 7.25 CH3 ACT A1181 B 182 GLY B 24 GLY~? 11.88 C1 GOL B1182 B 183 GLY A 16 GLY~? 8.84 CH3 ACT A1181 coo 38.36-101.47-135.52 39.62-101.29-136.35 -46.52 21.79 -16.07 -47.44 21.93 -17.26 coo 41.93-102.35-126.87 41.52-101.89-126.30 -52.31 16.92 -18.92 -51.97 16.19 -18.78 coo 38.37-101.99-128.11 38.63-102.24-127.37 -52.14 19.77 -14.51 -52.26 20.60 -14.34 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA B 20 ALA~? 7.98 CH3 ACT A1181 B 182 GLY A 16 GLY~? 8.84 CH3 ACT A1181 B 183 GLY B 24 GLY~? 11.88 C1 GOL B1182 coo 38.36-101.47-135.52 39.62-101.29-136.35 -44.41 18.69 -18.32 -43.53 19.83 -18.84 coo 41.93-102.35-126.87 41.52-101.89-126.30 -52.14 19.77 -14.51 -52.26 20.60 -14.34 coo 38.37-101.99-128.11 38.63-102.24-127.37 -52.31 16.92 -18.92 -51.97 16.19 -18.78 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA B 20 ALA~? 7.98 CH3 ACT A1181 B 182 GLY A 24 GLY~? 6.98 CH3 ACT A1181 B 183 GLY B 16 GLY~? 6.98 OXT ACT A1181 coo 38.36-101.47-135.52 39.62-101.29-136.35 -44.41 18.69 -18.32 -43.53 19.83 -18.84 coo 41.93-102.35-126.87 41.52-101.89-126.30 -38.70 23.07 -14.67 -39.06 23.24 -13.96 coo 38.37-101.99-128.11 38.63-102.24-127.37 -38.85 18.09 -15.57 -38.71 17.64 -16.26 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 420 ALA B 20 ALA~? 7.98 CH3 ACT A1181 B 182 GLY B 24 GLY~? 11.88 C1 GOL B1182 B 183 GLY A 16 GLY~? 8.84 CH3 ACT A1181 coo 38.36-101.47-135.52 39.62-101.29-136.35 -44.41 18.69 -18.32 -43.53 19.83 -18.84 coo 41.93-102.35-126.87 41.52-101.89-126.30 -52.31 16.92 -18.92 -51.97 16.19 -18.78 coo 38.37-101.99-128.11 38.63-102.24-127.37 -52.14 19.77 -14.51 -52.26 20.60 -14.34 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 420 ALA C 20 ALA~? 7.71 O1 GOL D1181 B 182 GLY C 24 GLY~? 11.82 O1 GOL D1181 B 183 GLY D 16 GLY~? 8.64 C1 GOL D1181 coo 38.36-101.47-135.52 39.62-101.29-136.35 -44.43 -18.68 44.80 -43.59 -19.87 45.33 coo 41.93-102.35-126.87 41.52-101.89-126.30 -52.31 -16.92 45.35 -51.96 -16.19 45.23 coo 38.37-101.99-128.11 38.63-102.24-127.37 -52.16 -19.77 41.01 -52.26 -20.58 40.82 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 8 3 # 8 A 420 ALA C 20 ALA~? 7.71 O1 GOL D1181 B 182 GLY D 16 GLY~? 8.64 C1 GOL D1181 B 183 GLY C 24 GLY~? 11.82 O1 GOL D1181 coo 38.36-101.47-135.52 39.62-101.29-136.35 -44.43 -18.68 44.80 -43.59 -19.87 45.33 coo 41.93-102.35-126.87 41.52-101.89-126.30 -52.16 -19.77 41.01 -52.26 -20.58 40.82 coo 38.37-101.99-128.11 38.63-102.24-127.37 -52.31 -16.92 45.35 -51.96 -16.19 45.23 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 9 3 # 9 A 420 ALA C 20 ALA~? 7.71 O1 GOL D1181 B 182 GLY D 24 GLY~? 5.25 CA CA C1182 B 183 GLY C 16 GLY~? 6.74 C3 GOL D1181 coo 38.36-101.47-135.52 39.62-101.29-136.35 -44.43 -18.68 44.80 -43.59 -19.87 45.33 coo 41.93-102.35-126.87 41.52-101.89-126.30 -38.72 -23.09 41.13 -39.06 -23.23 40.41 coo 38.37-101.99-128.11 38.63-102.24-127.37 -38.82 -18.07 42.06 -38.69 -17.63 42.74 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 10 3 # 10 A 420 ALA D 20 ALA~? 6.95 O1 GOL D1181 B 182 GLY C 16 GLY~? 6.74 C3 GOL D1181 B 183 GLY D 24 GLY~? 5.25 CA CA C1182 coo 38.36-101.47-135.52 39.62-101.29-136.35 -46.53 -21.77 42.55 -47.47 -21.94 43.75 coo 41.93-102.35-126.87 41.52-101.89-126.30 -38.82 -18.07 42.06 -38.69 -17.63 42.74 coo 38.37-101.99-128.11 38.63-102.24-127.37 -38.72 -23.09 41.13 -39.06 -23.23 40.41 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 11 3 # 11 A 420 ALA D 20 ALA~? 6.95 O1 GOL D1181 B 182 GLY C 24 GLY~? 11.82 O1 GOL D1181 B 183 GLY D 16 GLY~? 8.64 C1 GOL D1181 coo 38.36-101.47-135.52 39.62-101.29-136.35 -46.53 -21.77 42.55 -47.47 -21.94 43.75 coo 41.93-102.35-126.87 41.52-101.89-126.30 -52.31 -16.92 45.35 -51.96 -16.19 45.23 coo 38.37-101.99-128.11 38.63-102.24-127.37 -52.16 -19.77 41.01 -52.26 -20.58 40.82 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 12 3 # 12 A 420 ALA D 20 ALA~? 6.95 O1 GOL D1181 B 182 GLY D 24 GLY~? 5.25 CA CA C1182 B 183 GLY C 16 GLY~? 6.74 C3 GOL D1181 coo 38.36-101.47-135.52 39.62-101.29-136.35 -46.53 -21.77 42.55 -47.47 -21.94 43.75 coo 41.93-102.35-126.87 41.52-101.89-126.30 -38.72 -23.09 41.13 -39.06 -23.23 40.41 coo 38.37-101.99-128.11 38.63-102.24-127.37 -38.82 -18.07 42.06 -38.69 -17.63 42.74 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 12 hits 1xny_c01 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER A 172 SER~? 20.14 OXT ACT A1181 A 178 TYR A 175 TYR~? 24.50 O ACT A1182 A 182 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 81.46 10.53 21.66 82.20 10.82 19.39 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 87.67 8.69 17.10 86.62 10.83 18.52 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 85.30 6.17 22.83 87.26 11.02 23.50 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 A 164 SER B 31 SER~? 8.40 O1 GOL B1182 A 178 TYR A 5 TYR~? 13.40 O1 GOL B1182 A 182 LYS B 35 LYS~? 11.04 CA CA B1183 coo 81.46 10.53 21.66 82.20 10.82 19.39 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 87.67 8.69 17.10 86.62 10.83 18.52 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 85.30 6.17 22.83 87.26 11.02 23.50 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 3 # 3 A 164 SER B 32 SER~? 5.72 CA CA B1183 A 178 TYR A 5 TYR~? 13.40 O1 GOL B1182 A 182 LYS B 35 LYS~? 11.04 CA CA B1183 coo 81.46 10.53 21.66 82.20 10.82 19.39 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 87.67 8.69 17.10 86.62 10.83 18.52 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 85.30 6.17 22.83 87.26 11.02 23.50 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 3 # 4 A 164 SER C 31 SER.? 11.23 CA CA C1184 A 178 TYR D 5 TYR~? 13.80 CA CA C1181 A 182 LYS C 35 LYS~? 10.20 CA CA C1184 coo 81.46 10.53 21.66 82.20 10.82 19.39 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 87.67 8.69 17.10 86.62 10.83 18.52 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 85.30 6.17 22.83 87.26 11.02 23.50 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 5 3 # 5 A 164 SER C 32 SER~? 5.57 CA CA C1184 A 178 TYR D 5 TYR~? 13.80 CA CA C1181 A 182 LYS C 35 LYS~? 10.20 CA CA C1184 coo 81.46 10.53 21.66 82.20 10.82 19.39 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 87.67 8.69 17.10 86.62 10.83 18.52 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 85.30 6.17 22.83 87.26 11.02 23.50 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 6 3 # 6 A 164 SER C 172 SER~? 11.19 CA CA C1181 A 178 TYR C 175 TYR~? 10.79 CA CA C1181 A 182 LYS C 177 LYS.? 13.52 CA CA C1181 coo 81.46 10.53 21.66 82.20 10.82 19.39 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 87.67 8.69 17.10 86.62 10.83 18.52 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 85.30 6.17 22.83 87.26 11.02 23.50 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 7 3 # 7 A 164 SER D 172 SER~? 19.02 O3 GOL D1181 A 178 TYR D 175 TYR.? 24.43 OXT ACT A1182 A 182 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 81.46 10.53 21.66 82.20 10.82 19.39 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 87.67 8.69 17.10 86.62 10.83 18.52 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 85.30 6.17 22.83 87.26 11.02 23.50 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 7 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER A 172 SER~? 20.14 OXT ACT A1181 B 178 TYR A 175 TYR~? 24.50 O ACT A1182 B 182 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 61.22 3.61 34.51 60.46 1.86 35.98 -25.78 5.39 -12.50 -27.32 6.81 -13.66 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -25.97 -0.55 -12.33 -27.68 -2.03 -10.65 coo 57.40 2.23 30.19 55.43 5.44 33.87 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 B 164 SER B 31 SER~? 8.40 O1 GOL B1182 B 178 TYR A 5 TYR~? 13.40 O1 GOL B1182 B 182 LYS B 35 LYS~? 11.04 CA CA B1183 coo 61.22 3.61 34.51 60.46 1.86 35.98 -64.40 11.60 -16.83 -66.74 12.27 -17.06 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 57.40 2.23 30.19 55.43 5.44 33.87 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 3 # 3 B 164 SER B 32 SER~? 5.72 CA CA B1183 B 178 TYR A 5 TYR~? 13.40 O1 GOL B1182 B 182 LYS B 35 LYS~? 11.04 CA CA B1183 coo 61.22 3.61 34.51 60.46 1.86 35.98 -65.53 8.28 -15.19 -66.24 6.55 -16.73 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 57.40 2.23 30.19 55.43 5.44 33.87 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 3 # 4 B 164 SER C 31 SER.? 11.23 CA CA C1184 B 178 TYR D 5 TYR~? 13.80 CA CA C1181 B 182 LYS C 35 LYS~? 10.20 CA CA C1184 coo 61.22 3.61 34.51 60.46 1.86 35.98 -64.71 -10.73 43.80 -66.67 -12.16 44.05 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 57.40 2.23 30.19 55.43 5.44 33.87 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 5 3 # 5 B 164 SER C 32 SER~? 5.57 CA CA C1184 B 178 TYR D 5 TYR~? 13.80 CA CA C1181 B 182 LYS C 35 LYS~? 10.20 CA CA C1184 coo 61.22 3.61 34.51 60.46 1.86 35.98 -65.86 -7.98 41.44 -65.87 -6.54 43.37 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 57.40 2.23 30.19 55.43 5.44 33.87 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 6 3 # 6 B 164 SER C 172 SER~? 11.19 CA CA C1181 B 178 TYR C 175 TYR~? 10.79 CA CA C1181 B 182 LYS C 177 LYS.? 13.52 CA CA C1181 coo 61.22 3.61 34.51 60.46 1.86 35.98 -65.29 -21.34 28.06 -63.76 -21.94 29.81 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 57.40 2.23 30.19 55.43 5.44 33.87 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 7 3 # 7 B 164 SER D 172 SER~? 19.02 O3 GOL D1181 B 178 TYR D 175 TYR.? 24.43 OXT ACT A1182 B 182 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 61.22 3.61 34.51 60.46 1.86 35.98 -25.73 -5.40 38.95 -27.34 -6.75 40.14 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -25.75 0.70 38.70 -27.49 2.18 37.04 coo 57.40 2.23 30.19 55.43 5.44 33.87 -22.65 -4.76 42.92 -27.69 -1.89 42.71 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 7 hits 1ybv_c01 naa= 3 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 1 3 # 1 146 SER A 53 SER^? 12.21 OXT ACT A1182 338 ASP A 55 ASP.? 17.41 O ACT A1181 397 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 2 3 # 2 146 SER B 53 SER^? 12.05 O ACT C1183 338 ASP B 55 ASP.? 14.29 O3 GOL B1182 397 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 3 3 # 3 146 SER C 53 SER^? 12.05 OXT ACT C1183 338 ASP C 55 ASP.? 19.45 CA CA C1184 397 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 4 3 # 4 146 SER D 53 SER^? 12.18 O ACT A1182 338 ASP D 55 ASP.? 17.43 O2 GOL D1181 397 HIS D 114 HIS^? 15.97 O ACT A1182 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1ysc_c01 source 1ysc SERINE CARBOXYPEPTIDASE (CPY, CPD-Y, OR PROTEI: 4 hits 1ysc_c01 naa= 3 ULMN 3 1zoi_c00 ESTERASE user 1 3 # 1 A 97 SER A 53 SER^? 12.21 OXT ACT A1182 A 227 ASP A 55 ASP.? 17.41 O ACT A1181 A 256 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 64.84 24.93 59.62 66.28 24.42 57.72 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 73.80 27.56 60.96 72.24 26.45 60.08 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 70.86 23.63 59.28 68.91 24.23 58.80 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1zoi_c00 ESTERASE user 2 3 # 2 A 97 SER B 53 SER^? 12.05 O ACT C1183 A 227 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 256 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 64.84 24.93 59.62 66.28 24.42 57.72 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 73.80 27.56 60.96 72.24 26.45 60.08 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 70.86 23.63 59.28 68.91 24.23 58.80 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1zoi_c00 ESTERASE user 3 3 # 3 A 97 SER C 53 SER^? 12.05 OXT ACT C1183 A 227 ASP C 55 ASP.? 19.45 CA CA C1184 A 256 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 64.84 24.93 59.62 66.28 24.42 57.72 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 73.80 27.56 60.96 72.24 26.45 60.08 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 70.86 23.63 59.28 68.91 24.23 58.80 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1zoi_c00 ESTERASE user 4 3 # 4 A 97 SER D 53 SER^? 12.18 O ACT A1182 A 227 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 256 HIS D 114 HIS^? 15.97 O ACT A1182 coo 64.84 24.93 59.62 66.28 24.42 57.72 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 73.80 27.56 60.96 72.24 26.45 60.08 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 70.86 23.63 59.28 68.91 24.23 58.80 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1zoi_c00 source 1zoi ESTERASE : 4 hits 1zoi_c00 naa= 3 ULMN 3 1zoi_c01 ESTERASE user 1 3 # 1 B 97 SER A 53 SER^? 12.21 OXT ACT A1182 B 227 ASP A 55 ASP.? 17.41 O ACT A1181 B 256 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1zoi_c01 ESTERASE user 2 3 # 2 B 97 SER B 53 SER^? 12.05 O ACT C1183 B 227 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 256 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1zoi_c01 ESTERASE user 3 3 # 3 B 97 SER C 53 SER^? 12.05 OXT ACT C1183 B 227 ASP C 55 ASP.? 19.45 CA CA C1184 B 256 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1zoi_c01 ESTERASE user 4 3 # 4 B 97 SER D 53 SER^? 12.18 O ACT A1182 B 227 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 256 HIS D 114 HIS^? 15.97 O ACT A1182 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1zoi_c01 source 1zoi ESTERASE : 4 hits 1zoi_c01 naa= 3 ULMN 3 1zoi_c02 ESTERASE user 1 3 # 1 C 97 SER A 53 SER^? 12.21 OXT ACT A1182 C 227 ASP A 55 ASP.? 17.41 O ACT A1181 C 256 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 1zoi_c02 ESTERASE user 2 3 # 2 C 97 SER B 53 SER^? 12.05 O ACT C1183 C 227 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 256 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 1zoi_c02 ESTERASE user 3 3 # 3 C 97 SER C 53 SER^? 12.05 OXT ACT C1183 C 227 ASP C 55 ASP.? 19.45 CA CA C1184 C 256 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 1zoi_c02 ESTERASE user 4 3 # 4 C 97 SER D 53 SER^? 12.18 O ACT A1182 C 227 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 256 HIS D 114 HIS^? 15.97 O ACT A1182 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -34.02 -15.52 17.15 -35.80 -16.25 16.32 1zoi_c02 source 1zoi ESTERASE : 4 hits 1zoi_c02 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 6 ASP~? 16.17 CA CA B1181 A 371 LYS A 2 LYS^? 14.71 CA CA B1181 A 374 ASN A 3 ASN^? 12.04 CA CA B1181 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -72.70 21.43 -11.05 -73.07 19.35 -11.09 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 95 ASP~? 18.75 OXT ACT A1182 A 371 LYS A 93 LYS.? 11.72 OXT ACT A1182 A 374 ASN A 94 ASN.? 20.31 OXT ACT A1182 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -30.02 14.86 26.58 -28.64 13.51 27.46 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -36.14 12.80 22.42 -38.75 8.18 20.02 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -34.68 14.84 26.15 -33.66 16.63 26.68 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP C 6 ASP~? 17.85 CA CA C1182 A 371 LYS C 2 LYS^? 15.05 CA CA C1182 A 374 ASN C 3 ASN^? 20.98 CA CA C1182 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -18.27 -14.28 42.59 -18.15 -15.35 40.76 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP C 95 ASP~? 18.98 OXT ACT C1183 A 371 LYS C 93 LYS.? 19.61 OXT ACT C1183 A 374 ASN C 94 ASN.? 20.53 OXT ACT C1183 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -60.88 17.87 20.49 -62.76 18.57 19.77 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -54.93 14.23 21.55 -53.38 19.08 19.32 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -57.57 16.60 24.50 -56.01 17.74 25.39 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP D 6 ASP~? 16.12 CA CA C1181 A 371 LYS D 2 LYS.? 16.82 CA CA C1181 A 374 ASN D 3 ASN~? 12.07 CA CA C1181 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -72.61 -21.52 37.54 -72.85 -19.41 37.73 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 5 hits 1zrz_c03 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 7 TRP~? 13.17 CA CA B1181 223 ASP A 6 ASP~? 16.17 CA CA B1181 258 ALA B 38 ALA~? 12.14 CA CA B1181 coo 128.40 33.01 26.67 128.12 36.28 28.81 -64.51 23.48 -8.12 -63.01 20.07 -6.83 coo 127.91 41.73 23.55 129.18 40.35 24.44 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 141.00 37.49 25.74 139.80 37.53 24.78 -68.47 11.61 -6.00 -69.42 12.03 -7.12 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP A 7 TRP~? 13.17 CA CA B1181 223 ASP A 14 ASP~? 14.99 CH3 ACT A1181 258 ALA B 34 ALA~? 8.65 O1 GOL B1182 coo 128.40 33.01 26.67 128.12 36.28 28.81 -64.51 23.48 -8.12 -63.01 20.07 -6.83 coo 127.91 41.73 23.55 129.18 40.35 24.44 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 141.00 37.49 25.74 139.80 37.53 24.78 -65.40 11.95 -11.28 -65.85 13.06 -12.24 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 3 3 # 3 142 TRP B 7 TRP~? 18.47 OXT ACT A1181 223 ASP B 6 ASP~? 24.59 OXT ACT A1181 258 ALA A 38 ALA~? 22.67 OXT ACT A1181 coo 128.40 33.01 26.67 128.12 36.28 28.81 -26.39 11.02 -16.75 -27.73 11.07 -13.04 coo 127.91 41.73 23.55 129.18 40.35 24.44 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 141.00 37.49 25.74 139.80 37.53 24.78 -22.35 13.14 -5.03 -21.40 14.08 -5.75 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 4 3 # 4 142 TRP B 7 TRP~? 18.47 OXT ACT A1181 223 ASP B 14 ASP~? 13.85 OXT ACT A1181 258 ALA A 34 ALA~? 17.95 O ACT A1181 coo 128.40 33.01 26.67 128.12 36.28 28.81 -26.39 11.02 -16.75 -27.73 11.07 -13.04 coo 127.91 41.73 23.55 129.18 40.35 24.44 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.61 17.94 -7.13 -25.09 18.62 -8.43 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 5 3 # 5 142 TRP C 7 TRP~? 16.43 CA CA C1182 223 ASP C 6 ASP~? 17.85 CA CA C1182 258 ALA D 38 ALA~? 21.45 O3 GOL D1181 coo 128.40 33.01 26.67 128.12 36.28 28.81 -26.42 -11.04 43.18 -27.72 -11.10 39.46 coo 127.91 41.73 23.55 129.18 40.35 24.44 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 141.00 37.49 25.74 139.80 37.53 24.78 -22.38 -13.17 31.47 -21.46 -14.12 32.22 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 6 3 # 6 142 TRP C 7 TRP~? 16.43 CA CA C1182 223 ASP C 14 ASP~? 9.29 CA CA C1182 258 ALA D 34 ALA~? 16.85 CA CA C1182 coo 128.40 33.01 26.67 128.12 36.28 28.81 -26.42 -11.04 43.18 -27.72 -11.10 39.46 coo 127.91 41.73 23.55 129.18 40.35 24.44 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo 141.00 37.49 25.74 139.80 37.53 24.78 -25.61 -17.93 33.60 -25.08 -18.60 34.88 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 7 3 # 7 142 TRP D 7 TRP~? 13.25 CA CA C1181 223 ASP D 6 ASP~? 16.12 CA CA C1181 258 ALA C 38 ALA~? 12.06 CA CA C1181 coo 128.40 33.01 26.67 128.12 36.28 28.81 -64.48 -23.47 34.59 -63.03 -20.04 33.30 coo 127.91 41.73 23.55 129.18 40.35 24.44 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 141.00 37.49 25.74 139.80 37.53 24.78 -68.47 -11.63 32.46 -69.41 -12.04 33.57 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 8 3 # 8 142 TRP D 7 TRP~? 13.25 CA CA C1181 223 ASP D 14 ASP~? 14.81 O1 GOL D1181 258 ALA C 34 ALA~? 12.61 CA CA C1184 coo 128.40 33.01 26.67 128.12 36.28 28.81 -64.48 -23.47 34.59 -63.03 -20.04 33.30 coo 127.91 41.73 23.55 129.18 40.35 24.44 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 141.00 37.49 25.74 139.80 37.53 24.78 -65.39 -11.97 37.73 -65.91 -13.10 38.66 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 8 hits 2aat_c01 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER A 153 SER.? 8.36 O ACT A1181 327 GLU A 150 GLU.? 17.29 O ACT A1181 440 HIS A 151 HIS.? 15.84 O ACT A1181 coo 6.96 64.04 57.84 6.74 63.69 60.26 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 14.82 64.63 62.37 13.47 65.72 61.17 -43.03 24.31 5.88 -42.80 24.92 7.90 coo 9.52 66.51 63.07 8.75 65.02 61.81 -46.06 27.03 4.30 -45.69 27.09 6.36 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER B 153 SER.? 13.04 OXT ACT A1181 327 GLU B 150 GLU.? 13.13 O3 GOL B1182 440 HIS B 151 HIS.? 14.53 O3 GOL B1182 coo 6.96 64.04 57.84 6.74 63.69 60.26 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo 14.82 64.63 62.37 13.47 65.72 61.17 -48.00 -2.44 -12.49 -48.57 -4.48 -12.31 coo 9.52 66.51 63.07 8.75 65.02 61.81 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 3 3 # 3 200 SER C 153 SER.? 12.45 O3 GOL D1181 327 GLU C 150 GLU.? 16.95 CA CA C1184 440 HIS C 151 HIS.? 19.99 CA CA C1184 coo 6.96 64.04 57.84 6.74 63.69 60.26 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo 14.82 64.63 62.37 13.47 65.72 61.17 -48.03 2.43 38.96 -48.57 4.48 38.82 coo 9.52 66.51 63.07 8.75 65.02 61.81 -44.62 2.10 41.60 -44.48 3.82 40.41 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 4 3 # 4 200 SER D 153 SER.? 8.24 O2 GOL D1181 327 GLU D 150 GLU.? 17.20 O2 GOL D1181 440 HIS D 151 HIS.? 15.73 O2 GOL D1181 coo 6.96 64.04 57.84 6.74 63.69 60.26 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo 14.82 64.63 62.37 13.47 65.72 61.17 -42.98 -24.43 20.59 -42.64 -25.02 18.59 coo 9.52 66.51 63.07 8.75 65.02 61.81 -45.79 -27.28 22.21 -45.52 -27.23 20.13 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 4 hits 2ace_c00 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 48 HIS B 59 HIS~? 15.18 O ACT C1183 A 77 LYS A 72 LYS.? 19.74 O ACT A1182 coo 13.04 30.41 72.50 12.95 30.65 70.36 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 12.77 23.50 68.33 13.58 25.42 68.49 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 7.53 29.84 65.06 12.29 29.41 67.79 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 2 3 # 2 A 43 ASP C 55 ASP.? 19.45 CA CA C1184 A 48 HIS C 59 HIS~? 15.17 OXT ACT C1183 A 77 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 13.04 30.41 72.50 12.95 30.65 70.36 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 12.77 23.50 68.33 13.58 25.42 68.49 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 7.53 29.84 65.06 12.29 29.41 67.79 -39.21 6.22 27.81 -43.32 9.34 25.63 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 2 hits 2acu_c01 naa= 3 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 A 105 ASN A 109 ASN.? 14.39 CH3 ACT A1182 A 106 PRO A 110 PRO^? 10.22 CH3 ACT A1182 A 108 TYR A 107 TYR~? -4.55 CH3 ACT A1182s coo 34.91 38.94 20.48 33.53 38.20 19.00 -18.98 4.63 8.19 -18.49 6.24 6.88 coo 36.18 33.51 20.99 37.11 35.33 20.14 -22.64 7.30 11.97 -22.53 6.46 9.88 coo 33.01 33.46 15.68 31.96 34.97 17.80 -24.81 2.99 13.30 -27.48 2.42 13.94 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 2 3 # 2 A 105 ASN A 120 ASN~? 16.79 OXT ACT A1182 A 106 PRO A 92 PRO.? 12.61 OXT ACT A1182 A 108 TYR A 91 TYR.? 11.44 OXT ACT A1182 coo 34.91 38.94 20.48 33.53 38.20 19.00 -37.16 17.92 19.64 -35.92 16.19 19.48 coo 36.18 33.51 20.99 37.11 35.33 20.14 -32.22 13.08 18.59 -33.09 11.49 19.92 coo 33.01 33.46 15.68 31.96 34.97 17.80 -35.52 10.03 17.00 -36.51 12.40 15.90 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 3 3 # 3 A 105 ASN B 109 ASN.? 14.52 CH3 ACT C1183 A 106 PRO B 110 PRO^? 10.25 CH3 ACT C1183 A 108 TYR B 107 TYR~? -4.64 CH3 ACT C1183s coo 34.91 38.94 20.48 33.53 38.20 19.00 -71.64 2.73 6.90 -72.13 3.19 4.89 coo 36.18 33.51 20.99 37.11 35.33 20.14 -67.97 -1.84 6.26 -68.06 0.42 5.97 coo 33.01 33.46 15.68 31.96 34.97 17.80 -65.76 -1.20 10.47 -63.11 -1.54 11.28 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 4 3 # 4 A 105 ASN B 120 ASN~? 16.46 O ACT C1183 A 106 PRO B 92 PRO.? 12.61 O ACT C1183 A 108 TYR B 91 TYR.? 11.41 O ACT C1183 coo 34.91 38.94 20.48 33.53 38.20 19.00 -53.48 -12.76 -0.52 -54.66 -11.58 0.79 coo 36.18 33.51 20.99 37.11 35.33 20.14 -58.42 -10.09 3.41 -57.41 -10.70 5.34 coo 33.01 33.46 15.68 31.96 34.97 17.80 -54.93 -7.42 5.60 -53.90 -7.36 2.99 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 5 3 # 5 A 105 ASN C 109 ASN.? 14.51 CH3 ACT C1183 A 106 PRO C 110 PRO^? 10.26 CH3 ACT C1183 A 108 TYR C 107 TYR~? -4.63 CH3 ACT C1183s coo 34.91 38.94 20.48 33.53 38.20 19.00 -71.64 -2.74 19.53 -72.13 -3.21 21.54 coo 36.18 33.51 20.99 37.11 35.33 20.14 -67.97 1.82 20.25 -68.08 -0.45 20.47 coo 33.01 33.46 15.68 31.96 34.97 17.80 -65.75 1.19 15.99 -63.10 1.53 15.19 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 6 3 # 6 A 105 ASN C 120 ASN~? 16.45 OXT ACT C1183 A 106 PRO C 92 PRO.? 12.58 OXT ACT C1183 A 108 TYR C 91 TYR.? 11.38 OXT ACT C1183 coo 34.91 38.94 20.48 33.53 38.20 19.00 -53.50 12.76 27.01 -54.66 11.53 25.76 coo 36.18 33.51 20.99 37.11 35.33 20.14 -58.41 10.10 23.09 -57.44 10.70 21.14 coo 33.01 33.46 15.68 31.96 34.97 17.80 -54.93 7.42 20.88 -53.88 7.33 23.48 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 7 3 # 7 A 105 ASN D 109 ASN.? 14.36 CH3 ACT A1182 A 106 PRO D 110 PRO^? 10.21 CH3 ACT A1182 A 108 TYR D 107 TYR~? -4.59 CH3 ACT A1182s coo 34.91 38.94 20.48 33.53 38.20 19.00 -18.98 -4.62 18.28 -18.54 -6.24 19.59 coo 36.18 33.51 20.99 37.11 35.33 20.14 -22.64 -7.23 14.50 -22.56 -6.43 16.61 coo 33.01 33.46 15.68 31.96 34.97 17.80 -24.79 -2.98 13.13 -27.46 -2.42 12.49 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 8 3 # 8 A 105 ASN D 120 ASN~? 16.83 O ACT A1182 A 106 PRO D 92 PRO.? 12.67 O ACT A1182 A 108 TYR D 91 TYR.? 11.52 O ACT A1182 coo 34.91 38.94 20.48 33.53 38.20 19.00 -37.12 -17.90 6.86 -35.82 -16.19 6.99 coo 36.18 33.51 20.99 37.11 35.33 20.14 -32.19 -13.09 7.87 -33.10 -11.49 6.54 coo 33.01 33.46 15.68 31.96 34.97 17.80 -35.52 -10.04 9.46 -36.46 -12.45 10.54 2adm_c00 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 8 hits 2adm_c00 naa= 3 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 B 105 ASN A 109 ASN.? 14.39 CH3 ACT A1182 B 106 PRO A 110 PRO^? 10.22 CH3 ACT A1182 B 108 TYR A 107 TYR~? -4.55 CH3 ACT A1182s coo 5.98 38.14 46.94 7.30 38.92 45.46 -18.98 4.63 8.19 -18.49 6.24 6.88 coo 4.66 43.53 47.47 3.74 41.73 46.59 -22.64 7.30 11.97 -22.53 6.46 9.88 coo 7.86 43.80 42.15 8.87 42.26 44.27 -24.81 2.99 13.30 -27.48 2.42 13.94 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 2 3 # 2 B 105 ASN A 120 ASN~? 16.79 OXT ACT A1182 B 106 PRO A 92 PRO.? 12.61 OXT ACT A1182 B 108 TYR A 91 TYR.? 11.44 OXT ACT A1182 coo 5.98 38.14 46.94 7.30 38.92 45.46 -37.16 17.92 19.64 -35.92 16.19 19.48 coo 4.66 43.53 47.47 3.74 41.73 46.59 -32.22 13.08 18.59 -33.09 11.49 19.92 coo 7.86 43.80 42.15 8.87 42.26 44.27 -35.52 10.03 17.00 -36.51 12.40 15.90 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 3 3 # 3 B 105 ASN B 109 ASN.? 14.52 CH3 ACT C1183 B 106 PRO B 110 PRO^? 10.25 CH3 ACT C1183 B 108 TYR B 107 TYR~? -4.64 CH3 ACT C1183s coo 5.98 38.14 46.94 7.30 38.92 45.46 -71.64 2.73 6.90 -72.13 3.19 4.89 coo 4.66 43.53 47.47 3.74 41.73 46.59 -67.97 -1.84 6.26 -68.06 0.42 5.97 coo 7.86 43.80 42.15 8.87 42.26 44.27 -65.76 -1.20 10.47 -63.11 -1.54 11.28 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 4 3 # 4 B 105 ASN B 120 ASN~? 16.46 O ACT C1183 B 106 PRO B 92 PRO.? 12.61 O ACT C1183 B 108 TYR B 91 TYR.? 11.41 O ACT C1183 coo 5.98 38.14 46.94 7.30 38.92 45.46 -53.48 -12.76 -0.52 -54.66 -11.58 0.79 coo 4.66 43.53 47.47 3.74 41.73 46.59 -58.42 -10.09 3.41 -57.41 -10.70 5.34 coo 7.86 43.80 42.15 8.87 42.26 44.27 -54.93 -7.42 5.60 -53.90 -7.36 2.99 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 5 3 # 5 B 105 ASN C 109 ASN.? 14.51 CH3 ACT C1183 B 106 PRO C 110 PRO^? 10.26 CH3 ACT C1183 B 108 TYR C 107 TYR~? -4.63 CH3 ACT C1183s coo 5.98 38.14 46.94 7.30 38.92 45.46 -71.64 -2.74 19.53 -72.13 -3.21 21.54 coo 4.66 43.53 47.47 3.74 41.73 46.59 -67.97 1.82 20.25 -68.08 -0.45 20.47 coo 7.86 43.80 42.15 8.87 42.26 44.27 -65.75 1.19 15.99 -63.10 1.53 15.19 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 6 3 # 6 B 105 ASN C 120 ASN~? 16.45 OXT ACT C1183 B 106 PRO C 92 PRO.? 12.58 OXT ACT C1183 B 108 TYR C 91 TYR.? 11.38 OXT ACT C1183 coo 5.98 38.14 46.94 7.30 38.92 45.46 -53.50 12.76 27.01 -54.66 11.53 25.76 coo 4.66 43.53 47.47 3.74 41.73 46.59 -58.41 10.10 23.09 -57.44 10.70 21.14 coo 7.86 43.80 42.15 8.87 42.26 44.27 -54.93 7.42 20.88 -53.88 7.33 23.48 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 7 3 # 7 B 105 ASN D 109 ASN.? 14.36 CH3 ACT A1182 B 106 PRO D 110 PRO^? 10.21 CH3 ACT A1182 B 108 TYR D 107 TYR~? -4.59 CH3 ACT A1182s coo 5.98 38.14 46.94 7.30 38.92 45.46 -18.98 -4.62 18.28 -18.54 -6.24 19.59 coo 4.66 43.53 47.47 3.74 41.73 46.59 -22.64 -7.23 14.50 -22.56 -6.43 16.61 coo 7.86 43.80 42.15 8.87 42.26 44.27 -24.79 -2.98 13.13 -27.46 -2.42 12.49 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 8 3 # 8 B 105 ASN D 120 ASN~? 16.83 O ACT A1182 B 106 PRO D 92 PRO.? 12.67 O ACT A1182 B 108 TYR D 91 TYR.? 11.52 O ACT A1182 coo 5.98 38.14 46.94 7.30 38.92 45.46 -37.12 -17.90 6.86 -35.82 -16.19 6.99 coo 4.66 43.53 47.47 3.74 41.73 46.59 -32.19 -13.09 7.87 -33.10 -11.49 6.54 coo 7.86 43.80 42.15 8.87 42.26 44.27 -35.52 -10.04 9.46 -36.46 -12.45 10.54 2adm_c01 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 8 hits 2adm_c01 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP B 95 ASP.? 16.79 O ACT C1183 231 ASP A 73 ASP.? 22.06 O ACT A1182 294 ASP C 73 ASP.? 22.09 O ACT C1183 coo 27.89 102.52 14.98 29.35 101.92 13.57 -58.00 -16.84 6.87 -57.88 -17.33 8.94 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -38.43 -8.42 -5.54 -37.44 -9.76 -6.88 coo 33.16 106.80 7.72 33.34 104.87 6.92 -52.43 -20.77 12.85 -53.47 -22.46 12.11 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 152 ASP.? 8.52 O3 GOL B1182 231 ASP B 144 ASP.? 6.66 CA CA B1183 294 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 27.89 102.52 14.98 29.35 101.92 13.57 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP C 95 ASP~? 18.98 OXT ACT C1183 231 ASP C 84 ASP^? 7.78 OXT ACT C1183 294 ASP B 73 ASP.? 22.00 OXT ACT C1183 coo 27.89 102.52 14.98 29.35 101.92 13.57 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 33.16 106.80 7.72 33.34 104.87 6.92 -52.42 20.74 13.73 -53.54 22.42 14.42 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP C 152 ASP.? 13.45 O3 GOL D1181 231 ASP C 144 ASP.? 6.69 CA CA C1184 294 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 27.89 102.52 14.98 29.35 101.92 13.57 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 33.16 106.80 7.72 33.34 104.87 6.92 -44.46 -7.83 33.81 -43.76 -5.84 33.54 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 4 hits 2amg_c06 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 84 ASP^? 7.98 OXT ACT A1182 38 SER A 88 SER.? 4.86 OXT ACT A1182 218 ASP D 84 ASP^? 8.02 O ACT A1182 coo 41.14 58.72 105.19 42.39 59.85 103.92 -36.44 3.40 10.01 -38.05 4.61 10.68 coo 46.04 57.35 103.96 44.97 58.52 105.78 -34.67 3.69 16.47 -32.74 5.08 16.23 coo 41.33 60.20 97.63 42.00 60.96 99.49 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 3 # 2 35 ASP A 152 ASP.? 5.90 O ACT A1181 38 SER A 153 SER.? 8.36 O ACT A1181 218 ASP A 156 ASP~? 10.59 O ACT A1181 coo 41.14 58.72 105.19 42.39 59.85 103.92 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo 46.04 57.35 103.96 44.97 58.52 105.78 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo 41.33 60.20 97.63 42.00 60.96 99.49 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 3 3 # 3 35 ASP B 84 ASP^? 7.80 O ACT C1183 38 SER B 88 SER.? 4.64 O ACT C1183 218 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo 41.14 58.72 105.19 42.39 59.85 103.92 -54.22 1.68 8.96 -52.58 0.65 8.12 coo 46.04 57.35 103.96 44.97 58.52 105.78 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo 41.33 60.20 97.63 42.00 60.96 99.49 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 4 3 # 4 35 ASP B 152 ASP.? 8.52 O3 GOL B1182 38 SER B 153 SER.? 13.04 OXT ACT A1181 218 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo 41.14 58.72 105.19 42.39 59.85 103.92 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 46.04 57.35 103.96 44.97 58.52 105.78 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo 41.33 60.20 97.63 42.00 60.96 99.49 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 5 3 # 5 35 ASP C 84 ASP^? 7.78 OXT ACT C1183 38 SER C 88 SER.? 4.69 OXT ACT C1183 218 ASP B 84 ASP^? 7.80 O ACT C1183 coo 41.14 58.72 105.19 42.39 59.85 103.92 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo 46.04 57.35 103.96 44.97 58.52 105.78 -56.10 4.45 15.54 -58.39 5.12 16.05 coo 41.33 60.20 97.63 42.00 60.96 99.49 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 6 3 # 6 35 ASP C 152 ASP.? 13.45 O3 GOL D1181 38 SER C 153 SER.? 12.45 O3 GOL D1181 218 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo 41.14 58.72 105.19 42.39 59.85 103.92 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo 46.04 57.35 103.96 44.97 58.52 105.78 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo 41.33 60.20 97.63 42.00 60.96 99.49 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 7 3 # 7 35 ASP D 84 ASP^? 8.02 O ACT A1182 38 SER D 88 SER.? 4.67 O ACT A1182 218 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 41.14 58.72 105.19 42.39 59.85 103.92 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo 46.04 57.35 103.96 44.97 58.52 105.78 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo 41.33 60.20 97.63 42.00 60.96 99.49 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 8 3 # 8 35 ASP D 152 ASP.? 5.75 O2 GOL D1181 38 SER D 153 SER.? 8.24 O2 GOL D1181 218 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo 41.14 58.72 105.19 42.39 59.85 103.92 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo 46.04 57.35 103.96 44.97 58.52 105.78 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo 41.33 60.20 97.63 42.00 60.96 99.49 -46.26 -16.01 28.32 -46.92 -16.52 26.38 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 8 hits 2apr_c04 naa= 3 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 1 3 # 1 105 GLU D 17 GLU~? 13.36 O1 GOL D1181 107 ASP D 14 ASP~? 14.81 O1 GOL D1181 109 GLU D 10 GLU~? 18.53 CA CA C1181 coo 15.97 13.58 10.29 15.12 15.36 9.48 -53.10 -23.91 44.12 -54.66 -25.27 44.77 coo 20.07 16.34 11.47 18.03 16.15 11.04 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 20.99 19.84 9.56 19.07 20.34 10.22 -62.08 -25.49 39.96 -63.41 -27.01 39.21 2ayh_c00 source 2ayh 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROLASE (E.C.: 1 hits 2ayh_c00 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 163 ALA A 54 ALA^? 15.02 OXT ACT A1182 B 182 SER A 53 SER^? 12.21 OXT ACT A1182 coo 30.42 1.98 4.36 29.07 0.41 4.68 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -38.22 13.01 8.71 -39.06 12.37 7.62 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -35.29 10.69 9.61 -33.77 12.39 10.51 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS B 59 HIS~? 15.18 O ACT C1183 B 163 ALA B 54 ALA^? 14.74 O ACT C1183 B 182 SER B 53 SER^? 12.05 O ACT C1183 coo 30.42 1.98 4.36 29.07 0.41 4.68 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -52.33 -0.83 -0.35 -51.49 0.42 -0.07 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -55.28 -0.85 2.05 -56.85 -2.35 0.91 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 163 ALA C 54 ALA^? 14.74 OXT ACT C1183 B 182 SER C 53 SER^? 12.05 OXT ACT C1183 coo 30.42 1.98 4.36 29.07 0.41 4.68 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -52.34 0.82 26.82 -51.53 -0.42 26.55 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -55.28 0.90 24.40 -56.83 2.38 25.58 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS D 59 HIS~? 14.28 O ACT A1182 B 163 ALA D 54 ALA^? 15.02 O ACT A1182 B 182 SER D 53 SER^? 12.18 O ACT A1182 coo 30.42 1.98 4.36 29.07 0.41 4.68 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -38.21 -12.99 17.72 -39.03 -12.34 18.84 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -35.31 -10.69 16.86 -33.78 -12.33 15.90 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 5 3 # 5 B 46 HIS D 59 HIS~? 14.28 O ACT A1182 B 163 ALA D 54 ALA^? 15.02 O ACT A1182 B 182 SER D 56 SER.? 20.40 O ACT A1182 coo 30.42 1.98 4.36 29.07 0.41 4.68 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -38.21 -12.99 17.72 -39.03 -12.34 18.84 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -44.06 -14.32 15.00 -45.00 -16.31 13.86 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 5 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 30 ARG.? 15.23 O ACT A1181 A 161 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 174 TYR B 5 TYR~? 22.90 O ACT A1181 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -20.60 17.75 -11.10 -19.92 17.17 -8.44 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 58 ARG~? 14.46 O ACT A1181 A 161 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 174 TYR B 157 TYR~? 6.24 OXT ACT A1181 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -44.58 12.35 -10.09 -41.80 12.65 -10.19 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG A 77 ARG.? 18.54 O ACT A1182 A 161 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 174 TYR A 64 TYR~? 13.66 OXT ACT A1181 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -41.23 7.24 -1.52 -40.97 7.41 -4.31 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG B 58 ARG~? 12.97 O3 GOL B1182 A 161 ASP A 156 ASP~? 10.59 O ACT A1181 A 174 TYR A 157 TYR~? 5.66 OXT ACT A1181 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -46.22 16.76 -7.11 -49.01 16.68 -7.45 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 5 3 # 5 A 14 ARG B 77 ARG.? 16.85 CA CA B1181 A 161 ASP A 156 ASP~? 10.59 O ACT A1181 A 174 TYR B 64 TYR~? 13.94 OXT ACT A1181 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -57.98 19.33 8.28 -57.78 17.70 5.69 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -49.49 10.87 0.95 -49.71 13.38 -0.30 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 6 3 # 6 A 14 ARG C 58 ARG~? 18.42 O3 GOL D1181 A 161 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 174 TYR D 157 TYR~? -5.31 C1 GOL D1181s coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -46.23 -16.78 33.55 -49.03 -16.71 33.91 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 7 3 # 7 A 14 ARG C 77 ARG.? 17.10 CA CA C1181 A 161 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 174 TYR C 64 TYR~? 13.24 O3 GOL D1181 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -49.46 -10.91 25.49 -49.72 -13.40 26.79 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 8 3 # 8 A 14 ARG D 30 ARG.? 11.01 CA CA C1182 A 161 ASP C 6 ASP~? 17.85 CA CA C1182 A 174 TYR C 5 TYR~? 20.02 CA CA C1182 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -29.54 -28.66 35.64 -30.45 -28.64 38.59 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -20.63 -17.79 37.57 -20.04 -17.26 34.89 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 9 3 # 9 A 14 ARG D 58 ARG~? 14.52 O2 GOL D1181 A 161 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 174 TYR C 157 TYR~? 5.26 O3 GOL D1181 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -44.58 -12.33 36.53 -41.80 -12.65 36.66 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 10 3 # 10 A 14 ARG D 77 ARG.? 18.56 OXT ACT A1182 A 161 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 174 TYR D 64 TYR~? 12.19 O3 GOL D1181 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -32.91 2.84 33.04 -33.00 -0.18 32.51 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -41.23 -7.21 27.99 -40.99 -7.39 30.78 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 10 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 30 ARG.? 15.23 O ACT A1181 B 161 ASP B 6 ASP~? 24.59 OXT ACT A1181 B 174 TYR B 5 TYR~? 22.90 O ACT A1181 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -20.60 17.75 -11.10 -19.92 17.17 -8.44 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 58 ARG~? 14.46 O ACT A1181 B 161 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 174 TYR B 157 TYR~? 6.24 OXT ACT A1181 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -43.27 15.99 4.53 -43.95 18.83 5.47 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -44.58 12.35 -10.09 -41.80 12.65 -10.19 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG A 77 ARG.? 18.54 O ACT A1182 B 161 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 174 TYR A 64 TYR~? 13.66 OXT ACT A1181 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -41.23 7.24 -1.52 -40.97 7.41 -4.31 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG B 58 ARG~? 12.97 O3 GOL B1182 B 161 ASP A 156 ASP~? 10.59 O ACT A1181 B 174 TYR A 157 TYR~? 5.66 OXT ACT A1181 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -46.22 16.76 -7.11 -49.01 16.68 -7.45 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 5 3 # 5 B 14 ARG B 77 ARG.? 16.85 CA CA B1181 B 161 ASP A 156 ASP~? 10.59 O ACT A1181 B 174 TYR B 64 TYR~? 13.94 OXT ACT A1181 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -57.98 19.33 8.28 -57.78 17.70 5.69 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -49.49 10.87 0.95 -49.71 13.38 -0.30 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 6 3 # 6 B 14 ARG C 58 ARG~? 18.42 O3 GOL D1181 B 161 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 174 TYR D 157 TYR~? -5.31 C1 GOL D1181s coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -46.23 -16.78 33.55 -49.03 -16.71 33.91 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 7 3 # 7 B 14 ARG C 77 ARG.? 17.10 CA CA C1181 B 161 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 174 TYR C 64 TYR~? 13.24 O3 GOL D1181 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -49.46 -10.91 25.49 -49.72 -13.40 26.79 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 8 3 # 8 B 14 ARG D 30 ARG.? 11.01 CA CA C1182 B 161 ASP C 6 ASP~? 17.85 CA CA C1182 B 174 TYR C 5 TYR~? 20.02 CA CA C1182 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -29.54 -28.66 35.64 -30.45 -28.64 38.59 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -20.63 -17.79 37.57 -20.04 -17.26 34.89 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 9 3 # 9 B 14 ARG D 58 ARG~? 14.52 O2 GOL D1181 B 161 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 174 TYR C 157 TYR~? 5.26 O3 GOL D1181 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -44.58 -12.33 36.53 -41.80 -12.65 36.66 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 10 3 # 10 B 14 ARG D 77 ARG.? 18.56 OXT ACT A1182 B 161 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 174 TYR D 64 TYR~? 12.19 O3 GOL D1181 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -32.91 2.84 33.04 -33.00 -0.18 32.51 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -41.23 -7.21 27.99 -40.99 -7.39 30.78 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 10 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 30 ARG.? 15.23 O ACT A1181 C 161 ASP B 6 ASP~? 24.59 OXT ACT A1181 C 174 TYR B 5 TYR~? 22.90 O ACT A1181 coo 2.84 19.43 40.34 1.59 20.35 37.65 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 5.94 13.28 27.17 3.53 13.05 28.58 -20.60 17.75 -11.10 -19.92 17.17 -8.44 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 58 ARG~? 14.46 O ACT A1181 C 161 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 174 TYR B 157 TYR~? 6.24 OXT ACT A1181 coo 2.84 19.43 40.34 1.59 20.35 37.65 -43.27 15.99 4.53 -43.95 18.83 5.47 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 5.94 13.28 27.17 3.53 13.05 28.58 -44.58 12.35 -10.09 -41.80 12.65 -10.19 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG A 77 ARG.? 18.54 O ACT A1182 C 161 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 174 TYR A 64 TYR~? 13.66 OXT ACT A1181 coo 2.84 19.43 40.34 1.59 20.35 37.65 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 5.94 13.28 27.17 3.53 13.05 28.58 -41.23 7.24 -1.52 -40.97 7.41 -4.31 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG B 58 ARG~? 12.97 O3 GOL B1182 C 161 ASP A 156 ASP~? 10.59 O ACT A1181 C 174 TYR A 157 TYR~? 5.66 OXT ACT A1181 coo 2.84 19.43 40.34 1.59 20.35 37.65 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 5.94 13.28 27.17 3.53 13.05 28.58 -46.22 16.76 -7.11 -49.01 16.68 -7.45 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG B 77 ARG.? 16.85 CA CA B1181 C 161 ASP A 156 ASP~? 10.59 O ACT A1181 C 174 TYR B 64 TYR~? 13.94 OXT ACT A1181 coo 2.84 19.43 40.34 1.59 20.35 37.65 -57.98 19.33 8.28 -57.78 17.70 5.69 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 5.94 13.28 27.17 3.53 13.05 28.58 -49.49 10.87 0.95 -49.71 13.38 -0.30 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 6 3 # 6 C 14 ARG C 58 ARG~? 18.42 O3 GOL D1181 C 161 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 174 TYR D 157 TYR~? -5.31 C1 GOL D1181s coo 2.84 19.43 40.34 1.59 20.35 37.65 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 5.94 13.28 27.17 3.53 13.05 28.58 -46.23 -16.78 33.55 -49.03 -16.71 33.91 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 7 3 # 7 C 14 ARG C 77 ARG.? 17.10 CA CA C1181 C 161 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 174 TYR C 64 TYR~? 13.24 O3 GOL D1181 coo 2.84 19.43 40.34 1.59 20.35 37.65 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 5.94 13.28 27.17 3.53 13.05 28.58 -49.46 -10.91 25.49 -49.72 -13.40 26.79 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 8 3 # 8 C 14 ARG D 30 ARG.? 11.01 CA CA C1182 C 161 ASP C 6 ASP~? 17.85 CA CA C1182 C 174 TYR C 5 TYR~? 20.02 CA CA C1182 coo 2.84 19.43 40.34 1.59 20.35 37.65 -29.54 -28.66 35.64 -30.45 -28.64 38.59 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 5.94 13.28 27.17 3.53 13.05 28.58 -20.63 -17.79 37.57 -20.04 -17.26 34.89 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 9 3 # 9 C 14 ARG D 58 ARG~? 14.52 O2 GOL D1181 C 161 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 174 TYR C 157 TYR~? 5.26 O3 GOL D1181 coo 2.84 19.43 40.34 1.59 20.35 37.65 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 5.94 13.28 27.17 3.53 13.05 28.58 -44.58 -12.33 36.53 -41.80 -12.65 36.66 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 10 3 # 10 C 14 ARG D 77 ARG.? 18.56 OXT ACT A1182 C 161 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 174 TYR D 64 TYR~? 12.19 O3 GOL D1181 coo 2.84 19.43 40.34 1.59 20.35 37.65 -32.91 2.84 33.04 -33.00 -0.18 32.51 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 5.94 13.28 27.17 3.53 13.05 28.58 -41.23 -7.21 27.99 -40.99 -7.39 30.78 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 10 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 30 ARG.? 15.23 O ACT A1181 D 161 ASP B 6 ASP~? 24.59 OXT ACT A1181 D 174 TYR B 5 TYR~? 22.90 O ACT A1181 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -20.60 17.75 -11.10 -19.92 17.17 -8.44 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 58 ARG~? 14.46 O ACT A1181 D 161 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 174 TYR B 157 TYR~? 6.24 OXT ACT A1181 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -43.27 15.99 4.53 -43.95 18.83 5.47 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -44.58 12.35 -10.09 -41.80 12.65 -10.19 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG A 77 ARG.? 18.54 O ACT A1182 D 161 ASP B 156 ASP~? 13.25 OXT ACT A1181 D 174 TYR A 64 TYR~? 13.66 OXT ACT A1181 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -41.23 7.24 -1.52 -40.97 7.41 -4.31 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG B 58 ARG~? 12.97 O3 GOL B1182 D 161 ASP A 156 ASP~? 10.59 O ACT A1181 D 174 TYR A 157 TYR~? 5.66 OXT ACT A1181 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -46.22 16.76 -7.11 -49.01 16.68 -7.45 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 5 3 # 5 D 14 ARG B 77 ARG.? 16.85 CA CA B1181 D 161 ASP A 156 ASP~? 10.59 O ACT A1181 D 174 TYR B 64 TYR~? 13.94 OXT ACT A1181 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -57.98 19.33 8.28 -57.78 17.70 5.69 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -49.49 10.87 0.95 -49.71 13.38 -0.30 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 6 3 # 6 D 14 ARG C 58 ARG~? 18.42 O3 GOL D1181 D 161 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 174 TYR D 157 TYR~? -5.31 C1 GOL D1181s coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -46.23 -16.78 33.55 -49.03 -16.71 33.91 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 7 3 # 7 D 14 ARG C 77 ARG.? 17.10 CA CA C1181 D 161 ASP D 156 ASP~? 10.44 C2 GOL D1181 D 174 TYR C 64 TYR~? 13.24 O3 GOL D1181 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -49.46 -10.91 25.49 -49.72 -13.40 26.79 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 8 3 # 8 D 14 ARG D 30 ARG.? 11.01 CA CA C1182 D 161 ASP C 6 ASP~? 17.85 CA CA C1182 D 174 TYR C 5 TYR~? 20.02 CA CA C1182 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -29.54 -28.66 35.64 -30.45 -28.64 38.59 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -20.63 -17.79 37.57 -20.04 -17.26 34.89 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 9 3 # 9 D 14 ARG D 58 ARG~? 14.52 O2 GOL D1181 D 161 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 174 TYR C 157 TYR~? 5.26 O3 GOL D1181 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -44.58 -12.33 36.53 -41.80 -12.65 36.66 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 10 3 # 10 D 14 ARG D 77 ARG.? 18.56 OXT ACT A1182 D 161 ASP C 156 ASP~? 12.06 O3 GOL D1181 D 174 TYR D 64 TYR~? 12.19 O3 GOL D1181 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -32.91 2.84 33.04 -33.00 -0.18 32.51 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -41.23 -7.21 27.99 -40.99 -7.39 30.78 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 10 hits 2c7v_c11 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU B 10 GLU~? 20.86 OXT ACT A1181 A 156 GLU A 27 GLU~? -12.01 CH3 ACT A1181s A 194 ASN A 168 ASN~? 15.32 OXT ACT A1181 coo 74.14 15.91 8.55 72.08 15.36 8.63 -27.02 16.65 -20.13 -25.98 15.39 -21.46 coo 67.47 20.07 1.34 65.99 20.06 2.88 -34.14 22.58 -15.68 -34.47 22.99 -17.72 coo 67.44 25.26 13.91 67.54 23.65 15.28 -31.58 8.23 -11.56 -33.27 7.25 -12.34 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU C 10 GLU~? 13.45 CA CA C1182 A 156 GLU D 27 GLU~? 2.91 CA CA C1182s A 194 ASN D 168 ASN~? 14.11 O3 GOL D1181 coo 74.14 15.91 8.55 72.08 15.36 8.63 -27.27 -16.59 46.83 -26.38 -15.22 48.19 coo 67.47 20.07 1.34 65.99 20.06 2.88 -34.10 -22.57 42.20 -34.50 -23.02 44.23 coo 67.44 25.26 13.91 67.54 23.65 15.28 -31.58 -8.23 38.03 -33.25 -7.24 38.84 2dbt_c00 source 2dbt CHITINASE C : 2 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU B 10 GLU~? 20.86 OXT ACT A1181 B 156 GLU A 27 GLU~? -12.01 CH3 ACT A1181s B 194 ASN A 168 ASN~? 15.32 OXT ACT A1181 coo 45.64 63.11 17.20 47.48 62.43 16.45 -27.02 16.65 -20.13 -25.98 15.39 -21.46 coo 54.43 67.89 19.82 55.62 67.90 18.07 -34.14 22.58 -15.68 -34.47 22.99 -17.72 coo 49.79 70.75 7.78 50.10 68.90 6.86 -31.58 8.23 -11.56 -33.27 7.25 -12.34 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU C 10 GLU~? 13.45 CA CA C1182 B 156 GLU D 27 GLU~? 2.91 CA CA C1182s B 194 ASN D 168 ASN~? 14.11 O3 GOL D1181 coo 45.64 63.11 17.20 47.48 62.43 16.45 -27.27 -16.59 46.83 -26.38 -15.22 48.19 coo 54.43 67.89 19.82 55.62 67.90 18.07 -34.10 -22.57 42.20 -34.50 -23.02 44.23 coo 49.79 70.75 7.78 50.10 68.90 6.86 -31.58 -8.23 38.03 -33.25 -7.24 38.84 2dbt_c01 source 2dbt CHITINASE C : 2 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 10 GLU~? 17.55 CA CA B1181 C 156 GLU A 17 GLU~? 13.61 CH3 ACT A1181 C 194 ASN B 168 ASN~? 15.62 CH3 ACT A1181 coo 41.23 29.31 13.28 43.03 29.85 12.29 -63.89 24.62 -14.30 -65.11 25.98 -13.14 coo 44.75 23.09 5.51 46.77 22.91 6.12 -53.17 23.87 -17.57 -54.60 25.28 -18.31 coo 49.75 21.00 18.12 50.45 23.02 18.26 -59.27 19.54 -3.77 -57.59 20.58 -3.04 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU B 10 GLU~? 20.86 OXT ACT A1181 C 156 GLU A 27 GLU~? -12.01 CH3 ACT A1181s C 194 ASN A 168 ASN~? 15.32 OXT ACT A1181 coo 41.23 29.31 13.28 43.03 29.85 12.29 -27.02 16.65 -20.13 -25.98 15.39 -21.46 coo 44.75 23.09 5.51 46.77 22.91 6.12 -34.14 22.58 -15.68 -34.47 22.99 -17.72 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.58 8.23 -11.56 -33.27 7.25 -12.34 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU C 10 GLU~? 13.45 CA CA C1182 C 156 GLU D 27 GLU~? 2.91 CA CA C1182s C 194 ASN D 168 ASN~? 14.11 O3 GOL D1181 coo 41.23 29.31 13.28 43.03 29.85 12.29 -27.27 -16.59 46.83 -26.38 -15.22 48.19 coo 44.75 23.09 5.51 46.77 22.91 6.12 -34.10 -22.57 42.20 -34.50 -23.02 44.23 coo 49.75 21.00 18.12 50.45 23.02 18.26 -31.58 -8.23 38.03 -33.25 -7.24 38.84 2dbt_c02 source 2dbt CHITINASE C : 3 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS C 2 LYS^? 15.05 CA CA C1182 A 184 LYS D 177 LYS.? 22.56 O3 GOL D1181 A 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo 5.98 42.76 7.73 10.19 38.62 9.02 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 2.77 37.17 4.99 6.33 34.76 8.06 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -34.30 -14.69 46.01 -33.14 -15.11 47.72 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 2 LYS^? 14.71 CA CA B1181 B 184 LYS B 177 LYS.? 12.69 CA CA B1181 B 345 ASP A 14 ASP~? 14.99 CH3 ACT A1181 coo 38.76 2.27 4.00 34.00 5.99 4.37 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo 40.63 7.13 9.06 35.85 7.36 8.95 -68.49 25.09 -2.05 -63.14 26.93 0.36 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -56.57 24.69 -12.57 -57.85 26.13 -13.49 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 72 LYS.? 19.74 O ACT A1182 B 184 LYS D 93 LYS.? 12.21 O ACT A1182 B 345 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 38.76 2.27 4.00 34.00 5.99 4.37 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 40.63 7.13 9.06 35.85 7.36 8.95 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS A 177 LYS.? 21.69 OXT ACT A1181 B 184 LYS B 2 LYS^? 23.29 OXT ACT A1181 B 345 ASP B 14 ASP~? 13.85 OXT ACT A1181 coo 38.76 2.27 4.00 34.00 5.99 4.37 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo 40.63 7.13 9.06 35.85 7.36 8.95 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -34.30 14.67 -19.52 -35.49 13.01 -20.13 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS B 2 LYS^? 23.29 OXT ACT A1181 B 184 LYS A 177 LYS.? 21.69 OXT ACT A1181 B 345 ASP B 14 ASP~? 13.85 OXT ACT A1181 coo 38.76 2.27 4.00 34.00 5.99 4.37 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 40.63 7.13 9.06 35.85 7.36 8.95 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -34.30 14.67 -19.52 -35.49 13.01 -20.13 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS C 2 LYS^? 15.05 CA CA C1182 B 184 LYS D 177 LYS.? 22.56 O3 GOL D1181 B 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo 38.76 2.27 4.00 34.00 5.99 4.37 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 40.63 7.13 9.06 35.85 7.36 8.95 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -34.30 -14.69 46.01 -33.14 -15.11 47.72 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS D 2 LYS.? 16.82 CA CA C1181 B 184 LYS C 177 LYS.? 13.52 CA CA C1181 B 345 ASP D 14 ASP~? 14.81 O1 GOL D1181 coo 38.76 2.27 4.00 34.00 5.99 4.37 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo 40.63 7.13 9.06 35.85 7.36 8.95 -68.52 -25.10 28.52 -62.74 -26.81 28.79 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -56.61 -24.66 39.06 -57.85 -26.16 39.97 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 7 3 # 7 B 182 LYS D 72 LYS.? 18.40 OXT ACT A1182 B 184 LYS A 93 LYS.? 11.72 OXT ACT A1182 B 345 ASP D 84 ASP^? 8.02 O ACT A1182 coo 38.76 2.27 4.00 34.00 5.99 4.37 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 40.63 7.13 9.06 35.85 7.36 8.95 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 8 3 # 8 B 182 LYS D 177 LYS.? 22.56 O3 GOL D1181 B 184 LYS C 2 LYS^? 15.05 CA CA C1182 B 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo 38.76 2.27 4.00 34.00 5.99 4.37 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 40.63 7.13 9.06 35.85 7.36 8.95 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -34.30 -14.69 46.01 -33.14 -15.11 47.72 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS C 2 LYS^? 15.05 CA CA C1182 C 184 LYS D 177 LYS.? 22.56 O3 GOL D1181 C 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 0.95 12.72 73.51 1.58 12.72 68.31 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -34.30 -14.69 46.01 -33.14 -15.11 47.72 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS C 2 LYS^? 15.05 CA CA C1182 G 184 LYS D 177 LYS.? 22.56 O3 GOL D1181 G 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo 39.68 42.04 76.11 43.42 46.43 74.96 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 36.69 47.69 78.93 39.38 50.40 75.35 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 33.43 44.37 65.47 33.10 42.30 65.37 -34.30 -14.69 46.01 -33.14 -15.11 47.72 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 2 LYS^? 14.71 CA CA B1181 J 184 LYS B 177 LYS.? 12.69 CA CA B1181 J 345 ASP A 14 ASP~? 14.99 CH3 ACT A1181 coo 25.22 70.55 14.03 27.64 73.07 18.65 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo 31.73 69.87 11.50 32.73 70.19 16.40 -68.49 25.09 -2.05 -63.14 26.93 0.36 coo 25.87 58.42 18.79 23.95 58.54 17.90 -56.57 24.69 -12.57 -57.85 26.13 -13.49 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS B 2 LYS^? 23.29 OXT ACT A1181 J 184 LYS A 177 LYS.? 21.69 OXT ACT A1181 J 345 ASP B 14 ASP~? 13.85 OXT ACT A1181 coo 25.22 70.55 14.03 27.64 73.07 18.65 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 31.73 69.87 11.50 32.73 70.19 16.40 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo 25.87 58.42 18.79 23.95 58.54 17.90 -34.30 14.67 -19.52 -35.49 13.01 -20.13 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS C 2 LYS^? 15.05 CA CA C1182 J 184 LYS D 177 LYS.? 22.56 O3 GOL D1181 J 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo 25.22 70.55 14.03 27.64 73.07 18.65 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 31.73 69.87 11.50 32.73 70.19 16.40 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 25.87 58.42 18.79 23.95 58.54 17.90 -34.30 -14.69 46.01 -33.14 -15.11 47.72 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS D 2 LYS.? 16.82 CA CA C1181 J 184 LYS C 177 LYS.? 13.52 CA CA C1181 J 345 ASP D 14 ASP~? 14.81 O1 GOL D1181 coo 25.22 70.55 14.03 27.64 73.07 18.65 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo 31.73 69.87 11.50 32.73 70.19 16.40 -68.52 -25.10 28.52 -62.74 -26.81 28.79 coo 25.87 58.42 18.79 23.95 58.54 17.90 -56.61 -24.66 39.06 -57.85 -26.16 39.97 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS C 2 LYS^? 15.05 CA CA C1182 K 184 LYS D 177 LYS.? 22.56 O3 GOL D1181 K 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -34.30 -14.69 46.01 -33.14 -15.11 47.72 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 2 LYS^? 14.71 CA CA B1181 L 184 LYS B 177 LYS.? 12.69 CA CA B1181 L 345 ASP A 14 ASP~? 14.99 CH3 ACT A1181 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -68.49 25.09 -2.05 -63.14 26.93 0.36 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -56.57 24.69 -12.57 -57.85 26.13 -13.49 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 72 LYS.? 19.74 O ACT A1182 L 184 LYS D 93 LYS.? 12.21 O ACT A1182 L 345 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS B 2 LYS^? 23.29 OXT ACT A1181 L 184 LYS A 177 LYS.? 21.69 OXT ACT A1181 L 345 ASP B 14 ASP~? 13.85 OXT ACT A1181 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -34.30 14.67 -19.52 -35.49 13.01 -20.13 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS C 2 LYS^? 15.05 CA CA C1182 L 184 LYS D 177 LYS.? 22.56 O3 GOL D1181 L 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -34.30 -14.69 46.01 -33.14 -15.11 47.72 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS D 2 LYS.? 16.82 CA CA C1181 L 184 LYS C 177 LYS.? 13.52 CA CA C1181 L 345 ASP D 14 ASP~? 14.81 O1 GOL D1181 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -68.52 -25.10 28.52 -62.74 -26.81 28.79 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -56.61 -24.66 39.06 -57.85 -26.16 39.97 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS D 72 LYS.? 18.40 OXT ACT A1182 L 184 LYS A 93 LYS.? 11.72 OXT ACT A1182 L 345 ASP D 84 ASP^? 8.02 O ACT A1182 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -39.21 6.22 27.81 -43.32 9.34 25.63 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -36.44 -3.37 16.46 -38.06 -4.61 15.80 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 2 LYS^? 14.71 CA CA B1181 M 184 LYS B 177 LYS.? 12.69 CA CA B1181 M 345 ASP A 14 ASP~? 14.99 CH3 ACT A1181 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -68.49 25.09 -2.05 -63.14 26.93 0.36 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -56.57 24.69 -12.57 -57.85 26.13 -13.49 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 72 LYS.? 19.74 O ACT A1182 M 184 LYS D 93 LYS.? 12.21 O ACT A1182 M 345 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS A 177 LYS.? 21.69 OXT ACT A1181 M 184 LYS B 2 LYS^? 23.29 OXT ACT A1181 M 345 ASP B 14 ASP~? 13.85 OXT ACT A1181 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -34.30 14.67 -19.52 -35.49 13.01 -20.13 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS B 2 LYS^? 23.29 OXT ACT A1181 M 184 LYS A 177 LYS.? 21.69 OXT ACT A1181 M 345 ASP B 14 ASP~? 13.85 OXT ACT A1181 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -34.30 14.67 -19.52 -35.49 13.01 -20.13 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS C 2 LYS^? 15.05 CA CA C1182 M 184 LYS D 177 LYS.? 22.56 O3 GOL D1181 M 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -34.30 -14.69 46.01 -33.14 -15.11 47.72 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS D 2 LYS.? 16.82 CA CA C1181 M 184 LYS C 177 LYS.? 13.52 CA CA C1181 M 345 ASP D 14 ASP~? 14.81 O1 GOL D1181 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -68.52 -25.10 28.52 -62.74 -26.81 28.79 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -56.61 -24.66 39.06 -57.85 -26.16 39.97 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 7 3 # 7 M 182 LYS D 177 LYS.? 22.56 O3 GOL D1181 M 184 LYS C 2 LYS^? 15.05 CA CA C1182 M 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -34.30 -14.69 46.01 -33.14 -15.11 47.72 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 7 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS C 2 LYS^? 15.05 CA CA C1182 O 184 LYS D 177 LYS.? 22.56 O3 GOL D1181 O 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -34.30 -14.69 46.01 -33.14 -15.11 47.72 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 2 LYS^? 14.71 CA CA B1181 P 184 LYS B 177 LYS.? 12.69 CA CA B1181 P 345 ASP A 14 ASP~? 14.99 CH3 ACT A1181 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -68.49 25.09 -2.05 -63.14 26.93 0.36 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -56.57 24.69 -12.57 -57.85 26.13 -13.49 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 72 LYS.? 19.74 O ACT A1182 P 184 LYS D 93 LYS.? 12.21 O ACT A1182 P 345 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS A 177 LYS.? 21.69 OXT ACT A1181 P 184 LYS B 2 LYS^? 23.29 OXT ACT A1181 P 345 ASP B 14 ASP~? 13.85 OXT ACT A1181 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -34.30 14.67 -19.52 -35.49 13.01 -20.13 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS B 2 LYS^? 23.29 OXT ACT A1181 P 184 LYS A 177 LYS.? 21.69 OXT ACT A1181 P 345 ASP B 14 ASP~? 13.85 OXT ACT A1181 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -22.65 4.65 -16.37 -26.75 7.46 -18.74 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -34.30 14.67 -19.52 -35.49 13.01 -20.13 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS C 2 LYS^? 15.05 CA CA C1182 P 184 LYS D 177 LYS.? 22.56 O3 GOL D1181 P 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -34.30 -14.69 46.01 -33.14 -15.11 47.72 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS D 2 LYS.? 16.82 CA CA C1181 P 184 LYS C 177 LYS.? 13.52 CA CA C1181 P 345 ASP D 14 ASP~? 14.81 O1 GOL D1181 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -68.52 -25.10 28.52 -62.74 -26.81 28.79 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -56.61 -24.66 39.06 -57.85 -26.16 39.97 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 7 3 # 7 P 182 LYS D 177 LYS.? 22.56 O3 GOL D1181 P 184 LYS C 2 LYS^? 15.05 CA CA C1182 P 345 ASP C 14 ASP~? 9.29 CA CA C1182 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -34.30 -14.69 46.01 -33.14 -15.11 47.72 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 7 hits 2dw7_c47 naa= 3 ULMN 3 2f61_c00 ACID BETA-GLUCOSIDASE user 1 3 # 1 A 235 GLU A 139 GLU.? 21.64 O ACT A1181 A 340 GLU A 140 GLU.? 22.35 O ACT A1181 A 342 CYH A 145 CYH.? 18.06 O ACT A1181 coo 13.45 37.14 -1.68 12.32 37.89 -3.28 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 14.96 43.86 -2.28 14.91 42.15 -3.51 -27.69 26.26 5.34 -26.17 27.35 4.33 coo 11.37 47.97 -4.08 11.06 45.43 -5.26 -28.16 21.72 2.56 -30.09 23.43 3.54 ULMN 3 2f61_c00 ACID BETA-GLUCOSIDASE user 2 3 # 2 A 235 GLU B 139 GLU.? 13.29 O3 GOL B1182 A 340 GLU B 140 GLU.? 3.43 CA CA B1183s A 342 CYH B 145 CYH.? 5.45 CA CA B1183 coo 13.45 37.14 -1.68 12.32 37.89 -3.28 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 14.96 43.86 -2.28 14.91 42.15 -3.51 -61.69 -2.09 -15.49 -62.76 -1.73 -17.26 coo 11.37 47.97 -4.08 11.06 45.43 -5.26 -62.49 1.50 -10.58 -60.97 -0.38 -12.04 ULMN 3 2f61_c00 ACID BETA-GLUCOSIDASE user 3 3 # 3 A 235 GLU C 139 GLU.? 13.61 CA CA C1184 A 340 GLU C 140 GLU.? 3.48 CA CA C1184s A 342 CYH C 145 CYH.? 5.42 CA CA C1184 coo 13.45 37.14 -1.68 12.32 37.89 -3.28 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 14.96 43.86 -2.28 14.91 42.15 -3.51 -61.62 1.99 42.01 -62.64 1.68 43.84 coo 11.37 47.97 -4.08 11.06 45.43 -5.26 -62.51 -1.53 37.02 -61.06 0.37 38.52 ULMN 3 2f61_c00 ACID BETA-GLUCOSIDASE user 4 3 # 4 A 235 GLU D 139 GLU.? 21.84 O2 GOL D1181 A 340 GLU D 140 GLU.? 20.95 O2 GOL D1181 A 342 CYH D 145 CYH.? 17.92 O2 GOL D1181 coo 13.45 37.14 -1.68 12.32 37.89 -3.28 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 14.96 43.86 -2.28 14.91 42.15 -3.51 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 11.37 47.97 -4.08 11.06 45.43 -5.26 -28.17 -21.73 23.90 -30.12 -23.42 22.95 2f61_c00 source 2f61 ACID BETA-GLUCOSIDASE : 4 hits 2f61_c00 naa= 3 ULMN 3 2f61_c01 ACID BETA-GLUCOSIDASE user 1 3 # 1 B 235 GLU A 139 GLU.? 21.64 O ACT A1181 B 340 GLU A 140 GLU.? 22.35 O ACT A1181 B 342 CYH A 145 CYH.? 18.06 O ACT A1181 coo 41.63 98.81 4.74 43.45 99.80 5.19 -34.64 27.04 8.52 -35.38 28.56 9.82 coo 40.49 105.59 6.14 40.82 103.64 6.89 -27.69 26.26 5.34 -26.17 27.35 4.33 coo 45.58 109.64 7.60 45.90 106.93 8.23 -28.16 21.72 2.56 -30.09 23.43 3.54 ULMN 3 2f61_c01 ACID BETA-GLUCOSIDASE user 2 3 # 2 B 235 GLU B 139 GLU.? 13.29 O3 GOL B1182 B 340 GLU B 140 GLU.? 3.43 CA CA B1183s B 342 CYH B 145 CYH.? 5.45 CA CA B1183 coo 41.63 98.81 4.74 43.45 99.80 5.19 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 coo 40.49 105.59 6.14 40.82 103.64 6.89 -61.69 -2.09 -15.49 -62.76 -1.73 -17.26 coo 45.58 109.64 7.60 45.90 106.93 8.23 -62.49 1.50 -10.58 -60.97 -0.38 -12.04 ULMN 3 2f61_c01 ACID BETA-GLUCOSIDASE user 3 3 # 3 B 235 GLU C 139 GLU.? 13.61 CA CA C1184 B 340 GLU C 140 GLU.? 3.48 CA CA C1184s B 342 CYH C 145 CYH.? 5.42 CA CA C1184 coo 41.63 98.81 4.74 43.45 99.80 5.19 -54.75 6.31 40.61 -53.48 6.42 38.96 coo 40.49 105.59 6.14 40.82 103.64 6.89 -61.62 1.99 42.01 -62.64 1.68 43.84 coo 45.58 109.64 7.60 45.90 106.93 8.23 -62.51 -1.53 37.02 -61.06 0.37 38.52 ULMN 3 2f61_c01 ACID BETA-GLUCOSIDASE user 4 3 # 4 B 235 GLU D 139 GLU.? 21.84 O2 GOL D1181 B 340 GLU D 140 GLU.? 20.95 O2 GOL D1181 B 342 CYH D 145 CYH.? 17.92 O2 GOL D1181 coo 41.63 98.81 4.74 43.45 99.80 5.19 -34.44 -26.82 17.86 -34.96 -28.12 16.26 coo 40.49 105.59 6.14 40.82 103.64 6.89 -27.73 -26.26 21.28 -26.82 -26.69 23.16 coo 45.58 109.64 7.60 45.90 106.93 8.23 -28.17 -21.73 23.90 -30.12 -23.42 22.95 2f61_c01 source 2f61 ACID BETA-GLUCOSIDASE : 4 hits 2f61_c01 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 5 TYR~? 13.40 O1 GOL B1182 A 245 ASP A 6 ASP~? 16.17 CA CA B1181 A 273 LYS B 177 LYS.? 12.69 CA CA B1181 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 245 ASP A 156 ASP~? 10.59 O ACT A1181 A 273 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR B 5 TYR~? 22.90 O ACT A1181 A 245 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 273 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -20.60 17.75 -11.10 -19.92 17.17 -8.44 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 245 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 273 LYS A 158 LYS~? -4.64 O ACT A1181s coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 150 TYR C 5 TYR~? 20.02 CA CA C1182 A 245 ASP C 6 ASP~? 17.85 CA CA C1182 A 273 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -20.63 -17.79 37.57 -20.04 -17.26 34.89 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -22.65 -4.76 42.92 -27.69 -1.89 42.71 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 150 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 245 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 273 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 150 TYR D 5 TYR~? 13.80 CA CA C1181 A 245 ASP D 6 ASP~? 16.12 CA CA C1181 A 273 LYS C 177 LYS.? 13.52 CA CA C1181 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -70.23 -15.79 38.72 -70.77 -13.51 37.21 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 150 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 245 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 273 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -50.05 -10.42 36.79 -49.63 -8.70 42.89 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 8 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 245 ASP A 55 ASP.? 17.41 O ACT A1181 A 273 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 245 ASP A 156 ASP~? 10.59 O ACT A1181 A 273 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 245 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 273 LYS B 164 LYS~? 10.34 O ACT A1181 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE A 138 PHE.? 14.29 O ACT A1181 A 245 ASP A 55 ASP.? 17.41 O ACT A1181 A 273 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -40.70 16.96 10.07 -41.68 17.42 8.23 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 245 ASP A 156 ASP~? 10.59 O ACT A1181 A 273 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 245 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 273 LYS A 72 LYS.? 19.74 O ACT A1182 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 157 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 245 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 273 LYS A 158 LYS~? -4.64 O ACT A1181s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 157 PHE B 138 PHE.? 9.75 O3 GOL B1182 A 245 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 273 LYS A 72 LYS.? 19.74 O ACT A1182 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 157 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 245 ASP C 55 ASP.? 19.45 CA CA C1184 A 273 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 157 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 245 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 273 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 157 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 245 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 273 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -35.86 -9.73 34.54 -40.60 -7.29 35.38 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 12 3 # 12 A 157 PHE C 138 PHE.? 14.85 CA CA C1184 A 245 ASP C 55 ASP.? 19.45 CA CA C1184 A 273 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -49.79 3.61 29.96 -48.81 2.08 31.09 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -39.21 6.22 27.81 -43.32 9.34 25.63 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 13 3 # 13 A 157 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 245 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 273 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 14 3 # 14 A 157 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 245 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 273 LYS C 72 LYS.? 18.71 O ACT C1183 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 15 3 # 15 A 157 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 245 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 273 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 16 3 # 16 A 157 PHE D 138 PHE.? 14.22 O2 GOL D1181 A 245 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 273 LYS C 72 LYS.? 18.71 O ACT C1183 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -51.58 -16.11 13.18 -47.22 -15.59 10.10 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 16 hits 2gsa_c04 naa= 3 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 1 3 # 1 B 137 SER A 42 SER~? 22.64 CH3 ACT A1182 B 158 HIS A 43 HIS~? 14.01 CH3 ACT A1182 B 208 ASN A 46 ASN~? 20.18 CH3 ACT A1182 coo 50.29 50.10 71.46 47.85 50.06 71.46 -19.46 8.46 -2.16 -18.17 10.05 -3.40 coo 48.67 45.40 71.68 47.67 46.90 70.60 -21.65 8.05 3.64 -22.04 7.30 5.57 coo 48.91 49.12 65.17 47.29 49.14 66.54 -16.92 5.08 1.56 -15.60 6.18 0.30 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 2 3 # 2 B 137 SER A 49 SER^? 7.92 CH3 ACT A1182 B 158 HIS A 43 HIS~? 14.01 CH3 ACT A1182 B 208 ASN A 109 ASN.? 14.39 CH3 ACT A1182 coo 50.29 50.10 71.46 47.85 50.06 71.46 -24.82 3.72 6.45 -24.44 3.87 8.86 coo 48.67 45.40 71.68 47.67 46.90 70.60 -21.65 8.05 3.64 -22.04 7.30 5.57 coo 48.91 49.12 65.17 47.29 49.14 66.54 -18.98 4.63 8.19 -18.49 6.24 6.88 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 3 3 # 3 B 137 SER A 53 SER^? 12.21 OXT ACT A1182 B 158 HIS A 114 HIS^? 15.94 OXT ACT A1182 B 208 ASN A 86 ASN.? 11.67 OXT ACT A1182 coo 50.29 50.10 71.46 47.85 50.06 71.46 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 48.67 45.40 71.68 47.67 46.90 70.60 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 48.91 49.12 65.17 47.29 49.14 66.54 -38.42 8.17 12.63 -38.52 10.18 11.86 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 4 3 # 4 B 137 SER A 56 SER.? 20.33 OXT ACT A1182 B 158 HIS A 59 HIS~? 15.34 OXT ACT A1182 B 208 ASN A 86 ASN.? 11.67 OXT ACT A1182 coo 50.29 50.10 71.46 47.85 50.06 71.46 -44.08 14.33 11.46 -44.92 16.36 12.58 coo 48.67 45.40 71.68 47.67 46.90 70.60 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 48.91 49.12 65.17 47.29 49.14 66.54 -38.42 8.17 12.63 -38.52 10.18 11.86 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 5 3 # 5 B 137 SER B 42 SER~? 9.53 CA CA B1181 B 158 HIS B 43 HIS~? 14.15 CH3 ACT C1183 B 208 ASN B 46 ASN~? 10.46 CA CA B1181 coo 50.29 50.10 71.46 47.85 50.06 71.46 -71.32 10.68 -0.61 -72.48 11.28 -2.66 coo 48.67 45.40 71.68 47.67 46.90 70.60 -68.93 5.59 2.00 -68.67 4.03 3.39 coo 48.91 49.12 65.17 47.29 49.14 66.54 -74.04 8.69 3.83 -75.20 9.76 2.34 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 6 3 # 6 B 137 SER B 49 SER^? 8.06 CH3 ACT C1183 B 158 HIS B 43 HIS~? 14.15 CH3 ACT C1183 B 208 ASN B 109 ASN.? 14.52 CH3 ACT C1183 coo 50.29 50.10 71.46 47.85 50.06 71.46 -65.82 4.78 7.06 -66.17 2.51 7.90 coo 48.67 45.40 71.68 47.67 46.90 70.60 -68.93 5.59 2.00 -68.67 4.03 3.39 coo 48.91 49.12 65.17 47.29 49.14 66.54 -71.64 2.73 6.90 -72.13 3.19 4.89 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 7 3 # 7 B 137 SER B 53 SER^? 12.05 O ACT C1183 B 158 HIS B 114 HIS^? 14.73 O2 GOL B1182 B 208 ASN B 86 ASN.? 11.57 O ACT C1183 coo 50.29 50.10 71.46 47.85 50.06 71.46 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 48.67 45.40 71.68 47.67 46.90 70.60 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 48.91 49.12 65.17 47.29 49.14 66.54 -52.20 -2.48 5.54 -51.99 -2.60 3.42 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 8 3 # 8 B 137 SER B 56 SER.? 19.73 O3 GOL B1182 B 158 HIS B 59 HIS~? 15.18 O ACT C1183 B 208 ASN B 86 ASN.? 11.57 O ACT C1183 coo 50.29 50.10 71.46 47.85 50.06 71.46 -46.47 -3.76 -0.54 -45.56 -5.57 -1.92 coo 48.67 45.40 71.68 47.67 46.90 70.60 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 48.91 49.12 65.17 47.29 49.14 66.54 -52.20 -2.48 5.54 -51.99 -2.60 3.42 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 9 3 # 9 B 137 SER C 42 SER~? 9.40 CA CA C1181 B 158 HIS C 43 HIS~? 14.16 CH3 ACT C1183 B 208 ASN C 46 ASN~? 10.53 CA CA C1181 coo 50.29 50.10 71.46 47.85 50.06 71.46 -71.30 -10.68 27.08 -72.47 -11.31 29.07 coo 48.67 45.40 71.68 47.67 46.90 70.60 -69.05 -5.52 24.49 -68.63 -4.06 23.04 coo 48.91 49.12 65.17 47.29 49.14 66.54 -74.04 -8.67 22.63 -75.10 -9.60 24.27 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 10 3 # 10 B 137 SER C 49 SER^? 8.04 CH3 ACT C1183 B 158 HIS C 43 HIS~? 14.16 CH3 ACT C1183 B 208 ASN C 109 ASN.? 14.51 CH3 ACT C1183 coo 50.29 50.10 71.46 47.85 50.06 71.46 -65.83 -4.76 19.39 -66.15 -2.47 18.58 coo 48.67 45.40 71.68 47.67 46.90 70.60 -69.05 -5.52 24.49 -68.63 -4.06 23.04 coo 48.91 49.12 65.17 47.29 49.14 66.54 -71.64 -2.74 19.53 -72.13 -3.21 21.54 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 11 3 # 11 B 137 SER C 53 SER^? 12.05 OXT ACT C1183 B 158 HIS C 114 HIS^? 15.77 OXT ACT C1183 B 208 ASN C 86 ASN.? 11.54 OXT ACT C1183 coo 50.29 50.10 71.46 47.85 50.06 71.46 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 48.67 45.40 71.68 47.67 46.90 70.60 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 48.91 49.12 65.17 47.29 49.14 66.54 -52.20 2.48 20.90 -52.01 2.64 23.02 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 12 3 # 12 B 137 SER C 56 SER.? 20.22 OXT ACT C1183 B 158 HIS C 59 HIS~? 15.17 OXT ACT C1183 B 208 ASN C 86 ASN.? 11.54 OXT ACT C1183 coo 50.29 50.10 71.46 47.85 50.06 71.46 -46.48 3.79 27.00 -45.42 5.54 28.32 coo 48.67 45.40 71.68 47.67 46.90 70.60 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 48.91 49.12 65.17 47.29 49.14 66.54 -52.20 2.48 20.90 -52.01 2.64 23.02 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 13 3 # 13 B 137 SER D 42 SER~? 22.67 CH3 ACT A1182 B 158 HIS D 43 HIS~? 14.01 CH3 ACT A1182 B 208 ASN D 46 ASN~? 18.62 CH3 ACT A1182 coo 50.29 50.10 71.46 47.85 50.06 71.46 -19.49 -8.50 28.63 -18.22 -10.13 29.88 coo 48.67 45.40 71.68 47.67 46.90 70.60 -21.76 -7.99 22.88 -22.00 -7.32 20.90 coo 48.91 49.12 65.17 47.29 49.14 66.54 -16.96 -5.07 24.82 -15.16 -4.92 23.63 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 14 3 # 14 B 137 SER D 49 SER^? 7.93 CH3 ACT A1182 B 158 HIS D 43 HIS~? 14.01 CH3 ACT A1182 B 208 ASN D 109 ASN.? 14.36 CH3 ACT A1182 coo 50.29 50.10 71.46 47.85 50.06 71.46 -24.82 -3.74 20.02 -24.43 -3.84 17.62 coo 48.67 45.40 71.68 47.67 46.90 70.60 -21.76 -7.99 22.88 -22.00 -7.32 20.90 coo 48.91 49.12 65.17 47.29 49.14 66.54 -18.98 -4.62 18.28 -18.54 -6.24 19.59 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 15 3 # 15 B 137 SER D 53 SER^? 12.18 O ACT A1182 B 158 HIS D 114 HIS^? 15.97 O ACT A1182 B 208 ASN D 86 ASN.? 11.74 O ACT A1182 coo 50.29 50.10 71.46 47.85 50.06 71.46 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 48.67 45.40 71.68 47.67 46.90 70.60 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 48.91 49.12 65.17 47.29 49.14 66.54 -38.34 -8.19 13.90 -38.52 -10.20 14.65 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 16 3 # 16 B 137 SER D 56 SER.? 20.40 O ACT A1182 B 158 HIS D 59 HIS~? 14.28 O ACT A1182 B 208 ASN D 86 ASN.? 11.74 O ACT A1182 coo 50.29 50.10 71.46 47.85 50.06 71.46 -44.06 -14.32 15.00 -45.00 -16.31 13.86 coo 48.67 45.40 71.68 47.67 46.90 70.60 -44.08 -8.12 17.12 -43.68 -6.15 16.50 coo 48.91 49.12 65.17 47.29 49.14 66.54 -38.34 -8.19 13.90 -38.52 -10.20 14.65 2hdh_c02 source 2hdh L-3-HYDROXYACYL COA DEHYDROGENASE : 16 hits 2hdh_c02 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 84 ASP^? 7.98 OXT ACT A1182 A 35 SER A 88 SER.? 4.86 OXT ACT A1182 A 215 ASP D 84 ASP^? 8.02 O ACT A1182 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -36.44 3.40 10.01 -38.05 4.61 10.68 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -34.67 3.69 16.47 -32.74 5.08 16.23 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -36.44 -3.37 16.46 -38.06 -4.61 15.80 ULMN 3 2jxr_c04 LIGAND CP-081282 user 2 3 # 2 A 32 ASP A 152 ASP.? 5.90 O ACT A1181 A 35 SER A 153 SER.? 8.36 O ACT A1181 A 215 ASP A 156 ASP~? 10.59 O ACT A1181 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -48.21 23.38 -2.65 -49.08 24.42 -4.65 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -46.26 16.00 -1.85 -46.95 16.56 0.08 ULMN 3 2jxr_c04 LIGAND CP-081282 user 3 3 # 3 A 32 ASP B 84 ASP^? 7.80 O ACT C1183 A 35 SER B 88 SER.? 4.64 O ACT C1183 A 215 ASP C 84 ASP^? 7.78 OXT ACT C1183 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -54.22 1.68 8.96 -52.58 0.65 8.12 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -56.11 -4.45 10.90 -58.45 -5.07 10.53 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -54.24 -1.68 17.50 -52.62 -0.62 18.33 ULMN 3 2jxr_c04 LIGAND CP-081282 user 4 3 # 4 A 32 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 35 SER B 153 SER.? 13.04 OXT ACT A1181 A 215 ASP B 156 ASP~? 13.25 OXT ACT A1181 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -42.50 5.86 -14.56 -41.69 7.35 -16.29 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -44.48 7.85 -7.33 -43.76 5.86 -7.08 ULMN 3 2jxr_c04 LIGAND CP-081282 user 5 3 # 5 A 32 ASP C 84 ASP^? 7.78 OXT ACT C1183 A 35 SER C 88 SER.? 4.69 OXT ACT C1183 A 215 ASP B 84 ASP^? 7.80 O ACT C1183 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -54.24 -1.68 17.50 -52.62 -0.62 18.33 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -56.10 4.45 15.54 -58.39 5.12 16.05 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -54.22 1.68 8.96 -52.58 0.65 8.12 ULMN 3 2jxr_c04 LIGAND CP-081282 user 6 3 # 6 A 32 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 35 SER C 153 SER.? 12.45 O3 GOL D1181 A 215 ASP C 156 ASP~? 12.06 O3 GOL D1181 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -42.49 -5.86 41.01 -41.72 -7.33 42.77 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -44.46 -7.83 33.81 -43.76 -5.84 33.54 ULMN 3 2jxr_c04 LIGAND CP-081282 user 7 3 # 7 A 32 ASP D 84 ASP^? 8.02 O ACT A1182 A 35 SER D 88 SER.? 4.67 O ACT A1182 A 215 ASP A 84 ASP^? 7.98 OXT ACT A1182 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -36.44 -3.37 16.46 -38.06 -4.61 15.80 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -34.51 -3.89 10.07 -32.18 -4.55 9.73 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -36.44 3.40 10.01 -38.05 4.61 10.68 ULMN 3 2jxr_c04 LIGAND CP-081282 user 8 3 # 8 A 32 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 35 SER D 153 SER.? 8.24 O2 GOL D1181 A 215 ASP D 156 ASP~? 10.44 C2 GOL D1181 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -48.20 -23.41 29.14 -49.00 -24.50 31.12 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -46.26 -16.01 28.32 -46.92 -16.52 26.38 2jxr_c04 source 2jxr LIGAND CP-081282 : 8 hits 2jxr_c04 naa= 3 ULMN 3 2lip_c00 LIPASE user 1 3 # 1 87 SER A 53 SER^? 12.21 OXT ACT A1182 264 ASP A 55 ASP.? 17.41 O ACT A1181 286 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 10.47 25.91 18.67 10.67 27.13 20.84 -35.29 10.69 9.61 -33.77 12.39 10.51 coo 2.34 22.49 22.56 3.80 23.95 22.00 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 7.10 24.11 23.40 8.18 25.09 21.87 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 2lip_c00 LIPASE user 2 3 # 2 87 SER B 53 SER^? 12.05 O ACT C1183 264 ASP B 55 ASP.? 14.29 O3 GOL B1182 286 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 10.47 25.91 18.67 10.67 27.13 20.84 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo 2.34 22.49 22.56 3.80 23.95 22.00 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 7.10 24.11 23.40 8.18 25.09 21.87 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 2lip_c00 LIPASE user 3 3 # 3 87 SER C 53 SER^? 12.05 OXT ACT C1183 264 ASP C 55 ASP.? 19.45 CA CA C1184 286 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 10.47 25.91 18.67 10.67 27.13 20.84 -55.28 0.90 24.40 -56.83 2.38 25.58 coo 2.34 22.49 22.56 3.80 23.95 22.00 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 7.10 24.11 23.40 8.18 25.09 21.87 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 2lip_c00 LIPASE user 4 3 # 4 87 SER D 53 SER^? 12.18 O ACT A1182 264 ASP D 55 ASP.? 17.43 O2 GOL D1181 286 HIS D 114 HIS^? 15.97 O ACT A1182 coo 10.47 25.91 18.67 10.67 27.13 20.84 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo 2.34 22.49 22.56 3.80 23.95 22.00 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 7.10 24.11 23.40 8.18 25.09 21.87 -34.02 -15.52 17.15 -35.80 -16.25 16.32 2lip_c00 source 2lip LIPASE : 4 hits 2lip_c00 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 102 ASP A 55 ASP.? 17.41 O ACT A1181 A 193 GLY A 122 GLY~? 17.38 OXT ACT A1182 coo 14.96 29.22 19.55 15.62 29.93 17.67 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 19.64 30.69 22.61 18.18 29.94 21.25 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 14.54 28.99 9.76 15.06 29.59 10.02 -31.93 16.98 20.49 -32.19 17.34 19.79 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 102 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 193 GLY B 122 GLY~? 17.40 O ACT C1183 coo 14.96 29.22 19.55 15.62 29.93 17.67 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 19.64 30.69 22.61 18.18 29.94 21.25 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 14.54 28.99 9.76 15.06 29.59 10.02 -58.61 -13.33 0.48 -58.35 -12.82 -0.14 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS B 151 HIS.? 14.53 O3 GOL B1182 A 102 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 193 GLY B 116 GLY.? 11.34 O3 GOL B1182 coo 14.96 29.22 19.55 15.62 29.93 17.67 -44.56 -2.11 -14.97 -44.59 -3.90 -13.87 coo 19.64 30.69 22.61 18.18 29.94 21.25 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo 14.54 28.99 9.76 15.06 29.59 10.02 -52.33 -1.19 -6.26 -53.05 -1.53 -6.05 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 4 3 # 4 A 57 HIS C 114 HIS^? 15.77 OXT ACT C1183 A 102 ASP C 55 ASP.? 19.45 CA CA C1184 A 193 GLY C 122 GLY~? 17.34 OXT ACT C1183 coo 14.96 29.22 19.55 15.62 29.93 17.67 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 19.64 30.69 22.61 18.18 29.94 21.25 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 14.54 28.99 9.76 15.06 29.59 10.02 -58.64 13.32 25.99 -58.38 12.82 26.62 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 5 3 # 5 A 57 HIS D 114 HIS^? 15.97 O ACT A1182 A 102 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 193 GLY D 122 GLY~? 17.40 O ACT A1182 coo 14.96 29.22 19.55 15.62 29.93 17.67 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 19.64 30.69 22.61 18.18 29.94 21.25 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 14.54 28.99 9.76 15.06 29.59 10.02 -32.03 -16.93 5.96 -32.26 -17.35 6.67 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 5 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 11 PHE~? 14.32 C1 GOL B1182 A 263 ASP A 6 ASP~? 16.17 CA CA B1181 A 292 LYS B 35 LYS~? 11.04 CA CA B1183 coo 51.51 50.32 16.39 52.13 49.68 13.75 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 54.43 44.82 23.74 55.21 45.06 21.80 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 63.95 45.30 16.71 59.11 49.15 16.05 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 11 PHE~? 14.32 C1 GOL B1182 A 263 ASP A 6 ASP~? 16.17 CA CA B1181 A 292 LYS B 177 LYS.? 12.69 CA CA B1181 coo 51.51 50.32 16.39 52.13 49.68 13.75 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 54.43 44.82 23.74 55.21 45.06 21.80 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 63.95 45.30 16.71 59.11 49.15 16.05 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 263 ASP A 55 ASP.? 17.41 O ACT A1181 A 292 LYS A 149 LYS.? 8.87 O ACT A1181 coo 51.51 50.32 16.39 52.13 49.68 13.75 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 54.43 44.82 23.74 55.21 45.06 21.80 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 263 ASP A 156 ASP~? 10.59 O ACT A1181 A 292 LYS A 149 LYS.? 8.87 O ACT A1181 coo 51.51 50.32 16.39 52.13 49.68 13.75 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE A 61 PHE~? 13.18 OXT ACT A1181 A 263 ASP A 156 ASP~? 10.59 O ACT A1181 A 292 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 51.51 50.32 16.39 52.13 49.68 13.75 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 63.95 45.30 16.71 59.11 49.15 16.05 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE A 138 PHE.? 14.29 O ACT A1181 A 263 ASP A 55 ASP.? 17.41 O ACT A1181 A 292 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 51.51 50.32 16.39 52.13 49.68 13.75 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 54.43 44.82 23.74 55.21 45.06 21.80 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE B 11 PHE~? 13.58 OXT ACT A1181 A 263 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 292 LYS A 35 LYS~? 23.91 O ACT A1181 coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 54.43 44.82 23.74 55.21 45.06 21.80 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 63.95 45.30 16.71 59.11 49.15 16.05 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 177 PHE B 11 PHE~? 13.58 OXT ACT A1181 A 263 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 292 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 54.43 44.82 23.74 55.21 45.06 21.80 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 63.95 45.30 16.71 59.11 49.15 16.05 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 A 177 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 263 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 292 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 51.51 50.32 16.39 52.13 49.68 13.75 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 54.43 44.82 23.74 55.21 45.06 21.80 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 63.95 45.30 16.71 59.11 49.15 16.05 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 A 177 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 292 LYS A 158 LYS~? -4.64 O ACT A1181s coo 51.51 50.32 16.39 52.13 49.68 13.75 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 A 177 PHE B 61 PHE~? 12.02 O3 GOL B1182 A 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 292 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 51.51 50.32 16.39 52.13 49.68 13.75 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 63.95 45.30 16.71 59.11 49.15 16.05 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 A 177 PHE B 134 PHE^? 10.29 O2 GOL B1182 A 263 ASP B 144 ASP.? 6.66 CA CA B1183 A 292 LYS B 130 LYS.? 19.82 CH3 ACT C1183 coo 51.51 50.32 16.39 52.13 49.68 13.75 -62.26 5.34 -3.80 -61.37 7.78 -4.90 coo 54.43 44.82 23.74 55.21 45.06 21.80 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 63.95 45.30 16.71 59.11 49.15 16.05 -71.06 -6.27 -2.00 -70.24 -10.95 -0.22 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 A 177 PHE B 138 PHE.? 9.75 O3 GOL B1182 A 263 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 292 LYS B 124 LYS~? 15.51 CA CA B1183 coo 51.51 50.32 16.39 52.13 49.68 13.75 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 54.43 44.82 23.74 55.21 45.06 21.80 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 63.95 45.30 16.71 59.11 49.15 16.05 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 A 177 PHE C 11 PHE~? 12.63 O3 GOL D1181 A 263 ASP C 6 ASP~? 17.85 CA CA C1182 A 292 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 54.43 44.82 23.74 55.21 45.06 21.80 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 63.95 45.30 16.71 59.11 49.15 16.05 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 A 177 PHE C 11 PHE~? 12.63 O3 GOL D1181 A 263 ASP C 6 ASP~? 17.85 CA CA C1182 A 292 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 51.51 50.32 16.39 52.13 49.68 13.75 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 54.43 44.82 23.74 55.21 45.06 21.80 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 63.95 45.30 16.71 59.11 49.15 16.05 -22.65 -4.76 42.92 -27.69 -1.89 42.71 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 A 177 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 263 ASP C 55 ASP.? 19.45 CA CA C1184 A 292 LYS C 149 LYS.? 9.01 CA CA C1184 coo 51.51 50.32 16.39 52.13 49.68 13.75 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 54.43 44.82 23.74 55.21 45.06 21.80 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 63.95 45.30 16.71 59.11 49.15 16.05 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 A 177 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 292 LYS C 149 LYS.? 9.01 CA CA C1184 coo 51.51 50.32 16.39 52.13 49.68 13.75 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 A 177 PHE C 61 PHE~? 15.37 O3 GOL D1181 A 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 292 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 51.51 50.32 16.39 52.13 49.68 13.75 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 19 3 # 19 A 177 PHE C 134 PHE^? 13.25 CA CA C1184 A 263 ASP C 144 ASP.? 6.69 CA CA C1184 A 292 LYS C 130 LYS.? 19.26 CH3 ACT C1183 coo 51.51 50.32 16.39 52.13 49.68 13.75 -62.23 -5.37 30.24 -61.37 -7.83 31.34 coo 54.43 44.82 23.74 55.21 45.06 21.80 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 63.95 45.30 16.71 59.11 49.15 16.05 -71.03 6.26 28.36 -70.68 9.47 26.70 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 20 3 # 20 A 177 PHE C 138 PHE.? 14.85 CA CA C1184 A 263 ASP C 55 ASP.? 19.45 CA CA C1184 A 292 LYS C 124 LYS~? 15.99 CA CA C1184 coo 51.51 50.32 16.39 52.13 49.68 13.75 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 54.43 44.82 23.74 55.21 45.06 21.80 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 63.95 45.30 16.71 59.11 49.15 16.05 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 21 3 # 21 A 177 PHE D 11 PHE~? 14.07 C1 GOL D1181 A 263 ASP D 6 ASP~? 16.12 CA CA C1181 A 292 LYS C 35 LYS~? 10.20 CA CA C1184 coo 51.51 50.32 16.39 52.13 49.68 13.75 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 54.43 44.82 23.74 55.21 45.06 21.80 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 63.95 45.30 16.71 59.11 49.15 16.05 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 22 3 # 22 A 177 PHE D 11 PHE~? 14.07 C1 GOL D1181 A 263 ASP D 6 ASP~? 16.12 CA CA C1181 A 292 LYS C 177 LYS.? 13.52 CA CA C1181 coo 51.51 50.32 16.39 52.13 49.68 13.75 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 54.43 44.82 23.74 55.21 45.06 21.80 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 63.95 45.30 16.71 59.11 49.15 16.05 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 23 3 # 23 A 177 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 263 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 292 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 51.51 50.32 16.39 52.13 49.68 13.75 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 54.43 44.82 23.74 55.21 45.06 21.80 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 24 3 # 24 A 177 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 292 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 51.51 50.32 16.39 52.13 49.68 13.75 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 25 3 # 25 A 177 PHE D 61 PHE~? 11.72 O3 GOL D1181 A 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 292 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 51.51 50.32 16.39 52.13 49.68 13.75 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 26 3 # 26 A 177 PHE D 138 PHE.? 14.22 O2 GOL D1181 A 263 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 292 LYS D 124 LYS~? 24.78 O ACT A1182 coo 51.51 50.32 16.39 52.13 49.68 13.75 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 54.43 44.82 23.74 55.21 45.06 21.80 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 -30.92 -19.78 10.48 -31.91 -25.53 10.85 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 26 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 11 PHE~? 14.32 C1 GOL B1182 B 263 ASP A 6 ASP~? 16.17 CA CA B1181 B 292 LYS B 35 LYS~? 11.04 CA CA B1183 coo 49.99 26.05 6.28 51.46 26.87 8.49 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 60.53 31.67 0.97 57.79 27.51 3.63 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 11 PHE~? 14.32 C1 GOL B1182 B 263 ASP A 6 ASP~? 16.17 CA CA B1181 B 292 LYS B 177 LYS.? 12.69 CA CA B1181 coo 49.99 26.05 6.28 51.46 26.87 8.49 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 60.53 31.67 0.97 57.79 27.51 3.63 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE A 18 PHE~? 7.18 CH3 ACT A1181 B 263 ASP A 14 ASP~? 14.99 CH3 ACT A1181 B 292 LYS B 164 LYS~? 10.34 O ACT A1181 coo 49.99 26.05 6.28 51.46 26.87 8.49 -49.53 25.29 -10.30 -47.93 26.67 -8.41 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo 60.53 31.67 0.97 57.79 27.51 3.63 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE A 61 PHE~? 13.18 OXT ACT A1181 B 263 ASP A 55 ASP.? 17.41 O ACT A1181 B 292 LYS A 149 LYS.? 8.87 O ACT A1181 coo 49.99 26.05 6.28 51.46 26.87 8.49 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE A 61 PHE~? 13.18 OXT ACT A1181 B 263 ASP A 156 ASP~? 10.59 O ACT A1181 B 292 LYS A 149 LYS.? 8.87 O ACT A1181 coo 49.99 26.05 6.28 51.46 26.87 8.49 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 60.53 31.67 0.97 57.79 27.51 3.63 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE A 138 PHE.? 14.29 O ACT A1181 B 263 ASP A 55 ASP.? 17.41 O ACT A1181 B 292 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 49.99 26.05 6.28 51.46 26.87 8.49 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE B 11 PHE~? 13.58 OXT ACT A1181 B 263 ASP B 6 ASP~? 24.59 OXT ACT A1181 B 292 LYS A 35 LYS~? 23.91 O ACT A1181 coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 60.53 31.67 0.97 57.79 27.51 3.63 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE B 11 PHE~? 13.58 OXT ACT A1181 B 263 ASP B 6 ASP~? 24.59 OXT ACT A1181 B 292 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 60.53 31.67 0.97 57.79 27.51 3.63 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 177 PHE B 61 PHE~? 12.02 O3 GOL B1182 B 263 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 292 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 49.99 26.05 6.28 51.46 26.87 8.49 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 60.53 31.67 0.97 57.79 27.51 3.63 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 177 PHE B 61 PHE~? 12.02 O3 GOL B1182 B 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 292 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 49.99 26.05 6.28 51.46 26.87 8.49 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 60.53 31.67 0.97 57.79 27.51 3.63 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 B 177 PHE B 134 PHE^? 10.29 O2 GOL B1182 B 263 ASP B 144 ASP.? 6.66 CA CA B1183 B 292 LYS B 130 LYS.? 19.82 CH3 ACT C1183 coo 49.99 26.05 6.28 51.46 26.87 8.49 -62.26 5.34 -3.80 -61.37 7.78 -4.90 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 60.53 31.67 0.97 57.79 27.51 3.63 -71.06 -6.27 -2.00 -70.24 -10.95 -0.22 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 B 177 PHE B 138 PHE.? 9.75 O3 GOL B1182 B 263 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 292 LYS B 124 LYS~? 15.51 CA CA B1183 coo 49.99 26.05 6.28 51.46 26.87 8.49 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 60.53 31.67 0.97 57.79 27.51 3.63 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 B 177 PHE C 11 PHE~? 12.63 O3 GOL D1181 B 263 ASP C 6 ASP~? 17.85 CA CA C1182 B 292 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 60.53 31.67 0.97 57.79 27.51 3.63 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 B 177 PHE C 11 PHE~? 12.63 O3 GOL D1181 B 263 ASP C 6 ASP~? 17.85 CA CA C1182 B 292 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 49.99 26.05 6.28 51.46 26.87 8.49 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 60.53 31.67 0.97 57.79 27.51 3.63 -22.65 -4.76 42.92 -27.69 -1.89 42.71 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 B 177 PHE C 61 PHE~? 15.37 O3 GOL D1181 B 263 ASP C 55 ASP.? 19.45 CA CA C1184 B 292 LYS C 149 LYS.? 9.01 CA CA C1184 coo 49.99 26.05 6.28 51.46 26.87 8.49 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 60.53 31.67 0.97 57.79 27.51 3.63 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 B 177 PHE C 61 PHE~? 15.37 O3 GOL D1181 B 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 292 LYS C 149 LYS.? 9.01 CA CA C1184 coo 49.99 26.05 6.28 51.46 26.87 8.49 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 60.53 31.67 0.97 57.79 27.51 3.63 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 B 177 PHE C 134 PHE^? 13.25 CA CA C1184 B 263 ASP C 144 ASP.? 6.69 CA CA C1184 B 292 LYS C 130 LYS.? 19.26 CH3 ACT C1183 coo 49.99 26.05 6.28 51.46 26.87 8.49 -62.23 -5.37 30.24 -61.37 -7.83 31.34 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 60.53 31.67 0.97 57.79 27.51 3.63 -71.03 6.26 28.36 -70.68 9.47 26.70 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 B 177 PHE C 138 PHE.? 14.85 CA CA C1184 B 263 ASP C 55 ASP.? 19.45 CA CA C1184 B 292 LYS C 124 LYS~? 15.99 CA CA C1184 coo 49.99 26.05 6.28 51.46 26.87 8.49 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 60.53 31.67 0.97 57.79 27.51 3.63 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 19 3 # 19 B 177 PHE D 11 PHE~? 14.07 C1 GOL D1181 B 263 ASP D 6 ASP~? 16.12 CA CA C1181 B 292 LYS C 35 LYS~? 10.20 CA CA C1184 coo 49.99 26.05 6.28 51.46 26.87 8.49 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 60.53 31.67 0.97 57.79 27.51 3.63 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 20 3 # 20 B 177 PHE D 11 PHE~? 14.07 C1 GOL D1181 B 263 ASP D 6 ASP~? 16.12 CA CA C1181 B 292 LYS C 177 LYS.? 13.52 CA CA C1181 coo 49.99 26.05 6.28 51.46 26.87 8.49 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 60.53 31.67 0.97 57.79 27.51 3.63 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 21 3 # 21 B 177 PHE D 18 PHE~? 7.09 O1 GOL D1181 B 263 ASP D 14 ASP~? 14.81 O1 GOL D1181 B 292 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 49.99 26.05 6.28 51.46 26.87 8.49 -49.53 -25.28 36.78 -47.96 -26.67 34.88 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo 60.53 31.67 0.97 57.79 27.51 3.63 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 22 3 # 22 B 177 PHE D 61 PHE~? 11.72 O3 GOL D1181 B 263 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 292 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 49.99 26.05 6.28 51.46 26.87 8.49 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 23 3 # 23 B 177 PHE D 61 PHE~? 11.72 O3 GOL D1181 B 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 292 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 49.99 26.05 6.28 51.46 26.87 8.49 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 60.53 31.67 0.97 57.79 27.51 3.63 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 24 3 # 24 B 177 PHE D 138 PHE.? 14.22 O2 GOL D1181 B 263 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 292 LYS D 124 LYS~? 24.78 O ACT A1182 coo 49.99 26.05 6.28 51.46 26.87 8.49 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 -30.92 -19.78 10.48 -31.91 -25.53 10.85 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 24 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 11 PHE~? 14.32 C1 GOL B1182 C 263 ASP A 6 ASP~? 16.17 CA CA B1181 C 292 LYS B 35 LYS~? 11.04 CA CA B1183 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 19.84 12.02 9.33 18.68 11.23 7.75 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 12.82 3.49 4.98 17.80 5.59 1.90 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 11 PHE~? 14.32 C1 GOL B1182 C 263 ASP A 6 ASP~? 16.17 CA CA B1181 C 292 LYS B 177 LYS.? 12.69 CA CA B1181 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -59.46 20.91 -8.75 -57.53 20.52 -6.75 coo 19.84 12.02 9.33 18.68 11.23 7.75 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 12.82 3.49 4.98 17.80 5.59 1.90 -68.49 25.09 -2.05 -63.14 26.93 0.36 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE A 61 PHE~? 13.18 OXT ACT A1181 C 263 ASP A 55 ASP.? 17.41 O ACT A1181 C 292 LYS A 149 LYS.? 8.87 O ACT A1181 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 19.84 12.02 9.33 18.68 11.23 7.75 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE A 61 PHE~? 13.18 OXT ACT A1181 C 263 ASP A 156 ASP~? 10.59 O ACT A1181 C 292 LYS A 149 LYS.? 8.87 O ACT A1181 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE A 61 PHE~? 13.18 OXT ACT A1181 C 263 ASP A 156 ASP~? 10.59 O ACT A1181 C 292 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -40.24 11.67 1.36 -38.20 12.01 -0.57 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 12.82 3.49 4.98 17.80 5.59 1.90 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE A 138 PHE.? 14.29 O ACT A1181 C 263 ASP A 55 ASP.? 17.41 O ACT A1181 C 292 LYS A 124 LYS~? 24.92 OXT ACT A1182 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -38.96 23.20 5.34 -40.61 21.03 4.70 coo 19.84 12.02 9.33 18.68 11.23 7.75 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 -30.92 19.75 15.99 -32.39 25.70 15.74 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE B 11 PHE~? 13.58 OXT ACT A1181 C 263 ASP B 6 ASP~? 24.59 OXT ACT A1181 C 292 LYS A 35 LYS~? 23.91 O ACT A1181 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 19.84 12.02 9.33 18.68 11.23 7.75 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 12.82 3.49 4.98 17.80 5.59 1.90 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 177 PHE B 11 PHE~? 13.58 OXT ACT A1181 C 263 ASP B 6 ASP~? 24.59 OXT ACT A1181 C 292 LYS A 177 LYS.? 21.69 OXT ACT A1181 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.34 12.52 -14.69 -33.24 10.78 -13.61 coo 19.84 12.02 9.33 18.68 11.23 7.75 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 12.82 3.49 4.98 17.80 5.59 1.90 -22.65 4.65 -16.37 -26.75 7.46 -18.74 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 C 177 PHE B 61 PHE~? 12.02 O3 GOL B1182 C 263 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 292 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 19.84 12.02 9.33 18.68 11.23 7.75 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 12.82 3.49 4.98 17.80 5.59 1.90 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 C 177 PHE B 61 PHE~? 12.02 O3 GOL B1182 C 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 292 LYS A 158 LYS~? -4.64 O ACT A1181s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 C 177 PHE B 61 PHE~? 12.02 O3 GOL B1182 C 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 292 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -50.46 6.48 -2.03 -52.54 8.04 -3.12 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 12.82 3.49 4.98 17.80 5.59 1.90 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 C 177 PHE B 134 PHE^? 10.29 O2 GOL B1182 C 263 ASP B 144 ASP.? 6.66 CA CA B1183 C 292 LYS B 130 LYS.? 19.82 CH3 ACT C1183 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -62.26 5.34 -3.80 -61.37 7.78 -4.90 coo 19.84 12.02 9.33 18.68 11.23 7.75 -67.28 1.35 -10.84 -69.02 1.72 -11.95 coo 12.82 3.49 4.98 17.80 5.59 1.90 -71.06 -6.27 -2.00 -70.24 -10.95 -0.22 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 C 177 PHE B 138 PHE.? 9.75 O3 GOL B1182 C 263 ASP B 55 ASP.? 14.29 O3 GOL B1182 C 292 LYS B 124 LYS~? 15.51 CA CA B1183 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -51.50 -1.79 -11.00 -49.88 -0.29 -9.29 coo 19.84 12.02 9.33 18.68 11.23 7.75 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 12.82 3.49 4.98 17.80 5.59 1.90 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 C 177 PHE C 11 PHE~? 12.63 O3 GOL D1181 C 263 ASP C 6 ASP~? 17.85 CA CA C1182 C 292 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 19.84 12.02 9.33 18.68 11.23 7.75 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 12.82 3.49 4.98 17.80 5.59 1.90 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 C 177 PHE C 11 PHE~? 12.63 O3 GOL D1181 C 263 ASP C 6 ASP~? 17.85 CA CA C1182 C 292 LYS D 177 LYS.? 22.56 O3 GOL D1181 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -31.36 -12.51 41.16 -33.23 -10.77 40.01 coo 19.84 12.02 9.33 18.68 11.23 7.75 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 12.82 3.49 4.98 17.80 5.59 1.90 -22.65 -4.76 42.92 -27.69 -1.89 42.71 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 C 177 PHE C 61 PHE~? 15.37 O3 GOL D1181 C 263 ASP C 55 ASP.? 19.45 CA CA C1184 C 292 LYS C 149 LYS.? 9.01 CA CA C1184 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 19.84 12.02 9.33 18.68 11.23 7.75 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 12.82 3.49 4.98 17.80 5.59 1.90 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 17 3 # 17 C 177 PHE C 61 PHE~? 15.37 O3 GOL D1181 C 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 292 LYS C 149 LYS.? 9.01 CA CA C1184 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 18 3 # 18 C 177 PHE C 61 PHE~? 15.37 O3 GOL D1181 C 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 292 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -50.46 -6.48 28.51 -52.52 -8.03 29.62 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 19 3 # 19 C 177 PHE C 134 PHE^? 13.25 CA CA C1184 C 263 ASP C 144 ASP.? 6.69 CA CA C1184 C 292 LYS C 130 LYS.? 19.26 CH3 ACT C1183 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -62.23 -5.37 30.24 -61.37 -7.83 31.34 coo 19.84 12.02 9.33 18.68 11.23 7.75 -67.28 -1.35 37.26 -69.02 -1.78 38.35 coo 12.82 3.49 4.98 17.80 5.59 1.90 -71.03 6.26 28.36 -70.68 9.47 26.70 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 20 3 # 20 C 177 PHE C 138 PHE.? 14.85 CA CA C1184 C 263 ASP C 55 ASP.? 19.45 CA CA C1184 C 292 LYS C 124 LYS~? 15.99 CA CA C1184 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -51.47 1.75 37.48 -49.88 0.19 35.78 coo 19.84 12.02 9.33 18.68 11.23 7.75 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 12.82 3.49 4.98 17.80 5.59 1.90 -59.48 10.16 30.27 -60.09 12.26 35.28 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 21 3 # 21 C 177 PHE D 11 PHE~? 14.07 C1 GOL D1181 C 263 ASP D 6 ASP~? 16.12 CA CA C1181 C 292 LYS C 35 LYS~? 10.20 CA CA C1184 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 19.84 12.02 9.33 18.68 11.23 7.75 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 12.82 3.49 4.98 17.80 5.59 1.90 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 22 3 # 22 C 177 PHE D 11 PHE~? 14.07 C1 GOL D1181 C 263 ASP D 6 ASP~? 16.12 CA CA C1181 C 292 LYS C 177 LYS.? 13.52 CA CA C1181 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -59.47 -20.89 35.24 -57.56 -20.55 33.22 coo 19.84 12.02 9.33 18.68 11.23 7.75 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 12.82 3.49 4.98 17.80 5.59 1.90 -68.52 -25.10 28.52 -62.74 -26.81 28.79 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 23 3 # 23 C 177 PHE D 61 PHE~? 11.72 O3 GOL D1181 C 263 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 292 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 19.84 12.02 9.33 18.68 11.23 7.75 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 24 3 # 24 C 177 PHE D 61 PHE~? 11.72 O3 GOL D1181 C 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 292 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 25 3 # 25 C 177 PHE D 61 PHE~? 11.72 O3 GOL D1181 C 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 292 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -40.24 -11.67 25.11 -38.18 -12.04 26.99 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 26 3 # 26 C 177 PHE D 138 PHE.? 14.22 O2 GOL D1181 C 263 ASP D 55 ASP.? 17.43 O2 GOL D1181 C 292 LYS D 124 LYS~? 24.78 O ACT A1182 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -38.97 -23.18 21.12 -40.63 -21.01 21.77 coo 19.84 12.02 9.33 18.68 11.23 7.75 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 -30.92 -19.78 10.48 -31.91 -25.53 10.85 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 26 hits 2oat_c05 naa= 3 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 178 TRP A 7 TRP~? 13.17 CA CA B1181 A 263 ASP A 6 ASP~? 16.17 CA CA B1181 A 292 LYS B 35 LYS~? 11.04 CA CA B1183 coo 48.96 45.07 19.49 48.62 41.39 18.16 -64.51 23.48 -8.12 -63.01 20.07 -6.83 coo 54.43 44.82 23.74 55.21 45.06 21.80 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 63.95 45.30 16.71 59.11 49.15 16.05 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 178 TRP A 60 TRP~? 14.03 O ACT A1181 A 263 ASP A 156 ASP~? 10.59 O ACT A1181 A 292 LYS A 149 LYS.? 8.87 O ACT A1181 coo 48.96 45.07 19.49 48.62 41.39 18.16 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 178 TRP A 60 TRP~? 14.03 O ACT A1181 A 263 ASP A 156 ASP~? 10.59 O ACT A1181 A 292 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 48.96 45.07 19.49 48.62 41.39 18.16 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 63.95 45.30 16.71 59.11 49.15 16.05 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 178 TRP A 60 TRP~? 14.03 O ACT A1181 A 263 ASP A 156 ASP~? 10.59 O ACT A1181 A 292 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 48.96 45.07 19.49 48.62 41.39 18.16 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 63.95 45.30 16.71 59.11 49.15 16.05 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 178 TRP B 7 TRP~? 18.47 OXT ACT A1181 A 263 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 292 LYS A 35 LYS~? 23.91 O ACT A1181 coo 48.96 45.07 19.49 48.62 41.39 18.16 -26.39 11.02 -16.75 -27.73 11.07 -13.04 coo 54.43 44.82 23.74 55.21 45.06 21.80 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 63.95 45.30 16.71 59.11 49.15 16.05 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 178 TRP B 60 TRP~? 15.39 OXT ACT A1181 A 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 292 LYS A 158 LYS~? -4.64 O ACT A1181s coo 48.96 45.07 19.49 48.62 41.39 18.16 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 178 TRP B 60 TRP~? 15.39 OXT ACT A1181 A 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 292 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 48.96 45.07 19.49 48.62 41.39 18.16 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 63.95 45.30 16.71 59.11 49.15 16.05 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 A 178 TRP B 60 TRP~? 15.39 OXT ACT A1181 A 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 292 LYS B 164 LYS~? 10.34 O ACT A1181 coo 48.96 45.07 19.49 48.62 41.39 18.16 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 63.95 45.30 16.71 59.11 49.15 16.05 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 A 178 TRP C 7 TRP~? 16.43 CA CA C1182 A 263 ASP C 6 ASP~? 17.85 CA CA C1182 A 292 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 48.96 45.07 19.49 48.62 41.39 18.16 -26.42 -11.04 43.18 -27.72 -11.10 39.46 coo 54.43 44.82 23.74 55.21 45.06 21.80 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 63.95 45.30 16.71 59.11 49.15 16.05 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 A 178 TRP C 60 TRP~? 14.18 O3 GOL D1181 A 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 292 LYS C 149 LYS.? 9.01 CA CA C1184 coo 48.96 45.07 19.49 48.62 41.39 18.16 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 A 178 TRP C 60 TRP~? 14.18 O3 GOL D1181 A 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 292 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 48.96 45.07 19.49 48.62 41.39 18.16 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 A 178 TRP C 60 TRP~? 14.18 O3 GOL D1181 A 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 292 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 48.96 45.07 19.49 48.62 41.39 18.16 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 54.43 44.82 23.74 55.21 45.06 21.80 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 A 178 TRP D 7 TRP~? 13.25 CA CA C1181 A 263 ASP D 6 ASP~? 16.12 CA CA C1181 A 292 LYS C 35 LYS~? 10.20 CA CA C1184 coo 48.96 45.07 19.49 48.62 41.39 18.16 -64.48 -23.47 34.59 -63.03 -20.04 33.30 coo 54.43 44.82 23.74 55.21 45.06 21.80 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 63.95 45.30 16.71 59.11 49.15 16.05 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 A 178 TRP D 60 TRP~? 12.96 O3 GOL D1181 A 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 292 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 48.96 45.07 19.49 48.62 41.39 18.16 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 A 178 TRP D 60 TRP~? 12.96 O3 GOL D1181 A 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 292 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 48.96 45.07 19.49 48.62 41.39 18.16 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 A 178 TRP D 60 TRP~? 12.96 O3 GOL D1181 A 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 292 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 48.96 45.07 19.49 48.62 41.39 18.16 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 -35.86 -9.73 34.54 -40.60 -7.29 35.38 2oat_c06 source 2oat ORNITHINE AMINOTRANSFERASE : 16 hits 2oat_c06 naa= 3 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 178 TRP A 7 TRP~? 13.17 CA CA B1181 B 263 ASP A 6 ASP~? 16.17 CA CA B1181 B 292 LYS B 35 LYS~? 11.04 CA CA B1183 coo 45.83 31.15 4.65 45.88 34.74 6.24 -64.51 23.48 -8.12 -63.01 20.07 -6.83 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 60.53 31.67 0.97 57.79 27.51 3.63 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 178 TRP A 60 TRP~? 14.03 O ACT A1181 B 263 ASP A 156 ASP~? 10.59 O ACT A1181 B 292 LYS A 149 LYS.? 8.87 O ACT A1181 coo 45.83 31.15 4.65 45.88 34.74 6.24 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 60.53 31.67 0.97 57.79 27.51 3.63 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 178 TRP A 60 TRP~? 14.03 O ACT A1181 B 263 ASP A 156 ASP~? 10.59 O ACT A1181 B 292 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 45.83 31.15 4.65 45.88 34.74 6.24 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 60.53 31.67 0.97 57.79 27.51 3.63 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 178 TRP A 60 TRP~? 14.03 O ACT A1181 B 263 ASP A 156 ASP~? 10.59 O ACT A1181 B 292 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 45.83 31.15 4.65 45.88 34.74 6.24 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 60.53 31.67 0.97 57.79 27.51 3.63 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 178 TRP B 7 TRP~? 18.47 OXT ACT A1181 B 263 ASP B 6 ASP~? 24.59 OXT ACT A1181 B 292 LYS A 35 LYS~? 23.91 O ACT A1181 coo 45.83 31.15 4.65 45.88 34.74 6.24 -26.39 11.02 -16.75 -27.73 11.07 -13.04 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 60.53 31.67 0.97 57.79 27.51 3.63 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 178 TRP B 60 TRP~? 15.39 OXT ACT A1181 B 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 292 LYS A 158 LYS~? -4.64 O ACT A1181s coo 45.83 31.15 4.65 45.88 34.74 6.24 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 60.53 31.67 0.97 57.79 27.51 3.63 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 178 TRP B 60 TRP~? 15.39 OXT ACT A1181 B 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 292 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 45.83 31.15 4.65 45.88 34.74 6.24 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 60.53 31.67 0.97 57.79 27.51 3.63 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 178 TRP B 60 TRP~? 15.39 OXT ACT A1181 B 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 292 LYS B 164 LYS~? 10.34 O ACT A1181 coo 45.83 31.15 4.65 45.88 34.74 6.24 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 60.53 31.67 0.97 57.79 27.51 3.63 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 B 178 TRP C 7 TRP~? 16.43 CA CA C1182 B 263 ASP C 6 ASP~? 17.85 CA CA C1182 B 292 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 45.83 31.15 4.65 45.88 34.74 6.24 -26.42 -11.04 43.18 -27.72 -11.10 39.46 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 60.53 31.67 0.97 57.79 27.51 3.63 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 B 178 TRP C 60 TRP~? 14.18 O3 GOL D1181 B 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 292 LYS C 149 LYS.? 9.01 CA CA C1184 coo 45.83 31.15 4.65 45.88 34.74 6.24 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 60.53 31.67 0.97 57.79 27.51 3.63 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 B 178 TRP C 60 TRP~? 14.18 O3 GOL D1181 B 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 292 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 45.83 31.15 4.65 45.88 34.74 6.24 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 60.53 31.67 0.97 57.79 27.51 3.63 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 B 178 TRP C 60 TRP~? 14.18 O3 GOL D1181 B 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 292 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 45.83 31.15 4.65 45.88 34.74 6.24 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 60.53 31.67 0.97 57.79 27.51 3.63 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 B 178 TRP D 7 TRP~? 13.25 CA CA C1181 B 263 ASP D 6 ASP~? 16.12 CA CA C1181 B 292 LYS C 35 LYS~? 10.20 CA CA C1184 coo 45.83 31.15 4.65 45.88 34.74 6.24 -64.48 -23.47 34.59 -63.03 -20.04 33.30 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 60.53 31.67 0.97 57.79 27.51 3.63 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 B 178 TRP D 60 TRP~? 12.96 O3 GOL D1181 B 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 292 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 45.83 31.15 4.65 45.88 34.74 6.24 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 60.53 31.67 0.97 57.79 27.51 3.63 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 B 178 TRP D 60 TRP~? 12.96 O3 GOL D1181 B 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 292 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 45.83 31.15 4.65 45.88 34.74 6.24 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 60.53 31.67 0.97 57.79 27.51 3.63 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 B 178 TRP D 60 TRP~? 12.96 O3 GOL D1181 B 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 292 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 45.83 31.15 4.65 45.88 34.74 6.24 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 60.53 31.67 0.97 57.79 27.51 3.63 -35.86 -9.73 34.54 -40.60 -7.29 35.38 2oat_c07 source 2oat ORNITHINE AMINOTRANSFERASE : 16 hits 2oat_c07 naa= 3 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 178 TRP A 7 TRP~? 13.17 CA CA B1181 C 263 ASP A 6 ASP~? 16.17 CA CA B1181 C 292 LYS B 35 LYS~? 11.04 CA CA B1183 coo 20.52 16.65 4.15 17.32 18.91 4.39 -64.51 23.48 -8.12 -63.01 20.07 -6.83 coo 19.84 12.02 9.33 18.68 11.23 7.75 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 12.82 3.49 4.98 17.80 5.59 1.90 -68.46 9.78 -10.58 -72.55 6.75 -11.95 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 178 TRP A 60 TRP~? 14.03 O ACT A1181 C 263 ASP A 156 ASP~? 10.59 O ACT A1181 C 292 LYS A 149 LYS.? 8.87 O ACT A1181 coo 20.52 16.65 4.15 17.32 18.91 4.39 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 178 TRP A 60 TRP~? 14.03 O ACT A1181 C 263 ASP A 156 ASP~? 10.59 O ACT A1181 C 292 LYS A 164 LYS~? 11.79 OXT ACT A1181 coo 20.52 16.65 4.15 17.32 18.91 4.39 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 12.82 3.49 4.98 17.80 5.59 1.90 -35.84 9.74 -8.05 -40.64 7.29 -8.85 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 178 TRP A 60 TRP~? 14.03 O ACT A1181 C 263 ASP A 156 ASP~? 10.59 O ACT A1181 C 292 LYS B 158 LYS~? 6.73 O3 GOL B1182 coo 20.52 16.65 4.15 17.32 18.91 4.39 -46.08 11.97 3.88 -44.48 12.30 0.28 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo 12.82 3.49 4.98 17.80 5.59 1.90 -50.07 10.43 -10.30 -49.56 8.69 -16.32 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 178 TRP B 7 TRP~? 18.47 OXT ACT A1181 C 263 ASP B 6 ASP~? 24.59 OXT ACT A1181 C 292 LYS A 35 LYS~? 23.91 O ACT A1181 coo 20.52 16.65 4.15 17.32 18.91 4.39 -26.39 11.02 -16.75 -27.73 11.07 -13.04 coo 19.84 12.02 9.33 18.68 11.23 7.75 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 12.82 3.49 4.98 17.80 5.59 1.90 -22.68 18.18 -4.70 -20.35 22.35 -1.14 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 178 TRP B 60 TRP~? 15.39 OXT ACT A1181 C 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 292 LYS A 158 LYS~? -4.64 O ACT A1181s coo 20.52 16.65 4.15 17.32 18.91 4.39 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.67 17.71 -5.46 -41.24 24.02 -6.17 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 178 TRP B 60 TRP~? 15.39 OXT ACT A1181 C 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 292 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo 20.52 16.65 4.15 17.32 18.91 4.39 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 12.82 3.49 4.98 17.80 5.59 1.90 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 C 178 TRP B 60 TRP~? 15.39 OXT ACT A1181 C 263 ASP B 156 ASP~? 13.25 OXT ACT A1181 C 292 LYS B 164 LYS~? 10.34 O ACT A1181 coo 20.52 16.65 4.15 17.32 18.91 4.39 -44.62 4.14 -1.38 -46.23 7.33 -3.05 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo 12.82 3.49 4.98 17.80 5.59 1.90 -54.90 15.84 -3.99 -50.07 17.65 -1.98 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 9 3 # 9 C 178 TRP C 7 TRP~? 16.43 CA CA C1182 C 263 ASP C 6 ASP~? 17.85 CA CA C1182 C 292 LYS D 35 LYS~? 23.81 O2 GOL D1181 coo 20.52 16.65 4.15 17.32 18.91 4.39 -26.42 -11.04 43.18 -27.72 -11.10 39.46 coo 19.84 12.02 9.33 18.68 11.23 7.75 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 12.82 3.49 4.98 17.80 5.59 1.90 -22.65 -18.16 31.19 -20.45 -22.10 27.38 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 10 3 # 10 C 178 TRP C 60 TRP~? 14.18 O3 GOL D1181 C 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 292 LYS C 149 LYS.? 9.01 CA CA C1184 coo 20.52 16.65 4.15 17.32 18.91 4.39 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 11 3 # 11 C 178 TRP C 60 TRP~? 14.18 O3 GOL D1181 C 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 292 LYS C 164 LYS~? 9.98 C2 GOL D1181 coo 20.52 16.65 4.15 17.32 18.91 4.39 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 -54.90 -15.84 30.45 -50.06 -17.66 28.47 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 12 3 # 12 C 178 TRP C 60 TRP~? 14.18 O3 GOL D1181 C 263 ASP C 156 ASP~? 12.06 O3 GOL D1181 C 292 LYS D 158 LYS~? -4.46 O2 GOL D1181s coo 20.52 16.65 4.15 17.32 18.91 4.39 -44.60 -4.16 27.84 -46.25 -7.32 29.48 coo 19.84 12.02 9.33 18.68 11.23 7.75 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.69 -17.70 31.92 -41.11 -24.00 32.63 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 13 3 # 13 C 178 TRP D 7 TRP~? 13.25 CA CA C1181 C 263 ASP D 6 ASP~? 16.12 CA CA C1181 C 292 LYS C 35 LYS~? 10.20 CA CA C1184 coo 20.52 16.65 4.15 17.32 18.91 4.39 -64.48 -23.47 34.59 -63.03 -20.04 33.30 coo 19.84 12.02 9.33 18.68 11.23 7.75 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 12.82 3.49 4.98 17.80 5.59 1.90 -68.45 -9.84 37.00 -72.38 -5.53 38.73 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 14 3 # 14 C 178 TRP D 60 TRP~? 12.96 O3 GOL D1181 C 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 292 LYS C 158 LYS~? 13.55 O3 GOL D1181 coo 20.52 16.65 4.15 17.32 18.91 4.39 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 -50.05 -10.42 36.79 -49.63 -8.70 42.89 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 15 3 # 15 C 178 TRP D 60 TRP~? 12.96 O3 GOL D1181 C 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 292 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo 20.52 16.65 4.15 17.32 18.91 4.39 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 16 3 # 16 C 178 TRP D 60 TRP~? 12.96 O3 GOL D1181 C 263 ASP D 156 ASP~? 10.44 C2 GOL D1181 C 292 LYS D 164 LYS~? 10.47 O3 GOL D1181 coo 20.52 16.65 4.15 17.32 18.91 4.39 -46.06 -12.02 22.58 -44.46 -12.31 26.18 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 -35.86 -9.73 34.54 -40.60 -7.29 35.38 2oat_c08 source 2oat ORNITHINE AMINOTRANSFERASE : 16 hits 2oat_c08 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 6 ASP~? 16.17 CA CA B1181 A 151 LYS A 2 LYS^? 14.71 CA CA B1181 A 154 ASN A 3 ASN^? 12.04 CA CA B1181 coo 41.42 17.90 44.98 43.39 18.36 45.61 -69.29 22.53 -13.68 -71.00 22.18 -14.88 coo 45.75 16.58 39.61 47.43 18.26 45.54 -70.83 25.29 -8.78 -66.22 27.65 -9.14 coo 44.77 13.10 43.25 45.01 14.21 45.03 -72.70 21.43 -11.05 -73.07 19.35 -11.09 ULMN 3 2phk_c03 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 95 ASP~? 18.75 OXT ACT A1182 A 151 LYS A 93 LYS.? 11.72 OXT ACT A1182 A 154 ASN A 94 ASN.? 20.31 OXT ACT A1182 coo 41.42 17.90 44.98 43.39 18.36 45.61 -30.02 14.86 26.58 -28.64 13.51 27.46 coo 45.75 16.58 39.61 47.43 18.26 45.54 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 44.77 13.10 43.25 45.01 14.21 45.03 -34.68 14.84 26.15 -33.66 16.63 26.68 ULMN 3 2phk_c03 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 6 ASP~? 24.59 OXT ACT A1181 A 151 LYS B 2 LYS^? 23.29 OXT ACT A1181 A 154 ASN B 3 ASN^? 25.47 OXT ACT A1181 coo 41.42 17.90 44.98 43.39 18.36 45.61 -21.58 16.53 -17.87 -19.92 17.81 -18.11 coo 45.75 16.58 39.61 47.43 18.26 45.54 -20.20 10.38 -18.51 -23.30 13.86 -21.27 coo 44.77 13.10 43.25 45.01 14.21 45.03 -18.33 14.30 -16.20 -18.26 15.53 -14.45 ULMN 3 2phk_c03 MC-PEPTIDE user 4 3 # 4 A 149 ASP C 6 ASP~? 17.85 CA CA C1182 A 151 LYS C 2 LYS^? 15.05 CA CA C1182 A 154 ASN C 3 ASN^? 20.98 CA CA C1182 coo 41.42 17.90 44.98 43.39 18.36 45.61 -21.58 -16.53 44.38 -19.90 -17.78 44.62 coo 45.75 16.58 39.61 47.43 18.26 45.54 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 44.77 13.10 43.25 45.01 14.21 45.03 -18.27 -14.28 42.59 -18.15 -15.35 40.76 ULMN 3 2phk_c03 MC-PEPTIDE user 5 3 # 5 A 149 ASP C 95 ASP~? 18.98 OXT ACT C1183 A 151 LYS C 93 LYS.? 19.61 OXT ACT C1183 A 154 ASN C 94 ASN.? 20.53 OXT ACT C1183 coo 41.42 17.90 44.98 43.39 18.36 45.61 -60.88 17.87 20.49 -62.76 18.57 19.77 coo 45.75 16.58 39.61 47.43 18.26 45.54 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 44.77 13.10 43.25 45.01 14.21 45.03 -57.57 16.60 24.50 -56.01 17.74 25.39 ULMN 3 2phk_c03 MC-PEPTIDE user 6 3 # 6 A 149 ASP D 6 ASP~? 16.12 CA CA C1181 A 151 LYS D 2 LYS.? 16.82 CA CA C1181 A 154 ASN D 3 ASN~? 12.07 CA CA C1181 coo 41.42 17.90 44.98 43.39 18.36 45.61 -69.27 -22.53 40.17 -70.96 -22.24 41.39 coo 45.75 16.58 39.61 47.43 18.26 45.54 -70.92 -25.33 35.01 -67.02 -26.54 39.55 coo 44.77 13.10 43.25 45.01 14.21 45.03 -72.61 -21.52 37.54 -72.85 -19.41 37.73 2phk_c03 source 2phk MC-PEPTIDE : 6 hits 2phk_c03 naa= 3 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 1 3 # 1 10 ASN A 86 ASN.? 11.67 OXT ACT A1182 20 HIS A 59 HIS~? 15.34 OXT ACT A1182 93 ASP A 55 ASP.? 17.41 O ACT A1181 coo 45.21 45.27 48.24 46.79 44.92 46.88 -38.42 8.17 12.63 -38.52 10.18 11.86 coo 47.05 39.55 45.24 48.99 39.30 44.46 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 46.96 34.22 47.29 47.91 35.95 46.52 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 2 3 # 2 10 ASN B 86 ASN.? 11.57 O ACT C1183 20 HIS B 59 HIS~? 15.18 O ACT C1183 93 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 45.21 45.27 48.24 46.79 44.92 46.88 -52.20 -2.48 5.54 -51.99 -2.60 3.42 coo 47.05 39.55 45.24 48.99 39.30 44.46 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 46.96 34.22 47.29 47.91 35.95 46.52 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 2pth_c00 PEPTIDYL-TRNA HYDROLASE user 3 3 # 3 10 ASN C 86 ASN.? 11.54 OXT ACT C1183 20 HIS C 59 HIS~? 15.17 OXT ACT C1183 93 ASP C 55 ASP.? 19.45 CA CA C1184 coo 45.21 45.27 48.24 46.79 44.92 46.88 -52.20 2.48 20.90 -52.01 2.64 23.02 coo 47.05 39.55 45.24 48.99 39.30 44.46 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 46.96 34.22 47.29 47.91 35.95 46.52 -49.79 3.61 29.96 -48.81 2.08 31.09 2pth_c00 source 2pth PEPTIDYL-TRNA HYDROLASE : 3 hits 2pth_c00 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 14 ASP~? 14.99 CH3 ACT A1181 166 GLY A 24 GLY~? 6.98 CH3 ACT A1181 169 GLU A 29 GLU~? 11.10 O ACT A1181 coo 8.28 6.87 1.62 10.08 5.77 1.34 -56.57 24.69 -12.57 -57.85 26.13 -13.49 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -38.70 23.07 -14.67 -39.06 23.24 -13.96 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -32.63 23.57 -6.21 -33.51 24.93 -4.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 156 ASP~? 10.59 O ACT A1181 166 GLY B 116 GLY.? 11.34 O3 GOL B1182 169 GLU B 119 GLU.? 18.74 O3 GOL B1182 coo 8.28 6.87 1.62 10.08 5.77 1.34 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -52.33 -1.19 -6.26 -53.05 -1.53 -6.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 156 ASP~? 10.59 O ACT A1181 166 GLY B 116 GLY.? 11.34 O3 GOL B1182 169 GLU B 139 GLU.? 13.29 O3 GOL B1182 coo 8.28 6.87 1.62 10.08 5.77 1.34 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -52.33 -1.19 -6.26 -53.05 -1.53 -6.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -55.66 -6.36 -12.61 -53.57 -6.46 -12.15 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP B 14 ASP~? 13.85 OXT ACT A1181 166 GLY A 16 GLY~? 8.84 CH3 ACT A1181 169 GLU B 27 GLU~? 13.41 O1 GOL B1182 coo 8.28 6.87 1.62 10.08 5.77 1.34 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -52.14 19.77 -14.51 -52.26 20.60 -14.34 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -57.79 18.33 -19.74 -56.95 20.26 -20.07 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 14 ASP~? 13.85 OXT ACT A1181 166 GLY A 16 GLY~? 8.84 CH3 ACT A1181 169 GLU B 29 GLU~? -3.75 O1 GOL B1182s coo 8.28 6.87 1.62 10.08 5.77 1.34 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -52.14 19.77 -14.51 -52.26 20.60 -14.34 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -57.44 9.91 -17.53 -57.08 7.94 -18.23 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 14 ASP~? 13.85 OXT ACT A1181 166 GLY B 24 GLY~? 11.88 C1 GOL B1182 169 GLU B 29 GLU~? -3.75 O1 GOL B1182s coo 8.28 6.87 1.62 10.08 5.77 1.34 -34.30 14.67 -19.52 -35.49 13.01 -20.13 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -52.31 16.92 -18.92 -51.97 16.19 -18.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -57.44 9.91 -17.53 -57.08 7.94 -18.23 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP B 156 ASP~? 13.25 OXT ACT A1181 166 GLY A 116 GLY.? 16.42 O ACT A1181 169 GLU A 139 GLU.? 21.64 O ACT A1181 coo 8.28 6.87 1.62 10.08 5.77 1.34 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -38.20 18.52 6.75 -37.47 18.49 7.12 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -34.64 27.04 8.52 -35.38 28.56 9.82 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP C 14 ASP~? 9.29 CA CA C1182 166 GLY D 16 GLY~? 8.64 C1 GOL D1181 169 GLU C 27 GLU~? 15.61 O1 GOL D1181 coo 8.28 6.87 1.62 10.08 5.77 1.34 -34.30 -14.69 46.01 -33.14 -15.11 47.72 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -52.16 -19.77 41.01 -52.26 -20.58 40.82 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -57.81 -18.31 46.30 -57.05 -20.28 46.55 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP C 156 ASP~? 12.06 O3 GOL D1181 166 GLY D 116 GLY.? 16.41 O2 GOL D1181 169 GLU D 139 GLU.? 21.84 O2 GOL D1181 coo 8.28 6.87 1.62 10.08 5.77 1.34 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -38.19 -18.52 19.73 -37.45 -18.49 19.35 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -34.44 -26.82 17.86 -34.96 -28.12 16.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP D 14 ASP~? 14.81 O1 GOL D1181 166 GLY D 24 GLY~? 5.25 CA CA C1182 169 GLU D 29 GLU~? 11.05 O2 GOL D1181 coo 8.28 6.87 1.62 10.08 5.77 1.34 -56.61 -24.66 39.06 -57.85 -26.16 39.97 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -38.72 -23.09 41.13 -39.06 -23.23 40.41 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -32.61 -23.54 32.68 -33.42 -24.92 31.28 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP D 156 ASP~? 10.44 C2 GOL D1181 166 GLY C 116 GLY.? 15.57 CA CA C1184 169 GLU C 139 GLU.? 13.61 CA CA C1184 coo 8.28 6.87 1.62 10.08 5.77 1.34 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -52.37 1.22 32.72 -53.07 1.55 32.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -54.75 6.31 40.61 -53.48 6.42 38.96 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 11 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 214 ASP A 156 ASP~? 10.59 O ACT A1181 A 256 LYS A 117 LYS.? 20.14 O ACT A1181 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 214 ASP A 156 ASP~? 10.59 O ACT A1181 A 256 LYS A 149 LYS.? 8.87 O ACT A1181 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR A 157 TYR~? 5.66 OXT ACT A1181 A 214 ASP A 152 ASP.? 5.90 O ACT A1181 A 256 LYS A 117 LYS.? 20.14 O ACT A1181 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 214 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 256 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 214 ASP B 156 ASP~? 13.25 OXT ACT A1181 A 256 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR B 157 TYR~? 6.24 OXT ACT A1181 A 214 ASP B 152 ASP.? 8.52 O3 GOL B1182 A 256 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 214 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 256 LYS C 117 LYS.? 21.58 CA CA C1184 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 214 ASP C 156 ASP~? 12.06 O3 GOL D1181 A 256 LYS C 149 LYS.? 9.01 CA CA C1184 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 9 3 # 9 A 122 TYR C 157 TYR~? 5.26 O3 GOL D1181 A 214 ASP C 152 ASP.? 13.45 O3 GOL D1181 A 256 LYS C 117 LYS.? 21.58 CA CA C1184 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 10 3 # 10 A 122 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 214 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 256 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -38.62 -20.39 16.44 -44.46 -21.28 15.46 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 11 3 # 11 A 122 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 214 ASP D 156 ASP~? 10.44 C2 GOL D1181 A 256 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 12 3 # 12 A 122 TYR D 157 TYR~? -5.31 C1 GOL D1181s A 214 ASP D 152 ASP.? 5.75 O2 GOL D1181 A 256 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 -38.62 -20.39 16.44 -44.46 -21.28 15.46 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 12 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 64 TYR~? 13.66 OXT ACT A1181 B 214 ASP A 156 ASP~? 10.59 O ACT A1181 B 256 LYS A 149 LYS.? 8.87 O ACT A1181 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -46.26 16.00 -1.85 -46.95 16.56 0.08 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -40.01 25.58 0.52 -39.09 27.65 -5.03 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 157 TYR~? 5.66 OXT ACT A1181 B 214 ASP A 152 ASP.? 5.90 O ACT A1181 B 256 LYS A 117 LYS.? 20.14 O ACT A1181 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -43.60 24.63 -2.03 -43.51 24.01 -4.05 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -38.62 20.41 10.01 -44.40 21.40 11.23 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR B 64 TYR~? 13.94 OXT ACT A1181 B 214 ASP B 156 ASP~? 13.25 OXT ACT A1181 B 256 LYS B 149 LYS.? 7.98 O3 GOL B1182 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -44.48 7.85 -7.33 -43.76 5.86 -7.08 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -50.82 2.31 -15.26 -51.03 5.84 -20.47 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR B 157 TYR~? 6.24 OXT ACT A1181 B 214 ASP B 152 ASP.? 8.52 O3 GOL B1182 B 256 LYS B 117 LYS.? 17.47 O3 GOL B1182 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -44.58 12.35 -10.09 -41.80 12.65 -10.19 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -47.04 4.74 -15.30 -47.17 6.82 -15.76 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -51.85 -4.97 -6.63 -45.97 -6.38 -7.05 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR C 64 TYR~? 13.24 O3 GOL D1181 B 214 ASP C 156 ASP~? 12.06 O3 GOL D1181 B 256 LYS C 149 LYS.? 9.01 CA CA C1184 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -44.46 -7.83 33.81 -43.76 -5.84 33.54 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -50.86 -2.28 41.74 -55.49 -4.16 43.55 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR C 157 TYR~? 5.26 O3 GOL D1181 B 214 ASP C 152 ASP.? 13.45 O3 GOL D1181 B 256 LYS C 117 LYS.? 21.58 CA CA C1184 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -44.58 -12.33 36.53 -41.80 -12.65 36.66 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -47.03 -4.77 41.79 -47.13 -6.84 42.24 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -51.85 4.98 33.11 -46.06 6.47 33.64 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR D 64 TYR~? 12.19 O3 GOL D1181 B 214 ASP D 156 ASP~? 10.44 C2 GOL D1181 B 256 LYS D 149 LYS.? 13.85 O2 GOL D1181 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -46.26 -16.01 28.32 -46.92 -16.52 26.38 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -40.00 -25.59 26.00 -40.81 -29.12 24.35 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR D 157 TYR~? -5.31 C1 GOL D1181s B 214 ASP D 152 ASP.? 5.75 O2 GOL D1181 B 256 LYS D 117 LYS.? 19.88 O2 GOL D1181 coo -32.67 22.74 10.17 -32.85 23.98 7.70 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -43.59 -24.59 28.46 -43.51 -24.00 30.49 coo -16.04 12.06 11.09 -17.97 10.54 5.71 -38.62 -20.39 16.44 -44.46 -21.28 15.46 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 8 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 13 ARG~? 17.46 CH3 ACT A1181 A 130 SER B 23 SER~? 8.48 CH3 ACT A1181 A 159 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo 18.35 45.84 20.99 16.20 47.83 21.89 -58.47 23.67 -18.83 -59.87 25.50 -16.74 coo 15.14 43.67 10.77 15.61 44.43 13.04 -48.93 16.79 -17.08 -48.50 18.95 -17.97 coo 11.57 48.49 22.18 13.51 49.99 17.21 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG A 77 ARG.? 18.54 O ACT A1182 A 130 SER A 67 SER~? 15.83 O ACT A1182 A 159 LYS A 75 LYS.? 21.85 O3 GOL B1182 coo 18.35 45.84 20.99 16.20 47.83 21.89 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo 15.14 43.67 10.77 15.61 44.43 13.04 -39.02 0.91 0.50 -41.06 2.13 -0.03 coo 11.57 48.49 22.18 13.51 49.99 17.21 -33.45 -8.66 -7.93 -38.30 -6.69 -11.44 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG A 77 ARG.? 18.54 O ACT A1182 A 130 SER A 81 SER.? 8.12 CH3 ACT A1182 A 159 LYS A 72 LYS.? 19.74 O ACT A1182 coo 18.35 45.84 20.99 16.20 47.83 21.89 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo 15.14 43.67 10.77 15.61 44.43 13.04 -27.20 0.16 4.39 -25.70 0.48 6.25 coo 11.57 48.49 22.18 13.51 49.99 17.21 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 A 59 ARG A 77 ARG.? 18.54 O ACT A1182 A 130 SER B 57 SER.? 17.44 O3 GOL B1182 A 159 LYS A 75 LYS.? 21.85 O3 GOL B1182 coo 18.35 45.84 20.99 16.20 47.83 21.89 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo 15.14 43.67 10.77 15.61 44.43 13.04 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 coo 11.57 48.49 22.18 13.51 49.99 17.21 -33.45 -8.66 -7.93 -38.30 -6.69 -11.44 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 A 59 ARG B 13 ARG~? 17.43 OXT ACT A1181 A 130 SER A 23 SER~? -5.63 CH3 ACT A1181s A 159 LYS B 9 LYS~? 18.37 O ACT A1181 coo 18.35 45.84 20.99 16.20 47.83 21.89 -32.45 21.03 -20.61 -29.60 19.86 -21.02 coo 15.14 43.67 10.77 15.61 44.43 13.04 -42.07 21.42 -13.85 -42.41 21.34 -16.27 coo 11.57 48.49 22.18 13.51 49.99 17.21 -27.67 18.71 -15.51 -26.70 22.99 -17.12 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 A 59 ARG B 77 ARG.? 16.85 CA CA B1181 A 130 SER A 57 SER.? 18.23 O ACT A1181 A 159 LYS B 75 LYS.? 22.83 O ACT A1181 coo 18.35 45.84 20.99 16.20 47.83 21.89 -57.98 19.33 8.28 -57.78 17.70 5.69 coo 15.14 43.67 10.77 15.61 44.43 13.04 -45.76 15.37 8.19 -46.87 17.43 8.67 coo 11.57 48.49 22.18 13.51 49.99 17.21 -57.47 22.90 13.02 -52.58 24.12 11.55 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 7 3 # 7 A 59 ARG B 77 ARG.? 16.85 CA CA B1181 A 130 SER B 67 SER~? 15.74 OXT ACT C1183 A 159 LYS B 75 LYS.? 22.83 O ACT A1181 coo 18.35 45.84 20.99 16.20 47.83 21.89 -57.98 19.33 8.28 -57.78 17.70 5.69 coo 15.14 43.67 10.77 15.61 44.43 13.04 -51.74 11.42 7.51 -49.69 11.53 6.21 coo 11.57 48.49 22.18 13.51 49.99 17.21 -57.47 22.90 13.02 -52.58 24.12 11.55 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 8 3 # 8 A 59 ARG B 77 ARG.? 16.85 CA CA B1181 A 130 SER B 81 SER.? 8.11 CH3 ACT C1183 A 159 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 18.35 45.84 20.99 16.20 47.83 21.89 -57.98 19.33 8.28 -57.78 17.70 5.69 coo 15.14 43.67 10.77 15.61 44.43 13.04 -63.52 8.07 9.67 -64.94 6.18 10.18 coo 11.57 48.49 22.18 13.51 49.99 17.21 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 9 3 # 9 A 59 ARG C -1 ARG.? 22.70 CA CA C1182 A 130 SER C -3 SER.? 30.05 CA CA C1182 A 159 LYS C 2 LYS^? 15.05 CA CA C1182 coo 18.35 45.84 20.99 16.20 47.83 21.89 -23.32 -3.70 47.99 -26.29 -3.39 47.24 coo 15.14 43.67 10.77 15.61 44.43 13.04 -18.95 -1.86 56.73 -17.49 -3.58 57.60 coo 11.57 48.49 22.18 13.51 49.99 17.21 -20.31 -10.65 45.10 -24.59 -14.66 46.53 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 10 3 # 10 A 59 ARG C 13 ARG~? 8.07 CA CA C1182 A 130 SER D 23 SER~? -5.37 O1 GOL D1181s A 159 LYS C 9 LYS~? 14.61 CA CA C1182 coo 18.35 45.84 20.99 16.20 47.83 21.89 -32.51 -20.88 47.20 -29.56 -20.08 47.23 coo 15.14 43.67 10.77 15.61 44.43 13.04 -42.08 -21.40 40.30 -42.34 -21.31 42.73 coo 11.57 48.49 22.18 13.51 49.99 17.21 -27.74 -18.74 41.99 -22.99 -22.90 41.19 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 11 3 # 11 A 59 ARG C 77 ARG.? 17.10 CA CA C1181 A 130 SER C 67 SER~? 15.70 O ACT C1183 A 159 LYS C 75 LYS.? 21.97 O2 GOL D1181 coo 18.35 45.84 20.99 16.20 47.83 21.89 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo 15.14 43.67 10.77 15.61 44.43 13.04 -51.74 -11.42 18.94 -49.72 -11.51 20.26 coo 11.57 48.49 22.18 13.51 49.99 17.21 -57.40 -22.87 13.44 -53.97 -26.42 17.14 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 12 3 # 12 A 59 ARG C 77 ARG.? 17.10 CA CA C1181 A 130 SER C 81 SER.? 8.07 CH3 ACT C1183 A 159 LYS C 72 LYS.? 18.71 O ACT C1183 coo 18.35 45.84 20.99 16.20 47.83 21.89 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo 15.14 43.67 10.77 15.61 44.43 13.04 -63.54 -8.06 16.78 -64.93 -6.14 16.29 coo 11.57 48.49 22.18 13.51 49.99 17.21 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 13 3 # 13 A 59 ARG C 77 ARG.? 17.10 CA CA C1181 A 130 SER D 57 SER.? 18.28 O2 GOL D1181 A 159 LYS C 75 LYS.? 21.97 O2 GOL D1181 coo 18.35 45.84 20.99 16.20 47.83 21.89 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo 15.14 43.67 10.77 15.61 44.43 13.04 -45.75 -15.36 18.26 -46.91 -17.39 17.79 coo 11.57 48.49 22.18 13.51 49.99 17.21 -57.40 -22.87 13.44 -53.97 -26.42 17.14 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 14 3 # 14 A 59 ARG D 13 ARG~? 18.52 O1 GOL D1181 A 130 SER C 23 SER~? 8.22 O1 GOL D1181 A 159 LYS D 9 LYS~? 18.78 CA CA C1184 coo 18.35 45.84 20.99 16.20 47.83 21.89 -58.59 -23.71 45.22 -61.26 -24.52 43.91 coo 15.14 43.67 10.77 15.61 44.43 13.04 -48.92 -16.81 43.56 -48.52 -18.99 44.45 coo 11.57 48.49 22.18 13.51 49.99 17.21 -63.24 -19.53 41.29 -64.69 -19.90 45.47 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 15 3 # 15 A 59 ARG D 77 ARG.? 18.56 OXT ACT A1182 A 130 SER C 57 SER.? 20.56 O3 GOL D1181 A 159 LYS D 75 LYS.? 24.88 O3 GOL D1181 coo 18.35 45.84 20.99 16.20 47.83 21.89 -32.91 2.84 33.04 -33.00 -0.18 32.51 coo 15.14 43.67 10.77 15.61 44.43 13.04 -44.87 1.18 29.24 -43.70 2.34 31.00 coo 11.57 48.49 22.18 13.51 49.99 17.21 -33.47 8.69 34.45 -37.51 6.70 37.91 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 16 3 # 16 A 59 ARG D 77 ARG.? 18.56 OXT ACT A1182 A 130 SER D 67 SER~? 15.83 OXT ACT A1182 A 159 LYS D 75 LYS.? 24.88 O3 GOL D1181 coo 18.35 45.84 20.99 16.20 47.83 21.89 -32.91 2.84 33.04 -33.00 -0.18 32.51 coo 15.14 43.67 10.77 15.61 44.43 13.04 -39.02 -0.93 25.94 -41.07 -2.17 26.53 coo 11.57 48.49 22.18 13.51 49.99 17.21 -33.47 8.69 34.45 -37.51 6.70 37.91 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 17 3 # 17 A 59 ARG D 77 ARG.? 18.56 OXT ACT A1182 A 130 SER D 81 SER.? 8.08 CH3 ACT A1182 A 159 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 18.35 45.84 20.99 16.20 47.83 21.89 -32.91 2.84 33.04 -33.00 -0.18 32.51 coo 15.14 43.67 10.77 15.61 44.43 13.04 -27.23 -0.14 22.07 -25.72 -0.46 20.20 coo 11.57 48.49 22.18 13.51 49.99 17.21 -39.21 6.22 27.81 -43.32 9.34 25.63 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 17 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 13 ARG~? 17.46 CH3 ACT A1181 B 130 SER B 23 SER~? 8.48 CH3 ACT A1181 B 159 LYS A 9 LYS~? 15.21 O1 GOL B1182 coo 58.72 31.58 20.45 60.80 29.39 20.94 -58.47 23.67 -18.83 -59.87 25.50 -16.74 coo 61.66 35.17 10.39 61.29 34.14 12.56 -48.93 16.79 -17.08 -48.50 18.95 -17.97 coo 65.38 28.77 21.17 63.49 28.03 16.12 -63.23 19.50 -14.81 -65.35 21.15 -20.54 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG A 77 ARG.? 18.54 O ACT A1182 B 130 SER A 67 SER~? 15.83 O ACT A1182 B 159 LYS A 75 LYS.? 21.85 O3 GOL B1182 coo 58.72 31.58 20.45 60.80 29.39 20.94 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo 61.66 35.17 10.39 61.29 34.14 12.56 -39.02 0.91 0.50 -41.06 2.13 -0.03 coo 65.38 28.77 21.17 63.49 28.03 16.12 -33.45 -8.66 -7.93 -38.30 -6.69 -11.44 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG A 77 ARG.? 18.54 O ACT A1182 B 130 SER A 81 SER.? 8.12 CH3 ACT A1182 B 159 LYS A 72 LYS.? 19.74 O ACT A1182 coo 58.72 31.58 20.45 60.80 29.39 20.94 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo 61.66 35.17 10.39 61.29 34.14 12.56 -27.20 0.16 4.39 -25.70 0.48 6.25 coo 65.38 28.77 21.17 63.49 28.03 16.12 -39.12 -6.30 -1.31 -44.22 -9.01 -0.49 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 B 59 ARG A 77 ARG.? 18.54 O ACT A1182 B 130 SER B 57 SER.? 17.44 O3 GOL B1182 B 159 LYS A 75 LYS.? 21.85 O3 GOL B1182 coo 58.72 31.58 20.45 60.80 29.39 20.94 -32.84 -2.84 -6.53 -32.97 0.18 -5.99 coo 61.66 35.17 10.39 61.29 34.14 12.56 -44.85 -1.14 -2.80 -43.72 -2.31 -4.56 coo 65.38 28.77 21.17 63.49 28.03 16.12 -33.45 -8.66 -7.93 -38.30 -6.69 -11.44 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 B 59 ARG B 13 ARG~? 17.43 OXT ACT A1181 B 130 SER A 23 SER~? -5.63 CH3 ACT A1181s B 159 LYS B 9 LYS~? 18.37 O ACT A1181 coo 58.72 31.58 20.45 60.80 29.39 20.94 -32.45 21.03 -20.61 -29.60 19.86 -21.02 coo 61.66 35.17 10.39 61.29 34.14 12.56 -42.07 21.42 -13.85 -42.41 21.34 -16.27 coo 65.38 28.77 21.17 63.49 28.03 16.12 -27.67 18.71 -15.51 -26.70 22.99 -17.12 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 B 59 ARG B 77 ARG.? 16.85 CA CA B1181 B 130 SER A 57 SER.? 18.23 O ACT A1181 B 159 LYS B 75 LYS.? 22.83 O ACT A1181 coo 58.72 31.58 20.45 60.80 29.39 20.94 -57.98 19.33 8.28 -57.78 17.70 5.69 coo 61.66 35.17 10.39 61.29 34.14 12.56 -45.76 15.37 8.19 -46.87 17.43 8.67 coo 65.38 28.77 21.17 63.49 28.03 16.12 -57.47 22.90 13.02 -52.58 24.12 11.55 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 7 3 # 7 B 59 ARG B 77 ARG.? 16.85 CA CA B1181 B 130 SER B 67 SER~? 15.74 OXT ACT C1183 B 159 LYS B 75 LYS.? 22.83 O ACT A1181 coo 58.72 31.58 20.45 60.80 29.39 20.94 -57.98 19.33 8.28 -57.78 17.70 5.69 coo 61.66 35.17 10.39 61.29 34.14 12.56 -51.74 11.42 7.51 -49.69 11.53 6.21 coo 65.38 28.77 21.17 63.49 28.03 16.12 -57.47 22.90 13.02 -52.58 24.12 11.55 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 8 3 # 8 B 59 ARG B 77 ARG.? 16.85 CA CA B1181 B 130 SER B 81 SER.? 8.11 CH3 ACT C1183 B 159 LYS B 72 LYS.? 19.60 OXT ACT C1183 coo 58.72 31.58 20.45 60.80 29.39 20.94 -57.98 19.33 8.28 -57.78 17.70 5.69 coo 61.66 35.17 10.39 61.29 34.14 12.56 -63.52 8.07 9.67 -64.94 6.18 10.18 coo 65.38 28.77 21.17 63.49 28.03 16.12 -51.55 16.08 13.28 -45.97 15.76 16.18 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 9 3 # 9 B 59 ARG C -1 ARG.? 22.70 CA CA C1182 B 130 SER C -3 SER.? 30.05 CA CA C1182 B 159 LYS C 2 LYS^? 15.05 CA CA C1182 coo 58.72 31.58 20.45 60.80 29.39 20.94 -23.32 -3.70 47.99 -26.29 -3.39 47.24 coo 61.66 35.17 10.39 61.29 34.14 12.56 -18.95 -1.86 56.73 -17.49 -3.58 57.60 coo 65.38 28.77 21.17 63.49 28.03 16.12 -20.31 -10.65 45.10 -24.59 -14.66 46.53 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 10 3 # 10 B 59 ARG C 13 ARG~? 8.07 CA CA C1182 B 130 SER D 23 SER~? -5.37 O1 GOL D1181s B 159 LYS C 9 LYS~? 14.61 CA CA C1182 coo 58.72 31.58 20.45 60.80 29.39 20.94 -32.51 -20.88 47.20 -29.56 -20.08 47.23 coo 61.66 35.17 10.39 61.29 34.14 12.56 -42.08 -21.40 40.30 -42.34 -21.31 42.73 coo 65.38 28.77 21.17 63.49 28.03 16.12 -27.74 -18.74 41.99 -22.99 -22.90 41.19 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 11 3 # 11 B 59 ARG C 77 ARG.? 17.10 CA CA C1181 B 130 SER B 89 SER.? 7.47 O ACT C1183 B 159 LYS C 75 LYS.? 21.97 O2 GOL D1181 coo 58.72 31.58 20.45 60.80 29.39 20.94 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo 61.66 35.17 10.39 61.29 34.14 12.56 -56.52 -7.84 12.62 -56.01 -7.64 14.93 coo 65.38 28.77 21.17 63.49 28.03 16.12 -57.40 -22.87 13.44 -53.97 -26.42 17.14 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 12 3 # 12 B 59 ARG C 77 ARG.? 17.10 CA CA C1181 B 130 SER C 67 SER~? 15.70 O ACT C1183 B 159 LYS C 75 LYS.? 21.97 O2 GOL D1181 coo 58.72 31.58 20.45 60.80 29.39 20.94 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo 61.66 35.17 10.39 61.29 34.14 12.56 -51.74 -11.42 18.94 -49.72 -11.51 20.26 coo 65.38 28.77 21.17 63.49 28.03 16.12 -57.40 -22.87 13.44 -53.97 -26.42 17.14 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 13 3 # 13 B 59 ARG C 77 ARG.? 17.10 CA CA C1181 B 130 SER C 81 SER.? 8.07 CH3 ACT C1183 B 159 LYS C 72 LYS.? 18.71 O ACT C1183 coo 58.72 31.58 20.45 60.80 29.39 20.94 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo 61.66 35.17 10.39 61.29 34.14 12.56 -63.54 -8.06 16.78 -64.93 -6.14 16.29 coo 65.38 28.77 21.17 63.49 28.03 16.12 -51.58 -16.11 13.18 -47.22 -15.59 10.10 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 14 3 # 14 B 59 ARG C 77 ARG.? 17.10 CA CA C1181 B 130 SER D 57 SER.? 18.28 O2 GOL D1181 B 159 LYS C 75 LYS.? 21.97 O2 GOL D1181 coo 58.72 31.58 20.45 60.80 29.39 20.94 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo 61.66 35.17 10.39 61.29 34.14 12.56 -45.75 -15.36 18.26 -46.91 -17.39 17.79 coo 65.38 28.77 21.17 63.49 28.03 16.12 -57.40 -22.87 13.44 -53.97 -26.42 17.14 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 15 3 # 15 B 59 ARG D 13 ARG~? 18.52 O1 GOL D1181 B 130 SER C 23 SER~? 8.22 O1 GOL D1181 B 159 LYS D 9 LYS~? 18.78 CA CA C1184 coo 58.72 31.58 20.45 60.80 29.39 20.94 -58.59 -23.71 45.22 -61.26 -24.52 43.91 coo 61.66 35.17 10.39 61.29 34.14 12.56 -48.92 -16.81 43.56 -48.52 -18.99 44.45 coo 65.38 28.77 21.17 63.49 28.03 16.12 -63.24 -19.53 41.29 -64.69 -19.90 45.47 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 16 3 # 16 B 59 ARG D 77 ARG.? 18.56 OXT ACT A1182 B 130 SER C 57 SER.? 20.56 O3 GOL D1181 B 159 LYS D 75 LYS.? 24.88 O3 GOL D1181 coo 58.72 31.58 20.45 60.80 29.39 20.94 -32.91 2.84 33.04 -33.00 -0.18 32.51 coo 61.66 35.17 10.39 61.29 34.14 12.56 -44.87 1.18 29.24 -43.70 2.34 31.00 coo 65.38 28.77 21.17 63.49 28.03 16.12 -33.47 8.69 34.45 -37.51 6.70 37.91 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 17 3 # 17 B 59 ARG D 77 ARG.? 18.56 OXT ACT A1182 B 130 SER D 67 SER~? 15.83 OXT ACT A1182 B 159 LYS D 75 LYS.? 24.88 O3 GOL D1181 coo 58.72 31.58 20.45 60.80 29.39 20.94 -32.91 2.84 33.04 -33.00 -0.18 32.51 coo 61.66 35.17 10.39 61.29 34.14 12.56 -39.02 -0.93 25.94 -41.07 -2.17 26.53 coo 65.38 28.77 21.17 63.49 28.03 16.12 -33.47 8.69 34.45 -37.51 6.70 37.91 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 18 3 # 18 B 59 ARG D 77 ARG.? 18.56 OXT ACT A1182 B 130 SER D 81 SER.? 8.08 CH3 ACT A1182 B 159 LYS D 72 LYS.? 18.40 OXT ACT A1182 coo 58.72 31.58 20.45 60.80 29.39 20.94 -32.91 2.84 33.04 -33.00 -0.18 32.51 coo 61.66 35.17 10.39 61.29 34.14 12.56 -27.23 -0.14 22.07 -25.72 -0.46 20.20 coo 65.38 28.77 21.17 63.49 28.03 16.12 -39.21 6.22 27.81 -43.32 9.34 25.63 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 18 hits 2tps_c01 naa= 3 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 1 3 # 1 18 ARG A 58 ARG~? 14.46 O ACT A1181 195 HIS A 59 HIS~? 15.34 OXT ACT A1182 199 ASP A 55 ASP.? 17.41 O ACT A1181 coo 21.96 2.03 15.24 19.33 1.86 13.55 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -43.78 10.05 10.24 -43.35 10.65 12.21 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 2 3 # 2 18 ARG A 58 ARG~? 14.46 O ACT A1181 195 HIS A 114 HIS^? 15.94 OXT ACT A1182 199 ASP A 55 ASP.? 17.41 O ACT A1181 coo 21.96 2.03 15.24 19.33 1.86 13.55 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -33.97 15.61 9.27 -35.78 16.19 10.17 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -40.70 16.96 10.07 -41.68 17.42 8.23 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 3 3 # 3 18 ARG B 58 ARG~? 12.97 O3 GOL B1182 195 HIS B 59 HIS~? 15.18 O ACT C1183 199 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 21.96 2.03 15.24 19.33 1.86 13.55 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -46.85 -1.06 2.89 -47.27 -3.11 3.11 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 4 3 # 4 18 ARG B 58 ARG~? 12.97 O3 GOL B1182 195 HIS B 114 HIS^? 14.73 O2 GOL B1182 199 ASP B 55 ASP.? 14.29 O3 GOL B1182 coo 21.96 2.03 15.24 19.33 1.86 13.55 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 5 3 # 5 18 ARG C 58 ARG~? 18.42 O3 GOL D1181 195 HIS C 59 HIS~? 15.17 OXT ACT C1183 199 ASP C 55 ASP.? 19.45 CA CA C1184 coo 21.96 2.03 15.24 19.33 1.86 13.55 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -46.89 1.05 23.56 -47.29 3.11 23.40 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 6 3 # 6 18 ARG C 58 ARG~? 18.42 O3 GOL D1181 195 HIS C 114 HIS^? 15.77 OXT ACT C1183 199 ASP C 55 ASP.? 19.45 CA CA C1184 coo 21.96 2.03 15.24 19.33 1.86 13.55 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -56.52 2.47 29.05 -54.69 3.49 29.13 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -49.79 3.61 29.96 -48.81 2.08 31.09 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 7 3 # 7 18 ARG D 58 ARG~? 14.52 O2 GOL D1181 195 HIS D 114 HIS^? 15.97 O ACT A1182 199 ASP D 55 ASP.? 17.43 O2 GOL D1181 coo 21.96 2.03 15.24 19.33 1.86 13.55 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -34.02 -15.52 17.15 -35.80 -16.25 16.32 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -40.72 -16.97 16.40 -41.69 -17.43 18.23 3cla_c00 source 3cla TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE ( C: 7 hits 3cla_c00 naa= 3 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 A 158 ASP A 55 ASP.? 17.41 O ACT A1181 A 161 ARG A 58 ARG~? 14.46 O ACT A1181 A 186 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo 18.62 26.83 58.17 18.48 28.64 57.08 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 23.76 27.69 57.88 24.05 29.81 55.69 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 16.67 31.22 54.64 18.74 31.15 54.14 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 A 158 ASP A 55 ASP.? 17.41 O ACT A1181 A 161 ARG A 58 ARG~? 14.46 O ACT A1181 A 186 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 18.62 26.83 58.17 18.48 28.64 57.08 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 23.76 27.69 57.88 24.05 29.81 55.69 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 16.67 31.22 54.64 18.74 31.15 54.14 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 A 158 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 161 ARG B 58 ARG~? 12.97 O3 GOL B1182 A 186 HIS B 59 HIS~? 15.18 O ACT C1183 coo 18.62 26.83 58.17 18.48 28.64 57.08 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 23.76 27.69 57.88 24.05 29.81 55.69 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 16.67 31.22 54.64 18.74 31.15 54.14 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 A 158 ASP B 55 ASP.? 14.29 O3 GOL B1182 A 161 ARG B 58 ARG~? 12.97 O3 GOL B1182 A 186 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 18.62 26.83 58.17 18.48 28.64 57.08 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 23.76 27.69 57.88 24.05 29.81 55.69 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 16.67 31.22 54.64 18.74 31.15 54.14 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 3 # 5 A 158 ASP C 55 ASP.? 19.45 CA CA C1184 A 161 ARG C 58 ARG~? 18.42 O3 GOL D1181 A 186 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo 18.62 26.83 58.17 18.48 28.64 57.08 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 23.76 27.69 57.88 24.05 29.81 55.69 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 16.67 31.22 54.64 18.74 31.15 54.14 -46.89 1.05 23.56 -47.29 3.11 23.40 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 6 3 # 6 A 158 ASP C 55 ASP.? 19.45 CA CA C1184 A 161 ARG C 58 ARG~? 18.42 O3 GOL D1181 A 186 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 18.62 26.83 58.17 18.48 28.64 57.08 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 23.76 27.69 57.88 24.05 29.81 55.69 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 16.67 31.22 54.64 18.74 31.15 54.14 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 7 3 # 7 A 158 ASP D 55 ASP.? 17.43 O2 GOL D1181 A 161 ARG D 58 ARG~? 14.52 O2 GOL D1181 A 186 HIS D 114 HIS^? 15.97 O ACT A1182 coo 18.62 26.83 58.17 18.48 28.64 57.08 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 23.76 27.69 57.88 24.05 29.81 55.69 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 16.67 31.22 54.64 18.74 31.15 54.14 -34.02 -15.52 17.15 -35.80 -16.25 16.32 4mdh_c02 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 7 hits 4mdh_c02 naa= 3 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 B 158 ASP A 55 ASP.? 17.41 O ACT A1181 B 161 ARG A 58 ARG~? 14.46 O ACT A1181 B 186 HIS A 59 HIS~? 15.34 OXT ACT A1182 coo 44.53 16.44 28.54 44.89 18.45 28.77 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 39.64 19.27 28.15 40.19 21.74 29.94 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 48.32 20.00 31.44 46.45 20.91 31.50 -43.78 10.05 10.24 -43.35 10.65 12.21 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 B 158 ASP A 55 ASP.? 17.41 O ACT A1181 B 161 ARG A 58 ARG~? 14.46 O ACT A1181 B 186 HIS A 114 HIS^? 15.94 OXT ACT A1182 coo 44.53 16.44 28.54 44.89 18.45 28.77 -40.70 16.96 10.07 -41.68 17.42 8.23 coo 39.64 19.27 28.15 40.19 21.74 29.94 -43.27 15.99 4.53 -43.95 18.83 5.47 coo 48.32 20.00 31.44 46.45 20.91 31.50 -33.97 15.61 9.27 -35.78 16.19 10.17 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 B 158 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 161 ARG B 58 ARG~? 12.97 O3 GOL B1182 B 186 HIS B 59 HIS~? 15.18 O ACT C1183 coo 44.53 16.44 28.54 44.89 18.45 28.77 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 39.64 19.27 28.15 40.19 21.74 29.94 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 48.32 20.00 31.44 46.45 20.91 31.50 -46.85 -1.06 2.89 -47.27 -3.11 3.11 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 B 158 ASP B 55 ASP.? 14.29 O3 GOL B1182 B 161 ARG B 58 ARG~? 12.97 O3 GOL B1182 B 186 HIS B 114 HIS^? 14.73 O2 GOL B1182 coo 44.53 16.44 28.54 44.89 18.45 28.77 -49.77 -3.61 -3.50 -48.83 -2.06 -4.64 coo 39.64 19.27 28.15 40.19 21.74 29.94 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 coo 48.32 20.00 31.44 46.45 20.91 31.50 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 3 # 5 B 158 ASP C 55 ASP.? 19.45 CA CA C1184 B 161 ARG C 58 ARG~? 18.42 O3 GOL D1181 B 186 HIS C 59 HIS~? 15.17 OXT ACT C1183 coo 44.53 16.44 28.54 44.89 18.45 28.77 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 39.64 19.27 28.15 40.19 21.74 29.94 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 48.32 20.00 31.44 46.45 20.91 31.50 -46.89 1.05 23.56 -47.29 3.11 23.40 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 6 3 # 6 B 158 ASP C 55 ASP.? 19.45 CA CA C1184 B 161 ARG C 58 ARG~? 18.42 O3 GOL D1181 B 186 HIS C 114 HIS^? 15.77 OXT ACT C1183 coo 44.53 16.44 28.54 44.89 18.45 28.77 -49.79 3.61 29.96 -48.81 2.08 31.09 coo 39.64 19.27 28.15 40.19 21.74 29.94 -48.43 -0.71 31.25 -46.65 0.17 33.60 coo 48.32 20.00 31.44 46.45 20.91 31.50 -56.52 2.47 29.05 -54.69 3.49 29.13 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 7 3 # 7 B 158 ASP D 55 ASP.? 17.43 O2 GOL D1181 B 161 ARG D 58 ARG~? 14.52 O2 GOL D1181 B 186 HIS D 114 HIS^? 15.97 O ACT A1182 coo 44.53 16.44 28.54 44.89 18.45 28.77 -40.72 -16.97 16.40 -41.69 -17.43 18.23 coo 39.64 19.27 28.15 40.19 21.74 29.94 -43.20 -16.00 21.95 -43.92 -18.81 20.94 coo 48.32 20.00 31.44 46.45 20.91 31.50 -34.02 -15.52 17.15 -35.80 -16.25 16.32 4mdh_c03 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 7 hits 4mdh_c03 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 3 ASN^? 12.04 CA CA B1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -72.70 21.43 -11.05 -73.07 19.35 -11.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 46 ASN~? 20.18 CH3 ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.92 5.08 1.56 -15.60 6.18 0.30 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 63 ASN~? 15.00 O ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 68 ASN~? 16.27 OXT ACT A1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -37.69 3.73 -3.29 -39.63 4.05 -4.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 70 ASN~? 11.41 O ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -33.93 -2.05 0.89 -31.84 -1.69 1.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 86 ASN.? 11.67 OXT ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -38.42 8.17 12.63 -38.52 10.18 11.86 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 94 ASN.? 20.31 OXT ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -34.68 14.84 26.15 -33.66 16.63 26.68 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 97 ASN~? 20.44 OXT ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -24.46 14.50 24.96 -23.77 16.46 24.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN A 109 ASN.? 14.39 CH3 ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -18.98 4.63 8.19 -18.49 6.24 6.88 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN A 120 ASN~? 16.79 OXT ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -37.16 17.92 19.64 -35.92 16.19 19.48 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN A 168 ASN~? 15.32 OXT ACT A1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.58 8.23 -11.56 -33.27 7.25 -12.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN A 176 ASN.? 29.75 CH3 ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -19.36 1.51 -14.26 -19.79 -0.51 -14.77 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN B 3 ASN^? 25.47 OXT ACT A1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -18.33 14.30 -16.20 -18.26 15.53 -14.45 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN B 46 ASN~? 10.46 CA CA B1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -74.04 8.69 3.83 -75.20 9.76 2.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN B 68 ASN~? 15.57 O ACT A1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -53.02 13.76 3.43 -51.10 14.43 2.89 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN B 70 ASN~? 11.40 OXT ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -56.88 12.21 10.31 -58.96 11.82 10.06 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN B 86 ASN.? 11.57 O ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -52.20 -2.48 5.54 -51.99 -2.60 3.42 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN B 94 ASN.? 19.97 O ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -55.90 -18.81 5.77 -53.88 -19.30 6.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN B 97 ASN~? 15.65 O ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -64.58 -14.76 3.84 -63.20 -13.18 4.05 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN B 109 ASN.? 14.52 CH3 ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -71.64 2.73 6.90 -72.13 3.19 4.89 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN B 120 ASN~? 16.46 O ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -53.48 -12.76 -0.52 -54.66 -11.58 0.79 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN B 168 ASN~? 15.62 CH3 ACT A1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -59.27 19.54 -3.77 -57.59 20.58 -3.04 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN B 176 ASN.? -3.27 CA CA B1181s coo 5.80 63.03 55.85 5.52 65.03 56.45 -71.77 24.24 1.63 -73.32 22.93 2.33 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 25 1 # 25 A 461 ASN C 3 ASN^? 20.98 CA CA C1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -18.27 -14.28 42.59 -18.15 -15.35 40.76 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 26 1 # 26 A 461 ASN C 46 ASN~? 10.53 CA CA C1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -74.04 -8.67 22.63 -75.10 -9.60 24.27 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 27 1 # 27 A 461 ASN C 63 ASN~? 14.81 O ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -47.81 -6.22 21.11 -47.01 -7.28 19.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 28 1 # 28 A 461 ASN C 68 ASN~? 15.25 C2 GOL D1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -53.02 -13.76 23.01 -51.11 -14.42 23.60 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 29 1 # 29 A 461 ASN C 70 ASN~? 11.43 O ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -56.89 -12.17 16.15 -58.98 -11.84 16.38 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 30 1 # 30 A 461 ASN C 86 ASN.? 11.54 OXT ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -52.20 2.48 20.90 -52.01 2.64 23.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 31 1 # 31 A 461 ASN C 94 ASN.? 20.53 OXT ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -57.57 16.60 24.50 -56.01 17.74 25.39 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 32 1 # 32 A 461 ASN C 97 ASN~? 20.34 OXT ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -66.13 16.32 22.33 -66.34 16.55 24.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 33 1 # 33 A 461 ASN C 109 ASN.? 14.51 CH3 ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -71.64 -2.74 19.53 -72.13 -3.21 21.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 34 1 # 34 A 461 ASN C 120 ASN~? 16.45 OXT ACT C1183 coo 5.80 63.03 55.85 5.52 65.03 56.45 -53.50 12.76 27.01 -54.66 11.53 25.76 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 35 1 # 35 A 461 ASN C 168 ASN~? 14.78 C1 GOL D1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -59.24 -19.55 30.22 -57.56 -20.59 29.47 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 36 1 # 36 A 461 ASN C 176 ASN.? 3.44 CA CA C1181s coo 5.80 63.03 55.85 5.52 65.03 56.45 -71.77 -24.28 24.84 -73.29 -22.94 24.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 37 1 # 37 A 461 ASN D 3 ASN~? 12.07 CA CA C1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -72.61 -21.52 37.54 -72.85 -19.41 37.73 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 38 1 # 38 A 461 ASN D 46 ASN~? 18.62 CH3 ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.96 -5.07 24.82 -15.16 -4.92 23.63 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 39 1 # 39 A 461 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 40 1 # 40 A 461 ASN D 68 ASN~? 14.78 O3 GOL D1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -37.72 -3.74 29.70 -39.65 -4.05 30.55 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 41 1 # 41 A 461 ASN D 70 ASN~? 11.36 OXT ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -33.95 2.02 25.56 -31.86 1.70 25.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 42 1 # 42 A 461 ASN D 86 ASN.? 11.74 O ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -38.34 -8.19 13.90 -38.52 -10.20 14.65 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 43 1 # 43 A 461 ASN D 97 ASN~? 15.89 O ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -26.32 -14.61 3.13 -27.44 -14.01 4.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 44 1 # 44 A 461 ASN D 109 ASN.? 14.36 CH3 ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -18.98 -4.62 18.28 -18.54 -6.24 19.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 45 1 # 45 A 461 ASN D 120 ASN~? 16.83 O ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -37.12 -17.90 6.86 -35.82 -16.19 6.99 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 46 1 # 46 A 461 ASN D 168 ASN~? 14.11 O3 GOL D1181 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.58 -8.23 38.03 -33.25 -7.24 38.84 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 47 1 # 47 A 461 ASN D 176 ASN.? 28.38 CH3 ACT A1182 coo 5.80 63.03 55.85 5.52 65.03 56.45 -19.41 -1.59 41.01 -18.50 -0.80 39.26 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 47 hits 1kbk_p00 naa= 1 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 1 4 # 1 A 25 ILE A 65 ILE~? 14.20 O ACT A1182 A 52 ASN D 176 ASN.? 28.38 CH3 ACT A1182 A 53 VAL D 173 VAL~? 22.95 O3 GOL D1181 A 78 ASN A 63 ASN~? 15.00 O ACT A1182 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -36.41 7.24 1.85 -35.53 8.33 2.09 coo 81.20 29.47 37.49 79.47 28.44 38.24 -19.41 -1.59 41.01 -18.50 -0.80 39.26 coo 82.17 24.86 36.27 81.03 23.67 37.80 -22.46 -5.38 36.98 -22.51 -6.79 35.29 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 2 4 # 2 A 25 ILE B 65 ILE~? 14.12 OXT ACT C1183 A 52 ASN C 176 ASN.? 3.44 CA CA C1181s A 53 VAL C 173 VAL~? 5.89 CA CA C1181 A 78 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -54.29 7.74 2.23 -55.14 7.06 1.34 coo 81.20 29.47 37.49 79.47 28.44 38.24 -71.77 -24.28 24.84 -73.29 -22.94 24.12 coo 82.17 24.86 36.27 81.03 23.67 37.80 -68.43 -19.34 27.44 -69.06 -17.29 28.23 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 3 4 # 3 A 25 ILE C 65 ILE~? 14.09 O ACT C1183 A 52 ASN B 176 ASN.? -3.27 CA CA B1181s A 53 VAL B 173 VAL~? 5.77 CA CA B1181 A 78 ASN C 63 ASN~? 14.81 O ACT C1183 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -54.29 -7.76 24.24 -55.13 -7.05 25.11 coo 81.20 29.47 37.49 79.47 28.44 38.24 -71.77 24.24 1.63 -73.32 22.93 2.33 coo 82.17 24.86 36.27 81.03 23.67 37.80 -68.41 19.35 -0.98 -69.08 17.31 -1.74 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -47.81 -6.22 21.11 -47.01 -7.28 19.44 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 4 4 # 4 A 25 ILE D 65 ILE~? 14.16 OXT ACT A1182 A 52 ASN A 176 ASN.? 29.75 CH3 ACT A1182 A 53 VAL A 173 VAL~? 24.47 OXT ACT A1181 A 78 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -36.40 -7.21 24.61 -35.55 -8.30 24.35 coo 81.20 29.47 37.49 79.47 28.44 38.24 -19.36 1.51 -14.26 -19.79 -0.51 -14.77 coo 82.17 24.86 36.27 81.03 23.67 37.80 -22.49 5.36 -10.60 -21.95 6.78 -8.92 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -42.87 -5.02 21.89 -43.66 -3.06 22.11 1qfw_p00 source 1qfw GONADOTROPIN ALPHA SUBUNIT : 4 hits 1qfw_p00 naa= 4 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 108 ASN A 86 ASN.? 11.67 OXT ACT A1182 A 135 ASN A 63 ASN~? 15.00 O ACT A1182 coo 17.59 4.66 17.88 15.38 5.96 18.97 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 12.36 16.24 15.27 12.06 14.29 16.05 -38.42 8.17 12.63 -38.52 10.18 11.86 coo 18.05 11.56 12.71 17.57 10.75 14.60 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 108 ASN B 68 ASN~? 15.57 O ACT A1181 A 135 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo 17.59 4.66 17.88 15.38 5.96 18.97 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 12.36 16.24 15.27 12.06 14.29 16.05 -53.02 13.76 3.43 -51.10 14.43 2.89 coo 18.05 11.56 12.71 17.57 10.75 14.60 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR A 107 TYR~? -4.55 CH3 ACT A1182s A 108 ASN A 46 ASN~? 20.18 CH3 ACT A1182 A 135 ASN A 109 ASN.? 14.39 CH3 ACT A1182 coo 17.59 4.66 17.88 15.38 5.96 18.97 -24.81 2.99 13.30 -27.48 2.42 13.94 coo 12.36 16.24 15.27 12.06 14.29 16.05 -16.92 5.08 1.56 -15.60 6.18 0.30 coo 18.05 11.56 12.71 17.57 10.75 14.60 -18.98 4.63 8.19 -18.49 6.24 6.88 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 108 ASN A 68 ASN~? 16.27 OXT ACT A1181 A 135 ASN A 63 ASN~? 15.00 O ACT A1182 coo 17.59 4.66 17.88 15.38 5.96 18.97 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 12.36 16.24 15.27 12.06 14.29 16.05 -37.69 3.73 -3.29 -39.63 4.05 -4.09 coo 18.05 11.56 12.71 17.57 10.75 14.60 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR B 91 TYR.? 11.41 O ACT C1183 A 108 ASN B 94 ASN.? 19.97 O ACT C1183 A 135 ASN B 120 ASN~? 16.46 O ACT C1183 coo 17.59 4.66 17.88 15.38 5.96 18.97 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 12.36 16.24 15.27 12.06 14.29 16.05 -55.90 -18.81 5.77 -53.88 -19.30 6.35 coo 18.05 11.56 12.71 17.57 10.75 14.60 -53.48 -12.76 -0.52 -54.66 -11.58 0.79 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR B 107 TYR~? -4.64 CH3 ACT C1183s A 108 ASN B 46 ASN~? 10.46 CA CA B1181 A 135 ASN B 109 ASN.? 14.52 CH3 ACT C1183 coo 17.59 4.66 17.88 15.38 5.96 18.97 -65.76 -1.20 10.47 -63.11 -1.54 11.28 coo 12.36 16.24 15.27 12.06 14.29 16.05 -74.04 8.69 3.83 -75.20 9.76 2.34 coo 18.05 11.56 12.71 17.57 10.75 14.60 -71.64 2.73 6.90 -72.13 3.19 4.89 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 7 3 # 7 A 51 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 108 ASN C 86 ASN.? 11.54 OXT ACT C1183 A 135 ASN C 63 ASN~? 14.81 O ACT C1183 coo 17.59 4.66 17.88 15.38 5.96 18.97 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 12.36 16.24 15.27 12.06 14.29 16.05 -52.20 2.48 20.90 -52.01 2.64 23.02 coo 18.05 11.56 12.71 17.57 10.75 14.60 -47.81 -6.22 21.11 -47.01 -7.28 19.44 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 8 3 # 8 A 51 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 108 ASN D 68 ASN~? 14.78 O3 GOL D1181 A 135 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo 17.59 4.66 17.88 15.38 5.96 18.97 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 12.36 16.24 15.27 12.06 14.29 16.05 -37.72 -3.74 29.70 -39.65 -4.05 30.55 coo 18.05 11.56 12.71 17.57 10.75 14.60 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 9 3 # 9 A 51 TYR C 91 TYR.? 11.38 OXT ACT C1183 A 108 ASN C 97 ASN~? 20.34 OXT ACT C1183 A 135 ASN C 94 ASN.? 20.53 OXT ACT C1183 coo 17.59 4.66 17.88 15.38 5.96 18.97 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 12.36 16.24 15.27 12.06 14.29 16.05 -66.13 16.32 22.33 -66.34 16.55 24.44 coo 18.05 11.56 12.71 17.57 10.75 14.60 -57.57 16.60 24.50 -56.01 17.74 25.39 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 10 3 # 10 A 51 TYR C 107 TYR~? -4.63 CH3 ACT C1183s A 108 ASN C 46 ASN~? 10.53 CA CA C1181 A 135 ASN C 109 ASN.? 14.51 CH3 ACT C1183 coo 17.59 4.66 17.88 15.38 5.96 18.97 -65.75 1.19 15.99 -63.10 1.53 15.19 coo 12.36 16.24 15.27 12.06 14.29 16.05 -74.04 -8.67 22.63 -75.10 -9.60 24.27 coo 18.05 11.56 12.71 17.57 10.75 14.60 -71.64 -2.74 19.53 -72.13 -3.21 21.54 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 11 3 # 11 A 51 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 108 ASN C 68 ASN~? 15.25 C2 GOL D1181 A 135 ASN C 63 ASN~? 14.81 O ACT C1183 coo 17.59 4.66 17.88 15.38 5.96 18.97 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 12.36 16.24 15.27 12.06 14.29 16.05 -53.02 -13.76 23.01 -51.11 -14.42 23.60 coo 18.05 11.56 12.71 17.57 10.75 14.60 -47.81 -6.22 21.11 -47.01 -7.28 19.44 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 12 3 # 12 A 51 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 108 ASN D 86 ASN.? 11.74 O ACT A1182 A 135 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo 17.59 4.66 17.88 15.38 5.96 18.97 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 12.36 16.24 15.27 12.06 14.29 16.05 -38.34 -8.19 13.90 -38.52 -10.20 14.65 coo 18.05 11.56 12.71 17.57 10.75 14.60 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 13 3 # 13 A 51 TYR D 107 TYR~? -4.59 CH3 ACT A1182s A 108 ASN D 46 ASN~? 18.62 CH3 ACT A1182 A 135 ASN D 109 ASN.? 14.36 CH3 ACT A1182 coo 17.59 4.66 17.88 15.38 5.96 18.97 -24.79 -2.98 13.13 -27.46 -2.42 12.49 coo 12.36 16.24 15.27 12.06 14.29 16.05 -16.96 -5.07 24.82 -15.16 -4.92 23.63 coo 18.05 11.56 12.71 17.57 10.75 14.60 -18.98 -4.62 18.28 -18.54 -6.24 19.59 1uy2_p00 source 1uy2 ENDO-1,4-BETA-XYLANASE A : 13 hits 1uy2_p00 naa= 3 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 108 ASN A 86 ASN.? 11.67 OXT ACT A1182 A 135 ASN A 63 ASN~? 15.00 O ACT A1182 coo 17.50 4.57 17.85 15.28 5.88 18.97 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 12.22 15.98 15.24 11.94 14.05 16.09 -38.42 8.17 12.63 -38.52 10.18 11.86 coo 17.94 11.43 12.65 17.42 10.61 14.53 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 64 TYR~? 13.66 OXT ACT A1181 A 108 ASN B 68 ASN~? 15.57 O ACT A1181 A 135 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo 17.50 4.57 17.85 15.28 5.88 18.97 -41.23 7.24 -1.52 -40.97 7.41 -4.31 coo 12.22 15.98 15.24 11.94 14.05 16.09 -53.02 13.76 3.43 -51.10 14.43 2.89 coo 17.94 11.43 12.65 17.42 10.61 14.53 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR A 107 TYR~? -4.55 CH3 ACT A1182s A 108 ASN A 46 ASN~? 20.18 CH3 ACT A1182 A 135 ASN A 109 ASN.? 14.39 CH3 ACT A1182 coo 17.50 4.57 17.85 15.28 5.88 18.97 -24.81 2.99 13.30 -27.48 2.42 13.94 coo 12.22 15.98 15.24 11.94 14.05 16.09 -16.92 5.08 1.56 -15.60 6.18 0.30 coo 17.94 11.43 12.65 17.42 10.61 14.53 -18.98 4.63 8.19 -18.49 6.24 6.88 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR B 64 TYR~? 13.94 OXT ACT A1181 A 108 ASN A 68 ASN~? 16.27 OXT ACT A1181 A 135 ASN A 63 ASN~? 15.00 O ACT A1182 coo 17.50 4.57 17.85 15.28 5.88 18.97 -49.49 10.87 0.95 -49.71 13.38 -0.30 coo 12.22 15.98 15.24 11.94 14.05 16.09 -37.69 3.73 -3.29 -39.63 4.05 -4.09 coo 17.94 11.43 12.65 17.42 10.61 14.53 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR B 91 TYR.? 11.41 O ACT C1183 A 108 ASN B 94 ASN.? 19.97 O ACT C1183 A 135 ASN B 120 ASN~? 16.46 O ACT C1183 coo 17.50 4.57 17.85 15.28 5.88 18.97 -54.93 -7.42 5.60 -53.90 -7.36 2.99 coo 12.22 15.98 15.24 11.94 14.05 16.09 -55.90 -18.81 5.77 -53.88 -19.30 6.35 coo 17.94 11.43 12.65 17.42 10.61 14.53 -53.48 -12.76 -0.52 -54.66 -11.58 0.79 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR B 107 TYR~? -4.64 CH3 ACT C1183s A 108 ASN B 46 ASN~? 10.46 CA CA B1181 A 135 ASN B 109 ASN.? 14.52 CH3 ACT C1183 coo 17.50 4.57 17.85 15.28 5.88 18.97 -65.76 -1.20 10.47 -63.11 -1.54 11.28 coo 12.22 15.98 15.24 11.94 14.05 16.09 -74.04 8.69 3.83 -75.20 9.76 2.34 coo 17.94 11.43 12.65 17.42 10.61 14.53 -71.64 2.73 6.90 -72.13 3.19 4.89 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 7 3 # 7 A 51 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 108 ASN C 86 ASN.? 11.54 OXT ACT C1183 A 135 ASN C 63 ASN~? 14.81 O ACT C1183 coo 17.50 4.57 17.85 15.28 5.88 18.97 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 12.22 15.98 15.24 11.94 14.05 16.09 -52.20 2.48 20.90 -52.01 2.64 23.02 coo 17.94 11.43 12.65 17.42 10.61 14.53 -47.81 -6.22 21.11 -47.01 -7.28 19.44 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 8 3 # 8 A 51 TYR C 64 TYR~? 13.24 O3 GOL D1181 A 108 ASN D 68 ASN~? 14.78 O3 GOL D1181 A 135 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo 17.50 4.57 17.85 15.28 5.88 18.97 -49.46 -10.91 25.49 -49.72 -13.40 26.79 coo 12.22 15.98 15.24 11.94 14.05 16.09 -37.72 -3.74 29.70 -39.65 -4.05 30.55 coo 17.94 11.43 12.65 17.42 10.61 14.53 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 9 3 # 9 A 51 TYR C 91 TYR.? 11.38 OXT ACT C1183 A 108 ASN C 97 ASN~? 20.34 OXT ACT C1183 A 135 ASN C 94 ASN.? 20.53 OXT ACT C1183 coo 17.50 4.57 17.85 15.28 5.88 18.97 -54.93 7.42 20.88 -53.88 7.33 23.48 coo 12.22 15.98 15.24 11.94 14.05 16.09 -66.13 16.32 22.33 -66.34 16.55 24.44 coo 17.94 11.43 12.65 17.42 10.61 14.53 -57.57 16.60 24.50 -56.01 17.74 25.39 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 10 3 # 10 A 51 TYR C 107 TYR~? -4.63 CH3 ACT C1183s A 108 ASN C 46 ASN~? 10.53 CA CA C1181 A 135 ASN C 109 ASN.? 14.51 CH3 ACT C1183 coo 17.50 4.57 17.85 15.28 5.88 18.97 -65.75 1.19 15.99 -63.10 1.53 15.19 coo 12.22 15.98 15.24 11.94 14.05 16.09 -74.04 -8.67 22.63 -75.10 -9.60 24.27 coo 17.94 11.43 12.65 17.42 10.61 14.53 -71.64 -2.74 19.53 -72.13 -3.21 21.54 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 11 3 # 11 A 51 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 108 ASN C 68 ASN~? 15.25 C2 GOL D1181 A 135 ASN C 63 ASN~? 14.81 O ACT C1183 coo 17.50 4.57 17.85 15.28 5.88 18.97 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 12.22 15.98 15.24 11.94 14.05 16.09 -53.02 -13.76 23.01 -51.11 -14.42 23.60 coo 17.94 11.43 12.65 17.42 10.61 14.53 -47.81 -6.22 21.11 -47.01 -7.28 19.44 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 12 3 # 12 A 51 TYR D 64 TYR~? 12.19 O3 GOL D1181 A 108 ASN D 86 ASN.? 11.74 O ACT A1182 A 135 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo 17.50 4.57 17.85 15.28 5.88 18.97 -41.23 -7.21 27.99 -40.99 -7.39 30.78 coo 12.22 15.98 15.24 11.94 14.05 16.09 -38.34 -8.19 13.90 -38.52 -10.20 14.65 coo 17.94 11.43 12.65 17.42 10.61 14.53 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 13 3 # 13 A 51 TYR D 107 TYR~? -4.59 CH3 ACT A1182s A 108 ASN D 46 ASN~? 18.62 CH3 ACT A1182 A 135 ASN D 109 ASN.? 14.36 CH3 ACT A1182 coo 17.50 4.57 17.85 15.28 5.88 18.97 -24.79 -2.98 13.13 -27.46 -2.42 12.49 coo 12.22 15.98 15.24 11.94 14.05 16.09 -16.96 -5.07 24.82 -15.16 -4.92 23.63 coo 17.94 11.43 12.65 17.42 10.61 14.53 -18.98 -4.62 18.28 -18.54 -6.24 19.59 1uy4_p00 source 1uy4 ENDO-1,4-BETA-XYLANASE A : 13 hits 1uy4_p00 naa= 3 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 1 3 # 1 A 44 ASN A 70 ASN~? 11.41 O ACT A1182 A 213 PRO A 71 PRO.? 16.51 O ACT A1182 A 219 ASN A 63 ASN~? 15.00 O ACT A1182 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -33.93 -2.05 0.89 -31.84 -1.69 1.12 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -36.18 -2.89 -4.28 -36.87 -2.69 -2.15 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -42.85 5.00 4.60 -43.72 3.09 4.23 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 2 3 # 2 A 44 ASN A 109 ASN.? 14.39 CH3 ACT A1182 A 213 PRO A 110 PRO^? 10.22 CH3 ACT A1182 A 219 ASN D 109 ASN.? 14.36 CH3 ACT A1182 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -18.98 4.63 8.19 -18.49 6.24 6.88 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -22.64 7.30 11.97 -22.53 6.46 9.88 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -18.98 -4.62 18.28 -18.54 -6.24 19.59 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 3 3 # 3 A 44 ASN B 70 ASN~? 11.40 OXT ACT C1183 A 213 PRO B 71 PRO.? 16.48 OXT ACT C1183 A 219 ASN B 63 ASN~? 14.86 OXT ACT C1183 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -56.88 12.21 10.31 -58.96 11.82 10.06 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -54.75 17.37 9.13 -53.97 15.34 9.74 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -47.83 6.22 5.31 -46.99 7.23 6.98 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 4 3 # 4 A 44 ASN B 109 ASN.? 14.52 CH3 ACT C1183 A 213 PRO B 110 PRO^? 10.25 CH3 ACT C1183 A 219 ASN C 109 ASN.? 14.51 CH3 ACT C1183 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -71.64 2.73 6.90 -72.13 3.19 4.89 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -67.97 -1.84 6.26 -68.06 0.42 5.97 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -71.64 -2.74 19.53 -72.13 -3.21 21.54 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 5 3 # 5 A 44 ASN C 70 ASN~? 11.43 O ACT C1183 A 213 PRO C 71 PRO.? 16.49 O ACT C1183 A 219 ASN B 94 ASN.? 19.97 O ACT C1183 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -56.89 -12.17 16.15 -58.98 -11.84 16.38 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -54.81 -17.35 17.42 -54.02 -15.34 16.73 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -55.90 -18.81 5.77 -53.88 -19.30 6.35 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 6 3 # 6 A 44 ASN C 70 ASN~? 11.43 O ACT C1183 A 213 PRO C 71 PRO.? 16.49 O ACT C1183 A 219 ASN C 63 ASN~? 14.81 O ACT C1183 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -56.89 -12.17 16.15 -58.98 -11.84 16.38 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -54.81 -17.35 17.42 -54.02 -15.34 16.73 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -47.81 -6.22 21.11 -47.01 -7.28 19.44 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 7 3 # 7 A 44 ASN C 109 ASN.? 14.51 CH3 ACT C1183 A 213 PRO C 110 PRO^? 10.26 CH3 ACT C1183 A 219 ASN B 109 ASN.? 14.52 CH3 ACT C1183 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -71.64 -2.74 19.53 -72.13 -3.21 21.54 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -67.97 1.82 20.25 -68.08 -0.45 20.47 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -71.64 2.73 6.90 -72.13 3.19 4.89 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 8 3 # 8 A 44 ASN D 70 ASN~? 11.36 OXT ACT A1182 A 213 PRO D 71 PRO.? 16.45 OXT ACT A1182 A 219 ASN A 94 ASN.? 20.31 OXT ACT A1182 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -33.95 2.02 25.56 -31.86 1.70 25.35 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -36.05 2.95 30.71 -36.86 2.69 28.65 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -34.68 14.84 26.15 -33.66 16.63 26.68 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 9 3 # 9 A 44 ASN D 70 ASN~? 11.36 OXT ACT A1182 A 213 PRO D 71 PRO.? 16.45 OXT ACT A1182 A 219 ASN D 63 ASN~? 14.84 OXT ACT A1182 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -33.95 2.02 25.56 -31.86 1.70 25.35 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -36.05 2.95 30.71 -36.86 2.69 28.65 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -42.87 -5.02 21.89 -43.66 -3.06 22.11 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 10 3 # 10 A 44 ASN D 109 ASN.? 14.36 CH3 ACT A1182 A 213 PRO D 110 PRO^? 10.21 CH3 ACT A1182 A 219 ASN A 109 ASN.? 14.39 CH3 ACT A1182 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 -18.98 -4.62 18.28 -18.54 -6.24 19.59 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 -22.64 -7.23 14.50 -22.56 -6.43 16.61 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 -18.98 4.63 8.19 -18.49 6.24 6.88 1wbf_p00 source 1wbf PROTEIN (AGGLUTININ) : 10 hits 1wbf_p00 naa= 3 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 30 ARG.? 15.23 O ACT A1181 A 188 TYR A 33 TYR~? 13.22 O ACT A1181 A 190 SER A 31 SER.? 13.84 O ACT A1181 coo 37.69 7.64 13.51 38.82 8.84 16.11 -29.59 28.63 -9.22 -30.43 28.64 -12.20 coo 47.14 12.10 13.73 48.75 12.33 16.01 -29.65 19.68 -6.55 -29.87 20.32 -9.24 coo 43.77 6.93 15.46 45.49 7.21 17.11 -28.88 24.94 -3.50 -30.71 23.40 -2.97 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG B 30 ARG.? -4.36 CA CA B1183s A 188 TYR B 33 TYR~? -4.73 C1 GOL B1182s A 190 SER B 31 SER~? 8.40 O1 GOL B1182 coo 37.69 7.64 13.51 38.82 8.84 16.11 -65.37 6.99 -20.70 -65.41 4.49 -18.90 coo 47.14 12.10 13.73 48.75 12.33 16.01 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 43.77 6.93 15.46 45.49 7.21 17.11 -64.40 11.60 -16.83 -66.74 12.27 -17.06 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG B 30 ARG.? -4.36 CA CA B1183s A 188 TYR B 33 TYR~? -4.73 C1 GOL B1182s A 190 SER B 32 SER~? 5.72 CA CA B1183 coo 37.69 7.64 13.51 38.82 8.84 16.11 -65.37 6.99 -20.70 -65.41 4.49 -18.90 coo 47.14 12.10 13.73 48.75 12.33 16.01 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 43.77 6.93 15.46 45.49 7.21 17.11 -65.53 8.28 -15.19 -66.24 6.55 -16.73 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG C 30 ARG.? 14.99 CA CA C1184 A 188 TYR C 33 TYR~? 11.20 CA CA C1184 A 190 SER C 31 SER.? 11.23 CA CA C1184 coo 37.69 7.64 13.51 38.82 8.84 16.11 -62.22 -10.49 50.42 -61.88 -13.41 51.37 coo 47.14 12.10 13.73 48.75 12.33 16.01 -61.66 -10.64 39.47 -61.26 -13.15 40.60 coo 43.77 6.93 15.46 45.49 7.21 17.11 -64.71 -10.73 43.80 -66.67 -12.16 44.05 ULMN 3 2p3i_p00 VP4 user 5 3 # 5 A 101 ARG D 30 ARG.? 11.01 CA CA C1182 A 188 TYR D 33 TYR~? 12.91 O3 GOL D1181 A 190 SER D 31 SER.? 13.74 O2 GOL D1181 coo 37.69 7.64 13.51 38.82 8.84 16.11 -29.54 -28.66 35.64 -30.45 -28.64 38.59 coo 47.14 12.10 13.73 48.75 12.33 16.01 -29.64 -19.70 33.03 -29.80 -20.31 35.72 coo 43.77 6.93 15.46 45.49 7.21 17.11 -28.89 -24.92 29.95 -30.70 -23.38 29.44 2p3i_p00 source 2p3i VP4 : 5 hits 2p3i_p00 naa= 3 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 1 3 # 1 A 459 ASN A 46 ASN~? 20.18 CH3 ACT A1182 A 460 GLY A 47 GLY.? 14.54 CH3 ACT A1182 A 461 ASN A 109 ASN.? 14.39 CH3 ACT A1182 coo 15.00 94.38 6.97 13.00 93.59 6.99 -16.92 5.08 1.56 -15.60 6.18 0.30 coo 19.48 94.04 5.03 19.26 94.00 5.78 -19.56 1.31 2.99 -19.68 2.11 3.04 coo 20.23 95.69 9.16 21.55 97.37 9.20 -18.98 4.63 8.19 -18.49 6.24 6.88 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 2 3 # 2 A 459 ASN A 46 ASN~? 20.18 CH3 ACT A1182 A 460 GLY A 48 GLY.? 12.55 CH3 ACT A1182 A 461 ASN A 109 ASN.? 14.39 CH3 ACT A1182 coo 15.00 94.38 6.97 13.00 93.59 6.99 -16.92 5.08 1.56 -15.60 6.18 0.30 coo 19.48 94.04 5.03 19.26 94.00 5.78 -21.38 4.08 4.86 -21.74 3.48 4.45 coo 20.23 95.69 9.16 21.55 97.37 9.20 -18.98 4.63 8.19 -18.49 6.24 6.88 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 3 3 # 3 A 459 ASN A 94 ASN.? 20.31 OXT ACT A1182 A 460 GLY A 122 GLY~? 17.38 OXT ACT A1182 A 461 ASN A 120 ASN~? 16.79 OXT ACT A1182 coo 15.00 94.38 6.97 13.00 93.59 6.99 -34.68 14.84 26.15 -33.66 16.63 26.68 coo 19.48 94.04 5.03 19.26 94.00 5.78 -31.93 16.98 20.49 -32.19 17.34 19.79 coo 20.23 95.69 9.16 21.55 97.37 9.20 -37.16 17.92 19.64 -35.92 16.19 19.48 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 4 3 # 4 A 459 ASN A 109 ASN.? 14.39 CH3 ACT A1182 A 460 GLY A 47 GLY.? 14.54 CH3 ACT A1182 A 461 ASN A 46 ASN~? 20.18 CH3 ACT A1182 coo 15.00 94.38 6.97 13.00 93.59 6.99 -18.98 4.63 8.19 -18.49 6.24 6.88 coo 19.48 94.04 5.03 19.26 94.00 5.78 -19.56 1.31 2.99 -19.68 2.11 3.04 coo 20.23 95.69 9.16 21.55 97.37 9.20 -16.92 5.08 1.56 -15.60 6.18 0.30 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 5 3 # 5 A 459 ASN A 109 ASN.? 14.39 CH3 ACT A1182 A 460 GLY A 48 GLY.? 12.55 CH3 ACT A1182 A 461 ASN A 46 ASN~? 20.18 CH3 ACT A1182 coo 15.00 94.38 6.97 13.00 93.59 6.99 -18.98 4.63 8.19 -18.49 6.24 6.88 coo 19.48 94.04 5.03 19.26 94.00 5.78 -21.38 4.08 4.86 -21.74 3.48 4.45 coo 20.23 95.69 9.16 21.55 97.37 9.20 -16.92 5.08 1.56 -15.60 6.18 0.30 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 6 3 # 6 A 459 ASN B 46 ASN~? 10.46 CA CA B1181 A 460 GLY B 47 GLY.? 13.54 CA CA B1181 A 461 ASN B 109 ASN.? 14.52 CH3 ACT C1183 coo 15.00 94.38 6.97 13.00 93.59 6.99 -74.04 8.69 3.83 -75.20 9.76 2.34 coo 19.48 94.04 5.03 19.26 94.00 5.78 -71.37 8.67 7.89 -71.19 8.33 7.17 coo 20.23 95.69 9.16 21.55 97.37 9.20 -71.64 2.73 6.90 -72.13 3.19 4.89 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 7 3 # 7 A 459 ASN B 46 ASN~? 10.46 CA CA B1181 A 460 GLY B 48 GLY.? 12.64 CH3 ACT C1183 A 461 ASN B 109 ASN.? 14.52 CH3 ACT C1183 coo 15.00 94.38 6.97 13.00 93.59 6.99 -74.04 8.69 3.83 -75.20 9.76 2.34 coo 19.48 94.04 5.03 19.26 94.00 5.78 -69.35 5.93 6.20 -69.01 6.58 6.53 coo 20.23 95.69 9.16 21.55 97.37 9.20 -71.64 2.73 6.90 -72.13 3.19 4.89 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 8 3 # 8 A 459 ASN B 109 ASN.? 14.52 CH3 ACT C1183 A 460 GLY B 47 GLY.? 13.54 CA CA B1181 A 461 ASN B 46 ASN~? 10.46 CA CA B1181 coo 15.00 94.38 6.97 13.00 93.59 6.99 -71.64 2.73 6.90 -72.13 3.19 4.89 coo 19.48 94.04 5.03 19.26 94.00 5.78 -71.37 8.67 7.89 -71.19 8.33 7.17 coo 20.23 95.69 9.16 21.55 97.37 9.20 -74.04 8.69 3.83 -75.20 9.76 2.34 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 9 3 # 9 A 459 ASN B 109 ASN.? 14.52 CH3 ACT C1183 A 460 GLY B 48 GLY.? 12.64 CH3 ACT C1183 A 461 ASN B 46 ASN~? 10.46 CA CA B1181 coo 15.00 94.38 6.97 13.00 93.59 6.99 -71.64 2.73 6.90 -72.13 3.19 4.89 coo 19.48 94.04 5.03 19.26 94.00 5.78 -69.35 5.93 6.20 -69.01 6.58 6.53 coo 20.23 95.69 9.16 21.55 97.37 9.20 -74.04 8.69 3.83 -75.20 9.76 2.34 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 10 3 # 10 A 459 ASN C 46 ASN~? 10.53 CA CA C1181 A 460 GLY C 47 GLY.? 13.62 CA CA C1181 A 461 ASN C 109 ASN.? 14.51 CH3 ACT C1183 coo 15.00 94.38 6.97 13.00 93.59 6.99 -74.04 -8.67 22.63 -75.10 -9.60 24.27 coo 19.48 94.04 5.03 19.26 94.00 5.78 -71.37 -8.66 18.59 -71.18 -8.34 19.31 coo 20.23 95.69 9.16 21.55 97.37 9.20 -71.64 -2.74 19.53 -72.13 -3.21 21.54 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 11 3 # 11 A 459 ASN C 46 ASN~? 10.53 CA CA C1181 A 460 GLY C 48 GLY.? 12.66 CH3 ACT C1183 A 461 ASN C 109 ASN.? 14.51 CH3 ACT C1183 coo 15.00 94.38 6.97 13.00 93.59 6.99 -74.04 -8.67 22.63 -75.10 -9.60 24.27 coo 19.48 94.04 5.03 19.26 94.00 5.78 -69.33 -5.95 20.30 -68.98 -6.61 19.95 coo 20.23 95.69 9.16 21.55 97.37 9.20 -71.64 -2.74 19.53 -72.13 -3.21 21.54 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 12 3 # 12 A 459 ASN C 94 ASN.? 20.53 OXT ACT C1183 A 460 GLY C 122 GLY~? 17.34 OXT ACT C1183 A 461 ASN C 120 ASN~? 16.45 OXT ACT C1183 coo 15.00 94.38 6.97 13.00 93.59 6.99 -57.57 16.60 24.50 -56.01 17.74 25.39 coo 19.48 94.04 5.03 19.26 94.00 5.78 -58.64 13.32 25.99 -58.38 12.82 26.62 coo 20.23 95.69 9.16 21.55 97.37 9.20 -53.50 12.76 27.01 -54.66 11.53 25.76 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 13 3 # 13 A 459 ASN C 109 ASN.? 14.51 CH3 ACT C1183 A 460 GLY C 47 GLY.? 13.62 CA CA C1181 A 461 ASN C 46 ASN~? 10.53 CA CA C1181 coo 15.00 94.38 6.97 13.00 93.59 6.99 -71.64 -2.74 19.53 -72.13 -3.21 21.54 coo 19.48 94.04 5.03 19.26 94.00 5.78 -71.37 -8.66 18.59 -71.18 -8.34 19.31 coo 20.23 95.69 9.16 21.55 97.37 9.20 -74.04 -8.67 22.63 -75.10 -9.60 24.27 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 14 3 # 14 A 459 ASN C 109 ASN.? 14.51 CH3 ACT C1183 A 460 GLY C 48 GLY.? 12.66 CH3 ACT C1183 A 461 ASN C 46 ASN~? 10.53 CA CA C1181 coo 15.00 94.38 6.97 13.00 93.59 6.99 -71.64 -2.74 19.53 -72.13 -3.21 21.54 coo 19.48 94.04 5.03 19.26 94.00 5.78 -69.33 -5.95 20.30 -68.98 -6.61 19.95 coo 20.23 95.69 9.16 21.55 97.37 9.20 -74.04 -8.67 22.63 -75.10 -9.60 24.27 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 15 3 # 15 A 459 ASN C 120 ASN~? 16.45 OXT ACT C1183 A 460 GLY C 122 GLY~? 17.34 OXT ACT C1183 A 461 ASN C 94 ASN.? 20.53 OXT ACT C1183 coo 15.00 94.38 6.97 13.00 93.59 6.99 -53.50 12.76 27.01 -54.66 11.53 25.76 coo 19.48 94.04 5.03 19.26 94.00 5.78 -58.64 13.32 25.99 -58.38 12.82 26.62 coo 20.23 95.69 9.16 21.55 97.37 9.20 -57.57 16.60 24.50 -56.01 17.74 25.39 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 16 3 # 16 A 459 ASN D 46 ASN~? 18.62 CH3 ACT A1182 A 460 GLY D 47 GLY.? 14.54 CH3 ACT A1182 A 461 ASN D 109 ASN.? 14.36 CH3 ACT A1182 coo 15.00 94.38 6.97 13.00 93.59 6.99 -16.96 -5.07 24.82 -15.16 -4.92 23.63 coo 19.48 94.04 5.03 19.26 94.00 5.78 -19.61 -1.27 23.53 -19.70 -2.10 23.45 coo 20.23 95.69 9.16 21.55 97.37 9.20 -18.98 -4.62 18.28 -18.54 -6.24 19.59 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 17 3 # 17 A 459 ASN D 46 ASN~? 18.62 CH3 ACT A1182 A 460 GLY D 48 GLY.? 12.54 CH3 ACT A1182 A 461 ASN D 109 ASN.? 14.36 CH3 ACT A1182 coo 15.00 94.38 6.97 13.00 93.59 6.99 -16.96 -5.07 24.82 -15.16 -4.92 23.63 coo 19.48 94.04 5.03 19.26 94.00 5.78 -21.37 -4.03 21.60 -21.75 -3.45 22.02 coo 20.23 95.69 9.16 21.55 97.37 9.20 -18.98 -4.62 18.28 -18.54 -6.24 19.59 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 18 3 # 18 A 459 ASN D 109 ASN.? 14.36 CH3 ACT A1182 A 460 GLY D 47 GLY.? 14.54 CH3 ACT A1182 A 461 ASN D 46 ASN~? 18.62 CH3 ACT A1182 coo 15.00 94.38 6.97 13.00 93.59 6.99 -18.98 -4.62 18.28 -18.54 -6.24 19.59 coo 19.48 94.04 5.03 19.26 94.00 5.78 -19.61 -1.27 23.53 -19.70 -2.10 23.45 coo 20.23 95.69 9.16 21.55 97.37 9.20 -16.96 -5.07 24.82 -15.16 -4.92 23.63 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 19 3 # 19 A 459 ASN D 109 ASN.? 14.36 CH3 ACT A1182 A 460 GLY D 48 GLY.? 12.54 CH3 ACT A1182 A 461 ASN D 46 ASN~? 18.62 CH3 ACT A1182 coo 15.00 94.38 6.97 13.00 93.59 6.99 -18.98 -4.62 18.28 -18.54 -6.24 19.59 coo 19.48 94.04 5.03 19.26 94.00 5.78 -21.37 -4.03 21.60 -21.75 -3.45 22.02 coo 20.23 95.69 9.16 21.55 97.37 9.20 -16.96 -5.07 24.82 -15.16 -4.92 23.63 2qv4_p00 source 2qv4 PANCREATIC ALPHA-AMYLASE : 19 hits 2qv4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 3 ASN^? 12.04 CA CA B1181 A 384 ASN B 68 ASN~? 15.57 O ACT A1181 A 385 GLU B 167 GLU~? 15.72 O ACT A1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -72.70 21.43 -11.05 -73.07 19.35 -11.09 coo 7.06 50.07 96.17 8.50 48.54 96.31 -53.02 13.76 3.43 -51.10 14.43 2.89 coo 11.59 49.83 99.41 10.92 47.97 100.16 -56.85 16.74 -0.78 -55.11 17.01 0.42 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 63 ASN~? 15.00 O ACT A1182 A 384 ASN B 168 ASN~? 15.62 CH3 ACT A1181 A 385 GLU B 167 GLU~? 15.72 O ACT A1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -42.85 5.00 4.60 -43.72 3.09 4.23 coo 7.06 50.07 96.17 8.50 48.54 96.31 -59.27 19.54 -3.77 -57.59 20.58 -3.04 coo 11.59 49.83 99.41 10.92 47.97 100.16 -56.85 16.74 -0.78 -55.11 17.01 0.42 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 86 ASN.? 11.67 OXT ACT A1182 A 384 ASN A 168 ASN~? 15.32 OXT ACT A1181 A 385 GLU A 167 GLU~? 17.93 OXT ACT A1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -38.42 8.17 12.63 -38.52 10.18 11.86 coo 7.06 50.07 96.17 8.50 48.54 96.31 -31.58 8.23 -11.56 -33.27 7.25 -12.34 coo 11.59 49.83 99.41 10.92 47.97 100.16 -32.78 4.71 -6.52 -34.47 3.65 -5.83 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN A 94 ASN.? 20.31 OXT ACT A1182 A 384 ASN C 94 ASN.? 20.53 OXT ACT C1183 A 385 GLU C 121 GLU~? 20.76 CA CA C1184 coo 22.28 63.17 110.61 22.47 65.06 111.53 -34.68 14.84 26.15 -33.66 16.63 26.68 coo 7.06 50.07 96.17 8.50 48.54 96.31 -57.57 16.60 24.50 -56.01 17.74 25.39 coo 11.59 49.83 99.41 10.92 47.97 100.16 -56.38 16.29 30.73 -57.04 15.33 32.51 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN A 109 ASN.? 14.39 CH3 ACT A1182 A 384 ASN A 168 ASN~? 15.32 OXT ACT A1181 A 385 GLU A 167 GLU~? 17.93 OXT ACT A1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -18.98 4.63 8.19 -18.49 6.24 6.88 coo 7.06 50.07 96.17 8.50 48.54 96.31 -31.58 8.23 -11.56 -33.27 7.25 -12.34 coo 11.59 49.83 99.41 10.92 47.97 100.16 -32.78 4.71 -6.52 -34.47 3.65 -5.83 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN B 3 ASN^? 25.47 OXT ACT A1181 A 384 ASN A 68 ASN~? 16.27 OXT ACT A1181 A 385 GLU A 167 GLU~? 17.93 OXT ACT A1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -18.33 14.30 -16.20 -18.26 15.53 -14.45 coo 7.06 50.07 96.17 8.50 48.54 96.31 -37.69 3.73 -3.29 -39.63 4.05 -4.09 coo 11.59 49.83 99.41 10.92 47.97 100.16 -32.78 4.71 -6.52 -34.47 3.65 -5.83 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN B 63 ASN~? 14.86 OXT ACT C1183 A 384 ASN A 168 ASN~? 15.32 OXT ACT A1181 A 385 GLU A 167 GLU~? 17.93 OXT ACT A1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -47.83 6.22 5.31 -46.99 7.23 6.98 coo 7.06 50.07 96.17 8.50 48.54 96.31 -31.58 8.23 -11.56 -33.27 7.25 -12.34 coo 11.59 49.83 99.41 10.92 47.97 100.16 -32.78 4.71 -6.52 -34.47 3.65 -5.83 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN B 86 ASN.? 11.57 O ACT C1183 A 384 ASN B 168 ASN~? 15.62 CH3 ACT A1181 A 385 GLU B 167 GLU~? 15.72 O ACT A1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -52.20 -2.48 5.54 -51.99 -2.60 3.42 coo 7.06 50.07 96.17 8.50 48.54 96.31 -59.27 19.54 -3.77 -57.59 20.58 -3.04 coo 11.59 49.83 99.41 10.92 47.97 100.16 -56.85 16.74 -0.78 -55.11 17.01 0.42 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 9 3 # 9 A 270 ASN B 94 ASN.? 19.97 O ACT C1183 A 384 ASN C 168 ASN~? 14.78 C1 GOL D1181 A 385 GLU C 167 GLU~? 15.18 C1 GOL D1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -55.90 -18.81 5.77 -53.88 -19.30 6.35 coo 7.06 50.07 96.17 8.50 48.54 96.31 -59.24 -19.55 30.22 -57.56 -20.59 29.47 coo 11.59 49.83 99.41 10.92 47.97 100.16 -56.84 -16.73 27.22 -55.09 -16.98 26.08 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 10 3 # 10 A 270 ASN B 109 ASN.? 14.52 CH3 ACT C1183 A 384 ASN B 168 ASN~? 15.62 CH3 ACT A1181 A 385 GLU B 167 GLU~? 15.72 O ACT A1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -71.64 2.73 6.90 -72.13 3.19 4.89 coo 7.06 50.07 96.17 8.50 48.54 96.31 -59.27 19.54 -3.77 -57.59 20.58 -3.04 coo 11.59 49.83 99.41 10.92 47.97 100.16 -56.85 16.74 -0.78 -55.11 17.01 0.42 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 11 3 # 11 A 270 ASN C 3 ASN^? 20.98 CA CA C1182 A 384 ASN D 68 ASN~? 14.78 O3 GOL D1181 A 385 GLU D 167 GLU~? 14.12 O3 GOL D1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -18.27 -14.28 42.59 -18.15 -15.35 40.76 coo 7.06 50.07 96.17 8.50 48.54 96.31 -37.72 -3.74 29.70 -39.65 -4.05 30.55 coo 11.59 49.83 99.41 10.92 47.97 100.16 -33.98 -6.43 34.19 -35.73 -5.26 33.93 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 12 3 # 12 A 270 ASN C 63 ASN~? 14.81 O ACT C1183 A 384 ASN D 168 ASN~? 14.11 O3 GOL D1181 A 385 GLU D 167 GLU~? 14.12 O3 GOL D1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -47.81 -6.22 21.11 -47.01 -7.28 19.44 coo 7.06 50.07 96.17 8.50 48.54 96.31 -31.58 -8.23 38.03 -33.25 -7.24 38.84 coo 11.59 49.83 99.41 10.92 47.97 100.16 -33.98 -6.43 34.19 -35.73 -5.26 33.93 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 13 3 # 13 A 270 ASN C 86 ASN.? 11.54 OXT ACT C1183 A 384 ASN C 168 ASN~? 14.78 C1 GOL D1181 A 385 GLU C 167 GLU~? 15.18 C1 GOL D1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -52.20 2.48 20.90 -52.01 2.64 23.02 coo 7.06 50.07 96.17 8.50 48.54 96.31 -59.24 -19.55 30.22 -57.56 -20.59 29.47 coo 11.59 49.83 99.41 10.92 47.97 100.16 -56.84 -16.73 27.22 -55.09 -16.98 26.08 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 14 3 # 14 A 270 ASN C 109 ASN.? 14.51 CH3 ACT C1183 A 384 ASN C 168 ASN~? 14.78 C1 GOL D1181 A 385 GLU C 167 GLU~? 15.18 C1 GOL D1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -71.64 -2.74 19.53 -72.13 -3.21 21.54 coo 7.06 50.07 96.17 8.50 48.54 96.31 -59.24 -19.55 30.22 -57.56 -20.59 29.47 coo 11.59 49.83 99.41 10.92 47.97 100.16 -56.84 -16.73 27.22 -55.09 -16.98 26.08 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 15 3 # 15 A 270 ASN D 3 ASN~? 12.07 CA CA C1181 A 384 ASN C 68 ASN~? 15.25 C2 GOL D1181 A 385 GLU C 167 GLU~? 15.18 C1 GOL D1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -72.61 -21.52 37.54 -72.85 -19.41 37.73 coo 7.06 50.07 96.17 8.50 48.54 96.31 -53.02 -13.76 23.01 -51.11 -14.42 23.60 coo 11.59 49.83 99.41 10.92 47.97 100.16 -56.84 -16.73 27.22 -55.09 -16.98 26.08 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 16 3 # 16 A 270 ASN D 63 ASN~? 14.84 OXT ACT A1182 A 384 ASN C 168 ASN~? 14.78 C1 GOL D1181 A 385 GLU C 167 GLU~? 15.18 C1 GOL D1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -42.87 -5.02 21.89 -43.66 -3.06 22.11 coo 7.06 50.07 96.17 8.50 48.54 96.31 -59.24 -19.55 30.22 -57.56 -20.59 29.47 coo 11.59 49.83 99.41 10.92 47.97 100.16 -56.84 -16.73 27.22 -55.09 -16.98 26.08 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 17 3 # 17 A 270 ASN D 86 ASN.? 11.74 O ACT A1182 A 384 ASN D 168 ASN~? 14.11 O3 GOL D1181 A 385 GLU D 167 GLU~? 14.12 O3 GOL D1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -38.34 -8.19 13.90 -38.52 -10.20 14.65 coo 7.06 50.07 96.17 8.50 48.54 96.31 -31.58 -8.23 38.03 -33.25 -7.24 38.84 coo 11.59 49.83 99.41 10.92 47.97 100.16 -33.98 -6.43 34.19 -35.73 -5.26 33.93 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 18 3 # 18 A 270 ASN D 109 ASN.? 14.36 CH3 ACT A1182 A 384 ASN D 168 ASN~? 14.11 O3 GOL D1181 A 385 GLU D 167 GLU~? 14.12 O3 GOL D1181 coo 22.28 63.17 110.61 22.47 65.06 111.53 -18.98 -4.62 18.28 -18.54 -6.24 19.59 coo 7.06 50.07 96.17 8.50 48.54 96.31 -31.58 -8.23 38.03 -33.25 -7.24 38.84 coo 11.59 49.83 99.41 10.92 47.97 100.16 -33.98 -6.43 34.19 -35.73 -5.26 33.93 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 18 hits 2v3r_p00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR B 175 TYR~? 10.51 CA CA B1181 I 306 VAL B 173 VAL~? 5.77 CA CA B1181 I 308 VAL B 178 VAL^? 7.85 CA CA B1181 coo 26.18 35.24 6.87 24.33 35.18 8.97 -65.36 23.11 4.03 -63.61 22.29 6.06 coo 23.55 29.53 9.81 23.15 27.39 10.24 -68.41 19.35 -0.98 -69.08 17.31 -1.74 coo 16.43 30.18 9.35 15.05 30.67 11.01 -69.98 22.73 -4.63 -68.10 21.76 -5.26 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR C 175 TYR~? 10.79 CA CA C1181 I 306 VAL C 173 VAL~? 5.89 CA CA C1181 I 308 VAL C 178 VAL.? 7.90 CA CA C1181 coo 26.18 35.24 6.87 24.33 35.18 8.97 -65.38 -23.09 22.41 -63.58 -22.29 20.40 coo 23.55 29.53 9.81 23.15 27.39 10.24 -68.43 -19.34 27.44 -69.06 -17.29 28.23 coo 16.43 30.18 9.35 15.05 30.67 11.01 -69.98 -22.72 31.09 -68.09 -21.77 31.79 1cqt_d00 source 1cqt GENE REGULATION/DNA : 2 hits 1cqt_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG B 13 ARG~? 17.43 OXT ACT A1181 C 71 LYS B 9 LYS~? 18.37 O ACT A1181 C 72 VAL B 12 VAL~? 11.34 OXT ACT A1181 coo 23.89 33.54 29.21 26.59 34.86 28.68 -32.45 21.03 -20.61 -29.60 19.86 -21.02 coo 25.82 26.89 29.68 23.33 22.98 25.84 -27.67 18.71 -15.51 -26.70 22.99 -17.12 coo 28.86 29.08 30.37 28.04 31.02 29.93 -32.64 17.14 -14.35 -32.11 18.38 -12.61 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG C -1 ARG.? 22.70 CA CA C1182 C 71 LYS C 2 LYS^? 15.05 CA CA C1182 C 72 VAL D 178 VAL^? 21.47 CA CA C1182 coo 23.89 33.54 29.21 26.59 34.86 28.68 -23.32 -3.70 47.99 -26.29 -3.39 47.24 coo 25.82 26.89 29.68 23.33 22.98 25.84 -20.31 -10.65 45.10 -24.59 -14.66 46.53 coo 28.86 29.08 30.37 28.04 31.02 29.93 -21.39 -7.86 41.14 -22.96 -9.33 40.54 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG C -1 ARG.? 22.70 CA CA C1182 C 71 LYS D 177 LYS.? 22.56 O3 GOL D1181 C 72 VAL D 178 VAL^? 21.47 CA CA C1182 coo 23.89 33.54 29.21 26.59 34.86 28.68 -23.32 -3.70 47.99 -26.29 -3.39 47.24 coo 25.82 26.89 29.68 23.33 22.98 25.84 -22.65 -4.76 42.92 -27.69 -1.89 42.71 coo 28.86 29.08 30.37 28.04 31.02 29.93 -21.39 -7.86 41.14 -22.96 -9.33 40.54 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 4 3 # 4 C 70 ARG C 13 ARG~? 8.07 CA CA C1182 C 71 LYS C 9 LYS~? 14.61 CA CA C1182 C 72 VAL C 12 VAL~? 9.37 CA CA C1182 coo 23.89 33.54 29.21 26.59 34.86 28.68 -32.51 -20.88 47.20 -29.56 -20.08 47.23 coo 25.82 26.89 29.68 23.33 22.98 25.84 -27.74 -18.74 41.99 -22.99 -22.90 41.19 coo 28.86 29.08 30.37 28.04 31.02 29.93 -32.65 -17.13 40.83 -32.11 -18.43 39.13 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 5 3 # 5 C 70 ARG D 13 ARG~? 18.52 O1 GOL D1181 C 71 LYS D 9 LYS~? 18.78 CA CA C1184 C 72 VAL D 12 VAL~? 14.32 C1 GOL D1181 coo 23.89 33.54 29.21 26.59 34.86 28.68 -58.59 -23.71 45.22 -61.26 -24.52 43.91 coo 25.82 26.89 29.68 23.33 22.98 25.84 -63.24 -19.53 41.29 -64.69 -19.90 45.47 coo 28.86 29.08 30.37 28.04 31.02 29.93 -58.25 -19.00 39.51 -58.79 -16.93 40.00 1hwt_d00 source 1hwt GENE REGULATION/DNA : 5 hits 1hwt_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG B 30 ARG.? -4.36 CA CA B1183s E 41 TYR B 33 TYR~? -4.73 C1 GOL B1182s E 83 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -65.37 6.99 -20.70 -65.41 4.49 -18.90 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -61.61 10.66 -12.93 -61.26 13.14 -14.14 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -43.20 -16.00 21.95 -43.92 -18.81 20.94 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 1 hits 1id3_d00 naa= 3 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 35 LYS~? 23.91 O ACT A1181 D 25 THR A 40 THR~? 17.59 CH3 ACT A1182 D 27 SER A 133 SER^? 18.22 CH3 ACT A1182 coo 86.60 33.38 44.00 87.05 39.52 42.71 -22.68 18.18 -4.70 -20.35 22.35 -1.14 coo 81.20 31.58 48.03 79.23 32.24 47.54 -23.93 10.90 -0.33 -25.94 11.33 0.34 coo 79.09 29.82 54.20 77.17 28.90 53.05 -25.30 14.53 6.77 -25.42 16.79 7.63 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS B 35 LYS~? 11.04 CA CA B1183 D 25 THR B 40 THR~? 13.23 O2 GOL B1182 D 27 SER B 133 SER^? 12.08 CA CA B1183 coo 86.60 33.38 44.00 87.05 39.52 42.71 -68.46 9.78 -10.58 -72.55 6.75 -11.95 coo 81.20 31.58 48.03 79.23 32.24 47.54 -66.85 8.08 -2.24 -64.82 7.37 -2.52 coo 79.09 29.82 54.20 77.17 28.90 53.05 -65.35 0.26 -2.64 -65.36 -1.24 -4.55 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 3 3 # 3 D 23 LYS C 35 LYS~? 10.20 CA CA C1184 D 25 THR C 40 THR~? 15.04 CA CA C1184 D 27 SER C 133 SER^? 12.04 CA CA C1184 coo 86.60 33.38 44.00 87.05 39.52 42.71 -68.45 -9.84 37.00 -72.38 -5.53 38.73 coo 81.20 31.58 48.03 79.23 32.24 47.54 -66.85 -8.05 28.72 -64.85 -7.34 28.99 coo 79.09 29.82 54.20 77.17 28.90 53.05 -65.34 -0.23 29.09 -65.38 1.19 31.06 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 4 3 # 4 D 23 LYS D 35 LYS~? 23.81 O2 GOL D1181 D 25 THR D 40 THR~? 17.62 CH3 ACT A1182 D 27 SER D 133 SER^? 18.24 CH3 ACT A1182 coo 86.60 33.38 44.00 87.05 39.52 42.71 -22.65 -18.16 31.19 -20.45 -22.10 27.38 coo 81.20 31.58 48.03 79.23 32.24 47.54 -23.95 -10.93 26.82 -25.97 -11.31 26.17 coo 79.09 29.82 54.20 77.17 28.90 53.05 -25.30 -14.52 19.70 -25.48 -16.79 18.86 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 4 hits 1mjo_d00 naa= 3 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS B 9 LYS~? 18.37 O ACT A1181 A 564 VAL B 12 VAL~? 11.34 OXT ACT A1181 A 568 ARG B 13 ARG~? 17.43 OXT ACT A1181 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -27.67 18.71 -15.51 -26.70 22.99 -17.12 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -32.64 17.14 -14.35 -32.11 18.38 -12.61 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -32.45 21.03 -20.61 -29.60 19.86 -21.02 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 563 LYS C 9 LYS~? 14.61 CA CA C1182 A 564 VAL C 12 VAL~? 9.37 CA CA C1182 A 568 ARG C 13 ARG~? 8.07 CA CA C1182 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -27.74 -18.74 41.99 -22.99 -22.90 41.19 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -32.65 -17.13 40.83 -32.11 -18.43 39.13 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -32.51 -20.88 47.20 -29.56 -20.08 47.23 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 2 hits 1r4i_d00 naa= 3 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 93 LYS.? 11.72 OXT ACT A1182 A1294 ASN A 120 ASN~? 16.79 OXT ACT A1182 A1297 GLU A 119 GLU.? 19.75 OXT ACT A1182 coo 39.24 18.84-161.99 36.62 21.47-165.99 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 33.53 17.37-161.81 34.31 17.81-163.76 -37.16 17.92 19.64 -35.92 16.19 19.48 coo 29.78 23.31-161.30 31.23 23.66-162.84 -40.83 18.78 13.92 -42.39 17.53 13.21 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS A 93 LYS.? 11.72 OXT ACT A1182 A1294 ASN A 120 ASN~? 16.79 OXT ACT A1182 A1297 GLU A 121 GLU~? 23.87 OXT ACT A1182 coo 39.24 18.84-161.99 36.62 21.47-165.99 -36.14 12.80 22.42 -38.75 8.18 20.02 coo 33.53 17.37-161.81 34.31 17.81-163.76 -37.16 17.92 19.64 -35.92 16.19 19.48 coo 29.78 23.31-161.30 31.23 23.66-162.84 -33.98 22.68 21.15 -32.78 23.95 19.94 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS A 124 LYS~? 24.92 OXT ACT A1182 A1294 ASN A 120 ASN~? 16.79 OXT ACT A1182 A1297 GLU A 119 GLU.? 19.75 OXT ACT A1182 coo 39.24 18.84-161.99 36.62 21.47-165.99 -30.92 19.75 15.99 -32.39 25.70 15.74 coo 33.53 17.37-161.81 34.31 17.81-163.76 -37.16 17.92 19.64 -35.92 16.19 19.48 coo 29.78 23.31-161.30 31.23 23.66-162.84 -40.83 18.78 13.92 -42.39 17.53 13.21 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 4 3 # 4 A1290 LYS B 93 LYS.? 14.57 O ACT C1183 A1294 ASN B 120 ASN~? 16.46 O ACT C1183 A1297 GLU B 119 GLU.? 18.74 O3 GOL B1182 coo 39.24 18.84-161.99 36.62 21.47-165.99 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 33.53 17.37-161.81 34.31 17.81-163.76 -53.48 -12.76 -0.52 -54.66 -11.58 0.79 coo 29.78 23.31-161.30 31.23 23.66-162.84 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 5 3 # 5 A1290 LYS B 93 LYS.? 14.57 O ACT C1183 A1294 ASN B 120 ASN~? 16.46 O ACT C1183 A1297 GLU B 121 GLU~? 20.57 CA CA B1183 coo 39.24 18.84-161.99 36.62 21.47-165.99 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 33.53 17.37-161.81 34.31 17.81-163.76 -53.48 -12.76 -0.52 -54.66 -11.58 0.79 coo 29.78 23.31-161.30 31.23 23.66-162.84 -56.51 -16.27 -4.35 -57.29 -15.23 -6.03 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 6 3 # 6 A1290 LYS B 124 LYS~? 15.51 CA CA B1183 A1294 ASN B 120 ASN~? 16.46 O ACT C1183 A1297 GLU B 119 GLU.? 18.74 O3 GOL B1182 coo 39.24 18.84-161.99 36.62 21.47-165.99 -59.47 -10.21 -3.79 -60.04 -11.72 -8.85 coo 33.53 17.37-161.81 34.31 17.81-163.76 -53.48 -12.76 -0.52 -54.66 -11.58 0.79 coo 29.78 23.31-161.30 31.23 23.66-162.84 -49.69 -7.93 -3.61 -48.19 -6.64 -2.78 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 7 3 # 7 A1290 LYS C 93 LYS.? 19.61 OXT ACT C1183 A1294 ASN C 94 ASN.? 20.53 OXT ACT C1183 A1297 GLU C 121 GLU~? 20.76 CA CA C1184 coo 39.24 18.84-161.99 36.62 21.47-165.99 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 33.53 17.37-161.81 34.31 17.81-163.76 -57.57 16.60 24.50 -56.01 17.74 25.39 coo 29.78 23.31-161.30 31.23 23.66-162.84 -56.38 16.29 30.73 -57.04 15.33 32.51 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 8 3 # 8 A1290 LYS C 93 LYS.? 19.61 OXT ACT C1183 A1294 ASN C 120 ASN~? 16.45 OXT ACT C1183 A1297 GLU C 119 GLU.? 19.60 OXT ACT C1183 coo 39.24 18.84-161.99 36.62 21.47-165.99 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 33.53 17.37-161.81 34.31 17.81-163.76 -53.50 12.76 27.01 -54.66 11.53 25.76 coo 29.78 23.31-161.30 31.23 23.66-162.84 -49.67 7.91 30.13 -48.14 6.69 29.28 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 9 3 # 9 A1290 LYS C 93 LYS.? 19.61 OXT ACT C1183 A1294 ASN C 120 ASN~? 16.45 OXT ACT C1183 A1297 GLU C 121 GLU~? 20.76 CA CA C1184 coo 39.24 18.84-161.99 36.62 21.47-165.99 -54.93 14.23 21.55 -53.38 19.08 19.32 coo 33.53 17.37-161.81 34.31 17.81-163.76 -53.50 12.76 27.01 -54.66 11.53 25.76 coo 29.78 23.31-161.30 31.23 23.66-162.84 -56.38 16.29 30.73 -57.04 15.33 32.51 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 10 3 # 10 A1290 LYS C 124 LYS~? 15.99 CA CA C1184 A1294 ASN C 120 ASN~? 16.45 OXT ACT C1183 A1297 GLU C 119 GLU.? 19.60 OXT ACT C1183 coo 39.24 18.84-161.99 36.62 21.47-165.99 -59.48 10.16 30.27 -60.09 12.26 35.28 coo 33.53 17.37-161.81 34.31 17.81-163.76 -53.50 12.76 27.01 -54.66 11.53 25.76 coo 29.78 23.31-161.30 31.23 23.66-162.84 -49.67 7.91 30.13 -48.14 6.69 29.28 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 11 3 # 11 A1290 LYS D 93 LYS.? 12.21 O ACT A1182 A1294 ASN D 120 ASN~? 16.83 O ACT A1182 A1297 GLU D 119 GLU.? 19.65 O ACT A1182 coo 39.24 18.84-161.99 36.62 21.47-165.99 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 33.53 17.37-161.81 34.31 17.81-163.76 -37.12 -17.90 6.86 -35.82 -16.19 6.99 coo 29.78 23.31-161.30 31.23 23.66-162.84 -40.78 -18.80 12.54 -42.26 -17.44 13.18 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 12 3 # 12 A1290 LYS D 93 LYS.? 12.21 O ACT A1182 A1294 ASN D 120 ASN~? 16.83 O ACT A1182 A1297 GLU D 121 GLU~? 23.78 O ACT A1182 coo 39.24 18.84-161.99 36.62 21.47-165.99 -36.07 -12.96 3.87 -39.26 -8.07 6.08 coo 33.53 17.37-161.81 34.31 17.81-163.76 -37.12 -17.90 6.86 -35.82 -16.19 6.99 coo 29.78 23.31-161.30 31.23 23.66-162.84 -33.90 -22.59 5.14 -32.85 -23.80 6.52 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 13 3 # 13 A1290 LYS D 124 LYS~? 24.78 O ACT A1182 A1294 ASN D 120 ASN~? 16.83 O ACT A1182 A1297 GLU D 119 GLU.? 19.65 O ACT A1182 coo 39.24 18.84-161.99 36.62 21.47-165.99 -30.92 -19.78 10.48 -31.91 -25.53 10.85 coo 33.53 17.37-161.81 34.31 17.81-163.76 -37.12 -17.90 6.86 -35.82 -16.19 6.99 coo 29.78 23.31-161.30 31.23 23.66-162.84 -40.78 -18.80 12.54 -42.26 -17.44 13.18 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 13 hits 1xpx_d00 naa= 3 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 53 SER^? 12.21 OXT ACT A1182 E 5 VAL A 115 VAL^? 15.97 O ACT A1181 E 7 ARG A 58 ARG~? 14.46 O ACT A1181 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -35.29 10.69 9.61 -33.77 12.39 10.51 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -36.13 15.59 5.61 -36.83 14.64 3.78 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -43.27 15.99 4.53 -43.95 18.83 5.47 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER B 53 SER^? 12.05 O ACT C1183 E 5 VAL B 115 VAL^? 11.10 O3 GOL B1182 E 7 ARG B 58 ARG~? 12.97 O3 GOL B1182 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -55.28 -0.85 2.05 -56.85 -2.35 0.91 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -54.47 1.00 -3.95 -53.73 3.06 -3.76 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -47.41 1.88 -4.86 -46.76 -0.16 -7.06 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER D 53 SER^? 12.18 O ACT A1182 E 5 VAL D 115 VAL^? 15.36 O3 GOL D1181 E 7 ARG D 58 ARG~? 14.52 O2 GOL D1181 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -35.31 -10.69 16.86 -33.78 -12.33 15.90 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -36.13 -15.57 20.89 -36.85 -14.63 22.69 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -43.20 -16.00 21.95 -43.92 -18.81 20.94 2bsq_d00 source 2bsq TRANSCRIPTION : 3 hits 2bsq_d00 naa= 3 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG C 77 ARG.? 17.10 CA CA C1181 A 50 LYS B 93 LYS.? 14.57 O ACT C1183 A 51 ASN B 94 ASN.? 19.97 O ACT C1183 coo 28.68 23.77 42.74 27.76 26.72 42.93 -57.96 -19.37 18.15 -57.76 -17.78 20.77 coo 14.40 30.33 40.28 14.25 28.31 45.36 -54.77 -14.10 4.84 -51.86 -13.62 10.10 coo 19.09 30.55 41.51 19.09 28.89 42.82 -55.90 -18.81 5.77 -53.88 -19.30 6.35 2hos_d00 source 2hos TRANSCRIPTION/DNA : 1 hits 2hos_d00 naa= 3 ULMN 4 2p0j_d00 HYDROLASE/DNA user 1 4 # 1 A 46 GLU B 17 GLU~? -13.09 CH3 ACT A1181s A 133 LYS A 158 LYS~? -4.64 O ACT A1181s A 134 TYR A 157 TYR~? 5.66 OXT ACT A1181 A 172 SER A 23 SER~? -5.63 CH3 ACT A1181s coo 29.36 7.53 2.81 27.47 7.30 3.73 -38.08 19.88 -20.29 -36.49 20.35 -21.57 coo 20.43 15.67 9.20 23.49 12.62 10.53 -40.67 17.71 -5.46 -41.24 24.02 -6.17 coo 18.60 12.45 12.36 19.78 10.10 11.41 -46.22 16.76 -7.11 -49.01 16.68 -7.45 coo 23.78 7.59 5.40 26.01 7.14 6.26 -42.07 21.42 -13.85 -42.41 21.34 -16.27 ULMN 4 2p0j_d00 HYDROLASE/DNA user 2 4 # 2 A 46 GLU B 29 GLU~? -3.75 O1 GOL B1182s A 133 LYS B 35 LYS~? 11.04 CA CA B1183 A 134 TYR A 5 TYR~? 13.40 O1 GOL B1182 A 172 SER B 31 SER~? 8.40 O1 GOL B1182 coo 29.36 7.53 2.81 27.47 7.30 3.73 -57.44 9.91 -17.53 -57.08 7.94 -18.23 coo 20.43 15.67 9.20 23.49 12.62 10.53 -68.46 9.78 -10.58 -72.55 6.75 -11.95 coo 18.60 12.45 12.36 19.78 10.10 11.41 -70.28 15.77 -12.22 -70.83 13.52 -10.65 coo 23.78 7.59 5.40 26.01 7.14 6.26 -64.40 11.60 -16.83 -66.74 12.27 -17.06 ULMN 4 2p0j_d00 HYDROLASE/DNA user 3 4 # 3 A 46 GLU C 17 GLU~? 3.68 CA CA C1182s A 133 LYS D 158 LYS~? -4.46 O2 GOL D1181s A 134 TYR D 157 TYR~? -5.31 C1 GOL D1181s A 172 SER D 23 SER~? -5.37 O1 GOL D1181s coo 29.36 7.53 2.81 27.47 7.30 3.73 -38.10 -19.90 46.72 -36.47 -20.40 47.99 coo 20.43 15.67 9.20 23.49 12.62 10.53 -40.69 -17.70 31.92 -41.11 -24.00 32.63 coo 18.60 12.45 12.36 19.78 10.10 11.41 -46.23 -16.78 33.55 -49.03 -16.71 33.91 coo 23.78 7.59 5.40 26.01 7.14 6.26 -42.08 -21.40 40.30 -42.34 -21.31 42.73 2p0j_d00 source 2p0j HYDROLASE/DNA : 3 hits 2p0j_d00 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 42 SER~? 22.64 CH3 ACT A1182 B 37 ASN A 46 ASN~? 20.18 CH3 ACT A1182 B 45 THR D 102 THR~? 11.03 O ACT A1182 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -19.46 8.46 -2.16 -18.17 10.05 -3.40 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -16.92 5.08 1.56 -15.60 6.18 0.30 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -24.39 -5.56 5.17 -25.97 -4.66 3.97 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 49 SER^? 7.92 CH3 ACT A1182 B 37 ASN A 109 ASN.? 14.39 CH3 ACT A1182 B 45 THR A 102 THR~? 11.01 OXT ACT A1182 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -24.82 3.72 6.45 -24.44 3.87 8.86 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -18.98 4.63 8.19 -18.49 6.24 6.88 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -24.41 5.58 21.31 -25.97 4.66 22.51 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER A 67 SER~? 15.83 O ACT A1182 B 37 ASN A 68 ASN~? 16.27 OXT ACT A1181 B 45 THR A 40 THR~? 17.59 CH3 ACT A1182 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -39.02 0.91 0.50 -41.06 2.13 -0.03 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -37.69 3.73 -3.29 -39.63 4.05 -4.09 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -23.93 10.90 -0.33 -25.94 11.33 0.34 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER B 42 SER~? 9.53 CA CA B1181 B 37 ASN B 46 ASN~? 10.46 CA CA B1181 B 45 THR C 102 THR~? 11.11 OXT ACT C1183 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -71.32 10.68 -0.61 -72.48 11.28 -2.66 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -74.04 8.69 3.83 -75.20 9.76 2.34 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -66.13 9.63 15.26 -64.66 10.40 13.87 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER B 49 SER^? 8.06 CH3 ACT C1183 B 37 ASN B 109 ASN.? 14.52 CH3 ACT C1183 B 45 THR B 102 THR~? 11.18 CH3 ACT C1183 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -65.82 4.78 7.06 -66.17 2.51 7.90 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -71.64 2.73 6.90 -72.13 3.19 4.89 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -66.17 -9.62 11.24 -64.70 -10.41 12.61 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER B 67 SER~? 15.74 OXT ACT C1183 B 37 ASN B 68 ASN~? 15.57 O ACT A1181 B 45 THR B 40 THR~? 13.23 O2 GOL B1182 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -51.74 11.42 7.51 -49.69 11.53 6.21 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -53.02 13.76 3.43 -51.10 14.43 2.89 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -66.85 8.08 -2.24 -64.82 7.37 -2.52 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 B 34 SER B 67 SER~? 15.74 OXT ACT C1183 B 37 ASN B 70 ASN~? 11.40 OXT ACT C1183 B 45 THR C 106 THR~? 6.77 CH3 ACT C1183 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -51.74 11.42 7.51 -49.69 11.53 6.21 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -56.88 12.21 10.31 -58.96 11.82 10.06 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -67.58 4.27 12.99 -65.51 4.70 12.57 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 B 34 SER C 42 SER~? 9.40 CA CA C1181 B 37 ASN C 46 ASN~? 10.53 CA CA C1181 B 45 THR B 102 THR~? 11.18 CH3 ACT C1183 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -71.30 -10.68 27.08 -72.47 -11.31 29.07 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -74.04 -8.67 22.63 -75.10 -9.60 24.27 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -66.17 -9.62 11.24 -64.70 -10.41 12.61 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 B 34 SER C 49 SER^? 8.04 CH3 ACT C1183 B 37 ASN C 109 ASN.? 14.51 CH3 ACT C1183 B 45 THR C 102 THR~? 11.11 OXT ACT C1183 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -65.83 -4.76 19.39 -66.15 -2.47 18.58 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -71.64 -2.74 19.53 -72.13 -3.21 21.54 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -66.13 9.63 15.26 -64.66 10.40 13.87 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 10 3 # 10 B 34 SER C 67 SER~? 15.70 O ACT C1183 B 37 ASN C 68 ASN~? 15.25 C2 GOL D1181 B 45 THR C 40 THR~? 15.04 CA CA C1184 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -51.74 -11.42 18.94 -49.72 -11.51 20.26 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -53.02 -13.76 23.01 -51.11 -14.42 23.60 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -66.85 -8.05 28.72 -64.85 -7.34 28.99 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 11 3 # 11 B 34 SER C 67 SER~? 15.70 O ACT C1183 B 37 ASN C 70 ASN~? 11.43 O ACT C1183 B 45 THR B 106 THR~? 6.80 CH3 ACT C1183 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -51.74 -11.42 18.94 -49.72 -11.51 20.26 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -56.89 -12.17 16.15 -58.98 -11.84 16.38 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -67.60 -4.27 13.49 -65.53 -4.72 13.89 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 12 3 # 12 B 34 SER D 42 SER~? 22.67 CH3 ACT A1182 B 37 ASN D 46 ASN~? 18.62 CH3 ACT A1182 B 45 THR A 102 THR~? 11.01 OXT ACT A1182 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -19.49 -8.50 28.63 -18.22 -10.13 29.88 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -16.96 -5.07 24.82 -15.16 -4.92 23.63 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -24.41 5.58 21.31 -25.97 4.66 22.51 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 13 3 # 13 B 34 SER D 49 SER^? 7.93 CH3 ACT A1182 B 37 ASN D 109 ASN.? 14.36 CH3 ACT A1182 B 45 THR D 102 THR~? 11.03 O ACT A1182 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -24.82 -3.74 20.02 -24.43 -3.84 17.62 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -18.98 -4.62 18.28 -18.54 -6.24 19.59 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -24.39 -5.56 5.17 -25.97 -4.66 3.97 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 14 3 # 14 B 34 SER D 67 SER~? 15.83 OXT ACT A1182 B 37 ASN D 68 ASN~? 14.78 O3 GOL D1181 B 45 THR D 40 THR~? 17.62 CH3 ACT A1182 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -39.02 -0.93 25.94 -41.07 -2.17 26.53 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -37.72 -3.74 29.70 -39.65 -4.05 30.55 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -23.95 -10.93 26.82 -25.97 -11.31 26.17 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 14 hits 2z3x_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 133 SER^? 18.22 CH3 ACT A1182 A 20 HIS A 43 HIS~? 14.01 CH3 ACT A1182 A 22 LEU A 45 LEU~? 20.56 CH3 ACT A1182 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -25.30 14.53 6.77 -25.42 16.79 7.63 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -21.65 8.05 3.64 -22.04 7.30 5.57 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -19.05 4.33 -3.11 -20.15 4.65 -4.98 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER A 133 SER^? 18.22 CH3 ACT A1182 A 20 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 22 LEU A 62 LEU~? 11.91 OXT ACT A1182 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -25.30 14.53 6.77 -25.42 16.79 7.63 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -39.55 8.38 6.71 -38.08 7.45 8.12 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 18 SER A 133 SER^? 18.22 CH3 ACT A1182 A 20 HIS A 114 HIS^? 15.94 OXT ACT A1182 A 22 LEU A 123 LEU~? 14.88 OXT ACT A1182 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -25.30 14.53 6.77 -25.42 16.79 7.63 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -33.97 15.61 9.27 -35.78 16.19 10.17 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -33.56 16.12 15.97 -33.69 15.04 14.07 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 18 SER B 133 SER^? 12.08 CA CA B1183 A 20 HIS B 43 HIS~? 14.15 CH3 ACT C1183 A 22 LEU B 45 LEU~? 6.36 CA CA B1181 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -65.35 0.26 -2.64 -65.36 -1.24 -4.55 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -68.93 5.59 2.00 -68.67 4.03 3.39 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -71.79 13.10 2.71 -72.25 15.18 2.44 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 18 SER B 133 SER^? 12.08 CA CA B1183 A 20 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 22 LEU B 62 LEU~? 11.69 O ACT C1183 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -65.35 0.26 -2.64 -65.36 -1.24 -4.55 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -56.53 -2.49 -2.49 -54.69 -3.47 -2.77 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -51.17 2.84 3.08 -52.53 1.95 4.64 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 18 SER B 133 SER^? 12.08 CA CA B1183 A 20 HIS B 114 HIS^? 14.73 O2 GOL B1182 A 22 LEU B 123 LEU~? 14.76 O ACT C1183